<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36227638</PMID><DateRevised><Year>2022</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>13</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>Coronary Artery Computed Tomography Angiography for Preventing Cardio-Cerebrovascular Disease: Observational Cohort Study Using the Observational Health Data Sciences and Informatics' Common Data Model.</ArticleTitle><Pagination><StartPage>e41503</StartPage><MedlinePgn>e41503</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e41503</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/41503</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cardio-cerebrovascular diseases (CVDs) result in 17.5 million deaths annually worldwide, accounting for 46.2% of noncommunicable causes of death, and are the leading cause of death, followed by cancer, respiratory disease, and diabetes mellitus. Coronary artery computed tomography angiography (CCTA), which detects calcification in the coronary arteries, can be used to detect asymptomatic but serious vascular disease. It allows for noninvasive and quick testing despite involving radiation exposure.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The objective of our study was to investigate the effectiveness of CCTA screening on CVD outcomes by using the Observational Health Data Sciences and Informatics' Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM) data and the population-level estimation method.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using electronic health record-based OMOP-CDM data, including health questionnaire responses, adults (aged 30-74 years) without a history of CVD were selected, and 5-year CVD outcomes were compared between patients undergoing CCTA (target group) and a comparison group via 1:1 propensity score matching. Participants were stratified into low-risk and high-risk groups based on the American College of Cardiology/American Heart Association atherosclerotic cardiovascular disease (ASCVD) risk score and Framingham risk score (FRS) for subgroup analyses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The 2-year and 5-year risk scores were compared as secondary outcomes between the two groups. In total, 8787 participants were included in both the target group and comparison group. No significant differences (calibration P=.37) were found between the hazard ratios of the groups at 5 years. The subgroup analysis also revealed no significant differences between the ASCVD risk scores and FRSs of the groups at 5 years (ASCVD risk score: P=.97; FRS: P=.85). However, the CCTA group showed a significantly lower increase in risk scores at 2 years (ASCVD risk score: P=.03; FRS: P=.02).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although we could not confirm a significant difference in the preventive effects of CCTA screening for CVDs over a long period of 5 years, it may have a beneficial effect on risk score management over 2 years.</AbstractText><CopyrightInformation>&#xa9;Woo Kyung Bae, Jihoon Cho, Seok Kim, Borham Kim, Hyunyoung Baek, Wongeun Song, Sooyoung Yoo. Originally published in JMIR Medical Informatics (https://medinform.jmir.org), 13.10.2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Bae</LastName><ForeName>Woo Kyung</ForeName><Initials>WK</Initials><Identifier Source="ORCID">0000-0001-6729-4128</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Health Promotion Center, Seoul National University Bundang Hospital, Republic of Korea, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Cho</LastName><ForeName>Jihoon</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0568-9380</Identifier><AffiliationInfo><Affiliation>Healthcare Information and Communication Technology Research Center, Office of eHealth Research and Business, Seoul National University Bundang Hospital, Republic of Korea, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seok</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4996-8613</Identifier><AffiliationInfo><Affiliation>Healthcare Information and Communication Technology Research Center, Office of eHealth Research and Business, Seoul National University Bundang Hospital, Republic of Korea, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Borham</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6914-5721</Identifier><AffiliationInfo><Affiliation>Healthcare Information and Communication Technology Research Center, Office of eHealth Research and Business, Seoul National University Bundang Hospital, Republic of Korea, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baek</LastName><ForeName>Hyunyoung</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0810-9396</Identifier><AffiliationInfo><Affiliation>Healthcare Information and Communication Technology Research Center, Office of eHealth Research and Business, Seoul National University Bundang Hospital, Republic of Korea, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Wongeun</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-4314-3995</Identifier><AffiliationInfo><Affiliation>Healthcare Information and Communication Technology Research Center, Office of eHealth Research and Business, Seoul National University Bundang Hospital, Republic of Korea, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Sooyoung</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8620-4925</Identifier><AffiliationInfo><Affiliation>Healthcare Information and Communication Technology Research Center, Office of eHealth Research and Business, Seoul National University Bundang Hospital, Republic of Korea, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">angiography</Keyword><Keyword MajorTopicYN="N">cardiology</Keyword><Keyword MajorTopicYN="N">cardiovascular diseases</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">computed tomography</Keyword><Keyword MajorTopicYN="N">coronary artery computed tomography angiography</Keyword><Keyword MajorTopicYN="N">data modeling</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">health data science</Keyword><Keyword MajorTopicYN="N">medical informatics</Keyword><Keyword MajorTopicYN="N">observational study</Keyword><Keyword MajorTopicYN="N">population level estimation</Keyword><Keyword MajorTopicYN="N">risk score</Keyword><Keyword MajorTopicYN="N">vascular disease</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>13</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36227638</ArticleId><ArticleId IdType="pmc">PMC9614618</ArticleId><ArticleId IdType="doi">10.2196/41503</ArticleId><ArticleId IdType="pii">v10i10e41503</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  Global status report on noncommunicable diseases 2014. World Helath Organization. 2014.  [2022-09-28].  
 https://apps.who.int/iris/bitstream/handle/10665/148114/9789241564854_eng.pdf;jsessionid=81554E9296D494A6A458F32FE22DA357?sequence=1
.</Citation></Reference><Reference><Citation>Gal R, van Velzen SGM, Hooning MJ, Emaus MJ, van der Leij F, Gregorowitsch ML, Blezer ELA, Gernaat SAM, Lessmann N, Sattler MGA, Leiner T, de Jong PA, Teske AJ, Verloop J, Penninkhof JJ, Vaartjes I, Meijer H, van Tol-Geerdink JJ, Pignol JP, van den Bongard DHJG, I&#x161;gum I, Verkooijen HM. Identification of risk of cardiovascular disease by automatic quantification of coronary artery calcifications on radiotherapy planning CT scans in patients With breast cancer. JAMA Oncol. 2021 Jul 01;7(7):1024&#x2013;1032. doi: 10.1001/jamaoncol.2021.1144. 
 
2779524</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2021.1144</ArticleId><ArticleId IdType="pmc">PMC8283560</ArticleId><ArticleId IdType="pubmed">33956083</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh R, Patel A, Lu B, Senapati A, Mahmarian J, Chang SM. Cardiac computed tomography for comprehensive coronary assessment: Beyond diagnosis of anatomic stenosis. Methodist Debakey Cardiovasc J. 2020;16(2):77&#x2013;85. doi: 10.14797/mdcj-16-2-77. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.14797/mdcj-16-2-77</ArticleId><ArticleId IdType="pmc">PMC7350823</ArticleId><ArticleId IdType="pubmed">32670467</ArticleId></ArticleIdList></Reference><Reference><Citation>Marano R, Rovere G, Savino G, Flammia FC, Carafa MRP, Steri L, Merlino B, Natale L. CCTA in the diagnosis of coronary artery disease. Radiol Med. 2020 Nov;125(11):1102&#x2013;1113. doi: 10.1007/s11547-020-01283-y.10.1007/s11547-020-01283-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11547-020-01283-y</ArticleId><ArticleId IdType="pubmed">32964325</ArticleId></ArticleIdList></Reference><Reference><Citation>Emaus MJ, I&#x161;gum I, van Velzen SGM, van den Bongard HJGD, Gernaat SAM, Lessmann N, Sattler MGA, Teske AJ, Penninkhof J, Meijer H, Pignol J, Verkooijen HM, Bragatston study group  Bragatston study protocol: a multicentre cohort study on automated quantification of cardiovascular calcifications on radiotherapy planning CT scans for cardiovascular risk prediction in patients with breast cancer. BMJ Open. 2019 Jul 27;9(7):e028752. doi: 10.1136/bmjopen-2018-028752. 
 
bmjopen-2018-028752</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-028752</ArticleId><ArticleId IdType="pmc">PMC6661654</ArticleId><ArticleId IdType="pubmed">31352417</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60. doi: 10.1136/amiajnl-2011-000376. 
 
amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn C, Kim J, Bae W. The framingham risk score, diet, and inflammatory markers in Korean men with metabolic syndrome. Nutr Res Pract. 2012 Jun;6(3):246&#x2013;253. doi: 10.4162/nrp.2012.6.3.246. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.4162/nrp.2012.6.3.246</ArticleId><ArticleId IdType="pmc">PMC3395791</ArticleId><ArticleId IdType="pubmed">22808350</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshi B, van den Berge JC, van Dijk B, Deckers JW, Ikram MA, Kavousi M. Implications of the ACC/AHA risk score for prediction of heart failure: the Rotterdam Study. BMC Med. 2021 Feb 16;19(1):43. doi: 10.1186/s12916-021-01916-7. 
 
10.1186/s12916-021-01916-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-01916-7</ArticleId><ArticleId IdType="doi">10.1186/s12916-021-01916-7</ArticleId><ArticleId IdType="pmc">PMC7885616</ArticleId><ArticleId IdType="pubmed">33588853</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie M, Suchard M, Ryan P. New-user cohort method with large scale propensity and outcome models. CohortMethod.  [2022-09-28].  
 https://ohdsi.github.io/CohortMethod/
</Citation></Reference><Reference><Citation>R: The R Project for statistical computing. R Foundation for Statistical Computing.  [2022-09-28].  
 https://www.r-project.org/
</Citation></Reference><Reference><Citation>Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983 Apr;70(1):41&#x2013;55. doi: 10.1093/biomet/70.1.41. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/70.1.41</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, Reich CG, Duke J, Madigan D, Hripcsak G, Ryan PB. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019 Nov 16;394(10211):1816&#x2013;1826. doi: 10.1016/S0140-6736(19)32317-7. 
 
S0140-6736(19)32317-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med. 2014 Jan 30;33(2):209&#x2013;218. doi: 10.1002/sim.5925. doi: 10.1002/sim.5925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5925</ArticleId><ArticleId IdType="doi">10.1002/sim.5925</ArticleId><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):2571&#x2013;2577. doi: 10.1073/pnas.1708282114. 
 
1708282114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708282114</ArticleId><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Cho J, Shin DW, Lee SP, Hwang SS, Oh J, Yang HK, Hwang SH, Son KY, Chun SH, Cho B, Guallar E. Association of cardiovascular health screening with mortality, clinical outcomes, and health care cost: a nationwide cohort study. Prev Med. 2015 Jan;70:19&#x2013;25. doi: 10.1016/j.ypmed.2014.11.007.S0091-7435(14)00418-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2014.11.007</ArticleId><ArticleId IdType="pubmed">25445334</ArticleId></ArticleIdList></Reference><Reference><Citation>Son KY, Lee CM, Cho B, Lym YL, Oh SW, Chung W, Lee JS, Park D, Kim HS. Effect of additional brief counselling after periodic health examination on motivation for health behavior change [corrected] J Korean Med Sci. 2012 Nov;27(11):1285&#x2013;1291. doi: 10.3346/jkms.2012.27.11.1285. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2012.27.11.1285</ArticleId><ArticleId IdType="pmc">PMC3492660</ArticleId><ArticleId IdType="pubmed">23166407</ArticleId></ArticleIdList></Reference><Reference><Citation>Son KY, Shin DW, Yang HK, Yun JM, Chun SH, Lee JK, Cho BL. Effect of one-time brief additional counseling on periodic health examination for 40- and 66-year-olds: 2-Year follow up of 101 260 participants. Geriatr Gerontol Int. 2018 Feb;18(2):329&#x2013;337. doi: 10.1111/ggi.13175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ggi.13175</ArticleId><ArticleId IdType="pubmed">29044867</ArticleId></ArticleIdList></Reference><Reference><Citation>Engberg M, Christensen B, Karlsmose B, Lous J, Lauritzen T. General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. J Fam Pract. 2002 Jun;51(6):546&#x2013;552.jfp_0602_00546</Citation><ArticleIdList><ArticleId IdType="pubmed">12100779</ArticleId></ArticleIdList></Reference><Reference><Citation>McCambridge J, Strang J. Deterioration over time in effect of motivational interviewing in reducing drug consumption and related risk among young people. Addiction. 2005 Apr;100(4):470&#x2013;478. doi: 10.1111/j.1360-0443.2005.01013.x.ADD1013</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1360-0443.2005.01013.x</ArticleId><ArticleId IdType="pubmed">15784061</ArticleId></ArticleIdList></Reference><Reference><Citation>Cropsey K, Eldridge G, Weaver M, Villalobos G, Stitzer M, Best A. Smoking cessation intervention for female prisoners: addressing an urgent public health need. Am J Public Health. 2008 Oct;98(10):1894&#x2013;1901. doi: 10.2105/AJPH.2007.128207.AJPH.2007.128207</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2007.128207</ArticleId><ArticleId IdType="pmc">PMC2636452</ArticleId><ArticleId IdType="pubmed">18703440</ArticleId></ArticleIdList></Reference><Reference><Citation>Hersh WR, Weiner MG, Embi PJ, Logan JR, Payne PRO, Bernstam EV, Lehmann HP, Hripcsak G, Hartzog TH, Cimino TJ, Saltz JH. Caveats for the use of operational electronic health record data in comparative effectiveness research. Med Care. 2013 Aug;51(8 Suppl 3):S30&#x2013;S37. doi: 10.1097/MLR.0b013e31829b1dbd. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31829b1dbd</ArticleId><ArticleId IdType="pmc">PMC3748381</ArticleId><ArticleId IdType="pubmed">23774517</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstein RB, Ryan P, Berlin JA, Matcho A, Schuemie M, Swerdel J, Patel K, Fife D. Channeling in the use of nonprescription paracetamol and ibuprofen in an electronic medical records database: Evidence and implications. Drug Saf. 2017 Dec;40(12):1279&#x2013;1292. doi: 10.1007/s40264-017-0581-7.10.1007/s40264-017-0581-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-017-0581-7</ArticleId><ArticleId IdType="pmc">PMC5688206</ArticleId><ArticleId IdType="pubmed">28780741</ArticleId></ArticleIdList></Reference><Reference><Citation>Waugh N, Black C, Walker S, McIntyre L, Cummins E, Hillis G. The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: systematic review. Health Technol Assess. 2006 Oct;10(39):iii&#x2013;iv, ix-x. doi: 10.3310/hta10390. doi: 10.3310/hta10390.04-45-01</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta10390</ArticleId><ArticleId IdType="doi">10.3310/hta10390</ArticleId><ArticleId IdType="pubmed">17018228</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondos GT, Hoff JA, Sevrukov A, Daviglus ML, Garside DB, Devries SS, Chomka EV, Liu K. Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults. Circulation. 2003 May 27;107(20):2571&#x2013;2576. doi: 10.1161/01.CIR.0000068341.61180.55.01.CIR.0000068341.61180.55</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000068341.61180.55</ArticleId><ArticleId IdType="pubmed">12743005</ArticleId></ArticleIdList></Reference><Reference><Citation>Naghavi M, Maron DJ, Kloner RA, Berman DS, Budoff M, Superko HR, Shah PK. Coronary artery calcium testing: A call for universal coverage. Prev Med Rep. 2019 Sep 02;15:100879. doi: 10.1016/j.pmedr.2019.100879. 
 
S2211-3355(19)30059-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmedr.2019.100879</ArticleId><ArticleId IdType="pmc">PMC6525277</ArticleId><ArticleId IdType="pubmed">31193256</ArticleId></ArticleIdList></Reference><Reference><Citation>McEvoy JW, Blaha MJ, Nasir K, Yoon YE, Choi EK, Cho IS, Chun EJ, Choi SI, Rivera JJ, Blumenthal RS, Chang HJ. Impact of coronary computed tomographic angiography results on patient and physician behavior in a low-risk population. Arch Intern Med. 2011 Jul 25;171(14):1260&#x2013;1268. doi: 10.1001/archinternmed.2011.204.archinternmed.2011.204</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2011.204</ArticleId><ArticleId IdType="pubmed">21606093</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36233137</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>19</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>05</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>OMOP CDM Can Facilitate Data-Driven Studies for Cancer Prediction: A Systematic Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">11834</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms231911834</ELocationID><Abstract><AbstractText>The current generation of sequencing technologies has led to significant advances in identifying novel disease-associated mutations and generated large amounts of data in a high-throughput manner. Such data in conjunction with clinical routine data are proven to be highly useful in deriving population-level and patient-level predictions, especially in the field of cancer precision medicine. However, data harmonization across multiple national and international clinical sites is an essential step for the assessment of events and outcomes associated with patients, which is currently not adequately addressed. The Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) is an internationally established research data repository introduced by the Observational Health Data Science and Informatics (OHDSI) community to overcome this issue. To address the needs of cancer research, the genomic vocabulary extension was introduced in 2020 to support the standardization of subsequent data analysis. In this review, we evaluate the current potential of the OMOP CDM to be applicable in cancer prediction and how comprehensively the genomic vocabulary extension of the OMOP can serve current needs of AI-based predictions. For this, we systematically screened the literature for articles that use the OMOP CDM in predictive analyses in cancer and investigated the underlying predictive models/tools. Interestingly, we found 248 articles, of which most use the OMOP for harmonizing their data, but only 5 make use of predictive algorithms on OMOP-based data and fulfill our criteria. The studies present multicentric investigations, in which the OMOP played an essential role in discovering and optimizing machine learning (ML)-based models. Ultimately, the use of the OMOP CDM leads to standardized data-driven studies for multiple clinical sites and enables a more solid basis utilizing, e.g., ML models that can be reused and combined in early prediction, diagnosis, and improvement of personalized cancer care and biomarker discovery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmadi</LastName><ForeName>Najia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-9769-5109</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Fetscherstra&#xdf;e 74, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Fetscherstra&#xdf;e 74, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolfien</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1887-4772</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Fetscherstra&#xdf;e 74, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoch</LastName><ForeName>Mich&#xe9;le</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5577-7760</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Fetscherstra&#xdf;e 74, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9888-8460</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Fetscherstra&#xdf;e 74, 01307 Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FKZ: 01lZZ180L (Dresden)</GrantID><Agency>German Federal Ministry of Education and Research (BMBF) within the Medical Informatics Initiative; MIRACUM Consortium</Agency><Country/></Grant><Grant><GrantID>FKZ: ZMI1-2520DAT02C</GrantID><Agency>Federal Ministry of Health (BMG)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078332" MajorTopicYN="N">Data Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EHR</Keyword><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">PLP</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">prediction</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>2</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36233137</ArticleId><ArticleId IdType="pmc">PMC9569469</ArticleId><ArticleId IdType="doi">10.3390/ijms231911834</ArticleId><ArticleId IdType="pii">ijms231911834</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Felmeister A.S., Waanders A.J., Leary S.E.S., Stevens J., Mason J.L., Teneralli R., Hu X., Bailey L.C. Preliminary exploratory data analysis of simulated national clinical data research network for future use in annotation of a rare tumor biobanking initiative; Proceedings of the 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM); Kansas City, MO, USA. 13&#x2013;16 November 2017; Kansas City, MO, USA: IEEE; 2017. pp. 2098&#x2013;2104.</Citation></Reference><Reference><Citation>Briganti G., Le Moine O. Artificial Intelligence in Medicine: Today and Tomorrow. Front. Med. 2020;7:27. doi: 10.3389/fmed.2020.00027.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00027</ArticleId><ArticleId IdType="pmc">PMC7012990</ArticleId><ArticleId IdType="pubmed">32118012</ArticleId></ArticleIdList></Reference><Reference><Citation>Belenkaya R., Gurley M.J., Golozar A., Dymshyts D., Miller R.T., Williams A.E., Ratwani S., Siapos A., Korsik V., Warner J., et al. Extending the OMOP Common Data Model and Standardized Vocabularies to Support Observational Cancer Research. JCO Clin. Cancer Inform. 2021;5:12&#x2013;20. doi: 10.1200/CCI.20.00079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.20.00079</ArticleId><ArticleId IdType="pmc">PMC8140810</ArticleId><ArticleId IdType="pubmed">33411620</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., Duke J.D., Shah N.H., Reich C.G., Huser V., Schuemie M.J., Suchard M.A., Park R.W., Wong I.C.K., Rijnbeek P.R., et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud. Health Technol. Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M., Del Fiol G., Tenenbaum J., Walden A., Zozus M.N. Evaluating common data models for use with a longitudinal community registry. J. Biomed. Inform. 2016;64:333&#x2013;341. doi: 10.1016/j.jbi.2016.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>ICD.  [(accessed on 30 June 2022)].  Available online:  https://www.dimdi.de/dynamic/de/klassifikationen/icd/</Citation></Reference><Reference><Citation>Millar J. The Need for a Global Language-SNOMED CT Introduction. Stud. Health Technol. Inform. 2016;225:683&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pubmed">27332304</ArticleId></ArticleIdList></Reference><Reference><Citation>RxNorm.  [(accessed on 30 June 2022)]; Available online:  https://www.nlm.nih.gov/research/umls/rxnorm/index.html.</Citation></Reference><Reference><Citation>Athena.  [(accessed on 30 June 2022)].  Available online:  https://athena.ohdsi.org/search-terms/start.</Citation></Reference><Reference><Citation>Voss E.A., Makadia R., Matcho A., Ma Q., Knoll C., Schuemie M., DeFalco F.J., Londhe A., Zhu V., Ryan P.B. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J. Am. Med. Inform. Assoc. 2015;22:553&#x2013;564. doi: 10.1093/jamia/ocu023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Unberath P., Prokosch H.U., Gr&#xfc;ndner J., Erpenbeck M., Maier C., Christoph J. EHR-Independent Predictive Decision Support Architecture Based on OMOP. Appl. Clin. Inform. 2020;11:399&#x2013;404. doi: 10.1055/s-0040-1710393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1710393</ArticleId><ArticleId IdType="pmc">PMC7269719</ArticleId><ArticleId IdType="pubmed">32492716</ArticleId></ArticleIdList></Reference><Reference><Citation>Povey S., Lovering R., Bruford E., Wright M., Lush M., Wain H. The HUGO Gene Nomenclature Committee (HGNC) Hum. Genet. 2001;109:678&#x2013;680. doi: 10.1007/s00439-001-0615-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-001-0615-0</ArticleId><ArticleId IdType="pubmed">11810281</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin S.J., You S.C., Park Y.R., Roh J., Kim J.-H., Haam S., Reich C.G., Blacketer C., Son D.-S., Oh S., et al. Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective Study. J. Med. Internet Res. 2019;21:e13249. doi: 10.2196/13249.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/13249</ArticleId><ArticleId IdType="pmc">PMC6454347</ArticleId><ArticleId IdType="pubmed">30912749</ArticleId></ArticleIdList></Reference><Reference><Citation>ATLAS&#x2013;A unified interface for the OHDSI tools&#x2013;OHDSI.  [(accessed on 7 July 2022)].  Available online:  https://www.ohdsi.org/atlas-a-unified-interface-for-the-ohdsi-tools/</Citation></Reference><Reference><Citation>Reps J.M., Schuemie M.J., Suchard M.A., Ryan P.B., Rijnbeek P.R. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J. Am. Med. Inform. Assoc. 2018;25:969&#x2013;975. doi: 10.1093/jamia/ocy032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Rijnbeek P., Reps J.  The Book of OHDSI. 2021.  [(accessed on 7 July 2022)]. Chapter 13 Patient-Level Prediction. Available online:  https://ohdsi.github.io/TheBookOfOhdsi/PatientLevelPrediction.html.</Citation></Reference><Reference><Citation>Kaduk D., Komar V., Golozar A., Robinson P., Wagner A.H., Gurley M., You S.C., Seojeong S., Mehr S., Williams A., et al. Genomic Data Harmonization through the OMOP Standardized Vocabularies; Proceedings of the 2020 OHDSI Global Symposium (Showcase 13); Virtual Symposium. 18&#x2013;21 October 2020.</Citation></Reference><Reference><Citation>ClinVar.  [(accessed on 30 June 2022)]; Available online:  https://www.ncbi.nlm.nih.gov/clinvar/</Citation></Reference><Reference><Citation>CIViC-Clinical Interpretation of Variants in Cancer.  [(accessed on 30 June 2022)].  Available online:  https://civicdb.org/welcome.</Citation></Reference><Reference><Citation>OncoKBTM-MSK&#x2019;s Precision Oncology Knowledge Base.  [(accessed on 30 June 2022)].  Available online:  https://www.oncokb.org/</Citation></Reference><Reference><Citation>Percy C., van Holten V., Muir C.S., World Health Organization . International Classification of Diseases for Oncology. World Health Organization; Lyon, France: 1976.</Citation></Reference><Reference><Citation>Warner J.L., Dymshyts D., Reich C.G., Gurley M.J., Hochheiser H., Moldwin Z.H., Belenkaya R., Williams A.E., Yang P.C. HemOnc: A new standard vocabulary for chemotherapy regimen representation in the OMOP common data model. J. Biomed. Inform. 2019;96:103239. doi: 10.1016/j.jbi.2019.103239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103239</ArticleId><ArticleId IdType="pmc">PMC6697579</ArticleId><ArticleId IdType="pubmed">31238109</ArticleId></ArticleIdList></Reference><Reference><Citation>HemOnc.org-A Hematology Oncology Wiki.  [(accessed on 17 May 2022)].  Available online:  https://hemonc.org/wiki/Main_Page.</Citation></Reference><Reference><Citation>NAACCR.  [(accessed on 17 May 2022)].  Available online:  https://www.naaccr.org/</Citation></Reference><Reference><Citation>Renshaw A.A., Mena-Allauca M., Gould E.W., Sirintrapun S.J. Synoptic Reporting: Evidence-Based Review and Future Directions. JCO Clin. Cancer Inform. 2018;2:1&#x2013;9. doi: 10.1200/CCI.17.00088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.17.00088</ArticleId><ArticleId IdType="pmc">PMC6873952</ArticleId><ArticleId IdType="pubmed">30652566</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell W.S., Campbell J.R., West W.W., McClay J.C., Hinrichs S.H. Semantic analysis of SNOMED CT for a post-coordinated database of histopathology findings. J. Am. Med. Inform. Assoc. 2014;21:885&#x2013;892. doi: 10.1136/amiajnl-2013-002456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-002456</ArticleId><ArticleId IdType="pmc">PMC4147616</ArticleId><ArticleId IdType="pubmed">24833774</ArticleId></ArticleIdList></Reference><Reference><Citation>NCI Thesaurus.  [(accessed on 17 May 2022)]; Available online:  https://ncithesaurus.nci.nih.gov/ncitbrowser/</Citation></Reference><Reference><Citation>Anatomical Therapeutic Chemical (ATC) Classification.  [(accessed on 17 May 2022)].  Available online:  https://www.who.int/tools/atc-ddd-toolkit/atc-classification.</Citation></Reference><Reference><Citation>Park C., You S.C., Jeon H., Jeong C.W., Choi J.W., Park R.W. Development and Validation of the Radiology Common Data Model (R-CDM) for the International Standardization of Medical Imaging Data. Yonsei Med. J. 2022;63:S74&#x2013;S83. doi: 10.3349/ymj.2022.63.S74.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2022.63.S74</ArticleId><ArticleId IdType="pmc">PMC8790584</ArticleId><ArticleId IdType="pubmed">35040608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bathelt F., Reinecke I., Peng Y., Henke E., Weidner J., Bartos M., G&#xf6;tt R., Waltemath D., Engelmann K., Schwarz P.E., et al. Opportunities of Digital Infrastructures for Disease Management&#x2014;Exemplified on COVID-19-Related Change in Diagnosis Counts for Diabetes-Related Eye Diseases. Nutrients. 2022;14:2016. doi: 10.3390/nu14102016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14102016</ArticleId><ArticleId IdType="pmc">PMC9147678</ArticleId><ArticleId IdType="pubmed">35631157</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobas M., Martinez Elicegui J., Villaverde Ramiro A., Gonz&#xe1;lez T., Hernandez-Sanchez A., Azibeiro Melchor R., Benner A., Str&#xe4;ng E., Gastone C., Heckman C.A., et al. Harmony Alliance Provides a Machine Learning Researching Tool to Predict the Risk of Relapse after First Remission in AML Patients Treated without Allogeneic Haematopoietic Stem Cell Transplantation. Blood. 2021;138:4041. doi: 10.1182/blood-2021-149521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2021-149521</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo S., Yoon E., Boo D., Kim B., Kim S., Paeng J.C., Yoo I.R., Choi I.Y., Kim K., Ryoo H.G., et al. Transforming Thyroid Cancer Diagnosis and Staging Information from Unstructured Reports to the Observational Medical Outcome Partnership Common Data Model. Appl. Clin. Inform. 2022;13:521&#x2013;531. doi: 10.1055/s-0042-1748144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1748144</ArticleId><ArticleId IdType="pmc">PMC9200482</ArticleId><ArticleId IdType="pubmed">35705182</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Chi Y., Butler A., Sun Y., Weng C. A knowledge base of clinical trial eligibility criteria. J. Biomed. Inform. 2021;117:103771. doi: 10.1016/j.jbi.2021.103771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2021.103771</ArticleId><ArticleId IdType="pmc">PMC8407851</ArticleId><ArticleId IdType="pubmed">33813032</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon H., You S.C., Kang S.Y., Seo S.I., Warner J.L., Belenkaya R., Park R.W. Characterizing the Anticancer Treatment Trajectory and Pattern in Patients Receiving Chemotherapy for Cancer Using Harmonized Observational Databases: Retrospective Study. JMIR Med. Inform. 2021;9:e25035. doi: 10.2196/25035.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/25035</ArticleId><ArticleId IdType="pmc">PMC8058693</ArticleId><ArticleId IdType="pubmed">33720842</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie M.J., Weinstein R., Ryan P.B., Berlin J.A. Quantifying bias in epidemiologic studies evaluating the association between acetaminophen use and cancer. Regul. Toxicol. Pharmacol. 2021;120:104866. doi: 10.1016/j.yrtph.2021.104866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yrtph.2021.104866</ArticleId><ArticleId IdType="pubmed">33454352</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood W.A., Marks P., Plovnick R.M., Hewitt K., Neuberg D.S., Walters S., Dolan B.K., Tucker E.A., Abrams C.S., Thompson A.A., et al. ASH Research Collaborative: A real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematology. Blood Adv. 2021;5:5429&#x2013;5438. doi: 10.1182/bloodadvances.2021005902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021005902</ArticleId><ArticleId IdType="pmc">PMC9153041</ArticleId><ArticleId IdType="pubmed">34673922</ArticleId></ArticleIdList></Reference><Reference><Citation>Felmeister A.S., Waanders A.J., Mason J.L., Stevens J., Bailey L.C., Ganesan S., Helbig I. A Framework for Analysis, Ontological Evaluation, and Visualization in Preparation to Predictive Analytics in Pediatric Brain Tumor Research; Proceedings of the 2020 IEEE International Conference on Bioinformatics and Biomedicine (BIBM); Seoul, Korea. 16&#x2013;19 December 2020; pp. 1943&#x2013;1950.</Citation></Reference><Reference><Citation>Li J., Tian Y., Zhu Y., Zhou T., Li J., Ding K., Li J. A multicenter random forest model for effective prognosis prediction in collaborative clinical research network. Artif. Intell. Med. 2020;103:101814. doi: 10.1016/j.artmed.2020.101814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2020.101814</ArticleId><ArticleId IdType="pubmed">32143809</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke C.L., Feigelson H.S. Developing an Algorithm to Identify History of Cancer Using Electronic Medical Records. eGEMs (Gener. Evid. Methods Improv. Patient Outcomes) 2016;4:5. doi: 10.13063/2327-9214.1209.</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1209</ArticleId><ArticleId IdType="pmc">PMC4862761</ArticleId><ArticleId IdType="pubmed">27195308</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Tian Y., Li R., Zhou T., Li J., Ding K., Li J. Improving prediction for medical institution with limited patient data: Leveraging hospital-specific data based on multicenter collaborative research network. Artif. Intell. Med. 2021;113:102024. doi: 10.1016/j.artmed.2021.102024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2021.102024</ArticleId><ArticleId IdType="pubmed">33685587</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C., You S.C., Reps J.M., Cheong J.Y., Park R.W. Machine-learning model to predict the cause of death using a stacking ensemble method for observational data. J. Am. Med. Inform. Assoc. 2021;28:1098&#x2013;1107. doi: 10.1093/jamia/ocaa277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa277</ArticleId><ArticleId IdType="pmc">PMC8200274</ArticleId><ArticleId IdType="pubmed">33211841</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y., Shang Y., Tong D.-Y., Chi S.-Q., Li J., Kong X.-X., Ding K.-F., Li J.-S. POPCORN: A web service for individual PrognOsis prediction based on multi-center clinical data CollabORatioN without patient-level data sharing. J. Biomed. Inform. 2018;86:1&#x2013;14. doi: 10.1016/j.jbi.2018.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2018.08.008</ArticleId><ArticleId IdType="pubmed">30103028</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S., Kim I., Kim Y., Seok J. Vocabulary Domain Prediction for Pathological Report Analysis Using ICD-O3; Proceedings of the 2019 Eleventh International Conference on Ubiquitous and Future Networks (ICUFN); Zagreb, Croatia. 2&#x2013;5 July 2019; pp. 520&#x2013;522.</Citation></Reference><Reference><Citation>Boehm K.M., Khosravi P., Vanguri R., Gao J., Shah S.P. Harnessing multimodal data integration to advance precision oncology. Nat. Rev. Cancer. 2022;22:114&#x2013;126. doi: 10.1038/s41568-021-00408-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-021-00408-3</ArticleId><ArticleId IdType="pmc">PMC8810682</ArticleId><ArticleId IdType="pubmed">34663944</ArticleId></ArticleIdList></Reference><Reference><Citation>Edmondson M.J., Luo C., Duan R., Maltenfort M., Chen Z., Locke K., Shults J., Bian J., Ryan P.B., Forrest C.B., et al. An efficient and accurate distributed learning algorithm for modeling multi-site zero-inflated count outcomes. Sci. Rep. 2021;11:19647. doi: 10.1038/s41598-021-99078-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-99078-2</ArticleId><ArticleId IdType="pmc">PMC8490431</ArticleId><ArticleId IdType="pubmed">34608222</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardin J., Reps J.M. Evaluating the impact of covariate lookback times on performance of patient-level prediction models. BMC Med. Res. Methodol. 2021;21:180. doi: 10.1186/s12874-021-01370-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-021-01370-2</ArticleId><ArticleId IdType="pmc">PMC8403343</ArticleId><ArticleId IdType="pubmed">34454423</ArticleId></ArticleIdList></Reference><Reference><Citation>Meystre S.M., Heider P.M., Kim Y., Aruch D.B., Britten C.D. Automatic trial eligibility surveillance based on unstructured clinical data. Int. J. Med. Inform. 2019;129:13&#x2013;19. doi: 10.1016/j.ijmedinf.2019.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2019.05.018</ArticleId><ArticleId IdType="pmc">PMC6717538</ArticleId><ArticleId IdType="pubmed">31445247</ArticleId></ArticleIdList></Reference><Reference><Citation>Seneviratne M.G., Banda J.M., Brooks J.D., Shah N.H., Hernandez-Boussard T.M. Identifying Cases of Metastatic Prostate Cancer Using Machine Learning on Electronic Health Records. AMIA Annu. Symp. Proc. 2018;2018:1498&#x2013;1504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6371284</ArticleId><ArticleId IdType="pubmed">30815195</ArticleId></ArticleIdList></Reference><Reference><Citation>IT Future of Cancer.  [(accessed on 17 May 2022)].  Available online:  https://itfoc.eu/</Citation></Reference><Reference><Citation>Tsopra R., Fernandez X., Luchinat C., Alberghina L., Lehrach H., Vanoni M., Dreher F., Sezerman O.U., Cuggia M., de Tayrac M., et al. A framework for validating AI in precision medicine: Considerations from the European ITFoC consortium. BMC Med. Inform. Decis. Mak. 2021;21:274. doi: 10.1186/s12911-021-01634-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-021-01634-3</ArticleId><ArticleId IdType="pmc">PMC8487519</ArticleId><ArticleId IdType="pubmed">34600518</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.-H., Chun K.J., Park J., Kim J., Sung J.D., Park R.W., Choi J., Yang K. Angiotensin converting enzyme inhibitors and incidence of lung cancer in a population based cohort of common data model in Korea. Sci. Rep. 2021;11:18576. doi: 10.1038/s41598-021-97989-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-97989-8</ArticleId><ArticleId IdType="pmc">PMC8448874</ArticleId><ArticleId IdType="pubmed">34535723</ArticleId></ArticleIdList></Reference><Reference><Citation>CMS 2008&#x2013;2010 Data Entrepreneurs&#x2019; Synthetic Public Use File (DE-SynPUF) | CMS.  [(accessed on 19 September 2022)]; Available online:  https://www.cms.gov/Research-Statistics-Data-and-Systems/Downloadable-Public-Use-Files/SynPUFs/DE_Syn_PUF.</Citation></Reference><Reference><Citation>Cirillo D., Valencia A. Big data analytics for personalized medicine. Curr. Opin. Biotechnol. 2019;58:161&#x2013;167. doi: 10.1016/j.copbio.2019.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.copbio.2019.03.004</ArticleId><ArticleId IdType="pubmed">30965188</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissler E.H., Naumann T., Andersson T., Ranganath R., Elemento O., Luo Y., Freitag D.F., Benoit J., Hughes M.C., Khan F., et al. The role of machine learning in clinical research: Transforming the future of evidence generation. Trials. 2021;22:537. doi: 10.1186/s13063-021-05489-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05489-x</ArticleId><ArticleId IdType="pmc">PMC8365941</ArticleId><ArticleId IdType="pubmed">34399832</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury R.I., Tomal J.H. Risk prediction for repeated measures health outcomes: A divide and recombine framework. Inform. Med. Unlocked. 2022;28:100847. doi: 10.1016/j.imu.2022.100847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imu.2022.100847</ArticleId></ArticleIdList></Reference><Reference><Citation>EMA Data Analysis and Real World Interrogation Network (DARWIN EU)  [(accessed on 2 June 2022)].  Available online:  https://www.ema.europa.eu/en/about-us/how-we-work/big-data/data-analysis-real-world-interrogation-network-darwin-eu.</Citation></Reference><Reference><Citation>DARWIN EU Initiative Presentation&#x2013;OHDSI.  [(accessed on 30 June 2022)].  Available online:  https://ohdsi.org/darwin-eu-initiative-presentation/</Citation></Reference><Reference><Citation>Omar M.I., Roobol M.J., Ribal M.J., Abbott T., Agapow P.-M., Araujo S., Asiimwe A., Auffray C., Balaur I., Beyer K., et al. Introducing PIONEER: A project to harness big data in prostate cancer research. Nat. Rev. Urol. 2020;17:351&#x2013;362. doi: 10.1038/s41585-020-0324-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41585-020-0324-x</ArticleId><ArticleId IdType="pubmed">32461687</ArticleId></ArticleIdList></Reference><Reference><Citation>PIONEER joins forces with EHDEN &amp; OHDSI for prostate cancer study-a-thon. PIONEER-Eur. Netw. Excell. Big Data Prostate Cancer 2021.  [(accessed on 30 June 2022)].  Available online:  https://prostate-pioneer.eu/pioneer-joins-forces-with-ehden-ohdsi-for-prostate-cancer-study-a-thon/</Citation></Reference><Reference><Citation>Tricco A.C., Lillie E., Zarin W., O&#x2019;Brien K.K., Colquhoun H., Levac D., Moher D., Peters M.D.J., Horsley T., Weeks L., et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann. Intern. Med. 2018;169:467&#x2013;473. doi: 10.7326/M18-0850.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-0850</ArticleId><ArticleId IdType="pubmed">30178033</ArticleId></ArticleIdList></Reference><Reference><Citation>Zotero | Your Personal Research Assistant.  [(accessed on 10 February 2022)].  Available online:  https://www.zotero.org/</Citation></Reference><Reference><Citation>Rehm H.L., Page A.J.H., Smith L., Adams J.B., Alterovitz G., Babb L.J., Barkley M.P., Baudis M., Beauvais M.J.S., Beck T., et al. GA4GH: International policies and standards for data sharing across genomic research and healthcare. Cell Genom. 2021;1:100029. doi: 10.1016/j.xgen.2021.100029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xgen.2021.100029</ArticleId><ArticleId IdType="pmc">PMC8774288</ArticleId><ArticleId IdType="pubmed">35072136</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36247446</PMID><DateRevised><Year>2022</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Factors affecting the changes in antihypertensive medications in patients with hypertension.</ArticleTitle><Pagination><StartPage>999548</StartPage><MedlinePgn>999548</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">999548</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2022.999548</ELocationID><Abstract><AbstractText>As frequent changes in anti-hypertensive (HTN) medications may reduce adherence to the treatments, identifying modifiable factors leading to changes in anti-HTN medications can help clinicians optimize treatment strategies for individual patients. We performed this study to explore the pattern of anti-HTN medications and to identify factors that are associated with the changes in anti-HTN medications. To this end, we used a clinical database of Seoul National University Hospital, extracted, transformed, and loaded by the observational medical outcomes partnership common data model. Demographic and all recorded clinical diagnoses, medications, and procedures data of eligible subjects were collected. Of 636 subjects who were eligible for this study, 297 subjects with a record of &#x2265;1 anti-HTN medication changes and other 297 subjects without a record of medication change were selected for the study population. High diastolic blood pressure (adjusted odds ratio [OR]: 1.02, 95% confidence interval [CI]: 1.001-1.040, <i>p</i> = 0.040), arrhythmia (adjusted OR: 10.01, 95% CI: 1.86-185.57, <i>p</i> = 0.030), and angina pectoris with antianginal agents (adjusted OR: 4.85, CI: 1.05-23.89, <i>p</i> = 0.046) were associated with the changes in anti-HTN medications, indicating that any patients with these covariates require additional attention to reduce the likelihood of changing anti-HTN medications.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Chung, Jeon, Hong, Hong, Moon and Lee.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Tae Kyu</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Convergence Approaches in Drug Development, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Yoomin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Convergence Approaches in Drug Development, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>YeSol</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Convergence Approaches in Drug Development, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Suyeon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for Convergence Approaches in Drug Development, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Jun Sik</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Center for Convergence Approaches in Drug Development, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Howard</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Applied Bioengineering, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Convergence Approaches in Drug Development, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Advanced Institutes of Convergence Technology, Suwon, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anti-hypertensive medication</Keyword><Keyword MajorTopicYN="N">cardiovascular disease</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">hypertension</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>17</Day><Hour>4</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36247446</ArticleId><ArticleId IdType="pmc">PMC9561640</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2022.999548</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kjeldsen SE. Hypertension and cardiovascular risk: general aspects. Pharmacol Res. (2018) 129:95&#x2013;9. 10.1016/j.phrs.2017.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2017.11.003</ArticleId><ArticleId IdType="pubmed">29127059</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzau VJ, Balatbat CA. Future of hypertension. Hypertension. (2019) 74:450&#x2013;7. 10.1161/HYPERTENSIONAHA.119.13437</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.119.13437</ArticleId><ArticleId IdType="pubmed">31352827</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization WH. Noncommunicable Disease.  (2021). Available online at: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases</Citation></Reference><Reference><Citation>Kotchen TA. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens. (2010) 23:1170&#x2013;8. 10.1038/ajh.2010.172</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajh.2010.172</ArticleId><ArticleId IdType="pubmed">20706196</ArticleId></ArticleIdList></Reference><Reference><Citation>Moser M, Franklin SS. Hypertension management: results of a new national survey for the hypertension education foundation: harris interactive. J Clin Hyperten. (2007) 9:316&#x2013;23. 10.1111/j.1524-6175.2007.07152.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-6175.2007.07152.x</ArticleId><ArticleId IdType="pmc">PMC8109855</ArticleId><ArticleId IdType="pubmed">17485966</ArticleId></ArticleIdList></Reference><Reference><Citation>Poulter NR, Borghi C, Parati G, Pathak A, Toli D, Williams B, et al. . Medication adherence in hypertension. J Hypertens. (2020) 38:579&#x2013;87. 10.1097/HJH.0000000000002294</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HJH.0000000000002294</ArticleId><ArticleId IdType="pubmed">31834123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SJ, Kwon OD, Han EB, Lee CM, Oh SW, Joh HK, et al. . Impact of number of medications and age on adherence to antihypertensive medications: a nationwide population-based study. Medicine. (2019) 98:e17825. 10.1097/MD.0000000000017825</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000017825</ArticleId><ArticleId IdType="pmc">PMC6919523</ArticleId><ArticleId IdType="pubmed">31804305</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the department of veterans affairs. Am J Med. (2007) 120:26&#x2013;32. 10.1016/j.amjmed.2006.06.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2006.06.028</ArticleId><ArticleId IdType="pubmed">17208076</ArticleId></ArticleIdList></Reference><Reference><Citation>Warriner AH, Curtis JR. Adherence to osteoporosis treatments: room for improvement. Curr Opin Rheumatol. (2009) 21:356&#x2013;62. 10.1097/BOR.0b013e32832c6aa4</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e32832c6aa4</ArticleId><ArticleId IdType="pmc">PMC2913429</ArticleId><ArticleId IdType="pubmed">19412103</ArticleId></ArticleIdList></Reference><Reference><Citation>Jungst C, Graber S, Simons S, Wedemeyer H, Lammert F. Medication adherence among patients with chronic diseases: a survey-based study in pharmacies. QJM. (2019) 112:505&#x2013;12. 10.1093/qjmed/hcz058</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcz058</ArticleId><ArticleId IdType="pubmed">30840076</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong MC, Jiang JY, Griffiths SM. Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients. Am J Hypertens. (2009) 22:904&#x2013;10. 10.1038/ajh.2009.95</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajh.2009.95</ArticleId><ArticleId IdType="pubmed">19478791</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong MC, Su X, Jiang JY, Tang JL, Griffiths SM. Profiles of discontinuation and switching of thiazide diuretics: a cohort study among 9398 Chinese hypertensive patients. Hypertens Res. (2011) 34:888&#x2013;93. 10.1038/hr.2011.43</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/hr.2011.43</ArticleId><ArticleId IdType="pubmed">21562510</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong MC, Jiang JY, Gibbs T, Griffiths SM. Factors associated with antihypertensive drug discontinuation among Chinese patients: a cohort study. Am J Hypertens. (2009) 22:802&#x2013;10. 10.1038/ajh.2009.67</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajh.2009.67</ArticleId><ArticleId IdType="pubmed">19360004</ArticleId></ArticleIdList></Reference><Reference><Citation>Informatics OHDSa,. 2020 Data Network. (2021). Available online at: https://www.ohdsi.org/web/wiki/doku.php?id=resources:2020_data_network</Citation></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, Shah NH, Park RW, Huser V, et al. . Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. (2016) 113:7329&#x2013;36. 10.1073/pnas.1510502113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee E-J, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, et al. . 2018 Guidelines for the management of dyslipidemia in Korea. J Lipid Atheroscler. (2019) 8:78&#x2013;131. 10.12997/jla.2019.8.2.78</Citation><ArticleIdList><ArticleId IdType="doi">10.12997/jla.2019.8.2.78</ArticleId><ArticleId IdType="pmc">PMC7379116</ArticleId><ArticleId IdType="pubmed">32821702</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Y, Kim SH, Park SY, Park BY, Lee JH, An J, et al. . Evaluation of Drug-Induced Liver Injury Developed During Hospitalization Using Electronic Health Record (EHR)-Based Algorithm. Allergy Asthma Immunol Res. (2020) 12:430&#x2013;42. 10.4168/aair.2020.12.3.430</Citation><ArticleIdList><ArticleId IdType="doi">10.4168/aair.2020.12.3.430</ArticleId><ArticleId IdType="pmc">PMC7061161</ArticleId><ArticleId IdType="pubmed">32141257</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee for the Korean Guidelines for the Management of D . 2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation). Korean Circ J. (2016) 46:275&#x2013;306. 10.4070/kcj.2016.46.3.275</Citation><ArticleIdList><ArticleId IdType="doi">10.4070/kcj.2016.46.3.275</ArticleId><ArticleId IdType="pmc">PMC4891593</ArticleId><ArticleId IdType="pubmed">27275165</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes Blood Pressure Work G. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. (2021) 99:S1&#x2013;S87. 10.1016/j.kint.2020.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.11.003</ArticleId><ArticleId IdType="pubmed">33637192</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HY, Shin J, Kim GH, Park S, Ihm SH, Kim HC, et al. . 2018 Korean society of hypertension guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension. Clin Hypertens. (2019) 25:20. 10.1186/s40885-019-0124-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40885-019-0124-x</ArticleId><ArticleId IdType="pmc">PMC6670135</ArticleId><ArticleId IdType="pubmed">31388453</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasubramanian K, Singh A. Data visualization in R. Machine learning using R: Springer; 2017. p. 129-79. 10.1007/978-1-4842-2334-5_4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4842-2334-5_4</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z. Variable selection with stepwise and best subset approaches. Ann Transl Med. (2016) 4:136. 10.21037/atm.2016.03.35</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2016.03.35</ArticleId><ArticleId IdType="pmc">PMC4842399</ArticleId><ArticleId IdType="pubmed">27162786</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Shin DW, Kim S, Han K, Park S-h, Kim Y-H, et al. . Prescribing patterns of antihypertensives for treatment-na&#xef;ve patients in South Korea: from Korean NHISS claim data. International Journal of Hypertension. (2019) 2019. 10.1155/2019/4735876</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/4735876</ArticleId><ArticleId IdType="pmc">PMC6732595</ArticleId><ArticleId IdType="pubmed">31534797</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung M, Choo E, Lee S. Comprehensive trends and patterns of antihypertensive prescriptions using a nationwide claims database in Korea. Clin Epidemiol. (2020) 12:963&#x2013;75. 10.2147/CLEP.S265966</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S265966</ArticleId><ArticleId IdType="pmc">PMC7494009</ArticleId><ArticleId IdType="pubmed">32982461</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HL, Hwang D, Lee JH, Lee HY, Ihm SH, Kim KI, et al. . Diuretics versus others for long-term clinical outcomes as first-line antihypertensive medications: analysis of national real-world database. Hypertens Res. (2022) 45:758&#x2013;68. 10.1038/s41440-022-00890-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41440-022-00890-8</ArticleId><ArticleId IdType="pubmed">35338336</ArticleId></ArticleIdList></Reference><Reference><Citation>Beevers G Lip GY O'Brien E ABC ABC of hypertension: the pathophysiology of hypertension . BMJ. (2001) 322:912&#x2013;6. 10.1136/bmj.322.7291.912</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.322.7291.912</ArticleId><ArticleId IdType="pmc">PMC1120075</ArticleId><ArticleId IdType="pubmed">11302910</ArticleId></ArticleIdList></Reference><Reference><Citation>Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. (2009) 122:290&#x2013;300. 10.1016/j.amjmed.2008.09.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2008.09.038</ArticleId><ArticleId IdType="pubmed">19272490</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald TM, Williams B, Webb DJ, Morant S, Caulfield M, Cruickshank JK, et al. . Combination therapy is superior to sequential monotherapy for the initial treatment of hypertension: a double-blind randomized controlled trial. J Am Heart Assoc. (2017) 6. 10.1161/JAHA.117.006986</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.006986</ArticleId><ArticleId IdType="pmc">PMC5721778</ArticleId><ArticleId IdType="pubmed">29151036</ArticleId></ArticleIdList></Reference><Reference><Citation>Sino CG, Stuffken R, Heerdink ER, Schuurmans MJ, Souverein PC, Egberts TA. The association between prescription change frequency, chronic disease score and hospital admissions: a case control study. BMC Pharmacol Toxicol. (2013) 14:39. 10.1186/2050-6511-14-39</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2050-6511-14-39</ArticleId><ArticleId IdType="pmc">PMC3734123</ArticleId><ArticleId IdType="pubmed">23915423</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee FY, Islahudin F, Makmor-Bakry M, Wong HS, Bavanandan S. Factors associated with the frequency of antihypertensive drug adjustments in chronic kidney disease patients: a multicentre, 2-year retrospective study. Int J Clin Pharm. (2021) 43:1311&#x2013;21. 10.1007/s11096-021-01252-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11096-021-01252-z</ArticleId><ArticleId IdType="pmc">PMC7936864</ArticleId><ArticleId IdType="pubmed">33677789</ArticleId></ArticleIdList></Reference><Reference><Citation>Agbor-Etang BB, Setaro JF. Management of hypertension in patients with ischemic heart disease. Curr Cardiol Rep. (2015) 17:119. 10.1007/s11886-015-0662-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-015-0662-0</ArticleId><ArticleId IdType="pubmed">26482762</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual I, Moris C, Avanzas P. Beta-blockers and calcium channel blockers: first line agents. Cardiovasc Drugs Ther. (2016) 30:357&#x2013;65. 10.1007/s10557-016-6682-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-016-6682-1</ArticleId><ArticleId IdType="pubmed">27576497</ArticleId></ArticleIdList></Reference><Reference><Citation>Quiroz JC, Chard T, Sa Z, Ritchie A, Jorm L, Gallego B. Extract, transform, load framework for the conversion of health databases to OMOP. PLoS ONE. (2022) 17:e0266911. 10.1371/journal.pone.0266911</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0266911</ArticleId><ArticleId IdType="pmc">PMC9000122</ArticleId><ArticleId IdType="pubmed">35404974</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang L, Miao S, Xu H, Yin Y, Zhu Y, et al. . Analysis of treatment pathways for three chronic diseases using OMOP CDM. J Med Syst. (2018) 42:260. 10.1007/s10916-018-1076-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-018-1076-5</ArticleId><ArticleId IdType="pmc">PMC6244882</ArticleId><ArticleId IdType="pubmed">30421323</ArticleId></ArticleIdList></Reference><Reference><Citation>Algabbani FM, Algabbani AM. Treatment adherence among patients with hypertension: findings from a cross-sectional study. Clin Hypertens. (2020) 26:1&#x2013;9. 10.1186/s40885-020-00151-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40885-020-00151-1</ArticleId><ArticleId IdType="pmc">PMC7491181</ArticleId><ArticleId IdType="pubmed">32944283</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36251369</PMID><DateRevised><Year>2022</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>17</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>Standardized Description of the Feature Extraction Process to Transform Raw Data Into Meaningful Information for Enhancing Data Reuse: Consensus Study.</ArticleTitle><Pagination><StartPage>e38936</StartPage><MedlinePgn>e38936</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e38936</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/38936</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite the many opportunities data reuse offers, its implementation presents many difficulties, and raw data cannot be reused directly. Information is not always directly available in the source database and needs to be computed afterwards with raw data for defining an algorithm.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The main purpose of this article is to present a standardized description of the steps and transformations required during the feature extraction process when conducting retrospective observational studies. A secondary objective is to identify how the features could be stored in the schema of a data warehouse.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study involved the following 3 main steps: (1) the collection of relevant study cases related to feature extraction and based on the automatic and secondary use of data; (2) the standardized description of raw data, steps, and transformations, which were common to the study cases; and (3) the identification of an appropriate table to store the features in the Observation Medical Outcomes Partnership (OMOP) common data model (CDM).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We interviewed 10 researchers from 3 French university hospitals and a national institution, who were involved in 8 retrospective and observational studies. Based on these studies, 2 states (track and feature) and 2 transformations (track definition and track aggregation) emerged. "Track" is a time-dependent signal or period of interest, defined by a statistical unit, a value, and 2 milestones (a start event and an end event). "Feature" is time-independent high-level information with dimensionality identical to the statistical unit of the study, defined by a label and a value. The time dimension has become implicit in the value or name of the variable. We propose the 2 tables "TRACK" and "FEATURE" to store variables obtained in feature extraction and extend the OMOP CDM.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We propose a standardized description of the feature extraction process. The process combined the 2 steps of track definition and track aggregation. By dividing the feature extraction into these 2 steps, difficulty was managed during track definition. The standardization of tracks requires great expertise with regard to the data, but allows the application of an infinite number of complex transformations. On the contrary, track aggregation is a very simple operation with a finite number of possibilities. A complete description of these steps could enhance the reproducibility of retrospective studies.</AbstractText><CopyrightInformation>&#xa9;Antoine Lamer, Mathilde Fruchart, Nicolas Paris, Benjamin Popoff, Ana&#xef;s Payen, Thibaut Balcaen, William Gacquer, Guillaume Bouzill&#xe9;, Marc Cuggia, Matthieu Doutreligne, Emmanuel Chazard. Originally published in JMIR Medical Informatics (https://medinform.jmir.org), 17.10.2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lamer</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9546-1808</Identifier><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694 - METRICS: &#xc9;valuation des Technologies de sant&#xe9; et des Pratiques m&#xe9;dicales, Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>F&#xe9;d&#xe9;ration r&#xe9;gionale de recherche en psychiatrie et sant&#xe9; mentale (F2RSM Psy), Hauts-de-France, Saint-Andr&#xe9;-Lez-Lille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>InterHop, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fruchart</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7826-0713</Identifier><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694 - METRICS: &#xc9;valuation des Technologies de sant&#xe9; et des Pratiques m&#xe9;dicales, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paris</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-1533-5087</Identifier><AffiliationInfo><Affiliation>InterHop, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popoff</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-2854-0909</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, Rouen University Hospital, Rouen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Payen</LastName><ForeName>Ana&#xef;s</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3311-324X</Identifier><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694 - METRICS: &#xc9;valuation des Technologies de sant&#xe9; et des Pratiques m&#xe9;dicales, Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balcaen</LastName><ForeName>Thibaut</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3694-4508</Identifier><AffiliationInfo><Affiliation>Medical Information Department, Amiens-Picardy University Hospital, Amiens, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gacquer</LastName><ForeName>William</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-4876-3803</Identifier><AffiliationInfo><Affiliation>Digital Services Department, Amiens-Picardy University Hospital, Amiens, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouzill&#xe9;</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-3637-6558</Identifier><AffiliationInfo><Affiliation>Institut national de la sant&#xe9; et de la recherche m&#xe9;dicale (INSERM), LTSI-UMR 1099, Univ Rennes, CHU Rennes, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuggia</LastName><ForeName>Marc</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6943-3937</Identifier><AffiliationInfo><Affiliation>Institut national de la sant&#xe9; et de la recherche m&#xe9;dicale (INSERM), LTSI-UMR 1099, Univ Rennes, CHU Rennes, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doutreligne</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8072-9966</Identifier><AffiliationInfo><Affiliation>Mission Data, Haute Autorit&#xe9; de Sant&#xe9;, Saint-Denis, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>SoDa project team, National Institute for Research in Digital Science and Technology (INRIA), Saclay-&#xce;le de France, Gif-sur-Yvette, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chazard</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7841-5925</Identifier><AffiliationInfo><Affiliation>Univ. Lille, CHU Lille, ULR 2694 - METRICS: &#xc9;valuation des Technologies de sant&#xe9; et des Pratiques m&#xe9;dicales, Lille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Observation Medical Outcomes Partnership</Keyword><Keyword MajorTopicYN="N">algorithm</Keyword><Keyword MajorTopicYN="N">data reuse</Keyword><Keyword MajorTopicYN="N">data warehouse</Keyword><Keyword MajorTopicYN="N">database</Keyword><Keyword MajorTopicYN="N">feature extraction</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>17</Day><Hour>11</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36251369</ArticleId><ArticleId IdType="pmc">PMC9623460</ArticleId><ArticleId IdType="doi">10.2196/38936</ArticleId><ArticleId IdType="pii">v10i10e38936</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weng C, Kahn MG. Clinical Research Informatics for Big Data and Precision Medicine. Yearb Med Inform. 2016 Nov 10;(1):211&#x2013;218. doi: 10.15265/IY-2016-019. 
 
me2016-019</Citation><ArticleIdList><ArticleId IdType="doi">10.15265/IY-2016-019</ArticleId><ArticleId IdType="pmc">PMC5171548</ArticleId><ArticleId IdType="pubmed">27830253</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler-Milstein J, DesRoches CM, Kralovec P, Foster G, Worzala C, Charles D, Searcy T, Jha AK. Electronic Health Record Adoption In US Hospitals: Progress Continues, But Challenges Persist. Health Aff (Millwood) 2015 Dec;34(12):2174&#x2013;80. doi: 10.1377/hlthaff.2015.0992.hlthaff.2015.0992</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2015.0992</ArticleId><ArticleId IdType="pubmed">26561387</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran C, Bloomrosen M, Hammond WE, Labkoff S, Markel-Fox S, Tang PC, Detmer DE, Expert Panel  Toward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper. J Am Med Inform Assoc. 2007;14(1):1&#x2013;9. doi: 10.1197/jamia.M2273. 
 
M2273</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M2273</ArticleId><ArticleId IdType="pmc">PMC2329823</ArticleId><ArticleId IdType="pubmed">17077452</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ. Next-generation phenotyping of electronic health records. J Am Med Inform Assoc. 2013 Jan 01;20(1):117&#x2013;21. doi: 10.1136/amiajnl-2012-001145. 
 
amiajnl-2012-001145</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2012-001145</ArticleId><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, Margolis PA, Bailey LC, Marsolo K, Del Beccaro MA, Finkelstein JA, Milov DE, Vieland VJ, Wolf BA, Yu FB, Kahn MG. PEDSnet: a National Pediatric Learning Health System. J Am Med Inform Assoc. 2014;21(4):602&#x2013;6. doi: 10.1136/amiajnl-2014-002743. 
 
amiajnl-2014-002743</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002743</ArticleId><ArticleId IdType="pmc">PMC4078288</ArticleId><ArticleId IdType="pubmed">24821737</ArticleId></ArticleIdList></Reference><Reference><Citation>McGlynn EA, Lieu TA, Durham ML, Bauck A, Laws R, Go AS, Chen J, Feigelson HS, Corley DA, Young DR, Nelson AF, Davidson AJ, Morales LS, Kahn MG. Developing a data infrastructure for a learning health system: the PORTAL network. J Am Med Inform Assoc. 2014;21(4):596&#x2013;601. doi: 10.1136/amiajnl-2014-002746. 
 
amiajnl-2014-002746</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002746</ArticleId><ArticleId IdType="pmc">PMC4078291</ArticleId><ArticleId IdType="pubmed">24821738</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran C. Reuse of clinical data. Yearb Med Inform. 2014 Aug 15;9:52&#x2013;4. doi: 10.15265/IY-2014-0013. 
 
me2014-0013</Citation><ArticleIdList><ArticleId IdType="doi">10.15265/IY-2014-0013</ArticleId><ArticleId IdType="pmc">PMC4287069</ArticleId><ArticleId IdType="pubmed">25123722</ArticleId></ArticleIdList></Reference><Reference><Citation>De Moor G, Sundgren M, Kalra D, Schmidt A, Dugas M, Claerhout B, Karakoyun T, Ohmann C, Lastic P, Ammour N, Kush R, Dupont D, Cuggia M, Daniel C, Thienpont G, Coorevits P. Using electronic health records for clinical research: the case of the EHR4CR project. J Biomed Inform. 2015 Feb;53:162&#x2013;73. doi: 10.1016/j.jbi.2014.10.006. 
 
S1532-0464(14)00226-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2014.10.006</ArticleId><ArticleId IdType="pubmed">25463966</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin K, Schneeweiss S. Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs. Clin Pharmacol Ther. 2016 Aug 12;100(2):147&#x2013;59. doi: 10.1002/cpt.359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.359</ArticleId><ArticleId IdType="pubmed">26916672</ArticleId></ArticleIdList></Reference><Reference><Citation>Meystre SM, Lovis C, B&#xfc;rkle T, Tognola G, Budrionis A, Lehmann CU. Clinical Data Reuse or Secondary Use: Current Status and Potential Future Progress. Yearb Med Inform. 2017 Sep 11;26(01):38&#x2013;52. doi: 10.15265/iy-2017-007.</Citation><ArticleIdList><ArticleId IdType="doi">10.15265/iy-2017-007</ArticleId><ArticleId IdType="pmc">PMC6239225</ArticleId><ArticleId IdType="pubmed">28480475</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnankutty B, Bellary S, Kumar NBR, Moodahadu LS. Data management in clinical research: An overview. Indian J Pharmacol. 2012 Mar;44(2):168&#x2013;72. doi: 10.4103/0253-7613.93842. 
 
IJPharm-44-168</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0253-7613.93842</ArticleId><ArticleId IdType="pmc">PMC3326906</ArticleId><ArticleId IdType="pubmed">22529469</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc. 2013 Jan 01;20(1):144&#x2013;51. doi: 10.1136/amiajnl-2011-000681. 
 
amiajnl-2011-000681</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000681</ArticleId><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran C. Medicine based upon data. J Gen Intern Med. 2013 Dec;28(12):1545&#x2013;6. doi: 10.1007/s11606-013-2549-3. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-013-2549-3</ArticleId><ArticleId IdType="pmc">PMC3832715</ArticleId><ArticleId IdType="pubmed">23838902</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Bakken S, Hripcsak G, Weng C. A Data Quality Assessment Guideline for Electronic Health Record Data Reuse. EGEMS (Wash DC) 2017 Sep 04;5(1):14. doi: 10.5334/egems.218. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/egems.218</ArticleId><ArticleId IdType="pmc">PMC5983018</ArticleId><ArticleId IdType="pubmed">29881734</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendl C, Duftschmid G, Gezgin D, Popper N, Miksch F, Rinner C. A Web-Based Tool to Evaluate Data Quality of Reused Health Data Assets. Stud Health Technol Inform. 2017;236:204&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">28508797</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Dagtas S, Talburt J, Baghal A, Zozus M. Rule-Based Data Quality Assessment and Monitoring System in Healthcare Facilities. Stud Health Technol Inform. 2019;257:460&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6692115</ArticleId><ArticleId IdType="pubmed">30741240</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahm E, Do HH. Data Cleaning: Problems and Current Approaches. Better Evaluation.  [2022-09-24].  
 https://www.betterevaluation.org/sites/default/files/data_cleaning.pdf
.</Citation></Reference><Reference><Citation>Weng C. Clinical data quality: a data life cycle perspective. Biostat Epidemiol. 2020;4(1):6&#x2013;14. doi: 10.1080/24709360.2019.1572344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/24709360.2019.1572344</ArticleId><ArticleId IdType="pmc">PMC7133741</ArticleId><ArticleId IdType="pubmed">32258941</ArticleId></ArticleIdList></Reference><Reference><Citation>Murff HJ, FitzHenry F, Matheny ME, Gentry N, Kotter KL, Crimin K, Dittus RS, Rosen AK, Elkin PL, Brown SH, Speroff T. Automated identification of postoperative complications within an electronic medical record using natural language processing. JAMA. 2011 Aug 24;306(8):848&#x2013;55. doi: 10.1001/jama.2011.1204.306/8/848</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2011.1204</ArticleId><ArticleId IdType="pubmed">21862746</ArticleId></ArticleIdList></Reference><Reference><Citation>Smischney NJ, Velagapudi VM, Onigkeit JA, Pickering BW, Herasevich V, Kashyap R. Derivation and validation of a search algorithm to retrospectively identify mechanical ventilation initiation in the intensive care unit. BMC Med Inform Decis Mak. 2014 Jun 25;14:55. doi: 10.1186/1472-6947-14-55. 
 
1472-6947-14-55</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6947-14-55</ArticleId><ArticleId IdType="doi">10.1186/1472-6947-14-55</ArticleId><ArticleId IdType="pmc">PMC4082421</ArticleId><ArticleId IdType="pubmed">24965680</ArticleId></ArticleIdList></Reference><Reference><Citation>Tien M, Kashyap R, Wilson GA, Hernandez-Torres V, Jacob AK, Schroeder DR, Mantilla CB. Retrospective Derivation and Validation of an Automated Electronic Search Algorithm to Identify Post Operative Cardiovascular and Thromboembolic Complications. Appl Clin Inform. 2015;6(3):565&#x2013;76. doi: 10.4338/ACI-2015-03-RA-0026. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/ACI-2015-03-RA-0026</ArticleId><ArticleId IdType="pmc">PMC4586343</ArticleId><ArticleId IdType="pubmed">26448798</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Jeanne M, Marcilly R, Kipnis E, Schiro J, Logier R, Tavernier B. Methodology to automatically detect abnormal values of vital parameters in anesthesia time-series: Proposal for an adaptable algorithm. Comput Methods Programs Biomed. 2016 Jun;129:160&#x2013;71. doi: 10.1016/j.cmpb.2016.01.004.S0169-2607(16)00005-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2016.01.004</ArticleId><ArticleId IdType="pubmed">26817405</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabel E, Hofer IS, Satou N, Grogan T, Shemin R, Mahajan A, Cannesson M. Creation and Validation of an Automated Algorithm to Determine Postoperative Ventilator Requirements After Cardiac Surgery. Anesth Analg. 2017 May;124(5):1423&#x2013;1430. doi: 10.1213/ANE.0000000000001997.00000539-201705000-00014</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000001997</ArticleId><ArticleId IdType="pubmed">28431419</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayyad U, Piatetsky-Shapiro G, Smyth P. From data mining to knowledge discovery in databases. AI Magazine. 1996;17(3):37&#x2013;54. doi: 10.1609/aimag.v17i3.1230. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1609/aimag.v17i3.1230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Jeanne M, Ficheur G, Marcilly R. Automated Data Aggregation for Time-Series Analysis: Study Case on Anaesthesia Data Warehouse. Stud Health Technol Inform. 2016;221:102&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27071886</ArticleId></ArticleIdList></Reference><Reference><Citation>Price A, Caciula A, Guo C, Lee B, Morrison J, Rasmussen A, Lipkin WI, Jain K. DEvis: an R package for aggregation and visualization of differential expression data. BMC Bioinformatics. 2019 Mar 04;20(1):110. doi: 10.1186/s12859-019-2702-z. 
 
10.1186/s12859-019-2702-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-019-2702-z</ArticleId><ArticleId IdType="doi">10.1186/s12859-019-2702-z</ArticleId><ArticleId IdType="pmc">PMC6399874</ArticleId><ArticleId IdType="pubmed">30832568</ArticleId></ArticleIdList></Reference><Reference><Citation>Chazard E, Ficheur G, Caron A, Lamer A, Labreuche J, Cuggia M, Genin M, Bouzille G, Duhamel A. Secondary Use of Healthcare Structured Data: The Challenge of Domain-Knowledge Based Extraction of Features. Stud Health Technol Inform. 2018;255:15&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">30306898</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasma W, Peelen LM, van Buuren S, van Klei WA, de Graaff JC. Artifact Processing Methods Influence on Intraoperative Hypotension Quantification and Outcome Effect Estimates. Anesthesiology. 2020 Apr;132(4):723&#x2013;737. doi: 10.1097/ALN.0000000000003131. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003131</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000003131</ArticleId><ArticleId IdType="pubmed">32022770</ArticleId></ArticleIdList></Reference><Reference><Citation>Breil B, Kenneweg J, Fritz F, Bruland P, Doods D, Trinczek B, Dugas M. Multilingual Medical Data Models in ODM Format: A Novel Form-based Approach to Semantic Interoperability between Routine Healthcare and Clinical Research. Appl Clin Inform. 2012;3(3):276&#x2013;89. doi: 10.4338/ACI-2012-03-RA-0011. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/ACI-2012-03-RA-0011</ArticleId><ArticleId IdType="pmc">PMC3613023</ArticleId><ArticleId IdType="pubmed">23620720</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivovarov R, Albers DJ, Sepulveda JL, Elhadad N. Identifying and mitigating biases in EHR laboratory tests. J Biomed Inform. 2014 Oct;51:24&#x2013;34. doi: 10.1016/j.jbi.2014.03.016. 
 
S1532-0464(14)00084-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2014.03.016</ArticleId><ArticleId IdType="pmc">PMC4194228</ArticleId><ArticleId IdType="pubmed">24727481</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumm R, Semjonow A, Tio J, Duhme H, B&#xfc;rkle T, Haier J, Dugas M, Breil B. The need for harmonized structured documentation and chances of secondary use - results of a systematic analysis with automated form comparison for prostate and breast cancer. J Biomed Inform. 2014 Oct;51:86&#x2013;99. doi: 10.1016/j.jbi.2014.04.008. 
 
S1532-0464(14)00093-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2014.04.008</ArticleId><ArticleId IdType="pubmed">24747879</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhombres F, Bodenreider O. Interoperability between phenotypes in research and healthcare terminologies--Investigating partial mappings between HPO and SNOMED CT. J Biomed Semantics. 2016;7:3. doi: 10.1186/s13326-016-0047-3. 
 
47</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13326-016-0047-3</ArticleId><ArticleId IdType="doi">10.1186/s13326-016-0047-3</ArticleId><ArticleId IdType="pmc">PMC4748471</ArticleId><ArticleId IdType="pubmed">26865946</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugas M, Neuhaus P, Meidt A, Doods J, Storck M, Bruland P, Varghese J. Portal of medical data models: information infrastructure for medical research and healthcare. Database (Oxford) 2016;2016:bav121. doi: 10.1093/database/bav121. 
 
bav121</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/database/bav121</ArticleId><ArticleId IdType="doi">10.1093/database/bav121</ArticleId><ArticleId IdType="pmc">PMC4750548</ArticleId><ArticleId IdType="pubmed">26868052</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, Sauer BC, Liu Q, Moll K, Pasquale MK, Nair VP, Bate A. A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance. Drug Saf. 2015 Aug;38(8):749&#x2013;65. doi: 10.1007/s40264-015-0297-5.10.1007/s40264-015-0297-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-015-0297-5</ArticleId><ArticleId IdType="pubmed">26055920</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016 Dec;64:333&#x2013;341. doi: 10.1016/j.jbi.2016.10.016. 
 
S1532-0464(16)30153-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann JG, Abend A, Raghavan VA, Mandl KD, Murphy SN. Data interchange using i2b2. J Am Med Inform Assoc. 2016 Sep;23(5):909&#x2013;15. doi: 10.1093/jamia/ocv188. 
 
ocv188</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv188</ArticleId><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>Hume S, Aerts J, Sarnikar S, Huser V. Current applications and future directions for the CDISC Operational Data Model standard: A methodological review. J Biomed Inform. 2016 Apr;60:352&#x2013;62. doi: 10.1016/j.jbi.2016.02.016. 
 
S1532-0464(16)00038-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.02.016</ArticleId><ArticleId IdType="pmc">PMC4837012</ArticleId><ArticleId IdType="pubmed">26944737</ArticleId></ArticleIdList></Reference><Reference><Citation>Liyanage H, Liaw S, Jonnagaddala J, Hinton W, de Lusignan S. Common Data Models (CDMs) to Enhance International Big Data Analytics: A Diabetes Use Case to Compare Three CDMs. Stud Health Technol Inform. 2018;255:60&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">30306907</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, Overhage JM, Hartzema AG, Reich C, Welebob E, Scarnecchia T, Woodcock J. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med. 2010 Nov 02;153(9):600&#x2013;6. doi: 10.7326/0003-4819-153-9-201011020-00010.153/9/600</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-153-9-201011020-00010</ArticleId><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60. doi: 10.1136/amiajnl-2011-000376. 
 
amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li Y, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics.  [2019-05-03].  
 https://www.ohdsi.org/
</Citation></Reference><Reference><Citation>Areas of Focus. Observational Health Data Sciences and Informatics.  [2022-07-07].  
 https://www.ohdsi.org/who-we-are/areas-of-focus/
</Citation></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, Reich CG, Duke J, Madigan D, Hripcsak G, Ryan PB. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019 Nov 16;394(10211):1816&#x2013;1826. doi: 10.1016/S0140-6736(19)32317-7. 
 
S0140-6736(19)32317-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, You SC, Sena AG, Kostka K, Abedtash H, Abrah&#xe3;o MTF, Alberga A, Alghoul H, Alser O, Alshammari TM, Aragon M, Areia C, Banda JM, Cho J, Culhane AC, Davydov A, DeFalco FJ, Duarte-Salles T, DuVall S, Falconer T, Fernandez-Bertolin S, Gao W, Golozar A, Hardin J, Hripcsak G, Huser V, Jeon H, Jing Y, Jung CY, Kaas-Hansen BS, Kaduk D, Kent S, Kim Y, Kolovos S, Lane JCE, Lee H, Lynch KE, Makadia R, Matheny ME, Mehta PP, Morales DR, Natarajan K, Nyberg F, Ostropolets A, Park RW, Park J, Posada JD, Prats-Uribe A, Rao G, Reich C, Rho Y, Rijnbeek P, Schilling LM, Schuemie M, Shah NH, Shoaibi A, Song S, Spotnitz M, Suchard MA, Swerdel JN, Vizcaya D, Volpe S, Wen H, Williams AE, Yimer BB, Zhang L, Zhuk O, Prieto-Alhambra D, Ryan P. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun. 2020 Oct 06;11(1):5009. doi: 10.1038/s41467-020-18849-z. doi: 10.1038/s41467-020-18849-z.10.1038/s41467-020-18849-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Belenkaya R, Gurley MJ, Golozar A, Dymshyts D, Miller RT, Williams AE, Ratwani S, Siapos A, Korsik V, Warner J, Campbell WS, Rivera D, Banokina T, Modina E, Bethusamy S, Stewart HM, Patel M, Chen R, Falconer T, Park RW, You SC, Jeon H, Shin SJ, Reich C. Extending the OMOP Common Data Model and Standardized Vocabularies to Support Observational Cancer Research. JCO Clin Cancer Inform. 2021 Jan;5:12&#x2013;20. doi: 10.1200/CCI.20.00079. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.20.00079?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed</ArticleId><ArticleId IdType="doi">10.1200/CCI.20.00079</ArticleId><ArticleId IdType="pmc">PMC8140810</ArticleId><ArticleId IdType="pubmed">33411620</ArticleId></ArticleIdList></Reference><Reference><Citation>Conversion of Diagnosis and Chemotherapy Data in Electronic Health Records to Episode-based Oncology Extension of OMOP-CDM. Observational Health Data Sciences and Informatics.  [2021-10-22].  
 https://www.ohdsi.org/2019-us-symposium-&#x200b;showcase-12/
</Citation></Reference><Reference><Citation>Warner JL, Dymshyts D, Reich CG, Gurley MJ, Hochheiser H, Moldwin ZH, Belenkaya R, Williams AE, Yang PC. HemOnc: A new standard vocabulary for chemotherapy regimen representation in the OMOP common data model. J Biomed Inform. 2019 Aug;96:103239. doi: 10.1016/j.jbi.2019.103239. 
 
S1532-0464(19)30158-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103239</ArticleId><ArticleId IdType="pmc">PMC6697579</ArticleId><ArticleId IdType="pubmed">31238109</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon H, You SC, Kang SY, Seo SI, Warner JL, Belenkaya R, Park RW. Characterizing the Anticancer Treatment Trajectory and Pattern in Patients Receiving Chemotherapy for Cancer Using Harmonized Observational Databases: Retrospective Study. JMIR Med Inform. 2021 Apr 06;9(4):e25035. doi: 10.2196/25035. 
 
v9i4e25035</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/25035</ArticleId><ArticleId IdType="pmc">PMC8058693</ArticleId><ArticleId IdType="pubmed">33720842</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudemaghe T, Belhadj I. Data Resource Profile: The French National Uniform Hospital Discharge Data Set Database (PMSI) Int J Epidemiol. 2017 Apr 01;46(2):392&#x2013;392d. doi: 10.1093/ije/dyw359.2972209</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw359</ArticleId><ArticleId IdType="pubmed">28168290</ArticleId></ArticleIdList></Reference><Reference><Citation>Scailteux L, Droitcourt C, Balusson F, Nowak E, Kerbrat S, Dupuy A, Drezen E, Happe A, Oger E. French administrative health care database (SNDS): The value of its enrichment. Therapie. 2019 Apr;74(2):215&#x2013;223. doi: 10.1016/j.therap.2018.09.072.S0040-5957(18)30240-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.therap.2018.09.072</ArticleId><ArticleId IdType="pubmed">30392702</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Jeanne M, Vallet B, Ditilyeu G, Delaby F, Tavernier B, Logier R. Development of an anesthesia data warehouse: Preliminary results. IRBM. 2013 Dec;34(6):376&#x2013;378. doi: 10.1016/j.irbm.2013.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.irbm.2013.09.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberger AL, Amaral LA, Glass L, Hausdorff JM, Ivanov PC, Mark RG, Mietus JE, Moody GB, Peng CK, Stanley HE. PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation. 2000 Jun 13;101(23):E215&#x2013;20. doi: 10.1161/01.cir.101.23.e215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.101.23.e215</ArticleId><ArticleId IdType="pubmed">10851218</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson AEW, Pollard TJ, Shen L, Lehman LH, Feng M, Ghassemi M, Moody B, Szolovits P, Celi LA, Mark RG. MIMIC-III, a freely accessible critical care database. Sci Data. 2016 May 24;3:160035. doi: 10.1038/sdata.2016.35. doi: 10.1038/sdata.2016.35.sdata201635</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2016.35</ArticleId><ArticleId IdType="doi">10.1038/sdata.2016.35</ArticleId><ArticleId IdType="pmc">PMC4878278</ArticleId><ArticleId IdType="pubmed">27219127</ArticleId></ArticleIdList></Reference><Reference><Citation>French A, Taylor LK, Lemke MR. Chapter 6 - Task analysis. In: Privitera MB, editor. Applied Human Factors in Medical Device Design. Cambridge, MA: Academic Press; 2019. pp. 63&#x2013;81.</Citation></Reference><Reference><Citation>Popoff B, Besnier E, Dureuil B, Veber B, Clavier T. Effect of early hyperoxemia on mortality in mechanically ventilated septic shock patients according to Sepsis-3 criteria: analysis of the MIMIC-III database. Eur J Emerg Med. 2021 Dec 01;28(6):469&#x2013;475. doi: 10.1097/MEJ.0000000000000854.00063110-900000000-99022</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEJ.0000000000000854</ArticleId><ArticleId IdType="pubmed">34285171</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurent G, Moussa MD, Cirenei C, Tavernier B, Marcilly R, Lamer A. Development, implementation and preliminary evaluation of clinical dashboards in a department of anesthesia. J Clin Monit Comput. 2021 May;35(3):617&#x2013;626. doi: 10.1007/s10877-020-00522-x. 
 
10.1007/s10877-020-00522-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-020-00522-x</ArticleId><ArticleId IdType="pmc">PMC7229430</ArticleId><ArticleId IdType="pubmed">32418147</ArticleId></ArticleIdList></Reference><Reference><Citation>Laroche M, Charmes J, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007 Aug;63(8):725&#x2013;31. doi: 10.1007/s00228-007-0324-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-007-0324-2</ArticleId><ArticleId IdType="pubmed">17554532</ArticleId></ArticleIdList></Reference><Reference><Citation>Chazard E, Boudry A, Beeler PE, Dalleur O, Hubert H, Tr&#xe9;hou E, Beuscart J, Bates DW. Towards The Automated, Empirical Filtering of Drug-Drug Interaction Alerts in Clinical Decision Support Systems: Historical Cohort Study of Vitamin K Antagonists. JMIR Med Inform. 2021 Jan 20;9(1):e20862. doi: 10.2196/20862. 
 
v9i1e20862</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/20862</ArticleId><ArticleId IdType="pmc">PMC7857948</ArticleId><ArticleId IdType="pubmed">33470938</ArticleId></ArticleIdList></Reference><Reference><Citation>EPISODE. Observational Health Data Sciences and Informatics.  [2021-10-21].  
 https://ohdsi.github.io/CommonDataModel/cdm54.html#EPISODE
.</Citation></Reference><Reference><Citation>Liang H, Sun X, Sun Y, Gao Y. Text feature extraction based on deep learning: a review. EURASIP J Wirel Commun Netw. 2017;2017(1):211. doi: 10.1186/s13638-017-0993-1. 
 
993</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13638-017-0993-1</ArticleId><ArticleId IdType="pmc">PMC5732309</ArticleId><ArticleId IdType="pubmed">29263717</ArticleId></ArticleIdList></Reference><Reference><Citation>LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015 May 28;521(7553):436&#x2013;44. doi: 10.1038/nature14539.nature14539</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14539</ArticleId><ArticleId IdType="pubmed">26017442</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters M, Neumann M, Iyyer M, Gardner M, Clark C, Lee K, Zettlemoyer L. Deep contextualized word representations. arXiv. 2018.  [2022-09-24].  
 https://arxiv.org/abs/1802.05365
.</Citation></Reference><Reference><Citation>Devlin J, Chang M, Lee K, Toutanova K. BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding. arXiv. 2019.  [2022-09-24].  
 https://arxiv.org/abs/1810.04805
.</Citation></Reference><Reference><Citation>Brown T, Mann B, Ryder N, Subbiah M, Kaplan J, Dhariwal P, Neelakantan A, Shyam P, Sastry G, Askell A, Agarwal S, Herbert-Voss A, Krueger G, Henighan T, Child R, Ramesh A, Ziegler D, Wu J, Winter C, Hesse C, Chen M, Sigler E, Litwin M, Gray S, Chess B, Clark J, Berner C, McCandlish S, Radford A, Sutskever I, Amodei D. Language Models are Few-Shot Learners. arXiv. 2020.  [2022-09-24].  
 https://arxiv.org/abs/2005.14165
.</Citation></Reference><Reference><Citation>Alsentzer E, Murphy J, Boag W, Weng W, Jin D, Naumann T, McDermott M. Publicly Available Clinical BERT Embeddings. arXiv. 2019.  [2022-09-24].  
 https://arxiv.org/abs/1904.03323
.</Citation></Reference><Reference><Citation>Copara J, Knafou J, Naderi N, Moro C, Ruch P, Teodoro D. Contextualized French Language Models for Biomedical Named Entity Recognition. HAL Archives.  [2022-07-18].  
 https://hal.archives-ouvertes.fr/hal-02784740
.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated"><PMID Version="2">36264262</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>16</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Integrating real-world data from Brazil and Pakistan into the OMOP common data model and standardized health analytics framework to characterize COVID-19 in the Global South.</ArticleTitle><Pagination><StartPage>643</StartPage><EndPage>655</EndPage><MedlinePgn>643-655</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocac180</ELocationID><Abstract><AbstractText Label="OBJECTIVES">The aim of this work is to demonstrate the use of a standardized health informatics framework to generate reliable and reproducible real-world evidence from Latin America and South Asia towards characterizing coronavirus disease 2019 (COVID-19) in the Global South.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Patient-level COVID-19 records collected in a patient self-reported notification system, hospital in-patient and out-patient records, and community diagnostic labs were harmonized to the Observational Medical Outcomes Partnership common data model and analyzed using a federated network analytics framework. Clinical characteristics of individuals tested for, diagnosed with or tested positive for, hospitalized with, admitted to intensive care unit with, or dying with COVID-19 were estimated.</AbstractText><AbstractText Label="RESULTS">Two COVID-19 databases covering 8.3 million people from Pakistan and 2.6 million people from Bahia, Brazil were analyzed. 109&#xa0;504 (Pakistan) and 921 (Brazil) medical concepts were harmonized to Observational Medical Outcomes Partnership common data model. In total, 341&#xa0;505 (4.1%) people in the Pakistan dataset and 1&#xa0;312&#xa0;832 (49.2%) people in the Brazilian dataset were tested for COVID-19 between January 1, 2020 and April 20, 2022, with a median [IQR] age of 36 [25, 76] and 38 (27, 50); 40.3% and 56.5% were female in Pakistan and Brazil, respectively. 1.2% percent individuals in the Pakistan dataset had Afghan ethnicity. In Brazil, 52.3% had mixed ethnicity. In agreement with international findings, COVID-19 outcomes were more severe in men, elderly, and those with underlying health conditions.</AbstractText><AbstractText Label="CONCLUSIONS">COVID-19 data from 2 large countries in the Global South were harmonized and analyzed using a standardized health informatics framework developed by an international community of health informaticians. This proof-of-concept study demonstrates a potential open science framework for global knowledge mobilization and clinical translation for timely response to healthcare needs in pandemics and beyond.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Junior</LastName><ForeName>Elzo Pereira Pinto</ForeName><Initials>EPP</Initials><Identifier Source="ORCID">0000-0002-6977-2071</Identifier><AffiliationInfo><Affiliation>Center of Data and Knowledge Integration for Health (Cidacs), Fiocruz-Brazil, Parque Tecnol&#xf3;gico da Edf, Tecnocentro, R. Mundo, Salvador, BA 41745-715, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Normando</LastName><ForeName>Priscilla</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Center of Data and Knowledge Integration for Health (Cidacs), Fiocruz-Brazil, Parque Tecnol&#xf3;gico da Edf, Tecnocentro, R. Mundo, Salvador, BA 41745-715, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flores-Ortiz</LastName><ForeName>Renzo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center of Data and Knowledge Integration for Health (Cidacs), Fiocruz-Brazil, Parque Tecnol&#xf3;gico da Edf, Tecnocentro, R. Mundo, Salvador, BA 41745-715, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afzal</LastName><ForeName>Muhammad Usman</ForeName><Initials>MU</Initials><AffiliationInfo><Affiliation>Shaukat Khanum Memorial Cancer Hospital and Research Centre, Johar Town, Lahore, 54840, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamil</LastName><ForeName>Muhammad Asaad</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Shaukat Khanum Memorial Cancer Hospital and Research Centre, Johar Town, Lahore, 54840, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertolin</LastName><ForeName>Sergio Fernandez</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut, Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, 587 08007, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Vin&#xed;cius de Ara&#xfa;jo</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Center of Data and Knowledge Integration for Health (Cidacs), Fiocruz-Brazil, Parque Tecnol&#xf3;gico da Edf, Tecnocentro, R. Mundo, Salvador, BA 41745-715, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martufi</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Center of Data and Knowledge Integration for Health (Cidacs), Fiocruz-Brazil, Parque Tecnol&#xf3;gico da Edf, Tecnocentro, R. Mundo, Salvador, BA 41745-715, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Sousa</LastName><ForeName>Fernanda</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center of Data and Knowledge Integration for Health (Cidacs), Fiocruz-Brazil, Parque Tecnol&#xf3;gico da Edf, Tecnocentro, R. Mundo, Salvador, BA 41745-715, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bashir</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Shaukat Khanum Memorial Cancer Hospital and Research Centre, Johar Town, Lahore, 54840, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9286-1128</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ichihara</LastName><ForeName>Maria Yury</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Center of Data and Knowledge Integration for Health (Cidacs), Fiocruz-Brazil, Parque Tecnol&#xf3;gico da Edf, Tecnocentro, R. Mundo, Salvador, BA 41745-715, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barreto</LastName><ForeName>Maur&#xed;cio L</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0000-0002-0215-4930</Identifier><AffiliationInfo><Affiliation>Center of Data and Knowledge Integration for Health (Cidacs), Fiocruz-Brazil, Parque Tecnol&#xf3;gico da Edf, Tecnocentro, R. Mundo, Salvador, BA 41745-715, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salles</LastName><ForeName>Talita Duarte</ForeName><Initials>TD</Initials><Identifier Source="ORCID">0000-0002-8274-0357</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut, Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, 587 08007, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3950-6346</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hafeez</LastName><ForeName>Haroon</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Shaukat Khanum Memorial Cancer Hospital and Research Centre, Johar Town, Lahore, 54840, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalid</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-2845-5731</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, Botnar Research Centre, University of Oxford, Oxford, OX3 7LD, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010154" MajorTopicYN="N" Type="Geographic">Pakistan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">OMOP common data model</Keyword><Keyword MajorTopicYN="N">federated data network</Keyword><Keyword MajorTopicYN="N">health equity</Keyword><Keyword MajorTopicYN="N">observational data</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>20</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36264262</ArticleId><ArticleId IdType="pmc">PMC9619798</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocac180</ArticleId><ArticleId IdType="pii">6764682</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Hannah R, Edouard M, Lucas R, et al. Coronavirus Pandemic (COVID-19). https://ourworldindata.org/coronavirus. Accessed April 20, 2022.</Citation></Reference><Reference><Citation>
John Hopkins University Coronavirus Resource Centre. https://coronavirus.jhu.edu/. Accessed April 20, 2022.</Citation></Reference><Reference><Citation>Pareek M, Bangash MN, Pareek N, et al.Ethnicity and COVID-19: an urgent public health research priority. Lancet 2020; 395 (10234): 1421&#x2013;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7173801</ArticleId><ArticleId IdType="pubmed">32330427</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison EM, Docherty AB, Barr B, et al. Ethnicity and outcomes from COVID-19: the ISARIC CCP-UK prospective observational cohort study of hospitalised patients. Preprints with TheLancet2020.</Citation></Reference><Reference><Citation>Bakken S. Informatics is a critical strategy in combating the COVID-19 pandemic. J Am Med Inform Assoc 2020; 27 (6): 843&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313991</ArticleId><ArticleId IdType="pubmed">32501484</ArticleId></ArticleIdList></Reference><Reference><Citation>Obeid JS, Tarczy-Hornoch P, Harris PA, et al.Sustainability considerations for clinical and translational research informatics infrastructure. J Clin Transl Sci 2018; 2 (5): 267&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6390401</ArticleId><ArticleId IdType="pubmed">30828467</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Luque L, Kushniruk AW, Georgiou A, et al.Evidence-based health informatics as the foundation for the COVID-19 response: a joint call for action. Methods Inf Med 2021; 59 (6): 183&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8279811</ArticleId><ArticleId IdType="pubmed">33975375</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt RW, Platt R, Brown JS, Henry DA, Klungel OH, Suissa S.. How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias. Pharmacoepidemiol Drug Saf 2019; 29 (S1): 3&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">30648307</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent S, Burn E, Dawoud D, et al.Common problems, common data model solutions: evidence generation for health technology assessment. Pharmacoeconomics 2021; 39 (3): 275&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7746423</ArticleId><ArticleId IdType="pubmed">33336320</ArticleId></ArticleIdList></Reference><Reference><Citation>
European Medicines Agency. A Common Data Model for Europe?&#x2014;Why? Which? How? 2018. https://www.ema.europa.eu/en/documents/report/common-data-model-europe-why-which-how-workshop-report_en.pdf. Accessed April 20, 2022.</Citation></Reference><Reference><Citation>Brown JS, Holmes JH, Shah K, et al.Distributed health data networks: a practical and preferred approach to multi-institutional evaluations of comparative effectiveness, safety, and quality of care. Med Care 2010; 48 (6 Suppl): S45&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">20473204</ArticleId></ArticleIdList></Reference><Reference><Citation>
Observational Health Data Sciences and Informatics. https://ohdsi.org/who-we-are/collaborators/. Accessed April 20, 2022.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al.Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015; 216: 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al.Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc 2015; 22 (3): 553&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE.. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc 2012; 19 (1): 54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x201c;The Book of OHDSI&#x201d; Observational Health Data Sciences and Informatics. 2020. https://ohdsi.github.io/TheBookOfOhdsi/. Accessed December 7, 2020.</Citation></Reference><Reference><Citation>Burn E, You SC, Sena AG, et al.Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun 2020; 11 (1): 5009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps J, Schuemie M, Suchard M, et al.Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc 2018; 25 (8): 969&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>
COVID-19: reminder of risk of serious side effects with chloroquine and hydroxychloroquine. European Medicines Agency, Amsterdam, The Netherlands. https://www.ema.europa.eu/en/news/covid-19-reminder-risk-serious-side-effects-chloroquine-hydroxychloroquine. Accessed April 23, 2020.</Citation></Reference><Reference><Citation>Lane JCE, Weaver J, Kostka K, et al.Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol 2020; 2 (11): e698&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7442425</ArticleId><ArticleId IdType="pubmed">32864627</ArticleId></ArticleIdList></Reference><Reference><Citation>
EMA COVID-19 Vaccines Authorised. https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines-covid-19.Accessed April 20, 2022.</Citation></Reference><Reference><Citation>Li X, Ostropolets A, Makadia R, et al.Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ 2021; 373: n1435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8193077</ArticleId><ArticleId IdType="pubmed">35727911</ArticleId></ArticleIdList></Reference><Reference><Citation>Golozar A, Lai LY, Sena AG, et al. Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including&gt; 3.32 million people tested with real-time PCR and&gt; 219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States. medRxiv2020. DOI: 10.1101/2020.10.25.20218875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.25.20218875</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai LYH, Golozar A, Sena A, et al. Clinical characteristics, symptoms, management and health outcomes in 8,598 pregnant women diagnosed with COVID-19 compared to 27,510 with seasonal influenza in France, Spain and the US: a network cohort analysis. medRxiv2020. DOI: 10.1101/2020.10.13.20211821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.13.20211821</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane JCE, Weaver J, Kostka K, et al. Risk of depression, suicidal ideation, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multi-national network cohort study. medRxiv2020. DOI: 10.1101/2020.07.17.20156059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.17.20156059</ArticleId><ArticleId IdType="pmc">PMC7798671</ArticleId><ArticleId IdType="pubmed">33367863</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalid S, Yang C, Blacketer C, et al.A standardized analytics pipeline for reliable and rapid development and validation of prediction models using observational health data. Comput Methods Programs Biomed 2021; 211: 106394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420135</ArticleId><ArticleId IdType="pubmed">34560604</ArticleId></ArticleIdList></Reference><Reference><Citation>Prats-Uribe A, Sena AG, Lai LYH, et al. Heterogeneity and temporal variation in the management of COVID-19: a multinational drug utilization study including 71,921 hospitalized patients from China, South Korea, Spain, and the United States of America. medRxiv2020. DOI: 10.1101/2020.09.15.20195545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.15.20195545</ArticleId></ArticleIdList></Reference><Reference><Citation>Recalde M, Roel E, Pistillo A, et al. Characteristics and outcomes of 627 044 COVID-19 patients with and without obesity in the United States, Spain, and the United Kingdom. medRxiv2020. DOI: 10.1101/2020.09.02.20185173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.02.20185173</ArticleId><ArticleId IdType="pmc">PMC8281807</ArticleId><ArticleId IdType="pubmed">34267326</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Kim C, Williams RD, et al. Can we trust the prediction model? Demonstrating the importance of external validation by investigating the COVID-19 Vulnerability (C-19) Index across an international network of observational healthcare datasets. medRxiv2020. DOI: 10.1101/2020.06.15.20130328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.15.20130328</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoaibi A, Fortin S, Weinstein R, et al. Comparative effectiveness of famotidine in hospitalized COVID-19 patients. medRxiv2020. DOI: 10.1101/2020.09.23.20199463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.23.20199463</ArticleId><ArticleId IdType="pubmed">33982938</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams RD, Markus AF, Yang C, et al. Seek COVER: development and validation of a personalized risk calculator for COVID-19 outcomes in an international network. medRxiv2020. DOI: 10.1101/2020.05.26.20112649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.05.26.20112649</ArticleId><ArticleId IdType="pmc">PMC8801189</ArticleId><ArticleId IdType="pubmed">35094685</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales DR, Conover MM, You SC, et al.Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Lancet Digit Health 2020; 3 (2): e98&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834915</ArticleId><ArticleId IdType="pubmed">33342753</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostka K, Duarte-Salles T, Khalid S, et al.Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS. Clin Epidemiol 2022; 14: 369&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957305</ArticleId><ArticleId IdType="pubmed">35345821</ArticleId></ArticleIdList></Reference><Reference><Citation>Prats-Uribe A, Sena A, Lai L, et al.Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. BMJ 2021; 373: n1038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8111167</ArticleId><ArticleId IdType="pubmed">33975825</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze S, Pan D, Nevill C, et al.Ethnicity and clinical outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine 2020; 29: 100630. doi:10.1016/j.eclinm.2020.100630</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100630</ArticleId><ArticleId IdType="pmc">PMC7658622</ArticleId><ArticleId IdType="pubmed">33200120</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynants L, Van Calster B, Collins GS, et al.Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ 2020; 369: m1328. doi:10.1136/bmj.m1328</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1328</ArticleId><ArticleId IdType="pmc">PMC7222643</ArticleId><ArticleId IdType="pubmed">32265220</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36281513</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2234-3814</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Annals of laboratory medicine</Title><ISOAbbreviation>Ann Lab Med</ISOAbbreviation></Journal><ArticleTitle>Common Data Model-based Analysis of Selective Leukoreduction Protocol Compliance at Three Hospitals.</ArticleTitle><Pagination><StartPage>187</StartPage><EndPage>195</EndPage><MedlinePgn>187-195</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3343/alm.2023.43.2.187</ELocationID><Abstract><AbstractText Label="BACKGROUND">The selective leukoreduction protocol (SLP) is limited in that patients who require it can be overlooked. We estimated SLP compliance (SLPC) using the Observational Medical Outcomes Partnership common data model (CDM).</AbstractText><AbstractText Label="METHODS">Patients were classified into eight groups: pre- and post-hematology disease (A and B), pre- and post-solid organ transplantation (C and D), solid cancer (E), immunodeficiency (F), anticancer therapy (G), and cardiovascular surgery (H). We examined the red blood cell (RBC) transfusion history from three hospital datasets comprising approximately three million patients over 20 years using CDM-based analysis. SLPC was calculated as the percentage of patients who received only leukoreduced RBCs in total patients transfused RBCs.</AbstractText><AbstractText Label="RESULTS">In total, 166,641 patients from three hospitals were enrolled in this study. From 2001 to 2021, SLPC in all groups, except H, tended to increase, although there were differences among the hospitals. Based on the most recent values (2017-2021), the SLPC in groups A, B, D, and G was maintained at &#x2265;75% until 1,095 days before or after diagnosis or treatment. Groups E, F, and H had &lt; 50% SLPC one day after diagnosis and treatment.</AbstractText><AbstractText Label="CONCLUSIONS">CDM analysis supports the review of large datasets for SLPC evaluation. Although SLPC tended to improve in most patient groups, additional education and monitoring are needed for groups that continue to show low SLPC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Sooin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4746-4809</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Genetics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Soo Jeong</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0003-3650-0798</Identifier><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Jeong Won</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0001-6913-4793</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Young Ahn</ForeName><Initials>YA</Initials><Identifier Source="ORCID">0000-0002-8284-6303</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Ann Lab Med</MedlineTA><NlmUniqueID>101571172</NlmUniqueID><ISSNLinking>2234-3806</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019983" MajorTopicYN="Y">Guideline Adherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="Y">Erythrocyte Transfusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004912" MajorTopicYN="N">Erythrocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dataset</Keyword><Keyword MajorTopicYN="N">Hematologic disease</Keyword><Keyword MajorTopicYN="N">Immunodeficiency disease</Keyword><Keyword MajorTopicYN="N">Leukocyte reduction</Keyword><Keyword MajorTopicYN="N">Red blood cell transfusion</Keyword><Keyword MajorTopicYN="N">Transplantation</Keyword></KeywordList><CoiStatement>
<b>CONFLICTS OF INTEREST</b>
. The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>25</Day><Hour>2</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36281513</ArticleId><ArticleId IdType="pmc">PMC9618907</ArticleId><ArticleId IdType="doi">10.3343/alm.2023.43.2.187</ArticleId><ArticleId IdType="pii">alm.2023.43.2.187</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ratko TA, Cummings JP, Oberman HA, Crookston KP, DeChristopher PJ, Eastlund DT, et al. Evidence&#x2010;based recommendations for the use of WBC&#x2010;reduced cellular blood components. Transfusion. 2001;41:1310&#x2013;9. doi: 10.1046/j.1537-2995.2001.41101310.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1537-2995.2001.41101310.x</ArticleId><ArticleId IdType="pubmed">11606834</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassuni WY, Blajchman MA, Al-Moshary MA. Why implement universal leukoreduction? Hematol. Oncol Stem Cell Ther. 2008;1:106&#x2013;23. doi: 10.1016/S1658-3876(08)50042-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1658-3876(08)50042-2</ArticleId><ArticleId IdType="pubmed">20063539</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SJ, Kim S, Kim HO, Kwon JR, Lee SW, Shin YH. The status of use of leukoreduced blood products in Korean hospitals. Lab Med Online. 2012;2:204&#x2013;8. doi: 10.3343/lmo.2012.2.4.204.</Citation><ArticleIdList><ArticleId IdType="doi">10.3343/lmo.2012.2.4.204</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker BI, Hinkins S. The 2011 national blood collection and utilization survey report. United States Department of Health and Human Services. 2011:1&#x2013;88.</Citation></Reference><Reference><Citation>Trial to Reduce Alloimmunization to Platelets Study Group, author. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med. 1997;337:1861&#x2013;9. doi: 10.1056/NEJM199712253372601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199712253372601</ArticleId><ArticleId IdType="pubmed">9417523</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S, Choi SJ, Kim JK, Nam KC, Lee S, Kim JH, et al. Preliminary feasibility assessment of CDM-based active surveillance using current status of medical device data in medical records and OMOP-CDM. Sci Rep. 2021;11:24070. doi: 10.1038/s41598-021-03332-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-03332-6</ArticleId><ArticleId IdType="pmc">PMC8674329</ArticleId><ArticleId IdType="pubmed">34911976</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Park RW. The distributed research network, observational health data sciences and informatics, and the South Korean research network. Korean J Med. 2019;94:309&#x2013;14. doi: 10.3904/kjm.2019.94.4.309.</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjm.2019.94.4.309</ArticleId></ArticleIdList></Reference><Reference><Citation>Seong Y, You SC, Ostropolets A, Rho Y, Park J, Cho J, et al. Incorporation of Korean electronic data interchange vocabulary into observational medical outcomes partnership vocabulary. Healthc Inform Res. 2021;27:29&#x2013;38. doi: 10.4258/hir.2021.27.1.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2021.27.1.29</ArticleId><ArticleId IdType="pmc">PMC7921574</ArticleId><ArticleId IdType="pubmed">33611874</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo BN, Kwon MA, Kim SH, Kim JY, Moon YJ, Park SY, et al. Korean clinical practice guideline for perioperative red blood cell transfusion from Korean Society of Anesthesiologists. Korean J Anesthesiol. 2019;72:91&#x2013;118. doi: 10.4097/kja.d.18.00322.</Citation><ArticleIdList><ArticleId IdType="doi">10.4097/kja.d.18.00322</ArticleId><ArticleId IdType="pmc">PMC6458508</ArticleId><ArticleId IdType="pubmed">30513567</ArticleId></ArticleIdList></Reference><Reference><Citation>National organ tissue blood management agency, author. Korean national transfusion guideline. 5th ed. National organ tissue blood management agency; Seoul: 2022. pp. 56&#x2013;8.</Citation></Reference><Reference><Citation>Choi S, Hyun J, Yu H, Cho D. ABO-incompatible transfusion events reported in written judgments and in the Korean hemovigilance system. Ann Lab Med. 2021;41:493&#x2013;8. doi: 10.3343/alm.2021.41.5.493.</Citation><ArticleIdList><ArticleId IdType="doi">10.3343/alm.2021.41.5.493</ArticleId><ArticleId IdType="pmc">PMC8041592</ArticleId><ArticleId IdType="pubmed">33824239</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar S, Seshadri D. Conducting record review studies in clinical practice. J Clin Diagn Res. 2014;8:JG01&#x2013;04. doi: 10.7860/JCDR/2014/8301.4806.</Citation><ArticleIdList><ArticleId IdType="doi">10.7860/JCDR/2014/8301.4806</ArticleId><ArticleId IdType="pmc">PMC4225918</ArticleId><ArticleId IdType="pubmed">25386466</ArticleId></ArticleIdList></Reference><Reference><Citation>Song MJ, Kim S, Boo D, Park C, Yoo S, Yoon HI, et al. Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit. Sci Rep. 2021;11:18467. doi: 10.1038/s41598-021-98069-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-98069-7</ArticleId><ArticleId IdType="pmc">PMC8446063</ArticleId><ArticleId IdType="pubmed">34531488</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephson CD, Glynn S, Mathew S, Birch R, Bakkour S, Baumann Kreuziger L, et al. The Recipient Epidemiology and Donor Evaluation Study&#x2010;IV&#x2010;Pediatric (REDS&#x2010;IV&#x2010;P): a research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan. Transfusion. 2022;62:982&#x2013;99. doi: 10.1111/trf.16869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.16869</ArticleId><ArticleId IdType="pmc">PMC9353062</ArticleId><ArticleId IdType="pubmed">35441384</ArticleId></ArticleIdList></Reference><Reference><Citation>Leffell MS, Kim D, Vega RM, Zachary AA, Petersen J, Hart JM, et al. Red blood cell transfusions and the risk of allosensitization in patients awaiting primary kidney transplantation. Transplantation. 2014;97:525&#x2013;33. doi: 10.1097/01.tp.0000437435.19980.8f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.tp.0000437435.19980.8f</ArticleId><ArticleId IdType="pubmed">24300013</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S, Lee KW, Park JB, Kim K, Jang HR, Huh W, et al. C3d-positive preformed DSAs tend to persist and result in a higher risk of AMR after kidney transplants. J Clin Med. 2020;9:375. doi: 10.3390/jcm9020375.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9020375</ArticleId><ArticleId IdType="pmc">PMC7073748</ArticleId><ArticleId IdType="pubmed">32019081</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallis JP, Chapman CE, Orr KE, Clark SC, Forty JR. Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion. 2002;42:1127&#x2013;34. doi: 10.1046/j.1537-2995.2002.00181.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1537-2995.2002.00181.x</ArticleId><ArticleId IdType="pubmed">12430668</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu YJ, devries AJ, Boonstra PW, van Oeveren W. Clinical performance of a high-efficiency rapid flow leucocyte removal filter for leucocyte depletion of heparinized cardiopulmonary bypass perfusate. Perfusion. 1995;10:425&#x2013;30. doi: 10.1177/026765919501000606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/026765919501000606</ArticleId><ArticleId IdType="pubmed">8747899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HI, Yoon JY, Kwak MS, Cha JM. Real-world use of colonoscopy in an older population: A nationwide standard cohort study using a common data model. Dig Dis Sci. 2021;66:2227&#x2013;34. doi: 10.1007/s10620-020-06494-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-020-06494-x</ArticleId><ArticleId IdType="pubmed">32691386</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon JY, Kwak MS, Kim HI, Cha JM. Seasonal variations in the diagnosis of the top 10 cancers in Korea: a nationwide population&#x2010;based study using a common data model. J Gastroenterol Hepatol. 2021;36:3371&#x2013;80. doi: 10.1111/jgh.15634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15634</ArticleId><ArticleId IdType="pubmed">34293206</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36283581</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Ontology-based categorization of clinical studies by their conditions.</ArticleTitle><Pagination><StartPage>104235</StartPage><MedlinePgn>104235</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2022.104235</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(22)00240-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The free-text Condition data field in the ClinicalTrials.gov is not amenable to computational processes for retrieving, aggregating and visualizing clinical studies by condition categories. This paper contributes a method for automated ontology-based categorization of clinical studies by their conditions.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Our method first maps text entries in ClinicalTrials.gov's Condition field to standard condition concepts in the OMOP Common Data Model by using SNOMED CT as a reference ontology and using Usagi for concept normalization, followed by hierarchical traversal of the SNOMED ontology for concept expansion, ontology-driven condition categorization, and visualization. We compared the accuracy of this method to that of the MeSH-based method.</AbstractText><AbstractText Label="RESULTS">We reviewed the 4,506 studies on Vivli.org categorized by our method. Condition terms of 4,501 (99.89%) studies were successfully mapped to SNOMED CT concepts, and with a minimum concept mapping score threshold, 4,428 (98.27%) studies were categorized into 31 predefined categories. When validating with manual categorization results on a random sample of 300 studies, our method achieved an estimated categorization accuracy of 95.7%, while the MeSH-based method had an accuracy of 85.0%.</AbstractText><AbstractText Label="CONCLUSION">We showed that categorizing clinical studies using their Condition terms with referencing to SNOMED CT achieved a better accuracy and coverage than using MeSH terms. The proposed ontology-driven condition categorization was useful to create accurate clinical study categorization that enables clinical researchers to aggregate evidence from a large number of clinical studies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carini</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhehuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips Hey</LastName><ForeName>Spencer</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Prism Analytic Technologies, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim</LastName><ForeName>Ida</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA. Electronic address: cw2384@cumc.columbia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D046650" MajorTopicYN="Y">Medical Subject Headings</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039061" MajorTopicYN="Y">Systematized Nomenclature of Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078326" MajorTopicYN="N">Data Visualization</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Categorization</Keyword><Keyword MajorTopicYN="N">Clinical Study</Keyword><Keyword MajorTopicYN="N">Data Visualization</Keyword><Keyword MajorTopicYN="N">Ontology</Keyword><Keyword MajorTopicYN="N">SNOMED CT</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>25</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36283581</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2022.104235</ArticleId><ArticleId IdType="pii">S1532-0464(22)00240-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36303318</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1367-4811</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>24</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>13</Day></PubDate></JournalIssue><Title>Bioinformatics (Oxford, England)</Title><ISOAbbreviation>Bioinformatics</ISOAbbreviation></Journal><ArticleTitle>Common data model for COVID-19 datasets.</ArticleTitle><Pagination><StartPage>5466</StartPage><EndPage>5468</EndPage><MedlinePgn>5466-5468</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bioinformatics/btac651</ELocationID><Abstract><AbstractText Label="MOTIVATION">A global medical crisis like the coronavirus disease 2019 (COVID-19) pandemic requires interdisciplinary and highly collaborative research from all over the world. One of the key challenges for collaborative research is a lack of interoperability among various heterogeneous data sources. Interoperability, standardization and mapping of datasets are necessary for data analysis and applications in advanced algorithms such as developing personalized risk prediction modeling.</AbstractText><AbstractText Label="RESULTS">To ensure the interoperability and compatibility among COVID-19 datasets, we present here a common data model (CDM) which has been built from 11 different COVID-19 datasets from various geographical locations. The current version of the CDM holds 4639 data variables related to COVID-19 such as basic patient information (age, biological sex and diagnosis) as well as disease-specific data variables, for example, Anosmia and Dyspnea. Each of the data variables in the data model is associated with specific data types, variable mappings, value ranges, data units and data encodings that could be used for standardizing any dataset. Moreover, the compatibility with established data standards like OMOP and FHIR makes the CDM a well-designed CDM for COVID-19 data interoperability.</AbstractText><AbstractText Label="AVAILABILITY AND IMPLEMENTATION">The CDM is available in a public repo here: https://github.com/Fraunhofer-SCAI-Applied-Semantics/COVID-19-Global-Model.</AbstractText><AbstractText Label="SUPPLEMENTARY INFORMATION">Supplementary data are available at Bioinformatics online.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wegner</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1159-9269</Identifier><AffiliationInfo><Affiliation>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, 53757, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jose</LastName><ForeName>Geena Mariya</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Causality Biomodels, Kinfra Hi-Tech Park, Cochin, Kerala 683503, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lage-Rupprecht</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, 53757, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golriz Khatami</LastName><ForeName>Sepehr</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, 53757, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Bide</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, 53757, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Springstubbe</LastName><ForeName>Stephan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, 53757, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Marc</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4153-3930</Identifier><AffiliationInfo><Affiliation>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, 53757, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linden</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, 53757, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ku</LastName><ForeName>Cindy</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, 53757, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, 53757, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofmann-Apitius</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9012-6720</Identifier><AffiliationInfo><Affiliation>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, 53757, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bonn-Aachen International Center for IT (B-IT), Rheinische Friedrich-Wilhelms-Universit&#xe4;t Bonn, Bonn 53115, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kodamullil</LastName><ForeName>Alpha Tom</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, Fraunhofer Institute for Algorithms and Scientific Computing (SCAI), Sankt Augustin, 53757, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bonn-Aachen International Center for IT (B-IT), Rheinische Friedrich-Wilhelms-Universit&#xe4;t Bonn, Bonn 53115, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>COPERIMOplus Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Fraunhofer 'Internal Programs Fraunhofer vs Corona'</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Bioinformatics</MedlineTA><NlmUniqueID>9808944</NlmUniqueID><ISSNLinking>1367-4803</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36303318</ArticleId><ArticleId IdType="pmc">PMC9750115</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btac651</ArticleId><ArticleId IdType="pii">6776111</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Capnetz Stiftung.</Citation></Reference><Reference><Citation>IBM Explorys Solutions.</Citation></Reference><Reference><Citation>Jakob C.E.M. et al. (2021) First results of the &#x201c;lean European open survey on SARS-CoV-2-Infected patients (LEOSS)&#x201d;. Infection, 49, 63&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7527665</ArticleId><ArticleId IdType="pubmed">33001409</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson A. et al. (2016) MIMIC-III, a freely accessible critical care database. Sci. Data, 3, 160035. 10.1038/sdata.2016.35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2016.35</ArticleId><ArticleId IdType="pmc">PMC4878278</ArticleId><ArticleId IdType="pubmed">27219127</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurth F. et al. (2020) Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19). Infection, 48, 619&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7293426</ArticleId><ArticleId IdType="pubmed">32535877</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G. et al. (2020) Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin. Chem. Lab. Med., 58(7), 1070&#x2013;1076.</Citation><ArticleIdList><ArticleId IdType="pubmed">32172228</ArticleId></ArticleIdList></Reference><Reference><Citation>Sass J. et al. (2020) The German Corona Consensus Dataset (GECCO): a standardized dataset for COVID-19 research in university medicine and beyond. BMC Med. Inform. Decis. Mak., 20, 341. 10.1186/s12911-020-01374-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-020-01374-w</ArticleId><ArticleId IdType="pmc">PMC7751265</ArticleId><ArticleId IdType="pubmed">33349259</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegner P. et al. (2021) Integrative data semantics through a model-enabled data stewardship .Bioinformatics, 38, 3850&#x2013;3852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9344835</ArticleId><ArticleId IdType="pubmed">35652780</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36307424</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2052-4463</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>28</Day></PubDate></JournalIssue><Title>Scientific data</Title><ISOAbbreviation>Sci Data</ISOAbbreviation></Journal><ArticleTitle>Harvesting metadata in clinical care: a crosswalk between FHIR, OMOP, CDISC and openEHR metadata.</ArticleTitle><Pagination><StartPage>659</StartPage><MedlinePgn>659</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">659</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41597-022-01792-7</ELocationID><Abstract><AbstractText>Metadata describe information about data source, type of creation, structure, status and semantics and are prerequisite for preservation and reuse of medical data. To overcome the hurdle of disparate data sources and repositories with heterogeneous data formats a metadata crosswalk was initiated, based on existing standards. FAIR Principles were included, as well as data format specifications. The metadata crosswalk is the foundation of data provision between a Medical Data Integration Center (MeDIC) and researchers, providing a selection of metadata information for research design and requests. Based on the crosswalk, metadata items were prioritized and categorized to demonstrate that not one single predefined standard meets all requirements of a MeDIC and only a maximum data set of metadata is suitable for use. The development of a convergence format including the maximum data set is the anticipated solution for an automated transformation of metadata in a MeDIC.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>B&#xf6;nisch</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7169-6090</Identifier><AffiliationInfo><Affiliation>Medical Data Integration Center, Department of Medical Informatics, University Medical Center G&#xf6;ttingen, Robert-Koch-Str. 40, 37075, G&#xf6;ttingen, Germany. caroline.boenisch@med.uni-goettingen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keszty&#xfc;s</LastName><ForeName>Dorothea</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2166-846X</Identifier><AffiliationInfo><Affiliation>Medical Data Integration Center, Department of Medical Informatics, University Medical Center G&#xf6;ttingen, Robert-Koch-Str. 40, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keszty&#xfc;s</LastName><ForeName>Tibor</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0813-2393</Identifier><AffiliationInfo><Affiliation>Medical Data Integration Center, Department of Medical Informatics, University Medical Center G&#xf6;ttingen, Robert-Koch-Str. 40, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Data</MedlineTA><NlmUniqueID>101640192</NlmUniqueID><ISSNLinking>2052-4463</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000071253" MajorTopicYN="Y">Metadata</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016247" MajorTopicYN="Y">Information Storage and Retrieval</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012660" MajorTopicYN="N">Semantics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012015" MajorTopicYN="N">Reference Standards</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>28</Day><Hour>23</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36307424</ArticleId><ArticleId IdType="pmc">PMC9616884</ArticleId><ArticleId IdType="doi">10.1038/s41597-022-01792-7</ArticleId><ArticleId IdType="pii">10.1038/s41597-022-01792-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baca, M. Introduction To Metadata 3rd edn (The Getty Research Institute Publications Program, 2016)</Citation></Reference><Reference><Citation>Hegselmann S, et al. Automatic conversion of metadata from the study of health in pomerania to ODM. Stud Health Technol Inform. 2017;236:88&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">28508783</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulsen, T. et al. From big data to precision medicine. Front Med6 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6405506</ArticleId><ArticleId IdType="pubmed">30881956</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson M, et al. The FAIR guiding principles for scientific data management and stewardship. Sci Data. 2016;3:160018. doi: 10.1038/sdata.2016.18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2016.18</ArticleId><ArticleId IdType="pmc">PMC4792175</ArticleId><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Colavizza, G., Hrynaszkiewicz, I., Staden, I., Whitaker, K., McGillivray, B. The citation advantage of linking publications to research data. PloS ONE15(4) (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7176083</ArticleId><ArticleId IdType="pubmed">32320428</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugas, M. et al. Memorandum &#x201c;open metadata&#x201d;. Methods Inf Med24 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26108979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno-Machado L, et al. Finding useful data across multiple biomedical data repositories using DataMed. Nature Genetics. 2017;49(6):816&#x2013;819. doi: 10.1038/ng.3864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3864</ArticleId><ArticleId IdType="pmc">PMC6460922</ArticleId><ArticleId IdType="pubmed">28546571</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira JD, In&#xe1;cio B, Salek RM, Couto FM. Assessing public metabolomics metadata, towards improving quality. J Integr Bioinform. 2017;14:20170054. doi: 10.1515/jib-2017-0054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jib-2017-0054</ArticleId><ArticleId IdType="pmc">PMC6042808</ArticleId><ArticleId IdType="pubmed">29236679</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves R, Musen M. The variable quality of metadata about biological samples used in biomedical experiments. Sci Data. 2019;6:190021. doi: 10.1038/sdata.2019.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2019.21</ArticleId><ArticleId IdType="pmc">PMC6380228</ArticleId><ArticleId IdType="pubmed">30778255</ArticleId></ArticleIdList></Reference><Reference><Citation>Canham S, Ohmann C. A metadata schema for data objects in clinical research. Trials. 2016;17:557. doi: 10.1186/s13063-016-1686-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-016-1686-5</ArticleId><ArticleId IdType="pmc">PMC5122021</ArticleId><ArticleId IdType="pubmed">27881150</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich, H. et al. Understanding the nature of metadata: systematic review. J Med Internet Res24(1) (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8790684</ArticleId><ArticleId IdType="pubmed">35014967</ArticleId></ArticleIdList></Reference><Reference><Citation>Doods J, Neuhaus P, Dugas M. Converting odm metadata to fhir questionnaire resources. Stud Health Technol Inform. 2016;228:456&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">27577424</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruland P, Dugas M. Transformations between cdisc odm and openehr archetypes. Stud Health Technol Inform. 2014;205:1225.</Citation></Reference><Reference><Citation>Kock-Schopenhauer AK, et al. Compatibility between metadata standards: import pipeline of cdisc odm to the samply.mdr. Stud Health Technol Inform. 2018;247:221&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pubmed">29677955</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley, J. Understanding Metadata (Bethesda, MD: NISO Press, National Information Standards Organization, 2004).</Citation></Reference><Reference><Citation>Baca, M., Gilliland, A. Introduction to metadata: pathway to digital information (Getty Education Institute for the Arts, 2000).</Citation></Reference><Reference><Citation>B&#xf6;nisch C, Keszty&#xfc;s D, Keszty&#xfc;s T. 2022. Harvesting metadata in clinical care: a crosswalk between FHIR, OMOP, CDISC and openEHR metadata. figshare.</Citation><ArticleIdList><ArticleId IdType="doi">10.6084/m9.figshare.21333042.v1</ArticleId><ArticleId IdType="pmc">PMC9616884</ArticleId><ArticleId IdType="pubmed">36307424</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36315520</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>10</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Temporal Events Detector for Pregnancy Care (TED-PC): A rule-based algorithm to infer gestational age and delivery date from electronic health records of pregnant women with and without COVID-19.</ArticleTitle><Pagination><StartPage>e0276923</StartPage><MedlinePgn>e0276923</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0276923</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0276923</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Identifying the time of SARS-CoV-2 viral infection relative to specific gestational weeks is critical for delineating the role of viral infection timing in adverse pregnancy outcomes. However, this task is difficult when it comes to Electronic Health Records (EHR). In combating the COVID-19 pandemic for maternal health, we sought to develop and validate a clinical information extraction algorithm to detect the time of clinical events relative to gestational weeks.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We used EHR from the National COVID Cohort Collaborative (N3C), in which the EHR are normalized by the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). We performed EHR phenotyping, resulting in 270,897 pregnant women (June 1st, 2018 to May 31st, 2021). We developed a rule-based algorithm and performed a multi-level evaluation to test content validity and clinical validity, and extreme length of gestation (&lt;150 or &gt;300).</AbstractText><AbstractText Label="RESULTS">The algorithm identified 296,194 pregnancies (16,659 COVID-19, 174,744 without COVID-19) in 270,897 pregnant women. For inferring gestational age, 95% cases (n = 40) have moderate-high accuracy (Cohen's Kappa = 0.62); 100% cases (n = 40) have moderate-high granularity of temporal information (Cohen's Kappa = 1). For inferring delivery dates, the accuracy is 100% (Cohen's Kappa = 1). The accuracy of gestational age detection for the extreme length of gestation is 93.3% (Cohen's Kappa = 1). Mothers with COVID-19 showed higher prevalence in obesity or overweight (35.1% vs. 29.5%), diabetes (17.8% vs. 17.0%), chronic obstructive pulmonary disease (0.2% vs. 0.1%), respiratory distress syndrome or acute respiratory failure (1.8% vs. 0.2%).</AbstractText><AbstractText Label="DISCUSSION">We explored the characteristics of pregnant women by different gestational weeks of SARS-CoV-2 infection with our algorithm. TED-PC is the first to infer the exact gestational week linked with every clinical event from EHR and detect the timing of SARS-CoV-2 infection in pregnant women.</AbstractText><AbstractText Label="CONCLUSION">The algorithm shows excellent clinical validity in inferring gestational age and delivery dates, which supports multiple EHR cohorts on N3C studying the impact of COVID-19 on pregnancy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lyu</LastName><ForeName>Tianchu</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-5937-4432</Identifier><AffiliationInfo><Affiliation>Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Chen</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-9803-9880</Identifier><AffiliationInfo><Affiliation>Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jihong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology &amp; Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Berry</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, School of Medicine, University of South Carolina, Columbia, South Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hung</LastName><ForeName>Peiyin</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1529-0819</Identifier><AffiliationInfo><Affiliation>Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Yi-Wen</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghumman</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaoming</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-5555-9034</Identifier><AffiliationInfo><Affiliation>Department of Health Promotion Education and Behaviors, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>National COVID Cohort Collaborative Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U24 TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI170171</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037841" MajorTopicYN="N">Pregnant Women</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005865" MajorTopicYN="N">Gestational Age</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="Y">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011256" MajorTopicYN="N">Pregnancy Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047928" MajorTopicYN="Y">Premature Birth</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>31</Day><Hour>13</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36315520</ArticleId><ArticleId IdType="pmc">PMC9621451</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0276923</ArticleId><ArticleId IdType="pii">PONE-D-22-20713</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al.. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320. doi: 10.1136/bmj.m3320</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3320</ArticleId><ArticleId IdType="pmc">PMC7459193</ArticleId><ArticleId IdType="pubmed">32873575</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al.. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status&#x2014;United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(44):1641&#x2013;7. doi: 10.15585/mmwr.mm6944e3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6944e3</ArticleId><ArticleId IdType="pmc">PMC7643892</ArticleId><ArticleId IdType="pubmed">33151921</ArticleId></ArticleIdList></Reference><Reference><Citation>Piekos SN, Roper RT, Hwang YM, Sorensen T, Price ND, Hood L, et al.. The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study. The Lancet Digital Health. 2022;4(2):e95&#x2013;e104. doi: 10.1016/S2589-7500(21)00250-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(21)00250-8</ArticleId><ArticleId IdType="pmc">PMC8758153</ArticleId><ArticleId IdType="pubmed">35034863</ArticleId></ArticleIdList></Reference><Reference><Citation>Class QA, Lichtenstein P, L&#xe5;ngstr&#xf6;m N, D&#x2019;Onofrio BM. Timing of prenatal maternal exposure to severe life events and adverse pregnancy outcomes: a population study of 2.6 million pregnancies. Psychosom Med. 2011;73(3):234&#x2013;41. doi: 10.1097/PSY.0b013e31820a62ce</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0b013e31820a62ce</ArticleId><ArticleId IdType="pmc">PMC3070756</ArticleId><ArticleId IdType="pubmed">21321257</ArticleId></ArticleIdList></Reference><Reference><Citation>Racicot K, Mor G. Risks associated with viral infections during pregnancy. The Journal of Clinical Investigation. 2017;127(5):1591&#x2013;9. doi: 10.1172/JCI87490</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI87490</ArticleId><ArticleId IdType="pmc">PMC5409792</ArticleId><ArticleId IdType="pubmed">28459427</ArticleId></ArticleIdList></Reference><Reference><Citation>MedlinePlus. Pregnancy care [cited 2022 Mar. 02]. Available from: https://medlineplus.gov/ency/article/007214.htm.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al.. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. MEDINFO 2015: eHealth-enabled Health: IOS Press; 2015. p. 574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, Eichmann DA, Guinney J, Kibbe WA, et al.. The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. Journal of the American Medical Informatics Association. 2020;28(3):427&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;yrinen K, Saranto K, Nyk&#xe4;nen P. Definition, structure, content, use and impacts of electronic health records: A review of the research literature. International Journal of Medical Informatics. 2008;77(5):291&#x2013;304. doi: 10.1016/j.ijmedinf.2007.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2007.09.001</ArticleId><ArticleId IdType="pubmed">17951106</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. Journal of the American Medical Informatics Association. 2013;20(1):144&#x2013;51. doi: 10.1136/amiajnl-2011-000681</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000681</ArticleId><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon LJ, McCarthy FP, Direk K, Gonzalez-Izquierdo A, Prieto-Merino D, Casas JP, et al.. Preeclampsia and Cardiovascular Disease in a Large UK Pregnancy Cohort of Linked Electronic Health Records. Circulation. 2019;140(13):1050&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">31545680</ArticleId></ArticleIdList></Reference><Reference><Citation>Liyanage H, Williams J, Byford R, de Lusignan S. Ontology to identify pregnant women in electronic health records: primary care sentinel network database study. BMJ Health Care Inform. 2019;26(1):e100013. doi: 10.1136/bmjhci-2019-100013</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjhci-2019-100013</ArticleId><ArticleId IdType="pmc">PMC7062332</ArticleId><ArticleId IdType="pubmed">31272998</ArticleId></ArticleIdList></Reference><Reference><Citation>Roser BJ, Rubin SE, Nagarajan N, Wieland DL, Benfield NC. A data extraction algorithm for assessment of contraceptive counseling and provision. American Journal of Obstetrics and Gynecology. 2018;218(3):333.e1&#x2013;.e5. doi: 10.1016/j.ajog.2017.11.578</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2017.11.578</ArticleId><ArticleId IdType="pubmed">29175248</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W, Rumshisky A, Uzuner O. Temporal reasoning over clinical text: the state of the art. Journal of the American Medical Informatics Association. 2013;20(5):814&#x2013;9. doi: 10.1136/amiajnl-2013-001760</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001760</ArticleId><ArticleId IdType="pmc">PMC3756277</ArticleId><ArticleId IdType="pubmed">23676245</ArticleId></ArticleIdList></Reference><Reference><Citation>Spong CY. Defining &#x201c;Term&#x201d; Pregnancy: Recommendations From the Defining &#x201c;Term&#x201d; Pregnancy Workgroup. JAMA. 2013;309(23):2445&#x2013;6. doi: 10.1001/jama.2013.6235</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.6235</ArticleId><ArticleId IdType="pubmed">23645117</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Seneviratne M, Hernandez-Boussard T, Shah NH. Advances in Electronic Phenotyping: From Rule-Based Definitions to Machine Learning Models. Annual Review of Biomedical Data Science. 2018;1(1):53&#x2013;68. doi: 10.1146/annurev-biodatasci-080917-013315</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biodatasci-080917-013315</ArticleId><ArticleId IdType="pmc">PMC6583807</ArticleId><ArticleId IdType="pubmed">31218278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornbrook MC, Whitlock EP, Berg CJ, Callaghan WM, Bachman DJ, Gold R, et al.. Development of an Algorithm to Identify Pregnancy Episodes in an Integrated Health Care Delivery System. Health Services Research. 2007;42(2):908&#x2013;27. doi: 10.1111/j.1475-6773.2006.00635.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1475-6773.2006.00635.x</ArticleId><ArticleId IdType="pmc">PMC1955367</ArticleId><ArticleId IdType="pubmed">17362224</ArticleId></ArticleIdList></Reference><Reference><Citation>Kova&#x10d;evi&#x107; A, Dehghan A, Filannino M, Keane JA, Nenadic G. Combining rules and machine learning for extraction of temporal expressions and events from clinical narratives. Journal of the American Medical Informatics Association. 2013;20(5):859&#x2013;66. doi: 10.1136/amiajnl-2013-001625</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001625</ArticleId><ArticleId IdType="pmc">PMC3756271</ArticleId><ArticleId IdType="pubmed">23605114</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Du J, He Y, Song H-Y, Madkour M, Rao G, et al.. Time event ontology (TEO): to support semantic representation and reasoning of complex temporal relations of clinical events. Journal of the American Medical Informatics Association. 2020;27(7):1046&#x2013;56. doi: 10.1093/jamia/ocaa058</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa058</ArticleId><ArticleId IdType="pmc">PMC7647306</ArticleId><ArticleId IdType="pubmed">32626903</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Andrade SE, Cooper WO, Davis RL, Dublin S, Hammad TA, et al.. Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiology and Drug Safety. 2013;22(5):524&#x2013;32. doi: 10.1002/pds.3407</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3407</ArticleId><ArticleId IdType="pmc">PMC3644383</ArticleId><ArticleId IdType="pubmed">23335117</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y-K, Chen H, Brown RA. MedTime: A temporal information extraction system for clinical narratives. Journal of Biomedical Informatics. 2013;46:S20&#x2013;S8. doi: 10.1016/j.jbi.2013.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2013.07.012</ArticleId><ArticleId IdType="pubmed">23911344</ArticleId></ArticleIdList></Reference><Reference><Citation>Margulis AV, Setoguchi S, Mittleman MA, Glynn RJ, Dormuth CR, Hern&#xe1;ndez-D&#xed;az S. Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiology and Drug Safety. 2013;22(1):16&#x2013;24. doi: 10.1002/pds.3284</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3284</ArticleId><ArticleId IdType="pmc">PMC3437228</ArticleId><ArticleId IdType="pubmed">22550030</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcho A, Ryan P, Fife D, Gifkins D, Knoll C, Friedman A. Inferring pregnancy episodes and outcomes within a network of observational databases. PloS one. 2018;13(2):e0192033. doi: 10.1371/journal.pone.0192033</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0192033</ArticleId><ArticleId IdType="pmc">PMC5794136</ArticleId><ArticleId IdType="pubmed">29389968</ArticleId></ArticleIdList></Reference><Reference><Citation>Canel&#xf3;n SP, Burris HH, Levine LD, Boland MR. Development and evaluation of MADDIE: Method to Acquire Delivery Date Information from Electronic health records. International Journal of Medical Informatics. 2021;145:104339. doi: 10.1016/j.ijmedinf.2020.104339</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2020.104339</ArticleId><ArticleId IdType="pubmed">33232918</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. OMOP Common Data Model
2021.  [cited 2022 Mar. 01]. Available from: https://www.ohdsi.org/data-standardization/the-common-data-model/.</Citation></Reference><Reference><Citation>Liu J, Hung P, Liang C, Zhang J, Qiao S, Campbell BA, et al.. Multilevel determinants of racial/ethnic disparities in severe maternal morbidity and mortality in the context of the COVID-19 pandemic in the USA: protocol for a concurrent triangulation, mixed-methods study. BMJ Open. 2022;12(6):e062294. doi: 10.1136/bmjopen-2022-062294</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-062294</ArticleId><ArticleId IdType="pmc">PMC9189547</ArticleId><ArticleId IdType="pubmed">35688597</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang C, Weissman S, Olatosi B, Poon EG, Yarrington ME, Li X. Curating a knowledge base for individuals with coinfection of HIV and SARS-CoV-2: a study protocol of EHR-based data mining and clinical implementation. BMJ Open. 2022;12(9):e067204. doi: 10.1136/bmjopen-2022-067204</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-067204</ArticleId><ArticleId IdType="pmc">PMC9471209</ArticleId><ArticleId IdType="pubmed">36100301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu T, Liang C, editors. Predict Pregnancy Outcomes in the COVID-19 Pandemic Using Electronic Health Records and Machine Learning Approach. 2022 IEEE 10th International Conference on Healthcare Informatics (ICHI); 2022. 11&#x2013;14 June 2022.</Citation></Reference><Reference><Citation>AIM. AIM Data Guide
2020.  [cited 2022 Mar. 07]. Available from: https://safehealthcareforeverywoman.org/wp-content/uploads/AIM_DataGuide_Oct2020.pdf.</Citation></Reference><Reference><Citation>Song YP, Skinner JP, Bynum JMDMPH, Sutherland JP, Wennberg JEMDMPH, Fisher ESMDMPH. Regional Variations in Diagnostic Practices. The New England Journal of Medicine. 2010;363(1):45&#x2013;53. doi: 10.1056/NEJMsa0910881</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa0910881</ArticleId><ArticleId IdType="pmc">PMC2924574</ArticleId><ArticleId IdType="pubmed">20463332</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloti&#xe8;re P-O, Weill A, Dalichampt M, Billionnet C, Mezzarobba M, Raguideau F, et al.. Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France. Pharmacoepidemiology and Drug Safety. 2018;27(7):763&#x2013;70. doi: 10.1002/pds.4556</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4556</ArticleId><ArticleId IdType="pmc">PMC6055607</ArticleId><ArticleId IdType="pubmed">29763992</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald SC, Cohen JM, Panchaud A, McElrath TF, Huybrechts KF, Hern&#xe1;ndez-D&#xed;az S. Identifying pregnancies in insurance claims data: Methods and application to retinoid teratogenic surveillance. Pharmacoepidemiology and Drug Safety. 2019;28(9):1211&#x2013;21. doi: 10.1002/pds.4794</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4794</ArticleId><ArticleId IdType="pmc">PMC6830505</ArticleId><ArticleId IdType="pubmed">31328328</ArticleId></ArticleIdList></Reference><Reference><Citation>Manson JM, McFarland B, Weiss S. Use of an Automated Database to Evaluate Markers for Early Detection of Pregnancy. American Journal of Epidemiology. 2001;154(2):180&#x2013;7. doi: 10.1093/aje/154.2.180</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/154.2.180</ArticleId><ArticleId IdType="pubmed">11447053</ArticleId></ArticleIdList></Reference><Reference><Citation>Naleway AL, Gold R, Kurosky S, Riedlinger K, Henninger ML, Nordin JD, et al.. Identifying pregnancy episodes, outcomes, and mother&#x2013;infant pairs in the Vaccine Safety Datalink. Vaccine. 2013;31(27):2898&#x2013;903. doi: 10.1016/j.vaccine.2013.03.069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.03.069</ArticleId><ArticleId IdType="pubmed">23639917</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36321557</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1469-493X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>2022</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>The Cochrane database of systematic reviews</Title><ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation></Journal><ArticleTitle>Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">CD014217</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD014217</ELocationID><Abstract><AbstractText Label="BACKGROUND">Description of the condition Malaria, an infectious disease transmitted by the bite of female mosquitoes from several Anopheles species, occurs in 87 countries with ongoing transmission (WHO 2020). The World Health Organization (WHO) estimated that, in 2019, approximately 229 million cases of malaria occurred worldwide, with 94% occurring in the WHO's African region (WHO 2020). Of these malaria cases, an estimated 409,000 deaths occurred globally, with 67% occurring in children under five years of age (WHO 2020). Malaria also negatively impacts the health of women during pregnancy, childbirth, and the postnatal period (WHO 2020). Sulfadoxine/pyrimethamine (SP), an antifolate antimalarial, has been widely used across sub-Saharan Africa as the first-line treatment for uncomplicated malaria since it was first introduced in Malawi in 1993 (Filler 2006). Due to increasing resistance to SP, in 2000 the WHO recommended that one of several artemisinin-based combination therapies (ACTs) be used instead of SP for the treatment of uncomplicated malaria caused by Plasmodium falciparum (Global Partnership to Roll Back Malaria 2001). However, despite these recommendations, SP continues to be advised for intermittent preventive treatment in pregnancy (IPTp) and intermittent preventive treatment in infants (IPTi), whether the person has malaria or not (WHO 2013). Description of the intervention Folate (vitamin B9) includes both naturally occurring folates and folic acid, the fully oxidized monoglutamic form of the vitamin, used in dietary supplements and fortified food. Folate deficiency (e.g. red blood cell (RBC) folate concentrations of less than 305 nanomoles per litre (nmol/L); serum or plasma concentrations of less than 7 nmol/L) is common in many parts of the world and often presents as megaloblastic anaemia, resulting from inadequate intake, increased requirements, reduced absorption, or abnormal metabolism of folate (Bailey 2015; WHO 2015a). Pregnant women have greater folate requirements; inadequate folate intake (evidenced by RBC folate concentrations of less than 400 nanograms per millilitre (ng/mL), or 906 nmol/L) prior to and during the first month of pregnancy increases the risk of neural tube defects, preterm delivery, low birthweight, and fetal growth restriction (Bourassa 2019). The WHO recommends that all women who are trying to conceive consume 400 micrograms (&#xb5;g) of folic acid daily from the time they begin trying to conceive through to 12 weeks of gestation (WHO 2017). In 2015, the WHO added the dosage of 0.4 mg of folic acid to the essential drug list (WHO 2015c). Alongside daily oral iron (30 mg to 60 mg elemental iron), folic acid supplementation is recommended for pregnant women to prevent neural tube defects, maternal anaemia, puerperal sepsis, low birthweight, and preterm birth in settings where anaemia in pregnant women is a severe public health problem (i.e. where at least 40% of pregnant women have a blood haemoglobin (Hb) concentration of less than 110 g/L). How the intervention might work Potential interactions between folate status and malaria infection The malaria parasite requires folate for survival and growth; this has led to the hypothesis that folate status may influence malaria risk and severity. In rhesus monkeys, folate deficiency has been found to be protective against Plasmodium cynomolgi malaria infection, compared to folate-replete animals (Metz 2007). Alternatively, malaria may induce or exacerbate folate deficiency due to increased folate utilization from haemolysis and fever. Further, folate status measured via RBC folate is not an appropriate biomarker of folate status in malaria-infected individuals since RBC folate values in these individuals are indicative of both the person's stores and the parasite's folate synthesis. A study in Nigeria found that children with malaria infection had significantly higher RBC folate concentrations compared to children without malaria infection, but plasma folate levels were similar (Bradley-Moore 1985). Why it is important to do this review The malaria parasite needs folate for survival and growth in humans. For individuals, adequate folate levels are critical for health and well-being, and for the prevention of anaemia and neural tube defects. Many countries rely on folic acid supplementation to ensure adequate folate status in at-risk populations. Different formulations for folic acid supplements are available in many international settings, with dosages ranging from 400 &#xb5;g to 5 mg. Evaluating folic acid dosage levels used in supplementation efforts may increase public health understanding of its potential impacts on malaria risk and severity and on treatment failures. Examining folic acid interactions with antifolate antimalarial medications and with malaria disease progression may help countries in malaria-endemic areas determine what are the most appropriate lower dose folic acid formulations for at-risk populations. The WHO has highlighted the limited evidence available and has indicated the need for further research on biomarkers of folate status, particularly interactions between RBC folate concentrations and tuberculosis, human immunodeficiency virus (HIV), and antifolate antimalarial drugs (WHO 2015b). An earlier Cochrane Review assessed the effects and safety of iron supplementation, with or without folic acid, in children living in hyperendemic or holoendemic malaria areas; it demonstrated that iron supplementation did not increase the risk of malaria, as indicated by fever and the presence of parasites in the blood (Neuberger 2016). Further, this review stated that folic acid may interfere with the efficacy of SP; however, the efficacy and safety of folic acid supplementation on these outcomes has not been established. This review will provide evidence on the effectiveness of daily folic acid supplementation in healthy and malaria-infected individuals living in malaria-endemic areas. Additionally, it will contribute to achieving both the WHO Global Technical Strategy for Malaria 2016-2030 (WHO 2015d), and United Nations Sustainable Development Goal 3 (to ensure healthy lives and to promote well-being for all of all ages) (United Nations 2021), and evaluating whether the potential effects of folic acid supplementation, at different doses (e.g. 0.4 mg, 1 mg, 5 mg daily), interferes with the effect of drugs used for prevention or treatment of malaria.</AbstractText><AbstractText Label="OBJECTIVES">To examine the effects of folic acid supplementation, at various doses, on malaria susceptibility (risk of infection) and severity among people living in areas with various degrees of malaria endemicity. We will examine the interaction between folic acid supplements and antifolate antimalarial drugs. Specifically, we will aim to answer the following. Among uninfected people living in malaria endemic areas, who are taking or not taking antifolate antimalarials for malaria prophylaxis, does taking a folic acid-containing supplement increase susceptibility to or severity of malaria infection? Among people with malaria infection who are being treated with antifolate antimalarials, does folic acid supplementation increase the risk of treatment failure?</AbstractText><AbstractText Label="METHODS">Criteria for considering studies for this review Types of studies Inclusion criteria Randomized controlled trials (RCTs) Quasi-RCTs with randomization at the individual or cluster level conducted in malaria-endemic areas (areas with ongoing, local malaria transmission, including areas approaching elimination, as listed in the World Malaria Report 2020) (WHO 2020) Exclusion criteria Ecological studies Observational studies In vivo/in vitro studies Economic studies Systematic literature reviews and meta-analyses (relevant systematic literature reviews and meta-analyses will be excluded but flagged for grey literature screening) Types of participants Inclusion criteria Individuals of any age or gender, living in a malaria endemic area, who are taking antifolate antimalarial medications (including but not limited to sulfadoxine/pyrimethamine (SP), pyrimethamine-dapsone, pyrimethamine, chloroquine and proguanil, cotrimoxazole) for the prevention or treatment of malaria (studies will be included if more than 70% of the participants live in malaria-endemic regions) Studies assessing participants with or without anaemia and with or without malaria parasitaemia at baseline will be included Exclusion criteria Individuals not taking antifolate antimalarial medications for prevention or treatment of malaria Individuals living in non-malaria endemic areas Types of interventions Inclusion criteria Folic acid supplementation Form: in tablet, capsule, dispersible tablet at any dose, during administration, or periodically Timing: during, before, or after (within a period of four to six weeks) administration of antifolate antimalarials Iron-folic acid supplementation Folic acid supplementation in combination with co-interventions that are identical between the intervention and control groups. Co-interventions include: anthelminthic treatment; multivitamin or multiple micronutrient supplementation; 5-methyltetrahydrofolate supplementation. Exclusion criteria Folate through folate-fortified water Folic acid administered through large-scale fortification of rice, wheat, or maize Comparators Placebo No treatment No folic acid/different doses of folic acid Iron Types of outcome measures Primary outcomes Uncomplicated malaria (defined as a history of fever with parasitological confirmation; acceptable parasitological confirmation will include rapid diagnostic tests (RDTs), malaria smears, or nucleic acid detection (i.e. polymerase chain reaction (PCR), loop-mediated isothermal amplification (LAMP), etc.)) (WHO 2010). This outcome is relevant for patients without malaria, given antifolate antimalarials for malaria prophylaxis. Severe malaria (defined as any case with cerebral malaria or acute P. falciparum malaria, with signs of severity or evidence of vital organ dysfunction, or both) (WHO 2010). This outcome is relevant for patients without malaria, given antifolate antimalarials for malaria prophylaxis. Parasite clearance (any Plasmodium species), defined as the time it takes for a patient who tests positive at enrolment and is treated to become smear-negative or PCR negative. This outcome is relevant for patients with malaria, treated with antifolate antimalarials. Treatment failure (defined as the inability to clear malaria parasitaemia or prevent recrudescence after administration of antimalarial medicine, regardless of whether clinical symptoms are resolved) (WHO 2019). This outcome is relevant for patients with malaria, treated with antifolate antimalarials. Secondary outcomes Duration of parasitaemia Parasite density Haemoglobin (Hb) concentrations (g/L) Anaemia: severe anaemia (defined as Hb less than 70 g/L in pregnant women and children aged six to 59 months; and Hb less than 80 g/L in other populations); moderate anaemia (defined as Hb less than 100 g/L in pregnant women and children aged six to 59 months; and less than 110 g/L in others) Death from any cause Among pregnant women: stillbirth (at less than 28 weeks gestation); low birthweight (less than 2500 g); active placental malaria (defined as Plasmodium detected in placental blood by smear or PCR, or by Plasmodium detected on impression smear or placental histology). Search methods for identification of studies A search will be conducted to identify completed and ongoing studies, without date or language restrictions. Electronic searches A search strategy will be designed to include the appropriate subject headings and text word terms related to each intervention of interest and study design of interest (see Appendix 1). Searches will be broken down by these two criteria (intervention of interest and study design of interest) to allow for ease of prioritization, if necessary. The study design filters recommended by the Scottish Intercollegiate Guidelines Network (SIGN), and those designed by Cochrane for identifying clinical trials for MEDLINE and Embase, will be used (SIGN 2020). There will be no date or language restrictions. Non-English articles identified for inclusion will be translated into English. If translations are not possible, advice will be requested from the Cochrane Infectious Diseases Group and the record will be stored in the "Awaiting assessment" section of the review until a translation is available. The following electronic databases will be searched for primary studies. Cochrane Central Register of Controlled Trials. Cumulative Index to Nursing and Allied Health Literature (CINAHL). Embase. MEDLINE. Scopus. Web of Science (both the Social Science Citation Index and the Science Citation Index). We will conduct manual searches of ClinicalTrials.gov, the International Clinical Trials Registry Platform (ICTRP), and the United Nations Children's Fund (UNICEF) Evaluation and Research Database (ERD), in order to identify relevant ongoing or planned trials, abstracts, and full-text reports of evaluations, studies, and surveys related to programmes on folic acid supplementation in malaria-endemic areas. Additionally, manual searches of grey literature to identify RCTs that have not yet been published but are potentially eligible for inclusion will be conducted in the following sources. Global Index Medicus (GIM). African Index Medicus (AIM). Index Medicus for the Eastern Mediterranean Region (IMEMR). Latin American &amp; Caribbean Health Sciences Literature (LILACS). Pan American Health Organization (PAHO). Western Pacific Region Index Medicus (WPRO). Index Medicus for the South-East Asian Region (IMSEAR). The Spanish Bibliographic Index in Health Sciences (IBECS) (ibecs.isciii.es/). Indian Journal of Medical Research (IJMR) (journals.lww.com/ijmr/pages/default.aspx). Native Health Database (nativehealthdatabase.net/). Scielo (www.scielo.br/). Searching other resources Handsearches of the five journals with the highest number of included studies in the last 12 months will be conducted to capture any relevant articles that may not have been indexed in the databases at the time of the search. We will contact the authors of included studies and will check reference lists of included papers for the identification of additional records. For assistance in identifying ongoing or unpublished studies, we will contact the Division of Nutrition, Physical Activity, and Obesity (DNPAO) and the Division of Parasitic Diseases and Malaria (DPDM) of the CDC, the United Nations World Food Programme (WFP), Nutrition International (NI), Global Alliance for Improved Nutrition (GAIN), and Hellen Keller International (HKI). Data collection and analysis Selection of studies Two review authors will independently screen the titles and abstracts of articles retrieved by each search to assess eligibility, as determined by the inclusion and exclusion criteria. Studies deemed eligible for inclusion by both review authors in the abstract screening phase will advance to the full-text screening phase, and full-text copies of all eligible papers will be retrieved. If full articles cannot be obtained, we will attempt to contact the authors to obtain further details of the studies. If such information is not obtained, we will classify the study as "awaiting assessment" until further information is published or made available to us. The same two review authors will independently assess the eligibility of full-text articles for inclusion in the systematic review. If any discrepancies occur between the studies selected by the two review authors, a third review author will provide arbitration. Each trial will be scrutinized to identify multiple publications from the same data set, and the justification for excluded trials will be documented. A PRISMA flow diagram of the study selection process will be presented to provide information on the number of records identified in the literature searches, the number of studies included and excluded, and the reasons for exclusion (Moher 2009). The list of excluded studies, along with their reasons for exclusion at the full-text screening phase, will also be created. Data extraction and management Two review authors will independently extract data for the final list of included studies using a standardized data specification form. Discrepancies observed between the data extracted by the two authors will be resolved by involving a third review author and reaching a consensus. Information will be extracted on study design components, baseline participant characteristics, intervention characteristics, and outcomes. For individually randomized trials, we will record the number of participants experiencing the event and the number analyzed in each treatment group or the effect estimate reported (e.g. risk ratio (RR)) for dichotomous outcome measures. For count data, we will record the number of events and the number of person-months of follow-up in each group. If the number of person-months is not reported, the product of the duration of follow-up and the number of children evaluated will be used to estimate this figure. We will calculate the rate ratio and standard error (SE) for each study. Zero events will be replaced by 0.5. We will extract both adjusted and unadjusted covariate incidence rate ratios if they are reported in the original studies. For continuous data, we will extract means (arithmetic or geometric) and a measure of variance (standard deviation (SD), SE, or confidence interval (CI)), percentage or mean change from baseline, and the numbers analyzed in each group. SDs will be computed from SEs or 95% CIs, assuming a normal distribution of the values. Haemoglobin values in g/dL will be calculated by multiplying haematocrit or packed cell volume values by 0.34, and studies reporting haemoglobin values in g/dL will be converted to g/L. In cluster-randomized trials, we will record the unit of randomization (e.g. household, compound, sector, or village), the number of clusters in the trial, and the average cluster size. The statistical methods used to analyze the trials will be documented, along with details describing whether these methods adjusted for clustering or other covariates. We plan to extract estimates of the intra-cluster correlation coefficient (ICC) for each outcome. Where results are adjusted for clustering, we will extract the treatment effect estimate and the SD or CI. If the results are not adjusted for clustering, we will extract the data reported. Assessment of risk of bias in included studies Two review authors (KSC, LFY) will independently assess the risk of bias for each included trial using the Cochrane 'Risk of bias 2' tool (RoB 2) for randomized studies (Sterne 2019). Judgements about the risk of bias of included studies will be made according to the recommendations outlined in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2021). Disagreements will be resolved by discussion, or by involving a third review author. The interest of our review will be to assess the effect of assignment to the interventions at baseline. We will evaluate each primary outcome using the RoB2 tool. The five domains of the Cochrane RoB2 tool include the following. Bias arising from the randomization process. Bias due to deviations from intended interventions. Bias due to missing outcome data. Bias in measurement of the outcome. Bias in selection of the reported result. Each domain of the RoB2 tool comprises the following. A series of 'signalling' questions. A judgement about the risk of bias for the domain, facilitated by an algorithm that maps responses to the signalling questions to a proposed judgement. Free-text boxes to justify responses to the signalling questions and 'Risk of bias' judgements. An option to predict (and explain) the likely direction of bias. Responses to signalling questions elicit information relevant to an assessment of the risk of bias. These response options are as follows. Yes (may indicate either low or high risk of bias, depending on the most natural way to ask the question). Probably yes. Probably no. No. No information (may indicate no evidence of that problem or an absence of information leading to concerns about there being a problem). Based on the answer to the signalling question, a 'Risk of bias' judgement is assigned to each domain. These judgements include one of the following. High risk of bias Low risk of bias Some concerns To generate the risk of bias judgement for each domain in the randomized studies, we will use the Excel template, available at www.riskofbias.info/welcome/rob-2-0-tool/current-version-of-rob-2. This file will be stored on a scientific data website, available to readers. Risk of bias in cluster randomized controlled trials For the cluster randomized trials, we will be using the RoB2 tool to analyze the five standard domains listed above along with Domain 1b (bias arising from the timing of identification or recruitment of participants) and its related signalling questions. To generate the risk of bias judgement for each domain in the cluster RCTs, we will use the Excel template available at https://sites.google.com/site/riskofbiastool/welcome/rob-2-0-tool/rob-2-for-cluster-randomized-trials. This file will be stored on a scientific data website, available to readers. Risk of bias in cross-over randomized controlled trials For cross-over randomized trials, we will be using the RoB2 tool to analyze the five standard domains listed above along with Domain 2 (bias due to deviations from intended interventions), and Domain 3 (bias due to missing outcome data), and their respective signalling questions. To generate the risk of bias judgement for each domain in the cross-over RCTs, we will use the Excel template, available at https://sites.google.com/site/riskofbiastool/welcome/rob-2-0-tool/rob-2-for-crossover-trials, for each risk of bias judgement of cross-over randomized studies. This file will be stored on a scientific data website, available to readers. Overall risk of bias The overall 'Risk of bias' judgement for each specific trial being assessed will be based on each domain-level judgement. The overall judgements include the following. Low risk of bias (the trial is judged to be at low risk of bias for all domains). Some concerns (the trial is judged to raise some concerns in at least one domain but is not judged to be at high risk of bias for any domain). High risk of bias (the trial is judged to be at high risk of bias in at least one domain, or is judged to have some concerns for multiple domains in a way that substantially lowers confidence in the result). The 'risk of bias' assessments will inform our GRADE evaluations of the certainty of evidence for our primary outcomes presented in the 'Summary of findings' tables and will also be used to inform the sensitivity analyses; (see Sensitivity analysis). If there is insufficient information in study reports to enable an assessment of the risk of bias, studies will be classified as "awaiting assessment" until further information is published or made available to us. Measures of treatment effect Dichotomous data For dichotomous data, we will present proportions and, for two-group comparisons, results as average RR or odds ratio (OR) with 95% CIs. Ordered categorical data Continuous data We will report results for continuous outcomes as the mean difference (MD) with 95% CIs, if outcomes are measured in the same way between trials. Where some studies have reported endpoint data and others have reported change-from-baseline data (with errors), we will combine these in the meta-analysis, if the outcomes were reported using the same scale. We will use the standardized mean difference (SMD), with 95% CIs, to combine trials that measured the same outcome but used different methods. If we do not find three or more studies for a pooled analysis, we will summarize the results in a narrative form. Unit of analysis issues Cluster-randomized trials We plan to combine results from both cluster-randomized and individually randomized studies, providing there is little heterogeneity between the studies. If the authors of cluster-randomized trials conducted their analyses at a different level from that of allocation, and they have not appropriately accounted for the cluster design in their analyses, we will calculate the trials' effective sample sizes to account for the effect of clustering in data. When one or more cluster-RCT reports RRs adjusted for clustering, we will compute cluster-adjusted SEs for the other trials. When none of the cluster-RCTs provide cluster-adjusted RRs, we will adjust the sample size for clustering. We will divide, by the estimated design effects (DE), the number of events and number evaluated for dichotomous outcomes and the number evaluated for continuous outcomes, where DE = 1 + ((average cluster size 1) * ICC). The derivation of the estimated ICCs and DEs will be reported. We will utilize the intra-cluster correlation coefficient (ICC), derived from the trial (if available), or from another source (e.g., using the ICCs derived from other, similar trials) and then calculate the design effect with the formula provided in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2021). If this approach is used, we will report it and undertake sensitivity analysis to investigate the effect of variations in ICC. Studies with more than two treatment groups If we identify studies with more than two intervention groups (multi-arm studies), where possible we will combine groups to create a single pair-wise comparison or use the methods set out in the Cochrane Handbook to avoid double counting study participants (Higgins 2021). For the subgroup analyses, when the control group was shared by two or more study arms, we will divide the control group (events and total population) over the number of relevant subgroups to avoid double counting the participants. Trials with several study arms can be included more than once for different comparisons. Cross-over trials From cross-over trials, we will consider the first period of measurement only and will analyze the results together with parallel-group studies. Multiple outcome events In several outcomes, a participant might experience more than one outcome event during the trial period. For all outcomes, we will extract the number of participants with at least one event. Dealing with missing data We will contact the trial authors if the available data are unclear, missing, or reported in a format that is different from the format needed. We aim to perform a 'per protocol' or 'as observed' analysis; otherwise, we will perform a complete case analysis. This means that for treatment failure, we will base the analyses on the participants who received treatment and the number of participants for which there was an inability to clear malarial parasitaemia or prevent recrudescence after administration of an antimalarial medicine reported in the studies. Assessment of heterogeneity Heterogeneity in the results of the trials will be assessed by visually examining the forest plot to detect non-overlapping CIs, using the Chi2 test of heterogeneity (where a P value of less than 0.1 indicates statistical significance) and the I2 statistic of inconsistency (with a value of greater than 50% denoting moderate levels of heterogeneity). When statistical heterogeneity is present, we will investigate the reasons for it, using subgroup analysis. Assessment of reporting biases We will construct a funnel plot to assess the effect of small studies for the main outcome (when including more than 10 trials). Data synthesis The primary analysis will include all eligible studies that provide data regardless of the overall risk of bias as assessed by the RoB2 tool. Analyses will be conducted using Review Manager 5.4 (Review Manager 2020). Cluster-RCTs will be included in the main analysis after adjustment for clustering (see the previous section on cluster-RCTs). The meta-analysis will be performed using the Mantel-Haenszel random-effects model or the generic inverse variance method (when adjustment for clustering is performed by adjusting SEs), as appropriate. Subgroup analysis and investigation of heterogeneity The overall risk of bias will not be used as the basis in conducting our subgroup analyses. However, where data are available, we plan to conduct the following subgroup analyses, independent of heterogeneity. Dose of folic acid supplementation: higher doses (4 mg or more, daily) versus lower doses (less than 4 mg, daily). Moderate-severe anaemia at baseline (mean haemoglobin of participants in a trial at baseline below 100 g/L for pregnant women and children aged six to 59 months, and below 110 g/L for other populations) versus normal at baseline (mean haemoglobin above 100 g/L for pregnant women and children aged six to 59 months, and above 110 g/L for other populations). Antimalarial drug resistance to parasite: known resistance versus no resistance versus unknown/mixed/unreported parasite resistance. Folate status at baseline: Deficient (e.g. RBC folate concentration of less than 305 nmol/L, or serum folate concentration of less than 7nmol/L) and Insufficient (e.g. RBC folate concentration from 305 to less than 906 nmol/L, or serum folate concentration from 7 to less than 25 nmol/L) versus Sufficient (e.g. RBC folate concentration above 906 nmol/L, or serum folate concentration above 25 nmol/L). Presence of anaemia at baseline: yes versus no. Mandatory fortification status: yes, versus no (voluntary or none). We will only use the primary outcomes in any subgroup analyses, and we will limit subgroup analyses to those outcomes for which three or more trials contributed data. Comparisons between subgroups will be performed using Review Manager 5.4 (Review Manager 2020). Sensitivity analysis We will perform a sensitivity analysis, using the risk of bias as a variable to explore the robustness of the findings in our primary outcomes. We will verify the behaviour of our estimators by adding and removing studies with a high risk of bias overall from the analysis. That is, studies with a low risk of bias versus studies with a high risk of bias. Summary of findings and assessment of the certainty of the evidence For the assessment across studies, we will use the GRADE approach, as outlined in (Sch&#xfc;nemann 2021). We will use the five GRADE considerations (study limitations based on RoB2 judgements, consistency of effect, imprecision, indirectness, and publication bias) to assess the certainty of the body of evidence as it relates to the studies which contribute data to the meta-analyses for the primary outcomes. The GRADEpro Guideline Development Tool (GRADEpro) will be used to import data from Review Manager 5.4 (Review Manager 2020) to create 'Summary of Findings' tables. The primary outcomes for the main comparison will be listed with estimates of relative effects, along with the number of participants and studies contributing data for those outcomes. These tables will provide outcome-specific information concerning the overall certainty of evidence from studies included in the comparison, the magnitude of the effect of the interventions examined, and the sum of available data on the outcomes we considered. We will include only primary outcomes in the summary of findings tables. For each individual outcome, two review authors (KSC, LFY) will independently assess the certainty of the evidence using the GRADE approach (Balshem 2011). For assessments of the overall certainty of evidence for each outcome that includes pooled data from included trials, we will downgrade the evidence from 'high certainty' by one level for serious (or by two for very serious) study limitations (risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates, or potential publication bias).</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crider</LastName><ForeName>Krista</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Yan Ping</ForeName><Initials>YP</Initials><AffiliationInfo><Affiliation>National Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutman</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Parasitic Diseases &amp; Malaria, Malaria Branch, Center for Global Health, US Centers for Disease Control and Prevention (CDC), Roybal Campus, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeung</LastName><ForeName>Lorraine</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mai</LastName><ForeName>Cara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finkelstain</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Nutritional Sciences, Cornell University, Ithaca, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Saurabh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Nutritional Sciences, Cornell University, Ithaca, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pons-Duran</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ISGlobal, Hospital Cl&#xed;nic Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Men&#xe9;ndez</LastName><ForeName>Clara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ISGlobal, Hospital Cl&#xed;nic Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moraleda</LastName><ForeName>Cinta</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>ISGlobal, Hospital Cl&#xed;nic Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Food &amp; Nutrition Action in Health Systems, Department of Nutrition and Food Safety, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniels</LastName><ForeName>Kelicia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Eagle Global Scientific LLC, Atlanta, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Center on Birth Defects and Developmental Disabilities, US Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cochrane Database Syst Rev</MedlineTA><NlmUniqueID>100909747</NlmUniqueID><ISSNLinking>1361-6137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance></Chemical><Chemical><RegistryNumber>88463U4SM5</RegistryNumber><NameOfSubstance UI="D013413">Sulfadoxine</NameOfSubstance></Chemical><Chemical><RegistryNumber>Z3614QOX8W</RegistryNumber><NameOfSubstance UI="D011739">Pyrimethamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005493">Folic Acid Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014815">Vitamins</NameOfSubstance></Chemical><Chemical><RegistryNumber>935E97BOY8</RegistryNumber><NameOfSubstance UI="D005492">Folic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>E1UOL152H7</RegistryNumber><NameOfSubstance UI="D007501">Iron</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531736">Acute malaria</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="Y">Antimalarials</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013413" MajorTopicYN="N">Sulfadoxine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011739" MajorTopicYN="N">Pyrimethamine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005493" MajorTopicYN="Y">Folic Acid Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001724" MajorTopicYN="N">Birth Weight</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018512" MajorTopicYN="N">Parasitemia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005492" MajorTopicYN="N">Folic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000740" MajorTopicYN="Y">Anemia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009436" MajorTopicYN="Y">Neural Tube Defects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="N">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007501" MajorTopicYN="N">Iron</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Krista S Crider: no conflicts ofinterestto declare.Krista S Crideris a full-time staI member ofthe Centers forDisease Control and Prevention (CDC). The findings and conclusions in this report are those of the authors and do not necessarily represent the oIicial position of the CDC. Jennifer L Williams: no conflicts of interest to declare. Jennifer L Williams is a full-time staI member of the CDC. The findings and conclusions in this report are those of the authors and do not necessarily represent the oIicial position of the CDC. Julie Gutman: no conflicts of interest to declare. Julie Gutman is a full-time staI member of the CDC. The findings and conclusions in this report are those of the authors and do not necessarily represent the oIicial position of the CDC. Yan Ping Qi: no conflicts of interest to declare. Yan Ping Qi is a full-time staI member of the CDC. The findings and conclusions in this report are those of the authors and do not necessarily represent the oIicial position of the CDC. Cara Mai: no conflicts of interest to declare. Cara Mai is a full-time staI member of the CDC. The findings and conclusions in this report are those of the authors and do not necessarily represent the oIicial position of the CDC. Lorraine Yeung: no conflicts of interest to declare. Lorraine Yeung is a full-time staI member of the CDC. The findings and conclusions in this report are those of the authors and do not necessarily represent the oIicial position of the CDC. Kelicia Daniels: no conflicts of interest to declare. Kelicia Daniels is a full-time contractor of Eagle Global Scientific (EGS) supporting a contract at the CDC. The findings and conclusions in this report are those of the authors and do not necessarily represent the oIicial position of EGS. Patricia P Green: no conflicts of interest to declare. Patricia P Green is a full-time staI member of the CDC. The findings and conclusions in this report are those of the authors and do not necessarily represent the oIicial position of the CDC. Julia L Finkelstein: no conflicts of interest to declare. Saurabh Mehta: no conflicts of interest to declare. In the interest of full disclosure, SM holds equity in VitaScan, a startup company, aiming to commercialize some of his research on point-of-care assessment of nutritional status as a faculty member at Cornell University. Clara Pons-Duran: no conflicts of interest to declare. Clara Men&#xe9;ndez: no conflicts of interest to declare. Cinta Moraleda: no conflicts of interest to declare. Lisa M Rogers: no conflicts of interest to declare. She is employed by the WHO, which has published guidance on the use of folic acid supplementation in malaria-endemic areas based on the latest scientific evidence.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36321557</ArticleId><ArticleId IdType="pmc">PMC8805585</ArticleId><ArticleId IdType="doi">10.1002/14651858.CD014217</ArticleId></ArticleIdList><ReferenceList><Title>Additional references</Title><ReferenceList><Title>Bailey 2015</Title><Reference><Citation>Bailey LB, Stover PJ, McNulty H, Fenech MF, Gregory JF 3rd, Mills JL, et al.Biomarkers of nutrition for development-folate review. Journal of Nutrition 2015;145(7):1636S&#x2013;80S. [DOI: 10.3945/jn.114.206599]</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/jn.114.206599</ArticleId><ArticleId IdType="pmc">PMC4478945</ArticleId><ArticleId IdType="pubmed">26451605</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Balshem 2011</Title><Reference><Citation>Balshem H, Helfand M, Sch&#xfc;nemann HJ, Oxman AD, Kunz R, Brozek J, et al.GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21208779</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bourassa 2019</Title><Reference><Citation>Bourassa M, Osendarp S, Adu&#x2010;Afarwuah S, Ahmed S, Ajello C, Bergeron G, et al.Review of the evidence regarding the use of antenatal multiple micronutrient supplementation in low&#x2010; and middle&#x2010;income countries. Annals of the New York Academy of Sciences 2019;1444(1):6-21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6852202</ArticleId><ArticleId IdType="pubmed">31134643</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Bradley&#x2010;Moore 1985</Title><Reference><Citation>Bradley-Moore AM, Greenwood BM, Bradley AK, Bartlett A, Bidwell DE, Voller A, et al.Malaria chemoprophylaxis with chloroquine in young Nigerian children. Annals of Tropical Medicine &amp; Parasitology 1985;79(6):549-62.</Citation><ArticleIdList><ArticleId IdType="pubmed">3914860</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Filler 2006</Title><Reference><Citation>Filler SJ, Kazembe P, Thigpen M, Macheso A, Parise ME, Newman RD, et al.Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. Journal of Infectious Diseases 2006;194(3):286-93.</Citation><ArticleIdList><ArticleId IdType="pubmed">16826475</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Global Partnership to Roll Back Malaria 2001</Title><Reference><Citation>Global Partnership to Roll Back Malaria.The use of antimalarial drugs: reports of a WHO informal consultation. https://apps.who.int/iris/handle/10665/66961 2001 (accessed 30 November 2020):141.</Citation></Reference></ReferenceList><ReferenceList><Title>GRADEpro [Computer program]</Title><Reference><Citation>McMaster University (developed by Evidence Prime) GRADEpro GDT.Version accessed 24 August 2020. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.</Citation></Reference></ReferenceList><ReferenceList><Title>Higgins 2021</Title><Reference><Citation>Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s).Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook.</Citation></Reference></ReferenceList><ReferenceList><Title>Metz 2007</Title><Reference><Citation>Metz J.Folic acid metabolism and malaria. Food and Nutrition Bulletin 2007;28(4 Suppl):S540-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18297892</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Moher 2009</Title><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, The Prisma Group.Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLOS Medicine 2009;6(7):e1000097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Neuberger 2016</Title><Reference><Citation>Neuberger A, Okebe J, Yahav D, Paul M.Oral iron supplements for children in malaria-endemic areas. Cochrane Database of Systematic Reviews 2016, Issue 2. Art. No: CD006589. [DOI: 10.1002/14651858.CD006589.pub4]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD006589.pub4</ArticleId><ArticleId IdType="pmc">PMC4916933</ArticleId><ArticleId IdType="pubmed">26921618</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>Review Manager 2020 [Computer program]</Title><Reference><Citation>Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5).Version 5.4. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2020.</Citation></Reference></ReferenceList><ReferenceList><Title>Sch&#xfc;nemann 2021</Title><Reference><Citation>Sch&#xfc;nemann H, Higgins J, Vist G, Glasziou P, Akl E, Skoetz N, Guyatt G.Chapter 14: Completing &#x2018;Summary of findings&#x2019; tables and grading the certainty of the evidence [Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021)]. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html 2021.</Citation></Reference></ReferenceList><ReferenceList><Title>SIGN 2020</Title><Reference><Citation>Scottish Intercollegiate Guidelines Network (SIGN).Search filters. www.sign.ac.uk/what-we-do/methodology/search-filters/ (accessed 24 August 2020).</Citation></Reference></ReferenceList><ReferenceList><Title>Sterne 2019</Title><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al.RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898.</Citation><ArticleIdList><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>United Nations 2021</Title><Reference><Citation>United Nations.Goal 3: Ensure healthy lives and promote well-being for all at all ages. sdgs.un.org/goals/goal3 (accessed 28 October 2021).</Citation></Reference></ReferenceList><ReferenceList><Title>WHO 2010</Title><Reference><Citation>World Health Organization (WHO).WHO Guidelines Approved by the Guidelines Review Committee. 2010. ncbi.nlm.nih.gov/books/NBK254223/ (accessed 18 December 2020).</Citation></Reference></ReferenceList><ReferenceList><Title>WHO 2013</Title><Reference><Citation>World Health Organization (WHO).WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). 2013. www.who.int/publications/i/item/WHO-HTM-GMP-2014.4 (accessed 26 October 2021).</Citation></Reference></ReferenceList><ReferenceList><Title>WHO 2015a</Title><Reference><Citation>World Health Organization (WHO).Serum and red blood cell folate concentrations for assessing folate status in populations. 2015. apps.who.int/iris/handle/10665/162114 (accessed 26 October 2021).</Citation></Reference></ReferenceList><ReferenceList><Title>WHO 2015b</Title><Reference><Citation>World Health Organization (WHO).Optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects. 2015. apps.who.int/iris/handle/10665/161988 (accessed 26 October 2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">25996016</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Title>WHO 2015c</Title><Reference><Citation>World Health Organization (WHO).19th WHO model list of essential medicines. 2015. www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf (accessed 28 August 2020).</Citation></Reference></ReferenceList><ReferenceList><Title>WHO 2015d</Title><Reference><Citation>World Health Organization (WHO).Global technical strategy for malaria 2016-2030. Published 1 May 2015. who.int/publications/i/item/9789241564991 (accessed 28 August 2020).</Citation></Reference></ReferenceList><ReferenceList><Title>WHO 2017</Title><Reference><Citation>World Health Organization (WHO).Periconceptional folic acid supplementation to prevent neural tube defects. www.who.int/elena/titles/folate_periconceptional/en/#:~:text=Neural%20tube%20defects%20such%20as,can%20prevent%20neural%20tube%20defects. 2017 (accessed 26 October 2021).</Citation></Reference></ReferenceList><ReferenceList><Title>WHO 2019</Title><Reference><Citation>World Health Organization (WHO).WHO malaria terminology. 2019. who.int/publications/i/item/WHO-HTM-GMP-2016.6 (accessed 26 October 2021).</Citation></Reference></ReferenceList><ReferenceList><Title>WHO 2020</Title><Reference><Citation>World Health Organization (WHO).World Malaria Report 2020. who.int/publications/i/item/9789240015791 (accessed 30 November 2020).</Citation></Reference></ReferenceList></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36322788</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>27</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>A Hybrid Architecture (CO-CONNECT) to Facilitate Rapid Discovery and Access to Data Across the United Kingdom in Response to the COVID-19 Pandemic: Development Study.</ArticleTitle><Pagination><StartPage>e40035</StartPage><MedlinePgn>e40035</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e40035</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/40035</ELocationID><Abstract><AbstractText Label="BACKGROUND">COVID-19 data have been generated across the United Kingdom as a by-product of clinical care and public health provision, as well as numerous bespoke and repurposed research endeavors. Analysis of these data has underpinned the United Kingdom's response to the pandemic, and informed public health policies and clinical guidelines. However, these data are held by different organizations, and this fragmented landscape has presented challenges for public health agencies and researchers as they struggle to find relevant data to access and interrogate the data they need to inform the pandemic response at pace.</AbstractText><AbstractText Label="OBJECTIVE">We aimed to transform UK COVID-19 diagnostic data sets to be findable, accessible, interoperable, and reusable (FAIR).</AbstractText><AbstractText Label="METHODS">A federated infrastructure model (COVID - Curated and Open Analysis and Research Platform [CO-CONNECT]) was rapidly built to enable the automated and reproducible mapping of health data partners' pseudonymized data to the Observational Medical Outcomes Partnership Common Data Model without the need for any data to leave the data controllers' secure environments, and to support federated cohort discovery queries and meta-analysis.</AbstractText><AbstractText Label="RESULTS">A total of 56 data sets from 19 organizations are being connected to the federated network. The data include research cohorts and COVID-19 data collected through routine health care provision linked to longitudinal health care records and demographics. The infrastructure is live, supporting aggregate-level querying of data across the United Kingdom.</AbstractText><AbstractText Label="CONCLUSIONS">CO-CONNECT was developed by a multidisciplinary team. It enables rapid COVID-19 data discovery and instantaneous meta-analysis across data sources, and it is researching streamlined data extraction for use in a Trusted Research Environment for research and public health analysis. CO-CONNECT has the potential to make UK health data more interconnected and better able to answer national-level research questions while maintaining patient confidentiality and local governance procedures.</AbstractText><CopyrightInformation>&#xa9;Emily Jefferson, Christian Cole, Shahzad Mumtaz, Samuel Cox, Thomas Charles Giles, Sam Adejumo, Esmond Urwin, Daniel Lea, Calum Macdonald, Joseph Best, Erum Masood, Gordon Milligan, Jenny Johnston, Scott Horban, Ipek Birced, Christopher Hall, Aaron S Jackson, Clare Collins, Sam Rising, Charlotte Dodsley, Jill Hampton, Andrew Hadfield, Roberto Santos, Simon Tarr, Vasiliki Panagi, Joseph Lavagna, Tracy Jackson, Antony Chuter, Jillian Beggs, Magdalena Martinez-Queipo, Helen Ward, Julie von Ziegenweidt, Frances Burns, Joanne Martin, Neil Sebire, Carole Morris, Declan Bradley, Rob Baxter, Anni Ahonen-Bishopp, Paul Smith, Amelia Shoemark, Ana M Valdes, Benjamin Ollivere, Charlotte Manisty, David Eyre, Stephanie Gallant, George Joy, Andrew McAuley, David Connell, Kate Northstone, Katie Jeffery, Emanuele Di Angelantonio, Amy McMahon, Mat Walker, Malcolm Gracie Semple, Jessica Mai Sims, Emma Lawrence, Bethan Davies, John Kenneth Baillie, Ming Tang, Gary Leeming, Linda Power, Thomas Breeze, Duncan Murray, Chris Orton, Iain Pierce, Ian Hall, Shamez Ladhani, Natalie Gillson, Matthew Whitaker, Laura Shallcross, David Seymour, Susheel Varma, Gerry Reilly, Andrew Morris, Susan Hopkins, Aziz Sheikh, Philip Quinlan. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 27.12.2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jefferson</LastName><ForeName>Emily</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2992-7582</Identifier><AffiliationInfo><Affiliation>Health Informatics Centre, Division of Population and Health Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cole</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-2560-2484</Identifier><AffiliationInfo><Affiliation>Health Informatics Centre, Division of Population and Health Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mumtaz</LastName><ForeName>Shahzad</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2606-2405</Identifier><AffiliationInfo><Affiliation>Health Informatics Centre, Division of Population and Health Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cox</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9841-9816</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giles</LastName><ForeName>Thomas Charles</ForeName><Initials>TC</Initials><Identifier Source="ORCID">0000-0003-1356-4289</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adejumo</LastName><ForeName>Sam</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6685-3047</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urwin</LastName><ForeName>Esmond</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-4626-2172</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lea</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8152-0398</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Macdonald</LastName><ForeName>Calum</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7857-9188</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Best</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6809-4179</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masood</LastName><ForeName>Erum</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-8790-5352</Identifier><AffiliationInfo><Affiliation>Health Informatics Centre, Division of Population and Health Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milligan</LastName><ForeName>Gordon</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-1171-5234</Identifier><AffiliationInfo><Affiliation>Health Informatics Centre, Division of Population and Health Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>Jenny</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6755-1267</Identifier><AffiliationInfo><Affiliation>Health Informatics Centre, Division of Population and Health Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horban</LastName><ForeName>Scott</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6431-8243</Identifier><AffiliationInfo><Affiliation>Health Informatics Centre, Division of Population and Health Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birced</LastName><ForeName>Ipek</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-0048-6720</Identifier><AffiliationInfo><Affiliation>Health Informatics Centre, Division of Population and Health Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1368-4619</Identifier><AffiliationInfo><Affiliation>Health Informatics Centre, Division of Population and Health Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Aaron S</ForeName><Initials>AS</Initials><Identifier Source="ORCID">0000-0003-3217-012X</Identifier><AffiliationInfo><Affiliation>Health Informatics Centre, Division of Population and Health Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Clare</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4679-9850</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rising</LastName><ForeName>Sam</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6934-4480</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dodsley</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4825-1266</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hampton</LastName><ForeName>Jill</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3874-0819</Identifier><AffiliationInfo><Affiliation>Health Informatics Centre, Division of Population and Health Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadfield</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2976-3605</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1333-2605</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarr</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8464-1240</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panagi</LastName><ForeName>Vasiliki</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-4206-4024</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavagna</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3907-255X</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Tracy</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-6188-3607</Identifier><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuter</LastName><ForeName>Antony</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0646-5939</Identifier><AffiliationInfo><Affiliation>Lay Partnership in Healthcare Research, Lindfield, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beggs</LastName><ForeName>Jillian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7591-3256</Identifier><AffiliationInfo><Affiliation>Health Informatics Centre, Division of Population and Health Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez-Queipo</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2847-334X</Identifier><AffiliationInfo><Affiliation>National Health Service Digital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Helen</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-8238-5036</Identifier><AffiliationInfo><Affiliation>School of Public Health, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Ziegenweidt</LastName><ForeName>Julie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8776-1125</Identifier><AffiliationInfo><Affiliation>Department of Haemotology, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Healthcare Research BioResource, Cambridge University Hospitals NHS Foundation, Cambridge Biomedical Campus, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Frances</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5885-1981</Identifier><AffiliationInfo><Affiliation>Centre for Public Health, Belfast Institute of Clinical Science, Queens University Belfast, Belfast, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Joanne</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2828-7253</Identifier><AffiliationInfo><Affiliation>Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sebire</LastName><ForeName>Neil</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5348-9063</Identifier><AffiliationInfo><Affiliation>Institute of Child Health, Great Ormond Street Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Carole</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-8150-8217</Identifier><AffiliationInfo><Affiliation>Public Health Scotland, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradley</LastName><ForeName>Declan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1468-1823</Identifier><AffiliationInfo><Affiliation>Centre for Public Health, Institute of Clinical Science, Queen's University Belfast, Belfast, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health Agency, Belfast, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baxter</LastName><ForeName>Rob</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3693-8725</Identifier><AffiliationInfo><Affiliation>EPCC, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahonen-Bishopp</LastName><ForeName>Anni</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4215-6228</Identifier><AffiliationInfo><Affiliation>BC Platforms, Espoo, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8598-1762</Identifier><AffiliationInfo><Affiliation>BC Platforms, Espoo, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoemark</LastName><ForeName>Amelia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7360-6060</Identifier><AffiliationInfo><Affiliation>Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdes</LastName><ForeName>Ana M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-1141-4471</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ollivere</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-1410-1756</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manisty</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0245-7090</Identifier><AffiliationInfo><Affiliation>Institute of Cardiovascular Sciences, University of College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eyre</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5095-6367</Identifier><AffiliationInfo><Affiliation>Big Data Institute, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallant</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9499-3936</Identifier><AffiliationInfo><Affiliation>Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joy</LastName><ForeName>George</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-1467-5490</Identifier><AffiliationInfo><Affiliation>Barts Heart Centre, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAuley</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6047-2400</Identifier><AffiliationInfo><Affiliation>Clinical and Protecting Health Directorate, Public Health Scotland, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Connell</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7008-8883</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Dundee, Dundee, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Northstone</LastName><ForeName>Kate</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-0602-1983</Identifier><AffiliationInfo><Affiliation>Population Health Sciences, Avon Longitudinal Study of Parents and Children, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeffery</LastName><ForeName>Katie</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-6506-2689</Identifier><AffiliationInfo><Affiliation>Radcliffe Department of Medicine, Oxford University, Oxford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Angelantonio</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-8776-6719</Identifier><AffiliationInfo><Affiliation>British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK Cambridge, Wellcome Genome Campus, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Science Research Centre, Human Technopole, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMahon</LastName><ForeName>Amy</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3973-2826</Identifier><AffiliationInfo><Affiliation>British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Mat</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6334-2732</Identifier><AffiliationInfo><Affiliation>British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semple</LastName><ForeName>Malcolm Gracie</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0001-9700-0418</Identifier><AffiliationInfo><Affiliation>Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infections, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Respiratory Department, Alder Hey Children's Hospital, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sims</LastName><ForeName>Jessica Mai</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0003-1565-7315</Identifier><AffiliationInfo><Affiliation>University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawrence</LastName><ForeName>Emma</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9018-6010</Identifier><AffiliationInfo><Affiliation>BioIndustry Association, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Bethan</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6585-7641</Identifier><AffiliationInfo><Affiliation>School of Public Health, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baillie</LastName><ForeName>John Kenneth</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0001-5258-793X</Identifier><AffiliationInfo><Affiliation>Outbreak Data Analysis Platform, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Ming</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5498-0839</Identifier><AffiliationInfo><Affiliation>NHS England, Worcestershire, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leeming</LastName><ForeName>Gary</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5554-5302</Identifier><AffiliationInfo><Affiliation>Civic Data Cooperative, Digital Innovation Facility, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Power</LastName><ForeName>Linda</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7503-107X</Identifier><AffiliationInfo><Affiliation>Public Health England, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breeze</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-2626-527X</Identifier><AffiliationInfo><Affiliation>Avon Longitudinal Study of Parents and Children, Bristol Medical School, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murray</LastName><ForeName>Duncan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-4664-3725</Identifier><AffiliationInfo><Affiliation>University of Birmingham, Birmingham, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital Coventry &amp; Warwickshire NHS Trust, Coventry, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orton</LastName><ForeName>Chris</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-9561-2493</Identifier><AffiliationInfo><Affiliation>Population Data Science, Swansea University Medical School, Swansea, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierce</LastName><ForeName>Iain</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-8546-5023</Identifier><AffiliationInfo><Affiliation>Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Cardiovascular Science, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Ian</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-9933-3216</Identifier><AffiliationInfo><Affiliation>Nottingham Biomedical Research Centre, School of Medicine, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladhani</LastName><ForeName>Shamez</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0856-2476</Identifier><AffiliationInfo><Affiliation>Immunisation and Countermeasures Division, Public Health England Colindale, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillson</LastName><ForeName>Natalie</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-6137-6728</Identifier><AffiliationInfo><Affiliation>UK Health Security Agency, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitaker</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1363-6537</Identifier><AffiliationInfo><Affiliation>School of Public Health, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shallcross</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1713-2555</Identifier><AffiliationInfo><Affiliation>Institute of Health Informatics, UCL, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seymour</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-4194-2056</Identifier><AffiliationInfo><Affiliation>Health Data Research UK, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varma</LastName><ForeName>Susheel</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1687-2754</Identifier><AffiliationInfo><Affiliation>Health Data Research UK, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reilly</LastName><ForeName>Gerry</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-1427-3598</Identifier><AffiliationInfo><Affiliation>Health Data Research UK, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1766-0473</Identifier><AffiliationInfo><Affiliation>Health Data Research UK, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hopkins</LastName><ForeName>Susan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5179-5702</Identifier><AffiliationInfo><Affiliation>Public Health England, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Aziz</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7022-3056</Identifier><AffiliationInfo><Affiliation>Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinlan</LastName><ForeName>Philip</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-3012-6646</Identifier><AffiliationInfo><Affiliation>Digital Research Service, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Nottingham, Nottingham, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/W014335/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_19009</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RG/13/13/30194</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_19059</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_19002</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/W026813/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G9815508</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>RG/18/13/33946</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V03488X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_15018</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>CH/12/2/29428</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20058</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">clinical care</Keyword><Keyword MajorTopicYN="N">data extraction</Keyword><Keyword MajorTopicYN="N">data governance</Keyword><Keyword MajorTopicYN="N">data privacy</Keyword><Keyword MajorTopicYN="N">federated network</Keyword><Keyword MajorTopicYN="N">health care</Keyword><Keyword MajorTopicYN="N">health care record</Keyword><Keyword MajorTopicYN="N">health data</Keyword><Keyword MajorTopicYN="N">infrastructure model</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">public health</Keyword></KeywordList><CoiStatement>Conflicts of Interest: A Sheikh is a member of the Scottish Government Chief Medical Officer&#x2019;s COVID-19 Advisory Group and its Standing Committee on Pandemics. PQ was previously on a paid secondment to BC Platforms and now resides on their Scientific Advisory Board as a paid consultant. AA-B and PS work for BC Platforms, whose solution CO-CONNECT utilized.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>15</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36322788</ArticleId><ArticleId IdType="pmc">PMC9822177</ArticleId><ArticleId IdType="doi">10.2196/40035</ArticleId><ArticleId IdType="pii">v24i12e40035</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Richter A, Plant T, Kidd M, Bosworth A, Mayhew M, Megram O, Ashworth F, Crawford L, White T, Moles-Garcia E, Mirza J, Percival B, McNally A. How to establish an academic SARS-CoV-2 testing laboratory. Nat Microbiol. 2020 Dec 02;5(12):1452&#x2013;1454. doi: 10.1038/s41564-020-00818-3.10.1038/s41564-020-00818-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-00818-3</ArticleId><ArticleId IdType="pubmed">33139885</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S, Elliott J, Berlin A, Hamer-Hunt J, Haines A. Strengthening the UK primary care response to covid-19. BMJ. 2020 Sep 25;370:m3691. doi: 10.1136/bmj.m3691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3691</ArticleId><ArticleId IdType="pubmed">32978177</ArticleId></ArticleIdList></Reference><Reference><Citation>Oral evidence: UK Science, Research and Technology Capability and Influence in Global Disease Outbreaks, HC 136. Science and Technology Committee. 2020.  [2021-08-14].  
 https://committees.parliament.uk/oralevidence/701/html/
</Citation></Reference><Reference><Citation>Better, broader, safer: using health data for research and analysis. GOV UK.  [2022-05-13].  
 https://www.gov.uk/government/publications/better-broader-safer-using-health-data-for-research-and-analysis
.</Citation><ArticleIdList><ArticleId IdType="pubmed">35973413</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallaro F, Lugg-Widger F, Cannings-John R, Harron K. Reducing barriers to data access for research in the public interest&#x2014;lessons from covid-19. BMJ Opinion. 2020.  [2022-05-13].  
 https://blogs.bmj.com/bmj/2020/07/06/reducing-barriers-&#x200b;to-data-access-for-research-in-the-public-interest-lessons-from-covid-19/
</Citation></Reference><Reference><Citation>Taylor JA, Crowe S, Espuny Pujol F, Franklin RC, Feltbower RG, Norman LJ, Doidge J, Gould DW, Pagel C. The road to hell is paved with good intentions: the experience of applying for national data for linkage and suggestions for improvement. BMJ Open. 2021 Aug 19;11(8):e047575&#x2013;7. doi: 10.1136/bmjopen-2020-047575. 
 
bmjopen-2020-047575</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-047575</ArticleId><ArticleId IdType="pmc">PMC8378388</ArticleId><ArticleId IdType="pubmed">34413101</ArticleId></ArticleIdList></Reference><Reference><Citation>Macnair A, Love SB, Murray ML, Gilbert DC, Parmar MKB, Denwood T, Carpenter J, Sydes MR, Langley RE, Cafferty FH. Accessing routinely collected health data to improve clinical trials: recent experience of access. Trials. 2021 May 10;22(1):340. doi: 10.1186/s13063-021-05295-5. 
 
10.1186/s13063-021-05295-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-021-05295-5</ArticleId><ArticleId IdType="doi">10.1186/s13063-021-05295-5</ArticleId><ArticleId IdType="pmc">PMC8108438</ArticleId><ArticleId IdType="pubmed">33971933</ArticleId></ArticleIdList></Reference><Reference><Citation>The researchers&#x2019; experience when attempting to access health data for research. NCRI. 2020.  [2022-05-13].  
 https://www.ncri.org.uk/accessing-health-data-for-research/
</Citation></Reference><Reference><Citation>Larrucea X, Moffie M, Asaf S, Santamaria I. Towards a GDPR compliant way to secure European cross border Healthcare Industry 4.0. Computer Standards &amp; Interfaces. 2020 Mar;69:103408. doi: 10.1016/j.csi.2019.103408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csi.2019.103408</ArticleId></ArticleIdList></Reference><Reference><Citation>Data sharing agreement template. NHS. 2020.  [2021-08-24].  
 https://www.nhsx.nhs.uk/information-governance/guidance/data-sharing-&#x200b;agreement-template/
</Citation></Reference><Reference><Citation>Lin C, Stephens KA, Baldwin L, Keppel GA, Whitener RJ, Echo-Hawk A, Korngiebel D. Developing Governance for Federated Community-based EHR Data Sharing. AMIA Jt Summits Transl Sci Proc. 2014;2014:71&#x2013;6. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4333692</ArticleId><ArticleId IdType="pubmed">25717404</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubbard T, Reilly G, Varma S, Seymour D. Trusted Research Environments (TRE) Green Paper. Zenodo. 2020.  [2022-11-04].  
 https://zenodo.org/record/4594704#.Y2UDxeRBzDc
.</Citation></Reference><Reference><Citation>Kruse CS, Smith B, Vanderlinden H, Nealand A. Security Techniques for the Electronic Health Records. J Med Syst. 2017 Aug;41(8):127. doi: 10.1007/s10916-017-0778-4. 
 
10.1007/s10916-017-0778-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-017-0778-4</ArticleId><ArticleId IdType="pmc">PMC5522514</ArticleId><ArticleId IdType="pubmed">28733949</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan P. The Compliance Case for Information Governance. Richmond Journal of Law &amp; Technology. 2014;20(2):Article 2. 
 
</Citation></Reference><Reference><Citation>Trifan A, Oliveira JL. Patient data discovery platforms as enablers of biomedical and translational research: A systematic review. J Biomed Inform. 2019 May;93:103154. doi: 10.1016/j.jbi.2019.103154. 
 
S1532-0464(19)30072-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103154</ArticleId><ArticleId IdType="pubmed">30922867</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharing Sensitive Health Data in a Federated Data Consortium Model: An Eight-Step Guide. World Economic Forum. 2020.  [2021-08-20].  
 https://www.weforum.org/reports/sharing-sensitive-health-data-in-a-federated-data-consortium-model-an-&#x200b;eight-step-guide
.</Citation></Reference><Reference><Citation>Knoppers BM. Framework for responsible sharing of genomic and health-related data. Hugo J. 2014 Dec;8(1):3. doi: 10.1186/s11568-014-0003-1. 
 
10.1186/s11568-014-0003-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s11568-014-0003-1</ArticleId><ArticleId IdType="pmc">PMC4685158</ArticleId><ArticleId IdType="pubmed">27090251</ArticleId></ArticleIdList></Reference><Reference><Citation>Dursi LJ, Bozoky Z, de Borja R, Li H, Bujold D, Lipski A, Rashid SF, Sethi A, Memon N, Naidoo D, Coral-Sasso F, Wong M, Quirion P, Lu Z, Agarwal S, Pavlov Y, Ponomarev A, Husic M, Pace K, Palmer S, Grover SA, Hakgor S, Siu LL, Malkin D, Virtanen C, Pugh TJ, Jacques P, Joly Y, Jones SJ, Bourque G, Brudno M. CanDIG: Federated network across Canada for multi-omic and health data discovery and analysis. Cell Genomics. 2021 Nov;1(2):100033. doi: 10.1016/j.xgen.2021.100033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xgen.2021.100033</ArticleId></ArticleIdList></Reference><Reference><Citation>CINECA - Common Infrastructure for National Cohorts in Europe, Canada, and Africa.  [2022-03-11].  
 https://www.cineca-project.eu
.</Citation></Reference><Reference><Citation>European Health Data Evidence Network.  [2021-08-11].  
 https://www.ehden.eu/
</Citation></Reference><Reference><Citation>Rahimzadeh V, Dyke SO, Knoppers BM. An International Framework for Data Sharing: Moving Forward with the Global Alliance for Genomics and Health. Biopreserv Biobank. 2016 Jun;14(3):256&#x2013;9. doi: 10.1089/bio.2016.0005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/bio.2016.0005</ArticleId><ArticleId IdType="pubmed">27082668</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobbins NJ, Spital CH, Black RA, Morrison JM, de Veer B, Zampino E, Harrington RD, Britt BD, Stephens KA, Wilcox AB, Tarczy-Hornoch P, Mooney SD. Leaf: an open-source, model-agnostic, data-driven web application for cohort discovery and translational biomedical research. J Am Med Inform Assoc. 2020 Jan 01;27(1):109&#x2013;118. doi: 10.1093/jamia/ocz165. 
 
5583724</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocz165</ArticleId><ArticleId IdType="pmc">PMC6913227</ArticleId><ArticleId IdType="pubmed">31592524</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S, Kohane I. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) J Am Med Inform Assoc. 2010;17(2):124&#x2013;30. doi: 10.1136/jamia.2009.000893. 
 
17/2/124</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.000893</ArticleId><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;ttler C, Prokosch H, Hummel M, Lablans M, Kroll B, Engels C, German Biobank Alliance IT Development Team  The journey to establishing an IT-infrastructure within the German Biobank Alliance. PLoS One. 2021 Sep 22;16(9):e0257632. doi: 10.1371/journal.pone.0257632. 
 
PONE-D-21-18148</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0257632</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0257632</ArticleId><ArticleId IdType="pmc">PMC8457464</ArticleId><ArticleId IdType="pubmed">34551019</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfson M, Wallace SE, Masca N, Rowe G, Sheehan NA, Ferretti V, LaFlamme P, Tobin MD, Macleod J, Little J, Fortier I, Knoppers BM, Burton PR. DataSHIELD: resolving a conflict in contemporary bioscience--performing a pooled analysis of individual-level data without sharing the data. Int J Epidemiol. 2010 Oct 14;39(5):1372&#x2013;82. doi: 10.1093/ije/dyq111. 
 
dyq111</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyq111</ArticleId><ArticleId IdType="pmc">PMC2972441</ArticleId><ArticleId IdType="pubmed">20630989</ArticleId></ArticleIdList></Reference><Reference><Citation>BC Platforms.  [2021-07-23].  
 https://www.bcplatforms.com
.</Citation></Reference><Reference><Citation>Stacey J, Mehta M. Using EHR Data Extraction to Streamline the Clinical Trial Process. Clinical Researcher. 2017.  [2022-11-04].  
 https://acrpnet.org/2017/04/01/using-ehr-data-extraction-streamline-clinical-trial-process/
</Citation></Reference><Reference><Citation>Clinerion.  [2021-11-30].  
 https://www.clinerion.com/index.html
.</Citation></Reference><Reference><Citation>Data science and AI in the age of COVID-19 &#x2013; report. The Alan Turing Institute.  [2021-08-11].  
 https://www.turing.ac.uk/research/publications/data-science-and-ai-age-covid-19-report
.</Citation></Reference><Reference><Citation>HDR UK Innovation Gateway.  [2021-07-28].  
 https://www.healthdatagateway.org/
</Citation></Reference><Reference><Citation>Sebire NJ, Cake C, Morris AD. HDR UK supporting mobilising computable biomedical knowledge in the UK. BMJ Health Care Inform. 2020 Jul 28;27(2):e100122. doi: 10.1136/bmjhci-2019-100122. 
 
bmjhci-2019-100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjhci-2019-100122</ArticleId><ArticleId IdType="pmc">PMC7388881</ArticleId><ArticleId IdType="pubmed">32723851</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 National Core Studies. HDR UK.  [2021-07-23].  
 https://www.hdruk.ac.uk/covid-19/covid-19-national-core-studies/
</Citation></Reference><Reference><Citation>Scientific Advisory Group for Emergencies. GOV UK.  [2022-10-04].  
 https://www.gov.uk/government/organisations/scientific-&#x200b;advisory-group-for-emergencies
.</Citation></Reference><Reference><Citation>Wilkinson MD, Dumontier M, Aalbersberg IJ, Appleton G, Axton M, Baak A, Blomberg N, Boiten J, da Silva Santos LB, Bourne PE, Bouwman J, Brookes AJ, Clark T, Crosas M, Dillo I, Dumon O, Edmunds S, Evelo CT, Finkers R, Gonzalez-Beltran A, Gray AJ, Groth P, Goble C, Grethe JS, Heringa J, 't Hoen PAC, Hooft R, Kuhn T, Kok R, Kok J, Lusher SJ, Martone ME, Mons A, Packer AL, Persson B, Rocca-Serra P, Roos M, van Schaik R, Sansone S, Schultes E, Sengstag T, Slater T, Strawn G, Swertz MA, Thompson M, van der Lei J, van Mulligen E, Velterop J, Waagmeester A, Wittenburg P, Wolstencroft K, Zhao J, Mons B. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016 Mar 15;3(1):160018. doi: 10.1038/sdata.2016.18. doi: 10.1038/sdata.2016.18.sdata201618</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2016.18</ArticleId><ArticleId IdType="doi">10.1038/sdata.2016.18</ArticleId><ArticleId IdType="pmc">PMC4792175</ArticleId><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>CO-CONNECT - Overview. YouTube.  [2022-09-30].  
 https://www.youtube.com/watch?v=dqZtWi6VGGo
.</Citation></Reference><Reference><Citation>OMOP CDM v5.3. OHDSI GitHub.  [2022-05-13].  
 https://ohdsi.github.io/CommonDataModel/cdm53.html#Clinical_Data_Tables
.</Citation></Reference><Reference><Citation>Cox S, Macdonald C, Lea D, Adejumo S, Panagi V, Tarr S, Mumtaz S, Santos R, Schlessinger D, Quinlan P. HDRUK/CaRROT-Mapper: 2.0.1. Zenodo. 2022.  [2022-11-04].  
 https://zenodo.org/record/6587677#.Y2UHT-RBzDc
.</Citation></Reference><Reference><Citation>Macdonald C, Panagi V, Tarr S, Santos R, Schlessinger D, Mumtaz S. HDRUK/CaRROT-CDM: CaRROT CDM Builder Version 0.6.0. Zenodo. 2022.  [2022-11-04].  
 https://zenodo.org/record/6593954#.Y2UHl-RBzDc
.</Citation></Reference><Reference><Citation>OHDSI - Observational Health Data Sciences and Informatics.  [2022-10-04].  
 https://www.ohdsi.org/
</Citation></Reference><Reference><Citation>White Rabbit. OHDSI GitHub.  [2021-07-23].  
 http://ohdsi.github.io/WhiteRabbit/WhiteRabbit.html
.</Citation></Reference><Reference><Citation>Cox S, Macdonald C, Mumtaz S, Panagi V, Tarr S, Quinlan P. CaRROT-Docs. HDRUK GitHub.  [2022-03-10].  
 https://hdruk.github.io/CaRROT-Docs/
</Citation></Reference><Reference><Citation>Cohort Discovery. HDR UK Innovation Gateway.  [2022-03-10].  
 https://www.healthdatagateway.org/about/cohort-discovery
.</Citation></Reference><Reference><Citation>Ritchie F. The 'Five Safes': a framework for planning, designing and evaluating data access solutions. Zenodo. 2017.  [2022-11-04].  
 https://zenodo.org/record/897821#.Y2UI3-RBzDc
.</Citation></Reference><Reference><Citation>The &#x2018;Five Safes&#x2019; &#x2013; Data Privacy at ONS. Office for National Statistics.  [2022-09-23].  
 https://blog.ons.gov.uk/2017/01/27/the-five-&#x200b;safes-data-privacy-at-ons/
</Citation></Reference><Reference><Citation>Data Access Request Process Overview. HDR UK Innovation Gateway.  [2022-02-03].  
 https://www.healthdatagateway.org/about/data-access-request-process
.</Citation></Reference><Reference><Citation>CO-CONNECT - Finding Data. YouTube.  [2022-09-30].  
 https://www.youtube.com/watch?v=HAI3NhJsCKE
.</Citation></Reference><Reference><Citation>CO-CONNECT - Accessing and Analysing Data. YouTube.  [2022-09-30].  
 https://www.youtube.com/watch?v=oc25k8WW440
.</Citation></Reference><Reference><Citation>CO-CONNECT | Unleashing the power of data through discovery.  [2022-05-31].  
 https://co-connect.ac.uk/
</Citation></Reference><Reference><Citation>Grandjean L, Saso A, Torres A, Lam T, Hatcher J, Thistlethwayte R, Harris M, Best T, Johnson M, Wagstaffe H, Ralph E, Mai A, Colijn C, Breuer J, Buckland M, Gilmour K, Goldblatt D, Co-Stars Study Team  Humoral Response Dynamics Following Infection with SARS-CoV-2. medRxiv. 2020.  [2022-11-04].  
 https://www.medrxiv.org/content/10.1101/2020.07.16.20155663v2
.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.16.20155663v2</ArticleId></ArticleIdList></Reference><Reference><Citation>Augusto JB, Menacho K, Andiapen M, Bowles R, Burton M, Welch S, Bhuva AN, Seraphim A, Pade C, Joy G, Jensen M, Davies RH, Captur G, Fontana M, Montgomery H, O'Brien B, Hingorani AD, Cutino-Moguel T, McKnight. Abbass H, Alfarih M, Alldis Z, Baca GL, Boulter A, Bracken OV, Bullock N, Champion N, Chan C, Couto-Parada X, Dieobi-Anene K, Feehan K, Figtree G, Figtree MC, Finlay M, Forooghi N, Gibbons JM, Griffiths P, Hamblin M, Howes L, Itua I, Jones M, Jardim V, Kapil V, Jason Lee W, Mandadapu V, Mfuko C, Mitchelmore O, Palma S, Patel K, Petersen SE, Piniera B, Raine R, Rapala A, Richards A, Sambile G, Couto de Sousa J, Sugimoto M, Thornton GD, Artico J, Zahedi D, Parker R, Robathan M, Hickling LM, Ntusi N, Semper A, Brooks T, Jones J, Tucker A, Veerapen J, Vijayakumar M, Wodehouse T, Wynne L, Treibel TA, Noursadeghi M, Manisty C, Moon JC. Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19. Wellcome Open Res. 2020 Oct 12;5:179. doi: 10.12688/wellcomeopenres.16051.2. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/wellcomeopenres.16051.2</ArticleId><ArticleId IdType="pmc">PMC7836029</ArticleId><ArticleId IdType="pubmed">33537459</ArticleId></ArticleIdList></Reference><Reference><Citation>Abo-Leyah H, Gallant S, Cassidy D, Giam Y, Killick J, Marshall B, Hay G, Snowdon C, Hothersall EJ, Pembridge T, Strachan R, Gallant N, Parcell BJ, George J, Furrie E, Chalmers JD. The protective effect of SARS-CoV-2 antibodies in Scottish healthcare workers. ERJ Open Res. 2021 Apr;7(2):5641. doi: 10.1183/23120541.00080-2021. 
 
00080-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00080-2021</ArticleId><ArticleId IdType="pmc">PMC8164012</ArticleId><ArticleId IdType="pubmed">34104643</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumley SF, O'Donnell D, Stoesser NE, Matthews PC, Howarth A, Hatch SB, Marsden BD, Cox S, James T, Warren F, Peck LJ, Ritter TG, de Toledo Z, Warren L, Axten D, Cornall RJ, Jones EY, Stuart DI, Screaton G, Ebner D, Hoosdally S, Chand M, Crook DW, O'Donnell AM, Conlon CP, Pouwels KB, Walker AS, Peto TE, Hopkins S, Walker TM, Jeffery K, Eyre DW, Oxford University Hospitals Staff Testing Group  Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers. N Engl J Med. 2021 Feb 11;384(6):533&#x2013;540. doi: 10.1056/NEJMoa2034545. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2034545</ArticleId><ArticleId IdType="pmc">PMC7781098</ArticleId><ArticleId IdType="pubmed">33369366</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdes AM, Moon JC, Vijay A, Chaturvedi N, Norrish A, Ikram A, Craxford S, Cusin LM, Nightingale J, Semper A, Brooks T, McKnight A, Kurdi H, Menni C, Tighe P, Noursadeghi M, Aithal G, Treibel TA, Ollivere BJ, Manisty C. Longitudinal assessment of symptoms and risk of SARS-CoV-2 infection in healthcare workers across 5 hospitals to understand ethnic differences in infection risk. EClinicalMedicine. 2021 Apr;34:100835. doi: 10.1016/j.eclinm.2021.100835. 
 
S2589-5370(21)00115-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100835</ArticleId><ArticleId IdType="pmc">PMC8049191</ArticleId><ArticleId IdType="pubmed">33880438</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall VJ, Foulkes S, Charlett A, Atti A, Monk EJM, Simmons R, Wellington E, Cole MJ, Saei A, Oguti B, Munro K, Wallace S, Kirwan PD, Shrotri M, Vusirikala A, Rokadiya S, Kall M, Zambon M, Ramsay M, Brooks T, Brown CS, Chand MA, Hopkins S, SIREN Study Group  SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) Lancet. 2021 Apr 17;397(10283):1459&#x2013;1469. doi: 10.1016/S0140-6736(21)00675-9. 
 
S0140-6736(21)00675-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00675-9</ArticleId><ArticleId IdType="pmc">PMC8040523</ArticleId><ArticleId IdType="pubmed">33844963</ArticleId></ArticleIdList></Reference><Reference><Citation>The TRACK-COVID Study. TRACK-COVID.  [2021-07-23].  
 https://www.trackcovid.org.uk/
</Citation></Reference><Reference><Citation>VIVALDI Study. UCL.  [2021-07-23].  
 https://www.ucl.ac.uk/health-informatics/research/vivaldi-study
.</Citation></Reference><Reference><Citation>Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, Holden KA, Read JM, Dondelinger F, Carson G, Merson L, Lee J, Plotkin D, Sigfrid L, Halpin S, Jackson C, Gamble C, Horby PW, Nguyen-Van-Tam JS, Ho A, Russell CD, Dunning J, Openshaw PJ, Baillie JK, Semple MG, ISARIC4C investigators  Features of 20&#x2009;133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020 May 22;369:m1985. doi: 10.1136/bmj.m1985. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 surveillance in school KIDs (sKIDs): pre and primary schools. GOV UK.  [2021-08-18].  
 https://www.gov.uk/government/publications/covid-19-surveillance-in-school-kids-skids-pre-and-primary-schools
.</Citation></Reference><Reference><Citation>Asymptomatic COVID-19 in Education (ACE) Cohort. HDR UK Innovation Gateway.  [2021-08-18].  
 https://web.www.healthdatagateway.org/dataset/48adf432-9b66-4d03-a25e-008fbbb24f56
.</Citation></Reference><Reference><Citation>Real-time Assessment of Community Transmission (REACT) Study. Imperial College London.  [2021-07-18].  
 http://www.imperial.ac.uk/medicine/research-and-impact/groups/react-study/
</Citation></Reference><Reference><Citation>FOLLOW-COVID. NHS.  [2022-11-16].  
 https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/follow-covid/
</Citation></Reference><Reference><Citation>ATLAS: Advanced data search tool for researchers. UKCRC Tissue Directory and Coordination Centre.  [2021-07-23].  
 https://biobankinguk.org/atlas/
</Citation></Reference><Reference><Citation>Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, Henderson J, Molloy L, Ness A, Ring S, Davey Smith G. Cohort Profile: the 'children of the 90s'--the index offspring of the Avon Longitudinal Study of Parents and Children. Int J Epidemiol. 2013 Feb;42(1):111&#x2013;27. doi: 10.1093/ije/dys064. 
 
dys064</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys064</ArticleId><ArticleId IdType="pmc">PMC3600618</ArticleId><ArticleId IdType="pubmed">22507743</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B, Campbell A, Linksted P, Fitzpatrick B, Jackson C, Kerr S, Deary I, Macintyre DJ, Campbell H, McGilchrist M, Hocking L, Wisely L, Ford I, Lindsay R, Morton R, Palmer C, Dominiczak A, Porteous D, Morris A. Cohort Profile: Generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. Int J Epidemiol. 2013 Jun;42(3):689&#x2013;700. doi: 10.1093/ije/dys084.dys084</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys084</ArticleId><ArticleId IdType="pubmed">22786799</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrine N, Portelli MA, John C, Soler Artigas M, Bennett N, Hall R, Lewis J, Henry AP, Billington CK, Ahmad A, Packer RJ, Shaw D, Pogson ZEK, Fogarty A, McKeever TM, Singapuri A, Heaney LG, Mansur AH, Chaudhuri R, Thomson NC, Holloway JW, Lockett GA, Howarth PH, Djukanovic R, Hankinson J, Niven R, Simpson A, Chung KF, Sterk PJ, Blakey JD, Adcock IM, Hu S, Guo Y, Obeidat M, Sin DD, van den Berge M, Nickle DC, Boss&#xe9; Y, Tobin MD, Hall IP, Brightling CE, Wain LV, Sayers I. Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study. Lancet Respir Med. 2019 Jan;7(1):20&#x2013;34. doi: 10.1016/S2213-2600(18)30389-8. 
 
S2213-2600(18)30389-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(18)30389-8</ArticleId><ArticleId IdType="pmc">PMC6314966</ArticleId><ArticleId IdType="pubmed">30552067</ArticleId></ArticleIdList></Reference><Reference><Citation>NIHR BioResource.  [2021-09-03].  
 https://bioresource.nihr.ac.uk/
</Citation></Reference><Reference><Citation>Moayyeri A, Hammond CJ, Valdes AM, Spector TD. Cohort Profile: TwinsUK and healthy ageing twin study. Int J Epidemiol. 2013 Feb;42(1):76&#x2013;85. doi: 10.1093/ije/dyr207. 
 
dyr207</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyr207</ArticleId><ArticleId IdType="pmc">PMC3600616</ArticleId><ArticleId IdType="pubmed">22253318</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohorts - COVID-19 Longitudinal Health and Wellbeing National Core Study. UCL.  [2021-09-03].  
 https://www.ucl.ac.uk/covid-19-longitudinal-health-wellbeing/cohorts
.</Citation></Reference><Reference><Citation>BREATHE - Health Data Research Hub.  [2021-07-23].  
 https://www.breathedatahub.com/
</Citation></Reference><Reference><Citation>Data dashboards. NHS.  [2021-07-18].  
 https://digital.nhs.uk/dashboards
.</Citation></Reference><Reference><Citation>Public Health England. GOV UK.  [2021-07-18].  
 https://www.gov.uk/government/organisations/public-health-england
.</Citation></Reference><Reference><Citation>COVID-19. Public Health Scotland.  [2021-07-18].  
 https://www.publichealthscotland.scot/our-areas-of-work/covid-19/
</Citation></Reference><Reference><Citation>Business Services Organisation.  [2021-08-25].  
 https://hscbusiness.hscni.net/
</Citation></Reference><Reference><Citation>Public Health Agency.  [2021-08-25].  
 https://www.publichealth.hscni.net/
</Citation></Reference><Reference><Citation>SAIL Databank - The Secure Anonymised Information Linkage Databank.  [2021-07-18].  
 https://saildatabank.com/
</Citation></Reference><Reference><Citation>Coronavirus (COVID-19) Office for National Statistics.  [2021-07-18].  
 https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases
.</Citation></Reference><Reference><Citation>Milligan G, Johnston J, Horban S, Masood E, Cox S, Urwin E, Hadfield A, Giles T, Best J, Macdonald C, Mumtaz S, Beggs J, Chuter A, Quinlan P, Jefferson E. COVID - Curated and OpeN aNalysis and rEsearCh plaTform (CO-CONNECT) Implementation Guide. Zenodo. 2022.  [2022-11-04].  
 https://zenodo.org/record/7150536#.Y2U34uRBzDc
.</Citation></Reference><Reference><Citation>Vezyridis P, Timmons S. Understanding the care.data conundrum: New information flows for economic growth. Big Data &amp; Society. 2017 Jan 01;4(1):205395171668849. doi: 10.1177/2053951716688490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2053951716688490</ArticleId></ArticleIdList></Reference><Reference><Citation>Church J. GP Data for Planning and Research: Letter from Parliamentary Under Secretary of State for Health and Social Care to general practices in England. NHS Digital. 2021.  [2021-11-10].  
 https://digital.nhs.uk/data-and-information/data-collections-&#x200b;and-data-sets/data-collections/general-practice-data-for-planning-and-research/secretary-of-state-letter-to-general-practice
.</Citation></Reference><Reference><Citation>Chapter 6 Extract Transform Load - The Book of OHDSI. OHDSI GitHub.  [2022-03-11].  
 https://ohdsi.github.io/TheBookOfOhdsi/ExtractTransformLoad.html
.</Citation></Reference><Reference><Citation>Raisaro JL, Marino F, Troncoso-Pastoriza J, Beau-Lejdstrom R, Bellazzi R, Murphy R, Bernstam EV, Wang H, Bucalo M, Chen Y, Gottlieb A, Harmanci A, Kim M, Kim Y, Klann J, Klersy C, Malin BA, M&#xe9;an M, Prasser F, Scudeller L, Torkamani A, Vaucher J, Puppala M, Wong STC, Frenkel-Morgenstern M, Xu H, Musa BM, Habib AG, Cohen T, Wilcox A, Salihu HM, Sofia H, Jiang X, Hubaux JP. SCOR: A secure international informatics infrastructure to investigate COVID-19. J Am Med Inform Assoc. 2020 Nov 01;27(11):1721&#x2013;1726. doi: 10.1093/jamia/ocaa172. 
 
5869802</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa172</ArticleId><ArticleId IdType="pmc">PMC7454652</ArticleId><ArticleId IdType="pubmed">32918447</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisaro JL, Troncoso-Pastoriza JR, Misbach M, Sousa JS, Pradervand S, Missiaglia E, Michielin O, Ford B, Hubaux J. MedCo: Enabling Secure and Privacy-Preserving Exploration of Distributed Clinical and Genomic Data. IEEE/ACM Trans Comput Biol Bioinform. 2019;16(4):1328&#x2013;1341. doi: 10.1109/TCBB.2018.2854776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TCBB.2018.2854776</ArticleId><ArticleId IdType="pubmed">30010584</ArticleId></ArticleIdList></Reference><Reference><Citation>Brat GA, Weber GM, Gehlenborg N, Avillach P, Palmer NP, Chiovato L, Cimino J, Waitman LR, Omenn GS, Malovini A, Moore JH, Beaulieu-Jones BK, Tibollo V, Murphy SN, Yi SL, Keller MS, Bellazzi R, Hanauer DA, Serret-Larmande A, Gutierrez-Sacristan A, Holmes JJ, Bell DS, Mandl KD, Follett RW, Klann JG, Murad DA, Scudeller L, Bucalo M, Kirchoff K, Craig J, Obeid J, Jouhet V, Griffier R, Cossin S, Moal B, Patel LP, Bellasi A, Prokosch HU, Kraska D, Sliz P, Tan ALM, Ngiam KY, Zambelli A, Mowery DL, Schiver E, Devkota B, Bradford RL, Daniar M, Daniel C, Benoit V, Bey R, Paris N, Serre P, Orlova N, Dubiel J, Hilka M, Jannot AS, Breant S, Leblanc J, Griffon N, Burgun A, Bernaux M, Sandrin A, Salamanca E, Cormont S, Ganslandt T, Gradinger T, Champ J, Boeker M, Martel P, Esteve L, Gramfort A, Grisel O, Leprovost D, Moreau T, Varoquaux G, Vie J, Wassermann D, Mensch A, Caucheteux C, Haverkamp C, Lemaitre G, Bosari S, Krantz ID, South A, Cai T, Kohane IS. International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium. NPJ Digit Med. 2020;3:109. doi: 10.1038/s41746-020-00308-0. doi: 10.1038/s41746-020-00308-0.308</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-00308-0</ArticleId><ArticleId IdType="doi">10.1038/s41746-020-00308-0</ArticleId><ArticleId IdType="pmc">PMC7438496</ArticleId><ArticleId IdType="pubmed">32864472</ArticleId></ArticleIdList></Reference><Reference><Citation>Prokosch H, Bahls T, Bialke M, Eils J, Fegeler C, Gruendner J, Haarbrandt B, Hampf C, Hoffmann W, Hund H, Kampf M, Kapsner LA, Kasprzak P, Kohlbacher O, Krefting D, Mang JM, Marschollek M, Mate S, M&#xfc;ller A, Prasser F, Sass J, Semler S, Stenzhorn H, Thun S, Zenker S, Eils R. The COVID-19 Data Exchange Platform of the German University Medicine. Stud Health Technol Inform. 2022 May 25;294:674&#x2013;678. doi: 10.3233/SHTI220554.SHTI220554</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI220554</ArticleId><ArticleId IdType="pubmed">35612174</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedlmayr B, Sedlmayr M, Kroll B, Prokosch H, Gruendner J, Sch&#xfc;ttler C. Improving COVID-19 Research of University Hospitals in Germany: Formative Usability Evaluation of the CODEX Feasibility Portal. Appl Clin Inform. 2022 Mar;13(2):400&#x2013;409. doi: 10.1055/s-0042-1744549. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1744549</ArticleId><ArticleId IdType="pmc">PMC9021003</ArticleId><ArticleId IdType="pubmed">35445386</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, Eichmann DA, Guinney J, Kibbe WA, Payne PRO, Pfaff ER, Robinson PN, Saltz JH, Spratt H, Suver C, Wilbanks J, Wilcox AB, Williams AE, Wu C, Blacketer C, Bradford RL, Cimino JJ, Clark M, Colmenares EW, Francis PA, Gabriel D, Graves A, Hemadri R, Hong SS, Hripscak G, Jiao D, Klann JG, Kostka K, Lee AM, Lehmann HP, Lingrey L, Miller RT, Morris M, Murphy SN, Natarajan K, Palchuk MB, Sheikh U, Solbrig H, Visweswaran S, Walden A, Walters KM, Weber GM, Zhang XT, Zhu RL, Amor B, Girvin AT, Manna A, Qureshi N, Kurilla MG, Michael SG, Portilla LM, Rutter JL, Austin CP, Gersing KR, N3C Consortium  The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. J Am Med Inform Assoc. 2021 Mar 01;28(3):427&#x2013;443. doi: 10.1093/jamia/ocaa196. 
 
5893482</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa196</ArticleId><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 2014;21(4):578&#x2013;82. doi: 10.1136/amiajnl-2014-002747. 
 
amiajnl-2014-002747</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002747</ArticleId><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>Visweswaran S, Becich M, D'Itri VS, Sendro E, MacFadden D, Anderson N, Allen K, Ranganathan D, Murphy S, Morrato E, Pincus H, Toto R, Firestein G, Nadler L, Reis S. Accrual to Clinical Trials (ACT): A Clinical and Translational Science Award Consortium Network. JAMIA Open. 2018 Oct;1(2):147&#x2013;152. doi: 10.1093/jamiaopen/ooy033. 
 
ooy033</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamiaopen/ooy033</ArticleId><ArticleId IdType="pmc">PMC6241502</ArticleId><ArticleId IdType="pubmed">30474072</ArticleId></ArticleIdList></Reference><Reference><Citation>Visweswaran S, Samayamuthu MJ, Morris M, Weber GM, MacFadden D, Trevvett P, Klann JG, Gainer V, Benoit B, Murphy SN, Patel L, Mirkovic N, Borovskiy Y, Johnson RD, Wyatt MC, Wang AY, Follett RW, Chau N, Zhu W, Abajian M, Chuang A, Bahroos N, Reeder P, Xie D, Cai J, Sendro ER, Toto RD, Firestein GS, Nadler LM, Reis SE. Development of a COVID-19 Application Ontology for the ACT Network. medRxiv. 2021 Apr 14;:2021.03.15.21253596. doi: 10.1101/2021.03.15.21253596. doi: 10.1101/2021.03.15.21253596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.15.21253596</ArticleId><ArticleId IdType="doi">10.1101/2021.03.15.21253596</ArticleId><ArticleId IdType="pmc">PMC8083220</ArticleId><ArticleId IdType="pubmed">34113801</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber GM, Murphy SN, McMurry AJ, MacFadden D, Nigrin DJ, Churchill S, Kohane IS. The Shared Health Research Information Network (SHRINE): A Prototype Federated Query Tool for Clinical Data Repositories. Journal of the American Medical Informatics Association. 2009 Sep 01;16(5):624&#x2013;630. doi: 10.1197/jamia.m3191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.m3191</ArticleId><ArticleId IdType="pmc">PMC2744712</ArticleId><ArticleId IdType="pubmed">19567788</ArticleId></ArticleIdList></Reference><Reference><Citation>Athey BD, Braxenthaler M, Haas M, Guo Y. tranSMART: An Open Source and Community-Driven Informatics and Data Sharing Platform for Clinical and Translational Research. AMIA Jt Summits Transl Sci Proc. 2013;2013:6&#x2013;8. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3814495</ArticleId><ArticleId IdType="pubmed">24303286</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;alvo JL, Mertens E, Ademovi&#x107; E, Akgun S, Baltazar AL, Buonfrate D, &#x10c;oklo M, Devleesschauwer B, Diaz Valencia PA, Fernandes JC, G&#xf3;mez EJ, Hynds P, Kabir Z, Klein J, Kostoulas P, Llanos Jim&#xe9;nez L, Lotrean LM, Majdan M, Menasalvas E, Nguewa P, Oh I, O'Sullivan G, Pereira DM, Reina Ortiz M, Riva S, Soriano G, Soriano JB, Spilki F, Tamang ME, Trofor AC, Vaillant M, Van Ierssel S, Vukovi&#x107; J, Castellano JM, unCoVer Network  Unravelling data for rapid evidence-based response to COVID-19: a summary of the unCoVer protocol. BMJ Open. 2021 Nov 18;11(11):e055630. doi: 10.1136/bmjopen-2021-055630. 
 
bmjopen-2021-055630</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-055630</ArticleId><ArticleId IdType="pmc">PMC8602928</ArticleId><ArticleId IdType="pubmed">34794999</ArticleId></ArticleIdList></Reference><Reference><Citation>Alleviate &#x2013; our Advanced Pain Discovery Platform (APDP) Hub. HDR UK.  [2021-07-29].  
 https://www.hdruk.ac.uk/helping-with-&#x200b;health-data/our-hubs-across-the-uk/alleviate/
</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36324116</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-244X</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>02</Day></PubDate></JournalIssue><Title>BMC psychiatry</Title><ISOAbbreviation>BMC Psychiatry</ISOAbbreviation></Journal><ArticleTitle>The sociodemographic characteristics and clinical features of the late-life depression patients: results from the Beijing Anding Hospital mental health big data platform.</ArticleTitle><Pagination><StartPage>677</StartPage><MedlinePgn>677</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">677</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12888-022-04339-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">The sociodemographic characteristics and clinical features of the Late-life depression (LLD) patients in psychiatric hospitals have not been thoroughly studied in China. This study aimed to explore the psychiatric outpatient attendance of LLD patients at a psychiatric hospital in China, with a subgroup analysis, such as with or without anxiety, gender differences.</AbstractText><AbstractText Label="METHODS">This retrospective study examined outpatients with LLD from January 2013 to August 2019 using data in the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM) in Beijing Anding Hospital. Age, sex, number of visits, use of drugs and comorbid conditions were extracted from medical records.</AbstractText><AbstractText Label="RESULTS">In a sample of 47,334 unipolar depression patients, 31,854 (67.30%) were women, and 15,480 (32.70%) were men. The main comorbidities of LDD are generalized anxiety disorder (GAD) (83.62%) and insomnia (74.52%).Among patients with unipolar depression, of which benzodiazepines accounted for the largest proportion (77.77%), Selective serotonin reuptake inhibitors (SSRIs) accounted for 59.00%, a noradrenergic and specific serotonergic antidepressant (NaSSAs) accounted for 36.20%. The average cost of each visit was approximately 646.27 yuan, and the cost of each visit was primarily attributed to Western medicine (22.97%) and Chinese herbal medicine (19.38%). For the cost of outpatient visits, depression comorbid anxiety group had a higher average cost than the non-anxiety group (p&#x2009;&lt;&#x2009;0.05). There are gender differences in outpatient costs, men spend more than women, for western medicine, men spend more than women, for Chinese herbal medicine, women spend more than men (all p&#x2009;&lt;&#x2009;0.05). The utilization rate of SSRIs and benzodiazepines in female patients is significantly higher than that in male patients (p&#x2009;&lt;&#x2009;0.05).</AbstractText><AbstractText Label="CONCLUSION">LLD patients are more commonly women than men and more commonly used SSRIs and NaSSAs. Elderly patients with depression often have comorbid generalized anxiety. LLD patients spend most of their visits on medicines, and while the examination costs are lower.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The National Clinical Research Center for Mental Disorders &amp; Beijing Key Laboratory of Mental Disorders &amp; Department of Psychiatry, Capital Medical University&amp; Beijing Anding Hospital, Capital Medical University, 5 Ankang Lane, Dewai Avenue, Xicheng District, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Wenwang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Unit of Psychiatry, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xueyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The National Clinical Research Center for Mental Disorders &amp; Beijing Key Laboratory of Mental Disorders &amp; Department of Psychiatry, Capital Medical University&amp; Beijing Anding Hospital, Capital Medical University, 5 Ankang Lane, Dewai Avenue, Xicheng District, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xinqiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The National Clinical Research Center for Mental Disorders &amp; Beijing Key Laboratory of Mental Disorders &amp; Department of Psychiatry, Capital Medical University&amp; Beijing Anding Hospital, Capital Medical University, 5 Ankang Lane, Dewai Avenue, Xicheng District, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The National Clinical Research Center for Mental Disorders &amp; Beijing Key Laboratory of Mental Disorders &amp; Department of Psychiatry, Capital Medical University&amp; Beijing Anding Hospital, Capital Medical University, 5 Ankang Lane, Dewai Avenue, Xicheng District, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xianglin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The National Clinical Research Center for Mental Disorders &amp; Beijing Key Laboratory of Mental Disorders &amp; Department of Psychiatry, Capital Medical University&amp; Beijing Anding Hospital, Capital Medical University, 5 Ankang Lane, Dewai Avenue, Xicheng District, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qinge</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The National Clinical Research Center for Mental Disorders &amp; Beijing Key Laboratory of Mental Disorders &amp; Department of Psychiatry, Capital Medical University&amp; Beijing Anding Hospital, Capital Medical University, 5 Ankang Lane, Dewai Avenue, Xicheng District, Beijing, China. zqe81@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Psychiatry</MedlineTA><NlmUniqueID>100968559</NlmUniqueID><ISSNLinking>1471-244X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004365">Drugs, Chinese Herbal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017367">Serotonin Uptake Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>12794-10-4</RegistryNumber><NameOfSubstance UI="D001569">Benzodiazepines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="Y">Depression</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="N">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004365" MajorTopicYN="Y">Drugs, Chinese Herbal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="N">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017367" MajorTopicYN="N">Selective Serotonin Reuptake Inhibitors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001569" MajorTopicYN="N">Benzodiazepines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antidepressants</Keyword><Keyword MajorTopicYN="N">LLD</Keyword><Keyword MajorTopicYN="N">Outpatient</Keyword></KeywordList><CoiStatement>All authors declare no conflicts of interest concerning this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>0</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36324116</ArticleId><ArticleId IdType="pmc">PMC9628045</ArticleId><ArticleId IdType="doi">10.1186/s12888-022-04339-7</ArticleId><ArticleId IdType="pii">10.1186/s12888-022-04339-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grover S, Sahoo S, Chakrabarti S, Avasthi A. Anxiety and somatic symptoms among elderly patients with depression. Asian J Psychiatr. 2019;41:66&#x2013;72. doi: 10.1016/j.ajp.2018.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2018.07.009</ArticleId><ArticleId IdType="pubmed">30054249</ArticleId></ArticleIdList></Reference><Reference><Citation>Vankova H, Holmerova I, Volicer L. Geriatric depression and inappropriate medication: benefits of interprofessional team cooperation in nursing homes. Int J Environ Res Public Health. 2021;18(23):12438. doi: 10.3390/ijerph182312438.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182312438</ArticleId><ArticleId IdType="pmc">PMC8657238</ArticleId><ArticleId IdType="pubmed">34886164</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Pe&#xf1;a C, Wagner FA, S&#xe1;nchez-Garc&#xed;a S, Espinel-Berm&#xfa;dez C, Ju&#xe1;rez-Cedillo T, P&#xe9;rez-Zepeda M, Arango-Lopera V, Franco-Marina F, Ram&#xed;rez-Aldana R, Gallo JJ. Late-life depressive symptoms: prediction models of change. J Affect Disord. 2013;150(3):886&#x2013;894. doi: 10.1016/j.jad.2013.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2013.05.007</ArticleId><ArticleId IdType="pmc">PMC3759587</ArticleId><ArticleId IdType="pubmed">23731940</ArticleId></ArticleIdList></Reference><Reference><Citation>Azulai A, Hall BL. Barriers to the recognition of geriatric depression in residential care facilities in Alberta. Issues Ment Health Nurs. 2020;41(10):887&#x2013;898. doi: 10.1080/01612840.2020.1742258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01612840.2020.1742258</ArticleId><ArticleId IdType="pubmed">32497452</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges MK, Aprahamian I, Romanini CV, Oliveira FM, Mingardi SVB, Lima NA, Cecato JF, Petrella M, Oude Voshaar RC. Depression as a determinant of frailty in late life. Aging Ment Health. 2021;25(12):2279&#x2013;2285. doi: 10.1080/13607863.2020.1857689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13607863.2020.1857689</ArticleId><ArticleId IdType="pubmed">33307781</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe1;lvez V, Ho KA, Alonzo A, Martin D, George D, Loo CK. Neuromodulation therapies for geriatric depression. Curr Psychiatry Rep. 2015;17(7):59. doi: 10.1007/s11920-015-0592-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11920-015-0592-y</ArticleId><ArticleId IdType="pubmed">25995098</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazer DG. Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci. 2003;58(3):249&#x2013;265. doi: 10.1093/gerona/58.3.M249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/58.3.M249</ArticleId><ArticleId IdType="pubmed">12634292</ArticleId></ArticleIdList></Reference><Reference><Citation>Oon-Arom A, Wongpakaran T, Satthapisit S, Saisavoey N, Kuntawong P, Wongpakaran N. Suicidality in the elderly: role of adult attachment. Asian J Psychiatr. 2019;44:8&#x2013;12. doi: 10.1016/j.ajp.2019.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2019.07.014</ArticleId><ArticleId IdType="pubmed">31302442</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexopoulos GS, Kelly RE., Jr Research advances in geriatric depression. World Psychiatry. 2009;8(3):140&#x2013;149. doi: 10.1002/j.2051-5545.2009.tb00234.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/j.2051-5545.2009.tb00234.x</ArticleId><ArticleId IdType="pmc">PMC2755271</ArticleId><ArticleId IdType="pubmed">19812743</ArticleId></ArticleIdList></Reference><Reference><Citation>Masse C, Chopard G, Bennabi D, Haffen E, Vandel P. Cognitive functions in late life depression. Geriatr Psychol Neuropsychiatr Vieil. 2021;19(2):202&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">34080982</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Wu X, Lai W, Long E, Zhang X, Li W, Zhu Y, Chen C, Zhong X, Liu Z, et al. Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis. BMJ Open. 2017;7(8):e017173. doi: 10.1136/bmjopen-2017-017173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-017173</ArticleId><ArticleId IdType="pmc">PMC5640125</ArticleId><ArticleId IdType="pubmed">28838903</ArticleId></ArticleIdList></Reference><Reference><Citation>Bock JO, Brettschneider C, Weyerer S, Werle J, Wagner M, Maier W, Scherer M, Kaduszkiewicz H, Wiese B, Moor L, et al. Excess health care costs of late-life depression - results of the agemoode study. J Affect Disord. 2016;199:139&#x2013;147. doi: 10.1016/j.jad.2016.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2016.04.008</ArticleId><ArticleId IdType="pubmed">27104802</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016;64:333&#x2013;341. doi: 10.1016/j.jbi.2016.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Dillon C, Tartaglini MF, Stefani D, Salgado P, Taragano FE, Allegri RF. Geriatric depression and its relation with cognitive impairment and dementia. Arch Gerontol Geriatr. 2014;59(2):450&#x2013;456. doi: 10.1016/j.archger.2014.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.archger.2014.04.006</ArticleId><ArticleId IdType="pubmed">24855979</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoevers RA, Beekman AT, Deeg DJ, Jonker C, van Tilburg W. Comorbidity and risk-patterns of depression, generalised anxiety disorder and mixed anxiety-depression in later life: results from the AMSTEL study. Int J Geriatr Psychiatry. 2003;18(11):994&#x2013;1001. doi: 10.1002/gps.1001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.1001</ArticleId><ArticleId IdType="pubmed">14618550</ArticleId></ArticleIdList></Reference><Reference><Citation>De Ronchi D, Berardi D, Menchetti M, Ferrari G, Serretti A, Dalmonte E, Fratiglioni L. Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. Dement Geriatr Cogn Disord. 2005;19(2&#x2013;3):97&#x2013;105. doi: 10.1159/000082660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000082660</ArticleId><ArticleId IdType="pubmed">15591799</ArticleId></ArticleIdList></Reference><Reference><Citation>Pachana NA, McLaughlin D, Leung J, Byrne G, Dobson A. Anxiety and depression in adults in their eighties: do gender differences remain? Int Psychogeriatr. 2012;24(1):145&#x2013;150. doi: 10.1017/S1041610211001372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610211001372</ArticleId><ArticleId IdType="pubmed">21777505</ArticleId></ArticleIdList></Reference><Reference><Citation>CH W: Four major hazards of depression. http://www.sohu.com/a/257286384710734. Accessed 1 Oct 2018.</Citation></Reference><Reference><Citation>Kastenschmidt EK, Kennedy GJ. Depression and anxiety in late life: diagnostic insights and therapeutic options. Mt Sinai J Med. 2011;78(4):527&#x2013;545. doi: 10.1002/msj.20266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/msj.20266</ArticleId><ArticleId IdType="pubmed">21748742</ArticleId></ArticleIdList></Reference><Reference><Citation>Kok RM, Nolen WA, Heeren TJ. Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. J Affect Disord. 2012;141(2&#x2013;3):103&#x2013;115. doi: 10.1016/j.jad.2012.02.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2012.02.036</ArticleId><ArticleId IdType="pubmed">22480823</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell AJ, Subramaniam H. Prognosis of depression in old age compared to middle age: a systematic review of comparative studies. Am J Psychiatry. 2005;162(9):1588&#x2013;1601. doi: 10.1176/appi.ajp.162.9.1588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.162.9.1588</ArticleId><ArticleId IdType="pubmed">16135616</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexopoulos GS, Morimoto SS. The inflammation hypothesis in geriatric depression. Int J Geriatr Psychiatry. 2011;26(11):1109&#x2013;1118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3160498</ArticleId><ArticleId IdType="pubmed">21370276</ArticleId></ArticleIdList></Reference><Reference><Citation>Holland J, Bhogle M. Sertraline and mirtazapine as geriatric antidepressants. Psychiatr Danub. 2013;25(Suppl 2):S286&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">23995195</ArticleId></ArticleIdList></Reference><Reference><Citation>Funaki K, Nakajima S, Suzuki T, Mimura M, Uchida H. Early improvements in individual symptoms to predict later remission in major depressive disorder treated with mirtazapine. J Clin Pharmacol. 2016;56(9):1111&#x2013;1119. doi: 10.1002/jcph.710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcph.710</ArticleId><ArticleId IdType="pubmed">26813241</ArticleId></ArticleIdList></Reference><Reference><Citation>Un&#xfc;tzer J, Schoenbaum M, Katon WJ, Fan MY, Pincus HA, Hogan D, Taylor J. Healthcare costs associated with depression in medically Ill fee-for-service medicare participants. J Am Geriatr Soc. 2009;57(3):506&#x2013;510. doi: 10.1111/j.1532-5415.2008.02134.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2008.02134.x</ArticleId><ArticleId IdType="pubmed">19175438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattarai N, Charlton J, Rudisill C, Gulliford MC. Prevalence of depression and utilization of health care in single and multiple morbidity: a population-based cohort study. Psychol Med. 2013;43(7):1423&#x2013;1431. doi: 10.1017/S0033291712002498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291712002498</ArticleId><ArticleId IdType="pubmed">23114010</ArticleId></ArticleIdList></Reference><Reference><Citation>Bock JO, Luppa M, Brettschneider C, Riedel-Heller S, Bickel H, Fuchs A, Gensichen J, Maier W, Mergenthal K, Sch&#xe4;fer I, et al. Impact of depression on health care utilization and costs among multimorbid patients&#x2013;from the MultiCare Cohort Study. PLoS ONE. 2014;9(3):e91973. doi: 10.1371/journal.pone.0091973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0091973</ArticleId><ArticleId IdType="pmc">PMC3956806</ArticleId><ArticleId IdType="pubmed">24638040</ArticleId></ArticleIdList></Reference><Reference><Citation>Katon WJ, Lin E, Russo J, Un&#xfc;tzer J. Increased medical costs of a population-based sample of depressed elderly patients. Arch Gen Psychiatry. 2003;60(9):897. doi: 10.1001/archpsyc.60.9.897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.60.9.897</ArticleId><ArticleId IdType="pubmed">12963671</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010) J Clin Psychiatry. 2015;76(2):155&#x2013;162. doi: 10.4088/JCP.14m09298.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.14m09298</ArticleId><ArticleId IdType="pubmed">25742202</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh CR, Qin X. Depression hurts, depression costs: the medical spending attributable to depression and depressive symptoms in China. Health Econ. 2018;27(3):525&#x2013;544. doi: 10.1002/hec.3604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hec.3604</ArticleId><ArticleId IdType="pubmed">28990318</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Zhou M, Huang L, Nuse B. Depressive costs: medical expenditures on depression and depressive symptoms among rural elderly in China. Public Health. 2020;181:141&#x2013;150. doi: 10.1016/j.puhe.2019.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2019.12.011</ArticleId><ArticleId IdType="pubmed">32032922</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittchen HU, Kessler RC, Beesdo K, Krause P, H&#xf6;fler M, Hoyer J. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry. 2002;63(Suppl 8):24&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">12044105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenze EJ, Wetherell JL. Anxiety disorders: new developments in old age. Am J Geriatr Psychiatry. 2011;19(4):301&#x2013;304. doi: 10.1097/JGP.0b013e31820db34f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JGP.0b013e31820db34f</ArticleId><ArticleId IdType="pmc">PMC4097117</ArticleId><ArticleId IdType="pubmed">21427638</ArticleId></ArticleIdList></Reference><Reference><Citation>Beekman AT, de Beurs E, van Balkom AJ, Deeg DJ, van Dyck R, van Tilburg W. Anxiety and depression in later life: co-occurrence and communality of risk factors. Am J Psychiatry. 2000;157(1):89&#x2013;95. doi: 10.1176/ajp.157.1.89.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/ajp.157.1.89</ArticleId><ArticleId IdType="pubmed">10618018</ArticleId></ArticleIdList></Reference><Reference><Citation>Suradom C, Wongpakaran N, Wongpakaran T, Lerttrakarnnon P, Jiraniramai S, Taemeeyapradit U, Lertkachatarn S, Arunpongpaisal S. Prevalence and associated factors of comorbid anxiety disorders in late-life depression: findings from geriatric tertiary outpatient settings. Neuropsychiatr Dis Treat. 2019;15:199&#x2013;204. doi: 10.2147/NDT.S184585.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S184585</ArticleId><ArticleId IdType="pmc">PMC6328289</ArticleId><ArticleId IdType="pubmed">30662265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou KL, Cheung KC. Major depressive disorder in vulnerable groups of older adults, their course and treatment, and psychiatric comorbidity. Depress Anxiety. 2013;30(6):528&#x2013;537. doi: 10.1002/da.22073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/da.22073</ArticleId><ArticleId IdType="pubmed">23423971</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Veen DC, van Zelst WH, Schoevers RA, Comijs HC, Voshaar RC. Comorbid anxiety disorders in late-life depression: results of a cohort study. Int Psychogeriatr. 2015;27(7):1157&#x2013;1165. doi: 10.1017/S1041610214002312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610214002312</ArticleId><ArticleId IdType="pubmed">25370017</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenze EJ, Mulsant BH, Shear MK, Schulberg HC, Dew MA, Begley AE, Pollock BG, Reynolds CF., 3rd Comorbid anxiety disorders in depressed elderly patients. Am J Psychiatry. 2000;157(5):722&#x2013;728. doi: 10.1176/appi.ajp.157.5.722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.157.5.722</ArticleId><ArticleId IdType="pubmed">10784464</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Norton J, Carri&#xe8;re I, Ritchie K, Chaudieu I, Ancelin ML. Generalized anxiety in community-dwelling elderly: prevalence and clinical characteristics. J Affect Disord. 2015;172:24&#x2013;29. doi: 10.1016/j.jad.2014.09.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2014.09.036</ArticleId><ArticleId IdType="pubmed">25451391</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer JL, Johnson KG. Advances in pharmacotherapy of late-life depression. Curr Psychiatry Rep. 2018;20(5):34. doi: 10.1007/s11920-018-0899-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11920-018-0899-6</ArticleId><ArticleId IdType="pubmed">29627920</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SC, Pan A, Kawachi I, Okereke OI. Risk factors for late-life depression: a prospective cohort study among older women. Prev Med. 2016;91:144&#x2013;151. doi: 10.1016/j.ypmed.2016.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2016.08.014</ArticleId><ArticleId IdType="pmc">PMC5455056</ArticleId><ArticleId IdType="pubmed">27514249</ArticleId></ArticleIdList></Reference><Reference><Citation>Li N, Pang L, Chen G, Song X, Zhang J, Zheng X. Risk factors for depression in older adults in Beijing. Can J Psychiatry. 2011;56(8):466&#x2013;473. doi: 10.1177/070674371105600804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/070674371105600804</ArticleId><ArticleId IdType="pubmed">21878157</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang M, Mirutse G, Guo L, Ma X. Role of socioeconomic status and housing conditions in geriatric depression in rural China: a cross-sectional study. BMJ Open. 2019;9(5):e024046. doi: 10.1136/bmjopen-2018-024046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-024046</ArticleId><ArticleId IdType="pmc">PMC6530296</ArticleId><ArticleId IdType="pubmed">31110082</ArticleId></ArticleIdList></Reference><Reference><Citation>Voshaar RC, Kapur N, Bickley H, Williams A, Purandare N. Suicide in later life: a comparison between cases with early-onset and late-onset depression. J Affect Disord. 2011;132(1&#x2013;2):185&#x2013;91. 10.1016/j.jad.2011.02.008.</Citation><ArticleIdList><ArticleId IdType="pubmed">21420737</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Naismith S, Ward PB, Turner K, Scott E, Mitchell P, Wilhelm K, Parker G. Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression. Br J Psychiatry. 2005;186:197&#x2013;202. doi: 10.1192/bjp.186.3.197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.186.3.197</ArticleId><ArticleId IdType="pubmed">15738499</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen J, Hulshoff Pol HE, de Leeuw FE, Schnack HG, Lampe IK, Kok RM, Kahn RS, Heeren TJ. Hippocampal volume and subcortical white matter lesions in late life depression: comparison of early and late onset depression. J Neurol Neurosurg Psychiatry. 2007;78(6):638&#x2013;640. doi: 10.1136/jnnp.2006.098087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.098087</ArticleId><ArticleId IdType="pmc">PMC2077968</ArticleId><ArticleId IdType="pubmed">17210630</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondimore FM, Zandi PP, Mackinnon DF, McInnis MG, Miller EB, Crowe RP, Scheftner WA, Marta DH, Weissman MM, Levinson DF, et al. Familial aggregation of illness chronicity in recurrent, early-onset major depression pedigrees. Am J Psychiatry. 2006;163(9):1554&#x2013;1560. doi: 10.1176/ajp.2006.163.9.1554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/ajp.2006.163.9.1554</ArticleId><ArticleId IdType="pubmed">16946180</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashem AH, M N, Gomaa MA, Khalaf OO. Late versus early onset depression in elderly patients: vascular risk and cognitive impairment. Curr Aging Sci. 2017;10(3):211&#x2013;216. doi: 10.2174/1874609810666170404105634.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874609810666170404105634</ArticleId><ArticleId IdType="pubmed">28382870</ArticleId></ArticleIdList></Reference><Reference><Citation>Eraydin IE, Mueller C, Corbett A, Ballard C, Brooker H, Wesnes K, Aarsland D, Huntley J. Investigating the relationship between age of onset of depressive disorder and cognitive function. Int J Geriatr Psychiatry. 2019;34(1):38&#x2013;46. doi: 10.1002/gps.4979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4979</ArticleId><ArticleId IdType="pubmed">30259558</ArticleId></ArticleIdList></Reference><Reference><Citation>Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF., 3rd Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329&#x2013;335. doi: 10.1192/bjp.bp.112.118307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.bp.112.118307</ArticleId><ArticleId IdType="pmc">PMC3640214</ArticleId><ArticleId IdType="pubmed">23637108</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachs-Ericsson N, Moxley JH, Corsentino E, Rushing NC, Sheffler J, Selby EA, Gotlib I, Steffens DC. Melancholia in later life: late and early onset differences in presentation, course, and dementia risk. Int J Geriatr Psychiatry. 2014;29(9):943&#x2013;951. doi: 10.1002/gps.4083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gps.4083</ArticleId><ArticleId IdType="pubmed">24677247</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36389281</PMID><DateRevised><Year>2022</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1756-2856</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Therapeutic advances in neurological disorders</Title><ISOAbbreviation>Ther Adv Neurol Disord</ISOAbbreviation></Journal><ArticleTitle>Long-term use of proton-pump inhibitor on Alzheimer's disease: a real-world distributed network analysis of six observational Korean databases using a Common Data Model.</ArticleTitle><Pagination><StartPage>17562864221135700</StartPage><MedlinePgn>17562864221135700</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17562864221135700</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/17562864221135700</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Dementia has a crucial impact on the quality of life of elderly patients and their caregivers. Proton-pump inhibitors (PPIs) are the most frequently prescribed treatment, but they have been shown to be associated with dementia. The data are inconsistent, however.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To investigate the association between PPIs use and Alzheimer's disease (AD) or all-cause dementia in six observational Korean databases using a Common Data Model (CDM) and to perform a distributed network analysis.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Subjects aged over 18&#x2009;years between 1 January 2004 and 31 December 2020. Among 7,293,565 subjects from 6 cohorts, 41,670 patients met the eligibility criteria. A total of 2206 patients who were included in both cohorts or with a history of dementia were excluded. After propensity matching, 5699 propensity-matched pairs between the PPIs and histamine-2 receptor antagonist (H<sub>2</sub>RA) users were included in this study. The primary outcome was the incidence of AD at least 365&#x2009;days after drug exposure. The secondary outcome was the incidence of all-cause dementia at least 365&#x2009;days after drug exposure.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In the 1:1 propensity score matching, the risk of AD or all-cause dementia was not significantly different between the PPIs and H<sub>2</sub>RA groups in all six databases. In the distributed network analysis, the long-term PPI users (&#x2a7e;365&#x2009;days) were unassociated with AD [hazard ratio (HR)&#x2009;=&#x2009;0.92, 95% confidence interval (CI)&#x2009;=&#x2009;0.68-1.23; <i>I</i> <sup>2</sup>&#x2009;=&#x2009;0%] and all-cause dementia (HR&#x2009;=1.04, 95% CI&#x2009;=&#x2009;0.82-1.31; <i>I</i> <sup>2</sup>&#x2009;=&#x2009;0%) compared with H<sub>2</sub>RA users.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">In the distributed network analysis of six Korean hospital databases using Observational Medical Outcomes Partnership (OMOP)-CDM data, the long-term use of PPI was not associated with a statistically significantly increased risk of AD or all-cause dementia. Therefore, we suggest that physicians should not avoid these medications because of concern about dementia risk.</AbstractText><CopyrightInformation>&#xa9; The Author(s), 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yerim</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7108-6302</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Kangdong Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Seung In</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kangdong Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Kyung Joo</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>University Industry Foundation, Hallym University, Chuncheon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jinseob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, School of Public Health, Seoul National University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Jong Jin</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Internal Medicine, Kangdong Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Won-Woo</ForeName><Initials>WW</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Kangdong Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hyung Seok</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, College of Medicine, Hallym University, Anyang, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Woon Geon</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology, Department of Internal Medicine, Kangdong Sacred Heart Hospital, College of Medicine, Hallym University, 150, Seongan-ro, Gangdong-gu, Seoul 05355, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ther Adv Neurol Disord</MedlineTA><NlmUniqueID>101480242</NlmUniqueID><ISSNLinking>1756-2856</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer disease</Keyword><Keyword MajorTopicYN="N">Common Data Model</Keyword><Keyword MajorTopicYN="N">H2 receptor antagonist</Keyword><Keyword MajorTopicYN="N">dementia</Keyword><Keyword MajorTopicYN="N">proton-pump inhibitors</Keyword></KeywordList><CoiStatement>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>17</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36389281</ArticleId><ArticleId IdType="pmc">PMC9647297</ArticleId><ArticleId IdType="doi">10.1177/17562864221135700</ArticleId><ArticleId IdType="pii">10.1177_17562864221135700</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mazer-Amirshahi M, Mullins PM, van den Anker J, et al.. Rising rates of proton pump inhibitor prescribing in US emergency departments. Am J Emerg Med 2014; 32: 618&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pubmed">24721025</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantor ED, Rehm CD, Haas JS, et al.. Trends in prescription drug use among adults in the United States from 1999&#x2013;2012. JAMA 2015; 314: 1818&#x2013;1831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4752169</ArticleId><ArticleId IdType="pubmed">26529160</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahami D, McDonald EG, Schnitzer M, et al.. Trends in acid suppressant drug prescriptions in primary care in the UK: a population-based cross-sectional study. BMJ Open 2020; 10: e041529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7722810</ArticleId><ArticleId IdType="pubmed">33293322</ArticleId></ArticleIdList></Reference><Reference><Citation>Janarthanan S, Ditah I, Adler DG, et al.. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol 2012; 107: 1001&#x2013;1010.</Citation><ArticleIdList><ArticleId IdType="pubmed">22710578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson C. Bone: proton-pump inhibitors and fractures. Nat Rev Endocrinol 2012; 8: 625.</Citation><ArticleIdList><ArticleId IdType="pubmed">22945361</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus B, Chen Y, Wilson FP, et al.. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med 2016; 176: 238&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4772730</ArticleId><ArticleId IdType="pubmed">26752337</ArticleId></ArticleIdList></Reference><Reference><Citation>Haenisch B, von Holt K, Wiese B, et al.. Risk of dementia in elderly patients with the use of proton pump inhibitors. Eur Arch Psychiatry Clin Neurosci 2015; 265: 419&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">25341874</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro DM, Dillon C, Machnicki G, et al.. The economic cost of Alzheimer&#x2019;s disease: family or public health burden? Dement Neuropsychol 2010; 4: 262&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5619058</ArticleId><ArticleId IdType="pubmed">29213697</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Guerrero G, Amador-Mu&#xf1;oz D, Calder&#xf3;n-Ospina CA, et al.. Proton pump inhibitors and dementia: physiopathological mechanisms and clinical consequences. Neural Plast 2018; 2018: 5257285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5883984</ArticleId><ArticleId IdType="pubmed">29755512</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam JR, Schneider JL, Zhao W, et al.. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA 2013; 310: 2435&#x2013;2442.</Citation><ArticleIdList><ArticleId IdType="pubmed">24327038</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomm W, von Holt K, Thom&#xe9; F, et al.. Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurol 2016; 73: 410&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">26882076</ArticleId></ArticleIdList></Reference><Reference><Citation>Badiola N, Alcalde V, Pujol A, et al.. The proton-pump inhibitor lansoprazole enhances amyloid beta production. PLoS ONE 2013; 8: e58837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3592824</ArticleId><ArticleId IdType="pubmed">23520537</ArticleId></ArticleIdList></Reference><Reference><Citation>Song YQ, Li Y, Zhang SL, et al.. Proton pump inhibitor use does not increase dementia and Alzheimer&#x2019;s disease risk: an updated meta-analysis of published studies involving 642305 patients. PLoS ONE 2019; 14: e0219213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6605652</ArticleId><ArticleId IdType="pubmed">31265473</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooksey R, Kennedy J, Dennis MS, et al.. Proton pump inhibitors and dementia risk: evidence from a cohort study using linked routinely collected national health data in Wales, UK. PLoS ONE 2020; 15: e0237676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500586</ArticleId><ArticleId IdType="pubmed">32946449</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al.. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc 2015; 22: 553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, Rho Y, Bikdeli B, et al.. Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. JAMA 2020; 324: 1640&#x2013;1650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7592033</ArticleId><ArticleId IdType="pubmed">33107944</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn EK, Park MY, et al.. Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a common data model for distributed network research. Healthc Inform Res 2016; 22: 54&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo SI, Park CH, You SC, et al.. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea. Gut 2021; 70: 2066&#x2013;2075.</Citation><ArticleIdList><ArticleId IdType="pubmed">33975868</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;n MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol 2016; 183: 758&#x2013;764.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4832051</ArticleId><ArticleId IdType="pubmed">26994063</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul S. Understanding the merits and drawbacks of noninferiority trials in cardiovascular medicine. Can J Cardiol 2021; 37: 1378&#x2013;1393.</Citation><ArticleIdList><ArticleId IdType="pubmed">34118378</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1898525</ArticleId><ArticleId IdType="pubmed">14283879</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaezi MF, Yang YX, Howden CW. Complications of proton pump inhibitor therapy. Gastroenterology 2017; 153: 35&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">28528705</ArticleId></ArticleIdList></Reference><Reference><Citation>Handley JD, Williams DM, Caplin S, et al.. Changes in cognitive function following bariatric surgery: a systematic review. Obes Surg 2016; 26: 2530&#x2013;2537.</Citation><ArticleIdList><ArticleId IdType="pubmed">27468905</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JE, Kim D, Lee JH. Association between Alzheimer&#x2019;s disease and cancer risk in South Korea: an 11-year nationwide population-based study. Dement Neurocogn Disord 2018; 17: 137&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6425881</ArticleId><ArticleId IdType="pubmed">30906403</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36395615</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8243</ISSN><JournalIssue CitedMedium="Internet"><Volume>169</Volume><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>International journal of medical informatics</Title><ISOAbbreviation>Int J Med Inform</ISOAbbreviation></Journal><ArticleTitle>An ETL-process design for data harmonization to participate in international research with German real-world data based on FHIR and OMOP CDM.</ArticleTitle><Pagination><StartPage>104925</StartPage><MedlinePgn>104925</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijmedinf.2022.104925</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1386-5056(22)00239-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">International studies are increasingly needed in order to gain more unbiased evidence from real-world data. To achieve this goal across the European Union, the EMA set up the DARWIN EU project based on OMOP CDM established by the OHDSI community. The harmonization of heterogeneous local health data in OMOP CDM is an essential step to participate in such networks. Using the widespread communication standard HL7 FHIR can reduce the complexity of the transformation process to OMOP CDM. Enabling German university hospitals to participate in such networks requires an Extract, Transform and Load (ETL)-process that satisfies the following criteria: 1) transforming German patient data from FHIR to OMOP CDM, 2) processing huge amount of data at once and 3) flexibility to cope with changes in FHIR profiles.</AbstractText><AbstractText Label="METHOD">A mapping of German patient data from FHIR to OMOP CDM was accomplished, validated by an interdisciplinary team and checked through the OHDSI Data Quality Dashboard (DQD). To satisfy criteria 2-3, we decided to use SpringBatch-Framework according to its chunk-oriented design and reusable functions for processing large amounts of data.</AbstractText><AbstractText Label="RESULTS">We have successfully developed an ETL-process that fulfills the defined criteria of transforming German patient data from FHIR into OMOP CDM. To measure the validity of the mapping conformance and performance of the ETL-process, it was tested with 392,022 FHIR resources. The ETL execution lasted approximately-one minute and the DQD result shows 99% conformance in OMOP CDM.</AbstractText><AbstractText Label="CONCLUSIONS">Our ETL-process has been successfully tested and integrated at 10 German university hospitals. The data harmonization utilizing international recognized standards like FHIR and OMOP fosters their ability to participate in international observational studies. Additionally, the ETL process can help to prepare more German hospitals with their data harmonization journey based on existing standards.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany. Electronic address: yuan.peng@tu-dresden.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henke</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany. Electronic address: elisa.henke@tu-dresden.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinecke</LastName><ForeName>Ines</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoch</LastName><ForeName>Mich&#xe9;le</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bathelt</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry at Carl Gustav Carus Faculty of Medicine at Technische Universit&#xe4;t Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Int J Med Inform</MedlineTA><NlmUniqueID>9711057</NlmUniqueID><ISSNLinking>1386-5056</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005062" MajorTopicYN="N">European Union</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="Y">Data Mining</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007391" MajorTopicYN="Y">International Cooperation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Core data set</Keyword><Keyword MajorTopicYN="N">ETL</Keyword><Keyword MajorTopicYN="N">FHIR</Keyword><Keyword MajorTopicYN="N">Interoperability</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>17</Day><Hour>18</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36395615</ArticleId><ArticleId IdType="doi">10.1016/j.ijmedinf.2022.104925</ArticleId><ArticleId IdType="pii">S1386-5056(22)00239-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36406796</PMID><DateRevised><Year>2022</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2574-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>JAMIA open</Title><ISOAbbreviation>JAMIA Open</ISOAbbreviation></Journal><ArticleTitle>Evaluating a novel approach to stimulate open science collaborations: a case series of "study-a-thon" events within the OHDSI and European IMI communities.</ArticleTitle><Pagination><StartPage>ooac100</StartPage><MedlinePgn>ooac100</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ooac100</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamiaopen/ooac100</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">We introduce and review the concept of a study-a-thon as a catalyst for open science in medicine, utilizing harmonized real world, observation health data, tools, skills, and methods to conduct network studies, generating insights for those wishing to use study-a-thons for future research.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">A series of historical study-a-thons since 2017 to present were reviewed for thematic insights as to the opportunity to accelerate the research method to conduct studies across therapeutic areas. Review of publications and experience of the authors generated insights to illustrate the conduct of study-a-thons, key learning, and direction for those wishing to conduct future such study-a-thons.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A review of six study-a-thons have provided insights into their scientific impact, and 13 areas of insights for those wishing to conduct future study-a-thons. Defining aspects of the study-a-thon method for rapid, collaborative research through network studies reinforce the need to clear scientific rationale, tools, skills, and methods being collaboratively to conduct a focused study. Well-characterized preparatory, execution and postevent phases, coalescing skills, experience, data, clinical input (ensuring representative clinical context to the research query), and well-defined, logical steps in conducting research via the study-a-thon method are critical.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">A study-a-thon is a focused multiday research event generating reliable evidence on a specific medical topic across different countries and health systems. In a study-a-thon, a multidisciplinary team collaborate to create an accelerated contribution to scientific evidence and clinical practice. It critically accelerates the research process, without inhibiting the quality of the research output and evidence generation, through a reproducible process.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>N</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-1168-0537</Identifier><AffiliationInfo><Affiliation>Epidemiology, Janssen R&amp;D, Beerse, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>P R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Bochove</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Hyve, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>T</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8274-0357</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinbeisser</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Steinbeisser Project Management, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vizcaya</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Bayer Pharmaceuticals, Sant Joan Despi, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>NDORMS, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Epidemiology, Janssen R&amp;D, Titusville, New Jersey, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMIA Open</MedlineTA><NlmUniqueID>101730643</NlmUniqueID><ISSNLinking>2574-2531</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clinical research</Keyword><Keyword MajorTopicYN="N">data sciences</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">observational research</Keyword><Keyword MajorTopicYN="N">research process</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>21</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36406796</ArticleId><ArticleId IdType="pmc">PMC9670330</ArticleId><ArticleId IdType="doi">10.1093/jamiaopen/ooac100</ArticleId><ArticleId IdType="pii">ooac100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Butler D. Tomorrow&#x2019;s world. Nature 2016; 530 (7591): 398&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">26911763</ArticleId></ArticleIdList></Reference><Reference><Citation>
Apuzzo M, Kirkpatrick DD. COVID-19 changed how the world does science, together. The New York Times. 2020. https://www.nytimes.com/2020/04/01/world/europe/coronavirus-science-research-cooperation.html. Accessed July 12, 2021.</Citation></Reference><Reference><Citation>Glasziou P, Sanders S, Hoffmann T.. Waste in COVID-19 research. BMJ 2020; 369: m1847.</Citation><ArticleIdList><ArticleId IdType="pubmed">32398241</ArticleId></ArticleIdList></Reference><Reference><Citation>
OHDSI. The Book of OHDSI; 2019. https://ohdsi.github.io/TheBookOfOhdsi/. Accessed July 12, 2021.</Citation></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al.Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A 2016; 113 (27): 7329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, et al.Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet 2019; 394 (10211): 1816&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Prats-Uribe A, Sena AG, Lai LYH, et al.Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. BMJ 2021; 373: n1038. doi:10.1136/bmj.n1038</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1038</ArticleId><ArticleId IdType="pmc">PMC8111167</ArticleId><ArticleId IdType="pubmed">33975825</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Ostropolets A, Makadia R, et al.Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ 2021; 373: n1435. doi:10.1136/bmj.n1435</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1435</ArticleId><ArticleId IdType="pmc">PMC8193077</ArticleId><ArticleId IdType="pubmed">35727911</ArticleId></ArticleIdList></Reference><Reference><Citation>
The European Health Data &amp; Evidence Network (EHDEN). https://ehden.eu. Accessed July 12, 2021.</Citation></Reference><Reference><Citation>Ryan P. Personal Communication; 2021.</Citation></Reference><Reference><Citation>Burn E, Weaver J, Morales D, et al.Opioid use, postoperative complications, and implant survival after unicompartmental versus total knee replacement: a population-based network study. Lancet Rheumatol 2019; 1 (4): E229&#x2013;E236.</Citation></Reference><Reference><Citation>Williams RD, Reps JM, Rijnbeek PR. et al.; The OHDSI/EHDEN Knee Arthroplasty Group. 90-Day all-cause mortality can be predicted following a total knee replacement: an international, network study to develop and validate a prediction model. Knee Surg Sports Traumatol Arthrosc 2022; 30 (9): 3068&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9418076</ArticleId><ArticleId IdType="pubmed">34870731</ArticleId></ArticleIdList></Reference><Reference><Citation>Beard D, Price A, Cook J, et al.Total or Partial Knee Arthroplasty Trial&#x2014;TOPKAT: study protocol for a randomised controlled trial. Trials 2013; 14: 292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3848560</ArticleId><ArticleId IdType="pubmed">24028414</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Williams RD, Swerdel JN, et al.Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: a multinational real-world cohort analysis. Semin Arthritis Rheum 2022; 56: 152050.</Citation><ArticleIdList><ArticleId IdType="pubmed">35728447</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane JCE, Weaver J, Kostka K. et al.; OHDSI-COVID-19 consortium. Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol 2020; 2 (11): E698&#x2013;E711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7442425</ArticleId><ArticleId IdType="pubmed">32864627</ArticleId></ArticleIdList></Reference><Reference><Citation>Study protocol. https://github.com/ohdsi-studies/Covid19EstimationHydroxychloroquine/blob/master/documents/OHDSI%20COVID-19%20Studyathon_PLE_HCQ_Protocol_v1.4.pdf. Accessed July 27, 2022.</Citation></Reference><Reference><Citation>Study protocol. https://github.com/ohdsi-studies/Covid19Icarius/blob/master/Documents/COVID19_ACE_ARB_Protocol_Version_1_2.pdf. Accessed July 27, 2022.</Citation></Reference><Reference><Citation>OHDSI PROTEUS Study-a-Thon. https://www.ohdsi.org/ohdsi2020-symposium-study-a-thon/. Accessed July 12, 2021.</Citation></Reference><Reference><Citation>PIONEER study-a-Thon. https://prostate-pioneer.eu/pioneer-joins-forces-with-ehden-ohdsi-for-prostate-cancer-study-a-thon/. Accessed July 12, 2021.</Citation></Reference><Reference><Citation>Gandaglia G, van Bochove K, Bjartell A, et al. Research Protocol for an Observational Health Data Analysis to Assess the Long-term Outcomes of Prostate Cancer Patients Undergoing Non-Interventional Management (i.e., Watchful Waiting) and the Impact of Comorbidities and Life Expectancy &#x2013; PIONEER IMI&#x2019;s &#x201c;Big Data for Better Outcomes&#x201d; program, 28 May 2021, PROTOCOL (Version 1) available at Protocol Exchange. doi.org/10.21203/rs.3.pex-1468/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.pex-1468/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayers A, Whitehouse MR.. Complications and adverse events of unicompartmental versus total knee replacement. Lancet Rheumatol 2019; 1 (4): E199&#x2013;E200. doi.org/10.1016/S2665-9913(19)30097-9</Citation></Reference><Reference><Citation>Prats-Uribe A, Illingens B, Vizcaya D. et al.; on behalf of European Health Data and Evidence Network (EHDEN) RA Research Group. Cardio- and cerebrovascular risk with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) in rheumatoid arthritis (RA): a real-world comparative assessment. Ann Rheum Dis 2020; 79 (Suppl 1): 1002.</Citation></Reference><Reference><Citation>Sena AG, Granados D, Hughes N. et al.; on behalf of &#x2018;European Health Data and Evidence Network (EHDEN) RA Research Group&#x2019;. First line treatment with conventional synthetic disease modifying antirheumatic drugs in rheumatoid arthritis: a multinational population-based cohort from 14 real world healthcare databases and 9 countries&#x2014;reality versus guidelines. Ann Rheum Dis 2020; 79 (Suppl 1): 331.</Citation></Reference><Reference><Citation>Carmona L, Weaver J, Burn E. et al.; on behalf of European Health Data and Evidence Network (EHDEN) RA Research Group. Drug-related pancytopenia and leukopenia in rheumatoid arthritis: are all csDMARDs equal? Ann Rheum Dis 2020; 79 (Suppl 1): 1006&#x2013;7.</Citation></Reference><Reference><Citation>Duarte-Salles T, Recalde M, Weaver J. et al.; on behalf of European Health Data and Evidence Network (EHDEN) RA Research Group. Comparative risk of cancer associated with first-line DMARDs use in rheumatoid arthritis: real world evidence from the OHDSI network. Ann Rheum Dis 2020; 79 (Suppl 1): 1004.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36461620</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1930-613X</ISSN><JournalIssue CitedMedium="Internet"><Volume>189</Volume><Issue>3-4</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>27</Day></PubDate></JournalIssue><Title>Military medicine</Title><ISOAbbreviation>Mil Med</ISOAbbreviation></Journal><ArticleTitle>Illustration of Continuous Enrollment and Beneficiary Categorization in DoD and VA Infrastructure for Clinical Intelligence.</ArticleTitle><Pagination><StartPage>466</StartPage><EndPage>474</EndPage><MedlinePgn>466-474</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/milmed/usac352</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The DoD and VA Infrastructure for Clinical Intelligence (DaVINCI) data-sharing initiative has bridged the gap between DoD and VA data. DaVINCI utilizes the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) to map DoD and VA-specific health care codes to a standardized terminology. Although OMOP CDM provides a standardized longitudinal view of health care concepts, it fails in capturing multiple and changing relationships beneficiaries have with DoD and VA as it has a static (vs. yearly) person characteristic table. Furthermore, DoD and VA utilize different policies and terminology to identify their respective beneficiaries, which makes it difficult to track patients longitudinally. The primary purpose of this report is to provide a methodology for categorizing beneficiaries and creating continuous longitudinal patient records to maximize the use of the joint DoD and VA data in DaVINCI.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">For calendar year 2000-2020, we combined DoD and VA OMOP CDM and source databases to uniquely categorize beneficiaries into the following hierarchical groups: Active Duty, Guard, and Reserve Service Members (ADSMs); Separatees; Retirees; Veterans; and Deceased. Once the cohorts were identified, we examined calendar year 2020 health care utilization data using the OMOP VISIT_OCCURRENCE, DRUG_EXPOSURE, MEASUREMENT, and PROCEDURE tables. We also used the Defense Enrollment and Eligibility Reporting System source table to derive enrollment periods for DoD beneficiaries. As VA does not have enrollment plans, we utilized the VA's priority groups (1-5) in the SPATIENT source table to crosswalk the DoD's enrollment concept to the VA. We then assessed lengths of continuous enrollments in DoD and VA and the impact of appending the longitudinal records together.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The majority of the ADSMs utilized the DoD system, but about 60,557 (3%) were seen in the VA for varied types of care. The market share of care provided to ADSMs by the VA varied by specialty and location. For Retirees, the split between DoD (1,625,874 [75%]) and VA (895,992 [41%]) health care utilization was more significant. The value added for utilizing DaVINCI in longitudinal studies was the highest for researchers normally limited to DoD data only. For beneficiaries who had 5&#x2009;years of continuous enrollment, DaVINCI increased the potential study population by over 202% compared to using DoD data alone and by over 14% compared to VA data alone. Among beneficiaries with 20&#x2009;years of continuous enrollment, DaVINCI increased the potential study population by over 133% compared to DoD data and by nearly 39% compared to VA data.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">DaVINCI has successfully combined DoD and VA data and utilized OMOP CDM to standardize health care concepts. However, to fully maximize the potential of DaVINCI's DoD and VA OMOP databases, researchers must uniquely categorize the DaVINCI cohort and build longitudinal patient records across DoD and VA. Because of the low other health insurance rates among DoD enrollees and their choice to enroll to a DoD Primary Care Manager, we believe this population to be the least censored in the DoD. Applying a similar concept through VA's priority groups (1-5) would enable researchers to follow ADSMs as they transition from the military.</AbstractText><CopyrightInformation>&#xa9; The Association of Military Surgeons of the United States 2022. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pav</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Kennell and Associates Inc., Falls Church, VA 22042, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Alqimi Technology Solutions, Inc., Rockville, MD 20850, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colahan</LastName><ForeName>Courtney</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Kennell and Associates Inc., Falls Church, VA 22042, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robison</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT 84148, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kean</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT 84148, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, VA Salt Lake City Health Care System, Salt Lake City, UT 84148, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>U.S. Department of Veterans Affairs</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mil Med</MedlineTA><NlmUniqueID>2984771R</NlmUniqueID><ISSNLinking>0026-4075</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014728" MajorTopicYN="Y">Veterans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008889" MajorTopicYN="Y">Military Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007360" MajorTopicYN="N">Intelligence</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>3</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36461620</ArticleId><ArticleId IdType="doi">10.1093/milmed/usac352</ArticleId><ArticleId IdType="pii">6867769</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36468484</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2093-2278</ISSN><JournalIssue CitedMedium="Print"><Volume>53</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of periodontal &amp; implant science</Title><ISOAbbreviation>J Periodontal Implant Sci</ISOAbbreviation></Journal><ArticleTitle>Association of periodontitis with menopause and hormone replacement therapy: a hospital cohort study using a common data model.</ArticleTitle><Pagination><StartPage>184</StartPage><EndPage>193</EndPage><MedlinePgn>184-193</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5051/jpis.2202480124</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The present study was designed to compare the incidence of periodontitis according to menopausal status and to investigate the possible effect of hormone replacement therapy (HRT) on periodontitis in postmenopausal women using a common data model (CDM) at a single institution.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study involved retrospective cohort data of 950,751 patients from a 20-year database (2001 to 2020) of Ewha Womans University Mokdong Hospital converted to the Observational Medical Outcomes Partnership CDM. One-way analysis of variance models and the &#x3c7;&#xb2; test were used to analyze the statistical differences in patient characteristics among groups. A time-dependent Cox regression analysis was used to calculate hazard ratios and 95% confidence intervals, and <i>P</i> values less than 0.05 were considered to indicate statistical significance.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 29,729 patients, 1,307 patients were diagnosed with periodontitis and 28,422 patients were not. Periodontitis was significantly more common among postmenopausal patients regardless of HRT status than among the non-menopausal group (<i>P</i>&lt;0.05). Time-dependent Cox regression analysis showed that the postmenopausal patients had a significantly higher chance of having periodontitis than non-menopausal patients (<i>P</i>&lt;0.05), but after adjustment for age, body mass index, and smoking status, the difference between the non-menopausal and post-menopausal HRT-treated groups was insignificant (<i>P</i>=0.140).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Postmenopausal women had a significantly greater risk of periodontitis than non-menopausal women. Additionally, the use of HRT in postmenopausal women could reduce the incidence of periodontitis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023. Korean Academy of Periodontology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Ki-Yeol</ForeName><Initials>KY</Initials><Identifier Source="ORCID">0000-0001-6723-3237</Identifier><AffiliationInfo><Affiliation>Department of Periodontology, Ewha Womans University Mokdong Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Min-Ho</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0003-4909-2308</Identifier><AffiliationInfo><Affiliation>Informatization Department, Ewha Womans University Seoul Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Seong-Ho</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0001-6704-6124</Identifier><AffiliationInfo><Affiliation>Department of Periodontology, College of Dentistry, Yonsei University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Eun-Kyoung</ForeName><Initials>EK</Initials><Identifier Source="ORCID">0000-0002-2633-109X</Identifier><AffiliationInfo><Affiliation>Department of Periodontology, Ewha Womans University Mokdong Hospital, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Periodontology, College of Medicine, Ewha Womans University, Seoul, Korea. ekpang@ewha.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>J Periodontal Implant Sci</MedlineTA><NlmUniqueID>101526931</NlmUniqueID><ISSNLinking>2093-2278</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hormone replacement therapy</Keyword><Keyword MajorTopicYN="N">Menopause</Keyword><Keyword MajorTopicYN="N">Periodontitis</Keyword></KeywordList><CoiStatement>No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>5</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36468484</ArticleId><ArticleId IdType="pmc">PMC10315258</ArticleId><ArticleId IdType="doi">10.5051/jpis.2202480124</ArticleId><ArticleId IdType="pii">52.e41</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Albandar JM. Global risk factors and risk indicators for periodontal diseases. Periodontol 2000. 2002;29:177&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">12102708</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolaou D, Gilling-Smith C. Early ovarian ageing: are women with polycystic ovaries protected? Hum Reprod. 2004;19:2175&#x2013;2179.</Citation><ArticleIdList><ArticleId IdType="pubmed">15256506</ArticleId></ArticleIdList></Reference><Reference><Citation>Bromberger JT, Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prospective study of the determinants of age at menopause. Am J Epidemiol. 1997;145:124&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">9006309</ArticleId></ArticleIdList></Reference><Reference><Citation>Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res. 2002;57:257&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pubmed">12017547</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedlander AH. The physiology, medical management and oral implications of menopause. J Am Dent Assoc. 2002;133:73&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">11811747</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhardt RA, Payne JB, Maze CA, Patil KD, Gallagher SJ, Mattson JS. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women. J Periodontol. 1999;70:823&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pubmed">10476887</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner UH. Bone remodeling in post-menopausal osteoporosis. J Dent Res. 2006;85:584&#x2013;595.</Citation><ArticleIdList><ArticleId IdType="pubmed">16798857</ArticleId></ArticleIdList></Reference><Reference><Citation>Guiglia R, Di Fede O, Lo Russo L, Sprini D, Rini GB, Campisi G. Osteoporosis, jawbones and periodontal disease. Med Oral Patol Oral Cir Bucal. 2013;18:e93&#x2013;e99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3548653</ArticleId><ArticleId IdType="pubmed">23229255</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Li C, Lin L, Pan Y, Wang H, Zhao J, et al. Assessment of alveolar bone status in middle aged Chinese (40-59 years) with chronic periodontitis&#x2014;using CBCT. PLoS One. 2015;10:e0139553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4592243</ArticleId><ArticleId IdType="pubmed">26431206</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves RC, F&#xe9;lix SA, Rodriguez-Archilla A, Oliveira P, Brito J, Dos Santos JM. Relationship between menopause and periodontal disease: a cross-sectional study in a Portuguese population. Int J Clin Exp Med. 2015;8:11412&#x2013;11419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4565340</ArticleId><ArticleId IdType="pubmed">26379957</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas AN, R&#xf6;sing CK, Oppermann RV, Albandar JM, Susin C. Association among menopause, hormone replacement therapy, and periodontal attachment loss in southern Brazilian women. J Periodontol. 2009;80:1380&#x2013;1387.</Citation><ArticleIdList><ArticleId IdType="pubmed">19722786</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobo RA, Pickar JH, Stevenson JC, Mack WJ, Hodis HN. Back to the future: hormone replacement therapy as part of a prevention strategy for women at the onset of menopause. Atherosclerosis. 2016;254:282&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">27745704</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagnacci A, Venier M. The controversial history of hormone replacement therapy. Medicina (Kaunas) 2019;55:602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6780820</ArticleId><ArticleId IdType="pubmed">31540401</ArticleId></ArticleIdList></Reference><Reference><Citation>de Villiers TJ, Gass ML, Haines CJ, Hall JE, Lobo RA, Pierroz DD, et al. Global consensus statement on menopausal hormone therapy. Climacteric. 2013;16:203&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">23488524</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, Ma Q, Knoll C, Schuemie M, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22:553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Makadia R, Ryan PB. Transforming the premier perspective&#xae; hospital database into the observational medical outcomes partnership (OMOP) common data model. EGEMS (Wash DC) 2014;2:1110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn EK, Park MY, Cho SY, Ryan P, Schuemie MJ, et al. Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a common data model for distributed network research. Healthc Inform Res. 2016;22:54&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>Biedermann P, Ong R, Davydov A, Orlova A, Solovyev P, Sun H, et al. Standardizing registry data to the OMOP Common Data Model: experience from three pulmonary hypertension databases. BMC Med Res Methodol. 2021;21:238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8565035</ArticleId><ArticleId IdType="pubmed">34727871</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016;64:333&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Liyanage H, Liaw ST, Jonnagaddala J, Hinton W, de Lusignan S. Common data models (CDMs) to enhance international big data analytics: a diabetes use case to compare three CDMs. Stud Health Technol Inform. 2018;255:60&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">30306907</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronderos M, Jacobs DR, Himes JH, Pihlstrom BL. Associations of periodontal disease with femoral bone mineral density and estrogen replacement therapy: cross-sectional evaluation of US adults from NHANES III. J Clin Periodontol. 2000;27:778&#x2013;786.</Citation><ArticleIdList><ArticleId IdType="pubmed">11034127</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzo G, Guiglia R, Licata ME, Pizzo I, Davis JM, Giuliana G. Effect of hormone replacement therapy (HRT) on periodontal status of postmenopausal women. Med Sci Monit. 2011;17:PH23&#x2013;PH27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3539527</ArticleId><ArticleId IdType="pubmed">21455116</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossi SG. Effect of estrogen supplementation on periodontal disease. Compend Contin Educ Dent Suppl. 1998:S30&#x2013;S36.</Citation><ArticleIdList><ArticleId IdType="pubmed">12089759</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Kim I, Song J, Hwang KG, Choi B, Hwang SS. The relationship between hormone replacement therapy and periodontal disease in postmenopausal women: a cross-sectional study the Korea National Health and Nutrition Examination Survey from 2007 to 2012. BMC Oral Health. 2019;19:151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6631997</ArticleId><ArticleId IdType="pubmed">31307452</ArticleId></ArticleIdList></Reference><Reference><Citation>Page RC, Eke PI. Case definitions for use in population-based surveillance of periodontitis. J Periodontol. 2007;78:1387&#x2013;1399.</Citation><ArticleIdList><ArticleId IdType="pubmed">17608611</ArticleId></ArticleIdList></Reference><Reference><Citation>Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">10863370</ArticleId></ArticleIdList></Reference><Reference><Citation>Greendale GA, Lee NP, Arriola ER. The menopause. Lancet. 1999;353:571&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">10028999</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36478647</PMID><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1738-5520</ISSN><JournalIssue CitedMedium="Print"><Volume>52</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Korean circulation journal</Title><ISOAbbreviation>Korean Circ J</ISOAbbreviation></Journal><ArticleTitle>Establishment of an International Evidence Sharing Network Through Common Data Model for Cardiovascular Research.</ArticleTitle><Pagination><StartPage>853</StartPage><EndPage>864</EndPage><MedlinePgn>853-864</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4070/kcj.2022.0294</ELocationID><Abstract><AbstractText>A retrospective observational study is one of the most widely used research methods in medicine. However, evidence postulated from a single data source likely contains biases such as selection bias, information bias, and confounding bias. Acquiring enough data from multiple institutions is one of the most effective methods to overcome the limitations. However, acquiring data from multiple institutions from many countries requires enormous effort because of financial, technical, ethical, and legal issues as well as standardization of data structure and semantics. The Observational Health Data Sciences and Informatics (OHDSI) research network standardized 928 million unique records or 12% of the world's population into a common structure and meaning and established a research network of 453 data partners from 41 countries around the world. OHDSI is a distributed research network wherein researchers do not own or directly share data but only analyzed results. However, sharing evidence without sharing data is difficult to understand. In this review, we will look at the basic principles of OHDSI, common data model, distributed research networks, and some representative studies in the cardiovascular field using the network. This paper also briefly introduces a Korean distributed research network named FeederNet.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. The Korean Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-5052-6399</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seongwon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0547-6492</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Byungjin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-1445-5888</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-4989-3287</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea. veritas@ajou.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>20003883</GrantID><Agency>Ministry of Trade, Industry and Energy</Agency><Country>Korea</Country></Grant><Grant><GrantID>20005021</GrantID><Agency>Ministry of Trade, Industry and Energy</Agency><Country>Korea</Country></Grant><Grant><GrantID>HR16C0001</GrantID><Agency>Korea Health Industry Development Institute</Agency><Country>Republic of Korea</Country></Grant><Grant><GrantID>HG22C0024</GrantID><Agency>Korea Health Industry Development Institute</Agency><Country>Republic of Korea</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Korean Circ J</MedlineTA><NlmUniqueID>101247141</NlmUniqueID><ISSNLinking>1738-5520</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">Open science</Keyword><Keyword MajorTopicYN="N">Real world data</Keyword><Keyword MajorTopicYN="N">Real world evidence</Keyword></KeywordList><CoiStatement>RW Park owns stock in Evidnet. SC You reports being CTO of PHI Digital Healthcare. The other authors declare no conflicts of financial interest in the subject matter or materials discussed in this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>8</Day><Hour>13</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36478647</ArticleId><ArticleId IdType="pmc">PMC9742390</ArticleId><ArticleId IdType="doi">10.4070/kcj.2022.0294</ArticleId><ArticleId IdType="pii">52.853</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, et al. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med. 2010;153:600&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19:54&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G.  OHDSI 2022 state of the community [Internet] place unknown: Observational Health Data Sciences and Informatics; 2022.  [cited 2022 October 23].  Available from:  https://www.ohdsi.org/wp-content/uploads/2022/10/OHDSI2022-state-of-community-Hripcsak-FDA-Titans.pdf.</Citation></Reference><Reference><Citation>Haendel MA, Chute CG, Robinson PN. Classification, ontology, and precision medicine. N Engl J Med. 2018;379:1452&#x2013;1462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6503847</ArticleId><ArticleId IdType="pubmed">30304648</ArticleId></ArticleIdList></Reference><Reference><Citation>Seong Y, You SC, Ostropolets A, et al. Incorporation of Korean electronic data interchange vocabulary into observational medical outcomes partnership vocabulary. Healthc Inform Res. 2021;27:29&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7921574</ArticleId><ArticleId IdType="pubmed">33611874</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn EK, Park MY, et al. Conversion and data quality assessment of electronic health record data at a Korean tertiary teaching hospital to a common data model for distributed network research. Healthc Inform Res. 2016;22:54&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacketer C, Defalco FJ, Ryan PB, Rijnbeek PR. Increasing trust in real-world evidence through evaluation of observational data quality. J Am Med Inform Assoc. 2021;28:2251&#x2013;2257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8449628</ArticleId><ArticleId IdType="pubmed">34313749</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al. Characterizing treatment pathways at scale using the OHDSI network. Proc Natl Acad Sci U S A. 2016;113:7329&#x2013;7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostka K, Duarte-Salles T, Prats-Uribe A, et al. Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS. Clin Epidemiol. 2022;14:369&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957305</ArticleId><ArticleId IdType="pubmed">35345821</ArticleId></ArticleIdList></Reference><Reference><Citation>Brat GA, Weber GM, Gehlenborg N, et al. International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium. NPJ Digit Med. 2020;3:109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438496</ArticleId><ArticleId IdType="pubmed">32864472</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, Jung S, Swerdel JN, et al. Comparison of first-line dual combination treatments in hypertension: real-world evidence from multinational heterogeneous cohorts. Korean Circ J. 2020;50:52&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6923236</ArticleId><ArticleId IdType="pubmed">31642211</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394:1816&#x2013;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Pratt N, et al. Principles of Large-scale Evidence Generation and Evaluation across a Network of Databases (LEGEND) J Am Med Inform Assoc. 2020;27:1331&#x2013;1337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7481029</ArticleId><ArticleId IdType="pubmed">32909033</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan You S, Krumholz HM, Suchard MA, et al. Comprehensive comparative effectiveness and safety of first-line &#x3b2;-blocker monotherapy in hypertensive patients: a large-scale multicenter observational study. Hypertension. 2021;77:1528&#x2013;1538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8035236</ArticleId><ArticleId IdType="pubmed">33775125</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, Rho Y, Bikdeli B, et al. Association of ticagrelor vs clopidogrel with net adverse clinical events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. JAMA. 2020;324:1640&#x2013;1650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7592033</ArticleId><ArticleId IdType="pubmed">33107944</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J Am Med Inform Assoc. 2018;25:969&#x2013;975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieke N, Hancox J, Li W, et al. The future of digital health with federated learning. NPJ Digit Med. 2020;3:119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7490367</ArticleId><ArticleId IdType="pubmed">33015372</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayan I, Roth HR, Zhong A, et al. Federated learning for predicting clinical outcomes in patients with COVID-19. Nat Med. 2021;27:1735&#x2013;1743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9157510</ArticleId><ArticleId IdType="pubmed">34526699</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamidi TK, Tran-Nguyen TK, Melvin RL, Worthey EA. Development of an individualized risk prediction model for COVID-19 using electronic health record data. Front Big Data. 2021;4:675882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8211871</ArticleId><ArticleId IdType="pubmed">34151259</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J, Luo C, Islam MN, et al. Distributed learning for heterogeneous clinical data with application to integrating COVID-19 data across 230 sites. NPJ Digit Med. 2022;5:76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9198031</ArticleId><ArticleId IdType="pubmed">35701668</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams RD, Markus AF, Yang C, et al. Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network. BMC Med Res Methodol. 2022;22:35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8801189</ArticleId><ArticleId IdType="pubmed">35094685</ArticleId></ArticleIdList></Reference><Reference><Citation>Nestsiarovich A, Reps JM, Matheny ME, et al. Predictors of diagnostic transition from major depressive disorder to bipolar disorder: a retrospective observational network study. Transl Psychiatry. 2021;11:642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8688463</ArticleId><ArticleId IdType="pubmed">34930903</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung H, Yoo S, Kim S, et al. Patient-Level fall risk prediction using the observational medical outcomes partnership&#x2019;s common data model: pilot feasibility study. JMIR Med Inform. 2022;10:e35104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957002</ArticleId><ArticleId IdType="pubmed">35275076</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340:c221.</Citation><ArticleIdList><ArticleId IdType="pubmed">20139215</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper H, Patall EA. The relative benefits of meta-analysis conducted with individual participant data versus aggregated data. Psychol Methods. 2009;14:165&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">19485627</ArticleId></ArticleIdList></Reference><Reference><Citation>Selmer R, Haglund B, Furu K, et al. Individual-based versus aggregate meta-analysis in multi-database studies of pregnancy outcomes: the Nordic example of selective serotonin reuptake inhibitors and venlafaxine in pregnancy. Pharmacoepidemiol Drug Saf. 2016;25:1160&#x2013;1169.</Citation><ArticleIdList><ArticleId IdType="pubmed">27193296</ArticleId></ArticleIdList></Reference><Reference><Citation>La Gamba F, Corrao G, Romio S, et al. Combining evidence from multiple electronic health care databases: performances of one-stage and two-stage meta-analysis in matched case-control studies. Pharmacoepidemiol Drug Saf. 2017;26:1213&#x2013;1219.</Citation><ArticleIdList><ArticleId IdType="pubmed">28799196</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Chen Y, Madigan D, Suchard MA. Combining cox regressions across a heterogeneous distributed research network facing small and zero counts. Stat Methods Med Res. 2022;31:438&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">34841975</ArticleId></ArticleIdList></Reference><Reference><Citation>Marquis-Gravel G, Roe MT, Robertson HR, et al. Rationale and design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) trial. JAMA Cardiol. 2020;5:598&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">32186653</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36506524</PMID><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in pharmacology</Title><ISOAbbreviation>Front Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Corrigendum: Vaccine safety surveillance using routinely collected healthcare data-An empirical evaluation of epidemiological designs.</ArticleTitle><Pagination><StartPage>1088973</StartPage><MedlinePgn>1088973</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1088973</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2022.1088973</ELocationID><Abstract><AbstractText>[This corrects the article DOI: 10.3389/fphar.2022.893484.].</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Schuemie, Arshad, Pratt, Nyberg, Alshammari, Hripcsak, Ryan, Prieto-Alhambra, Lai, Li, Fortin, Minty and Suchard.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen R&amp;D, Titusville, NJ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arshad</LastName><ForeName>Faaizah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pratt</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Quality Use of Medicines and Pharmacy Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen R&amp;D, Titusville, NJ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Lana Y H</ForeName><Initials>LYH</Initials><AffiliationInfo><Affiliation>O'Brien Institute for Public Health, Faculty of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xintong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Medical Sciences, University of Manchester, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortin</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen R&amp;D, Titusville, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minty</LastName><ForeName>Evan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>O'Brien Institute for Public Health, Faculty of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016425">Published Erratum</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pharmacol</MedlineTA><NlmUniqueID>101548923</NlmUniqueID><ISSNLinking>1663-9812</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumFor"><RefSource>Front Pharmacol. 2022 Jul 06;13:893484. doi: 10.3389/fphar.2022.893484</RefSource><PMID Version="1">35873596</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adverse event</Keyword><Keyword MajorTopicYN="N">methods</Keyword><Keyword MajorTopicYN="N">routinely collected data</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword><Keyword MajorTopicYN="N">vaccine safely</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>12</Day><Hour>11</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36506524</ArticleId><ArticleId IdType="pmc">PMC9731373</ArticleId><ArticleId IdType="doi">10.3389/fphar.2022.1088973</ArticleId><ArticleId IdType="pii">1088973</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36555858</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>24</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>19</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>iADRGSE: A Graph-Embedding and Self-Attention Encoding for Identifying Adverse Drug Reaction in the Earlier Phase of Drug Development.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">16216</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms232416216</ELocationID><Abstract><AbstractText>Adverse drug reactions (ADRs) are a major issue to be addressed by the pharmaceutical industry. Early and accurate detection of potential ADRs contributes to enhancing drug safety and reducing financial expenses. The majority of the approaches that have been employed to identify ADRs are limited to determining whether a drug exhibits an ADR, rather than identifying the exact type of ADR. By introducing the "multi-level feature-fusion deep-learning model", a new predictor, called iADRGSE, has been developed, which can be used to identify adverse drug reactions at the early stage of drug discovery. iADRGSE integrates a self-attentive module and a graph-network module that can extract one-dimensional sub-structure sequence information and two-dimensional chemical-structure graph information of drug molecules. As a demonstration, cross-validation and independent testing were performed with iADRGSE on a dataset of ADRs classified into 27 categories, based on SOC (system organ classification). In addition, experiments comparing iADRGSE with approaches such as NPF were conducted on the OMOP dataset, using the jackknife test method. Experiments show that iADRGSE was superior to existing state-of-the-art predictors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Computer, Jingdezhen Ceramic University, Jingdezhen 333403, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Meiling</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Computer, Jingdezhen Ceramic University, Jingdezhen 333403, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Liyi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Computer, Jingdezhen Ceramic University, Jingdezhen 333403, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-1016-7544</Identifier><AffiliationInfo><Affiliation>Department of Computer, Jingdezhen Ceramic University, Jingdezhen 333403, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>32260154</GrantID><Agency>The National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>31860312</GrantID><Agency>The National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>62062043</GrantID><Agency>The National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2018-3-3</GrantID><Agency>the China-Montenegro Intergovernmental S&amp;amp;T Cooperation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="Y">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="Y">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076722" MajorTopicYN="N">Drug Development</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adverse drug reactions</Keyword><Keyword MajorTopicYN="N">graph isomorphism network</Keyword><Keyword MajorTopicYN="N">multi-label learning</Keyword><Keyword MajorTopicYN="N">self-attention</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36555858</ArticleId><ArticleId IdType="pmc">PMC9786008</ArticleId><ArticleId IdType="doi">10.3390/ijms232416216</ArticleId><ArticleId IdType="pii">ijms232416216</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Edwards I.R., Aronson J.K. Adverse drug reactions: Definitions, diagnosis, and management. Lancet. 2000;356:1255&#x2013;1259. doi: 10.1016/S0140-6736(00)02799-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)02799-9</ArticleId><ArticleId IdType="pubmed">11072960</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarou J., Pomeranz B.H., Corey P.N. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA. 1998;279:1200&#x2013;1205. doi: 10.1001/jama.279.15.1200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.279.15.1200</ArticleId><ArticleId IdType="pubmed">9555760</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirmohamed M., James S., Meakin S., Green C., Scott A.K., Walley T.J., Farrar K., Park B.K., Breckenridge A.M. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ. 2004;329:15. doi: 10.1136/bmj.329.7456.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.329.7456.15</ArticleId><ArticleId IdType="pmc">PMC443443</ArticleId><ArticleId IdType="pubmed">15231615</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson M., Gagnon J.P. The cost of new drug discovery and development. Discov. Med. 2009;4:172&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pubmed">20704981</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitebread S., Hamon J., Bojanic D., Urban L. Keynote review: In vitro safety pharmacology profiling: An essential tool for successful drug development. Drug Discov. Today. 2005;10:1421&#x2013;1433. doi: 10.1016/S1359-6446(05)03632-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1359-6446(05)03632-9</ArticleId><ArticleId IdType="pubmed">16243262</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpaz R., Vilar S., Dumouchel W., Salmasian H., Haerian K., Shah N.H., Chase H.S., Friedman C. Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions. J. Am. Med. Inform. Assoc. 2013;20:413&#x2013;419. doi: 10.1136/amiajnl-2012-000930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2012-000930</ArticleId><ArticleId IdType="pmc">PMC3628045</ArticleId><ArticleId IdType="pubmed">23118093</ArticleId></ArticleIdList></Reference><Reference><Citation>Tutubalina E., Alimova I., Miftahutdinov Z., Sakhovskiy A., Malykh V., Nikolenko S. The Russian Drug Reaction Corpus and neural models for drug reactions and effectiveness detection in user reviews. Bioinformatics. 2021;37:243&#x2013;249. doi: 10.1093/bioinformatics/btaa675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btaa675</ArticleId><ArticleId IdType="pubmed">32722774</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagannatha A.N., Yu H. Bidirectional RNN for medical event detection in electronic health records; Proceedings of the Association for Computational Linguistics; Berlin, Germany. 7&#x2013;12 August 2016; p. 473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5119627</ArticleId><ArticleId IdType="pubmed">27885364</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocos A., Fiks A.G., Masino A.J. Deep learning for pharmacovigilance: Recurrent neural network architectures for labeling adverse drug reactions in Twitter posts. J. Am. Med. Inform. Assoc. 2017;24:813&#x2013;821. doi: 10.1093/jamia/ocw180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocw180</ArticleId><ArticleId IdType="pmc">PMC7651964</ArticleId><ArticleId IdType="pubmed">28339747</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding P., Zhou X., Zhang X., Wang J., Lei Z. An attentive neural sequence labeling model for adverse drug reactions mentions extraction. IEEE Access. 2018;6:73305&#x2013;73315. doi: 10.1109/ACCESS.2018.2882443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ACCESS.2018.2882443</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Lin H., Ren Y., Yang L., Xu B., Yang Z., Wang J., Zhang Y. Adverse drug reaction detection via a multihop self-attention mechanism. BMC Bioinform. 2019;20:479. doi: 10.1186/s12859-019-3053-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-019-3053-5</ArticleId><ArticleId IdType="pmc">PMC6751590</ArticleId><ArticleId IdType="pubmed">31533622</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Allaly E.-D., Sarrouti M., En-Nahnahi N., El Alaoui S.O. An adverse drug effect mentions extraction method based on weighted online recurrent extreme learning machine. Comput. Methods Programs Biomed. 2019;176:33&#x2013;41. doi: 10.1016/j.cmpb.2019.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2019.04.029</ArticleId><ArticleId IdType="pubmed">31200909</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo S., Lee T., Kim M.-H., Yoon Y. Prediction of Side Effects Using Comprehensive Similarity Measures. Biomed Res. Int. 2020;2020:1357630. doi: 10.1155/2020/1357630.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/1357630</ArticleId><ArticleId IdType="pmc">PMC7064827</ArticleId><ArticleId IdType="pubmed">32190647</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Yue X., Liu F., Chen Y., Tu S., Zhang X. A unified frame of predicting side effects of drugs by using linear neighborhood similarity. BMC Syst. Biol. 2017;11:101. doi: 10.1186/s12918-017-0477-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12918-017-0477-2</ArticleId><ArticleId IdType="pmc">PMC5751767</ArticleId><ArticleId IdType="pubmed">29297371</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Peng H., Ghosh S., Lan C., Li J. Inverse similarity and reliable negative samples for drug side-effect prediction. BMC Bioinform. 2019;19:554. doi: 10.1186/s12859-018-2563-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-018-2563-x</ArticleId><ArticleId IdType="pmc">PMC7402513</ArticleId><ArticleId IdType="pubmed">30717666</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang X., Zhang P., Li J., Fu Y., Qu L., Chen Y., Chen Z. Learning important features from multi-view data to predict drug side effects. J. Cheminformatics. 2019;11:79. doi: 10.1186/s13321-019-0402-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13321-019-0402-3</ArticleId><ArticleId IdType="pmc">PMC6916463</ArticleId><ArticleId IdType="pubmed">33430979</ArticleId></ArticleIdList></Reference><Reference><Citation>Emir Mu&#xf1;oz M., Nov&#xe1;&#x10d;ek V., Vandenbussche P.-Y. Using Drug Similarities for Discovery of Possible Adverse Reactions. AMIA Annu Symp Proc. 2017;2016:924&#x2013;933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333276</ArticleId><ArticleId IdType="pubmed">28269889</ArticleId></ArticleIdList></Reference><Reference><Citation>Bean D.M., Wu H., Iqbal E., Dzahini O., Ibrahim Z.M., Broadbent M., Stewart R., Dobson R.J. Knowledge graph prediction of unknown adverse drug reactions and validation in electronic health records. Sci. Rep. 2017;7:16416. doi: 10.1038/s41598-017-16674-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-16674-x</ArticleId><ArticleId IdType="pmc">PMC5703951</ArticleId><ArticleId IdType="pubmed">29180758</ArticleId></ArticleIdList></Reference><Reference><Citation>Emir M., Nov&#xe1;&#x10d;ek V., Vandenbussche P.-Y. Facilitating prediction of adverse drug reactions by using knowledge graphs and multi-label learning models. Brief. Bioinform. 2019;20:190&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">28968655</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F., Sun B., Diao X., Zhao W., Shu T. Prediction of adverse drug reactions based on knowledge graph embedding. BMC Med. Inform. Decis. Mak. 2021;21:38. doi: 10.1186/s12911-021-01402-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-021-01402-3</ArticleId><ArticleId IdType="pmc">PMC7863488</ArticleId><ArticleId IdType="pubmed">33541342</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Zhang P. Towards early detection of adverse drug reactions: Combining pre-clinical drug structures and post-market safety reports. BMC Med. Inform. Decis. Mak. 2019;19:279. doi: 10.1186/s12911-019-0999-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-019-0999-1</ArticleId><ArticleId IdType="pmc">PMC6918608</ArticleId><ArticleId IdType="pubmed">31849321</ArticleId></ArticleIdList></Reference><Reference><Citation>Timilsina M., Tandan M., d&#x2019;Aquin M., Yang H. Discovering Links Between Side Effects and Drugs Using a Diffusion Based Method. Sci. Rep. 2019;9:10436. doi: 10.1038/s41598-019-46939-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-46939-6</ArticleId><ArticleId IdType="pmc">PMC6639365</ArticleId><ArticleId IdType="pubmed">31320740</ArticleId></ArticleIdList></Reference><Reference><Citation>Xuan P., Song Y., Zhang T., Jia L. Prediction of Potential Drug&#x2013;Disease Associations through Deep Integration of Diversity and Projections of Various Drug Features. Int. J. Mol. Sci. 2019;20:4102. doi: 10.3390/ijms20174102.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20174102</ArticleId><ArticleId IdType="pmc">PMC6747548</ArticleId><ArticleId IdType="pubmed">31443472</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong J., Xiong Z., Chen K., Jiang H., Zheng M. Graph neural networks for automated de novo drug design. Drug Discov. Today. 2021;26:1382&#x2013;1393. doi: 10.1016/j.drudis.2021.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2021.02.011</ArticleId><ArticleId IdType="pubmed">33609779</ArticleId></ArticleIdList></Reference><Reference><Citation>Withnall M., Lindel&#xf6;f E., Engkvist O., Chen H. Building attention and edge message passing neural networks for bioactivity and physical&#x2013;chemical property prediction. J. Cheminformatics. 2020;12:1. doi: 10.1186/s13321-019-0407-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13321-019-0407-y</ArticleId><ArticleId IdType="pmc">PMC6951016</ArticleId><ArticleId IdType="pubmed">33430988</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaswani A., Shazeer N., Parmar N., Uszkoreit J., Jones L., Gomez A.N., Kaiser &#x141;., Polosukhin I. Attention is all you need; Proceedings of the 31st Conference on Neural Information Processing Systems (NIPS 2017); Long Beach, CA, USA. 4&#x2013;9 December 2017; p. 30.</Citation></Reference><Reference><Citation>Schwarz K., Allam A., Perez Gonzalez N.A., Krauthammer M. AttentionDDI: Siamese attention-based deep learning method for drug&#x2013;drug interaction predictions. BMC Bioinform. 2021;22:412. doi: 10.1186/s12859-021-04325-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-021-04325-y</ArticleId><ArticleId IdType="pmc">PMC8379737</ArticleId><ArticleId IdType="pubmed">34418954</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey S., Luo H., Fokoue A., Hu J., Zhang P. Predicting adverse drug reactions through interpretable deep learning framework. BMC Bioinform. 2018;19:476. doi: 10.1186/s12859-018-2544-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-018-2544-0</ArticleId><ArticleId IdType="pmc">PMC6300887</ArticleId><ArticleId IdType="pubmed">30591036</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin J., Chang M.-W., Lee K., Toutanova K. Bert: Pre-training of deep bidirectional transformers for language understanding. arXiv. 20181810.04805</Citation></Reference><Reference><Citation>Xiong Z., Wang D., Liu X., Zhong F., Wan X., Li X., Li Z., Luo X., Chen K., Jiang H., et al. Pushing the Boundaries of Molecular Representation for Drug Discovery with the Graph Attention Mechanism. J. Med. Chem. 2020;63:8749&#x2013;8760. doi: 10.1021/acs.jmedchem.9b00959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.9b00959</ArticleId><ArticleId IdType="pubmed">31408336</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers D., Hahn M. Extended-connectivity fingerprints. J. Chem. Inf. Modeling. 2010;50:742&#x2013;754. doi: 10.1021/ci100050t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ci100050t</ArticleId><ArticleId IdType="pubmed">20426451</ArticleId></ArticleIdList></Reference><Reference><Citation>DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am. Stat. 1999;53:177&#x2013;190.</Citation></Reference><Reference><Citation>Xiao C., Li Y., Baytas I.M., Zhou J., Wang F. An MCEM Framework for Drug Safety Signal Detection and Combination from Heterogeneous Real World Evidence. Sci. Rep. 2018;8:1806. doi: 10.1038/s41598-018-19979-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-19979-7</ArticleId><ArticleId IdType="pmc">PMC5789130</ArticleId><ArticleId IdType="pubmed">29379048</ArticleId></ArticleIdList></Reference><Reference><Citation>Park H., Byun J.M., Yoon S.-S., Koh Y., Yoon S.-W., Shin D.-Y., Hong J., Kim I. Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM. PLoS ONE. 2022;17:e0260113. doi: 10.1371/journal.pone.0260113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260113</ArticleId><ArticleId IdType="pmc">PMC8794080</ArticleId><ArticleId IdType="pubmed">35085238</ArticleId></ArticleIdList></Reference><Reference><Citation>Toropov A.A., Toropova A.P., Mukhamedzhanova D.V., Gutman I. Simplified molecular input line entry system (SMILES) as an alternative for constructing quantitative structure-property relationships (QSPR) Indian J. Chemistry. Sect. A Inorg. Phys. Theor. Anal. 2005;44:1545&#x2013;1552.</Citation></Reference><Reference><Citation>Landrum G. RDKit: Open-Source Cheminformatics and Machine Learning.  [(accessed on 12 September 2022)].  Available online:  https://www.rdkit.org.</Citation></Reference><Reference><Citation>Chen Y., Ma T., Yang X., Wang J., Song B., Zeng X. MUFFIN: Multi-scale feature fusion for drug&#x2013;drug interaction prediction. Bioinformatics. 2021;37:2651&#x2013;2658. doi: 10.1093/bioinformatics/btab169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btab169</ArticleId><ArticleId IdType="pubmed">33720331</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Boyle N.M., Banck M., James C.A., Morley C., Vandermeersch T., Hutchison G.R. Open Babel: An open chemical toolbox. J. Cheminformatics. 2011;3:33. doi: 10.1186/1758-2946-3-33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1758-2946-3-33</ArticleId><ArticleId IdType="pmc">PMC3198950</ArticleId><ArticleId IdType="pubmed">21982300</ArticleId></ArticleIdList></Reference><Reference><Citation>Veli&#x10d;kovi&#x107; P., Fedus W., Hamilton W.L., Li&#xf2; P., Bengio Y., Hjelm R.D. Deep Graph Infomax. arXiv. 20181809.10341</Citation></Reference><Reference><Citation>Hamilton W.L., Ying R., Leskovec J. Representation learning on graphs: Methods and applications. arXiv. 20171709.05584</Citation></Reference><Reference><Citation>Hu W., Liu B., Gomes J., Zitnik M., Liang P., Pande V., Leskovec J. Strategies for Pre-training Graph Neural Networks. arXiv. 20201905.12265</Citation></Reference><Reference><Citation>Ba J.L., Kiros J.R., Hinton G.E. Layer normalization. arXiv. 20161607.06450</Citation></Reference><Reference><Citation>He K., Zhang X., Ren S., Sun J. Deep residual learning for image recognition; Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition; Las Vegas, NV, USA. 27&#x2013;30 June 2016; pp. 770&#x2013;778.</Citation></Reference><Reference><Citation>Ioffe S., Szegedy C. Batch normalization: Accelerating deep network training by reducing internal covariate shift; Proceedings of the International Conference on Machine Learning 2015; Lille, France. 6&#x2013;11 July 2015; pp. 448&#x2013;456.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Curated"><PMID Version="2">36563487</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2352-3964</ISSN><JournalIssue CitedMedium="Internet"><Volume>87</Volume><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>EBioMedicine</Title><ISOAbbreviation>EBioMedicine</ISOAbbreviation></Journal><ArticleTitle>Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes.</ArticleTitle><Pagination><StartPage>104413</StartPage><MedlinePgn>104413</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">104413</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ebiom.2022.104413</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2352-3964(22)00595-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Stratification of patients with post-acute sequelae of SARS-CoV-2 infection (PASC, or long COVID) would allow precision clinical management strategies. However, long COVID is incompletely understood and characterised by a wide range of manifestations that are difficult to analyse computationally. Additionally, the generalisability of machine learning classification of COVID-19 clinical outcomes has rarely been tested.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We present a method for computationally modelling PASC phenotype data based on electronic healthcare records (EHRs) and for assessing pairwise phenotypic similarity between patients using semantic similarity. Our approach defines a nonlinear similarity function that maps from a feature space of phenotypic abnormalities to a matrix of pairwise patient similarity that can be clustered using unsupervised machine learning.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">We found six clusters of PASC patients, each with distinct profiles of phenotypic abnormalities, including clusters with distinct pulmonary, neuropsychiatric, and cardiovascular abnormalities, and a cluster associated with broad, severe manifestations and increased mortality. There was significant association of cluster membership with a range of pre-existing conditions and measures of severity during acute COVID-19. We assigned new patients from other healthcare centres to clusters by maximum semantic similarity to the original patients, and showed that the clusters were generalisable across different hospital systems. The increased mortality rate originally identified in one cluster was consistently observed in patients assigned to that cluster in other hospital systems.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Semantic phenotypic clustering provides a foundation for assigning patients to stratified subgroups for natural history or therapy studies on PASC.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">NIH (TR002306/OT2HL161847-01/OD011883/HG010860), U.S.D.O.E. (DE-AC02-05CH11231), Donald A. Roux Family Fund at Jackson Laboratory, Marsico Family at CU Anschutz.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reese</LastName><ForeName>Justin T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blau</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casiraghi</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA; AnacletoLab, Dipartimento di Informatica, Universit&#xe0; Degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergquist</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Sage Bionetworks, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loomba</LastName><ForeName>Johanna J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>The Integrated Translational Health Research Institute of Virginia (iTHRIV), University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Tiffany J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laraway</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Departments of Biomedical Informatics and Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonescu</LastName><ForeName>Corneliu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Arizona - Banner Health, Phoenix, AZ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coleman</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gargano</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkins</LastName><ForeName>Kenneth J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Biostatistics Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappelletti</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>AnacletoLab, Dipartimento di Informatica, Universit&#xe0; Degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fontana</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>AnacletoLab, Dipartimento di Informatica, Universit&#xe0; Degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ammar</LastName><ForeName>Nariman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Health Science Center, University of Tennessee, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antony</LastName><ForeName>Blessy</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Virginia Tech, Blacksburg, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murali</LastName><ForeName>T M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Virginia Tech, Blacksburg, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caufield</LastName><ForeName>J Harry</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Environmental Genomics and Systems Biology Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlebach</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMurry</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Departments of Biomedical Informatics and Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tufts Medical Center Clinical and Translational Science Institute, Tufts Medical Center, Boston, MA, USA; Tufts University School of Medicine, Institute for Clinical Research and Health Policy Studies, Boston, MA, USA; Northeastern University, OHDSI Center at the Roux Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moffitt</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics and Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Jineta</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Sage Bionetworks, Seattle, WA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solomonides</LastName><ForeName>Anthony E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>HealthSystem Research Institute, NorthShore University, Evanston, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Northeastern University, OHDSI Center at the Roux Institute, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valentini</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>AnacletoLab, Dipartimento di Informatica, Universit&#xe0; Degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahner</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Axle Informatics, Rockville, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chute</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Schools of Medicine, Public Health and Nursing, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madlock-Brown</LastName><ForeName>Charisse</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Health Science Center, University of Tennessee, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haendel</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Departments of Biomedical Informatics and Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Peter N</ForeName><Initials>PN</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, 10 Discovery Drive, Farmington, CT, USA; Institute for Systems Genomics, University of Connecticut, Farmington, CT, USA. Electronic address: Peter.Robinson@jax.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>N3C Consortium</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>RECOVER Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT2 HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K01 AG070329</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R24 OD011883</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 HG011449</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RM1 HG010860</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>EBioMedicine</MedlineTA><NlmUniqueID>101647039</NlmUniqueID><ISSNLinking>2352-3964</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2022 Jul 20:2022.05.24.22275398. doi: 10.1101/2022.05.24.22275398</RefSource><PMID Version="1">35665012</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Human Phenotype Ontology</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Precision medicine</Keyword><Keyword MajorTopicYN="N">Semantic similarity</Keyword></KeywordList><CoiStatement>Declaration of interests T. Bergquist received other support from Bill and Melinda Gates Foundation, H. Davis received support from Balvi Foundation and is a cofounder of Patient Led Research Collaborative. The other authors declare that they have no other competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Spratt</LastName><ForeName>Heidi</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Visweswaran</LastName><ForeName>Shyam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flack</LastName><ForeName>Joseph Eugene</ForeName><Initials>JE</Initials><Suffix>4th</Suffix></Investigator><Investigator ValidYN="Y"><LastName>Yoo</LastName><ForeName>Yun Jae</ForeName><Initials>YJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gabriel</LastName><ForeName>Davera</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Alexander</LastName><ForeName>G Caleb</ForeName><Initials>GC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehta</LastName><ForeName>Hemalkumar B</ForeName><Initials>HB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Liu</LastName><ForeName>Feifan</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miller</LastName><ForeName>Robert T</ForeName><Initials>RT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wong</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hill</LastName><ForeName>Elaine L</ForeName><Initials>EL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thorpe</LastName><ForeName>Lorna E</ForeName><Initials>LE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Divers</LastName><ForeName>Jasmin</ForeName><Initials>J</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>18</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36563487</ArticleId><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2022.104413</ArticleId><ArticleId IdType="pii">S2352-3964(22)00595-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weekly operational update on COVID-19-30 March 2022 [Internet] https://www.who.int/publications/m/item/weekly-operational-update-on-covid-19---30-march-2022 Available from:</Citation></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: an overview. Diabetes Metabol Syndr. 2021;15(3):869&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9) doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A'Court C., Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V., WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A&#xa0;clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G., McCann K., O'Brien C., et al. Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect Dis. 2022;9(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer R.R., Rock M.A., Vasilevsky N., et al. Characterizing long COVID: deep phenotype of a complex condition. eBioMedicine. 2021;74:103722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson P.N., K&#xf6;hler S., Bauer S., Seelow D., Horn D., Mundlos S. The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet. 2008;83(5):610&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2668030</ArticleId><ArticleId IdType="pubmed">18950739</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler S., Gargano M., Matentzoglu N., et al. The human phenotype ontology in 2021. Nucleic Acids Res. 2021;49(D1):D1207&#x2013;D1217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778952</ArticleId><ArticleId IdType="pubmed">33264411</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss E.A., Makadia R., Matcho A., et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J&#xa0;Am Med Inform Assoc. 2015;22(3):553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson P.N., Webber C. Phenotype ontologies and cross-species analysis for translational research. PLoS Genet. 2014;10(4):e1004268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3974665</ArticleId><ArticleId IdType="pubmed">24699242</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler S., Vasilevsky N.A., Engelstad M., et al. The Human Phenotype Ontology in 2017. Nucleic Acids Res. 2017;45(D1):D865&#x2013;D876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5210535</ArticleId><ArticleId IdType="pubmed">27899602</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson P.N., Mundlos S. The Human Phenotype Ontology. Clin Genet. 2010;77(6):525&#x2013;534.</Citation><ArticleIdList><ArticleId IdType="pubmed">20412080</ArticleId></ArticleIdList></Reference><Reference><Citation>Groza T., K&#xf6;hler S., Moldenhauer D., et al. The human phenotype ontology: semantic unification of common and rare disease. Am J Hum Genet. 2015;97(1):111&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4572507</ArticleId><ArticleId IdType="pubmed">26119816</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler S., Doelken S.C., Mungall C.J., et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Res. 2014;42(Database issue):D966&#x2013;D974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3965098</ArticleId><ArticleId IdType="pubmed">24217912</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X.A., Yates A., Vasilevsky N., et al. Semantic integration of clinical laboratory tests from electronic health records for deep phenotyping and biomarker discovery. NPJ Digit Med. 2019;2:32. doi: 10.1038/s41746-019-0110-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-019-0110-4</ArticleId><ArticleId IdType="pmc">PMC6527418</ArticleId><ArticleId IdType="pubmed">31119199</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan T.J., Stefanski A.L., Wyrwa J.M., et al. Ontologizing health systems data at scale: making translational discovery a reality. arXiv. 2022 doi: 10.48550/arXiv.2209.04732.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2209.04732</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson R., Matentzoglu N., Overton J.A., et al. OBO Foundry in 2021: operationalizing open data principles to evaluate ontologies. Database (Oxford) 2021;2021 doi: 10.1093/database/baab069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/database/baab069</ArticleId><ArticleId IdType="pmc">PMC8546234</ArticleId><ArticleId IdType="pubmed">34697637</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler S., Schulz M.H., Krawitz P., et al. Clinical diagnostics in human genetics with semantic similarity searches in ontologies. Am J Hum Genet. 2009;85(4):457&#x2013;464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2756558</ArticleId><ArticleId IdType="pubmed">19800049</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesquita C., Faria D., Falc&#xe3;o A.O., Lord P., Couto F.M. Semantic similarity in biomedical ontologies. PLoS Comput Biol. 2009;5(7):e1000443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2712090</ArticleId><ArticleId IdType="pubmed">19649320</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur D., Vassilvitskii S. k-means++: the advantages of careful seeding. SODA &#x2019;07 [Internet] 2007. https://www.semanticscholar.org/paper/5e0c61b7ee4a2de183a197f32c5013ad109531fa Available from:</Citation></Reference><Reference><Citation>Steinley D. K-means clustering: a half-century synthesis. Br J Math Stat Psychol. 2006;59(Pt 1):1&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">16709277</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennig C. Dissolution point and isolation robustness: robustness criteria for general cluster analysis methods. J&#xa0;Multivar Anal. 2008;99(6):1154&#x2013;1176.</Citation></Reference><Reference><Citation>Garc&#xed;a-Escudero L.&#xc1;., Gordaliza A. Robustness properties of k means and trimmed k means. J&#xa0;Am Stat Assoc. 1999;94(447):956&#x2013;969.</Citation></Reference><Reference><Citation>Barak S., Mokfi T. Evaluation and selection of clustering methods using a hybrid group MCDM. Expert Syst Appl. 2019;138:112817.</Citation></Reference><Reference><Citation>Dinno A. Nonparametric pairwise multiple comparisons in independent groups using Dunn's test. STATA J. 2015;15(1):292&#x2013;300.</Citation></Reference><Reference><Citation>Piepho H.P. An algorithm for a letter-based representation of all-pairwise comparisons. J&#xa0;Comput Graph Stat. 2004;13(2):456&#x2013;466.</Citation></Reference><Reference><Citation>Crawford K., Xian J., Helbig K.L., et al. Computational analysis of 10,860 phenotypic annotations in individuals with SCN2A-related disorders. Genet Med. 2021;23(7):1263&#x2013;1272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8257493</ArticleId><ArticleId IdType="pubmed">33731876</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson P.N., K&#xf6;hler S., Oellrich A., et al. Improved exome prioritization of disease genes through cross-species phenotype comparison. Genome Res. 2014;24(2):340&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3912424</ArticleId><ArticleId IdType="pubmed">24162188</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson P.N., Ravanmehr V., Jacobsen J.O.B., et al. Interpretable clinical genomics with a likelihood ratio paradigm. Am J Hum Genet. 2020;107(3):403&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7477017</ArticleId><ArticleId IdType="pubmed">32755546</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Robinson P.N., Wang K. Phenolyzer: phenotype-based prioritization of candidate genes for human diseases. Nat Methods. 2015;12(9):841&#x2013;843.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718403</ArticleId><ArticleId IdType="pubmed">26192085</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn O.J. Multiple comparisons among means. J&#xa0;Am Stat Assoc. 1961;56:52&#x2013;64. doi: 10.1080/01621459.1961.10482090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1961.10482090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lex A., Gehlenborg N., Strobelt H., Vuillemot R., Pfister H. UpSet: visualization of intersecting sets. IEEE Trans Vis Comput Graph. 2014;20(12):1983&#x2013;1992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4720993</ArticleId><ArticleId IdType="pubmed">26356912</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021;53(10):737&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Pott-Junior H., Bittencourt N.Q.P., Chacha S.F.G., Luporini R.L., Cominetti M.R., Anibal F.D.F. Elevations in liver transaminases in COVID-19: (how) are they related? Front Med (Lausanne) 2021;8:705247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8319468</ArticleId><ArticleId IdType="pubmed">34336904</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Pastora J., Weigand M., Kim J., et al. Hyperferritinemia in critically ill COVID-19 patients - is ferritin the product of inflammation or a pathogenic mediator? Clin Chim Acta. 2020;509:249&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7306200</ArticleId><ArticleId IdType="pubmed">32579952</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan Q., Gong B., Sun M., et al. A&#xa0;high percentage of patients recovered from COVID-19 but discharged with abnormal Liver function tests. Front Physiol. 2021;12:642922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8015938</ArticleId><ArticleId IdType="pubmed">33815147</ArticleId></ArticleIdList></Reference><Reference><Citation>Martha J.W., Wibowo A., Pranata R. Hypocalcemia is associated with severe COVID-19: a systematic review and meta-analysis. Diabetes Metabol Syndr. 2021;15(1):337&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832827</ArticleId><ArticleId IdType="pubmed">33493853</ArticleId></ArticleIdList></Reference><Reference><Citation>Litvinov R.I., Evtugina N.G., Peshkova A.D., et al. Altered platelet and coagulation function in moderate-to-severe COVID-19. Sci Rep. 2021;11(1):16290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8357814</ArticleId><ArticleId IdType="pubmed">34381066</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. The four most urgent questions about long COVID. Nature. 2021;594(7862):168&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">34108700</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K., Ghanima W., Olsen M.K., Gilboe H.M., Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021;76(4):405&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayaaslan B., Eser F., Kalem A.K., et al. Post-COVID syndrome: a single-center questionnaire study on 1007 participants recovered from COVID-19. J&#xa0;Med Virol. 2021;93(12):6566&#x2013;6574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426910</ArticleId><ArticleId IdType="pubmed">34255355</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T., Tymoszuk P., Sahanic S., et al. Investigating phenotypes of pulmonary COVID-19 recovery: a longitudinal observational prospective multicenter trial. Elife. 2022;11 doi: 10.7554/eLife.72500.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.72500</ArticleId><ArticleId IdType="pmc">PMC8896831</ArticleId><ArticleId IdType="pubmed">35131031</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Florencio L.L., et al. Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-19 survivors. Infection. 2022 doi: 10.1007/s15010-022-01822-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01822-x</ArticleId><ArticleId IdType="pmc">PMC9028890</ArticleId><ArticleId IdType="pubmed">35451721</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N., Gurdasani D., O'Hara M.E., et al. Characteristics and impact of long covid: findings from an online survey. PLoS One. 2022;17(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Gates K.M., Fisher Z.F., Arizmendi C., Henry T.R., Duffy K.A., Mucha P.J. Assessing the robustness of cluster solutions obtained&#xa0;from sparse count matrices. Psychol Methods. 2019;24(6):675&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6689462</ArticleId><ArticleId IdType="pubmed">30742473</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesan S., Galer P.D., Helbig K.L., et al. A&#xa0;longitudinal footprint of genetic epilepsies using automated electronic medical record interpretation. Genet Med. 2020;22(12):2060&#x2013;2070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7708303</ArticleId><ArticleId IdType="pubmed">32773773</ArticleId></ArticleIdList></Reference><Reference><Citation>100,000 Genomes Project Pilot Investigators. Smedley D., Smith K.R., et al. 100,000 genomes pilot on rare-disease diagnosis in health care - preliminary report. N&#xa0;Engl J Med. 2021;385(20):1868&#x2013;1880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7613219</ArticleId><ArticleId IdType="pubmed">34758253</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of&#xa0;post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen J.O.B., Baudis M., Baynam G.S., et al. The GA4GH phenopacket schema defines a computable representation of clinical data. Nat Biotechnol. 2022;40(6):817&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363006</ArticleId><ArticleId IdType="pubmed">35705716</ArticleId></ArticleIdList></Reference><Reference><Citation>Duerlund L.S., Shakar S., Nielsen H., Bodilsen J. Positive predictive value of the ICD-10 diagnosis code for long-COVID. Clin Epidemiol. 2022;14:141&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8843419</ArticleId><ArticleId IdType="pubmed">35177935</ArticleId></ArticleIdList></Reference><Reference><Citation>Barizien N., Le Guen M., Russel S., Touche P., Huang F., Vall&#xe9;e A. Clinical characterization of dysautonomia in long COVID-19 patients. Sci Rep. 2021;11(1):14042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8263555</ArticleId><ArticleId IdType="pubmed">34234251</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel M.A., Chute C.G., Bennett T.D., et al. The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment. J&#xa0;Am Med Inform Assoc. 2021;28(3):427&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36595527</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Exploring the potential of OMOP common data model for process mining in healthcare.</ArticleTitle><Pagination><StartPage>e0279641</StartPage><MedlinePgn>e0279641</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0279641</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0279641</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE">Recently, Electronic Health Records (EHR) are increasingly being converted to Common Data Models (CDMs), a database schema designed to provide standardized vocabularies to facilitate collaborative observational research. To date, however, rare attempts exist to leverage CDM data for healthcare process mining, a technique to derive process-related knowledge (e.g., process model) from event logs. This paper presents a method to extract, construct, and analyze event logs from the Observational Medical Outcomes Partnership (OMOP) CDM for process mining and demonstrates CDM-based healthcare process mining with several real-life study cases while answering frequently posed questions in process mining, in the CDM environment.</AbstractText><AbstractText Label="METHODS">We propose a method to extract, construct, and analyze event logs from the OMOP CDM for process types including inpatient, outpatient, emergency room processes, and patient journey. Using the proposed method, we extract the retrospective data of several surgical procedure cases (i.e., Total Laparoscopic Hysterectomy (TLH), Total Hip Replacement (THR), Coronary Bypass (CB), Transcatheter Aortic Valve Implantation (TAVI), Pancreaticoduodenectomy (PD)) from the CDM of a Korean tertiary hospital. Patient data are extracted for each of the operations and analyzed using several process mining techniques.</AbstractText><AbstractText Label="RESULTS">Using process mining, the clinical pathways, outpatient process models, emergency room process models, and patient journeys are demonstrated using the extracted logs. The result shows CDM's usability as a novel and valuable data source for healthcare process analysis, yet with a few considerations. We found that CDM should be complemented by different internal and external data sources to address the administrative and operational aspects of healthcare processes, particularly for outpatient and ER process analyses.</AbstractText><AbstractText Label="CONCLUSION">To the best of our knowledge, we are the first to exploit CDM for healthcare process mining. Specifically, we provide a step-by-step guidance by demonstrating process analysis from locating relevant CDM tables to visualizing results using process mining tools. The proposed method can be widely applicable across different institutions. This work can contribute to bringing a process mining perspective to the existing CDM users in the changing Hospital Information Systems (HIS) environment and also to facilitating CDM-based studies in the process mining research community.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Park et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Kangah</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2816-2944</Identifier><AffiliationInfo><Affiliation>Department of Industrial and Management Engineering, Pohang University of Science and Technology (POSTECH), Pohang, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Minsu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9442-9232</Identifier><AffiliationInfo><Affiliation>School of Information Convergence, Kwangwoon University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Minseok</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6813-8853</Identifier><AffiliationInfo><Affiliation>Department of Industrial and Management Engineering, Pohang University of Science and Technology (POSTECH), Pohang, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Sooyoung</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8620-4925</Identifier><AffiliationInfo><Affiliation>Healthcare ICT Research Center, Office of eHealth Research and Businesses, Seoul National University Bundang Hospital, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baek</LastName><ForeName>Hyunyoung</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Healthcare ICT Research Center, Office of eHealth Research and Businesses, Seoul National University Bundang Hospital, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seok</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Healthcare ICT Research Center, Office of eHealth Research and Businesses, Seoul National University Bundang Hospital, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kidong</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079803" MajorTopicYN="Y">Data Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006268" MajorTopicYN="Y">Health Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>3</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36595527</ArticleId><ArticleId IdType="pmc">PMC9810199</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0279641</ArticleId><ArticleId IdType="pii">PONE-D-22-14226</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dumas M, VanderAalst WM, Hofstede AH. Process-aware information systems: bridging people and software through process technology. John Wiley &amp; Sons.</Citation></Reference><Reference><Citation>Rebuge &#xc1;, Ferreira DR. Business process analysis in healthcare environments: A methodology based on process mining. Inf Syst. 2012;37(2):99&#x2013;116.</Citation></Reference><Reference><Citation>Kaymak U, Mans R, Van De Steeg T, Dierks M. On process mining in health care. Conf Proc IEEE Int Conf Syst Man Cybern. 2012;1859&#x2013;64.</Citation></Reference><Reference><Citation>Mans RS, van der Aalst WMP, Vanwersch RJB. Process Mining in Healthcare: Evaluating and Exploiting Operational Healthcare Processes. 2015. 79&#x2013;88 p.</Citation></Reference><Reference><Citation>Rojas E, Munoz-Gama J, Sep&#xfa;lveda M, Capurro D. Process mining in healthcare: A literature review. J Biomed Inform. 2016;61:224&#x2013;36. doi: 10.1016/j.jbi.2016.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.04.007</ArticleId><ArticleId IdType="pubmed">27109932</ArticleId></ArticleIdList></Reference><Reference><Citation>Glicksberg BS, Oskotsky B, Thangaraj PM, Giangreco N, Badgeley MA, Johnson KW, et al.. PatientExploreR: An extensible application for dynamic visualization of patient clinical history from electronic health records in the OMOP common data model. Bioinformatics. 2019;35(21):4515&#x2013;8. doi: 10.1093/bioinformatics/btz409</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btz409</ArticleId><ArticleId IdType="pmc">PMC6821222</ArticleId><ArticleId IdType="pubmed">31214700</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang L, Miao S, Xu H, Yin Y, Zhu Y, et al.. Analysis of treatment pathways for three chronic diseases using OMOP CDM. J Med Syst. 2018;42(12). doi: 10.1007/s10916-018-1076-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-018-1076-5</ArticleId><ArticleId IdType="pmc">PMC6244882</ArticleId><ArticleId IdType="pubmed">30421323</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinecke I, Zoch M, Reich C, Sedlmayr M, Bathelt F. The usage of OHDSI OMOP a scoping review. In: Studies in Health Technology and Informatics. IOS Press BV; 2021. p. 95&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">34545824</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. 2020_data_network [Internet]. Observational Healthcare Data Sciences and informatics (OHDSI). 2021 [cited 2022 Nov 10]. https://www.ohdsi.org/web/wiki/doku.php?id=resources:2020_data_network</Citation></Reference><Reference><Citation>Quiroz JC, Chard T, Sa Z, Ritchie A, Jorm L, Gallego B. Extract, Transform, Load Framework for the Conversion of Health Databases to OMOP. medRxiv. 2021;1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9000122</ArticleId><ArticleId IdType="pubmed">35404974</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoch M, Gierschner C, Peng Y, Gruhl M, Leutner LA, Sedlmayr M, et al.. Adaption of the OMOP CDM for Rare Diseases. Stud Health Technol Inform. 2021;281:138&#x2013;42. doi: 10.3233/SHTI210136</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI210136</ArticleId><ArticleId IdType="pubmed">34042721</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn EK, Park MY, Cho SY, Ryan P, Schuemie MJ, et al. Conversion and data quality assessment of electronic health record data at a korean tertiary teaching hospital to a common data model for distributed network research. Vol. 22, Healthcare Informatics Research. 2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, Lee S, Cho SY, Park H, Jung S, Cho J, et al.. Conversion of National Health Insurance Service-National Sample Cohort (NHIS-NSC) Database into Observational Medical Outcomes Partnership-Common Data Model (OMOP-CDM). Stud Health Technol Inform. 2017;245:467&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">29295138</ArticleId></ArticleIdList></Reference><Reference><Citation>Haberson A, Rinner C, Sch&#xf6;berl A, Gall W. Feasibility of Mapping Austrian Health Claims Data to the OMOP Common Data Model. J Med Syst. 2019;43(10).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6732152</ArticleId><ArticleId IdType="pubmed">31494719</ArticleId></ArticleIdList></Reference><Reference><Citation>Byun JH, Lee DY, Jeong CW, Kim Y, Rhee HY, Moon KW, et al.. Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer&#x2019;s dementia using OMOP CDM. Sci Rep. 2022. Dec 1;12(1). doi: 10.1038/s41598-022-08595-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-08595-1</ArticleId><ArticleId IdType="pmc">PMC8924152</ArticleId><ArticleId IdType="pubmed">35292697</ArticleId></ArticleIdList></Reference><Reference><Citation>Boudis F, Clement G, Bruandet A, Lamer A. Automated generation of individual and population clinical pathways with the OMOP common data model. In: Public Health and Informatics: Proceedings of MIE 2021. IOS Press; 2021. p. 218&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">34042737</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Laurent G, Pelayo S, el Amrani M, Chazard E, Marcilly R. Exploring patient path through Sankey diagram: A proof of concept. In: Studies in Health Technology and Informatics. IOS Press; 2020. p. 218&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">32570378</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho M. A Data Analysis Methodology for Process Diagnosis and Redesign in Healthcare [Doctoral Dissertation]. [Ulsan]: UNIST; 2018.</Citation></Reference><Reference><Citation>Choi M. Development of Clinical Pathway Analysis Program based on OMOP CDM (Observational Medical Outcomes Partnership Common Data Model) [Master&#x2019;s Thesis]. [Pohang]: POSTECH; 2019.</Citation></Reference><Reference><Citation>Bompelli A, Li J, Xu Y, Wang N, Wang Y, Adam T, et al. Deep Learning Approach to Parse Eligibility Criteria in Dietary Supplements Clinical Trials Following OMOP Common Data Model. In: AMIA Annual Symposium proceedings. 2020. p. 243&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075443</ArticleId><ArticleId IdType="pubmed">33936396</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Gama J, Martin N, Fernandez-Llatas C, Johnson OA, Sep&#xfa;lveda M, Helm E, et al.. Process mining for healthcare: Characteristics and challenges. J Biomed Inform [Internet]. 2022;127(September 2021):103994. Available from: 10.1016/j.jbi.2022.103994</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2022.103994</ArticleId><ArticleId IdType="pubmed">35104641</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon S, Seo J, Kim S, Lee J, Kim JH, Sohn JW, et al.. Proposal and assessment of a de-identification strategy to enhance anonymity of the observational medical outcomes partnership common data model (OMOP-CDM) in a public cloud-computing environment: Anonymization of medical data using privacy models. J Med Internet Res. 2020;22(11).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7728527</ArticleId><ArticleId IdType="pubmed">33177037</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima DM, Rodrigues-Jr JF, Traina AJM, Pires FA, Gutierrez MA. Transforming two decades of EPR data to OMOP CDM for clinical research. Stud Health Technol Inform. 2019;264(August):233&#x2013;7. doi: 10.3233/SHTI190218</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI190218</ArticleId><ArticleId IdType="pubmed">31437920</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheny ME, Ricket I, Goodrich CA, Shah RU, Stabler ME, Perkins AM, et al.. Development of Electronic Health Record-Based Prediction Models for 30-Day Readmission Risk among Patients Hospitalized for Acute Myocardial Infarction. JAMA Netw Open. 2021;4(1):1&#x2013;12. doi: 10.1001/jamanetworkopen.2020.35782</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.35782</ArticleId><ArticleId IdType="pmc">PMC7846941</ArticleId><ArticleId IdType="pubmed">33512518</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. Journal of the American Medical Informatics Association. 2018;25(8):969&#x2013;75. doi: 10.1093/jamia/ocy032</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Aalst W. Process mining: Data science in action. Process Mining: Data Science in Action. 2016. 1&#x2013;467 p.</Citation></Reference><Reference><Citation>Claus PL, Carpenter PC, Chute CG, Mohr DN, Gibbons PS. Clinical Care Management and Workflow by Episodes.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2233562</ArticleId><ArticleId IdType="pubmed">9357595</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider Abu Yazid M, Haikal Satria M, Soperi Mohd Zahid M, Shukor Talib M, Haron H, Abd Ghazi A. Clinical pathway variance prediction using artificial neural network for acute decompensated heart failure clinical pathway. / Malaysian Journal of Fundamental and Applied Sciences. 2018;14(1):116&#x2013;24.</Citation></Reference><Reference><Citation>Du G, Jiang Z, Diao X, Yao Y. Knowledge extraction algorithm for variances handling of CP using integrated hybrid genetic double multi-group cooperative PSO and DPSO. J Med Syst. 2012;36(2):979&#x2013;94. doi: 10.1007/s10916-010-9562-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-010-9562-4</ArticleId><ArticleId IdType="pubmed">20703636</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek H, Cho M, Kim S, Hwang H, Song M, Yoo S. Analysis of length of hospital stay using electronic health records: A statistical and data mining approach. PLoS One. 2018;13(4):1&#x2013;16. doi: 10.1371/journal.pone.0195901</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0195901</ArticleId><ArticleId IdType="pmc">PMC5898738</ArticleId><ArticleId IdType="pubmed">29652932</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Dong W, Ji L, Gan C, Lu X, Duan H. Discovery of clinical pathway patterns from event logs using probabilistic topic models. J Biomed Inform. 2014;47:39&#x2013;57. doi: 10.1016/j.jbi.2013.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2013.09.003</ArticleId><ArticleId IdType="pubmed">24076435</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HQ, Li JS, Zhang YF, Suzuki M, Araki K. Creating personalised clinical pathways by semantic interoperability with electronic health records. Artif Intell Med. 2013;58(2):81&#x2013;9. doi: 10.1016/j.artmed.2013.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2013.02.005</ArticleId><ArticleId IdType="pubmed">23466439</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang WS, Hwang SY. A process-mining framework for the detection of healthcare fraud and abuse. Expert Syst Appl. 2006;31(1):56&#x2013;68.</Citation></Reference><Reference><Citation>Huang Z, Lu X, Duan H. On mining clinical pathway patterns from medical behaviors. Artif Intell Med. 2012;56(1):35&#x2013;50. doi: 10.1016/j.artmed.2012.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2012.06.002</ArticleId><ArticleId IdType="pubmed">22809825</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouarfa L, Dankelman J. Workflow mining and outlier detection from clinical activity logs. J Biomed Inform. 2012;45(6):1185&#x2013;90. doi: 10.1016/j.jbi.2012.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2012.08.003</ArticleId><ArticleId IdType="pubmed">22925724</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E, Kim S, Song M, Kim S, Yoo D, Hwang H, et al.. Discovery of outpatient care process of a tertiary university hospital using process mining. Healthc Inform Res. 2013;19(1):42&#x2013;9. doi: 10.4258/hir.2013.19.1.42</Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2013.19.1.42</ArticleId><ArticleId IdType="pmc">PMC3633171</ArticleId><ArticleId IdType="pubmed">23626917</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano S. Temporal Data Mining on the Stay Time of Outpatients and Treatment Processes. In: IEEE International Conference on Data Mining Workshops, ICDMW. IEEE; 2016. p. 527&#x2013;30.</Citation></Reference><Reference><Citation>Cho M, Song M, Yoo S. A Systematic Methodology for Outpatient Process Analysis Based on Process Mining. In: Ouyang C, Jung JY, editors. Asia Pacific Business Process Management. Cham: Springer International Publishing; 2014. p. 31&#x2013;42.</Citation></Reference><Reference><Citation>Zhou Z, Wang Y, Li L. Process mining based modeling and analysis of workflows in clinical care&#x2014;A case study in a chicago outpatient clinic. Proceedings of the 11th IEEE International Conference on Networking, Sensing and Control, ICNSC 2014. 2014;590&#x2013;5.</Citation></Reference><Reference><Citation>Ganesha K, Dhanush S, Swapnil Raj SM. An Approach to Fuzzy Process Mining to Reduce Patient Waiting Time in a Hospital. In: International Conference on Innovations in information Embedded and Communication Systems. IEEE; 2017.</Citation></Reference><Reference><Citation>Thurston SUE, Member C. Effect of Clinical Pathway Implementation on Outpatient Wait Time in Urgent Outpatient Referral. 2017;(December):1&#x2013;51.</Citation></Reference><Reference><Citation>Yoo S, Cho M, Kim E, Kim S, Sim Y, Yoo D, et al.. Assessment of hospital processes using a process mining technique: Outpatient process analysis at a tertiary hospital. Int J Med Inform [Internet]. 2016;88:34&#x2013;43. Available from: 10.1016/j.ijmedinf.2015.12.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2015.12.018</ArticleId><ArticleId IdType="pubmed">26878760</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Klundert J, Gorissen P, Zeemering S. Measuring clinical pathway adherence. J Biomed Inform. 2010;43(6):861&#x2013;72. doi: 10.1016/j.jbi.2010.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2010.08.002</ArticleId><ArticleId IdType="pubmed">20696277</ArticleId></ArticleIdList></Reference><Reference><Citation>Durojaiye AB, Levin S, Toerper M, Kharrazi H, Lehmann HP, Gurses AP. Evaluation of multidisciplinary collaboration in pediatric trauma care using EHR data. Journal of the American Medical Informatics Association. 2019;26(6):506&#x2013;15. doi: 10.1093/jamia/ocy184</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy184</ArticleId><ArticleId IdType="pmc">PMC6515526</ArticleId><ArticleId IdType="pubmed">30889243</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez C, Rojas E, Arias M, Munoz-Gama J, Sep&#xfa;lveda M, Herskovic V, et al.. Discovering role interaction models in the Emergency Room using Process Mining. J Biomed Inform. 2018;78(June 2017):60&#x2013;77. doi: 10.1016/j.jbi.2017.12.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2017.12.015</ArticleId><ArticleId IdType="pubmed">29289628</ArticleId></ArticleIdList></Reference><Reference><Citation>Rismanchian F, Lee YH. Process Mining&#x2013;Based Method of Designing and Optimizing the Layouts of Emergency Departments in Hospitals. Health Environments Research and Design Journal. 2017;10(4):105&#x2013;20. doi: 10.1177/1937586716674471</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1937586716674471</ArticleId><ArticleId IdType="pubmed">28643568</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho M, Song M, Park J, Yeom SR, Wang IJ, Choi BK. Process mining-supported emergency room process performance indicators. Int J Environ Res Public Health. 2020;17(17):1&#x2013;20. doi: 10.3390/ijerph17176290</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17176290</ArticleId><ArticleId IdType="pmc">PMC7503251</ArticleId><ArticleId IdType="pubmed">32872350</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Padman R, Patel N. Paving the COWpath: Learning and visualizing clinical pathways from electronic health record data. J Biomed Inform. 2015;58:186&#x2013;97. doi: 10.1016/j.jbi.2015.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2015.09.009</ArticleId><ArticleId IdType="pubmed">26419864</ArticleId></ArticleIdList></Reference><Reference><Citation>Perer A, Wang F, Hu J. Mining and exploring care pathways from electronic medical records with visual analytics. J Biomed Inform. 2015;56:369&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">26146159</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. The Book of OHDSI [Internet]. 2019. p. 1&#x2013;470. https://ohdsi.github.io/TheBookOfOhdsi/TheBookOfOhdsi.pdf</Citation></Reference><Reference><Citation>Kim J et al. Development of a common data model for adverse drug reactions using hospital EMR. 2017.</Citation></Reference><Reference><Citation>Mans RS, Van Der Aalst WMP, Vanwersch RJB, Moleman AJ. Process mining in healthcare: Data challenges when answering frequently posed questions. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 2013;7738 LNAI(January 2020):140&#x2013;53.</Citation></Reference><Reference><Citation>Cho M, Kim K, Lim J, Baek H, Kim S, Hwang H, et al.. Developing data-driven clinical pathways using electronic health records: The cases of total laparoscopic hysterectomy and rotator cuff tears. Int J Med Inform. 2020;133(October 2019):104015. doi: 10.1016/j.ijmedinf.2019.104015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2019.104015</ArticleId><ArticleId IdType="pubmed">31683142</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36632328</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2574-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>JAMIA open</Title><ISOAbbreviation>JAMIA Open</ISOAbbreviation></Journal><ArticleTitle>Integrating real-world data to assess cardiac ablation device outcomes in a multicenter study using the OMOP common data model for regulatory decisions: implementation and evaluation.</ArticleTitle><Pagination><StartPage>ooac108</StartPage><MedlinePgn>ooac108</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ooac108</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamiaopen/ooac108</ELocationID><Abstract><AbstractText>The objective of this study is to describe application of the Observational Medical Outcomes Partnership (OMOP) common data model (CDM) to support medical device real-world evaluation in a National Evaluation System for health Technology Coordinating Center (NESTcc) Test-Case involving 2 healthcare systems, Mercy Health and Mayo Clinic. CDM implementation was coordinated across 2 healthcare systems with multiple hospitals to aggregate both medical device data from supply chain databases and patient outcomes and covariates from electronic health record data. Several data quality assurance (QA) analyses were implemented on the OMOP CDM to validate the data extraction, transformation, and load (ETL) process. OMOP CDM-based data of relevant patient encounters were successfully established to support studies for FDA regulatory submissions. QA analyses verified that the data transformation was robust between data sources and OMOP CDM. Our efforts provided useful insights in real-world data integration using OMOP CDM for medical device evaluation coordinated across multiple healthcare systems.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Guoqian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandt</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Mercy Research, Mercy, Chesterfield, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forsyth</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Mercy Research, Mercy, Chesterfield, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhruva</LastName><ForeName>Sanket S</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0003-0674-2032</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of California San Francisco, and Section of Cardiology, Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shumin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MedTech Epidemiology and Real-World Data Sciences, Office of the Chief Medical Officer, Johnson &amp; Johnson, New Brunswick, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jiajing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mercy Research, Mercy, Chesterfield, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noseworthy</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doshi</LastName><ForeName>Amit A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Mercy Clinic, Mercy, St. Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collison-Farr</LastName><ForeName>Kimberly</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Mercy Research, Mercy, Chesterfield, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Dure</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Evaluation System for Health Technology Coordinating Center (NESTcc), Medical Device Innovation Consortium, Arlington, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Joseph S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Yale School of Medicine, and the Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coplan</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>MedTech Epidemiology and Real-World Data Sciences, Office of the Chief Medical Officer, Johnson &amp; Johnson, New Brunswick, New Jersey, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drozda</LastName><ForeName>Joseph P</ForeName><Initials>JP</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Mercy Research, Mercy, Chesterfield, Missouri, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMIA Open</MedlineTA><NlmUniqueID>101730643</NlmUniqueID><ISSNLinking>2574-2531</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">UDI</Keyword><Keyword MajorTopicYN="N">medical data standardization</Keyword><Keyword MajorTopicYN="N">medical device</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>12</Day><Hour>1</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36632328</ArticleId><ArticleId IdType="pmc">PMC9831049</ArticleId><ArticleId IdType="doi">10.1093/jamiaopen/ooac108</ArticleId><ArticleId IdType="pii">ooac108</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Krucoff MW, Sedrakyan A, Normand SL.. Bridging nnmet medical device ecosystem needs with strategically coordinated registries networks. JAMA 2015; 314 (16): 1691&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">26302152</ArticleId></ArticleIdList></Reference><Reference><Citation>
Center for Devices and Radiological Health, US Food and Drug Administration. Strengthening our national system for medical device postmarket surveillance. 2013. http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHReports/UCM301924.pdf. Accessed July 29, 2022.</Citation></Reference><Reference><Citation>
US Food and Drug Administration. 2018-2020 Strategic Priorities. Center for Devices and Radiological Health. 2018. https://www.fda.gov/media/110478/download. Accessed July 29, 2022.</Citation></Reference><Reference><Citation>Drozda JP Jr, Roach J, Forsyth T, et al.Constructing the informatics and information technology foundations of a medical device evaluation system: a report from the FDA unique device identifier demonstration. J Am Med Inform Assoc 2018; 25 (2): 111&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7647129</ArticleId><ArticleId IdType="pubmed">28472359</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhalluin T, Fakhiri S, Bouzill&#xe9; G, et al.Role of real-world digital data for orthopedic implant automated surveillance: a systematic review. Expert Rev Med Devices 2021; 18 (8): 799&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">34148465</ArticleId></ArticleIdList></Reference><Reference><Citation>Tcheng JE, Crowley J, Tomes M, et al.MDEpiNet UDI Demonstration Expert Workgroup. Unique device identifiers for coronary stent postmarket surveillance and research: a report from the Food and Drug Administration Medical Device Epidemiology Network Unique Device Identifier demonstration. Am Heart J 2014; 168 (4): 405&#x2013;413.e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">25262248</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA Sentinel Common Data Model. 2021. https://www.sentinelinitiative.org/methods-data-tools/sentinel-common-data-model. Accessed July 29, 2022.</Citation></Reference><Reference><Citation>OMOP Common Data Model. 2021. https://ohdsi.github.io/CommonDataModel/. Accessed July 29, 2022.</Citation></Reference><Reference><Citation>PCORnet Common Data Model Specification. 2021. https://pcornet.org/wp-content/uploads/2020/12/PCORnet-Common-Data-Model-v60-2020_10_221.pdf. Accessed July 29, 2022.</Citation></Reference><Reference><Citation>I2B2 Common Data Model Documentation. 2021. https://community.i2b2.org/wiki/display/BUN/i2b2&#xb1;Common&#xb1;Data&#xb1;Model&#xb1;Documentation. Accessed July 29, 2022.</Citation></Reference><Reference><Citation>Visweswaran S, Becich MJ, D'Itri VS, et al.Accrual to clinical trials (ACT): A Clinical and Translational Science Award Consortium Network. JAMIA Open 2018; 1 (2): 147&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6241502</ArticleId><ArticleId IdType="pubmed">30474072</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Yu Y, Kingsbury PR, Shah N.. Augmenting medical device evaluation using a reusable unique device identifier interoperability solution based on the OHDSI Common Data Model. Stud Health Technol Inform 2019; 264: 1502&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">31438202</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S, Choi SJ, Kim JK, et al.Preliminary feasibility assessment of CDM-based active surveillance using current status of medical device data in medical records and OMOP-CDM. Sci Rep 2021; 11 (1): 24070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8674329</ArticleId><ArticleId IdType="pubmed">34911976</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Dhruva SS, Chen J, et al.Feasibility of capturing real-world data from health information technology systems at multiple centers to assess cardiac ablation device outcomes: a fit-for-purpose informatics analysis report. J Am Med Inform Assoc 2021; 28 (10): 2241&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8449615</ArticleId><ArticleId IdType="pubmed">34313748</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhruva SS, Jiang G, Doshi AA, et al.Feasibility of using real-world data in the evaluation of cardiac ablation catheters: a test-case of the National Evaluation System for Health Technology Coordinating Center. BMJ Surg Interv Health Technol 2021; 3 (1): e000089.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8749235</ArticleId><ArticleId IdType="pubmed">35047806</ArticleId></ArticleIdList></Reference><Reference><Citation>ATLAS. 2021. https://atlas.ohdsi.org/. Accessed July 29, 2022.</Citation></Reference><Reference><Citation>
https://accessgudid.nlm.nih.gov/resources/developers/device_snomed_api. Accessed July 29, 2022.</Citation></Reference><Reference><Citation>GUDID Device Lookup API. https://nestcc.org/portfolio-item/the-feasibility-of-using-real-world-data-in-the-evaluation-of-cardiac-ablation-catheters/. Accessed July 29, 2022.</Citation></Reference><Reference><Citation>Dhruva SS, Zhang S, Chen J,. et al. Safety and effectiveness of a catheter with contact force and 6-hole irrigation for ablation of persistent atrial fibrillation in routine clinical practice. JAMA Netw Open2022; 5 (8): e2227134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9386540</ArticleId><ArticleId IdType="pubmed">35976649</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated"><PMID Version="2">36692805</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1179-1950</ISSN><JournalIssue CitedMedium="Internet"><Volume>83</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Drugs</Title><ISOAbbreviation>Drugs</ISOAbbreviation></Journal><ArticleTitle>Risk of COVID-19 Diagnosis and Hospitalisation in Patients with Osteoarthritis or Back Pain Treated with Ibuprofen Compared to Other NSAIDs or Paracetamol: A Network Cohort Study.</ArticleTitle><Pagination><StartPage>249</StartPage><EndPage>263</EndPage><MedlinePgn>249-263</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40265-022-01822-z</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to investigate whether ibuprofen use, compared with other non-selective non-steroidal anti-inflammatory drugs (ns-NSAIDs), cyclooxygenase-2 inhibitors (COX-2i) or paracetamol, increases the risk of coronavirus disease 2019 (COVID-19) diagnosis or hospitalisation.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A prevalent user and active comparator cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Two US claims databases (Open Claims and PharMetrics Plus) mapped to the Observational Medical Outcomes Partnership Common Data Model.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Insured patients with a history of osteoarthritis or back pain and receiving ibuprofen, other ns-NSAIDs, COX-2i or paracetamol between 1 November, 2019 and 31 January, 2020 (study enrolment window 1) or between 1 February, 2020 and 31 October, 2020 (study enrolment window 2).</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Large-scale propensity score matching and empirical calibration were used to minimise confounding. Incidence and hazard ratios of COVID-19 diagnosis and hospitalisation according to drug/s use were estimated and pooled in the same study period across data sources using a fixed-effects meta-analysis. Index treatment episode was the primary risk evaluation window, censored at the time of discontinuation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 633,562 and 1,063,960 participants were included in periods 1 and 2, respectively, for the ibuprofen versus ns-NSAIDs comparison, 311,669 and 524,470 for ibuprofen versus COX-2i, and 492,002 and 878,598 for ibuprofen versus paracetamol. Meta-analyses of empirically calibrated hazard ratios revealed no significantly differential risk of COVID-19 outcomes in users of ibuprofen versus any of the other studied analgesic classes: hazard ratios were 1.13 (0.96-1.33) for the ibuprofen-ns-NSAIDs comparison, 1.03 (0.83-1.28) for the ibuprofen-COX-2i comparison and 1.13 (0.74-1.73) for ibuprofen-paracetamol comparison on COVID-19 diagnosis in the February 2020-October 2020 window. Similar hazard ratios were found on COVID-19 hospitalisation and across both study periods.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In patients with osteoarthritis or back pain, we found no differential risks of incident COVID-19 diagnosis or COVID-19 hospitalisation for ibuprofen users compared with other ns-NSAIDs, COX-2i or paracetamol. Our findings support regulatory recommendations that NSAIDs, including ibuprofen, should be prescribed as indicated in the same way as before the COVID-19 pandemic, especially for those who rely on ibuprofen or NSAIDs to manage chronic arthritis or musculoskeletal pain symptoms.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Junqing</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0040-0042</Identifier><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine-Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Windmill Road, OX37LD, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brash</LastName><ForeName>James T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>IQVIA, Real World Solutions, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turkmen</LastName><ForeName>Cigdem</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Established Pharmaceuticals Division, Global Medical Affairs, Abbott Products Operations AG, Allschwil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Driessen</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Established Pharmaceuticals Division, Global Biometrics, Abbott Healthcare Products B.V, Weesp, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varrassi</LastName><ForeName>Giustino</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Research, Paolo Procacci Foundation, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argyriou</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IQVIA, Real World Solutions, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seager</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IQVIA, Real World Solutions, Brighton, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IQVIA, Real World Solutions, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3950-6346</Identifier><AffiliationInfo><Affiliation>Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine-Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Windmill Road, OX37LD, Oxford, UK. daniel.prietoalhambra@ndorms.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics, Erasmus Medical Center University, Rotterdam, The Netherlands. daniel.prietoalhambra@ndorms.ox.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drugs</MedlineTA><NlmUniqueID>7600076</NlmUniqueID><ISSNLinking>0012-6667</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>WK2XYI10QM</RegistryNumber><NameOfSubstance UI="D007052">Ibuprofen</NameOfSubstance></Chemical><Chemical><RegistryNumber>362O9ITL9D</RegistryNumber><NameOfSubstance UI="D000082">Acetaminophen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052246">Cyclooxygenase 2 Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007052" MajorTopicYN="N">Ibuprofen</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000082" MajorTopicYN="N">Acetaminophen</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010003" MajorTopicYN="Y">Osteoarthritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052246" MajorTopicYN="N">Cyclooxygenase 2 Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001416" MajorTopicYN="N">Back Pain</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>All authors have completed the ICMJE disclosure form at http://www.icmje.org/disclosure-of-interest/ and declare the following interests: Dani Prieto-Alhambra receives funding from the UK National Institute for Health Research in the form of a senior research fellowship and from the Oxford National Institute for Health Research Biomedical Research Centre. Junqing Xie receives the Clarendon Fund and Jardine scholarship (University of Oxford) to support her DPhil study. Dani Prieto-Alhambra&#x2019;s research group has received research grants from the European Medicines Agency, the Innovative Medicines Initiative, Amgen, Chiesi and UCB Biopharma; and consultancy or speaker fees from Astellas, Amgen, AstraZeneca and UCB Biopharma.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>24</Day><Hour>11</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36692805</ArticleId><ArticleId IdType="pmc">PMC9872078</ArticleId><ArticleId IdType="doi">10.1007/s40265-022-01822-z</ArticleId><ArticleId IdType="pii">10.1007/s40265-022-01822-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ. 2020;368:m1086. doi: 10.1136/bmj.m1086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1086</ArticleId><ArticleId IdType="pubmed">32184201</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. Covid-19: ibuprofen can be used for symptoms, says UK agency, but reasons for change in advice are unclear. BMJ. 2020;369:m1555. doi: 10.1136/bmj.m1555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1555</ArticleId><ArticleId IdType="pubmed">32303505</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy S. Coronavirus: alerte sur l&#x2019;ibuprof&#xe8;ne et autres anti-inflammatoires. Le Figaro. Updated March 14, 2020. 2022. https://www.lefigaro.fr/sciences/coronavirus-alerte-sur-l-ibuprofene-et-autres-anti-inflammatoires-20200314. Accessed 28 Feb 2022.</Citation></Reference><Reference><Citation>Fernandez-Gutierrez B, Leon L, Madrid A, et al. Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents. Ther Adv Musculoskelet Dis. 2021. doi: 10.1177/1759720X20962692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869066</ArticleId><ArticleId IdType="pubmed">33613703</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30116-8</ArticleId><ArticleId IdType="pmc">PMC7118626</ArticleId><ArticleId IdType="pubmed">32171062</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271&#x2013;80.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Au K, Reed G, Curtis JR, et al. High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70(5):785&#x2013;791. doi: 10.1136/ard.2010.128637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2010.128637</ArticleId><ArticleId IdType="pubmed">21288960</ArticleId></ArticleIdList></Reference><Reference><Citation>European Medicines Agency. EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19. 2020. https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19. Accessed 5 Jul 2020 .</Citation></Reference><Reference><Citation>Monti S, Montecucco C. Non-steroidal anti-inflammatory treatment during COVID-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo et al. Ann Rheum Dis. 2021;80(2):e13.10.1136/annrheumdis-2020-217638</Citation><ArticleIdList><ArticleId IdType="pubmed">32354774</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. Key messages. COVID-19 rapid evidence summary: acute use of non-steroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19. 2020. https://www.nice.org.uk/advice/es23/chapter/Key-messages. Accessed 5 July 2020.</Citation></Reference><Reference><Citation>Chandan JS, Zemedikun DT, Thayakaran R, et al. Nonsteroidal antiinflammatory drugs and susceptibility to COVID-19. Arthritis Rheumatol. 2021;73(5):731&#x2013;739. doi: 10.1002/art.41593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41593</ArticleId><ArticleId IdType="pmc">PMC8252419</ArticleId><ArticleId IdType="pubmed">33185016</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AY, MacKenna B, Morton CE, et al. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts. Ann Rheum Dis. 2021;80(7):943&#x2013;951. doi: 10.1136/annrheumdis-2020-219517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219517</ArticleId><ArticleId IdType="pmc">PMC7823433</ArticleId><ArticleId IdType="pubmed">33478953</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. OMOP Common Data Model. 2021. https://www.ohdsi.org/data-standardization/the-common-data-model/. Accessed 7 Oct 2021.</Citation></Reference><Reference><Citation>Prieto-Alhambra D, Kostka K, Duarte-Salles T, et al. Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS. Clin Epidemiol. 2022;14:369&#x2013;84. doi: 10.2147/CLEP.S323292.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S323292</ArticleId><ArticleId IdType="pmc">PMC8957305</ArticleId><ArticleId IdType="pubmed">35345821</ArticleId></ArticleIdList></Reference><Reference><Citation>Prats-Uribe A, Sena AG, Lai LYH, et al. Use of repurposed and adjuvant drugs in hospital patients with COVID-19: multinational network cohort study. BMJ. 2021;373:n1038. doi: 10.1136/bmj.n1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1038</ArticleId><ArticleId IdType="pmc">PMC8111167</ArticleId><ArticleId IdType="pubmed">33975825</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodward M. Formulae for sample size, power and minimum detectable relative risk in medical studies. J R Stat Soc D. 1992;41(2):185. doi: 10.2307/2348252.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2348252</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Schuemie MJ, Suchard MA. Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int J Epidemiol. 2018;47(6):2005&#x2013;2014. doi: 10.1093/ije/dyy120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy120</ArticleId><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Robust empirical calibration of p-values using observational data. Stat Med. 2016;35(22):3883&#x2013;3888. doi: 10.1002/sim.6977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.6977</ArticleId><ArticleId IdType="pmc">PMC5108459</ArticleId><ArticleId IdType="pubmed">27592566</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. Proc Natl Acad Sci USA. 2018;115(11):2571&#x2013;2577. doi: 10.1073/pnas.1708282114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708282114</ArticleId><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen ML, Porter KE, Gruber S, Wang Y, van der Laan MJ. Diagnosing and responding to violations in the positivity assumption. Stat Methods Med Res. 2012;21(1):31&#x2013;54. doi: 10.1177/0962280210386207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280210386207</ArticleId><ArticleId IdType="pmc">PMC4107929</ArticleId><ArticleId IdType="pubmed">21030422</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92&#x2013;101. doi: 10.1038/nature13479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13479</ArticleId><ArticleId IdType="pmc">PMC4263681</ArticleId><ArticleId IdType="pubmed">24899309</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol. 2001;2(7):612&#x2013;619. doi: 10.1038/89759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/89759</ArticleId><ArticleId IdType="pubmed">11429545</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao W, Wang C, Chen B, et al. Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats. Cardiology. 2015;131(2):97&#x2013;106. doi: 10.1159/000375362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000375362</ArticleId><ArticleId IdType="pubmed">25896805</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu Esba LC, Alqahtani RA, Thomas A, Shamas N, Alswaidan L, Mardawi G. Ibuprofen and NSAID use in COVID-19 infected patients is not associated with worse outcomes: a prospective cohort study. Infect Dis Ther. 2021;10(1):253&#x2013;268. doi: 10.1007/s40121-020-00363-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-020-00363-w</ArticleId><ArticleId IdType="pmc">PMC7604230</ArticleId><ArticleId IdType="pubmed">33135113</ArticleId></ArticleIdList></Reference><Reference><Citation>Drake TM, Fairfield CJ, Pius R, et al. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. Lancet Rheumatol. 2021 doi: 10.1016/S2665-9913(21)00104-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00104-1</ArticleId><ArticleId IdType="pmc">PMC8104907</ArticleId><ArticleId IdType="pubmed">33997800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow CS, Hasan SS. The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis. Inflammopharmacology. 2021;29(3):641&#x2013;644. doi: 10.1007/s10787-021-00810-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00810-1</ArticleId><ArticleId IdType="pmc">PMC8059110</ArticleId><ArticleId IdType="pubmed">33881684</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Lee S-H, You SC, Kim J, Yang K. Non-steroidal anti-inflammatory agent use may not be associated with mortality of coronavirus disease 19. Sci Rep. 2021;11(1):5087. doi: 10.1038/s41598-021-84539-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84539-5</ArticleId><ArticleId IdType="pmc">PMC7930278</ArticleId><ArticleId IdType="pubmed">33658615</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore N, Pollack C, Butkerait P. Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther Clin Risk Manag. 2015;11:1061&#x2013;1075. doi: 10.2147/TCRM.S79135.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TCRM.S79135</ArticleId><ArticleId IdType="pmc">PMC4508078</ArticleId><ArticleId IdType="pubmed">26203254</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36696159</PMID><DateRevised><Year>2023</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2023</Year><Month>Jan</Month><Day>25</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>Assessment and Improvement of Drug Data Structuredness From Electronic Health Records: Algorithm Development and Validation.</ArticleTitle><Pagination><StartPage>e40312</StartPage><MedlinePgn>e40312</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e40312</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/40312</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Digitization offers a multitude of opportunities to gain insights into current diagnostics and therapies from retrospective data. In this context, real-world data and their accessibility are of increasing importance to support unbiased and reliable research on big data. However, routinely collected data are not readily usable for research owing to the unstructured nature of health care systems and a lack of interoperability between these systems. This challenge is evident in drug data.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to present an approach that identifies and increases the structuredness of drug data while ensuring standardization according to Anatomical Therapeutic Chemical (ATC) classification.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Our approach was based on available drug prescriptions and a drug catalog and consisted of 4 steps. First, we performed an initial analysis of the structuredness of local drug data to define a point of comparison for the effectiveness of the overall approach. Second, we applied 3 algorithms to unstructured data that translated text into ATC codes based on string comparisons in terms of ingredients and product names and performed similarity comparisons based on Levenshtein distance. Third, we validated the results of the 3 algorithms with expert knowledge based on the 1000 most frequently used prescription texts. Fourth, we performed a final validation to determine the increased degree of structuredness.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Initially, 47.73% (n=843,980) of 1,768,153 drug prescriptions were classified as structured. With the application of the 3 algorithms, we were able to increase the degree of structuredness to 85.18% (n=1,506,059) based on the 1000 most frequent medication prescriptions. In this regard, the combination of algorithms 1, 2, and 3 resulted in a correctness level of 100% (with 57,264 ATC codes identified), algorithms 1 and 3 resulted in 99.6% (with 152,404 codes identified), and algorithms 1 and 2 resulted in 95.9% (with 39,472 codes identified).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">As shown in the first analysis steps of our approach, the availability of a product catalog to select during the documentation process is not sufficient to generate structured data. Our 4-step approach reduces the problems and reliably increases the structuredness automatically. Similarity matching shows promising results, particularly for entries with no connection to a product catalog. However, further enhancement of the correctness of such a similarity matching algorithm needs to be investigated in future work.</AbstractText><CopyrightInformation>&#xa9;Ines Reinecke, Joscha Siebel, Saskia Fuhrmann, Andreas Fischer, Martin Sedlmayr, Jens Weidner, Franziska Bathelt. Originally published in JMIR Medical Informatics (https://medinform.jmir.org), 25.01.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reinecke</LastName><ForeName>Ines</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-0154-2867</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siebel</LastName><ForeName>Joscha</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3451-6051</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuhrmann</LastName><ForeName>Saskia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6806-3257</Identifier><AffiliationInfo><Affiliation>Center for Evidence-Based Healthcare, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Pharmacy, University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7426-0820</Identifier><AffiliationInfo><Affiliation>Hospital Pharmacy, University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9888-8460</Identifier><AffiliationInfo><Affiliation>Center for Evidence-Based Healthcare, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weidner</LastName><ForeName>Jens</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4373-8147</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bathelt</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-4139-5489</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ATC</Keyword><Keyword MajorTopicYN="N">Anatomical Therapeutic Chemical</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">Observational Medical Outcomes Partnership</Keyword><Keyword MajorTopicYN="N">RxNorm</Keyword><Keyword MajorTopicYN="N">data quality</Keyword><Keyword MajorTopicYN="N">drug data</Keyword><Keyword MajorTopicYN="N">interoperability</Keyword><Keyword MajorTopicYN="N">secondary usage</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>11</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36696159</ArticleId><ArticleId IdType="pmc">PMC9909518</ArticleId><ArticleId IdType="doi">10.2196/40312</ArticleId><ArticleId IdType="pii">v11i1e40312</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maissenhaelter BE, Woolmore AL, Schlag PM. Real-world evidence research based on big data: motivation-challenges-success factors. Onkologe (Berl) 2018 Jun 7;24(Suppl 2):91&#x2013;8. doi: 10.1007/s00761-018-0358-3. 
 
358</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00761-018-0358-3</ArticleId><ArticleId IdType="pmc">PMC6224010</ArticleId><ArticleId IdType="pubmed">30464373</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JD. A call to action to track generic drug quality using real-world data and the FDA's sentinel initiative. J Manag Care Spec Pharm. 2020 Aug;26(8):1050. doi: 10.18553/jmcp.2020.26.8.1050.</Citation><ArticleIdList><ArticleId IdType="doi">10.18553/jmcp.2020.26.8.1050</ArticleId><ArticleId IdType="pmc">PMC10390989</ArticleId><ArticleId IdType="pubmed">32715968</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai RJ, Matheny ME, Johnson K, Marsolo K, Curtis LH, Nelson JC, Heagerty PJ, Maro J, Brown J, Toh S, Nguyen M, Ball R, Dal Pan G, Wang SV, Gagne JJ, Schneeweiss S. Broadening the reach of the FDA Sentinel system: a roadmap for integrating electronic health record data in a causal analysis framework. NPJ Digit Med. 2021 Dec 20;4(1):170. doi: 10.1038/s41746-021-00542-0. doi: 10.1038/s41746-021-00542-0.10.1038/s41746-021-00542-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-021-00542-0</ArticleId><ArticleId IdType="doi">10.1038/s41746-021-00542-0</ArticleId><ArticleId IdType="pmc">PMC8688411</ArticleId><ArticleId IdType="pubmed">34931012</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocoros NM, Fuller CC, Adimadhyam S, Ball R, Brown JS, Dal Pan GJ, Kluberg SA, Lo Re V, Maro JC, Nguyen M, Orr R, Paraoan D, Perlin J, Poland RE, Driscoll MR, Sands K, Toh S, Yih WK, Platt R, And the FDA-Sentinel COVID-19 Working Group  A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System. Pharmacoepidemiol Drug Saf. 2021 Jul 18;30(7):827&#x2013;37. doi: 10.1002/pds.5240. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.5240</ArticleId><ArticleId IdType="pmc">PMC8250843</ArticleId><ArticleId IdType="pubmed">33797815</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrman RE, Benner JS, Brown JS, McClellan M, Woodcock J, Platt R. Developing the Sentinel System--a national resource for evidence development. N Engl J Med. 2011 Feb 10;364(6):498&#x2013;9. doi: 10.1056/NEJMp1014427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1014427</ArticleId><ArticleId IdType="pubmed">21226658</ArticleId></ArticleIdList></Reference><Reference><Citation>Robb MA, Racoosin JA, Sherman RE, Gross TP, Ball R, Reichman ME, Midthun K, Woodcock J. The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety. Pharmacoepidemiol Drug Saf. 2012 Jan 19;21 Suppl 1:9&#x2013;11. doi: 10.1002/pds.2311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.2311</ArticleId><ArticleId IdType="pubmed">22262587</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball R, Robb M, Anderson SA, Dal Pan G. The FDA's sentinel initiative--A comprehensive approach to medical product surveillance. Clin Pharmacol Ther. 2016 Mar;99(3):265&#x2013;8. doi: 10.1002/cpt.320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.320</ArticleId><ArticleId IdType="pubmed">26667601</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt R, Brown JS, Robb M, McClellan M, Ball R, Nguyen MD, Sherman RE. The FDA sentinel initiative &#x2014; an evolving national resource. N Engl J Med. 2018 Nov 29;379(22):2091&#x2013;3. doi: 10.1056/nejmp1809643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmp1809643</ArticleId><ArticleId IdType="pubmed">30485777</ArticleId></ArticleIdList></Reference><Reference><Citation>Gini R, Sturkenboom MC, Sultana J, Cave A, Landi A, Pacurariu A, Roberto G, Schink T, Candore G, Slattery J, Trifir&#xf2; G, Working Group 3 of ENCePP (Inventory of EU data sourcesmethodological approaches for multisource studies)  Different strategies to execute multi-database studies for medicines surveillance in real-world setting: a reflection on the European model. Clin Pharmacol Ther. 2020 Aug;108(2):228&#x2013;35. doi: 10.1002/cpt.1833. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1833</ArticleId><ArticleId IdType="pmc">PMC7484985</ArticleId><ArticleId IdType="pubmed">32243569</ArticleId></ArticleIdList></Reference><Reference><Citation>EHDEN Homepage. European Health Data &amp; Evidence Network.  [2022-05-05].  
 https://www.ehden.eu/
</Citation></Reference><Reference><Citation>COVID-19: EMA sets up infrastructure for real-world monitoring of treatments and vaccines. European Medicines Agency. 2020. Jul 21,  [2022-01-13].  
 https://www.ema.europa.eu/en/news/covid-19-ema-sets-infrastructure-real-world-monitoring-&#x200b;treatments-vaccines
.</Citation></Reference><Reference><Citation>Hripcsak G, Schuemie MJ, Madigan D, Ryan PB, Suchard MA. Drawing reproducible conclusions from observational clinical data with OHDSI. Yearb Med Inform. 2021 Aug;30(1):283&#x2013;9. doi: 10.1055/s-0041-1726481. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1726481</ArticleId><ArticleId IdType="pmc">PMC8416226</ArticleId><ArticleId IdType="pubmed">33882595</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong IC, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li Y, Stang PE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016 Dec;64:333&#x2013;41. doi: 10.1016/j.jbi.2016.10.016. 
 
S1532-0464(16)30153-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinecke I, Zoch M, Reich C, Sedlmayr M, Bathelt F. The usage of OHDSI OMOP - A scoping review. Stud Health Technol Inform. 2021 Sep 21;283:95&#x2013;103. doi: 10.3233/SHTI210546.SHTI210546</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI210546</ArticleId><ArticleId IdType="pubmed">34545824</ArticleId></ArticleIdList></Reference><Reference><Citation>Introduction to Drug Utilization Research. Geneva: World Health Organization; 2003.</Citation></Reference><Reference><Citation>Anatomical Therapeutic Chemical (ATC) Classification. World Health Organization.  [2022-05-05].  
 https://www.who.int/tools/atc-ddd-toolkit/atc-classification
.</Citation></Reference><Reference><Citation>Zozus MW, Hammond E, Green GG, Kahn MG, Richesson RL, Rusincovitch SA, Simon GE, Smerek MM. Data quality assessment recommendations for secondary ise of EHR data. Research Gate. 2015. Oct,  [2022-05-05].  
 https://www.researchgate.net/publication/283267713_Data_Quality_Assessment_Recommendations_for_Secondary_ise_of_EHR_Data
.</Citation></Reference><Reference><Citation>Weiskopf NG, Weng C. Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research. J Am Med Inform Assoc. 2013 Jan 01;20(1):144&#x2013;51. doi: 10.1136/amiajnl-2011-000681. 
 
amiajnl-2011-000681</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000681</ArticleId><ArticleId IdType="pmc">PMC3555312</ArticleId><ArticleId IdType="pubmed">22733976</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuzzy String Matching in Python. GitHub.  [2021-11-26].  
 https://github.com/seatgeek/fuzzywuzzy
.</Citation></Reference><Reference><Citation>Hutchison E, Zhang Y, Nampally S, Weatherall J, Khan F, Shameer K. Uncovering machine learning-ready data from public clinical trial resources: a case-study on normalization across aggregate content of ClinicalTrials.Gov24322. Proceedings of the 2020 IEEE International Conference on Bioinformatics and Biomedicine (BIBM); 2020 IEEE International Conference on Bioinformatics and Biomedicine (BIBM); Dec 16-19, 2020; Seoul, Korea (South). 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/bibm49941.2020.9313362</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobroske K, Larish C, Cattrell A, Bjarnad&#xf3;ttir MV, Huan L. The bird's-eye view: a data-driven approach to understanding patient journeys from claims data. J Am Med Inform Assoc. 2020 Jul 01;27(7):1037&#x2013;45. doi: 10.1093/jamia/ocaa052. 
 
5855725</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa052</ArticleId><ArticleId IdType="pmc">PMC7647282</ArticleId><ArticleId IdType="pubmed">32521006</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinecke I. source code of the implemented algorithm and visualization. ResearchGate. 2022.  [2023-01-04].  
 https://www.researchgate.net/publication/366867005_drug_data-publication
.</Citation></Reference><Reference><Citation>Defeo JA. Juran's Quality Handbook: The Complete Guide to Performance Excellence, Seventh Edition. New York: McGraw Hill Education; 2016. Nov 11,</Citation></Reference><Reference><Citation>Kahn MG, Callahan TJ, Barnard J, Bauck AE, Brown J, Davidson BN, Estiri H, Goerg C, Holve E, Johnson SG, Liaw S, Hamilton-Lopez M, Meeker D, Ong TC, Ryan P, Shang N, Weiskopf NG, Weng C, Zozus MN, Schilling L. A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. EGEMS (Wash DC) 2016 Sep 11;4(1):1244. doi: 10.13063/2327-9214.1244. 
 
egems1244</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1244</ArticleId><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Talburt JR, Wu N, Dagtas S, Zozus MN. A rule-based data quality assessment system for electronic health record data. Appl Clin Inform. 2020 Aug;11(4):622&#x2013;34. doi: 10.1055/s-0040-1715567. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1715567</ArticleId><ArticleId IdType="pmc">PMC7511263</ArticleId><ArticleId IdType="pubmed">32968999</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt CO, Struckmann S, Enzenbach C, Reineke A, Stausberg J, Damerow S, Huebner M, Schmidt B, Sauerbrei W, Richter A. Facilitating harmonized data quality assessments. A data quality framework for observational health research data collections with software implementations in R. BMC Med Res Methodol. 2021 Apr 02;21(1):63. doi: 10.1186/s12874-021-01252-7. 
 
10.1186/s12874-021-01252-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-021-01252-7</ArticleId><ArticleId IdType="doi">10.1186/s12874-021-01252-7</ArticleId><ArticleId IdType="pmc">PMC8019177</ArticleId><ArticleId IdType="pubmed">33810787</ArticleId></ArticleIdList></Reference><Reference><Citation>Vass A, Reinecke I, Boeker M, Prokosch H, Gulden C. Studies in Health Technology and Informatics. Amsterdam, Netherlands: IOS Press; 2021. Availability of structured data elements in electronic health records for supporting patient recruitment in clinical trials.</Citation><ArticleIdList><ArticleId IdType="pubmed">35672985</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruse CS, Kristof C, Jones B, Mitchell E, Martinez A. Barriers to electronic health record adoption: a systematic literature review. J Med Syst. 2016 Dec;40(12):252. doi: 10.1007/s10916-016-0628-9. 
 
10.1007/s10916-016-0628-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-016-0628-9</ArticleId><ArticleId IdType="pmc">PMC5054043</ArticleId><ArticleId IdType="pubmed">27714560</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruse CS, Stein A, Thomas H, Kaur H. The use of electronic health records to support population health: a systematic review of the literature. J Med Syst. 2018 Sep 29;42(11):214. doi: 10.1007/s10916-018-1075-6. 
 
10.1007/s10916-018-1075-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10916-018-1075-6</ArticleId><ArticleId IdType="pmc">PMC6182727</ArticleId><ArticleId IdType="pubmed">30269237</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson AR. Effective mapping of biomedical text to the UMLS Metathesaurus: the MetaMap program. Proc AMIA Symp. 2001:17&#x2013;21. 
 
D010001275</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2243666</ArticleId><ArticleId IdType="pubmed">11825149</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronson AR, Lang F. An overview of MetaMap: historical perspective and recent advances. J Am Med Inform Assoc. 2010;17(3):229&#x2013;36. doi: 10.1136/jamia.2009.002733. 
 
17/3/229</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.002733</ArticleId><ArticleId IdType="pmc">PMC2995713</ArticleId><ArticleId IdType="pubmed">20442139</ArticleId></ArticleIdList></Reference><Reference><Citation>Gehring S, Eulenfeld R. German medical informatics initiative: unlocking data for research and health care. Methods Inf Med. 2018 Jul 17;57(S 01):e46&#x2013;9. doi: 10.3414/me18-13-0001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/me18-13-0001</ArticleId><ArticleId IdType="pmc">PMC6178201</ArticleId><ArticleId IdType="pubmed">30016817</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler S, Wissing F, Heyder R. German medical informatics initiative. Methods Inf Med. 2018 Jul 17;57(S 01):e50&#x2013;6. doi: 10.3414/me18-03-0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/me18-03-0003</ArticleId><ArticleId IdType="pmc">PMC6178199</ArticleId><ArticleId IdType="pubmed">30016818</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36795690</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>2</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Using a data-driven approach for the development and evaluation of phenotype algorithms for systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>e0281929</StartPage><MedlinePgn>e0281929</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0281929</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0281929</ELocationID><Abstract><AbstractText Label="BACKGROUND">Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of unknown origin. The objective of this research was to develop phenotype algorithms for SLE suitable for use in epidemiological studies using empirical evidence from observational databases.</AbstractText><AbstractText Label="METHODS">We used a process for empirically determining and evaluating phenotype algorithms for health conditions to be analyzed in observational research. The process started with a literature search to discover prior algorithms used for SLE. We then used a set of Observational Health Data Sciences and Informatics (OHDSI) open-source tools to refine and validate the algorithms. These included tools to discover codes for SLE that may have been missed in prior studies and to determine possible low specificity and index date misclassification in algorithms for correction.</AbstractText><AbstractText Label="RESULTS">We developed four algorithms using our process: two algorithms for prevalent SLE and two for incident SLE. The algorithms for both incident and prevalent cases are comprised of a more specific version and a more sensitive version. Each of the algorithms corrects for possible index date misclassification. After validation, we found the highest positive predictive value estimate for the prevalent, specific algorithm (89%). The highest sensitivity estimate was found for the sensitive, prevalent algorithm (77%).</AbstractText><AbstractText Label="CONCLUSION">We developed phenotype algorithms for SLE using a data-driven approach. The four final algorithms may be used directly in observational studies. The validation of these algorithms provides researchers an added measure of confidence that the algorithms are selecting subjects correctly and allows for the application of quantitative bias analysis.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Swerdel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Swerdel</LastName><ForeName>Joel N</ForeName><Initials>JN</Initials><Identifier Source="ORCID">0000-0001-9491-2737</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development Epidemiology, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramcharran</LastName><ForeName>Darmendra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Janssen Research and Development Epidemiology, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hardin</LastName><ForeName>Jill</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Research and Development Epidemiology, Titusville, New Jersey, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Authors JS and JH are employees of Janssen Research and Development and shareholders of Johnson &amp; Johnson. DR was an employee of Janssen Research and Development and shareholder of Johnson &amp; Johnson and is currently affiliated with GSK.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>13</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36795690</ArticleId><ArticleId IdType="pmc">PMC9934349</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0281929</ArticleId><ArticleId IdType="pii">PONE-D-22-09946</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jump RL, Robinson ME, Armstrong AE, Barnes EV, Kilbourn KM, Richards HB. Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol. 2005;32(9):1699&#x2013;705.</Citation><ArticleIdList><ArticleId IdType="pubmed">16142863</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco CM, Rudy TE, Manzi S. Adaptation to chronic pain in systemic lupus erythematosus: applicability of the multidimensional pain inventory. Pain Med. 2003;4(1):39&#x2013;50. doi: 10.1046/j.1526-4637.2003.03001.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1526-4637.2003.03001.x</ArticleId><ArticleId IdType="pubmed">12873277</ArticleId></ArticleIdList></Reference><Reference><Citation>Miner JJ, Kim AH. Cardiac manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am. 2014;40(1):51&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">24268009</ArticleId></ArticleIdList></Reference><Reference><Citation>Danila MI, Pons-Estel GJ, Zhang J, Vil&#xe1; LM, Reveille JD, Alarc&#xf3;n GS. Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. Rheumatology (Oxford). 2009;48(5):542&#x2013;5. doi: 10.1093/rheumatology/kep012</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kep012</ArticleId><ArticleId IdType="pmc">PMC2722801</ArticleId><ArticleId IdType="pubmed">19233884</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2018;30(2):144&#x2013;50. doi: 10.1097/BOR.0000000000000480</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000480</ArticleId><ArticleId IdType="pmc">PMC6026543</ArticleId><ArticleId IdType="pubmed">29251660</ArticleId></ArticleIdList></Reference><Reference><Citation>Overby CL, Pathak J, Gottesman O, Haerian K, Perotte A, Murphy S, et al.. A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J Am Med Inform Assoc. 2013;20(e2):e243&#x2013;e52. doi: 10.1136/amiajnl-2013-001930</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001930</ArticleId><ArticleId IdType="pmc">PMC3861914</ArticleId><ArticleId IdType="pubmed">23837993</ArticleId></ArticleIdList></Reference><Reference><Citation>Tench CM, McCurdie I, White PD, D&#x2019;Cruz DP. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford). 2000;39(11):1249&#x2013;54. doi: 10.1093/rheumatology/39.11.1249</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/39.11.1249</ArticleId><ArticleId IdType="pubmed">11085805</ArticleId></ArticleIdList></Reference><Reference><Citation>Iaboni A, Ibanez D, Gladman DD, Urowitz MB, Moldofsky H. Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression. J Rheumatol. 2006;33(12):2453&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17143980</ArticleId></ArticleIdList></Reference><Reference><Citation>Cezarino RS, Cardoso JR, Rodrigues KN, Magalh&#xe3;es YS, Souza TY, Mota L, et al.. Chronic low back pain in patients with systemic lupus erythematosus: prevalence and predictors of back muscle strength and its correlation with disability. Rev Bras Reumatol Engl Ed. 2017;57(5):438&#x2013;44. doi: 10.1016/j.rbre.2017.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbre.2017.03.003</ArticleId><ArticleId IdType="pubmed">28461080</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdel JN, Hripcsak G, Ryan PB. PheValuator: Development and evaluation of a phenotype algorithm evaluator. Journal of Biomedical Informatics. 2019;97:103258. doi: 10.1016/j.jbi.2019.103258</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103258</ArticleId><ArticleId IdType="pmc">PMC7736922</ArticleId><ArticleId IdType="pubmed">31369862</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnado A, Casey C, Carroll RJ, Wheless L, Denny JC, Crofford LJ. Developing Electronic Health Record Algorithms That Accurately Identify Patients With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2017;69(5):687&#x2013;93. doi: 10.1002/acr.22989</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22989</ArticleId><ArticleId IdType="pmc">PMC5219863</ArticleId><ArticleId IdType="pubmed">27390187</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdel JN, Schuemie M, Murray G, Ryan PB. PheValuator 2.0: Methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation. J Biomed Inform. 2022:104177. doi: 10.1016/j.jbi.2022.104177</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2022.104177</ArticleId><ArticleId IdType="pubmed">35995107</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research. Communications in Statistics&#x2014;Simulation and Computation. 2009;38(6):1228&#x2013;34.</Citation></Reference><Reference><Citation>Mortensen K, Song PH. Minding the gap: a decomposition of emergency department use by Medicaid enrollees and the uninsured. Med Care. 2008;46(10):1099&#x2013;107. doi: 10.1097/MLR.0b013e318185c92d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e318185c92d</ArticleId><ArticleId IdType="pubmed">18815532</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, Hartzema AG. Defining a reference set to support methodological research in drug safety. Drug Saf. 2013;36 Suppl 1:S33&#x2013;47. doi: 10.1007/s40264-013-0097-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0097-8</ArticleId><ArticleId IdType="pubmed">24166222</ArticleId></ArticleIdList></Reference><Reference><Citation>Lash TL, Fox MP, MacLehose RF, Maldonado G, McCandless LC, Greenland S. Good practices for quantitative bias analysis. Int J Epidemiol. 2014;43(6):1969&#x2013;85. doi: 10.1093/ije/dyu149</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyu149</ArticleId><ArticleId IdType="pubmed">25080530</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner CA, Jacobs AD, Marques CK, Oates JC, Kamen DL, Anderson PE, et al.. Word2Vec inversion and traditional text classifiers for phenotyping lupus. BMC Med Inform Decis Mak. 2017;17(1):126. doi: 10.1186/s12911-017-0518-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-017-0518-1</ArticleId><ArticleId IdType="pmc">PMC5568290</ArticleId><ArticleId IdType="pubmed">28830409</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanly JG, Thompson K, Skedgel C. Identification of patients with systemic lupus erythematosus in administrative healthcare databases. Lupus. 2014;23(13):1377&#x2013;82. doi: 10.1177/0961203314543917</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314543917</ArticleId><ArticleId IdType="pubmed">25057038</ArticleId></ArticleIdList></Reference><Reference><Citation>Arkema EV, J&#xf6;nsen A, R&#xf6;nnblom L, Svenungsson E, Sj&#xf6;wall C, Simard JF. Case definitions in Swedish register data to identify systemic lupus erythematosus. BMJ open. 2016;6(1):e007769&#x2013;e. doi: 10.1136/bmjopen-2015-007769</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2015-007769</ArticleId><ArticleId IdType="pmc">PMC4716148</ArticleId><ArticleId IdType="pubmed">26729375</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein NP, Ray P, Carpenter D, Hansen J, Lewis E, Fireman B, et al.. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine. 2010;28(4):1062&#x2013;8. doi: 10.1016/j.vaccine.2009.10.115</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.10.115</ArticleId><ArticleId IdType="pubmed">19896453</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyree PT, Lind BK, Lafferty WE. Challenges of using medical insurance claims data for utilization analysis. American journal of medical quality: the official journal of the American College of Medical Quality. 2006;21(4):269&#x2013;75. doi: 10.1177/1062860606288774</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1062860606288774</ArticleId><ArticleId IdType="pmc">PMC1533763</ArticleId><ArticleId IdType="pubmed">16849784</ArticleId></ArticleIdList></Reference><Reference><Citation>Peabody JW, Luck J, Jain S, Bertenthal D, Glassman P. Assessing the accuracy of administrative data in health information systems. Med Care. 2004;42(11):1066&#x2013;72. doi: 10.1097/00005650-200411000-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-200411000-00005</ArticleId><ArticleId IdType="pubmed">15586833</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" VersionID="3" Owner="NLM"><PMID Version="3">36845321</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2398-502X</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Wellcome open research</Title><ISOAbbreviation>Wellcome Open Res</ISOAbbreviation></Journal><ArticleTitle>Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe.</ArticleTitle><Pagination><StartPage>22</StartPage><MedlinePgn>22</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.12688/wellcomeopenres.17403.2</ELocationID><Abstract><AbstractText><b>Background</b>: Characterization studies of COVID-19 patients with chronic obstructive pulmonary disease (COPD) are limited in size and scope. The aim of the study is to provide a large-scale characterization of COVID-19 patients with COPD. <b>Methods</b>: We included thirteen databases contributing data from January-June 2020 from North America (US), Europe and Asia. We defined two cohorts of patients with COVID-19 namely a 'diagnosed' and 'hospitalized' cohort. We followed patients from COVID-19 index date to 30 days or death. We performed descriptive analysis and reported the frequency of characteristics and outcomes among COPD patients with COVID-19. <b>Results</b>: The study included 934,778 patients in the diagnosed COVID-19 cohort and 177,201 in the hospitalized COVID-19 cohort. Observed COPD prevalence in the diagnosed cohort ranged from 3.8% (95%CI 3.5-4.1%) in French data to 22.7% (95%CI 22.4-23.0) in US data, and from 1.9% (95%CI 1.6-2.2) in South Korean to 44.0% (95%CI 43.1-45.0) in US data, in the hospitalized cohorts. COPD patients in the hospitalized cohort had greater comorbidity than those in the diagnosed cohort, including hypertension, heart disease, diabetes and obesity. Mortality was higher in COPD patients in the hospitalized cohort and ranged from 7.6% (95%CI 6.9-8.4) to 32.2% (95%CI 28.0-36.7) across databases. ARDS, acute renal failure, cardiac arrhythmia and sepsis were the most common outcomes among hospitalized COPD patients. &#xa0; <b>Conclusion</b>: COPD patients with COVID-19 have high levels of COVID-19-associated comorbidities and poor COVID-19 outcomes. Further research is required to identify patients with COPD at high risk of worse outcomes.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2022 Moreno-Martos D et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moreno-Martos</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-8652-6235</Identifier><AffiliationInfo><Affiliation>Population Health and Genomics, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verhamme</LastName><ForeName>Katia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Medical Informatics, Erasmus MC, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0847-6682</Identifier><AffiliationInfo><Affiliation>Biomedical Informatics, Columbia University Medical Center, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostka</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Center at The Roux Institute, Northeastern University, Portland, ME, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Sales</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Primaria de Salut Jordi Gol i Gurina (IDIAPJGol), IDIAPJGol, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>College of Pharmacy, Riyadh Elm University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alghoul</LastName><ForeName>Heba</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-8234-5843</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Islamic University of Gaza, Gaza, Palestinian Territory.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Waheed-Ul-Rahman</ForeName><Initials>WU</Initials><AffiliationInfo><Affiliation>Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Health, University of Exeter, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Informatics, Erasmus MC, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DuVall</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Lana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matheny</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Geriatrics Research Education and Clinical Care Service &amp; VINCI, Tennessee Valley Healthcare System VA, nashville, TN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0892-5668</Identifier><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posada</LastName><ForeName>Jose</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3864-0241</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Redwood City, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Informatics, Erasmus MC, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spotnitz</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2869-0237</Identifier><AffiliationInfo><Affiliation>Biomedical Informatics, Columbia University Medical Center, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Informatics, Erasmus MC, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Redwood City, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9818-479X</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics UCLA Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computational Medicine David Geffen School of Medicine at UCLA,, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan You</LastName><ForeName>Seng</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5052-6399</Identifier><AffiliationInfo><Affiliation>Department of Preventive Medicine, Yonsei University, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Biomedical Informatics, Columbia University Medical Center, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Biomedical Informatics, Columbia University Medical Center, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Janssen Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-0063-8069</Identifier><AffiliationInfo><Affiliation>Population Health and Genomics, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health, University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>INV-016201</GrantID><Acronym>GATES</Acronym><Agency>Bill &amp; Melinda Gates Foundation</Agency><Country>United States</Country></Grant><Grant><GrantID>INV-019257</GrantID><Acronym>GATES</Acronym><Agency>Bill &amp; Melinda Gates Foundation</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Wellcome Open Res</MedlineTA><NlmUniqueID>101696457</NlmUniqueID><ISSNLinking>2398-502X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COPD</Keyword><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">epidemiology.</Keyword></KeywordList><CoiStatement>Competing interests: Dr. Verhamme works for a research department who received/receives unconditional research grants from Pfizer/Boehringer Ingelheim, Yamanouchi, Novartis, GSK, Chiesi, Amgen, UCB, J&amp;J none of which are related to the content of this work; Ms. Kostka reports consulting fees from National Institutes of Health NCATS, outside the submitted work; and during the 36 months prior to publication, Ms. Kostka was an employee of IQVIA Inc (a commercial entity); Dr. Prieto-Alhambra reports grants and other from AMGEN, grants, non-financial support and other from UCB Biopharma, grants from Les Laboratoires Servier, outside the submitted work; and Janssen, on behalf of IMI-funded EHDEN and EMIF consortiums, and Synapse Management Partners have supported training programmes organised by DPA's department and open for external participants; Dr. Blacketer reports and full-time employee of Janssen R&amp;D and a stockholder of Johnson &amp; Johnson; Dr. DuVall reports grants from Anolinx, LLC, grants from Astellas Pharma, Inc, grants from AstraZeneca Pharmaceuticals LP, grants from Boehringer Ingelheim International GmbH, grants from Celgene Corporation, grants from Eli Lilly and Company, grants from Genentech Inc., grants from Genomic Health, Inc., grants from Gilead Sciences Inc., grants from GlaxoSmithKline PLC, grants from Innocrin Pharmaceuticals Inc., grants from Janssen Pharmaceuticals, Inc., grants from Kantar Health, grants from Myriad Genetic Laboratories, Inc., grants from Novartis International AG, grants from Parexel International Corporation through the University of Utah or Western Institute for Veteran Research, outside the submitted work; Dr. Nyberg reports other from AstraZeneca, outside the submitted work; Dr. Posada reports grants from National Library of Medicine, during the conduct of the study; Dr. Rijnbeek reports grants from Innovative Medicines Initiative, from Janssen Research and Development, during the conduct of the study; Dr. Sena reports and full-time employee of Janssen R&amp;D and a stockholder of Johnson &amp; Johnson; Dr. Shah reports grants from National Library of Medicine, during the conduct of the study; Dr. Suchard reports grants from US National Institutes of Health, grants from US Department of Veterans Affairs, during the conduct of the study; grants from US Food &amp; Drug Administration, personal fees from Janssen Research &amp; Development, outside the submitted work; Dr. Hripcsak reports grants from US National Institutes of Health, during the conduct of the study; grants from Janssen Research, outside the submitted work; Dr. Ryan reports and is employee of Janssen Research and Development and shareholder of Johnson &amp; Johnson; Dr. Morales is supported by a Wellcome Trust Clinical Research Development Fellowship (Grant 214588/Z/18/Z) and reports grants from Chief Scientist Office (CSO), grants from Health Data Research UK (HDR-UK), grants from National Institute of Health Research (NIHR), and Tenovus outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>28</Day><Hour>2</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36845321</ArticleId><ArticleId IdType="pmc">PMC9951545</ArticleId><ArticleId IdType="doi">10.12688/wellcomeopenres.17403.2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Worldometer:
COVID-19 CORONAVIRUS PANDEMIC. [cited 2021 Apr 20].
Reference Source
</Citation></Reference><Reference><Citation>
British Thoracic Society:
BTS guidance for health care professionals in relation to shielding. [cited 2020 Sep 20].
Reference Source
</Citation></Reference><Reference><Citation>Leung JM, Niikura M, Yang CWT, et al. : COVID-19 and COPD. Eur Respir J. 2020;56(2):2002108. 10.1183/13993003.02108-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02108-2020</ArticleId><ArticleId IdType="pmc">PMC7424116</ArticleId><ArticleId IdType="pubmed">32817205</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani JS, Oyelade T, Aldhahir AM, et al. : Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS One. 2020;15(5):e0233147. 10.1371/journal.pone.0233147</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0233147</ArticleId><ArticleId IdType="pmc">PMC7213702</ArticleId><ArticleId IdType="pubmed">32392262</ArticleId></ArticleIdList></Reference><Reference><Citation>Wark PA, Tooze M, Powell H, et al. : Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission. Respirology. 2013;18(6):996&#x2013;1002. 10.1111/resp.12099</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.12099</ArticleId><ArticleId IdType="pmc">PMC7169161</ArticleId><ArticleId IdType="pubmed">23600594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko FW, Chan PK, Chan RWY, et al. : Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease. Respir Res. 2019;20(1):210. 10.1186/s12931-019-1181-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-019-1181-0</ArticleId><ArticleId IdType="pmc">PMC6743175</ArticleId><ArticleId IdType="pubmed">31519188</ArticleId></ArticleIdList></Reference><Reference><Citation>Prieto-Alhambra D, Kostka K, Duarte-Salles T, et al. : Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS. Res Sq. 2021;rs.3.rs-279400. 10.21203/rs.3.rs-279400/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-279400/v1</ArticleId><ArticleId IdType="pmc">PMC8957305</ArticleId><ArticleId IdType="pubmed">35345821</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al. : Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(3):553&#x2013;64. 10.1093/jamia/ocu023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. : Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Sena A, Kostka K, Schuemie M, et al. : ohdsi-studies/Covid19CharacterizationCharybdis: Charybdis v1.1.1 - Publication Package (Version v1.1.1). Zenodo. 2020; [cited 2020 Sep 16]. 10.5281/zenodo.4033034</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.4033034</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Martos D, Morales DR: Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe - Supplementary Materials. Zenodo. 2021; [cited 2021 Dec 14]. 10.5281/zenodo.5729423</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.5729423</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte-Salles T, Vizcaya D, Pistillo A, et al. : Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France, Germany, Spain, South Korea and the United States: an international network cohort study. medRxiv. 2020;2020.10.29.20222083. 10.1101/2020.10.29.20222083</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.29.20222083</ArticleId><ArticleId IdType="pmc">PMC7605587</ArticleId><ArticleId IdType="pubmed">33140074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohler J, Kostka K, Makadia R, et al. : Using Real World Data to Understand HIV and COVID-19 in the U.S.A. and Spain: Characterizing Co-Infected Patients Across the Care Cascade. medRxiv. 2020;2020.11.10.20229401. 10.1101/2020.11.10.20229401</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.10.20229401</ArticleId></ArticleIdList></Reference><Reference><Citation>Du RH, Liang LR, Yang CQ, et al. : Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study. Eur Respir J. 2020;55(5):2000524. 10.1183/13993003.00524-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00524-2020</ArticleId><ArticleId IdType="pmc">PMC7144257</ArticleId><ArticleId IdType="pubmed">32269088</ArticleId></ArticleIdList></Reference><Reference><Citation>Verity R, Okell LC, Dorigatti I, et al. : Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20(6):669&#x2013;677. 10.1016/S1473-3099(20)30243-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30243-7</ArticleId><ArticleId IdType="pmc">PMC7158570</ArticleId><ArticleId IdType="pubmed">32240634</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, et al. : Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323(20):2052&#x2013;2059. 10.1001/jama.2020.6775</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Yu Y, Xu J, et al. : Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475&#x2013;481. 10.1016/S2213-2600(20)30079-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30079-5</ArticleId><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Yancy CW: COVID-19 and African Americans. JAMA. 2020;323(19):1891&#x2013;1892. 10.1001/jama.2020.6548</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6548</ArticleId><ArticleId IdType="pubmed">32293639</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimmer A: Covid-19: Two thirds of healthcare workers who have died were from ethnic minorities. BMJ. 2020;369:m1621. 10.1136/bmj.m1621</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1621</ArticleId><ArticleId IdType="pubmed">32327412</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, You SC, Sena AG, et al. : Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun. 2020;11(1):5009. 10.1038/s41467-020-18849-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze A, Walker AJ, MacKenna B, et al. : Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med. 2020;8(11):1106&#x2013;1120. 10.1016/S2213-2600(20)30415-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30415-X</ArticleId><ArticleId IdType="pmc">PMC7515601</ArticleId><ArticleId IdType="pubmed">32979987</ArticleId></ArticleIdList></Reference><Reference><Citation>Aveyard P, Gao M, Lindson N, et al. : Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study. Lancet Respir Med. 2021;9(8):909&#x2013;923. 10.1016/S2213-2600(21)00095-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00095-3</ArticleId><ArticleId IdType="pmc">PMC8016404</ArticleId><ArticleId IdType="pubmed">33812494</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan S, Nicolau DV Jr, Langford B, et al. : Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med. 2021;9(7):763&#x2013;772. 10.1016/S2213-2600(21)00160-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00160-0</ArticleId><ArticleId IdType="pmc">PMC8040526</ArticleId><ArticleId IdType="pubmed">33844996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Kristensen KB, Reilev M, et al. : Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study. PLoS Med. 2020;17(9):e1003308. 10.1371/journal.pmed.1003308</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003308</ArticleId><ArticleId IdType="pmc">PMC7478808</ArticleId><ArticleId IdType="pubmed">32898149</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong AY, MacKenna B, Morton CE, et al. : Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts. Ann Rheum Dis. 2021;80(7):943&#x2013;951. 10.1136/annrheumdis-2020-219517</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219517</ArticleId><ArticleId IdType="pmc">PMC7823433</ArticleId><ArticleId IdType="pubmed">33478953</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales DR, Ostropolets A, Lai L, et al. : Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe. J Asthma. 2022;11:1&#x2013;11. 10.1080/02770903.2021.2025392</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770903.2021.2025392</ArticleId><ArticleId IdType="pubmed">35012410</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin DMG, Criner GJ, Papi A, et al. : Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021;203(1):24&#x2013;36. 10.1164/rccm.202009-3533SO</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202009-3533SO</ArticleId><ArticleId IdType="pmc">PMC7781116</ArticleId><ArticleId IdType="pubmed">33146552</ArticleId></ArticleIdList></Reference><Reference><Citation>Sena A, Kostka K, Schuemie M, et al. : DavidMorenoMartos/Covid19CharacterizationCharybdis: v1.4.3 (v1.4.3). Zenodo. 2021; [cited 2021 Dec 14]. 10.5281/zenodo.5779264</Citation><ArticleIdList><ArticleId IdType="doi">10.5281/zenodo.5779264</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36847736</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>19</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Correction to: Transforming and evaluating the UK Biobank to the OMOP Common Data Model for COVID-19 research and beyond.</ArticleTitle><Pagination><StartPage>1006</StartPage><MedlinePgn>1006</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocad032</ELocationID><Language>eng</Language><PublicationTypeList><PublicationType UI="D016425">Published Erratum</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumFor"><RefSource>J Am Med Inform Assoc. 2022 Dec 13;30(1):103-111. doi: 10.1093/jamia/ocac203</RefSource><PMID Version="1">36227072</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>27</Day><Hour>10</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36847736</ArticleId><ArticleId IdType="pmc">PMC10114052</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocad032</ArticleId><ArticleId IdType="pii">7058992</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36884279</PMID><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2023</Year><Month>Mar</Month><Day>08</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>An Ontology-Based Approach for Consolidating Patient Data Standardized With European Norm/International Organization for Standardization 13606 (EN/ISO 13606) Into Joint Observational Medical Outcomes Partnership (OMOP) Repositories: Description of a Methodology.</ArticleTitle><Pagination><StartPage>e44547</StartPage><MedlinePgn>e44547</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e44547</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/44547</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To discover new knowledge from data, they must be correct and in a consistent format. OntoCR, a clinical repository developed at Hospital Cl&#xed;nic de Barcelona, uses ontologies to represent clinical knowledge and map locally defined variables to health information standards and common data models.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of the study is to design and implement a scalable methodology based on the dual-model paradigm and the use of ontologies to consolidate clinical data from different organizations in a standardized repository for research purposes without loss of meaning.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">First, the relevant clinical variables are defined, and the corresponding European Norm/International Organization for Standardization (EN/ISO) 13606 archetypes are created. Data sources are then identified, and an extract, transform, and load process is carried out. Once the final data set is obtained, the data are transformed to create EN/ISO 13606-normalized electronic health record (EHR) extracts. Afterward, ontologies that represent archetyped concepts and map them to EN/ISO 13606 and Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) standards are created and uploaded to OntoCR. Data stored in the extracts are inserted into its corresponding place in the ontology, thus obtaining instantiated patient data in the ontology-based repository. Finally, data can be extracted via SPARQL queries as OMOP CDM-compliant tables.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Using this methodology, EN/ISO 13606-standardized archetypes that allow for the reuse of clinical information were created, and the knowledge representation of our clinical repository by modeling and mapping ontologies was extended. Furthermore, EN/ISO 13606-compliant EHR extracts of patients (6803), episodes (13,938), diagnosis (190,878), administered medication (222,225), cumulative drug dose (222,225), prescribed medication (351,247), movements between units (47,817), clinical observations (6,736,745), laboratory observations (3,392,873), limitation of life-sustaining treatment (1,298), and procedures (19,861) were created. Since the creation of the application that inserts data from extracts into the ontologies is not yet finished, the queries were tested and the methodology was validated by importing data from a random subset of patients into the ontologies using a locally developed Prot&#xe9;g&#xe9; plugin ("OntoLoad"). In total, 10 OMOP CDM-compliant tables ("Condition_occurrence," 864 records; "Death," 110; "Device_exposure," 56; "Drug_exposure," 5609; "Measurement," 2091; "Observation," 195; "Observation_period," 897; "Person," 922; "Visit_detail," 772; and "Visit_occurrence," 971) were successfully created and populated.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study proposes a methodology for standardizing clinical data, thus allowing its reuse without any changes in the meaning of the modeled concepts. Although this paper focuses on health research, our methodology suggests that the data be initially standardized per EN/ISO 13606 to obtain EHR extracts with a high level of granularity that can be used for any purpose. Ontologies constitute a valuable approach for knowledge representation and standardization of health information in a standard-agnostic manner. With the proposed methodology, institutions can go from local raw data to standardized, semantically interoperable EN/ISO 13606 and OMOP repositories.</AbstractText><CopyrightInformation>&#xa9;Santiago Frid, Xavier Pastor Duran, Guillem Bracons Cuc&#xf3;, Miguel Pedrera-Jim&#xe9;nez, Pablo Serrano-Balazote, Adolfo Mu&#xf1;oz Carrero, Raimundo Lozano-Rub&#xed;. Originally published in JMIR Medical Informatics (https://medinform.jmir.org), 08.03.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Frid</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8400-5770</Identifier><AffiliationInfo><Affiliation>Medical Informatics Unit, Hospital Cl&#xed;nic de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Foundations Department, Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastor Duran</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-8267-7151</Identifier><AffiliationInfo><Affiliation>Medical Informatics Unit, Hospital Cl&#xed;nic de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Foundations Department, Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bracons Cuc&#xf3;</LastName><ForeName>Guillem</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-1274-7403</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Cl&#xed;nic per a la Recerca Biom&#xe9;dica, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedrera-Jim&#xe9;nez</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0187-3826</Identifier><AffiliationInfo><Affiliation>Data Science Unit, Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serrano-Balazote</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2958-6319</Identifier><AffiliationInfo><Affiliation>Direction of Planification, Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz Carrero</LastName><ForeName>Adolfo</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0141-7751</Identifier><AffiliationInfo><Affiliation>Unit of Investigation in Telemedicine and Digital Health, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lozano-Rub&#xed;</LastName><ForeName>Raimundo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7912-721X</Identifier><AffiliationInfo><Affiliation>Medical Informatics Unit, Hospital Cl&#xed;nic de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Foundations Department, Universitat de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">European Norm/International Organization for Standardization 13606</Keyword><Keyword MajorTopicYN="N">Observational Medical Outcomes Partnership Common Data Model</Keyword><Keyword MajorTopicYN="N">clinical data</Keyword><Keyword MajorTopicYN="N">dual model</Keyword><Keyword MajorTopicYN="N">health information interoperability</Keyword><Keyword MajorTopicYN="N">health information standards</Keyword><Keyword MajorTopicYN="N">health records</Keyword><Keyword MajorTopicYN="N">health research</Keyword><Keyword MajorTopicYN="N">ontologies</Keyword><Keyword MajorTopicYN="N">secondary use of health data</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>8</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36884279</ArticleId><ArticleId IdType="pmc">PMC10034609</ArticleId><ArticleId IdType="doi">10.2196/44547</ArticleId><ArticleId IdType="pii">v11i1e44547</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jungkunz M, K&#xf6;ngeter A, Mehlis K, Winkler EC, Schickhardt C. Secondary use of clinical data in data-gathering, non-interventional research or learning activities: definition, types, and a framework for risk assessment. J Med Internet Res. 2021;23(6):e26631. doi: 10.2196/26631. 
 
v23i6e26631</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/26631</ArticleId><ArticleId IdType="pmc">PMC8241435</ArticleId><ArticleId IdType="pubmed">34100760</ArticleId></ArticleIdList></Reference><Reference><Citation>Safran C, Bloomrosen M, Hammond WE, Labkoff S, Markel-Fox S, Tang PC, Detmer DE, Expert Panel  Toward a national framework for the secondary use of health data: an American Medical Informatics Association white paper. J Am Med Inform Assoc. 2007;14(1):1&#x2013;9. doi: 10.1197/jamia.M2273. 
 
M2273</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M2273</ArticleId><ArticleId IdType="pmc">PMC2329823</ArticleId><ArticleId IdType="pubmed">17077452</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson ARR, Nurmatov U, Sood HS, Cresswell K, Smith P, Sheikh A. A systematic scoping review of the domains and innovations in secondary uses of digitised health-related data. J Innov Health Inform. 2016;23(3):611&#x2013;619. doi: 10.14236/jhi.v23i3.841. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.14236/jhi.v23i3.841</ArticleId><ArticleId IdType="pubmed">28059695</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohmann C, Banzi R, Canham S, Battaglia S, Matei M, Ariyo C, Becnel L, Bierer B, Bowers S, Clivio L, Dias M, Druml C, Faure H, Fenner M, Galvez J, Ghersi D, Gluud C, Groves T, Houston P, Karam G, Kalra D, Knowles RL, Krle&#x17e;a-Jeri&#x107; K, Kubiak C, Kuchinke W, Kush R, Lukkarinen A, Marques PS, Newbigging A, O'Callaghan J, Ravaud P, Schl&#xfc;nder I, Shanahan D, Sitter H, Spalding D, Tudur-Smith C, van Reusel P, van Veen EB, Visser GR, Wilson J, Demotes-Mainard J. Sharing and reuse of individual participant data from clinical trials: principles and recommendations. BMJ Open. 2017;7(12):e018647. doi: 10.1136/bmjopen-2017-018647. 
 
bmjopen-2017-018647</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-018647</ArticleId><ArticleId IdType="pmc">PMC5736032</ArticleId><ArticleId IdType="pubmed">29247106</ArticleId></ArticleIdList></Reference><Reference><Citation>Hey T. The fourth paradigm&#x2014;data-intensive scientific discovery. In: Kurbano&#x11f;lu S, Al U, Erdo&#x11f;an PL, Tonta Y, U&#xe7;ak N, editors. E-Science and Information Management. IMCW 2012. Communications in Computer and Information Science, vol 317. Berlin: Springer; 2012.</Citation></Reference><Reference><Citation>Pedrera-Jim&#xe9;nez M, Garc&#xed;a-Barrio N, Rubio-Mayo P, Tato-G&#xf3;mez A, Cruz-Berm&#xfa;dez JL, Bernal-Sobrino JL, Mu&#xf1;oz-Carrero A, Serrano-Balazote P. TransformEHRs: a flexible methodology for building transparent ETL processes for EHR reuse. Methods Inf Med. 2022;61(S 02):e89&#x2013;e102. doi: 10.1055/s-0042-1757763. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1757763</ArticleId><ArticleId IdType="pmc">PMC9788916</ArticleId><ArticleId IdType="pubmed">36220109</ArticleId></ArticleIdList></Reference><Reference><Citation>Health informatics&#x2014;electronic health record communication&#x2014;Part 1: Reference model. ISO.  [2023-02-08].  
 https://www.iso.org/standard/67868.html
.</Citation></Reference><Reference><Citation>Health informatics&#x2014;electronic health record communication&#x2014;Part 2: Archetype interchange specification. ISO.  [2023-02-08].  
 https://www.iso.org/standard/62305.html
.</Citation></Reference><Reference><Citation>ISO 13940:2015&#x2014;Health informatics&#x2014;system of concepts to support continuity of care. ISO.  [2022-06-04].  
 https://www.iso.org/standard/58102.html
.</Citation></Reference><Reference><Citation>OHDSI . The Book of OHDSI: Observational Health Data Sciences and Informatics. North Bethesda, MD: OHDSI; 2019.</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, van der Lei J, Pratt N, Nor&#xe9;n GN, Li YC, Stang PlE, Madigan D, Ryan PB. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60. doi: 10.1136/amiajnl-2011-000376. 
 
amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016;64:333&#x2013;341. doi: 10.1016/j.jbi.2016.10.016. 
 
S1532-0464(16)30153-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado JA, Moner D, Bosc&#xe1; D, Fern&#xe1;ndez-Breis JT, Angulo C, Robles M. LinkEHR-Ed: a multi-reference model archetype editor based on formal semantics. Int J Med Inform. 2009;78(8):559&#x2013;570. doi: 10.1016/j.ijmedinf.2009.03.006.S1386-5056(09)00051-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2009.03.006</ArticleId><ArticleId IdType="pubmed">19386540</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggio LA, Stranack K. Understanding Creative Commons. Acad Med. 2020;95(2):322. doi: 10.1097/ACM.0000000000003031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACM.0000000000003031</ArticleId><ArticleId IdType="pubmed">31599759</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano-Rub&#xed; R, Mu&#xf1;oz Carrero A, Serrano Balazote P, Pastor X. OntoCR: a CEN/ISO-13606 clinical repository based on ontologies. J Biomed Inform. 2016;60:224&#x2013;233. doi: 10.1016/j.jbi.2016.02.007. 
 
S1532-0464(16)00029-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.02.007</ArticleId><ArticleId IdType="pubmed">26911524</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano-Rub&#xed; R. A Metamodel for Clinical Data Integration: Basis for a New EHR Model Driven by Ontologies. 2017.  [2023-02-08].  
 https://www.tdx.cat/bitstream/handle/10803/399855/rlr1de1.pdf?sequence=1
.</Citation></Reference><Reference><Citation>OWL Web Ontology Language Reference. OWL.  [2022-05-13].  
 http://www.w3.org/TR/owl-features
.</Citation></Reference><Reference><Citation>Musen MA, Prot&#xe9;g&#xe9; Team  The Prot&#xe9;g&#xe9; project: a look back and a look forward. AI Matters. 2015;1(4):4&#x2013;12. doi: 10.1145/2757001.2757003. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2757001.2757003</ArticleId><ArticleId IdType="pmc">PMC4883684</ArticleId><ArticleId IdType="pubmed">27239556</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrera-Jim&#xe9;nez M, Garc&#xed;a-Barrio N, Cruz-Rojo J, Terriza-Torres AI, L&#xf3;pez-Jim&#xe9;nez EA, Calvo-Boyero F, Jim&#xe9;nez-Cerezo MJ, Blanco-Mart&#xed;nez AJ, Roig-Dom&#xed;nguez G, Cruz-Berm&#xfa;dez JL, Bernal-Sobrino JL, Serrano-Balazote P, Mu&#xf1;oz-Carrero A. Obtaining EHR-derived datasets for COVID-19 research within a short time: a flexible methodology based on detailed clinical models. J Biomed Inform. 2021;115:103697. doi: 10.1016/j.jbi.2021.103697. 
 
S1532-0464(21)00026-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2021.103697</ArticleId><ArticleId IdType="pmc">PMC7857038</ArticleId><ArticleId IdType="pubmed">33548541</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra D, Beale T, Heard S. The openEHR Foundation. Stud Health Technol Inform. 2005;115:153&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">16160223</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayaz M, Pasha MF, Alzahrani MY, Budiarto R, Stiawan D. The fast health interoperability resources (FHIR) standard: systematic literature review of implementations, applications, challenges and opportunities. JMIR Med Inform. 2021;9(7):e21929. doi: 10.2196/21929. 
 
v9i7e21929</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/21929</ArticleId><ArticleId IdType="pmc">PMC8367140</ArticleId><ArticleId IdType="pubmed">34328424</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S, Kohane I. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) J Am Med Inform Assoc. 2010;17(2):124&#x2013;130. doi: 10.1136/jamia.2009.000893. 
 
17/2/124</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.000893</ArticleId><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrera-Jim&#xe9;nez M, Spanish Expert Group on EHR standards. Kalra D, Beale T, Mu&#xf1;oz-Carrero A, Serrano-Balazote P. Can OpenEHR, ISO 13606 and HL7 FHIR work together? An agnostic perspective for the selection and application of EHR standards from Spain. TechRxiv. Preprint posted online on May 25, 2022.  doi: 10.36227/techrxiv.19746484. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.36227/techrxiv.19746484</ArticleId></ArticleIdList></Reference><Reference><Citation>Haarbrandt B, Tute E, Marschollek M. Automated population of an i2b2 clinical data warehouse from an openEHR-based data repository. J Biomed Inform. 2016;63:277&#x2013;294. doi: 10.1016/j.jbi.2016.08.007. 
 
S1532-0464(16)30084-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.08.007</ArticleId><ArticleId IdType="pubmed">27507090</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak J, Bailey KR, Beebe CE, Bethard S, Carrell DS, Chen PJ, Dligach D, Endle CM, Hart LA, Haug PJ, Huff SM, Kaggal VC, Li D, Liu H, Marchant K, Masanz J, Miller T, Oniki TA, Palmer M, Peterson KJ, Rea S, Savova GK, Stancl CR, Sohn S, Solbrig HR, Suesse DB, Tao C, Taylor DP, Westberg L, Wu S, Zhuo N, Chute CG. Normalization and standardization of electronic health records for high-throughput phenotyping: the SHARPn consortium. J Am Med Inform Assoc. 2013;20(e2):e341&#x2013;e348. doi: 10.1136/amiajnl-2013-001939. 
 
amiajnl-2013-001939</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001939</ArticleId><ArticleId IdType="pmc">PMC3861933</ArticleId><ArticleId IdType="pubmed">24190931</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimino JJ, Ayres EJ. The clinical research data repository of the US National Institutes of Health. Stud Health Technol Inform. 2010;160(Pt 2):1299&#x2013;1303. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3408090</ArticleId><ArticleId IdType="pubmed">20841894</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson NR, Lee ES, Brockenbrough JS, Minie ME, Fuller S, Brinkley J, Tarczy-Hornoch P. Issues in biomedical research data management and analysis: needs and barriers. J Am Med Inform Assoc. 2007;14(4):478&#x2013;488. doi: 10.1197/jamia.M2114. 
 
M2114</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/jamia.M2114</ArticleId><ArticleId IdType="pmc">PMC2244904</ArticleId><ArticleId IdType="pubmed">17460139</ArticleId></ArticleIdList></Reference><Reference><Citation>Paris N, Lamer A, Parrot A. Transformation and evaluation of the MIMIC database in the OMOP common data model: development and usability study. JMIR Med Inform. 2021;9(12):e30970. doi: 10.2196/30970. 
 
v9i12e30970</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/30970</ArticleId><ArticleId IdType="pmc">PMC8715361</ArticleId><ArticleId IdType="pubmed">34904958</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacaci A, Gonul S, Sinaci AA, Yuksel M, Laleci Erturkmen GB. A semantic transformation methodology for the secondary use of observational healthcare data in postmarketing safety studies. Front Pharmacol. 2018;9:435. doi: 10.3389/fphar.2018.00435. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00435</ArticleId><ArticleId IdType="pmc">PMC5937227</ArticleId><ArticleId IdType="pubmed">29760661</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, Depraetere K, De Roo J, Mels G, De Vloed B, Twagirumukiza M, Colaert D. Semantic processing of EHR data for clinical research. J Biomed Inform. 2015;58:247&#x2013;259. doi: 10.1016/j.jbi.2015.10.009. 
 
S1532-0464(15)00231-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2015.10.009</ArticleId><ArticleId IdType="pubmed">26515501</ArticleId></ArticleIdList></Reference><Reference><Citation>infobank. Comunidad de Madrid.  [2023-02-08].  
 https://cpisanidadcm.org/infobanco/
</Citation></Reference><Reference><Citation>Gaudet-Blavignac C, Raisaro JL, Tour&#xe9; V, &#xd6;sterle S, Crameri K, Lovis C. A national, semantic-driven, three-pillar strategy to enable health data secondary usage interoperability for research within the Swiss personalized health network: methodological study. JMIR Med Inform. 2021;9(6):e27591. doi: 10.2196/27591. 
 
v9i6e27591</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/27591</ArticleId><ArticleId IdType="pmc">PMC8277320</ArticleId><ArticleId IdType="pubmed">34185008</ArticleId></ArticleIdList></Reference><Reference><Citation>Accelerating research in genomic oncology. ICGC ARGO.  [2023-02-08].  
 https://www.icgc-argo.org/
</Citation></Reference><Reference><Citation>Standards. CDISC.  [2023-02-08].  
 https://www.cdisc.org/standards
.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36909637</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2693-5015</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2023</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Research square</Title><ISOAbbreviation>Res Sq</ISOAbbreviation></Journal><ArticleTitle>Bumetanide Exposure Association with Alzheimer's Disease Risk.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">rs.3.rs-2574215</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.21203/rs.3.rs-2574215/v1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">To investigate whether exposure history to two common loop diuretics affects the risk of developing Alzheimer's disease (AD) after accounting for socioeconomic status and congestive heart failure.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Individuals exposed to bumetanide or furosemide were identified in the Stanford University electronic health record using the deidentified Observational Medical Outcomes Partnership platform. We matched the AD case cohort to a control cohort (1:20 case:control) on gender, race, ethnicity, hypertension and controlled for variables that could potentially be collinear with bumetanide exposure and/or AD diagnosis. Among individuals older than 65 years, 5,839 AD cases and 116,103 matched controls were included. A total of 1,759 patients (54 cases, 1,705 controls) were exposed to bumetanide.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">After adjusting for socioeconomic status and other confounders, bumetanide exposure was significantly associated with reduced AD risk (odds ratio = 0.50; 95% confidence interval, 0.37-0.68; p = 9.9&#xd7;10<sup>-6</sup>), while the most common loop diuretics, furosemide, was not associated with AD risk.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our study replicates in an independent sample that history of bumetanide exposure is associated with reduced risk of AD and emphasizes that this association is not confounded by difference in socioeconomic status, which was an important caveat given the cost difference between bumetanide and furosemide.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Graber-Naidich</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Stanford University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Stanford University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Younes</LastName><ForeName>Kyan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Stanford University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greicius</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Stanford University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Guen</LastName><ForeName>Yann</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Stanford University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Zihuai</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Stanford University.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG066515</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG066206</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Res Sq</MedlineTA><NlmUniqueID>101768035</NlmUniqueID><ISSNLinking>2693-5015</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>Front Aging. 2023 Sep 25;4:1211571. doi: 10.3389/fragi.2023.1211571</RefSource><PMID Version="1">37822457</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">bumetanide</Keyword><Keyword MajorTopicYN="N">electronic health record informatics</Keyword><Keyword MajorTopicYN="N">furosemide</Keyword></KeywordList><CoiStatement>Competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>13</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36909637</ArticleId><ArticleId IdType="pmc">PMC10002844</ArticleId><ArticleId IdType="doi">10.21203/rs.3.rs-2574215/v1</ArticleId><ArticleId IdType="pii">rs.3.rs-2574215</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shah NH, Milstein A, Bagley PhD SC. Making Machine Learning Models Clinically Useful. JAMA. United States; 2019;322:1351&#x2013;1352.</Citation><ArticleIdList><ArticleId IdType="pubmed">31393527</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkomar A, Dean J, Kohane I. Machine Learning in Medicine. The New England journal of medicine. United States; 2019;380:1347&#x2013;1358.</Citation><ArticleIdList><ArticleId IdType="pubmed">30943338</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA. Population estimate of people with clinical Alzheimer&#x2019;s disease and mild cognitive impairment in the United States (2020&#x2013;2060). Alzheimer&#x2019;s and Dementia. 2021;17:1966&#x2013;1975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013315</ArticleId><ArticleId IdType="pubmed">34043283</ArticleId></ArticleIdList></Reference><Reference><Citation>Taubes A, Nova P, Zalocusky KA, et al. APOE4 -related Alzheimer&#x2019; s disease. 2021;1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9514594</ArticleId><ArticleId IdType="pubmed">36172600</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S, Posada J, Olson G, et al. A new paradigm for accelerating clinical data science at Stanford Medicine. Epub 2020.</Citation></Reference><Reference><Citation>Johanson CE, Murphy VA, Dyas M. Ethacrynic acid and furosemide alter Cl, K, and Na distribution between blood, choroid plexus, CSF, and brain. Neurochemical Research. 1992;17:1079&#x2013;1085.</Citation><ArticleIdList><ArticleId IdType="pubmed">1461357</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;mermann K, Fedrowitz M, Hampel R et al. Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain. Neuropharmacology. 2017;117:182&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">28192112</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt C, Seja P, T&#xf6;llner K, et al. Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital&#x2019;s anti-seizure efficacy. Neuropharmacology. Elsevier; 2018;143:186&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">30248303</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtkamp M, Matzen J, Buchheim K, Walker MC, Meierkord H. Furosemide terminates limbic status epilepticus in freely moving rats. Epilepsia. 2003;44:1141&#x2013;1144.</Citation><ArticleIdList><ArticleId IdType="pubmed">12919384</ArticleId></ArticleIdList></Reference><Reference><Citation>Kharod SC, Kang SK, Kadam SD. Off-label use of bumetanide for brain disorders: An overview. Frontiers in Neuroscience. 2019;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6491514</ArticleId><ArticleId IdType="pubmed">31068771</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemonnier E, Degrez C, Phelep M, et al. A randomised controlled trial of bumetanide in the treatment of autism in children. Translational Psychiatry. Nature Publishing Group; 2012;2:e202&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3565189</ArticleId><ArticleId IdType="pubmed">23233021</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmanzadeh R, Eftekhari S, Shahbazi A, et al. Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial. Schizophrenia Research. Elsevier B.V.; 2017;184:145&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">27956008</ArticleId></ArticleIdList></Reference><Reference><Citation>Eftekhari S, Mehvari Habibabadi J, Najafi Ziarani M, et al. Bumetanide reduces seizure frequency in patients with temporal lobe epilepsy. Epilepsia. 2013;54:10&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">23061490</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen BB, Olsen Klopfer S. Optimal full matching and related designs via network flows. Journal of Computational and Graphical Statistics. 2006;15:609&#x2013;627.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36935011</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>142</Volume><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Representing and utilizing clinical textual data for real world studies: An OHDSI approach.</ArticleTitle><Pagination><StartPage>104343</StartPage><MedlinePgn>104343</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2023.104343</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(23)00064-3</ELocationID><Abstract><AbstractText>Clinical documentation in electronic health records contains crucial narratives and details about patients and their care. Natural language processing (NLP) can unlock the information conveyed in clinical notes and reports, and thus plays a critical role in real-world studies. The NLP Working Group at the Observational Health Data Sciences and Informatics (OHDSI) consortium was established to develop methods and tools to promote the use of textual data and NLP in real-world observational studies. In this paper, we describe a framework for representing and utilizing textual data in real-world evidence generation, including representations of information from clinical text in the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM), the workflow and tools that were developed to extract, transform and load (ETL) data from clinical notes into tables in OMOP CDM, as well as current applications and specific use cases of the proposed OHDSI NLP solution at large consortia and individual institutions with English textual data. Challenges faced and lessons learned during the process are also discussed to provide valuable insights for researchers who are planning to implement NLP solutions in real-world studies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Keloth</LastName><ForeName>Vipina K</ForeName><Initials>VK</Initials><AffiliationInfo><Affiliation>Section of Biomedical Informatics and Data Science, Yale School of Medicine, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Georgia State University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurley</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Lurie Cancer Center, Northwestern University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heider</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Biomedical Informatics Center, Medical University of South Carolina, Charleston, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Georgina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Ingham Institute for Applied Medical Research, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hongfang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Feifan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Computational Health Informatics Program, Boston Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V Patterson</LastName><ForeName>Olga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA; Division of Epidemiology, Department of Internal Medicine, School of Medicine, University of Utah, Salt Lake City, Utah, USA; Verily Life Sciences, Mountain View, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yifan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raja</LastName><ForeName>Kalpana</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Section of Biomedical Informatics and Data Science, Yale School of Medicine, Yale University, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reeves</LastName><ForeName>Ruth M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>TN Valley Healthcare System, U.S. Department of Veterans Affairs, Nashville, TN, USA; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouhizadeh</LastName><ForeName>Masoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Outcomes &amp; Policy, University of Florida, Gainesville, FL, USA; Biomedical Informatics and Data Science, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Jianlin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, Utah, USA; Division of Epidemiology, Department of Internal Medicine, School of Medicine, University of Utah, Salt Lake City, Utah, USA; Department of Biomedical Informatics, University of Utah, Salt Lake City, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaoyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Sema4 Mount Sinai Genomics Incorporation, Stamford, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanshan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Information Management, Department of Biomedical Informatics, and Intelligent Systems Program, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei-Qi</ForeName><Initials>WQ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>School of Medicine, Tufts University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Health Informatics, and Department of Pharmaceutical Care &amp; Health Systems, University of Minnesota, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belenkaya</LastName><ForeName>Rimma</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Memorial Sloan Kettering Cancer Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Real World Solutions, IQVIA, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Titusville, NJ, USA; Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA; Janssen Pharmaceutical Research and Development LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elhadad</LastName><ForeName>No&#xe9;mie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA. Electronic address: noemie.elhadad@columbia.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Hua</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Section of Biomedical Informatics and Data Science, Yale School of Medicine, Yale University, New Haven, CT, USA. Electronic address: hua.xu@yale.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG059307</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R00 LM013001</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 TR002062</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AT009457</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002494</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077488" MajorTopicYN="Y">Data Science</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="N">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033262" MajorTopicYN="N">Narration</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electronic health records</Keyword><Keyword MajorTopicYN="N">Natural language processing</Keyword><Keyword MajorTopicYN="N">Real-world study</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest Dr. Hua Xu and The University of Texas Health Science Center at Houston have research related financial interests at Melax Technologies Inc. Dr. Xiaoyan Wang has related financial interests at Sema4 Mount Sinai Genomics Inc.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>19</Day><Hour>20</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36935011</ArticleId><ArticleId IdType="mid">NIHMS1897646</ArticleId><ArticleId IdType="pmc">PMC10428170</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2023.104343</ArticleId><ArticleId IdType="pii">S1532-0464(23)00064-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Corrigan-Curay J, Sacks L, Woodcock J. Real-world evidence and real-world data for evaluating drug safety and effectiveness. Jama. 2018;320(9):867&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30105359</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumfeld Andre E, Reynolds R, Caubel P, Azoulay L, Dreyer NA. Trial designs using real-world data: the changing landscape of the regulatory approval process. Pharmacoepidemiology and Drug Safety. 2020;29(10):1201&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7687110</ArticleId><ArticleId IdType="pubmed">31823482</ArticleId></ArticleIdList></Reference><Reference><Citation>Skovlund E, Leufkens H, Smyth J. The use of real-world data in cancer drug development. European Journal of Cancer. 2018;101:69&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">30031168</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojano M, Tintore M, Montalban X, Hillert J, Kalincik T, Iaffaldano P, et al. Treatment decisions in multiple sclerosis&#x2014;insights from real-world observational studies. Nature Reviews Neurology. 2017;13(2):105&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">28084327</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug
Administration - Real-World Evidence
[cited 2022 Jan 30]. Available
from: https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence.</Citation></Reference><Reference><Citation>Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, et al. Real-world evidence&#x2014;what is it and what can it tell us? New England Journal of Medicine. 2016;375(23):2293&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27959688</ArticleId></ArticleIdList></Reference><Reference><Citation>Patorno E, Gopalakrishnan C, Franklin JM, Brodovicz KG, Masso-Gonzalez E, Bartels DB, et al. Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records. Diabetes, Obesity and Metabolism. 2018;20(4):974&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6207375</ArticleId><ArticleId IdType="pubmed">29206336</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Hammond WE, Nahm M, Wixted D, Simon GE, Robinson JG, et al. Electronic health records based phenotyping in next-generation clinical trials: a perspective from the NIH Health Care Systems Collaboratory. Journal of the American Medical Informatics Association. 2013;20(e2):e226&#x2013;e31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861929</ArticleId><ArticleId IdType="pubmed">23956018</ArticleId></ArticleIdList></Reference><Reference><Citation>Khozin S, Blumenthal GM, Pazdur R. Real-world data for clinical evidence generation in oncology. JNCI: Journal of the National Cancer Institute. 2017;109(11):djx187.</Citation><ArticleIdList><ArticleId IdType="pubmed">29059439</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinelli M, Quattrociocchi W, Galeazzi A, Valensise CM, Brugnoli E, Schmidt AL, et al. The COVID-19 social media infodemic. Scientific reports. 2020;10(1):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538912</ArticleId><ArticleId IdType="pubmed">33024152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ates HC, Yetisen AK, G&#xfc;der F, Dincer C. Wearable devices for the detection of COVID-19. Nature Electronics. 2021;4(1):13&#x2013;4.</Citation></Reference><Reference><Citation>Jeon J, Baruah G, Sarabadani S, Palanica A. Identification of risk factors and symptoms of COVID-19: Analysis of biomedical literature and social media data. Journal of medical Internet research. 2020;22(10):e20509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537723</ArticleId><ArticleId IdType="pubmed">32936770</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug
Administration - Framework for FDA&#x2019;s Real-World Evidence Program [cited 2022 Jan
30]. Available from: https://www.fda.gov/media/120060/download.</Citation></Reference><Reference><Citation>Klann JG, Abend A, Raghavan VA, Mandl KD, Murphy SN. Data interchange using i2b2. Journal of the American Medical Informatics Association. 2016;23(5):909&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4997035</ArticleId><ArticleId IdType="pubmed">26911824</ArticleId></ArticleIdList></Reference><Reference><Citation>Sentinel Common Data Model
[cited 2022 Jan 30]. Available
from: https://www.sentinelinitiative.org/sentinel/data/distributed-database-common-data-model.</Citation></Reference><Reference><Citation>Toh S, Rasmussen-Torvik LJ, Harmata EE, Pardee R, Saizan R, Malanga E, et al. The National Patient-Centered Clinical Research Network (PCORnet) bariatric study cohort: rationale, methods, and baseline characteristics. JMIR research protocols. 2017;6(12):e8323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5736875</ArticleId><ArticleId IdType="pubmed">29208590</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt R, Carnahan RM, Brown JS, Chrischilles E, Curtis LH, Hennessy S, et al. The US Food and Drug Administration&#x2019;s Mini-Sentinel program: status and direction. Pharmacoepidemiology and drug safety. 2012;21:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22262586</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Studies in health technology and informatics. 2015;216:574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>OMOP Common Data Model
[cited 2022 Jan 30]. Available
from: https://ohdsi.github.io/CommonDataModel/.</Citation></Reference><Reference><Citation>Sachson C
Our Journey: Where the OHDSI Community Has Been, and Where We Are Going. 2021.  [cited 2022 Jan
30]. Available from: https://www.ohdsi.org/wp-content/uploads/2021/09/OHDSI-OurJourney2021-Final.pdf.</Citation></Reference><Reference><Citation>Velupillai S, Suominen H, Liakata M, Roberts A, Shah AD, Morley K, et al. Using clinical natural language processing for health outcomes research: overview and actionable suggestions for future advances. Journal of biomedical informatics. 2018;88:11&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6986921</ArticleId><ArticleId IdType="pubmed">30368002</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y, Wang J, Xu H, Roberts K. Enhancing clinical concept extraction with contextual embeddings. Journal of the American Medical Informatics Association. 2019;26(11):1297&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6798561</ArticleId><ArticleId IdType="pubmed">31265066</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Danciu I, Alamudun F, Miller T, Lin C, Bitterman DS, et al. Use of natural language processing to extract clinical cancer phenotypes from electronic medical records. Cancer research. 2019;79(21):5463&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227798</ArticleId><ArticleId IdType="pubmed">31395609</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman C, Hripcsak G, DuMouchel W, Johnson SB, Clayton PD. Natural language processing in an operational clinical information system. Natural Language Engineering. 1995;1(1):83&#x2013;108.</Citation></Reference><Reference><Citation>Aronson AR, Lang F-M. An overview of MetaMap: historical perspective and recent advances. Journal of the American Medical Informatics Association. 2010;17(3):229&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995713</ArticleId><ArticleId IdType="pubmed">20442139</ArticleId></ArticleIdList></Reference><Reference><Citation>Demner-Fushman D, Rogers WJ, Aronson AR. MetaMap Lite: an evaluation of a new Java implementation of MetaMap. Journal of the American Medical Informatics Association. 2017;24(4):841&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6080672</ArticleId><ArticleId IdType="pubmed">28130331</ArticleId></ArticleIdList></Reference><Reference><Citation>Savova GK, Masanz JJ, Ogren PV, Zheng J, Sohn S, Kipper-Schuler KC, et al. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications. Journal of the American Medical Informatics Association. 2010;17(5):507&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2995668</ArticleId><ArticleId IdType="pubmed">20819853</ArticleId></ArticleIdList></Reference><Reference><Citation>Soysal E, Wang J, Jiang M, Wu Y, Pakhomov S, Liu H, et al. CLAMP&#x2013;a toolkit for efficiently building customized clinical natural language processing pipelines. Journal of the American Medical Informatics Association. 2018;25(3):331&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7378877</ArticleId><ArticleId IdType="pubmed">29186491</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI Natural Language Processing
Working Group [cited 2022 Jan
31]. Available from: https://www.ohdsi.org/web/wiki/doku.php?id=projects:workgroups:nlp-wg.</Citation></Reference><Reference><Citation>OMOP CDM 5.4
[cited 2022 May 19]. Available
from: http://ohdsi.github.io/CommonDataModel/cdm54.html.</Citation></Reference><Reference><Citation>McCarty CA, Chisholm RL, Chute CG, Kullo IJ, Jarvik GP, Larson EB, et al. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC medical genomics. 2011;4(1):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038887</ArticleId><ArticleId IdType="pubmed">21269473</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI NLP tools - Wrappers [cited 2022 Jan 31].
Available from: https://github.com/OHDSI/NLPTools/tree/master/Wrappers.</Citation></Reference><Reference><Citation>OHDSI Ananke - A Tool for Mapping Between OHDSI Concept Identifiers to Unified Medical Language System (UMLS) identifiers [cited 2022
Jan 31]. Available from: https://github.com/thepanacealab/OHDSIananke.</Citation></Reference><Reference><Citation>OHDSI NLP tools repository [cited 2022 Jan
31]. Available from: https://github.com/OHDSI/NLPTools.</Citation></Reference><Reference><Citation>Cronin RM, Jerome RN, Mapes B, Andrade R, Johnston R, Ayala J, et al. Development of the initial surveys for the All of Us Research Program. Epidemiology (Cambridge, Mass). 2019;30(4):597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548672</ArticleId><ArticleId IdType="pubmed">31045611</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, Eichmann DA, Guinney J, Kibbe WA, et al. The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment. Journal of the American Medical Informatics Association. 2021;28(3):427&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Bielinski SJ, Sohn S, Murphy S, Wagholikar KB, Jonnalagadda SR, et al. An information extraction framework for cohort identification using electronic health records. AMIA Summits on Translational Science Proceedings. 2013;2013:149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3845757</ArticleId><ArticleId IdType="pubmed">24303255</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Wen A, Wang L, He H, Fu S, Miller R, et al. An Open Natural Language Processing Development Framework for EHR-based Clinical Research: A case demonstration using the National COVID Cohort Collaborative (N3C). arXiv preprint arXiv:211010780. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10654844</ArticleId><ArticleId IdType="pubmed">37555837</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch KE, Deppen SA, DuVall SL, Viernes B, Cao A, Park D, et al. Incrementally transforming electronic medical records into the observational medical outcomes partnership common data model: a multidimensional quality assurance approach. Applied clinical informatics. 2019;10(05):794&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6811349</ArticleId><ArticleId IdType="pubmed">31645076</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F, Patterson OV, Denton J, Brannen J, Reeves RM, DuVall SL, et al. OMOP CDM for Natural Language Processing: Piloting a VA NLP Data Set. OHDSI Conference; 2017.</Citation></Reference><Reference><Citation>Shi J, Mowery D, Zhang M, Sanders J, Chapman W, Gawron L. Extracting intrauterine device usage from clinical texts using natural language processing. 2017 IEEE International Conference on Healthcare Informatics (ICHI); 2017: IEEE.</Citation></Reference><Reference><Citation>Johnson SA, Signor EA, Lappe KL, Shi J, Jenkins SL, Wikstrom SW, et al. A comparison of natural language processing to ICD-10 codes for identification and characterization of pulmonary embolism. Thrombosis Research. 2021;203:190&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">34044246</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch JS, Tanenbaum JS, Lipsky Gorman S, Liu C, Schmitz E, Hashorva D, et al. HARVEST, a longitudinal patient record summarizer. Journal of the American Medical Informatics Association. 2015;22(2):263&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4394965</ArticleId><ArticleId IdType="pubmed">25352564</ArticleId></ArticleIdList></Reference><Reference><Citation>MedTagger
[cited 2022 May 13]. Available
from: https://github.com/OHNLP/MedTagger.</Citation></Reference><Reference><Citation>Shang N, Liu C, Rasmussen LV, Ta CN, Caroll RJ, Benoit B, et al. Making work visible for electronic phenotype implementation: Lessons learned from the eMERGE network. Journal of biomedical informatics. 2019;99:103293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6894517</ArticleId><ArticleId IdType="pubmed">31542521</ArticleId></ArticleIdList></Reference><Reference><Citation>Zachariah P, Hill-Ricciuti A, Saiman L, Natarajan K. Using the &#x201c;Who, What, and When&#x201d; of free text documentation to improve hospital infectious disease surveillance. American Journal of Infection Control. 2020;48(10):1261&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">32070629</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y, Wang X, Lu L, Bagheri M, Summers R, Lu Z. NegBio: a high-performance tool for negation and uncertainty detection in radiology reports. AMIA Summits on Translational Science Proceedings. 2018;2018:188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5961822</ArticleId><ArticleId IdType="pubmed">29888070</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, Zhang R. Using natural language processing methods to classify use status of dietary supplements in clinical notes. BMC medical informatics and decision making. 2018;18(2):15&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6069512</ArticleId><ArticleId IdType="pubmed">30066648</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan Y, Zhou S, Li Y, Zhang R. Deep learning approaches for extracting adverse events and indications of dietary supplements from clinical text. Journal of the American Medical Informatics Association. 2021;28(3):569&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7936508</ArticleId><ArticleId IdType="pubmed">33150942</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammad HA, Sivarajkumar S, Viggiano S, Oniani D, Visweswaran S, Wang Y. Extraction of Sleep Information from Clinical Notes of Alzheimer&#x2019;s Disease Patients Using Natural Language Processing. medRxiv. 2022.</Citation></Reference><Reference><Citation>Luigi
[cited 2022 May 10]. Available
from: https://github.com/spotify/luigi.</Citation></Reference><Reference><Citation>Honnibal M, Johnson M. An improved non-monotonic transition system for dependency parsing. Proceedings of the 2015 conference on empirical methods in natural language processing; 2015.</Citation></Reference><Reference><Citation>Wolf T, Debut L, Sanh V, Chaumond J, Delangue C, Moi A, et al. Transformers: State-of-the-art natural language processing. Proceedings of the 2020 conference on empirical methods in natural language processing: system demonstrations; 2020.</Citation></Reference><Reference><Citation>Heider PM, Pipaliya RM, Meystre SM. A Natural Language Processing Tool Offering Data Extraction for COVID-19 Related Information (DECOVRI). MEDINFO 2021: The 18th World Congress on Medical and Health Informatics; 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">35673206</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci D, Lally A. UIMA: an architectural approach to unstructured information processing in the corporate research environment. Natural Language Engineering. 2004;10(3&#x2013;4):327&#x2013;48.</Citation></Reference><Reference><Citation>Eyre H, Chapman AB, Peterson KS, Shi J, Alba PR, Jones MM, et al. Launching into clinical space with medspaCy: a new clinical text processing toolkit in Python. arXiv preprint arXiv:210607799. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8861690</ArticleId><ArticleId IdType="pubmed">35308962</ArticleId></ArticleIdList></Reference><Reference><Citation>Off-the-Shelf Post-hoc Ensemble Generation Algorithms [cited 2022 May
13]. Available from: https://github.com/MUSC-TBIC/ots-ensemble-systems.</Citation></Reference><Reference><Citation>Social Determinants of Health Shared
Resource (SHARE) [cited 2023 Jan
16]. Available from: https://hollingscancercenter.musc.edu/research/shared-resources/social-determinants-of-health.</Citation></Reference><Reference><Citation>Genomic-CDM
[cited 2022 May 19]. Available
from: https://github.com/OHDSI/Genomic-CDM.</Citation></Reference><Reference><Citation>Paris N, Parrot A. MIMIC in the OMOP Common Data Model. medRxiv. 2020.</Citation></Reference><Reference><Citation>Ryu B, Yoon E, Kim S, Lee S, Baek H, Yi S, et al. Transformation of pathology reports into the common data model with oncology module: use case for colon cancer. Journal of medical Internet research. 2020;22(12):e18526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7758167</ArticleId><ArticleId IdType="pubmed">33295294</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma H, Mao C, Zhang Y, Vatani H, Yao L, Zhong Y, et al. Developing a portable natural language processing based phenotyping system. BMC Medical Informatics and Decision Making. 2019;19(3):79&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6448187</ArticleId><ArticleId IdType="pubmed">30943974</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S, Posada J, Olson G, Li W, O&#x2019;Reilly C, Balraj D, et al. A new paradigm for accelerating clinical data science at Stanford Medicine. arXiv preprint arXiv:200310534. 2020.</Citation></Reference><Reference><Citation>Zuo X, Li J, Zhao B, Zhou Y, Dong X, Duke J, et al. Normalizing Clinical Document Titles to LOINC Document Ontology: An Initial Study. AMIA Annual Symposium Proceedings; 2020: American Medical Informatics Association.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075502</ArticleId><ArticleId IdType="pubmed">33936520</ArticleId></ArticleIdList></Reference><Reference><Citation>LOINC Document Ontology
[cited 2022 May 13]. Available
from: https://loinc.org/document-ontology/.</Citation></Reference><Reference><Citation>Tao S, Cui L, Wu X, Zhang G-Q. Facilitating cohort discovery by enhancing ontology exploration, query management and query sharing for large clinical data repositories. AMIA Annual Symposium Proceedings; 2017: American Medical Informatics Association.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5977665</ArticleId><ArticleId IdType="pubmed">29854239</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Li X, Zhang G-Q. ELII: A novel inverted index for fast temporal query, with application to a large Covid-19 EHR dataset. Journal of Biomedical Informatics. 2021;117:103744.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9759789</ArticleId><ArticleId IdType="pubmed">33775815</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan A, Polony V, Posada JD, Banda JM, Gombar S, Shah NH. ACE: the Advanced Cohort Engine for searching longitudinal patient records. Journal of the American Medical Informatics Association. 2021;28(7):1468&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8279796</ArticleId><ArticleId IdType="pubmed">33712854</ArticleId></ArticleIdList></Reference><Reference><Citation>THEIA
[cited 2022 May 19]. Available
from: https://github.com/OHDSI/NLPTools/tree/master/THEIA.</Citation></Reference><Reference><Citation>Banda JM, Halpern Y, Sontag D, Shah NH. Electronic phenotyping with APHRODITE and the Observational Health Sciences and Informatics (OHDSI) data network. AMIA Summits on Translational Science Proceedings. 2017;2017:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543379</ArticleId><ArticleId IdType="pubmed">28815104</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal V, Podchiyska T, Banda JM, Goel V, Leung TI, Minty EP, et al. Learning statistical models of phenotypes using noisy labeled training data. Journal of the American Medical Informatics Association. 2016;23(6):1166&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070523</ArticleId><ArticleId IdType="pubmed">27174893</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpern Y, Horng S, Choi Y, Sontag D. Electronic medical record phenotyping using the anchor and learn framework. Journal of the American Medical Informatics Association. 2016;23(4):731&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4926745</ArticleId><ArticleId IdType="pubmed">27107443</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Z, Deng Y, Li X, Naumann T, Luo Y. Natural language processing for EHR-based computational phenotyping. IEEE/ACM transactions on computational biology and bioinformatics. 2018;16(1):139&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6388621</ArticleId><ArticleId IdType="pubmed">29994486</ArticleId></ArticleIdList></Reference><Reference><Citation>Real-World Data: Assessing Electronic Health Records and Medical Claims Data To Support Regulatory Decision-Making for Drug and Biological Products [cited 2022 May
12]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/real-world-data-assessing-electronic-health-records-and-medical-claims-data-support-regulatory.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9320939</ArticleId><ArticleId IdType="pubmed">35471704</ArticleId></ArticleIdList></Reference><Reference><Citation>Digan W, N&#xe9;v&#xe9;ol A, Neuraz A, Wack M, Baudoin D, Burgun A, et al. Can reproducibility be improved in clinical natural language processing? A study of 7 clinical NLP suites. Journal of the American Medical Informatics Association. 2021;28(3):504&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7936396</ArticleId><ArticleId IdType="pubmed">33319904</ArticleId></ArticleIdList></Reference><Reference><Citation>Stubbs A, Kotfila C, Uzuner &#xd6;. Automated systems for the de-identification of longitudinal clinical narratives: Overview of 2014 i2b2/UTHealth shared task Track 1. Journal of biomedical informatics. 2015;58:S11&#x2013;S9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4989908</ArticleId><ArticleId IdType="pubmed">26225918</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C, Islam M, Sheils NE, Buresh J, Reps J, Schuemie MJ, et al. DLMM as a lossless one-shot algorithm for collaborative multi-site distributed linear mixed models. Nature communications. 2022;13(1):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8967932</ArticleId><ArticleId IdType="pubmed">35354802</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36977531</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1533-0338</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><PubDate><Year>2023</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Technology in cancer research &amp; treatment</Title><ISOAbbreviation>Technol Cancer Res Treat</ISOAbbreviation></Journal><ArticleTitle>Cancer Research Line (CAREL): Development of Expanded Distributed Research Networks for Prostate Cancer and Lung Cancer.</ArticleTitle><Pagination><StartPage>15330338221149262</StartPage><MedlinePgn>15330338221149262</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">15330338221149262</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/15330338221149262</ELocationID><Abstract><AbstractText><b>Objectives:</b> Big data-based multicenter medical research is expected to bring significant advances to cancer treatment worldwide. However, there are concerns related to data sharing among multicenter networks. Clinical data can be shielded by firewalls using distributed research networks (DRNs). We attempted to develop DRNs for multicenter research that can be easily installed and used by any institution. <b>Patients and Methods:</b> We propose a DRN for multicenter cancer research called the cancer research line (CAREL) and present a data catalog based on a common data model (CDM). CAREL was validated using 1723 patients with prostate cancer and 14&#x2005;990 patients with lung cancer in a retrospective study. We used the attribute-value pairs and array data type JavaScript object notation (JSON) format to interface third-party security solutions such as blockchain. <b>Results:</b> We developed visualized data catalogs of prostate and lung cancer based on the observational medical outcomes partnership (OMOP) CDM, from which researchers can easily browse and select relevant data. We made the CAREL source code readily available for download and application for relevant purposes. In addition, it is possible to realize a multicenter research network using CAREL development sources. <b>Conclusion:</b> CAREL source can enable medical institutions to participate in multicenter cancer research. Our technology is open source, so small institutions that cannot afford to spend high costs can use it to develop a platform for multicenter research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jihwan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4027-1038</Identifier><AffiliationInfo><Affiliation>Department of Computer Education, Dankook Liberal Art College, Dankook University, Cheonan-si, Chungcheongnam-do, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ji Youl</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Urology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moon</LastName><ForeName>Mi Hyoung</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Yong Hyun</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Urology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rho</LastName><ForeName>Mi Jung</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-9862-0122</Identifier><AffiliationInfo><Affiliation>College of Health Science, Dankook University, Cheonan-si, Chungcheongnam-do, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Technol Cancer Res Treat</MedlineTA><NlmUniqueID>101140941</NlmUniqueID><ISSNLinking>1533-0338</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="Y">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="Y">Lung Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cancer research line</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">distributed research networks</Keyword><Keyword MajorTopicYN="N">lung cancer</Keyword><Keyword MajorTopicYN="N">prostate cancer</Keyword></KeywordList><CoiStatement>The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The Mi Jung Rho and Jihwan Park, are married couples. They participated in this project at the time of the research. For the remaining authors, there are no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>20</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36977531</ArticleId><ArticleId IdType="pmc">PMC10061631</ArticleId><ArticleId IdType="doi">10.1177/15330338221149262</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Center NC. 2017 Cancer Registration Statistics Press Release. In: 2020.</Citation></Reference><Reference><Citation>Center NC. National Cancer Registration Project Annual Report (2017 Cancer Registration Statistics). In: 2020.</Citation></Reference><Reference><Citation>Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207593</ArticleId></ArticleIdList></Reference><Reference><Citation>Toh S, Gagne JJ, Rassen JA, Fireman BH, Kulldorff M, Brown JSJMc. Confounding adjustment in comparative effectiveness research conducted within distributed research networks. Medical Care. 2013;51:S4-S10.</Citation><ArticleIdList><ArticleId IdType="pubmed">23752258</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54-60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes JH, Elliott TE, Brown JS, et al.. Clinical research data warehouse governance for distributed research networks in the USA: a systematic review of the literature. J Am Med Inform Assoc. 2014;21(4):730-736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078282</ArticleId><ArticleId IdType="pubmed">24682495</ArticleId></ArticleIdList></Reference><Reference><Citation>Welfare MoHa. Health and medical big data platform. https://hcdl.mohw.go.kr</Citation></Reference><Reference><Citation>Management KIoDSR. MOA project &#x2013; medical record observation and assessment for drug safety. https://moa.drugsafe.or.kr/main.</Citation></Reference><Reference><Citation>Son N, Kim B, Chung S, Han S. Korean Pharmacovigilance system based on EHR-CDM. Stud Health Technol Inform. 2019;264:1592-1593.</Citation><ArticleIdList><ArticleId IdType="pubmed">31438247</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi W, Yang Y-S, Chang D-J, et al.. Association between the use of allopurinol and risk of increased thyroid-stimulating hormone level. Sci Rep. 2021;11(1):1-10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8514499</ArticleId><ArticleId IdType="pubmed">34645831</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang W, Cheng J, Allaire JJ, Xie Y, McPherson J. shiny: Web application framework for R. In:2018.</Citation></Reference><Reference><Citation>Droettboom M. Understanding JSON Schema. 2015. Available on:
http://spacetelescope github io/understanding-jsonschema/UnderstandingJSONSchema pdf
(accessed on 14 April 2014).</Citation></Reference><Reference><Citation>Donnelly K. SNOMED-CT: The advanced terminology and coding system for eHealth. Stud Health Technol Inform. 2006;121:279.</Citation><ArticleIdList><ArticleId IdType="pubmed">17095826</ArticleId></ArticleIdList></Reference><Reference><Citation>Farzandipour M, Sheikhtaheri A, Sadoughi F. Effective factors on accuracy of principal diagnosis coding based on international classification of diseases, the 10th revision (ICD-10). Int J Inf Manage. 2010;30(1):78-84.</Citation></Reference><Reference><Citation>RxNorm. National Library of Medicine. RxNorm technical documentation 2018. https://www.nlm.nih.gov/research/umls/rxnorm/docs/index.html. Accessed 1 October, 2020.</Citation></Reference><Reference><Citation>Ji H, Kim S, Yi S, Hwang H, Kim J-W, Yoo S. Converting clinical document architecture documents to the common data model for incorporating health information exchange data in observational health studies: CDA to CDM. J Biomed Inform. 2020;10:103459.</Citation><ArticleIdList><ArticleId IdType="pubmed">32470694</ArticleId></ArticleIdList></Reference><Reference><Citation>Prats-Uribe A, Sena AG, Lai LYH, et al.. Use of repurposed and adjuvant drugs in hospital patients with COVID-19: multinational network cohort study. BMJ. 2021;37:n1038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8111167</ArticleId><ArticleId IdType="pubmed">33975825</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon S, Seo J, Kim S, et al.. Proposal and assessment of a de-identification strategy to enhance anonymity of the observational medical outcomes partnership common data model (OMOP-CDM) in a public cloud-computing environment: anonymization of medical data using privacy models. J Med Internet Res. 2020;22(11):e19597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7728527</ArticleId><ArticleId IdType="pubmed">33177037</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;nnapuu K, Ioannou S, Ligi K, et al.. Trajectories: A framework for detecting temporal clinical event sequences from health data standardized to the observational medical outcomes partnership (OMOP) common data model. JAMIA open. 2022;5(1):ooac021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9097714</ArticleId><ArticleId IdType="pubmed">35571357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Depas N, Doutreligne M, et al.. Transforming French electronic health records into the observational medical outcome partnership&#x2019;s common data model: a feasibility study. Appl Clin Inform. 2020;11(01):013-022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6949163</ArticleId><ArticleId IdType="pubmed">31914471</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung H, Yoo S, Kim S, et al.. Patient-level fall risk prediction using the observational medical outcomes partnership&#x2019;s common data model: pilot feasibility study. JMIR Med Inform. 2022;10(3):e35104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957002</ArticleId><ArticleId IdType="pubmed">35275076</ArticleId></ArticleIdList></Reference><Reference><Citation>Sentinel. Sentinel common data model version 7.1.0. https://www.sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/sentinel-common-data-model. Accessed 1 October 2020.</Citation></Reference><Reference><Citation>OHDSI. The observational health data sciences and informatics. https://www.ohdsi.org/.</Citation></Reference><Reference><Citation>PCORnet. The national patient-centered clinical research network. https://pcornet.org/. Accessed 1 October 2020.</Citation></Reference><Reference><Citation>Ross TR, Ng D, Brown JS, et al.. The HMO research network virtual data warehouse: a public data model to support collaboration. Egems. 2014;2(1):1049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371424</ArticleId><ArticleId IdType="pubmed">25848584</ArticleId></ArticleIdList></Reference><Reference><Citation>CDISC. Clinical Data Interchange Standards Consortium Study Data Tabulation Model (SDTM) v1.8. https://www.cdisc.org/standards/foundational/sdtm. Accessed 1 October 2020.</Citation></Reference><Reference><Citation>Shafranovich Y. Common format and MIME type for comma-separated values (CSV) files. 2005.</Citation></Reference><Reference><Citation>Rho MJ, Kim SR, Park SH, et al.. Common data model for decision support system of adverse drug reaction to extract knowledge from multi-center database. Information Technology and Management, 2016;17(1):57-66.</Citation></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016;64:333-341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36991144</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2398-6352</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>30</Day></PubDate></JournalIssue><Title>NPJ digital medicine</Title><ISOAbbreviation>NPJ Digit Med</ISOAbbreviation></Journal><ArticleTitle>A standardized framework for risk-based assessment of treatment effect heterogeneity in observational healthcare databases.</ArticleTitle><Pagination><StartPage>58</StartPage><MedlinePgn>58</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">58</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41746-023-00794-y</ELocationID><Abstract><AbstractText>Treatment effects are often anticipated to vary across groups of patients with different baseline risk. The Predictive Approaches to Treatment Effect Heterogeneity (PATH) statement focused on baseline risk as a robust predictor of treatment effect and provided guidance on risk-based assessment of treatment effect heterogeneity in a randomized controlled trial. The aim of this study is to extend this approach to the observational setting using a standardized scalable framework. The proposed framework consists of five steps: (1) definition of the research aim, i.e., the population, the treatment, the comparator and the outcome(s) of interest; (2) identification of relevant databases; (3) development of a prediction model for the outcome(s) of interest; (4) estimation of relative and absolute treatment effect within strata of predicted risk, after adjusting for observed confounding; (5) presentation of the results. We demonstrate our framework by evaluating heterogeneity of the effect of thiazide or thiazide-like diuretics versus angiotensin-converting enzyme inhibitors on three efficacy and nine safety outcomes across three observational databases. We provide a publicly available R software package for applying this framework to any database mapped to the Observational Medical Outcomes Partnership Common Data Model. In our demonstration, patients at low risk of acute myocardial infarction receive negligible absolute benefits for all three efficacy outcomes, though they are more pronounced in the highest risk group, especially for acute myocardial infarction. Our framework allows for the evaluation of differential treatment effects across risk strata, which offers the opportunity to consider the benefit-harm trade-off between alternative treatments.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rekkas</LastName><ForeName>Alexandros</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5352-943X</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands. a.rekkas@erasmusmc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Klaveren</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies (ICRHPS), Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, 125 Trenton Harbourton Road, Titusville, NJ, 08560, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steyerberg</LastName><ForeName>Ewout W</ForeName><Initials>EW</Initials><Identifier Source="ORCID">0000-0002-7787-0122</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kent</LastName><ForeName>David M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0002-9205-5070</Identifier><AffiliationInfo><Affiliation>Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies (ICRHPS), Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>80696</GrantID><Agency>Innovative Medicines Initiative (IMI)</Agency><Country/></Grant><Grant><GrantID>80696</GrantID><Agency>Innovative Medicines Initiative (IMI)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>NPJ Digit Med</MedlineTA><NlmUniqueID>101731738</NlmUniqueID><ISSNLinking>2398-6352</ISSNLinking></MedlineJournalInfo><CoiStatement>A.R. and P.R.R. work for a group that received unconditional research grants from Boehringer-Ingelheim, GSK, Janssen Research &amp; Development, Novartis, Pfizer, Yamanouchi, and Servier. None of these grants result in a conflict of interest for the content of this paper. P.B.R. is an employee of Janssen R&amp;D, subsidiary of Johnson &amp; Johnson. D.V.K., D.M.K., E.W.S. have nothing to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36991144</ArticleId><ArticleId IdType="pmc">PMC10060247</ArticleId><ArticleId IdType="doi">10.1038/s41746-023-00794-y</ArticleId><ArticleId IdType="pii">10.1038/s41746-023-00794-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rothwell PM. Can overall results of clinical trials be applied to all patients? Lancet. 1995;345:1616&#x2013;1619. doi: 10.1016/S0140-6736(95)90120-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(95)90120-5</ArticleId><ArticleId IdType="pubmed">7783541</ArticleId></ArticleIdList></Reference><Reference><Citation>Kravitz RL, Duan N, Braslow J. Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. Milbank Q. 2004;82:661&#x2013;687. doi: 10.1111/j.0887-378X.2004.00327.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0887-378X.2004.00327.x</ArticleId><ArticleId IdType="pmc">PMC2690188</ArticleId><ArticleId IdType="pubmed">15595946</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward RA, Kent DM, Vijan S, Hofer TP. Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis. BMC Med. Res. Methodol. 2006;6:18. doi: 10.1186/1471-2288-6-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-6-18</ArticleId><ArticleId IdType="pmc">PMC1523355</ArticleId><ArticleId IdType="pubmed">16613605</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent, D. M., Steyerberg, E. &amp; Klaveren, D. van. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. BMJ k4245 10.1136/bmj.k4245 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6889830</ArticleId><ArticleId IdType="pubmed">30530757</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothwell PM, Mehta Z, Howard SC, Gutnikov SA, Warlow CP. From subgroups to individuals: general principles and the example of carotid endarterectomy. Lancet. 2005;365:256&#x2013;265. doi: 10.1016/S0140-6736(05)70156-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)70156-2</ArticleId><ArticleId IdType="pubmed">15652609</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA. 2007;298:1209&#x2013;1212. doi: 10.1001/jama.298.10.1209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.298.10.1209</ArticleId><ArticleId IdType="pubmed">17848656</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent DM, Alsheikh-Ali A, Hayward RA. Competing risk and heterogeneity of treatment effect in clinical trials. Trials. 2008;9:30. doi: 10.1186/1745-6215-9-30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-9-30</ArticleId><ArticleId IdType="pmc">PMC2423182</ArticleId><ArticleId IdType="pubmed">18498644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010;11:85. doi: 10.1186/1745-6215-11-85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1745-6215-11-85</ArticleId><ArticleId IdType="pmc">PMC2928211</ArticleId><ArticleId IdType="pubmed">20704705</ArticleId></ArticleIdList></Reference><Reference><Citation>Thune JJ, et al. Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty. Circulation. 2005;112:2017&#x2013;2021. doi: 10.1161/CIRCULATIONAHA.105.558676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.558676</ArticleId><ArticleId IdType="pubmed">16186438</ArticleId></ArticleIdList></Reference><Reference><Citation>Sussman JB, Kent DM, Nelson JP, Hayward RA. Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program. BMJ. 2015;350:h454&#x2013;h454. doi: 10.1136/bmj.h454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h454</ArticleId><ArticleId IdType="pmc">PMC4353279</ArticleId><ArticleId IdType="pubmed">25697494</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent DM, et al. The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement. Ann. Intern. Med. 2019;172:35. doi: 10.7326/M18-3667.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-3667</ArticleId><ArticleId IdType="pmc">PMC7531587</ArticleId><ArticleId IdType="pubmed">31711134</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent DM, et al. The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration. Ann. Intern. Med. 2019;172:W1. doi: 10.7326/M18-3668.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-3668</ArticleId><ArticleId IdType="pmc">PMC7750907</ArticleId><ArticleId IdType="pubmed">31711094</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud. Health Technol. Inform. 2015;216:574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J. Am. Med. Inform. Assoc. 2012;19:54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Gruber S, Zorych I, Madigan D. Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system. Drug Saf. 2013;36:59&#x2013;72. doi: 10.1007/s40264-013-0099-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-013-0099-6</ArticleId><ArticleId IdType="pubmed">24166224</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394:1816&#x2013;1826. doi: 10.1016/S0140-6736(19)32317-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat. Med. 2014;33:209&#x2013;218. doi: 10.1002/sim.5925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5925</ArticleId><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. Proc. Natl Acad. Sci. USA. 2018;115:2571&#x2013;2577. doi: 10.1073/pnas.1708282114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708282114</ArticleId><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Hripcsak G, Madigan D, Suchard MA. Improving reproducibility by using high-throughput observational studies with empirical calibration. Philos. Trans. R. Soc. A: Math. Phys. Eng. Sci. 2018;376:20170356. doi: 10.1098/rsta.2017.0356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsta.2017.0356</ArticleId><ArticleId IdType="pmc">PMC6107542</ArticleId><ArticleId IdType="pubmed">30082302</ArticleId></ArticleIdList></Reference><Reference><Citation>Rekkas A, et al. Predictive approaches to heterogeneous treatment effects: a scoping review. BMC Med. Res. Methodol. 2020;20:264. doi: 10.1186/s12874-020-01145-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-020-01145-1</ArticleId><ArticleId IdType="pmc">PMC7585220</ArticleId><ArticleId IdType="pubmed">33096986</ArticleId></ArticleIdList></Reference><Reference><Citation>Varadhan R, Segal JB, Boyd CM, Wu AW, Weiss CO. A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research. J. Clin. Epidemiol. 2013;66:818&#x2013;825. doi: 10.1016/j.jclinepi.2013.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2013.02.009</ArticleId><ArticleId IdType="pmc">PMC4450361</ArticleId><ArticleId IdType="pubmed">23651763</ArticleId></ArticleIdList></Reference><Reference><Citation>Anglemyer A, Horvath HT, Bero L. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Cochrane Database Syst. Rev. 2014;2014:MR000034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8191367</ArticleId><ArticleId IdType="pubmed">24782322</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahabreh IJ, Hayward R, Kent DM. Using group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence. Int. J. Epidemiol. 2016;45:2184&#x2013;2193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5841616</ArticleId><ArticleId IdType="pubmed">27864403</ArticleId></ArticleIdList></Reference><Reference><Citation>Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13&#x2013;e115.</Citation><ArticleIdList><ArticleId IdType="pubmed">29133356</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Schuemie MJ, Suchard MA, Ryan PB, Rijnbeek PR. Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data. J. Am. Med. Inform. Assoc. 2018;25:969&#x2013;975. doi: 10.1093/jamia/ocy032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy032</ArticleId><ArticleId IdType="pmc">PMC6077830</ArticleId><ArticleId IdType="pubmed">29718407</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Reitsma JB, Altman DG, Moons K. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Med. 2015;13:1. doi: 10.1186/s12916-014-0241-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-014-0241-z</ArticleId><ArticleId IdType="pmc">PMC4284921</ArticleId><ArticleId IdType="pubmed">25563062</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KGM, et al. Transparent reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): explanation and elaboration. Ann. Intern. Med. 2015;162:W1&#x2013;W73. doi: 10.7326/M14-0698.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-0698</ArticleId><ArticleId IdType="pubmed">25560730</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke JF, Hayward RA, Nelson JP, Kent DM. Using internally developed risk models to assess heterogeneity in treatment effects in clinical trials. Circ. Cardiovasc. Qual. Outcomes. 2014;7:163&#x2013;169. doi: 10.1161/CIRCOUTCOMES.113.000497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.113.000497</ArticleId><ArticleId IdType="pmc">PMC3957096</ArticleId><ArticleId IdType="pubmed">24425710</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaveren D, van, Balan TA, Steyerberg EW, Kent DM. Models with interactions overestimated heterogeneity of treatment effects and were prone to treatment mistargeting. J. Clin. Epidemiol. 2019;114:72&#x2013;83. doi: 10.1016/j.jclinepi.2019.05.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2019.05.029</ArticleId><ArticleId IdType="pmc">PMC7497896</ArticleId><ArticleId IdType="pubmed">31195109</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar. Behav. Res. 2011;46:399&#x2013;424. doi: 10.1080/00273171.2011.568786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00273171.2011.568786</ArticleId><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37023843</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>141</Volume><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>The need for multimodal health data modeling: A practical approach for a federated-learning healthcare platform.</ArticleTitle><Pagination><StartPage>104338</StartPage><MedlinePgn>104338</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2023.104338</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(23)00059-X</ELocationID><Abstract><AbstractText>Federated learning initiatives in healthcare are being developed to collaboratively train predictive models without the need to centralize sensitive personal data. GenoMed4All is one such project, with the goal of connecting European clinical and -omics data repositories on rare diseases through a federated learning platform. Currently, the consortium faces the challenge of a lack of well-established international datasets and interoperability standards for federated learning applications on rare diseases. This paper presents our practical approach to select and implement a Common Data Model (CDM) suitable for the federated training of predictive models applied to the medical domain, during the initial design phase of our federated learning platform. We describe our selection process, composed of identifying the consortium's needs, reviewing our functional and technical architecture specifications, and extracting a list of business requirements. We review the state of the art and evaluate three widely-used approaches (FHIR, OMOP and Phenopackets) based on a checklist of requirements and specifications. We discuss the pros and cons of each approach considering the use cases specific to our consortium as well as the generic issues of implementing a European federated learning healthcare platform. A list of lessons learned from the experience in our consortium is discussed, from the importance of establishing the proper communication channels for all stakeholders to technical aspects related to -omics data. For federated learning projects focused on secondary use of health data for predictive modeling, encompassing multiple data modalities, a phase of data model convergence is sorely needed to gather different data representations developed in the context of medical research, interoperability of clinical care software, imaging, and -omics analysis into a coherent, unified data model. Our work identifies this need and presents our experience and a list of actionable lessons learned for future work in this direction.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cremonesi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Universit&#xe9; C&#xf4;te d'Azur, Inria Sophia Antipolis-M&#xe9;diteran&#xe9;e, Epione Research Project, France; Datawizard s.r.l., Rome, Italy. Electronic address: francesco.cremonesi@inria.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Planat</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Dedalus, Global Consulting, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalokyri</LastName><ForeName>Varvara</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation for Research and Technology - Hellas, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondylakis</LastName><ForeName>Haridimos</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, Foundation for Research and Technology - Hellas, Crete, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanavia</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences, University of Torino, Torino, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miguel Mateos Resinas</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Dedalus Healthcare, M&#xe1;laga, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Babita</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uribe</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Escuela T&#xe9;cnica Superior de Ingenier&#xed;a de Sistemas Inform&#xe1;ticos, Universidad Polit&#xe9;cnica de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035583" MajorTopicYN="Y">Rare Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057189" MajorTopicYN="N">Checklist</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003132" MajorTopicYN="N">Commerce</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003142" MajorTopicYN="N">Communication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data model</Keyword><Keyword MajorTopicYN="N">Federated learning</Keyword><Keyword MajorTopicYN="N">Healthcare</Keyword><Keyword MajorTopicYN="N">Lessons learned</Keyword><Keyword MajorTopicYN="N">Medical research</Keyword><Keyword MajorTopicYN="N">Omics</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: All authors reports financial support was provided by European Union.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>6</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37023843</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2023.104338</ArticleId><ArticleId IdType="pii">S1532-0464(23)00059-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37025303</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2639-8028</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Critical care explorations</Title><ISOAbbreviation>Crit Care Explor</ISOAbbreviation></Journal><ArticleTitle>A Path to Real-World Evidence in Critical Care Using Open-Source Data Harmonization Tools.</ArticleTitle><Pagination><StartPage>e0893</StartPage><MedlinePgn>e0893</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0893</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCE.0000000000000893</ELocationID><Abstract><AbstractText>COVID-19 highlighted the need for use of real-world data (RWD) in critical care as a near real-time resource for clinical, research, and policy efforts. Analysis of RWD is gaining momentum and can generate important evidence for policy makers and regulators. Extracting high quality RWD from electronic health records (EHRs) requires sophisticated infrastructure and dedicated resources. We sought to customize freely available public tools, supporting all phases of data harmonization, from data quality assessments to de-identification procedures, and generation of robust, data science ready RWD from EHRs. These data are made available to clinicians and researchers through CURE ID, a free platform which facilitates access to case reports of challenging clinical cases and repurposed treatments hosted by the National Center for Advancing Translational Sciences/National Institutes of Health in partnership with the Food and Drug Administration. This commentary describes the partnership, rationale, process, use case, impact in critical care, and future directions for this collaborative effort.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heavner</LastName><ForeName>Smith F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>CURE Drug Repurposing Collaboratory, Critical Path Institute, Tucson, AZ.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health Sciences, Clemson University, Clemson, SC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>Wesley</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Quantitative Medicine, Critical Path Institute, Tucson, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kashyap</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Research, WellSpan Health, York, PA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care Medicine, Mayo Clinic, Rochester, MN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dasher</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>CURE Drug Repurposing Collaboratory, Critical Path Institute, Tucson, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Math&#xe9;</LastName><ForeName>Ewy A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merson</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>ISARIC, Pandemic Sciences Institute, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerin</LastName><ForeName>Philippe J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Infectious Diseases Data Observatory, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weaver</LastName><ForeName>Jeff</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Office of Information Technology, Emory University, Atlanta, GA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine-Infectious Disease, Johns Hopkins University, Baltimore, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schito</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CURE Drug Repurposing Collaboratory, Critical Path Institute, Tucson, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Vishakha K</ForeName><Initials>VK</Initials><AffiliationInfo><Affiliation>Society for Critical Care Medicine, Mount Prospect, IL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagy</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Johns Hopkins University School of Medicine, Baltimore, MD.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Explor</MedlineTA><NlmUniqueID>101746347</NlmUniqueID><ISSNLinking>2639-8028</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Observational Medical Outcomes Partnership (OMOP)</Keyword><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">data harmonization</Keyword><Keyword MajorTopicYN="N">drug repurposing</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">real-world data</Keyword></KeywordList><CoiStatement>The authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>7</Day><Hour>2</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37025303</ArticleId><ArticleId IdType="pmc">PMC10072311</ArticleId><ArticleId IdType="doi">10.1097/CCE.0000000000000893</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Concato J, Corrigan-Curay J: Real-World evidence &#x2014; where are we now? N Engl J Med 2022; 386:1680&#x2013;1682</Citation><ArticleIdList><ArticleId IdType="pubmed">35485775</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkey AJ, Sheldrick RC, Kashyap R, et al. : Guiding principles for the conduct of observational critical care research for coronavirus disease 2019 pandemics and beyond: The Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study Registry. Crit Care Med 2020; 48:e1038&#x2013;e1044</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540620</ArticleId><ArticleId IdType="pubmed">32932348</ArticleId></ArticleIdList></Reference><Reference><Citation>Peacock FW, Hauser GR, Toshev P, et al. : 59 Artificial intelligence occult sepsis detection in the emergency department: A large, multicenter real-world data study. Ann Emerg Med 2021; 78:S24</Citation></Reference><Reference><Citation>Williams E, Szakmany T, Spernaes I, et al. : Discrete-event simulation modeling of critical care flow: New hospital, old challenges. Crit Care Explor 2020; 2:e0174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491890</ArticleId><ArticleId IdType="pubmed">32984824</ArticleId></ArticleIdList></Reference><Reference><Citation>Derman BA, Belli AJ, Battiwalla M, et al. : Reality check: Real-world evidence to support therapeutic development in hematologic malignancies. Blood Rev 2022; 53100913.</Citation><ArticleIdList><ArticleId IdType="pubmed">35272867</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrigan-Curay J, Sacks L, Woodcock J: Real-World evidence and real-world data for evaluating drug safety and effectiveness. JAMA 2018; 320:867&#x2013;868</Citation><ArticleIdList><ArticleId IdType="pubmed">30105359</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh TU, Parida S, Lingaraju MC, et al. : Drug repurposing approach to fight COVID-19. Pharmacol Rep 2020; 72:1479&#x2013;1508</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7474498</ArticleId><ArticleId IdType="pubmed">32889701</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahoo BM, Ravi Kumar BVV, Sruti J, et al. : Drug repurposing strategy (DRS): Emerging approach to identify potential therapeutics for treatment of novel coronavirus infection. Front Mol Biosci 2021; 8:628144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7953054</ArticleId><ArticleId IdType="pubmed">33718434</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh CC, Thamm K, Berghelli AV, et al. : Drug repurposing screen identifies Foxo1-dependent angiopoietin-2 regulation in sepsis. Crit Care Med 2015; 43:e230&#x2013;e240</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4806531</ArticleId><ArticleId IdType="pubmed">25855898</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink MP, Warren HS: Strategies to improve drug development for sepsis. Nat Rev Drug Discov 2014; 13:741&#x2013;758</Citation><ArticleIdList><ArticleId IdType="pubmed">25190187</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrido-Mesa J, Adams K, Galvez J, et al. : Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: A critical discussion of recent publications. Expert Opin Investig Drugs 2022; 31:475&#x2013;482</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115781</ArticleId><ArticleId IdType="pubmed">35294307</ArticleId></ArticleIdList></Reference><Reference><Citation>Katkade VB, Sanders KN, Zou KH: Real world data: An opportunity to supplement existing evidence for the use of long-established medicines in health care decision making. J Multidiscip Healthc 2018; 11:295&#x2013;304</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6033114</ArticleId><ArticleId IdType="pubmed">29997436</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagenais S, Russo L, Madsen A, et al. : Use of real-world evidence to drive drug development strategy and inform clinical trial design. Clin Pharmacol Ther 2022; 111:77&#x2013;89</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9299990</ArticleId><ArticleId IdType="pubmed">34839524</ArticleId></ArticleIdList></Reference><Reference><Citation>Cave A, Kurz X, Arlett P: Real-world data for regulatory decision making: Challenges and possible solutions for Europe. Clin Pharmacol Ther 2019; 106:36&#x2013;39</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6617710</ArticleId><ArticleId IdType="pubmed">30970161</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, et al. ; N3C Consortium: The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. J Am Med Inform Assoc 2021; 28:427&#x2013;443</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkey AJ, Kumar VK, Harhay MO, et al. : The viral infection and respiratory illness universal study (VIRUS). Crit Care Explor 2020; 2:e0113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188422</ArticleId><ArticleId IdType="pubmed">32426754</ArticleId></ArticleIdList></Reference><Reference><Citation>Domecq JP, Lal A, Sheldrick CR, et al. ; Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry Investigator Group: Outcomes of patients with coronavirus disease 2019 receiving organ support therapies: The international viral infection and respiratory illness universal study registry. Crit Care Med 2021; 49:437&#x2013;448</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9520995</ArticleId><ArticleId IdType="pubmed">33555777</ArticleId></ArticleIdList></Reference><Reference><Citation>Khin NA, Grandinetti C, Dixey H, et al. : Tackling challenging data integrity topics in 2020: Update on good clinical practice perspectives from the US FDA and MHRA UK. Clin Pharmacol Ther 2022; 112:31&#x2013;43</Citation><ArticleIdList><ArticleId IdType="pubmed">34358334</ArticleId></ArticleIdList></Reference><Reference><Citation>Paris N, Lamer A, Parrot A: Transformation and evaluation of the MIMIC database in the OMOP Common Data Model: Development and usability study. JMIR Med Inform 2021; 9:e30970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715361</ArticleId><ArticleId IdType="pubmed">34904958</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamer A, Abou-Arab O, Bourgeois A, et al. : Transforming anesthesia data into the observational medical outcomes partnership common data model: Development and usability study. J Med Internet Res 2021; 23:e29259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8590192</ArticleId><ArticleId IdType="pubmed">34714250</ArticleId></ArticleIdList></Reference><Reference><Citation>Seto T, Sung L, Posada J, et al. : Integrating flowsheet data in OMOP common data model for clinical research. arXiv Preprint posted online September 16, 2021. doi: 10.48550/arXiv.2109.08235</Citation></Reference><Reference><Citation>Hripcsak G, Mirhaji P, Low AF, et al. : Preserving temporal relations in clinical data while maintaining privacy. J Am Med Inform Assoc 2016; 23:1040&#x2013;1045</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070517</ArticleId><ArticleId IdType="pubmed">27013522</ArticleId></ArticleIdList></Reference><Reference><Citation>Taksler GB, Dalton JE, Perzynski AT, et al. : Opportunities, pitfalls, and alternatives in adapting electronic health records for health services research. Med Decis Making 2021; 41:133&#x2013;142</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7878193</ArticleId><ArticleId IdType="pubmed">32969760</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated"><PMID Version="2">37034358</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study.</ArticleTitle><Pagination><StartPage>101932</StartPage><MedlinePgn>101932</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101932</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2023.101932</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Adverse events of special interest (AESIs) were pre-specified to be monitored for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with COVID-19. Our aim was to characterise the incidence rates of AESIs following SARS-CoV-2 infection in patients and compare these to historical rates in the general population.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A multi-national cohort study with data from primary care, electronic health records, and insurance claims mapped to a common data model. This study's evidence was collected between Jan 1, 2017 and the conclusion of each database (which ranged from Jul 2020 to May 2022). The 16 pre-specified prevalent AESIs were: acute myocardial infarction, anaphylaxis, appendicitis, Bell's palsy, deep vein thrombosis, disseminated intravascular coagulation, encephalomyelitis, Guillain- Barr&#xe9; syndrome, haemorrhagic stroke, non-haemorrhagic stroke, immune thrombocytopenia, myocarditis/pericarditis, narcolepsy, pulmonary embolism, transverse myelitis, and thrombosis with thrombocytopenia. Age-sex standardised incidence rate ratios (SIR) were estimated to compare post-COVID-19 to pre-pandemic rates in each of the databases.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">Substantial heterogeneity by age was seen for AESI rates, with some clearly increasing with age but others following the opposite trend. Similarly, differences were also observed across databases for same health outcome and age-sex strata. All studied AESIs appeared consistently more common in the post-COVID-19 compared to the historical cohorts, with related meta-analytic SIRs ranging from 1.32 (1.05 to 1.66) for narcolepsy to 11.70 (10.10 to 13.70) for pulmonary embolism.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">Our findings suggest all AESIs are more common after COVID-19 than in the general population. Thromboembolic events were particularly common, and over 10-fold more so. More research is needed to contextualise post-COVID-19 complications in the longer term.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">None.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Voss</LastName><ForeName>Erica A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoaibi</LastName><ForeName>Azza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin Hui Lai</LastName><ForeName>Lana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Informatics, Imaging &amp; Data Sciences, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Kingdom of Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makadia</LastName><ForeName>Rupa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haynes</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Anthony G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Gowtham</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Sandijk</LastName><ForeName>Sebastiaan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Odysseus Data Services, Prague, Czechia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraboulet</LastName><ForeName>Clement</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Information, Assistance Publique - Hopitaux de Marseille, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyer</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medical Information, Assistance Publique - Hopitaux de Marseille, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Carrour</LastName><ForeName>Tanguy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Easter Eggs, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horban</LastName><ForeName>Scott</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Health Informatics Centre, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Division of Population Health and Genomics, University of Dundee, Dundee, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health, University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez Rold&#xe1;n</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital del Mar, Department of Innovation and Digital Transformation, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez-Anguita</LastName><ForeName>Juan Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Miguel A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Wilde</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>John</LastName><ForeName>Luis H</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la Recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roel</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la Recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pistillo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la Recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolde</LastName><ForeName>Raivo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Tartu, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maljkovi&#x107;</LastName><ForeName>Filip</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Heliant, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denaxas</LastName><ForeName>Spiros</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University College London, Institute of Health Informatics, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>British Heart Foundation Data Science Centre, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papez</LastName><ForeName>Vaclav</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University College London, Institute of Health Informatics, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Colorado Anschutz Medical Campus, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>IQVIA, Falls Church, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Secora</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IQVIA, Falls Church, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minty</LastName><ForeName>Evan P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>O'Brien Institute for Public Health, Faculty of Medicine, University of Calgary, Alberta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nigam H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford School of Medicine, Stanford University, Palo Alto, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Posada</LastName><ForeName>Jose D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Systems Engineering, School of Engineering, Universidad del Norte, Barranquilla, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia Morales</LastName><ForeName>Maria Teresa</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n, Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosca</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>VeraTech for Health, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cadenas Juanino</LastName><ForeName>Honorio</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3;n para la Investigaci&#xf3;n e Innovaci&#xf3;n Biosanitaria en Atenci&#xf3;n Primaria (FIIBAP), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz Holgado</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3;n para la Investigaci&#xf3;n e Innovaci&#xf3;n Biosanitaria en Atenci&#xf3;n Primaria (FIIBAP), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedrera Jim&#xe9;nez</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serrano Balazote</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a Barrio</LastName><ForeName>Noelia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hospital Universitario 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x15e;en</LastName><ForeName>Sel&#xe7;uk</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Clinical Pharmacology, Department of Medical Pharmacology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xdc;resin</LastName><ForeName>Ali Ya&#x11f;&#x131;z</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Division of Clinical Pharmacology, Department of Medical Pharmacology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erdogan</LastName><ForeName>Baris</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Clinerion, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belmans</LastName><ForeName>Luc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medaman BV, Geel, Flanders, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byttebier</LastName><ForeName>Geert</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medaman BV, Geel, Flanders, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malbrain</LastName><ForeName>Manu L N G</ForeName><Initials>MLNG</Initials><AffiliationInfo><Affiliation>Medaman BV, Geel, Flanders, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>1st Department Anaesthesiology and Intensive Therapy, Professor Critical Care Research, Medical University Lublin, Lublin, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dedman</LastName><ForeName>Daniel J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory Agency, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuccu</LastName><ForeName>Zara</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Clinical Practice Research Datalink, Medicines and Healthcare Products Regulatory Agency, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vashisht</LastName><ForeName>Rohit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butte</LastName><ForeName>Atul J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Data-driven Insights and Innovation, University of California Health, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Ayan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bakar Computational Health Sciences Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahm</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Data-driven Insights and Innovation, University of California Health, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Cora</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Data-driven Insights and Innovation, University of California Health, Oakland, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bu</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arshad</LastName><ForeName>Faaizah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, US Department of Veterans Affairs, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Dani</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development LLC, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adverse events of special interest</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">Observational research</Keyword></KeywordList><CoiStatement>EAV, AS, CB, RM, KH, AGS, GR, MJS, and PBR are employees of Janssen Research and Development LLC and shareholders of Johnson &amp; Johnson (J&amp;J) stock. Many data partners (including JMR, JMRA, MAM, MdW, LHJ, GB, PRR) on this project have received funding from the Innovative Medicines Initiative (IMI) 2 Joint Undertaking (JU) under grant agreement No 806968. The JU receives support from the European Union&#x2019;s Horizon 2020 research and innovation programme and EFPIA. The funding source had no role in writing the manuscript or the decision to submit it for publication. Odysseus Data Services, where SvS is employed, is a beneficiary of the mentioned IMI 2 JU project. DPA has received support from the EMA and Innovative Medicines Initiative. DPA's research group has received grant support from Amgen, Chesi-Taylor, Novartis, GSK, UCB Biopharma and J&amp;J. DPA's department has received advisory/consultancy fees from AstraZeneca, Amgen, Astellas, J&amp;J, and UCB Biopharma. DPA's department has received fees for speaker services from Amgen and UCB Biopharma. DPA's has other financial or non-financial interests in Janssen, on behalf of the IMI-funded EHDEN and European Medical Information Framework (EMIF) consortiums, and Synapse Management Partners have supported training programmes organised by DPA's department that was open for external participants. TDS received financial support from the Institute de Salud Carlos Ill (ISCIII; Miguel Servet 2021: CP21/00023) which is co-funded by the European Union. The funding source had no role in writing the manuscript or the decision to submit it for publication. PRR, MdW, LHJ work for a research group who received/receives unconditional research grants from Chiesi, Amgen, UCB, J&amp;J, European Medicines Agency (EMA), and IMI. GH provided funding for use of the CUIMC database and the OHDSI infrastructure. GH received support through a grant to Columbia University (NIH R01 LM006910). MAS receives grants from the US Department of Veterans Affairs within the scope of this work, and grants and contracts from the US National Institutes of Health, US Food &amp; Drug Administration, and Janssen Research &amp; Development outside the scope of this work. EPM receives salary support from the Department of Medicine at University of Calgary. EPM receives consulting fees from Janssen Research &amp; Development for work that is outside the scope of the current study. FM's main employment is for Heliant d.o.o, an EHR provider in Serbia. JDP received salary support through the Universidad de Norte. DJD and ZC are full-time employees of CPRD, which provides contract research services for government and related healthcare authorities, and the pharmaceutical industry, including Janssen. FN holds some AstraZeneca shares and was employed there until 2019. RV, AJB, AP2, LD, and CH received partial funding for this work by the University of California Health System and its Center for Data-Driven Insights and Innovation. MGK received support for the manuscript via institutional (internal funding) only. AJB's research has been funded by NIH, Peraton (as the prime on an NIH contract), Genentech, Johnson and Johnson, FDA, Robert Wood Johnson Foundation, Leon Lowenstein Foundation, Intervalien Foundation, Priscilla Chan and Mark Zuckerberg, the Barbara and Gerson Bakar Foundation, and in the recent past, the March of Dimes, Juvenile Diabetes Research Foundation, California Governor&#x2019;s Office of Planning and Research, California Institute for Regenerative Medicine, L&#x2019;Or&#xe9;al, and Progenity. AJB receives royalty payments through Stanford University, for several patents and other disclosures licensed to NuMedii and Personalis. AJB is a co-founder and consultant to Personalis and NuMedii; consultant to Mango Tree Corporation, and in the recent past, Samsung, 10x Genomics, Helix, Pathway Genomics, and Verinata (Illumina); has served on paid advisory panels or boards for Geisinger Health, Regenstrief Institute, Gerson Lehman Group, AlphaSights, Covance, Novartis, Genentech, Merck, and Roche. AJB has received honoraria and travel reimbursement for invited talks from J&amp;J, Roche, Genentech, Pfizer, Merck, Lilly, Takeda, Varian, Mars, Siemens, Optum, Abbott, Celgene, AstraZeneca, AbbVie, Westat, many academic institutions, medical or disease specific foundations and associations, and health systems. AJB is a shareholder in Personalis and NuMedii; is a minor shareholder in Apple, Meta (Facebook), Alphabet (Google), Microsoft, Amazon, Snap, 10x Genomics, Illumina, Regeneron, Sanofi, Pfizer, Royalty Pharma, Moderna, Sutro, Doximity, BioNtech, Invitae, Pacific Biosciences, Editas Medicine, Nuna Health, Assay Depot, Vet24seven, and several other non-health related companies and mutual funds. DRM has grants or contracts from Wellcome Trust Clinical Research Fellowship (214588/Z/18/Z). FB has a leadership or fiduciary role as the program chair of j-ISBA.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>10</Day><Hour>4</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37034358</ArticleId><ArticleId IdType="pmc">PMC10072853</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2023.101932</ArticleId><ArticleId IdType="pii">S2589-5370(23)00109-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO coronavirus (COVID-19) dashboard. 2022. https://covid19.who.int/</Citation></Reference><Reference><Citation>Dagan N., Barda N., Kepten E., et al. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. N&#xa0;Engl J Med. 2021;384(15):1412&#x2013;1423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7944975</ArticleId><ArticleId IdType="pubmed">33626250</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasileiou E., Simpson C.R., Shi T., et al. Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study. Lancet. 2021;397(10285):1646&#x2013;1657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064669</ArticleId><ArticleId IdType="pubmed">33901420</ArticleId></ArticleIdList></Reference><Reference><Citation>Holder J. Tracking coronavirus vaccinations around the world. New York Times. 2022</Citation></Reference><Reference><Citation>Li X., Ostropolets A., Makadia R., et al. Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study. BMJ. 2021;373:n1435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8193077</ArticleId><ArticleId IdType="pubmed">35727911</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong H.-L., Hu M., Zhou C.K., et al. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases. Lancet. 2022;399(10342):2191&#x2013;2199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9183215</ArticleId><ArticleId IdType="pubmed">35691322</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo E.J., Mba-Jonas A., Dimova R.B., Alimchandani M., Zinderman C.E., Nair N. Association of receipt of the Ad26.COV2.S COVID-19 vaccine with presumptive guillain-barr&#xe9; syndrome, february-July 2021. JAMA. 2021;326(16):1606&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8498927</ArticleId><ArticleId IdType="pubmed">34617967</ArticleId></ArticleIdList></Reference><Reference><Citation>Greinacher A., Thiele T., Warkentin T.E., Weisser K., Kyrle P.A., Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N&#xa0;Engl J Med. 2021;384(22):2092&#x2013;2101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8095372</ArticleId><ArticleId IdType="pubmed">33835769</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., Duke J.D., Shah N.H., et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura S., Sato T., Ikeda S., et al. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol. 2010;20(5):413&#x2013;419. doi: 10.2188/jea.je20090066.</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.je20090066</ArticleId><ArticleId IdType="pmc">PMC3900837</ArticleId><ArticleId IdType="pubmed">20699602</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S., Posada J., Olson G., et al. A new paradigm for accelerating clinical data science at Stanford Medicine. arXiv preprint arXiv. 2020:200310534.</Citation></Reference><Reference><Citation>Sudlow C., Gallacher J., Allen N., et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. doi: 10.1371/journal.pmed.1001779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001779</ArticleId><ArticleId IdType="pmc">PMC4380465</ArticleId><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference><Reference><Citation>de Ridder M.A.J., de Wilde M., de Ben C., et al. Data Resource Profile: The Integrated Primary Care Information (IPCI) database, The Netherlands. Int J Epidemiol. 2022 doi: 10.1093/ije/dyac026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyac026</ArticleId><ArticleId IdType="pmc">PMC9749682</ArticleId><ArticleId IdType="pubmed">35182144</ArticleId></ArticleIdList></Reference><Reference><Citation>Becher H., Kostev K., Schr&#xf6;der-Bernhardi D. Validity and representativeness of the &#x201c;Disease Analyzer&#x201d; patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Therap. 2009;47(10):617&#x2013;626. doi: 10.5414/cpp47617.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/cpp47617</ArticleId><ArticleId IdType="pubmed">19825325</ArticleId></ArticleIdList></Reference><Reference><Citation>Recalde M., Rodr&#xed;guez C., Burn E., et al. Data Resource Profile: The Information System for Research in Primary Care (SIDIAP) Int J Epidemiol. 2022 doi: 10.1093/ije/dyac068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyac068</ArticleId><ArticleId IdType="pmc">PMC9749711</ArticleId><ArticleId IdType="pubmed">35415748</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss E.A., Shoaibi A., Ostropolets A., et al.   2021. [RESEARCH PROTOCOL] adverse events of special interest within COVID-19 subjects.https://ohdsi-studies.github.io/Covid19SubjectsAesiIncidenceRate/Protocol.html</Citation></Reference><Reference><Citation>Kostka K., Duarte-Salles T., Prats-Uribe A., et al. Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using charybdis. Clin Epidemiol. 2022;14:369&#x2013;384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957305</ArticleId><ArticleId IdType="pubmed">35345821</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales D.R., Ostropolets A., Lai L., et al. Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe. J&#xa0;Asthma. 2023:76&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">35012410</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte-Salles T., Vizcaya D., Pistillo A., et al. Thirty-day outcomes of children and adolescents with COVID-19: an international experience. Pediatrics. 2021;148(3)</Citation><ArticleIdList><ArticleId IdType="pubmed">34049958</ArticleId></ArticleIdList></Reference><Reference><Citation>Prats-Uribe A., Sena A.G., Lai L.Y.H., et al. Use of repurposed and adjuvant drugs in hospital patients with Covid-19: multinational network cohort study. BMJ. 2021;373:n1038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8111167</ArticleId><ArticleId IdType="pubmed">33975825</ArticleId></ArticleIdList></Reference><Reference><Citation>Background Rates of Adverse Events of Special Interest for COVID-19 Vaccine Safety Monitoring Protocol. 2021. https://www.bestinitiative.org/wp-content/uploads/2021/02/C19-Vaccine-Safety-AESI-Background-Rate-Protocol-FINAL-2020.pdf 01.12. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9640387</ArticleId><ArticleId IdType="pubmed">36404170</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan C.K., Feinstein A.R., Jekel J.F., Wells C.K. The value and hazards of standardization in clinical epidemiologic research. J&#xa0;Clin Epidemiol. 1988;41(11):1125&#x2013;1134.</Citation><ArticleIdList><ArticleId IdType="pubmed">3256304</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidelines for preparing core clinical-safety information on drugs. 1999. https://cioms.ch/wp-content/uploads/2018/03/Guidelines-for-Preparing-Core-Clinical-Safety-Info-Drugs-Report-of-CIOMS-Working-Group-III-and-V.pdf</Citation></Reference><Reference><Citation>Rao G., Schuemie M.J., Ryan P.B., W J., G J. 2022. CohortDiagnostics: diagnostics for OHDSI cohorts.</Citation></Reference><Reference><Citation>Ostropolets A., Li X., Makadia R., et al. Factors influencing background incidence rate calculation: systematic empirical evaluation across an international network of observational databases. Front Pharmacol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9087898</ArticleId><ArticleId IdType="pubmed">35559254</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Zhang D., Zheng T., Yu Y., Jiang J. DVT incidence and risk factors in critically ill patients with COVID-19. J&#xa0;Thromb Thrombolysis. 2021;51(1):33&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324310</ArticleId><ArticleId IdType="pubmed">32607652</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Zheng T., Wang S., et al. Association between risk of venous thromboembolism and mortality in patients with COVID-19. Int J Infect Dis. 2021;108:543&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180091</ArticleId><ArticleId IdType="pubmed">34107325</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Wang X., Zhang S., et al. Characteristics of acute pulmonary embolism in patients with COVID-19 associated pneumonia from the city of wuhan. Clin Appl Thromb Hemost. 2020;26</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391435</ArticleId><ArticleId IdType="pubmed">32726134</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Ani F., Chehade S., Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res. 2020;192:152&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255332</ArticleId><ArticleId IdType="pubmed">32485418</ArticleId></ArticleIdList></Reference><Reference><Citation>Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html 3033.</Citation></Reference><Reference><Citation>Filosto M., Cotti Piccinelli S., Gazzina S., et al. Guillain-Barr&#xe9; syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions. J&#xa0;Neurol Neurosurg Psychiatry. 2021;92(7):751&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pubmed">33158914</ArticleId></ArticleIdList></Reference><Reference><Citation>Barda N., Dagan N., Ben-Shlomo Y., et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N&#xa0;Engl J Med. 2021;385(12):1078&#x2013;1090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8427535</ArticleId><ArticleId IdType="pubmed">34432976</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M., Handunnetthi L., Saatci D., et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021;27(12):2144&#x2013;2153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8629105</ArticleId><ArticleId IdType="pubmed">34697502</ArticleId></ArticleIdList></Reference><Reference><Citation>Block J., Boehmer T., Forrest C., et al.  Cardiac complications after SARS-CoV-2 infection and mRNA COVID-19 vaccination &#x2014; PCORnet. 2022. https://www.cdc.gov/mmwr/volumes/71/wr/mm7114e1.htm</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8989373</ArticleId><ArticleId IdType="pubmed">35389977</ArticleId></ArticleIdList></Reference><Reference><Citation>Patone M., Mei X.W., Handunnetthi L., et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med. 2022;28(2):410&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863574</ArticleId><ArticleId IdType="pubmed">34907393</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoaibi A., Rao G.A., Voss E.A., et al. Phenotype algorithms for the identification and characterization of vaccine-induced thrombotic thrombocytopenia in real world data: a multinational network cohort study. Drug Saf. 2022;45:685&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9160850</ArticleId><ArticleId IdType="pubmed">35653017</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Lai L.Y., Ostropolets A., et al. Bias, precision and timeliness of historical (background) rate comparison methods for vaccine safety monitoring: an empirical multi-database analysis. Front Pharmacol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8652333</ArticleId><ArticleId IdType="pubmed">34899334</ArticleId></ArticleIdList></Reference><Reference><Citation>CRediT, Contributor roles Taxonomy. 2022. https://groups.niso.org/higherlogic/ws/public/download/26466/ANSI-NISO-Z39.104-2022.pdf</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37041475</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2288</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>11</Day></PubDate></JournalIssue><Title>BMC medical research methodology</Title><ISOAbbreviation>BMC Med Res Methodol</ISOAbbreviation></Journal><ArticleTitle>Piloting an automated clinical trial eligibility surveillance and provider alert system based on artificial intelligence and standard data models.</ArticleTitle><Pagination><StartPage>88</StartPage><MedlinePgn>88</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">88</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12874-023-01916-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">To advance new therapies into clinical care, clinical trials must recruit enough participants. Yet, many trials fail to do so, leading to delays, early trial termination, and wasted resources. Under-enrolling trials make it impossible to draw conclusions about the efficacy of new therapies. An oft-cited reason for insufficient enrollment is lack of study team and provider awareness about patient eligibility. Automating clinical trial eligibility surveillance and study team and provider notification could offer a solution.</AbstractText><AbstractText Label="METHODS">To address this need for an automated solution, we conducted an observational pilot study of our TAES (TriAl Eligibility Surveillance) system. We tested the hypothesis that an automated system based on natural language processing and machine learning algorithms could detect patients eligible for specific clinical trials by linking the information extracted from trial descriptions to the corresponding clinical information in the electronic health record (EHR). To evaluate the TAES information extraction and matching prototype (i.e., TAES prototype), we selected five open cardiovascular and cancer trials at the Medical University of South Carolina and created a new reference standard of 21,974 clinical text notes from a random selection of 400 patients (including at least 100 enrolled in the selected trials), with a small subset of 20 notes annotated in detail. We also developed a simple web interface for a new database that stores all trial eligibility criteria, corresponding clinical information, and trial-patient match characteristics using the Observational Medical Outcomes Partnership (OMOP) common data model. Finally, we investigated options for integrating an automated clinical trial eligibility system into the EHR and for notifying health care providers promptly of potential patient eligibility without interrupting their clinical workflow.</AbstractText><AbstractText Label="RESULTS">Although the rapidly implemented TAES prototype achieved only moderate accuracy (recall up to 0.778; precision up to 1.000), it enabled us to assess options for integrating an automated system successfully into the clinical workflow at a healthcare system.</AbstractText><AbstractText Label="CONCLUSIONS">Once optimized, the TAES system could exponentially enhance identification of patients potentially eligible for clinical trials, while simultaneously decreasing the burden on research teams of manual EHR review. Through timely notifications, it could also raise physician awareness of patient eligibility for clinical trials.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meystre</LastName><ForeName>St&#xe9;phane M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>OnePlanet Research Center and imec, Toernooiveld 300, Nijmegen, 6525 EC, The Netherlands. stephane.meystre@imec.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heider</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Medical University of South Carolina, Charleston, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cates</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical University of South Carolina, Charleston, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastian</LastName><ForeName>Grace</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Medical University of South Carolina, Charleston, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pittman</LastName><ForeName>Tara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Medical University of South Carolina, Charleston, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gentilin</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical University of South Carolina, Charleston, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelechi</LastName><ForeName>Teresa J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Medical University of South Carolina, Charleston, SC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Res Methodol</MedlineTA><NlmUniqueID>100968545</NlmUniqueID><ISSNLinking>1471-2288</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="Y">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical trial enrollment/recruitment</Keyword><Keyword MajorTopicYN="N">Data science [L01.305]</Keyword><Keyword MajorTopicYN="N">Medical informatics [L01.313.500]</Keyword><Keyword MajorTopicYN="N">Natural language processing (NLP) [L01.224.050.375.580]</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>23</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37041475</ArticleId><ArticleId IdType="pmc">PMC10088225</ArticleId><ArticleId IdType="doi">10.1186/s12874-023-01916-6</ArticleId><ArticleId IdType="pii">10.1186/s12874-023-01916-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sung NS, Crowley WF, Genel M, Salber P, Sandy L, Sherwood LM, Johnson SB, Catanese V, Tilson H, Getz K, Larson EL, Scheinberg D, Reece EA, Slavkin H, Dobs A, Grebb J, Martinez RA, Korn A, Rimoin D. Central challenges facing the national clinical research enterprise. JAMA. 2003;289(10):1278&#x2013;1287. doi: 10.1001/jama.289.10.1278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.289.10.1278</ArticleId><ArticleId IdType="pubmed">12633190</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilts DM, Sandler AB. Activating &amp; Opening Oncology Clinical Trials: Process &amp; Timing Analysis. NCI presentation. 2008. Available at: https://deainfo.nci.nih.gov/advisory/bsa/archive/bsa0308/presentations/Monday/1110am_Dorowshow1.pdf.</Citation></Reference><Reference><Citation>Unger JM, Vaidya R, Hershman DL, Minasian LM, Fleury ME. Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. J Natl Cancer Inst. 2019;111(3):245&#x2013;255. doi: 10.1093/jnci/djy221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djy221</ArticleId><ArticleId IdType="pmc">PMC6410951</ArticleId><ArticleId IdType="pubmed">30856272</ArticleId></ArticleIdList></Reference><Reference><Citation>Lara PN, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, Wun T, Welborn J, Meyers FJ, Christensen S, O'Donnell R, Richman C, Scudder SA, Tuscano J, Gandara DR, Lam KS. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001;19(6):1728&#x2013;1733. doi: 10.1200/JCO.2001.19.6.1728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2001.19.6.1728</ArticleId><ArticleId IdType="pubmed">11251003</ArticleId></ArticleIdList></Reference><Reference><Citation>Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291(22):2720&#x2013;2726. doi: 10.1001/jama.291.22.2720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.291.22.2720</ArticleId><ArticleId IdType="pubmed">15187053</ArticleId></ArticleIdList></Reference><Reference><Citation>North CM, Dougan ML, Sacks CA. Improving clinical trial enrollment - in the covid-19 era and beyond. N Engl J Med. 2020;383(15):1406&#x2013;1408. doi: 10.1056/NEJMp2019989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2019989</ArticleId><ArticleId IdType="pubmed">32668133</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C. Black Patients Miss Out On Promising Cancer Drugs. ProPublica. 2018. Available from : https://www.propublica.org/article/black-patients-miss-out-on-promising-cancer-drugs.</Citation></Reference><Reference><Citation>Zucker I, Prendergast BJ. Sex differences in pharmacokinetics predict adverse drug reactions in women. Biol Sex Differ. 2020;11(1):32. doi: 10.1186/s13293-020-00308-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-020-00308-5</ArticleId><ArticleId IdType="pmc">PMC7275616</ArticleId><ArticleId IdType="pubmed">32503637</ArticleId></ArticleIdList></Reference><Reference><Citation>Somkin CP, Altschuler A, Ackerson L, Geiger AM, Greene SM, Mouchawar J, Holup J, Fehrenbacher L, Nelson A, Glass A, Polikoff J, Tishler S, Schmidt C, Field T, Wagner E. Organizational barriers to physician participation in cancer clinical trials. Am J Manag Care. 2005;11(7):413&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pubmed">16044978</ArticleId></ArticleIdList></Reference><Reference><Citation>CISCRP. 2017 Public and Patient Perceptions &amp; Insights Study. Available from: https://www.ciscrp.org/services/research-services/perceptions-and-insights-study/.</Citation></Reference><Reference><Citation>Somkin CP, Ackerson L, Husson G, Gomez V, Kolevska T, Goldstein D, Fehrenbacher L. Effect of medical oncologists&#x2019; attitudes on accrual to clinical trials in a community setting. J Oncol Pract Am Soc Clin Oncol. 2013;9(6):e275&#x2013;e283. doi: 10.1200/JOP.2013.001120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JOP.2013.001120</ArticleId><ArticleId IdType="pmc">PMC5706122</ArticleId><ArticleId IdType="pubmed">24151327</ArticleId></ArticleIdList></Reference><Reference><Citation>Obeid JS, Beskow LM, Rape M, Gouripeddi R, Black RA, Cimino JJ, Embi PJ, Weng C, Marnocha R, Buse JB. Methods for the, Process, Workgroup IDTF. A survey of practices for the use of electronic health records to support research recruitment. J Clin Transl Sci. 2017;1(4):246&#x2013;252. doi: 10.1017/cts.2017.301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cts.2017.301</ArticleId><ArticleId IdType="pmc">PMC5890320</ArticleId><ArticleId IdType="pubmed">29657859</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull J, Uhlenbrauck G, Mahon E, Furlong P, Roberts J. Barriers to Clinical Trial Recruitment and Possible Solutions: A Stakeholder Survey. Applied Clinical Trials. 2015. Available from: https://www.appliedclinicaltrialsonline.com/view/barriers-clinical-trial-recruitment-and-possible-solutions-stakeholder-survey.</Citation></Reference><Reference><Citation>Penberthy LT, Dahman BA, Petkov VI, DeShazo JP. Effort required in eligibility screening for clinical trials. J Oncol Pract Am Soc Clin Oncol. 2012;8(6):365&#x2013;370. doi: 10.1200/JOP.2012.000646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JOP.2012.000646</ArticleId><ArticleId IdType="pmc">PMC3500483</ArticleId><ArticleId IdType="pubmed">23598846</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal J, Pasuparthi K, Rogers P, Buskirk J, Mekhjian H. Using an information warehouse to screen patients for clinical trials: a prototype. AMIA Annu Symp Proc. 2005;2005:1004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1560829</ArticleId><ArticleId IdType="pubmed">16779291</ArticleId></ArticleIdList></Reference><Reference><Citation>Nkoy FL, Wolfe D, Hales JW, Lattin G, Rackham M, Maloney CG. Enhancing an existing clinical information system to improve study recruitment and census gathering efficiency. AMIA Annu Symp Proc. 2009;14(2009):476&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2815472</ArticleId><ArticleId IdType="pubmed">20351902</ArticleId></ArticleIdList></Reference><Reference><Citation>Butte AJ, Weinstein DA, Kohane IS. Enrolling patients into clinical trials faster using RealTime Recuiting. Proc AMIA Symp. 2000;111&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2244056</ArticleId><ArticleId IdType="pubmed">11079855</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner DL, Butte AJ, Hibberd PL, Fleisher GR. Computerized recruiting for clinical trials in real time. YMEM. 2003;41(2):242&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">12548275</ArticleId></ArticleIdList></Reference><Reference><Citation>Embi PJ, Jain A, Clark J, Bizjack S, Hornung R, Harris CM. Effect of a clinical trial alert system on physician participation in trial recruitment. Arch Intern Med. 2005;165(19):2272&#x2013;2277. doi: 10.1001/archinte.165.19.2272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.165.19.2272</ArticleId><ArticleId IdType="pmc">PMC1343501</ArticleId><ArticleId IdType="pubmed">16246994</ArticleId></ArticleIdList></Reference><Reference><Citation>Akers L, Gordon JS. Using facebook for large-scale online randomized clinical trial recruitment: effective advertising strategies. J Med Internet Res. 2018;20(11):e290. doi: 10.2196/jmir.9372.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.9372</ArticleId><ArticleId IdType="pmc">PMC6250956</ArticleId><ArticleId IdType="pubmed">30409765</ArticleId></ArticleIdList></Reference><Reference><Citation>Meystre SM, Heider PM, Kim Y, Aruch DB, Britten CD. Automatic trial eligibility surveillance based on unstructured clinical data. Int J Med Inf. 2019;129:13&#x2013;19. doi: 10.1016/j.ijmedinf.2019.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2019.05.018</ArticleId><ArticleId IdType="pmc">PMC6717538</ArticleId><ArticleId IdType="pubmed">31445247</ArticleId></ArticleIdList></Reference><Reference><Citation>Borlawsky T, Payne PRO. Evaluating an NLP-based approach to modeling computable clinical trial eligibility criteria. AMIA Annu Symp Proc. 2007;11:878.</Citation><ArticleIdList><ArticleId IdType="pubmed">18693979</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, Erdengasileng A, Yang X, Guo Y, Wu Y, Zhang J, Bian J, He Z. Transformer-based named entity recognition for parsing clinical trial eligibility criteria. Proc 12th ACM Conf Bioinforma Comput Biol Health Inform Gainesville Florida: ACM; 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8373041</ArticleId><ArticleId IdType="pubmed">34414397</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Wu X, Luo Z, Boland MR, Theodoratos D, Johnson SB. EliXR: an approach to eligibility criteria extraction and representation. J Am Med Inform Assoc. 2011;18(Suppl 1):i116&#x2013;24. doi: 10.1136/amiajnl-2011-000321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000321</ArticleId><ArticleId IdType="pmc">PMC3241167</ArticleId><ArticleId IdType="pubmed">21807647</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang T, Zhang S, Tang Y, Hruby GW, Rusanov A, Elhadad N, Weng C. EliIE: An open-source information extraction system for clinical trial eligibility criteria. J Am Med Inform Assoc. 2017;24(6):1062&#x2013;1071. doi: 10.1093/jamia/ocx019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocx019</ArticleId><ArticleId IdType="pmc">PMC6259668</ArticleId><ArticleId IdType="pubmed">28379377</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C, Ryan PB, Ta C, Guo Y, Li Z, Hardin J, Makadia R, Jin P, Shang N, Kang T, Weng C. Criteria2Query: a natural language interface to clinical databases for cohort definition. J Am Med Inform Assoc. 2019;26(4):294&#x2013;305. doi: 10.1093/jamia/ocy178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocy178</ArticleId><ArticleId IdType="pmc">PMC6402359</ArticleId><ArticleId IdType="pubmed">30753493</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan C, Ryan PB, Guo Y, Jin P, Tian K, Weng C. Criteria2Query: Automatically Transforming Clinical Research Eligibility Criteria Text to OMOP Common Data Model (CDM)-based Cohort Queries. AMIA Annu Symp Proc. 2017:230&#x2013;1.</Citation></Reference><Reference><Citation>Fang Y, Idnay B, Sun Y, Liu H, Chen Z, Marder K, Xu H, Schnall R, Weng C. Combining human and machine intelligence for clinical trial eligibility querying. J Am Med Inform Assoc. 2022;29(7):1161&#x2013;1171. doi: 10.1093/jamia/ocac051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocac051</ArticleId><ArticleId IdType="pmc">PMC9196697</ArticleId><ArticleId IdType="pubmed">35426943</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck JT, Rammage M, Jackson GP, Preininger AM, Dankwa-Mullan I, Roebuck MC, Torres A, Holtzen H, Coverdill SE, Williamson MP, Chau Q, Rhee K, Vinegra M. Artificial intelligence tool for optimizing eligibility screening for clinical trials in a large community cancer center. JCO Clin Cancer Inform. 2020;4:50&#x2013;59. doi: 10.1200/CCI.19.00079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.19.00079</ArticleId><ArticleId IdType="pubmed">31977254</ArticleId></ArticleIdList></Reference><Reference><Citation>Helgeson J, Rammage M, Urman A, Roebuck MC, Coverdill S, Pomerleau K, Dankwa-Mullan I, Liu L-I, Sweetman RW, Chau Q, Williamson MP, Vinegra M, Haddad TC, Goetz MP. Clinical performance pilot using cognitive computing for clinical trial matching at Mayo Clinic. J Clin Oncol. 2018;36(15_suppl):e18598&#x2013;e18598. doi: 10.1200/JCO.2018.36.15_suppl.e18598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2018.36.15_suppl.e18598</ArticleId></ArticleIdList></Reference><Reference><Citation>Penberthy L, Brown R, Puma F, Dahman B. Automated matching software for clinical trials eligibility: measuring efficiency and flexibility. Contemp Clin Trials. 2010;31(3):207&#x2013;217. doi: 10.1016/j.cct.2010.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2010.03.005</ArticleId><ArticleId IdType="pmc">PMC4387843</ArticleId><ArticleId IdType="pubmed">20230913</ArticleId></ArticleIdList></Reference><Reference><Citation>Voorhees EM, Hersh W. Overview of the TREC 2012 Medical Records Track | NIST. Spec Publ NIST SP - 2013;500&#x2013;298:500&#x2013;298.</Citation></Reference><Reference><Citation>Ni Y, Kennebeck S, Dexheimer JW, McAneney CM, Tang H, Lingren T, Li Q, Zhai H, Solti I. Automated clinical trial eligibility prescreening: increasing the efficiency of patient identification for clinical trials in the emergency department. J Am Med Inform Assoc. 2015;22(1):166&#x2013;178. doi: 10.1136/amiajnl-2014-002887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002887</ArticleId><ArticleId IdType="pmc">PMC4433376</ArticleId><ArticleId IdType="pubmed">25030032</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni Y, Wright J, Perentesis J, Lingren T, Deleger L, Kaiser M, Kohane IS, Solti I. Increasing the efficiency of trial-patient matching: automated clinical trial eligibility Pre-screening for pediatric oncology patients. BMC Med Inform Decis Mak. 2015;15(1):28. doi: 10.1186/s12911-015-0149-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-015-0149-3</ArticleId><ArticleId IdType="pmc">PMC4407835</ArticleId><ArticleId IdType="pubmed">25881112</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni Y, Bermudez M, Kennebeck S. A real-time automated patient screening system for clinical trials eligibility in an emergency department: design and evaluation. JMIR Med Inform. 2019;7(3):e14185. doi: 10.2196/14185.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/14185</ArticleId><ArticleId IdType="pmc">PMC6685132</ArticleId><ArticleId IdType="pubmed">31342909</ArticleId></ArticleIdList></Reference><Reference><Citation>Heider P, Kim Y, AAlAbdulsalam AK, Kim C, Meystre SM. Hybrid Approaches for Automated Clinical Trial Cohort Selection. n2c2 Shared Task and Workshop at AMIA Annu Symp. San Francisco. 2018.</Citation></Reference><Reference><Citation>Heider PM, Meystre SM. Patient-Pivoted automated trial eligibility pipeline: the first of three phases in a modular architecture. Stud Health Technol Inf. 2019;21(264):1476&#x2013;1477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6944198</ArticleId><ArticleId IdType="pubmed">31438189</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. OHDSI ATLAS. Available from: http://atlas-demo.ohdsi.org/#/home.</Citation></Reference><Reference><Citation>Meystre SM, Kim Y, Heider P. COVID-19 Information Extraction Rapid Deployment Using Natural Language Processing and Machine Learning. AMIA NLP WG Pre-Symp at AMIA Annu Symp. 2020.</Citation></Reference><Reference><Citation>Heider P, Pipaliya R, Meystre SM. A natural language processing tool offering data extraction for COVID-19 related information (DECOVRI). Stud Health Technol Inform. 2022;290:1062&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">35673206</ArticleId></ArticleIdList></Reference><Reference><Citation>Heider PM, Meystre SM. Targeted Terminology Generation Tool for Natural Language Processing Applications. Present AMIA NLP-WG Pre-Symp 2019.</Citation></Reference><Reference><Citation>Klie J-C, Bugert M, Boullosa B, de Castilho RE, Gurevych I. The INCEpTION Platform: Machine-Assisted and Knowledge-Oriented Interactive Annotation. COLING 2018. p. 5.</Citation></Reference><Reference><Citation>Bootstrap. Available from: https://getbootstrap.com.</Citation></Reference><Reference><Citation>OHDSI. OHDSI WebAPI. Available from: https://github.com/OHDSI/WebAPI.</Citation></Reference><Reference><Citation>Kim Y, Meystre SM. Ensemble method-based extraction of medication and related information from clinical texts. J Am Med Inf Assoc. 2020;27(1):31&#x2013;38. doi: 10.1093/jamia/ocz100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocz100</ArticleId><ArticleId IdType="pmc">PMC7489099</ArticleId><ArticleId IdType="pubmed">31282932</ArticleId></ArticleIdList></Reference><Reference><Citation>Epic Systems Corp. BestPractice Advisory Web Services Setup and Support Guide. Epic Galaxy. 2020. Available from: https://galaxy.epic.com.</Citation></Reference><Reference><Citation>Epic Systems Corp. App Orchard Developer Guide. Epic Galaxy. 2020. Available from: https://galaxy.epic.com.</Citation></Reference><Reference><Citation>Haendel M, Chute C, Gersing K, Consortium authors (including Stephane Meystre) The National COVID Cohort Collaborative (N3C): Rationale, Design, Infrastructure, and Deployment. J Am Med Inf Assoc. 2021;28(3):427&#x2013;443. doi: 10.1093/jamia/ocaa196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa196</ArticleId><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37087110</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-974X</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>19</Day></PubDate></JournalIssue><Title>Journal of the American Medical Informatics Association : JAMIA</Title><ISOAbbreviation>J Am Med Inform Assoc</ISOAbbreviation></Journal><ArticleTitle>Clinical encounter heterogeneity and methods for resolving in networked EHR data: a study from N3C and RECOVER programs.</ArticleTitle><Pagination><StartPage>1125</StartPage><EndPage>1136</EndPage><MedlinePgn>1125-1136</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamia/ocad057</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Clinical encounter data are heterogeneous and vary greatly from institution to institution. These problems of variance affect interpretability and usability of clinical encounter data for analysis. These problems are magnified when multisite electronic health record (EHR) data are networked together. This article presents a novel, generalizable method for resolving encounter heterogeneity for analysis by combining related atomic encounters into composite "macrovisits."</AbstractText><AbstractText Label="MATERIALS AND METHODS">Encounters were composed of data from 75 partner sites harmonized to a common data model as part of the NIH Researching COVID to Enhance Recovery Initiative, a project of the National Covid Cohort Collaborative. Summary statistics were computed for overall and site-level data to assess issues and identify modifications. Two algorithms were developed to refine atomic encounters into cleaner, analyzable longitudinal clinical visits.</AbstractText><AbstractText Label="RESULTS">Atomic inpatient encounters data were found to be widely disparate between sites in terms of length-of-stay (LOS) and numbers of OMOP CDM measurements per encounter. After aggregating encounters to macrovisits, LOS and measurement variance decreased. A subsequent algorithm to identify hospitalized macrovisits further reduced data variability.</AbstractText><AbstractText Label="DISCUSSION">Encounters are a complex and heterogeneous component of EHR data and native data issues are not addressed by existing methods. These types of complex and poorly studied issues contribute to the difficulty of deriving value from EHR data, and these types of foundational, large-scale explorations, and developments are necessary to realize the full potential of modern real-world data.</AbstractText><AbstractText Label="CONCLUSION">This article presents method developments to manipulate and resolve EHR encounter data issues in a generalizable way as a foundation for future research and analysis.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leese</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9730-1675</Identifier><AffiliationInfo><Affiliation>NC TraCS Institute, UNC-School of Medicine, Chapel Hill, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anand</LastName><ForeName>Adit</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7310-6848</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stony Brook University, Stony Brook, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girvin</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2031-9209</Identifier><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manna</LastName><ForeName>Amin</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4711-2128</Identifier><AffiliationInfo><Affiliation>Palantir Technologies, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Saaya</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4674-2646</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stony Brook University, Stony Brook, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Yun Jae</ForeName><Initials>YJ</Initials><Identifier Source="ORCID">0000-0003-2144-8480</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stony Brook University, Stony Brook, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3108-7324</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stony Brook University, Stony Brook, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haendel</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9114-8737</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chute</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0001-5437-2545</Identifier><AffiliationInfo><Affiliation>Schools of Medicine, Public Health, and Nursing, Johns Hopkins University, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Tellen</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1483-4236</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University of Colorado Anschutz Medical Campus, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajagos</LastName><ForeName>Janos</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6251-9586</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stony Brook University, Stony Brook, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfaff</LastName><ForeName>Emily</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6840-9756</Identifier><AffiliationInfo><Affiliation>Department of Medicine, UNC Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moffitt</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-2723-5902</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Stony Brook University, Stony Brook, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Emory University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UM1 TR004404</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001998</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002535</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003017</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002736</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001878</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002369</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001433</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002537</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002014</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001425</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104938</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002544</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115516</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001453</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002003</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001876</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002538</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001881</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115677</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003107</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001414</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115428</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003098</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2HL161847</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002001</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 TR004406</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104940</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115458</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002378</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002494</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002645</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 HL161847</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002649</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM115371</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001420</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001422</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001442</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001860</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002366</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002377</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002733</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002550</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002553</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002541</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001439</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003096</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002529</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002319</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104941</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR002306</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002389</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001436</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001872</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002384</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002240</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003142</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001412</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002373</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002345</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001855</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002556</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001449</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001409</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001866</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003015</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001873</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104942</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001427</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR003167</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Med Inform Assoc</MedlineTA><NlmUniqueID>9430800</NlmUniqueID><ISSNLinking>1067-5027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006268" MajorTopicYN="N">Health Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">database</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">informatics</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>23</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>22</Day><Hour>20</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37087110</ArticleId><ArticleId IdType="pmc">PMC10198518</ArticleId><ArticleId IdType="doi">10.1093/jamia/ocad057</ArticleId><ArticleId IdType="pii">7136721</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cohen GR, Friedman CP, Ryan AM, et al.Variation in physicians&#x2019; electronic health record documentation and potential patient harm from that variation. J Gen Intern Med 2019; 34 (11): 2355&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6848521</ArticleId><ArticleId IdType="pubmed">31183688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancker JS, Kern LM, Edwards A, et al.; with the HITEC Investigators. How is the electronic health record being used? Use of EHR data to assess physician-level variability in technology use. J Am Med Inform Assoc 2014; 21 (6): 1001&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4215048</ArticleId><ArticleId IdType="pubmed">24914013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanham HJ, Sittig DF, Leykum LK, et al.Understanding differences in electronic health record (EHR) use: linking individual physicians&#x2019; perceptions of uncertainty and EHR use patterns in ambulatory care. J Am Med Inform Assoc 2014; 21 (1): 73&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3912724</ArticleId><ArticleId IdType="pubmed">23698256</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard SE, Neri PM, Wilcox AR, et al.How physicians document outpatient visit notes in an electronic health record. Int J Med Inform 2013; 82 (1): 39&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">22542717</ArticleId></ArticleIdList></Reference><Reference><Citation>Berwick DM. Controlling variation in health care: a consultation from Walter Shewhart. Med Care 1991; 29 (12): 1212&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">1745079</ArticleId></ArticleIdList></Reference><Reference><Citation>Wennberg DE. Variation in the delivery of health care: the stakes are high. Ann Intern Med 1998; 128 (10): 866&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9599201</ArticleId></ArticleIdList></Reference><Reference><Citation>Wunsch H, Angus DC, Harrison DA, et al.Variation in critical care services across North America and Western Europe. Crit Care Med 2008; 36 (10): 2787&#x2013;93, e1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18766102</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynn EF, Hoffman MA.. Heterogeneity introduced by EHR system implementation in a de-identified data resource from 100 non-affiliated organizations. JAMIA Open 2019; 2 (4): 554&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6993994</ArticleId><ArticleId IdType="pubmed">32025653</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss RW, Schmidt TD, Weiskopf N, et al.Comparing ascertainment of chronic condition status with problem lists versus encounter diagnoses from electronic health records. J Am Med Inform Assoc 2022; 29 (5): 770&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9006679</ArticleId><ArticleId IdType="pubmed">35165743</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang PE, Ryan PB, Racoosin JA, et al.Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership. Ann Intern Med 2010; 153 (9): 600&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21041580</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, et al.Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc 2014; 21 (4): 578&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, et al.Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). J Am Med Inform Assoc 2010; 17 (2): 124&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, Chute CG, Bennett TD, et al.; N3C Consortium. The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. J Am Med Inform Assoc 2021; 28 (3): 427&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett TD, Moffitt RA, Hajagos JG, et al.; National COVID Cohort Collaborative (N3C) Consortium. Clinical characterization and prediction of clinical severity of SARS-CoV-2 infection among US adults using data from the US National COVID Cohort Collaborative. JAMA Netw Open 2021; 4 (7): e2116901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278272</ArticleId><ArticleId IdType="pubmed">34255046</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Girvin AT, Gabriel DL, et al.; The N3C Consortium. Synergies between centralized and federated approaches to data quality: a report from the National COVID Cohort Collaborative. J Am Med Inform Assoc 2022; 29 (4): 609&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500110</ArticleId><ArticleId IdType="pubmed">34590684</ArticleId></ArticleIdList></Reference><Reference><Citation>Rees EM, Nightingale ES, Jafari Y, et al.COVID-19 length of hospital stay: a systematic review and data synthesis. BMC Med 2020; 18 (1): 270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467845</ArticleId><ArticleId IdType="pubmed">32878619</ArticleId></ArticleIdList></Reference><Reference><Citation>
Project (HCUP) HCAU. Overview Statistics for Inpatient Hospital Stays. Agency for Healthcare Research and Quality (US), 2011. https://www.ncbi.nlm.nih.gov/books/NBK179196/. Accessed August 30, 2022.</Citation></Reference><Reference><Citation>Baek H, Cho M, Kim S, et al.Analysis of length of hospital stay using electronic health records: a statistical and data mining approach. PLoS One 2018; 13 (4): e0195901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5898738</ArticleId><ArticleId IdType="pubmed">29652932</ArticleId></ArticleIdList></Reference><Reference><Citation>
2022 CMS OPPS specs. https://www.cms.gov/license/ama?file%3D/files/zip/2023-nprm-opps-addenda.zip&amp;sa=D&amp;source=docs&amp;ust=1661789122510102&amp;usg=AOvVaw3JugfDTg2XUaZZbafUBmuC. Accessed August 30, 2022.</Citation></Reference><Reference><Citation>Oude Lansink-Hartgring A, van Minnen O, Vermeulen KM, et al.; Dutch Extracorporeal Life Support Study Group. Hospital costs of extracorporeal membrane oxygenation in adults: a systematic review. Pharmacoecon Open 2021; 5 (4): 613&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8166371</ArticleId><ArticleId IdType="pubmed">34060061</ArticleId></ArticleIdList></Reference><Reference><Citation>
Osman M, Quail J, Hudema N, et al.Using SAS&#xae; to Create Episodes-of-Hospitalization for Health Services Research. https://support.sas.com/resources/papers/proceedings15/3281-2015.pdf. Accessed August 30, 2022.</Citation></Reference><Reference><Citation>Fransoo R, Yogendran M, Olafson K, et al.Constructing episodes of inpatient care: data infrastructure for population-based research. BMC Med Res Methodol 2012; 12: 133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3503719</ArticleId><ArticleId IdType="pubmed">22943606</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender D, Sartipi K. HL7 FHIR: an agile and RESTful approach to healthcare information exchange. In: Proceedings of the 26th IEEE International Symposium on Computer-Based Medical Systems. 2013: 326&#x2013;31; Porto, Portugal.</Citation></Reference><Reference><Citation>
United States Congress, United States House of Representatives, Committee on Energy and Commerce. HITECH Act of 2009, 42 USC sec 139w-4(0)(2) (February 2009). 2017. https://play.google.com/store/books/details?id=FNSGtAEACAAJ. Accessed August 30, 2022.</Citation></Reference><Reference><Citation>CMS. CMS EHR Meaningful Use Overview. 2010. https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Meaningful_Use.html. Accessed August 23, 2022.</Citation></Reference><Reference><Citation>Lin KJ, Singer DE, Glynn RJ, et al.Identifying patients with high data completeness to improve validity of comparative effectiveness research in electronic health records data. Clin Pharmacol Ther 2018; 103 (5): 899&#x2013;905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6026022</ArticleId><ArticleId IdType="pubmed">28865143</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Rusanov A, Weng C.. Sick patients have more data: the non-random completeness of electronic health records. AMIA Annu Symp Proc 2013; 2013: 1472&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3900159</ArticleId><ArticleId IdType="pubmed">24551421</ArticleId></ArticleIdList></Reference><Reference><Citation>Poulos J, Zhu L, Shah AD.. Data gaps in electronic health record (EHR) systems: An audit of problem list completeness during the COVID-19 pandemic. Int J Med Inform 2021; 150: 104452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9759969</ArticleId><ArticleId IdType="pubmed">33864979</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf NG, Hripcsak G, Swaminathan S, et al.Defining and measuring completeness of electronic health records for secondary use. J Biomed Inform 2013; 46 (5): 830&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3810243</ArticleId><ArticleId IdType="pubmed">23820016</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37128407</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2022</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Phenotyping in distributed data networks: selecting the right codes for the right patients.</ArticleTitle><Pagination><StartPage>826</StartPage><EndPage>835</EndPage><MedlinePgn>826-835</MedlinePgn></Pagination><Abstract><AbstractText>Observational data can be used to conduct drug surveillance and effectiveness studies, investigate treatment pathways, and predict patient outcomes. Such studies require developing executable algorithms to find patients of interest or phenotype algorithms. Creating reliable and comprehensive phenotype algorithms in data networks is especially hard as differences in patient representation and data heterogeneity must be considered. In this paper, we discuss a process for creating a comprehensive concept set and a recommender system we built to facilitate it. PHenotype Observed Entity Baseline Endorsements (PHOEBE) uses the data on code utilization across 22 electronic health record and claims datasets mapped to the Observational Health Data Sciences and Informatics (OHDSI) Common Data Model from the 6 countries to recommend semantically and lexically similar codes. Coupled with Cohort Diagnostics, it is now used in major network OHDSI studies. When used to create patient cohorts, PHOEBE identifies more patients and captures them earlier in the course of the disease.</AbstractText><CopyrightInformation>&#xa9;2022 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>New York-Presbyterian Hospital, New York, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>1</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37128407</ArticleId><ArticleId IdType="pmc">PMC10148372</ArticleId><ArticleId IdType="pii">1144</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dreyer NA, Tunis SR, Berger M, et al. Why Observational Studies Should Be Among The Tools Used In Comparative Effectiveness Research. Health Affairs. 2010;29:1818&#x2013;25. doi:10.1377/hlthaff.2010.0666.</Citation><ArticleIdList><ArticleId IdType="pubmed">20921481</ArticleId></ArticleIdList></Reference><Reference><Citation>Holve E, Lopez MH, Scott L, et al. A tall order on a tight timeframe: stakeholder perspectives on comparative effectiveness research using electronic clinical data. J Comp Eff Res. 2012;1:441&#x2013;51. doi:10.2217/cer.12.47.</Citation><ArticleIdList><ArticleId IdType="pubmed">24236421</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Albers DJ. Next-generation phenotyping of electronic health records. Journal of the American Medical Informatics Association. 2013;20:117&#x2013;21. doi:10.1136/amiajnl-2012-001145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby JC, Speltz P, Rasmussen LV, et al. PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc. 2016;23:1046&#x2013;52. doi:10.1093/jamia/ocv202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>Shivade C, Raghavan P, Fosler-Lussier E, et al. A review of approaches to identifying patient phenotype cohorts using electronic health records. Journal of the American Medical Informatics Association. 2014;21:221&#x2013;30. doi:10.1136/amiajnl-2013-001935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932460</ArticleId><ArticleId IdType="pubmed">24201027</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross MK, Zhu B, Natesan A, et al. B52. PEDIATRIC ASTHMA AND ALLERGY. American Thoracic Society; 2020. Accuracy of Asthma Computable Phenotypes to Identify Pediatric Asthma Cases at an Academic Institution; p. A3710&#x2013;A3710. doi:10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A3710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9113735</ArticleId><ArticleId IdType="pubmed">34261147</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Zhang Y, Cai T, et al. Automated grouping of medical codes via multiview banded spectral clustering. Journal of Biomedical Informatics. 2019;100:103322. doi:10.1016/j.jbi.2019.103322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261410</ArticleId><ArticleId IdType="pubmed">31672532</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Zhang Y, Schlueter DJ, et al. Detecting time-evolving phenotypic topics via tensor factorization on electronic health records: Cardiovascular disease case study. Journal of Biomedical Informatics. 2019;98:103270. doi:10.1016/j.jbi.2019.103270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6783385</ArticleId><ArticleId IdType="pubmed">31445983</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Dong W, Lu X, et al. Deep representation learning for individualized treatment effect estimation using electronic health records. Journal of biomedical informatics. 2019;100:103303.</Citation><ArticleIdList><ArticleId IdType="pubmed">31610264</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Liu C, Kim JH, et al. Comparative effectiveness of medical concept embedding for feature engineering in phenotyping. JAMIA Open. 2021;4:ooab028. doi:10.1093/jamiaopen/ooab028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206403</ArticleId><ArticleId IdType="pubmed">34142015</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Chakrabortty A, Liao KP, et al. Surrogate-assisted feature extraction for high-throughput phenotyping. Journal of the American Medical Informatics Association. 2017;24:e143&#x2013;9. doi:10.1093/jamia/ocw135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6080726</ArticleId><ArticleId IdType="pubmed">27632993</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong C, Rush E, Liu M, et al. Clinical knowledge extraction via sparse embedding regression (KESER) with multi-center large scale electronic health record data. npj Digit Med. 2021;4:151. doi:10.1038/s41746-021-00519-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8551205</ArticleId><ArticleId IdType="pubmed">34707226</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y. Opportunities and Challenges in Data-Driven Healthcare Research. MEDICINE &amp; PHARMACOLOGY. 2018. doi:10.20944/preprints201806.0137.v1.</Citation></Reference><Reference><Citation>Ostropolets A. Concept Heterogeneity in the OHDSI Network. 2019.  
 https://www.ohdsi.org/2019-us-symposium-showcase-19/
</Citation></Reference><Reference><Citation>Ostropolets A. Characterizing database granularity using SNOMED-CT hierarchy. AMIA 2020 Proceedings. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075504</ArticleId><ArticleId IdType="pubmed">33936474</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>and The eMERGE Network. Gottesman O, Kuivaniemi H, et al. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genetics in Medicine. 2013;15:761&#x2013;71. doi:10.1038/gim.2013.72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Levine ME, Shang N, et al. Effect of vocabulary mapping for conditions on phenotype cohorts. Journal of the American Medical Informatics Association. 2018;25:1618&#x2013;25. doi:10.1093/jamia/ocy124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289550</ArticleId><ArticleId IdType="pubmed">30395248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kagawa R, Kawazoe Y, Ida Y, et al. Development of Type 2 Diabetes Mellitus Phenotyping Framework Using Expert Knowledge and Machine Learning Approach. J Diabetes Sci Technol. 2017;11:791&#x2013;9. doi:10.1177/1932296816681584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5588819</ArticleId><ArticleId IdType="pubmed">27932531</ArticleId></ArticleIdList></Reference><Reference><Citation>Spratt SE, Pereira K, Granger BB, et al. Assessing electronic health record phenotypes against gold-standard diagnostic criteria for diabetes mellitus. Journal of the American Medical Informatics Association. 2017;24:e121&#x2013;8. doi:10.1093/jamia/ocw123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6080723</ArticleId><ArticleId IdType="pubmed">27616701</ArticleId></ArticleIdList></Reference><Reference><Citation>Blecker S, Katz SD, Horwitz LI, et al. Comparison of Approaches for Heart Failure Case Identification From Electronic Health Record Data. JAMA Cardiol. 2016;1:1014. doi:10.1001/jamacardio.2016.3236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5289894</ArticleId><ArticleId IdType="pubmed">27706470</ArticleId></ArticleIdList></Reference><Reference><Citation>Slaby I, Hain HS, Abrams D, et al. An electronic health record (EHR) phenotype algorithm to identify patients with attention deficit hyperactivity disorders (ADHD) and psychiatric comorbidities. J Neurodevelop Disord. 2022;14:37. doi:10.1186/s11689-022-09447-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9188139</ArticleId><ArticleId IdType="pubmed">35690720</ArticleId></ArticleIdList></Reference><Reference><Citation>Prieto-Alhambra D, Kostka K, Duarte-Salles T, et al. Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957305</ArticleId><ArticleId IdType="pubmed">35345821</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, You SC, Sena AG, et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nature communications. 2020;11:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Recalde M, Roel E, Pistillo A, et al. Characteristics and outcomes of 627 044 COVID-19 patients with and without obesity in the United States, Spain, and the United Kingdom. Published Online First: 3 September 2020. doi:10.1101/2020.09.02.20185173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8281807</ArticleId><ArticleId IdType="pubmed">34267326</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes C, Pistillo A, Fern&#xe1;ndez-Bertol&#xed;n S, et al. Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study. BMJ Open. 2021;11:e057632. doi:10.1136/bmjopen-2021-057632.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8704062</ArticleId><ArticleId IdType="pubmed">34937726</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EH, Sena AG, Prats-Uribe A, et al. COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology. 2021;60:SI37&#x2013;50. doi:10.1093/rheumatology/keab250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989171</ArticleId><ArticleId IdType="pubmed">33725121</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales DR, Ostropolets A, Lai L, et al. Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and Europe. Journal of Asthma. 2022. pp. 1&#x2013;11. doi:10.1080/02770903.2021.2025392.</Citation><ArticleIdList><ArticleId IdType="pubmed">35012410</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps J, Kim C, Williams R, et al. Can we trust the prediction model? Demonstrating the importance of external validation by investigating the COVID-19 Vulnerability (C-19) Index across an international network of observational healthcare datasets. 2020.</Citation></Reference><Reference><Citation>Ostropolets A, Li X, Makadia R, et al. Empirical evaluation of the sensitivity of background incidence rate characterization for adverse events across an international observational data network. Health Informatics. 2021. doi:10.1101/2021.06.27.21258701.</Citation></Reference><Reference><Citation>Khera R, Scheumie MJ, Lu Y, et al. RESEARCH PROTOCOL: Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus. Endocrinology (including Diabetes Mellitus and Metabolic Disease) 2021. doi:10.1101/2021.09.27.21264139.</Citation></Reference><Reference><Citation>Schneeweiss S, Brown JS, Bate A, et al. Choosing Among Common Data Models for Real&#x2010;World Data Analyses Fit for Making Decisions About the Effectiveness of Medical Products. Clin Pharmacol Ther. 2020;107:827&#x2013;33. doi:10.1002/cpt.1577.</Citation><ArticleIdList><ArticleId IdType="pubmed">31330042</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanes S, Brown JS, Haynes K, et al. Identifying health outcomes in healthcare databases: Identifying Health Outcomes. Pharmacoepidemiol Drug Saf. 2015;24:1009&#x2013;16. doi:10.1002/pds.3856.</Citation><ArticleIdList><ArticleId IdType="pubmed">26282185</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al. Characterizing treatment pathways at scale using the OHDSI network. Proceedings of the National Academy of Sciences. 2016;113:7329&#x2013;36. doi:10.1073/pnas.1510502113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JS, Maro JC, Nguyen M, et al. Using and improving distributed data networks to generate actionable evidence: the case of real-world outcomes in the Food and Drug Administration&#x2019;s Sentinel system. Journal of the American Medical Informatics Association. 2020;27:793&#x2013;7. doi:10.1093/jamia/ocaa028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7647264</ArticleId><ArticleId IdType="pubmed">32279080</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball R, Robb M, Anderson S, et al. The FDA&#x2019;s sentinel initiative-A comprehensive approach to medical product surveillance. Clin Pharmacol Ther. 2016;99:265&#x2013;8. doi:10.1002/cpt.320.</Citation><ArticleIdList><ArticleId IdType="pubmed">26667601</ArticleId></ArticleIdList></Reference><Reference><Citation>Morley KI, Wallace J, Denaxas SC, et al. Defining Disease Phenotypes Using National Linked Electronic Health Records: A Case Study of Atrial Fibrillation. PLoS ONE. 2014;9:e110900. doi:10.1371/journal.pone.0110900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4219705</ArticleId><ArticleId IdType="pubmed">25369203</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad FS, Ricket IM, Hammill BG, et al. Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLE. Circ: Cardiovascular Quality and Outcomes. 2020;13 doi:10.1161/CIRCOUTCOMES.119.006292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7321832</ArticleId><ArticleId IdType="pubmed">32466729</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Thompson WK, Rasmussen LV, et al. Desiderata for computable representations of electronic health records-driven phenotype algorithms. Journal of the American Medical Informatics Association. 2015;22:1220&#x2013;30. doi:10.1093/jamia/ocv112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4639716</ArticleId><ArticleId IdType="pubmed">26342218</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman M, Mumtaz S, Rasmussen LV, et al. Desiderata for the development of next-generation electronic health record phenotype libraries. GigaScience. 2021;10:giab059. doi:10.1093/gigascience/giab059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8434766</ArticleId><ArticleId IdType="pubmed">34508578</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37128452</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2022</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Hierarchy-aware Adverse Reaction Embeddings for Signal Detection.</ArticleTitle><Pagination><StartPage>596</StartPage><EndPage>605</EndPage><MedlinePgn>596-605</MedlinePgn></Pagination><Abstract><AbstractText>Post-market drug surveillance monitors new and evolving treatments for their effectiveness and safety in real-world conditions. A large amount of drug safety surveillance data is captured by spontaneous reporting systems such as the FAERS. Developing automated methods to identify actionable safety signals from these databases is an active area of research. In this paper, we propose two novel network representation learning methods (HARE and T-HARE) for signal detection that jointly utilize association information between drugs and medical outcomes from the FAERS and ancestral information in medical ontologies. We evaluate these methods using two publicly available reference datasets, EU-ADR and OMOP corpus. Experimental results showed that the proposed methods significantly outper-formed standard methodologies based on disproportionality metrics and the existing state-of-the-art aer2vec method with statistically significant improvements on both EU-ADR and OMOP datasets. Through quantitative and qualitative analysis, we demonstrate the potential of the proposed methods for effective signal detection.</AbstractText><CopyrightInformation>&#xa9;2022 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joopudi</LastName><ForeName>Venkata</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>IBM Research, Yorktown Heights, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dandala</LastName><ForeName>Bharath</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>IBM Research, Yorktown Heights, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsou</LastName><ForeName>Ching-Huei</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>IBM Research, Yorktown Heights, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Jennifer J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>IBM Research, Yorktown Heights, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="N">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034621" MajorTopicYN="Y">Hares</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="Y">Drug-Related Side Effects and Adverse Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016903" MajorTopicYN="N">Drug Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>1</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37128452</ArticleId><ArticleId IdType="pmc">PMC10148317</ArticleId><ArticleId IdType="pii">868</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Organization WH, et al. The importance of pharmacovigilance. 2002.</Citation></Reference><Reference><Citation>Coloma PM, Trifiro` G, Patadia V, Sturkenboom M. Postmarketing safety surveillance. Drug safety. 2013;36(3):183&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">23377696</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenbroucke JP. In defense of case reports and case series. Annals of internal medicine. 2001;134(4):330&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">11182844</ArticleId></ArticleIdList></Reference><Reference><Citation>van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepi-demiology and drug safety. 2002;11(1):3&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">11998548</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiology and drug safety. 2004;13(8):519&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">15317031</ArticleId></ArticleIdList></Reference><Reference><Citation>for International Organizations of Medical Sciences C, for International Organizations of Medical Sciences C, et al. Practical aspects of signal detection in pharmacovigilance: report of CIOMS Working Group VIII. Geneva: Council for International Organizations of Medical Sciences; 2010.</Citation></Reference><Reference><Citation>Sultana J, Trifiro` G. The potential role of big data in the detection of adverse drug reactions. Taylor &amp; Francis; 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32176553</ArticleId></ArticleIdList></Reference><Reference><Citation>Ina&#xb4;cio P, Cavaco A, Airaksinen M. The value of patient reporting to the pharmacovigilance system: a systematic review. British journal of clinical pharmacology. 2017;83(2):227&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5237689</ArticleId><ArticleId IdType="pubmed">27558545</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D, Yin J, Zhu X, Zhang C. Network representation learning: A survey. IEEE transactions on Big Data. 2018.</Citation></Reference><Reference><Citation>Wu Z, Pan S, Chen F, Long G, Zhang C, Philip SY. A comprehensive survey on graph neural networks. IEEE Transactions on Neural Networks and Learning Systems. 2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">32217482</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue X, Wang Z, Huang J, Parthasarathy S, Moosavinasab S, Huang Y, et al. Graph embedding on biomedical networks: methods, applications and evaluations. Bioinformatics. 2020;36(4):1241&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7703771</ArticleId><ArticleId IdType="pubmed">31584634</ArticleId></ArticleIdList></Reference><Reference><Citation>Portanova J, Murray N, Mower J, Subramanian D, Cohen T. AMIA Annual Symposium Proceedings. vol. 2019. American Medical Informatics Association; 2019. aer2vec: distributed representations of adverse event reporting system data as a means to identify drug/side-effect associations; p. 717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153155</ArticleId><ArticleId IdType="pubmed">32308867</ArticleId></ArticleIdList></Reference><Reference><Citation>Banda JM, Evans L, Vanguri RS, Tatonetti NP, Ryan PB, Shah NH. A curated and standardized adverse drug event resource to accelerate drug safety research. Scientific data. 2016;3:160026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4872271</ArticleId><ArticleId IdType="pubmed">27193236</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson SJ, Zeng K, Kilbourne J, Powell T, Moore R. Normalized names for clinical drugs: RxNorm at 6 years. Journal of the American Medical Informatics Association. 2011;18(4):441&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128404</ArticleId><ArticleId IdType="pubmed">21515544</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA) Drug safety. 1999;20(2):109&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">10082069</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison J, Mozzicato P. Side effects of drugs annual. vol. 31. Elsevier; 2009. MedDRA&#xae;: The tale of a terminology: side effects of drugs essay; pp. xxxiii&#x2013;xli.</Citation></Reference><Reference><Citation>Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, Hartzema AG. Defining a reference set to support methodological research in drug safety. Drug safety. 2013;36(1):33&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166222</ArticleId></ArticleIdList></Reference><Reference><Citation>Coloma PM, Avillach P, Salvo F, Schuemie MJ, Ferrajolo C, Pariente A, et al. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases. Drug safety. 2013;36(1):13&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">23315292</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi E, Bahadori MT, Song L, Stewart WF, Sun J. GRAM: graph-based attention model for healthcare representation learning. Proceedings of the 23rd ACM SIGKDD international conference on knowledge discovery and data mining. 2017. pp. 787&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7954122</ArticleId><ArticleId IdType="pubmed">33717639</ArticleId></ArticleIdList></Reference><Reference><Citation>Galassi A, Lippi M, Torroni P. Attention in natural language processing. IEEE Transactions on Neural Networks and Learning Systems. 2020;32(10):4291&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pubmed">32915750</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaswani A, Shazeer N, Parmar N, Uszkoreit J, Jones L, Gomez AN, et al. Attention is all you need. Advances in neural information processing systems. 2017;30</Citation></Reference><Reference><Citation>Tang J, Qu M, Wang M, Zhang M, Yan J, Mei Q. Line: Large-scale information network embedding. Proceedings of the 24th international conference on world wide web. 2015. pp. 1067&#x2013;77.</Citation></Reference><Reference><Citation>Li AQ, Ahmed A, Ravi S, Smola AJ. Reducing the sampling complexity of topic models. Proceedings of the 20th ACM SIGKDD international conference on Knowledge discovery and data mining. 2014. pp. 891&#x2013;900.</Citation></Reference><Reference><Citation>Xie R, Liu Z, Lin F, Lin L. Does william shakespeare really write hamlet? knowledge representation learning with confidence. Proceedings of the AAAI Conference on Artificial Intelligence. 2018;vol. 32</Citation></Reference><Reference><Citation>Shan Y, Bu C, Liu X, Ji S, Li L. 2018 IEEE International Conference on Big Knowledge (ICBK) IEEE; 2018. Confidence-aware negative sampling method for noisy knowledge graph embedding; pp. 33&#x2013;40.</Citation></Reference><Reference><Citation>Bouma G. Normalized (pointwise) mutual information in collocation extraction. Proceedings of GSCL. 2009;30:31&#x2013;40.</Citation></Reference><Reference><Citation>Kingma DP, Ba J. Adam: A method for stochastic optimization. arXiv preprint arXiv:14126980. 2014.</Citation></Reference><Reference><Citation>Lingamaneni R, Hemmings HC., Jr Differential interaction of anaesthetics and antiepileptic drugs with neuronal Na+ channels, Ca2+ channels, and GABAA receptors. British Journal of Anaesthesia. 2003;90(2):199&#x2013;211. Available from:  https://www.sciencedirect.com/science/article/pii/S0007091217368940.</Citation><ArticleIdList><ArticleId IdType="pubmed">12538378</ArticleId></ArticleIdList></Reference><Reference><Citation>Noorani I, Durnford A, Sadek AR, Charalambides C, Grundy P. Phenytoin-induced methaemoglobinaemia in a patient with glioblastoma multiforme. Br J Neurosurg. 2015 Feb;29(1):112.</Citation><ArticleIdList><ArticleId IdType="pubmed">25135180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal T, Hooda S, Jaiswal R, Bansal M. Delayed recovery from anaesthesia due to acute phenytoin therapy. Indian J Anaesth. 2014 Nov;58(6):783&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4296382</ArticleId><ArticleId IdType="pubmed">25624561</ArticleId></ArticleIdList></Reference><Reference><Citation>Herna&#xb4;ndez-Palazo&#xb4;n J, Tortosa JA, Mart&#xb4;&#x131;nez-Lage JF, Pe&#xb4;rez-Ayala M. Rocuronium-induced neuromuscular block-ade is affected by chronic phenytoin therapy. J Neurosurg Anesthesiol. 2001 Apr;13(2):79&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">11294462</ArticleId></ArticleIdList></Reference><Reference><Citation>Demner-Fushman D, Shooshan SE, Rodriguez L, Aronson AR, Lang F, Rogers W, et al. A dataset of 200 structured product labels annotated for adverse drug reactions. Scientific data. 2018;5(1):1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5789866</ArticleId><ArticleId IdType="pubmed">29381145</ArticleId></ArticleIdList></Reference><Reference><Citation>Khattab O, Zaharia M. Colbert: Efficient and effective passage search via contextualized late interaction over bert. Proceedings of the 43rd International ACM SIGIR conference on research and development in Information Retrieval. 2020. pp. 39&#x2013;48.</Citation></Reference><Reference><Citation>Bhowmik R, Melo Gd. International Semantic Web Conference. Springer; 2020. Explainable link prediction for emerging entities in knowledge graphs; pp. 39&#x2013;55.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37128466</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1942-597X</ISSN><JournalIssue CitedMedium="Internet"><Volume>2022</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>AMIA ... Annual Symposium proceedings. AMIA Symposium</Title><ISOAbbreviation>AMIA Annu Symp Proc</ISOAbbreviation></Journal><ArticleTitle>Feasibility of Linking Area Deprivation Index Data to the OMOP Common Data Model.</ArticleTitle><Pagination><StartPage>587</StartPage><EndPage>595</EndPage><MedlinePgn>587-595</MedlinePgn></Pagination><Abstract><AbstractText>Linking Area Deprivation Index (ADI) scores to observational data offers the opportunity to characterize healthcare treatment and outcomes that are driven by socioeconomic deprivation. The current study aims to assess the feasibility of creating an analysis package to link ADI rankings to multiple patient-level EHR datasets transformed into the OMOP CDM. Patients within two cancer cohorts (breast cancer and multiple myeloma) were identified within two OMOP datasets and their records were linked with ADI scores using address information in the OMOP location table. With ADI linked to patient addresses, we generated visualizations showing the geographic distribution of each cohort based on ADI scores. Additionally, further assessment showed that over 89% of patient addresses could successfully be linked with ADI rankings. In conducting this assessment, we have demonstrated that developing a package to link ADI scores with multiple OMOP datasets is feasible.</AbstractText><CopyrightInformation>&#xa9;2022 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xinzhuo</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Columbia University Irvine Medical Center, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaton</LastName><ForeName>Maura A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Columbia University Irvine Medical Center, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gillberg</LastName><ForeName>Jake</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Tufts Medical Center, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tufts Medical Center, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Columbia University Irvine Medical Center, New York, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Annu Symp Proc</MedlineTA><NlmUniqueID>101209213</NlmUniqueID><ISSNLinking>1559-4076</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="Y">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000091489" MajorTopicYN="Y">Social Deprivation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>1</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37128466</ArticleId><ArticleId IdType="pmc">PMC10148322</ArticleId><ArticleId IdType="pii">1078</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005 Oct 27;353(17):1784&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">16251534</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz D, Near AM, van Ravesteyn NT, Lee SJ, Schechter CB, Alagoz O, et al. Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality. JNCI: Journal of the National Cancer Institute. 2014 Nov 1;106(11):dju289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4271026</ArticleId><ArticleId IdType="pubmed">25255803</ArticleId></ArticleIdList></Reference><Reference><Citation>Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995. pp. Spec No: 80&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">7560851</ArticleId></ArticleIdList></Reference><Reference><Citation>Asare M, Flannery M, Kamen C. Social determinants of health: A framework for studying cancer health disparities and minority participation in research. Oncol Nurs Forum. 2017 Jan 2;44(1):20&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5583708</ArticleId><ArticleId IdType="pubmed">28060469</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlin SS. Social determinants of breast cancer risk, stage, and survival. Breast Cancer Res Treat. 2019 Oct;177(3):537&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">31270761</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamoun K, Firoozmand A, Caimi P, Fu P, Cao S, Otegbeye F, et al. Socioeconomic factors and survival of multiple myeloma patients. Cancers (Basel) 2021 Feb 3;13(4):590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7913279</ArticleId><ArticleId IdType="pubmed">33546206</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004 Apr;54(2):78&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">15061598</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavala VA, Bracci PM, Carethers JM, Carvajal-Carmona L, Coggins NB, Cruz-Correa MR, et al. Cancer health disparities in racial/ethnic minorities in the United States. Br J Cancer. 2021 Jan;124(2):315&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852513</ArticleId><ArticleId IdType="pubmed">32901135</ArticleId></ArticleIdList></Reference><Reference><Citation>Monson JRT, Probst CP, Wexner SD, Remzi FH, Fleshman JW, Garcia-Aguilar J, et al. Failure of evidence-based cancer care in the United States: The association between rectal cancer treatment, cancer center volume, and geography. Annals of Surgery. 2014 Oct;260(4):625&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">25203879</ArticleId></ArticleIdList></Reference><Reference><Citation>Villanueva C, Chang J, Bartell SM, Ziogas A, Bristow R, Vieira VM. Contribution of geographic location to disparities in ovarian cancer treatment. Journal of the National Comprehensive Cancer Network. 2019 Nov 1;17(11):1318&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6839545</ArticleId><ArticleId IdType="pubmed">31693984</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Tan X, Padman R. Social determinants of health in electronic health records and their impact on analysis and risk prediction: A systematic review. J Am Med Inform Assoc. 2020 Nov 1;27(11):1764&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7671639</ArticleId><ArticleId IdType="pubmed">33202021</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh GK. Area deprivation and widening inequalities in US mortality, 1969-1998. Am J Public Health. 2003 Jul;93(7):1137&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1447923</ArticleId><ArticleId IdType="pubmed">12835199</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh GK, Miller BA, Hankey BF, Feuer EJ, Pickle LW. Changing area socioeconomic patterns in U.S. cancer mortality, 1950-1998: Part I--All cancers among men. J Natl Cancer Inst. 2002 Jun 19;94(12):904&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">12072544</ArticleId></ArticleIdList></Reference><Reference><Citation>Maroko AR, Doan TM, Arno PS, Hubel M, Yi S, Viola D. Integrating social determinants of health with treatment and prevention: A new tool to assess local area deprivation. Prev Chronic Dis. 2016 Sep 15;13:E128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5027849</ArticleId><ArticleId IdType="pubmed">27634778</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairfield KM, Lucas FL, Earle CC, Small L, Trimble EL, Warren JL. Regional variation in cancer-directed surgery and mortality among women with epithelial ovarian cancer in the Medicare population. Cancer. 2010 Oct 15;116(20):4840&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20578182</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich C, Ryan P, Belenkaya R, Natarajan K, Blacketer C. OMOP Common Data Model Specifications [Internet] OHDSI Common Data Model. 2021.  [cited 2021 Sep 10]. Available from:  https://github.com/OHDSI/CommonDataModel.</Citation></Reference><Reference><Citation>OMOP CDM v5.3.1 [Internet]. [cited 2022 Jul 28]  Available from:  https://ohdsi.github.io/CommonDataModel/cdm531.html.</Citation></Reference><Reference><Citation>OHDSI/GIS [Internet]. Observational Health Data Sciences and Informatics. 2023.  [cited 2022 Mar 1]. Available from:  https://github.com/OHDSI/GIS.</Citation></Reference><Reference><Citation>Kind AJH, Buckingham WR. Making neighborhood-disadvantage metrics accessible &#x2014; The neighborhood atlas. New England Journal of Medicine. 2018 Jun 28;378(26):2456&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6051533</ArticleId><ArticleId IdType="pubmed">29949490</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassman BE. The Multidimensional Deprivation Index Using Different Neighborhood Quality Definitions [Internet] 2020.  [cited 2022 Aug 2]. Available from:  https://www.semanticscholar.org/paper/The-Multidimensional-Deprivation-Index-Using-Glassman/e6d43c90971466f79bb0816b11d2fb2f6e9cdf08.</Citation></Reference><Reference><Citation>Diez-Roux AV, Kiefe CI, Jacobs DR, Haan M, Jackson SA, Nieto FJ, et al. Area characteristics and individual-level socioeconomic position indicators in three population-based epidemiologic studies. Ann Epidemiol. 2001 Aug;11(6):395&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">11454499</ArticleId></ArticleIdList></Reference><Reference><Citation>Relating Block Groups to ZIP Code Areas [Internet]  [cited 2022 Feb 17]. Available from:  http://proximityone.com/bg-zip.htm.</Citation></Reference><Reference><Citation>CDC/ATSDR&#x2019;s Social Vulnerability Index (SVI) [Internet] 2023.  [cited 2022 Mar 8]. Available from:  https://www.atsdr.cdc.gov/placeandhealth/svi/index.html.</Citation></Reference><Reference><Citation>Bureau UC. The Census Multidimensional Deprivation Index: Revised and Updated [Internet]. Census.gov.  [cited 2022 Mar 8]. Available from:  https://www.census.gov/library/working-papers/2021/demo/SEHSD-WP2021-03.html.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37167578</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2473-4276</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>JCO clinical cancer informatics</Title><ISOAbbreviation>JCO Clin Cancer Inform</ISOAbbreviation></Journal><ArticleTitle>How to Improve Cancer Patients ENrollment in Clinical Trials From rEal-Life Databases Using the Observational Medical Outcomes Partnership Oncology Extension: Results of the PENELOPE Initiative in Urologic Cancers.</ArticleTitle><Pagination><StartPage>e2200179</StartPage><MedlinePgn>e2200179</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1200/CCI.22.00179</ELocationID><Abstract><AbstractText Label="PURPOSE">To compare the computability of Observational Medical Outcomes Partnership (OMOP)-based queries related to prescreening of patients using two versions of the OMOP common data model (CDM; v5.3 and v5.4) and to assess the performance of the Greater Paris University Hospital (APHP) prescreening tool.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We identified the prescreening information items being relevant for prescreening of patients with cancer. We randomly selected 15 academic and industry-sponsored urology phase I-IV clinical trials (CTs) launched at APHP between 2016 and 2021. The computability of the related prescreening criteria (PC) was defined by their translation rate in OMOP-compliant queries and by their execution rate on the APHP clinical data warehouse (CDW) containing data of 205,977 patients with cancer. The overall performance of the prescreening tool was assessed by the rate of true- and false-positive cases of three randomly selected CTs.</AbstractText><AbstractText Label="RESULTS">We defined a list of 15 minimal information items being relevant for patients' prescreening. We identified 83 PC of the 534 eligibility criteria from the 15 CTs. We translated 33 and 62 PC in queries on the basis of OMOP CDM v5.3 and v5.4, respectively (translation rates of 40% and 75%, respectively). Of the 33 PC translated in the v5.3 of the OMOP CDM, 19 could be executed on the APHP CDW (execution rate of 58%). Of 83 PC, the computability rate on the APHP CDW reached 23%. On the basis of three CTs, we identified 17, 32, and 63 patients as being potentially eligible for inclusion in those CTs, resulting in positive predictive values of 53%, 41%, and 21%, respectively.</AbstractText><AbstractText Label="CONCLUSION">We showed that PC could be formalized according to the OMOP CDM and that the oncology extension increased their translation rate through better representation of cancer natural history.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kempf</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9285-1966</Identifier><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Inserm, Universit&#xe9; Sorbonne Paris Nord, Laboratoire d'Informatique M&#xe9;dicale et d'Ing&#xe9;nierie des Connaissances pour la e-Sant&#xe9;, LIMICS, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Oncology, Assistance Publique H&#xf4;pitaux de Paris, Henri Mondor Teaching Hospital, Cr&#xe9;teil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaterkowski</LastName><ForeName>Morgan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Innovation and Data, Paris, IT Department, Assistance Publique H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>EPITA School of Engineering and Computer Science, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leprovost</LastName><ForeName>Damien</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Inserm, Universit&#xe9; Sorbonne Paris Nord, Laboratoire d'Informatique M&#xe9;dicale et d'Ing&#xe9;nierie des Connaissances pour la e-Sant&#xe9;, LIMICS, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Innovation and Data, Paris, IT Department, Assistance Publique H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffon</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-9602-6429</Identifier><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Inserm, Universit&#xe9; Sorbonne Paris Nord, Laboratoire d'Informatique M&#xe9;dicale et d'Ing&#xe9;nierie des Connaissances pour la e-Sant&#xe9;, LIMICS, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Innovation and Data, Paris, IT Department, Assistance Publique H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouagne</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Innovation and Data, Paris, IT Department, Assistance Publique H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breant</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3559-6994</Identifier><AffiliationInfo><Affiliation>Innovation and Data, Paris, IT Department, Assistance Publique H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serre</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Innovation and Data, Paris, IT Department, Assistance Publique H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mouchet</LastName><ForeName>Alexandre</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Innovation and Data, Paris, IT Department, Assistance Publique H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rance</LastName><ForeName>Bastien</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-4417-1197</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Assistance Publique H&#xf4;pitaux de Paris, Centre-Universit&#xe9; de Paris (APHP-CUP), Universit&#xe9; de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatellier</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Assistance Publique H&#xf4;pitaux de Paris, Centre-Universit&#xe9; de Paris (APHP-CUP), Universit&#xe9; de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellamine</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Innovation and Data, Paris, IT Department, Assistance Publique H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Information, Paris Saclay Teaching Hospital, Assistance Publique H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerin</LastName><ForeName>Julien</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3024-8483</Identifier><AffiliationInfo><Affiliation>IT Department, Curie Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tannier</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Inserm, Universit&#xe9; Sorbonne Paris Nord, Laboratoire d'Informatique M&#xe9;dicale et d'Ing&#xe9;nierie des Connaissances pour la e-Sant&#xe9;, LIMICS, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livartowski</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IT Department, Curie Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilka</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Innovation and Data, Paris, IT Department, Assistance Publique H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daniel</LastName><ForeName>Christel</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-7938-8156</Identifier><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Inserm, Universit&#xe9; Sorbonne Paris Nord, Laboratoire d'Informatique M&#xe9;dicale et d'Ing&#xe9;nierie des Connaissances pour la e-Sant&#xe9;, LIMICS, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Innovation and Data, Paris, IT Department, Assistance Publique H&#xf4;pitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCO Clin Cancer Inform</MedlineTA><NlmUniqueID>101708809</NlmUniqueID><ISSNLinking>2473-4276</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073458" MajorTopicYN="N">Data Warehousing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014572" MajorTopicYN="Y">Urology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014571" MajorTopicYN="Y">Urologic Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>16</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37167578</ArticleId><ArticleId IdType="doi">10.1200/CCI.22.00179</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37169362</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2005-7563</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Korean journal of anesthesiology</Title><ISOAbbreviation>Korean J Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Perioperative adverse cardiac events and mortality after non-cardiac surgery: a multicenter study.</ArticleTitle><Pagination><StartPage>66</StartPage><EndPage>76</EndPage><MedlinePgn>66-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4097/kja.23043</ELocationID><Abstract><AbstractText Label="BACKGROUND">Perioperative adverse cardiac events (PACE), a composite of myocardial infarction, coronary revascularization, congestive heart failure, arrhythmic attack, acute pulmonary embolism, cardiac arrest, and stroke during 30-day postoperative period, is associated with long-term mortality, but with limited clinical evidence. We compared long-term mortality with PACE using data from nationwide multicenter electronic health records.</AbstractText><AbstractText Label="METHODS">Data from 7 hospitals, converted to Observational Medical Outcomes Partnership Common Data Model, were used. We extracted records of 277,787 adult patients over 18 years old undergoing non-cardiac surgery for the first time at the hospital and had medical records for more than 180 days before surgery. We performed propensity score matching and then an aggregated meta&#x2011;analysis.</AbstractText><AbstractText Label="RESULTS">After 1:4 propensity score matching, 7,970 patients with PACE and 28,807 patients without PACE were matched. The meta&#x2011;analysis showed that PACE was associated with higher one-year mortality risk (hazard ratio [HR]: 1.33, 95% CI [1.10, 1.60], P = 0.005) and higher three-year mortality (HR: 1.18, 95% CI [1.01, 1.38], P = 0.038). In subgroup analysis, the risk of one-year mortality by PACE became greater with higher-risk surgical procedures (HR: 1.20, 95% CI [1.04, 1.39], P = 0.020 for low-risk surgery; HR: 1.69, 95% CI [1.45, 1.96], P &lt; 0.001 for intermediate-risk; and HR: 2.38, 95% CI [1.47, 3.86], P = 0.034 for high-risk).</AbstractText><AbstractText Label="CONCLUSIONS">A nationwide multicenter study showed that PACE was significantly associated with increased one-year mortality. This association was stronger in high-risk surgery, older, male, and chronic kidney disease subgroups. Further studies to improve mortality associated with PACE are needed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Byungjin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Ah Ran</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kangwon National University Hospital, Chuncheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jungchan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jong-Hwan</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kwangmo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Promotion, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Dong Yun</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhee</LastName><ForeName>Sang Youl</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Sang-Soo</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, Kangdong Sacred Heart Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seung Do</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sun Hack</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Internal Medicine, Pusan National University Hospital, Busan, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Chang Won</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Central Research Center of Biomedical Research Institute, Wonkwang University Hospital, Iksan, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Bumhee</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of Biostatistics, Medical Research Collaborating Center, Ajou Research Institute for Innovative Medicine, Ajou University Medical Center, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seol</LastName><ForeName>Soobeen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seunghwa</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Wiltse Memorial Hospital, Suwon, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>20003883</GrantID><Agency>Ministry of Trade, Industry and Energy</Agency><Country/></Grant><Grant><GrantID>20005021</GrantID><Agency>Ministry of Trade, Industry and Energy</Agency><Country/></Grant><Grant><GrantID>HR16C0001</GrantID><Agency>Ministry of Health and Welfare</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Korean J Anesthesiol</MedlineTA><NlmUniqueID>101502451</NlmUniqueID><ISSNLinking>2005-6419</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Korean J Anesthesiol. 2024 Feb;77(1):3-4. doi: 10.4097/kja.24038</RefSource><PMID Version="1">38267834</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="Y">Heart Arrest</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071076" MajorTopicYN="N">Network Meta-Analysis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac arrhythmias</Keyword><Keyword MajorTopicYN="N">Cardiovascular diseases</Keyword><Keyword MajorTopicYN="N">Embolism</Keyword><Keyword MajorTopicYN="N">General surgery</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Myocardial infarction.</Keyword></KeywordList><CoiStatement>
<b>Conflicts of Interest</b>
. No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>11</Day><Hour>20</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37169362</ArticleId><ArticleId IdType="pmc">PMC10834726</ArticleId><ArticleId IdType="doi">10.4097/kja.23043</ArticleId><ArticleId IdType="pii">kja.23043</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Devereaux PJ, Sessler DI. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med. 2015;373:2258&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">26630144</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, et al. Mortality after surgery in Europe: a 7 day cohort study. Lancet. 2012;380:1059&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3493988</ArticleId><ArticleId IdType="pubmed">22998715</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh SR, Tang T, Wijewardena C, Yarham SI, Boyle JR, Gaunt ME. Postoperative arrhythmias in general surgical patients. Ann R Coll Surg Engl. 2007;89:91&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1964549</ArticleId><ArticleId IdType="pubmed">17346395</ArticleId></ArticleIdList></Reference><Reference><Citation>Poise Study Group. Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">18479744</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh AR, Park J, Lee JH, Kim H, Yang K, Choi JH, et al. Association between perioperative adverse cardiac events and mortality during one-year follow-up after noncardiac surgery. J Am Heart Assoc. 2022;11:e024325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9238468</ArticleId><ArticleId IdType="pubmed">35411778</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394:1816&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo WW, Seo SI, Kim Y, Yoo JJ, Shin WG, Kim J, et al. Impact of pitavastatin on new-onset diabetes mellitus compared to atorvastatin and rosuvastatin: a distributed network analysis of 10 real-world databases. Cardiovasc Diabetol. 2022;21:82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9128291</ArticleId><ArticleId IdType="pubmed">35606846</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan CJ. Reducing bias using propensity score matching. J Nucl Cardiol. 2018;25:404&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">28776312</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57:1288&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">15617955</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristensen SD, Knuuti J, Saraste A, Anker S, B&#xf8;tker HE, Hert SD, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA) Eur Heart J. 2014;35:2383&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pubmed">25086026</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong PW, Westerhout CM. Composite end points in clinical research: a time for reappraisal. Circulation. 2017;135:2299&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">28584030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankoh AJ, Li H, D&#x2019;Agostino RB Sr. Use of composite endpoints in clinical trials. Stat Med. 2014;33:4709&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">24833282</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta NN, Yu Y, Pinnelas R, Krishnamoorthy P, Shin DB, Troxel AB, et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med. 2011;124:775.e1-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3146037</ArticleId><ArticleId IdType="pubmed">21787906</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhave PD, Goldman LE, Vittinghoff E, Maselli J, Auerbach A. Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery. Am Heart J. 2012;164:918&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096141</ArticleId><ArticleId IdType="pubmed">23194493</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh SR, Tang T, Gaunt ME, Schneider HJ. New arrhythmias after non-cardiothoracic surgery. BMJ. 2006;333:715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1592375</ArticleId><ArticleId IdType="pubmed">17023439</ArticleId></ArticleIdList></Reference><Reference><Citation>Albini A, Malavasi VL, Vitolo M, Imberti JF, Marietta M, Lip GY, et al. Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: a systematic review and metanalysis. Eur J Intern Med. 2021;85:27&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">33402281</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzal S, Arshad A. Ethical issues among healthcare workers using electronic medical records: a systematic review. Comput Methods Programs Biomed Update. 2021;1:100030.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37172152</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>301</Volume><PubDate><Year>2023</Year><Month>May</Month><Day>02</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Transforming Documents of the Austrian Nationwide EHR System into the OMOP CDM.</ArticleTitle><Pagination><StartPage>54</StartPage><EndPage>59</EndPage><MedlinePgn>54-59</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230011</ELocationID><Abstract><AbstractText>The Austrian nationwide EHR system ELGA can contribute valuable data for research due to its high volume of data and broad population coverage. In order to be applicable in international research projects, transformation to a standardized, research-oriented data model such as the OMOP common data model is essential. In this paper we describe our experience with the corresponding transformation task. Using Python scripts, we implemented a prototypical process that extracts, transforms, maps, and loads fully structured sections of ELGA documents to an OMOP database.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Korntheuer</LastName><ForeName>Raffael Lukas</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Section of Medical Information Management, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsch</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Section of Medical Information Management, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ludwig Boltzmann Institute for Digital Health and Prevention, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duftschmid</LastName><ForeName>Georg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Section of Medical Information Management, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001317" MajorTopicYN="N" Type="Geographic">Austria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011996" MajorTopicYN="Y">Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008962" MajorTopicYN="N">Models, Theoretical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ELGA</Keyword><Keyword MajorTopicYN="N">ETL process</Keyword><Keyword MajorTopicYN="N">HL7 CDA</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>19</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>12</Day><Hour>14</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37172152</ArticleId><ArticleId IdType="doi">10.3233/SHTI230011</ArticleId><ArticleId IdType="pii">SHTI230011</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37181728</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2574-2531</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>JAMIA open</Title><ISOAbbreviation>JAMIA Open</ISOAbbreviation></Journal><ArticleTitle>A metadata framework for computational phenotypes.</ArticleTitle><Pagination><StartPage>ooad032</StartPage><MedlinePgn>ooad032</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ooad032</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/jamiaopen/ooad032</ELocationID><Abstract><AbstractText>With the burgeoning development of computational phenotypes, it is increasingly difficult to identify the right phenotype for the right tasks. This study uses a mixed-methods approach to develop and evaluate a novel metadata framework for retrieval of and reusing computational phenotypes. Twenty active phenotyping researchers from 2 large research networks, Electronic Medical Records and Genomics and Observational Health Data Sciences and Informatics, were recruited to suggest metadata elements. Once consensus was reached on 39 metadata elements, 47 new researchers were surveyed to evaluate the utility of the metadata framework. The survey consisted of 5-Likert multiple-choice questions and open-ended questions. Two more researchers were asked to use the metadata framework to annotate 8 type-2 diabetes mellitus phenotypes. More than 90% of the survey respondents rated metadata elements regarding phenotype definition and validation methods and metrics positively with a score of 4 or 5. Both researchers completed annotation of each phenotype within 60&#x2009;min. Our thematic analysis of the narrative feedback indicates that the metadata framework was effective in capturing rich and explicit descriptions and enabling the search for phenotypes, compliance with data standards, and comprehensive validation metrics. Current limitations were its complexity for data collection and the entailed human costs.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the American Medical Informatics Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Spotnitz</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2869-0237</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acharya</LastName><ForeName>Nripendra</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cimino</LastName><ForeName>James J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Informatics Institute, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Shawn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Computer Science, Mass General Brigham, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Mass General Brigham, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Namjou</LastName><ForeName>Bahram</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crimmins</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walunas</LastName><ForeName>Theresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crosslin</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Biomedical Informatics and Genomics, Tulane University School of Medicine, New Orleans, Louisiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benoit</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Research Information Science &amp; Computing, Mass General Brigham, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosenthal</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Genetics, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pacheco</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Center for Genetic Medicine, Northwestern University, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0847-6682</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes Nieva</LastName><ForeName>Harry</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-7774-2561</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patterson</LastName><ForeName>Jason S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>Lauren R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Tiffany J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elhussein</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pang</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiryluk</LastName><ForeName>Krzysztof</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nestor</LastName><ForeName>Jordan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1418-3103</Identifier><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Atlas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohan</LastName><ForeName>Sumit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Nephrology, Department of Medicine, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minty</LastName><ForeName>Evan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Calgary, Calgary, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Wendy</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Wei-Qi</ForeName><Initials>WQ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vanderbilt University, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weng</LastName><ForeName>Chunhua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Vagelos College of Physicians &amp; Surgeons, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KL2 TR001874</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM139891</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG011172</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMIA Open</MedlineTA><NlmUniqueID>101730643</NlmUniqueID><ISSNLinking>2574-2531</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">metadata</Keyword><Keyword MajorTopicYN="N">phenotype</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>12</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37181728</ArticleId><ArticleId IdType="pmc">PMC10168627</ArticleId><ArticleId IdType="doi">10.1093/jamiaopen/ooad032</ArticleId><ArticleId IdType="pii">ooad032</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Newton KM, Peissig PL, Kho AN, et al.Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. J Am Med Inform Assoc 2013; 20 (e1): e147&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3715338</ArticleId><ArticleId IdType="pubmed">23531748</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Shang N, Peissig PL, et al.Facilitating phenotype transfer using a common data model. J Biomed Inform 2019; 96: 103253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6697565</ArticleId><ArticleId IdType="pubmed">31325501</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty CA, Chisholm RL, Chute CG, et al.The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics 2011; 4: 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038887</ArticleId><ArticleId IdType="pubmed">21269473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby JC, Speltz P, Rasmussen LV, et al.PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability. J Am Med Inform Assoc 2016; 23 (6): 1046&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5070514</ArticleId><ArticleId IdType="pubmed">27026615</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo H, Thompson WK, Rasmussen LV, et al.Desiderata for computable representations of electronic health records-driven phenotype algorithms. J Am Med Inform Assoc 2015; 22 (6): 1220&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4639716</ArticleId><ArticleId IdType="pubmed">26342218</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman M, Rasmussen LV, Pacheco JA, et al.Phenoflow: a microservice architecture for portable workflow-based phenotype definitions. AMIA Jt Summits Transl Sci Proc 2021; 2021: 142&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8378606</ArticleId><ArticleId IdType="pubmed">34457128</ArticleId></ArticleIdList></Reference><Reference><Citation>
https://phenotypes.healthdatagateway.org/. Accessed April 28, 2023.</Citation></Reference><Reference><Citation>Richesson R, Smerek M, Cameron CB.. A framework to support the sharing and re-use of computable phenotype definitions across health care delivery and clinical research applications. eGEMs 2016; 4 (3): 2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4975566</ArticleId><ArticleId IdType="pubmed">27563686</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Rusincovitch SA, Wixted D, et al.A comparison of phenotype definitions for diabetes mellitus. J Am Med Inform Assoc 2013; 20 (e2): e319&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861928</ArticleId><ArticleId IdType="pubmed">24026307</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman M, Mumtaz S, Rasmussen LV, et al.Desiderata for the development of next-generation electronic health record phenotype libraries. GigaScience 2021; 10 (9): 1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8434766</ArticleId><ArticleId IdType="pubmed">34508578</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G, Solbrig HR, Kiefer R, et al.A standards-based semantic metadata repository to support EHR-driven phenotype authoring and execution. Stud Health Technol Inform 2015; 216: 1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4898771</ArticleId><ArticleId IdType="pubmed">26262397</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottesman O, Kuivaniemi H, Tromp G, et al.The electronic medical records and genomics (eMERGE) network: past, present, and future. Genet Med 2013; 15 (10): 761&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3795928</ArticleId><ArticleId IdType="pubmed">23743551</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37190737</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2093-3681</ISSN><JournalIssue CitedMedium="Print"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Healthcare informatics research</Title><ISOAbbreviation>Healthc Inform Res</ISOAbbreviation></Journal><ArticleTitle>Standardized Database of 12-Lead Electrocardiograms with a Common Standard for the Promotion of Cardiovascular Research: KURIAS-ECG.</ArticleTitle><Pagination><StartPage>132</StartPage><EndPage>144</EndPage><MedlinePgn>132-144</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4258/hir.2023.29.2.132</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Electrocardiography (ECG)-based diagnosis by experts cannot maintain uniform quality because individual differences may occur. Previous public databases can be used for clinical studies, but there is no common standard that would allow databases to be combined. For this reason, it is difficult to conduct research that derives results by combining databases. Recent commercial ECG machines offer diagnoses similar to those of a physician. Therefore, the purpose of this study was to construct a standardized ECG database using computerized diagnoses.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The constructed database was standardized using Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) and Observational Medical Outcomes Partnership-common data model (OMOP-CDM), and data were then categorized into 10 groups based on the Minnesota classification. In addition, to extract high-quality waveforms, poor-quality ECGs were removed, and database bias was minimized by extracting at least 2,000 cases for each group. To check database quality, the difference in baseline displacement according to whether poor ECGs were removed was analyzed, and the usefulness of the database was verified with seven classification models using waveforms.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The standardized KURIAS-ECG database consists of high-quality ECGs from 13,862 patients, with about 20,000 data points, making it possible to obtain more than 2,000 for each Minnesota classification. An artificial intelligence classification model using the data extracted through SNOMED-CT showed an average accuracy of 88.03%.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The KURIAS-ECG database contains standardized ECG data extracted from various machines. The proposed protocol should promote cardiovascular disease research using big data and artificial intelligence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Hakje</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Korea University Research Institute for Medical Bigdata Science, Korea University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yum</LastName><ForeName>Yunjin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Korea University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Soo Wan</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Korea University Research Institute for Medical Bigdata Science, Korea University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jeong Moon</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Korea University Research Institute for Medical Bigdata Science, Korea University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Moonjoung</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Korea University Research Institute for Medical Bigdata Science, Korea University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yoojoong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Computer Science and Information Engineering, The Catholic University of Korea, Bucheon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jong-Ho</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Cardiovascular Center, Korea University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Hyun-Joon</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Korea University Research Institute for Healthcare Service Innovation, Korea University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Kap Su</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Korea University Research Institute for Healthcare Service Innovation, Korea University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jae Hyoung</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Cardiovascular Center, Korea University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Hyung Joon</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Korea University Research Institute for Medical Bigdata Science, Korea University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Cardiovascular Center, Korea University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Korea University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021R1I1A1A01059747</GrantID><Agency>National Research Foundation of Korea</Agency><Country/></Grant><Grant><Agency>Ministry of Education</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Healthc Inform Res</MedlineTA><NlmUniqueID>101534553</NlmUniqueID><ISSNLinking>2093-3681</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial Intelligence</Keyword><Keyword MajorTopicYN="N">Biological Ontologies</Keyword><Keyword MajorTopicYN="N">Cardiovascular Diseases</Keyword><Keyword MajorTopicYN="N">Database</Keyword><Keyword MajorTopicYN="N">Electrocardiograms</Keyword></KeywordList><CoiStatement>
<b>Conflict of Interest</b>
. No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>2</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37190737</ArticleId><ArticleId IdType="pmc">PMC10209728</ArticleId><ArticleId IdType="doi">10.4258/hir.2023.29.2.132</ArticleId><ArticleId IdType="pii">hir.2023.29.2.132</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, et al. Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12&#x2013;25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. Circulation. 2014;130(15):1303&#x2013;34. doi: 10.1161/CIR.0000000000000025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000025</ArticleId><ArticleId IdType="pubmed">25223981</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao P, Gao X, Li Z, Zhang J, Wu F, Bai C. Multi-branch fusion network for Myocardial infarction screening from 12-lead ECG images. Comput Methods Programs Biomed. 2020;184:105286. doi: 10.1016/j.cmpb.2019.105286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2019.105286</ArticleId><ArticleId IdType="pubmed">31891901</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkumar A, Ganesan M, Lavanya R. Arrhythmia classification on ECG using deep learning. Proceedings of 2019 5th International Conference on advanced Computing &amp; Communication Systems (ICACCS); 2019 Mar 15&#x2013;16; Coimbatore, India. pp. 365&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ICACCS.2019.8728362</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Wang H, Li Z, Qin L. Deep learning in ECG diagnosis: a review. Knowl Based Syst. 2021;227:107187. doi: 10.1016/j.knosys.2021.107187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.knosys.2021.107187</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Zhou Y, Shang J, Xiao C, Sun J. Opportunities and challenges of deep learning methods for electrocardiogram data: a systematic review. Comput Biol Med. 2020;122:103801. doi: 10.1016/j.compbiomed.2020.103801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2020.103801</ArticleId><ArticleId IdType="pubmed">32658725</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberger AL, Amaral LAN, Glass L, Hausdorff JM, Ivanov PCh, Mark RG, Mietus JE, Moody GB, Peng C-K, Stanley HE. PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation. 2000;101:e215&#x2013;e220. 
 http://circ.ahajournals.org/cgi/content/full/101/23/e215
.</Citation><ArticleIdList><ArticleId IdType="pubmed">10851218</ArticleId></ArticleIdList></Reference><Reference><Citation>Taddei A, Distante G, Emdin M, Pisani P, Moody GB, Zeelenberg C, et al. The European ST-T database: standard for evaluating systems for the analysis of ST-T changes in ambulatory electrocardiography. Eur Heart J. 1992;13(9):1164&#x2013;72. doi: 10.1093/oxfordjournals.eurheartj.a060332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.eurheartj.a060332</ArticleId><ArticleId IdType="pubmed">1396824</ArticleId></ArticleIdList></Reference><Reference><Citation>Jager F, Taddei A, Moody GB, Emdin M, Antolic G, Dorn R, et al. Long-term ST database: a reference for the development and evaluation of automated ischaemia detectors and for the study of the dynamics of myocardial ischaemia. Med Biol Eng Comput. 2003;41(2):172&#x2013;82. doi: 10.1007/BF02344885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02344885</ArticleId><ArticleId IdType="pubmed">12691437</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody GB, Mark RG. The impact of the MIT-BIH arrhythmia database. IEEE Eng Med Biol Mag. 2001;20(3):45&#x2013;50. doi: 10.1109/51.932724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/51.932724</ArticleId><ArticleId IdType="pubmed">11446209</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody GB, Muldrow W, Mark RG. A noise stress test for arrhythmia detectors. Comput Cardiol. 1984;11(3):381&#x2013;4.</Citation></Reference><Reference><Citation>Laguna P, Sornmo L. The STAFF III ECG database and its significance for methodological development and evaluation. J Electrocardiol. 2014;47(4):408&#x2013;17. doi: 10.1016/j.jelectrocard.2014.04.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2014.04.018</ArticleId><ArticleId IdType="pubmed">24881972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreiseler D, Bousseljot R. Automatisierte EKG-Auswertung mit Hilfe der EKG-Signaldatenbank CARDIODAT der PTB. Biomed Tech (Berl) 1995;40(s1):319&#x2013;20. doi: 10.1515/bmte.1995.40.s1.319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/bmte.1995.40.s1.319</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakushenko E.  St Petersburg INCART 12-lead Arrhythmia Database [Internet] Cambridge (MA): PhysioNet; 2008.  [cited at 2023 Mar 30]. Available from:  https://physionet.org/content/incartdb/1.0.0/</Citation></Reference><Reference><Citation>Moody GB. The PhysioNet/Computers in Cardiology challenge 2008: T-wave alternans. Proceedings of 2008 Computers in Cardiology; 2008 Sep 14&#x2013;17; Bologna, Italy. pp. 505&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/CIC.2008.4749089</ArticleId><ArticleId IdType="pmc">PMC2749698</ArticleId><ArticleId IdType="pubmed">19779602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalyakulina AI, Yusipov II, Moskalenko VA, Nikolskiy AV, Kosonogov KA, Osipov GV, et al. LUDB: a new open-access validation tool for electrocardiogram delineation algorithms. IEEE Access. 2020;8:186181&#x2013;90. doi: 10.1109/ACCESS.2020.3029211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ACCESS.2020.3029211</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Zhang J, Danioko S, Yao H, Guo H, Rakovski C. A 12-lead electrocardiogram database for arrhythmia research covering more than 10,000 patients. Sci Data. 2020;7(1):48. doi: 10.1038/s41597-020-0386-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-020-0386-x</ArticleId><ArticleId IdType="pmc">PMC7016169</ArticleId><ArticleId IdType="pubmed">32051412</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner P, Strodthoff N, Bousseljot RD, Kreiseler D, Lunze FI, Samek W, et al. PTB-XL, a large publicly available electrocardiography dataset. Sci Data. 2020;7(1):154. doi: 10.1038/s41597-020-0495-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-020-0495-6</ArticleId><ArticleId IdType="pmc">PMC7248071</ArticleId><ArticleId IdType="pubmed">32451379</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly K. SNOMED-CT: the advanced terminology and coding system for eHealth. Stud Health Technol Inform. 2006;121:279&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">17095826</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D, de Keizer N, Lau F, Cornet R. Literature review of SNOMED CT use. J Am Med Inform Assoc. 2014;21(e1):e11&#x2013;9. doi: 10.1136/amiajnl-2013-001636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001636</ArticleId><ArticleId IdType="pmc">PMC3957381</ArticleId><ArticleId IdType="pubmed">23828173</ArticleId></ArticleIdList></Reference><Reference><Citation>Prineas RJ, Crow RS, Zhang ZM. The Minnesota code manual of electrocardiographic findings. New York (NY): Springer Science &amp; Business Media; 2009.</Citation></Reference><Reference><Citation>Willems JL, Abreu-Lima C, Arnaud P, van Bemmel JH, Brohet C, Degani R, et al. The diagnostic performance of computer programs for the interpretation of electrocardiograms. N Engl J Med. 1991;325(25):1767&#x2013;73. doi: 10.1056/NEJM199112193252503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199112193252503</ArticleId><ArticleId IdType="pubmed">1834940</ArticleId></ArticleIdList></Reference><Reference><Citation>Smulyan H. The computerized ECG: friend and foe. Am J Med. 2019;132(2):153&#x2013;60. doi: 10.1016/j.amjmed.2018.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2018.08.025</ArticleId><ArticleId IdType="pubmed">30205084</ArticleId></ArticleIdList></Reference><Reference><Citation>Makadia R, Ryan PB. Transforming the premier perspective hospital database into the Observational Medical Outcomes Partnership (OMOP) common data model. EGEMS (Wash DC) 2014;2(1):1110. doi: 10.13063/2327-9214.1110.</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1110</ArticleId><ArticleId IdType="pmc">PMC4371500</ArticleId><ArticleId IdType="pubmed">25848597</ArticleId></ArticleIdList></Reference><Reference><Citation>Altay Y, Kremlev A, Zimenko K, Margun A. The effect of filter parameters on the accuracy of ECG signal measurement. Biomed Eng. 2019;53(3):176&#x2013;80. doi: 10.1007/s10527-019-09903-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10527-019-09903-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn J, Yang S, Lee J, Ku Y, Kim HC. Reconstruction of 12-lead electrocardiogram from a three-lead patch-type device using a LSTM network. Sensors (Basel) 2020;20(11):3278. doi: 10.3390/s20113278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/s20113278</ArticleId><ArticleId IdType="pmc">PMC7309162</ArticleId><ArticleId IdType="pubmed">32526828</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan F, Ruan G, Mo J. Baseline correction by improved iterative polynomial fitting with automatic threshold. Chemometr Intell Lab Syst. 2006;82(1&#x2013;2):59&#x2013;65. doi: 10.1016/j.chemolab.2005.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chemolab.2005.08.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek SJ, Park A, Ahn YJ, Choo J. Baseline correction using asymmetrically reweighted penalized least squares smoothing. Analyst. 2015;140(1):250&#x2013;7. doi: 10.1039/c4an01061b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c4an01061b</ArticleId><ArticleId IdType="pubmed">25382860</ArticleId></ArticleIdList></Reference><Reference><Citation>Meek S, Morris F, ABC of clinical electrocardiography Introduction. I-Leads, rate, rhythm, and cardiac axis. BMJ. 2002;324(7334):415&#x2013;8. doi: 10.1136/bmj.324.7334.415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.324.7334.415</ArticleId><ArticleId IdType="pmc">PMC1122339</ArticleId><ArticleId IdType="pubmed">11850377</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimi Z, Loni M, Daneshtalab M, Gharehbaghi A. A review on deep learning methods for ECG arrhythmia classification. Exp Syst Appl. 2020;7:100033. doi: 10.1016/j.eswax.2020.100033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eswax.2020.100033</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo H, Chung SH, Lee C-N, Joo HJ. Deep Learning Algorithm of 12-Lead Electrocardiogram for Parkinson Disease Screening. J Parkinsons Dis. 2023. pp. 1&#x2013;12. Preprint.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-223549</ArticleId><ArticleId IdType="pmc">PMC9912717</ArticleId><ArticleId IdType="pubmed">36641685</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37190741</PMID><DateRevised><Year>2023</Year><Month>05</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2093-3681</ISSN><JournalIssue CitedMedium="Print"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Healthcare informatics research</Title><ISOAbbreviation>Healthc Inform Res</ISOAbbreviation></Journal><ArticleTitle>Feasibility Study of Federated Learning on the Distributed Research Network of OMOP Common Data Model.</ArticleTitle><Pagination><StartPage>168</StartPage><EndPage>173</EndPage><MedlinePgn>168-173</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4258/hir.2023.29.2.168</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Since protecting patients' privacy is a major concern in clinical research, there has been a growing need for privacy-preserving data analysis platforms. For this purpose, a federated learning (FL) method based on the Observational Medical Outcomes Partnership (OMOP) common data model (CDM) was implemented, and its feasibility was demonstrated.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We implemented an FL platform on FeederNet, which is a distributed clinical data analysis platform based on the OMOP CDM in Korea. We trained it through an artificial neural network (ANN) using data from patients who received steroid prescriptions or injections, with the aim of predicting the occurrence of side effects depending on the prescribed dose. The ANN was trained using the FL platform with the OMOP CDMs of Kyung Hee University Medical Center (KHMC) and Ajou University Hospital (AUH).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The area under the receiver operating characteristic curves (AUROCs) for predicting bone fracture, osteonecrosis, and osteoporosis using only data from each hospital were 0.8426, 0.6920, and 0.7727 for KHMC and 0.7891, 0.7049, and 0.7544 for AUH, respectively. In contrast, when using FL, the corresponding AUROCs were 0.8260, 0.7001, and 0.7928 for KHMC and 0.7912, 0.8076, and 0.7441 for AUH, respectively. In particular, FL led to a 14% improvement in performance for osteonecrosis at AUH.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">FL can be performed with the OMOP CDM, and FL often shows better performance than using only a single institution's data. Therefore, research using OMOP CDM has been expanded from statistical analysis to machine learning so that researchers can conduct more diverse research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Geun Hyeong</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intelligent Precision Healthcare Convergence, Sungkyunkwan University, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jonggul</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Evidnet Inc., Seongnam, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jihyeong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Evidnet Inc., Seongnam, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yeesuk</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Hanyang University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Byungjin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Graduate School of Medicine, Ajou University, Suwon, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhee</LastName><ForeName>Sang Youl</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, College of Medicine, Kyung Hee University, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Soo-Yong</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intelligent Precision Healthcare Convergence, Sungkyunkwan University, Suwon, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Research Resource Standardization, Samsung Medical Center, Seoul, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Evidnet Inc</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Healthc Inform Res</MedlineTA><NlmUniqueID>101534553</NlmUniqueID><ISSNLinking>2093-3681</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Common Data Element</Keyword><Keyword MajorTopicYN="N">Deep Learning</Keyword><Keyword MajorTopicYN="N">Distributed Systems</Keyword><Keyword MajorTopicYN="N">Machine Learning</Keyword><Keyword MajorTopicYN="N">Privacy</Keyword></KeywordList><CoiStatement>
<b>Conflict of Interest</b>
. This study was conducted with support by Evidnet. Jonggul Park and Jihyeong Kim supported the use of FeederNet. And Rae Woong Park is an editorial member of Healthcare Informatics Research; however, he did not involve in the peer reviewer selection, evaluation, and decision process of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>2</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37190741</ArticleId><ArticleId IdType="pmc">PMC10209729</ArticleId><ArticleId IdType="doi">10.4258/hir.2023.29.2.168</ArticleId><ArticleId IdType="pii">hir.2023.29.2.168</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McMahan B, Moore E, Ramage D, Hampson S, y Arcas BA. Communication-efficient learning of deep networks from decentralized data. Proc Mach Learn Res. 2017;54:1273&#x2013;82.</Citation></Reference><Reference><Citation>Bonawitz K, Eichner H, Grieskamp W, Huba D, Ingerman A, Ivanov V, et al. Towards federated learning at scale: System design. Proceedings of Machine Learning and Systems (MLSys); 2019 Mar 31&#x2013;Apr 2; Stanford, CA. pp. 374&#x2013;88.</Citation></Reference><Reference><Citation>Konecny J, McMahan HB, Yu FX, Richtrik P, Suresh AT, Bacon D. Federated learning: strategies for improving communication efficiency [Internet] Ithaca (NY): arXiv.org; 2016. [cited at 2023 Mar 20]. Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1610.05492</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Glicksberg BS, Su C, Walker P, Bian J, Wang F. Federated learning for healthcare informatics. J Healthc Inform Res. 2021;5(1):1&#x2013;19. doi: 10.1007/s41666-020-00082-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41666-020-00082-4</ArticleId><ArticleId IdType="pmc">PMC7659898</ArticleId><ArticleId IdType="pubmed">33204939</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieke N, Hancox J, Li W, Milletari F, Roth HR, Albarqouni S, et al. The future of digital health with federated learning. NPJ Digit Med. 2020;3:119. doi: 10.1038/s41746-020-00323-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-00323-1</ArticleId><ArticleId IdType="pmc">PMC7490367</ArticleId><ArticleId IdType="pubmed">33015372</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee GH, Shin SY. Federated learning on clinical benchmark data: performance assessment. J Med Internet Res. 2020;22(10):e20891. doi: 10.2196/20891.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/20891</ArticleId><ArticleId IdType="pmc">PMC7652692</ArticleId><ArticleId IdType="pubmed">33104011</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaid A, Jaladanki SK, Xu J, Teng S, Kumar A, Lee S, et al. Federated learning of electronic health records to improve mortality prediction in hospitalized patients with COVID-19: machine learning approach. JMIR Med Inform. 2021;9(1):e24207. doi: 10.2196/24207.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/24207</ArticleId><ArticleId IdType="pmc">PMC7842859</ArticleId><ArticleId IdType="pubmed">33400679</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Milletari F, Xu D, Rieke N, Hancox J, Zhu W, et al. Privacy-preserving federated brain tumour segmentation. In: Suk HI, Liu M, Yan P, Lian C, editors. Machine learning in medical imaging. Cham, Switzerland: Springer; 2019. pp. 133&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-32692-0_16</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheller MJ, Edwards B, Reina GA, Martin J, Pati S, Kotrotsou A, et al. Federated learning in medicine: facilitating multi-institutional collaborations without sharing patient data. Sci Rep. 2020;10(1):12598. doi: 10.1038/s41598-020-69250-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-69250-1</ArticleId><ArticleId IdType="pmc">PMC7387485</ArticleId><ArticleId IdType="pubmed">32724046</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JS, Holmes JH, Shah K, Hall K, Lazarus R, Platt R. Distributed health data networks: a practical and preferred approach to multi-institutional evaluations of comparative effectiveness, safety, and quality of care. Med Care. 2010;48(6 Suppl):S45&#x2013;51. doi: 10.1097/MLR.0b013e3181d9919f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e3181d9919f</ArticleId><ArticleId IdType="pubmed">20473204</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen RA, Zeng P, Ryan P, Gao J, Sonawane K, Teeter B, et al. Exploration of heterogeneity in distributed research network drug safety analyses. Res Synth Methods. 2014;5(4):352&#x2013;70. doi: 10.1002/jrsm.1121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1121</ArticleId><ArticleId IdType="pubmed">26052957</ArticleId></ArticleIdList></Reference><Reference><Citation>Toh S, Gagne JJ, Rassen JA, Fireman BH, Kulldorff M, Brown JS. Confounding adjustment in comparative effectiveness research conducted within distributed research networks. Med Care. 2013;51(8 Suppl 3):S4&#x2013;10. doi: 10.1097/MLR.0b013e31829b1bb1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e31829b1bb1</ArticleId><ArticleId IdType="pubmed">23752258</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI) [Internet] [place unknown]: OHDSI; 2022.  [cited at 2023 Mar 20]. Available from:  https://www.ohdsi.org/</Citation></Reference><Reference><Citation>FeederNet: a distributed clinical data analysis platform in Korea [Internet] Seongnam, Korea: Evidnet; c2022.  [cited at 2023 Mar 20]. Available from:  https://feedernet.com/member/main.</Citation></Reference><Reference><Citation>Kim Y, Tian Y, Yang J, Huser V, Jin P, Lambert CG, et al. Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis. Sci Rep. 2020;10(1):11115. doi: 10.1038/s41598-020-68037-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-68037-8</ArticleId><ArticleId IdType="pmc">PMC7338498</ArticleId><ArticleId IdType="pubmed">32632237</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis. Lancet. 2019;394(10211):1816&#x2013;26. doi: 10.1016/S0140-6736(19)32317-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37203475</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><PubDate><Year>2023</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Fitness for Use of Anatomical Therapeutic Classification for Real World Data Research.</ArticleTitle><Pagination><StartPage>711</StartPage><EndPage>715</EndPage><MedlinePgn>711-715</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230245</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Real-world data (RWD) is gaining importance in research. For instance, the European Medicines Agency (EMA) is currently in the process of establishing a cross-national research network that utilizes RWD for research. However, data harmonization across countries must be carefully considered to avoid misclassification and bias.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This paper aims to investigate the extent to which a correct assignment of RxNorm ingredients is possible for medication orders that include only ATC codes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this study, we analyzed 1,506,059 medication orders from the University Hospital Dresden (UKD) and merged them with the ATC vocabulary in the Observational Medical Outcomes Partnership (OMOP) including relevant relationship mappings to RxNorm.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 70.25% of all medication orders were single ingredients with direct mapping to RxNorm. However, we also identified a significant complexity in mappings for the other medication orders that was visualized in an interactive scatterplot.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The majority of medication orders under observation (70.25%) are single ingredients and can be standardized to RxNorm, combination drugs pose a challenge due to the different approaches of ingredient assignments in ATC and RxNorm. The provided visualization can help research teams gain a better understanding of problematic data and further investigate identified issues.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reinecke</LastName><ForeName>Ines</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Carl Gustav Carus Faculty of Medicine, Center for Medical Informatics, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henke</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Carl Gustav Carus Faculty of Medicine, Center for Medical Informatics, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Carl Gustav Carus Faculty of Medicine, Center for Medical Informatics, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Carl Gustav Carus Faculty of Medicine, Center for Medical Informatics, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bathelt</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Carl Gustav Carus Faculty of Medicine, Center for Medical Informatics, Institute for Medical Informatics and Biometry, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018875" MajorTopicYN="Y">Vocabulary, Controlled</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062245" MajorTopicYN="Y">RxNorm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011996" MajorTopicYN="N">Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014825" MajorTopicYN="N">Vocabulary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ATC</Keyword><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">RWD</Keyword><Keyword MajorTopicYN="N">RxNorm</Keyword><Keyword MajorTopicYN="N">interoperability</Keyword><Keyword MajorTopicYN="N">medication</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37203475</ArticleId><ArticleId IdType="doi">10.3233/SHTI230245</ArticleId><ArticleId IdType="pii">SHTI230245</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37203486</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><PubDate><Year>2023</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Towards ETL Processes to OMOP CDM Using Metadata and Modularization.</ArticleTitle><Pagination><StartPage>751</StartPage><EndPage>752</EndPage><MedlinePgn>751-752</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230256</ELocationID><Abstract><AbstractText>OMOP common data model (CDM) is designed for analyzing large clinical data and building cohorts for medical research, which requires Extract-Transform-Load processes (ETL) of local heterogeneous medical data. We present a concept for developing and evaluating a modularized metadata-driven ETL process, which can transform data into OMOP CDM regardless of 1) the source data format, 2) its versions and 3) context of use.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henke</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bathelt</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000071253" MajorTopicYN="Y">Metadata</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="Y">Biomedical Research</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ETL</Keyword><Keyword MajorTopicYN="N">Metadata</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">data harmonization</Keyword><Keyword MajorTopicYN="N">interoperability</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37203486</ArticleId><ArticleId IdType="doi">10.3233/SHTI230256</ArticleId><ArticleId IdType="pii">SHTI230256</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37203488</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><PubDate><Year>2023</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Modeling Patient Treatment Trajectories Using Markov Chains for Cost Analysis.</ArticleTitle><Pagination><StartPage>755</StartPage><EndPage>756</EndPage><MedlinePgn>755-756</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230258</ELocationID><Abstract><AbstractText>Electronically stored medical records offer a rich source of data for investigating treatment trajectories and identifying best practices in healthcare. These trajectories, which consist of medical interventions, give us a foundation to evaluate the economics of treatment patterns and model the treatment paths. The aim of this work is to introduce a technical solution for the aforementioned tasks. The developed tools use the open source Observational Health Data Sciences and Informatics Observational Medical Outcomes Partnership Common Data Model to construct treatment trajectories and implement these to compose Markov models for composing financial analysis between standard of care and alternatives.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haug</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolde</LastName><ForeName>Raivo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oja</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pajusalu</LastName><ForeName>Maarja</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Estonia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008390" MajorTopicYN="N">Markov Chains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003365" MajorTopicYN="N">Costs and Cost Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="Y">Delivery of Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Markov chain</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">cost-effectiveness</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword><Keyword MajorTopicYN="N">medical data</Keyword><Keyword MajorTopicYN="N">treatment trajectories</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37203488</ArticleId><ArticleId IdType="doi">10.3233/SHTI230258</ArticleId><ArticleId IdType="pii">SHTI230258</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37203528</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><PubDate><Year>2023</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Converting HL7 CDA Based Nationwide Austrian Medication Data to OMOP CDM.</ArticleTitle><Pagination><StartPage>899</StartPage><EndPage>900</EndPage><MedlinePgn>899-900</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230300</ELocationID><Abstract><AbstractText>Austria's national Electronic Health Record (EHR) system holds information on medication prescriptions and dispenses in highly structured HL7 Clinical Document Architecture (CDA) documents. Making these data accessible for research is desirable due to their volume and completeness. This work describes our approach of transforming the HL7 CDA data into Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) and highlights a key challenge, namely mapping the Austrian drug terminology to OMOP standard concepts.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Katsch</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Ludwig Boltzmann Institute for Digital Health and Prevention, Salzburg, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussein</LastName><ForeName>Rada</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ludwig Boltzmann Institute for Digital Health and Prevention, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korntheuer</LastName><ForeName>Raffael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duftschmid</LastName><ForeName>Georg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D001317" MajorTopicYN="N" Type="Geographic">Austria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="Y">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electronic Health Record</Keyword><Keyword MajorTopicYN="N">Electronic Prescription</Keyword><Keyword MajorTopicYN="N">HL7 CDA</Keyword><Keyword MajorTopicYN="N">Health Information Interoperability</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>5</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37203528</ArticleId><ArticleId IdType="doi">10.3233/SHTI230300</ArticleId><ArticleId IdType="pii">SHTI230300</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37203598</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><PubDate><Year>2023</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>German Claims Data for Real-World Research: Content Coverage Evaluation in OMOP CDM.</ArticleTitle><Pagination><StartPage>3</StartPage><EndPage>7</EndPage><MedlinePgn>3-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230053</ELocationID><Abstract><AbstractText>Research on real-world data is becoming increasingly important. The current restriction to clinical data in Germany limits the view of the patient. To gain comprehensive insights, claims data can be added to the existing knowledge. However, standardized transfer of German claims data into OMOP CDM is currently not possible. In this paper, we conducted an evaluation regarding the coverage of source vocabularies and data elements of German claims data in OMOP CDM. We point out the need to extend vocabularies and mappings to support research on German claims data.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Henke</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoch</LastName><ForeName>Mich&#xe9;le</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinecke</LastName><ForeName>Ines</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spoden</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>AOK Research Institute, WIdO, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruhnke</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>AOK Research Institute, WIdO, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nster</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>AOK Research Institute, WIdO, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bathelt</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014825" MajorTopicYN="Y">Vocabulary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">claims data</Keyword><Keyword MajorTopicYN="N">interoperability</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37203598</ArticleId><ArticleId IdType="doi">10.3233/SHTI230053</ArticleId><ArticleId IdType="pii">SHTI230053</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37203630</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><PubDate><Year>2023</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>The DELPHI Library: Improving Model Validation, Transparency and Dissemination Through a Centralised Library of Prediction Models.</ArticleTitle><Pagination><StartPage>139</StartPage><EndPage>140</EndPage><MedlinePgn>139-140</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230085</ELocationID><Abstract><AbstractText>The Deposit, Evaluate and Lookup Predictive Healthcare Information (DELPHI) library provides a centralised location for the depositing, exploring and analysing of patient-level prediction models that are compatible with data mapped to the observational medical outcomes partnership common data model.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Ross D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>den Otter</LastName><ForeName>Sicco</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reps</LastName><ForeName>Jenna M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Interoperability</Keyword><Keyword MajorTopicYN="N">Prediction Model</Keyword><Keyword MajorTopicYN="N">communication</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37203630</ArticleId><ArticleId IdType="doi">10.3233/SHTI230085</ArticleId><ArticleId IdType="pii">SHTI230085</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37203671</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><PubDate><Year>2023</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Data Quality Assessment for Observational Medical Outcomes Partnership Common Data Model of Multi-Center.</ArticleTitle><Pagination><StartPage>322</StartPage><EndPage>326</EndPage><MedlinePgn>322-326</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230127</ELocationID><Abstract><AbstractText>The amount of research on the gathering and handling of healthcare data keeps growing. To support multi-center research, numerous institutions have sought to create a common data model (CDM). However, data quality issues continue to be a major obstacle in the development of CDM. To address these limitations, a data quality assessment system was created based on the representative data model OMOP CDM v5.3.1. Additionally, 2,433 advanced evaluation rules were created and incorporated into the system by mapping the rules of existing OMOP CDM quality assessment systems. The data quality of six hospitals was verified using the developed system and an overall error rate of 0.197% was confirmed. Finally, we proposed a plan for high-quality data generation and the evaluation of multi-center CDM quality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Seol Whan</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine &amp;Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Soo Jeong</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine &amp;Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Im</LastName><ForeName>Yun Seon</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine &amp;Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Surin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Bo Yeon</ForeName><Initials>BY</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine &amp;Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jae Yoon</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine &amp;Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Wona</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>In Young</ForeName><Initials>IY</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000068598" MajorTopicYN="Y">Data Accuracy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="Y">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Common Data Model</Keyword><Keyword MajorTopicYN="N">Data Quality</Keyword><Keyword MajorTopicYN="N">Data Quality Management System</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37203671</ArticleId><ArticleId IdType="doi">10.3233/SHTI230127</ArticleId><ArticleId IdType="pii">SHTI230127</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37203683</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>302</Volume><PubDate><Year>2023</Year><Month>May</Month><Day>18</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>RD-MON - Building a Rare Disease Monitor to Enhance Awareness for Patients with Rare Diseases in Intensive Care.</ArticleTitle><Pagination><StartPage>358</StartPage><EndPage>359</EndPage><MedlinePgn>358-359</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230139</ELocationID><Abstract><AbstractText>Rare diseases are commonly defined by an incidence of less than 5/10000 inhabitants. There are some 8000 different rare diseases known. So even if a single rare disease is seldom, together they pose a relevant problem for diagnosis and treatment. This is especially true if a patient is treated for another common disease. University hospital of Gie&#xdf;en is part of the CORD-MI Project on rare diseases within the German Medical Informatics Initiative (MII) and a member of the MIRACUM consortium within the MII. As part of the ongoing Development for a clinical research study monitor within the use case 1 of MIRACUM, the study monitor has been configured to detect patients with rare diseases during their routine clinical encounters. The goal was to send a documentation request to the corresponding patient chart within the patient data management system for extended disease documentation to enhance clinical awareness for the patients' potential problems. The project was started in late 2022 and has so far been successfully tuned to detect patients with Mucoviscidosis and place notifications within the patient chart of the patient data management system (PDMS) on intensive care units.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blasini</LastName><ForeName>Romina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of medical informatics, University of Gie&#xdf;en, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michel-Backofen</LastName><ForeName>Achim</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of clinical and administrative data processing, University Hospital of Gie&#xdf;en and Marburg, site Gie&#xdf;en, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Henning</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of medical informatics, University of Gie&#xdf;en, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marquardt</LastName><ForeName>Kurt</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of clinical and administrative data processing, University Hospital of Gie&#xdf;en and Marburg, site Gie&#xdf;en, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035583" MajorTopicYN="Y">Rare Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="Y">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079803" MajorTopicYN="N">Data Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FHIR</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">Rare diseases</Keyword><Keyword MajorTopicYN="N">mucoviscidosis</Keyword><Keyword MajorTopicYN="N">patient data management system</Keyword><Keyword MajorTopicYN="N">study monitor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37203683</ArticleId><ArticleId IdType="doi">10.3233/SHTI230139</ArticleId><ArticleId IdType="pii">SHTI230139</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" VersionID="2" Owner="NLM" IndexingMethod="Automated"><PMID Version="2">37208468</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2398-6352</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>19</Day></PubDate></JournalIssue><Title>NPJ digital medicine</Title><ISOAbbreviation>NPJ Digit Med</ISOAbbreviation></Journal><ArticleTitle>Ontologizing health systems data at scale: making translational discovery a reality.</ArticleTitle><Pagination><StartPage>89</StartPage><MedlinePgn>89</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">89</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41746-023-00830-x</ELocationID><Abstract><AbstractText>Common data models solve many challenges of standardizing electronic health record (EHR) data but are unable to semantically integrate all of the resources needed for deep phenotyping. Open Biological and Biomedical Ontology (OBO) Foundry ontologies provide computable representations of biological knowledge and enable the integration of heterogeneous data. However, mapping EHR data to OBO ontologies requires significant manual curation and domain expertise. We introduce OMOP2OBO, an algorithm for mapping Observational Medical Outcomes Partnership (OMOP) vocabularies to OBO ontologies. Using OMOP2OBO, we produced mappings for 92,367 conditions, 8611 drug ingredients, and 10,673 measurement results, which covered 68-99% of concepts used in clinical practice when examined across 24 hospitals. When used to phenotype rare disease patients, the mappings helped systematically identify undiagnosed patients who might benefit from genetic testing. By aligning OMOP vocabularies to OBO ontologies our algorithm presents new opportunities to advance EHR-based deep phenotyping.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Callahan</LastName><ForeName>Tiffany J</ForeName><Initials>TJ</Initials><Identifier Source="ORCID">0000-0002-8169-9049</Identifier><AffiliationInfo><Affiliation>Computational Bioscience Program, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA. tiffany.callahan@cuanschutz.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, 10032, USA. tiffany.callahan@cuanschutz.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefanski</LastName><ForeName>Adrianne L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Computational Bioscience Program, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyrwa</LastName><ForeName>Jordan M</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-5455-5859</Identifier><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Chenjie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostropolets</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banda</LastName><ForeName>Juan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Computer Science, Georgia State University, Atlanta, GA, 30303, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baumgartner</LastName><ForeName>William A</ForeName><Initials>WA</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Computational Bioscience Program, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyce</LastName><ForeName>Richard D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15260, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casiraghi</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2024-7572</Identifier><AffiliationInfo><Affiliation>Computer Science, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coleman</LastName><ForeName>Ben D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Janine H</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0002-8716-3261</Identifier><AffiliationInfo><Affiliation>Department of Haematology, University of Cambridge, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deakyne Davies</LastName><ForeName>Sara J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0002-8602-1624</Identifier><AffiliationInfo><Affiliation>Department of Research Informatics &amp; Data Science, Analytics Resource Center, Children's Hospital Colorado, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feinstein</LastName><ForeName>James A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Adult and Child Center for Health Outcomes Research and Delivery Science (ACCORDS), University of Colorado Anschutz School of Medicine, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Asiyah Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Blake</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-5683-8310</Identifier><AffiliationInfo><Affiliation>Departments of Biomedical Informatics and Pediatrics, University of Colorado School of Medicine, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matentzoglu</LastName><ForeName>Nicolas A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Semanticly, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meeker</LastName><ForeName>Daniella</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Yale School of Medicine, New Haven, CT, 06510, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reese</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Environmental Genomics and Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinclair</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>HealthLinc, Valparaiso, IN, 46383, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taneja</LastName><ForeName>Sanya B</ForeName><Initials>SB</Initials><Identifier Source="ORCID">0000-0003-1707-1617</Identifier><AffiliationInfo><Affiliation>Intelligent Systems Program, University of Pittsburgh, Pittsburgh, PA, 15260, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trinkley</LastName><ForeName>Katy E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, University of Colorado Anschutz School of Medicine, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasilevsky</LastName><ForeName>Nicole A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Translational and Integrative Sciences Lab, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><Identifier Source="ORCID">0000-0002-0692-412X</Identifier><AffiliationInfo><Affiliation>Tufts Institute for Clinical Research and Health Policy Studies, Tufts University, Boston, MA, 02155, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xingmin A</ForeName><Initials>XA</Initials><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denny</LastName><ForeName>Joshua C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, NJ, 08869, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Tellen D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Departments of Biomedical Informatics and Pediatrics, University of Colorado School of Medicine, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haendel</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Departments of Biomedical Informatics and Pediatrics, University of Colorado School of Medicine, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Peter N</ForeName><Initials>PN</Initials><Identifier Source="ORCID">0000-0002-0736-9199</Identifier><AffiliationInfo><Affiliation>The Jackson Laboratory for Genomic Medicine, Farmington, CT, 06032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hunter</LastName><ForeName>Lawrence E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Computational Bioscience Program, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0003-4786-6875</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, CO, 80045, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/P02002X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 LM006910</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 HG011449</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 HD091295</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RM1 HG010860</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R24 OD011883</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ZIA HG200417</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 HL161352</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM008111</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>NPJ Digit Med</MedlineTA><NlmUniqueID>101731738</NlmUniqueID><ISSNLinking>2398-6352</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>20</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>20</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>23</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37208468</ArticleId><ArticleId IdType="pmc">PMC10196319</ArticleId><ArticleId IdType="doi">10.1038/s41746-023-00830-x</ArticleId><ArticleId IdType="pii">10.1038/s41746-023-00830-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adler-Milstein J, Jha AK. HITECH act drove large gains In hospital electronic health record adoption. Health Aff. 2017;36:1416&#x2013;1422. doi: 10.1377/hlthaff.2016.1651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2016.1651</ArticleId><ArticleId IdType="pubmed">28784734</ArticleId></ArticleIdList></Reference><Reference><Citation>Atasoy H, Greenwood BN, McCullough JS. The digitization of patient care: a review of the effects of electronic health records on health care quality and utilization. Annu. Rev. Public Health. 2019;40:487&#x2013;500. doi: 10.1146/annurev-publhealth-040218-044206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-publhealth-040218-044206</ArticleId><ArticleId IdType="pubmed">30566385</ArticleId></ArticleIdList></Reference><Reference><Citation>Dexter PR, et al. A computerized reminder system to increase the use of preventive care for hospitalized patients. N. Engl. J. Med. 2001;345:965&#x2013;970. doi: 10.1056/NEJMsa010181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa010181</ArticleId><ArticleId IdType="pubmed">11575289</ArticleId></ArticleIdList></Reference><Reference><Citation>King J, Patel V, Jamoom EW, Furukawa MF. Clinical benefits of electronic health record use: national findings. Health Serv. Res. 2014;49:392&#x2013;404. doi: 10.1111/1475-6773.12135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1475-6773.12135</ArticleId><ArticleId IdType="pmc">PMC3925409</ArticleId><ArticleId IdType="pubmed">24359580</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RS. Electronic health records: then, now, and in the future. Yearb. Med. Inform. 2016;Suppl 1:S48&#x2013;S61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5171496</ArticleId><ArticleId IdType="pubmed">27199197</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulsen T, et al. From big data to precision medicine. Front. Med. 2019;6:34. doi: 10.3389/fmed.2019.00034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2019.00034</ArticleId><ArticleId IdType="pmc">PMC6405506</ArticleId><ArticleId IdType="pubmed">30881956</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson PN. Deep phenotyping for precision medicine. Hum. Mutat. 2012;33:777&#x2013;780. doi: 10.1002/humu.22080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22080</ArticleId><ArticleId IdType="pubmed">22504886</ArticleId></ArticleIdList></Reference><Reference><Citation>Richesson RL, Sun J, Pathak J, Kho AN, Denny JC. Clinical phenotyping in selected national networks: demonstrating the need for high-throughput, portable, and computational methods. Artif. Intell. Med. 2016;71:57&#x2013;61. doi: 10.1016/j.artmed.2016.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2016.05.005</ArticleId><ArticleId IdType="pmc">PMC5480212</ArticleId><ArticleId IdType="pubmed">27506131</ArticleId></ArticleIdList></Reference><Reference><Citation>Denny JC, Bastarache L, Roden DM. Phenome-wide association studies as a tool to advance precision medicine. Annu. Rev. Genomics Hum. Genet. 2016;17:353&#x2013;373. doi: 10.1146/annurev-genom-090314-024956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genom-090314-024956</ArticleId><ArticleId IdType="pmc">PMC5480096</ArticleId><ArticleId IdType="pubmed">27147087</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi RL, Grifantini RM. Big data: challenge and opportunity for translational and industrial research in healthcare. Front. Digit. Humanit. 2018;5:13. doi: 10.3389/fdigh.2018.00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fdigh.2018.00013</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha S, Topol EJ. Adapting to artificial intelligence: radiologists and pathologists as information specialists. JAMA. 2016;316:2353&#x2013;2354. doi: 10.1001/jama.2016.17438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.17438</ArticleId><ArticleId IdType="pubmed">27898975</ArticleId></ArticleIdList></Reference><Reference><Citation>Butte AJ. Big data opens a window onto wellness. Nat. Biotechnol. 2017;35:720&#x2013;721. doi: 10.1038/nbt.3934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3934</ArticleId><ArticleId IdType="pmc">PMC5961487</ArticleId><ArticleId IdType="pubmed">28787419</ArticleId></ArticleIdList></Reference><Reference><Citation>Beam AL, Kohane IS. Big data and machine learning in health care. JAMA. 2018;319:1317&#x2013;1318. doi: 10.1001/jama.2017.18391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.18391</ArticleId><ArticleId IdType="pubmed">29532063</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinton G. Deep learning&#x2014;a technology with the potential to transform health care. JAMA. 2018;320:1101&#x2013;1102. doi: 10.1001/jama.2018.11100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.11100</ArticleId><ArticleId IdType="pubmed">30178065</ArticleId></ArticleIdList></Reference><Reference><Citation>Leopold JA, Loscalzo J. Emerging role of precision medicine in cardiovascular disease. Circ. Res. 2018;122:1302&#x2013;1315. doi: 10.1161/CIRCRESAHA.117.310782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.310782</ArticleId><ArticleId IdType="pmc">PMC6021027</ArticleId><ArticleId IdType="pubmed">29700074</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolio TA, et al. Finding the missing heritability of complex diseases. Nature. 2009;461:747&#x2013;753. doi: 10.1038/nature08494.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08494</ArticleId><ArticleId IdType="pmc">PMC2831613</ArticleId><ArticleId IdType="pubmed">19812666</ArticleId></ArticleIdList></Reference><Reference><Citation>Freimer N, Sabatti C. The human phenome project. Nat. Genet. 2003;34:15&#x2013;21. doi: 10.1038/ng0503-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0503-15</ArticleId><ArticleId IdType="pubmed">12721547</ArticleId></ArticleIdList></Reference><Reference><Citation>Basile AO, Ritchie MD. Informatics and machine learning to define the phenotype. Expert Rev. Mol. Diagn. 2018;18:219&#x2013;226. doi: 10.1080/14737159.2018.1439380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737159.2018.1439380</ArticleId><ArticleId IdType="pmc">PMC6080627</ArticleId><ArticleId IdType="pubmed">29431517</ArticleId></ArticleIdList></Reference><Reference><Citation>Delude CM. Deep phenotyping: the details of disease. Nature. 2015;527:S14&#x2013;S15. doi: 10.1038/527S14a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/527S14a</ArticleId><ArticleId IdType="pubmed">26536218</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng C, Shah NH, Hripcsak G. Deep phenotyping: embracing complexity and temporality-towards scalability, portability, and interoperability. J. Biomed. Inform. 2020;105:103433. doi: 10.1016/j.jbi.2020.103433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2020.103433</ArticleId><ArticleId IdType="pmc">PMC7179504</ArticleId><ArticleId IdType="pubmed">32335224</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorsey ER, et al. Deep phenotyping of Parkinson&#x2019;s disease. J. Parkinsons. Dis. 2020;10:855&#x2013;873. doi: 10.3233/JPD-202006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JPD-202006</ArticleId><ArticleId IdType="pmc">PMC7458535</ArticleId><ArticleId IdType="pubmed">32444562</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiou M, et al. Deep phenotyping of PDE6C-associated achromatopsia. Invest. Ophthalmol. Vis. Sci. 2019;60:5112&#x2013;5123. doi: 10.1167/iovs.19-27761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.19-27761</ArticleId><ArticleId IdType="pmc">PMC6905659</ArticleId><ArticleId IdType="pubmed">31826238</ArticleId></ArticleIdList></Reference><Reference><Citation>Fassihi H, et al. Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect. Proc. Natl Acad. Sci. USA. 2016;113:E1236&#x2013;E1245. doi: 10.1073/pnas.1519444113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1519444113</ArticleId><ArticleId IdType="pmc">PMC4780618</ArticleId><ArticleId IdType="pubmed">26884178</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo RS, et al. Deep phenotyping in 3q29 deletion syndrome: recommendations for clinical care. Genet. Med. 2021;23:872&#x2013;880. doi: 10.1038/s41436-020-01053-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-020-01053-1</ArticleId><ArticleId IdType="pmc">PMC8105170</ArticleId><ArticleId IdType="pubmed">33564151</ArticleId></ArticleIdList></Reference><Reference><Citation>Daich Varela M, et al. The peroxisomal disorder spectrum and Heimler syndrome: deep phenotyping and review of the literature. Am. J. Med. Genet. C. Semin. Med. Genet. 2020;184:618&#x2013;630. doi: 10.1002/ajmg.c.31823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.c.31823</ArticleId><ArticleId IdType="pmc">PMC8117942</ArticleId><ArticleId IdType="pubmed">32866347</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei C, et al. Deep phenotyping of speech and language skills in individuals with 16p11.2 deletion. Eur. J. Hum. Genet. 2018;26:676&#x2013;686. doi: 10.1038/s41431-018-0102-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-018-0102-x</ArticleId><ArticleId IdType="pmc">PMC5945616</ArticleId><ArticleId IdType="pubmed">29445122</ArticleId></ArticleIdList></Reference><Reference><Citation>Droogmans G, Swillen A, Van Buggenhout G. Deep phenotyping of development, communication and behaviour in Phelan-McDermid syndrome. Mol. Syndromol. 2020;10:294&#x2013;305. doi: 10.1159/000503840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000503840</ArticleId><ArticleId IdType="pmc">PMC6995976</ArticleId><ArticleId IdType="pubmed">32021603</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes SA, Cooper GE, Gibson RA, Kishnani PS. Benign or not benign? Deep phenotyping of liver glycogen storage disease IX. Mol. Genet. Metab. 2020;131:299&#x2013;305. doi: 10.1016/j.ymgme.2020.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7953588</ArticleId><ArticleId IdType="pubmed">33317799</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak E, et al. Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in down syndrome: a deep-phenotyping case report. Alzheimers Dement. 2019;11:654&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6939035</ArticleId><ArticleId IdType="pubmed">31909173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra R, et al. Robinow syndrome and brachydactyly: an Interplay of high-throughput sequencing and deep phenotyping in a kindred. Mol. Syndromol. 2020;11:43&#x2013;49. doi: 10.1159/000505506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000505506</ArticleId><ArticleId IdType="pmc">PMC7109436</ArticleId><ArticleId IdType="pubmed">32256301</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsink-Karssies MM, et al. Deep phenotyping classical galactosemia: clinical outcomes and biochemical markers. Brain Commun. 2020;2:fcaa006. doi: 10.1093/braincomms/fcaa006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa006</ArticleId><ArticleId IdType="pmc">PMC7425409</ArticleId><ArticleId IdType="pubmed">32954279</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim Y, et al. Deep phenotyping in 1p36 deletion syndrome. Ann. Child Neurol. 2020;28:131&#x2013;137. doi: 10.26815/acn.2020.00108.</Citation><ArticleIdList><ArticleId IdType="doi">10.26815/acn.2020.00108</ArticleId></ArticleIdList></Reference><Reference><Citation>Spedicati B, et al. Natural human knockouts and mendelian disorders: deep phenotyping in Italian isolates. Eur. J. Hum. Genet. 2021;29:1272&#x2013;1281. doi: 10.1038/s41431-021-00850-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41431-021-00850-9</ArticleId><ArticleId IdType="pmc">PMC8384846</ArticleId><ArticleId IdType="pubmed">33727708</ArticleId></ArticleIdList></Reference><Reference><Citation>Yurkovich JT, Tian Q, Price ND, Hood L. A systems approach to clinical oncology uses deep phenotyping to deliver personalized care. Nat. Rev. Clin. Oncol. 2020;17:183&#x2013;194. doi: 10.1038/s41571-019-0273-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41571-019-0273-6</ArticleId><ArticleId IdType="pubmed">31619755</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadimitriou K, et al. Deep phenotyping reveals distinct immune signatures correlating with prognostication, treatment responses, and MRD status in multiple myeloma. Cancers. 2020;12:3245. doi: 10.3390/cancers12113245.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12113245</ArticleId><ArticleId IdType="pmc">PMC7692501</ArticleId><ArticleId IdType="pubmed">33158030</ArticleId></ArticleIdList></Reference><Reference><Citation>Christopoulos P, et al. Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial. BMC Cancer. 2021;21:743. doi: 10.1186/s12885-021-08460-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-021-08460-w</ArticleId><ArticleId IdType="pmc">PMC8240323</ArticleId><ArticleId IdType="pubmed">34182952</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirinukunwattana, K. et al. Improving the diagnosis and classification of Ph-negative myeloproliferative neoplasms through deep phenotyping. bioRxiv 762013 10.1101/762013 (2019).</Citation></Reference><Reference><Citation>Nagaoka K, et al. Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy. J. Immunother. Cancer. 2020;8:e001358. doi: 10.1136/jitc-2020-001358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2020-001358</ArticleId><ArticleId IdType="pmc">PMC7583806</ArticleId><ArticleId IdType="pubmed">33093158</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, T. H. et al. Deep learning-based phenotyping of breast cancer cells using lens-free digital In-line holography. bioRxiv 2021.05.29.446284. 10.1101/2021.05.29.446284 (2021).</Citation></Reference><Reference><Citation>Kuai R, Ochyl LJ, Bahjat KS, Schwendeman A, Moon JJ. Designer vaccine nanodiscs for personalized cancer immunotherapy. Nat. Mater. 2017;16:489&#x2013;496. doi: 10.1038/nmat4822.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmat4822</ArticleId><ArticleId IdType="pmc">PMC5374005</ArticleId><ArticleId IdType="pubmed">28024156</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquette AG, Hood L, Price ND, Sadovsky Y. Deep phenotyping during pregnancy for predictive and preventive medicine. Sci. Transl. Med. 2020;12:eaay1059. doi: 10.1126/scitranslmed.aay1059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aay1059</ArticleId><ArticleId IdType="pmc">PMC7268934</ArticleId><ArticleId IdType="pubmed">31969484</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson L, Boland MR. Towards deep phenotyping pregnancy: a systematic review on artificial intelligence and machine learning methods to improve pregnancy outcomes. Brief. Bioinform. 2021;22:bbaa369. doi: 10.1093/bib/bbaa369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbaa369</ArticleId><ArticleId IdType="pmc">PMC8424395</ArticleId><ArticleId IdType="pubmed">33406530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy SH, et al. Deep clinical and biological phenotyping of the preterm birth and small for gestational age syndromes: The INTERBIO-21 st Newborn Case-Control Study protocol. Gates Open Res. 2018;2:49. doi: 10.12688/gatesopenres.12869.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/gatesopenres.12869.1</ArticleId><ArticleId IdType="pmc">PMC6545521</ArticleId><ArticleId IdType="pubmed">31172050</ArticleId></ArticleIdList></Reference><Reference><Citation>Alterovitz G, et al. SMART on FHIR genomics: facilitating standardized clinico-genomic apps. J. Am. Med. Inform. Assoc. 2015;22:1173&#x2013;1178. doi: 10.1093/jamia/ocv045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocv045</ArticleId><ArticleId IdType="pubmed">26198304</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperber NR, et al. Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) network. BMC Med. Genomics. 2017;10:35. doi: 10.1186/s12920-017-0273-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12920-017-0273-2</ArticleId><ArticleId IdType="pmc">PMC5441047</ArticleId><ArticleId IdType="pubmed">28532511</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, et al. A census of disease ontologies. Annu. Rev. Biomed. Data Sci. 2018;1:305&#x2013;331. doi: 10.1146/annurev-biodatasci-080917-013459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biodatasci-080917-013459</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond WE. Call for a standard clinical vocabulary. J. Am. Med. Inform. Assoc. 1997;4:254&#x2013;255. doi: 10.1136/jamia.1997.0040254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.1997.0040254</ArticleId><ArticleId IdType="pmc">PMC61241</ArticleId><ArticleId IdType="pubmed">9147345</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornet R, Chute CG. Health concept and knowledge management: twenty-five years of evolution. Yearb. Med. Inform. 2016;25:S32&#x2013;S41. doi: 10.15265/IYS-2016-s037.</Citation><ArticleIdList><ArticleId IdType="doi">10.15265/IYS-2016-s037</ArticleId><ArticleId IdType="pmc">PMC5171511</ArticleId><ArticleId IdType="pubmed">27488404</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, Chute CG, Robinson PN. Classification, ontology, and precision medicine. N. Engl. J. Med. 2018;379:1452&#x2013;1462. doi: 10.1056/NEJMra1615014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1615014</ArticleId><ArticleId IdType="pmc">PMC6503847</ArticleId><ArticleId IdType="pubmed">30304648</ArticleId></ArticleIdList></Reference><Reference><Citation>Knibbs GH. The International Classification of Disease and Causes of Death and its revision. Med. Dent. J. 1929;1:2&#x2013;12.</Citation></Reference><Reference><Citation>McDonald CJ, et al. LOINC, a universal standard for identifying laboratory observations: a 5-year update. Clin. Chem. 2003;49:624&#x2013;633. doi: 10.1373/49.4.624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/49.4.624</ArticleId><ArticleId IdType="pubmed">12651816</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson SJ, Zeng K, Kilbourne J, Powell T, Moore R. Normalized names for clinical drugs: RxNorm at 6 years. J. Am. Med. Inform. Assoc. 2011;18:441&#x2013;448. doi: 10.1136/amiajnl-2011-000116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000116</ArticleId><ArticleId IdType="pmc">PMC3128404</ArticleId><ArticleId IdType="pubmed">21515544</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J. Am. Med. Inform. Assoc. 2012;19:54&#x2013;60. doi: 10.1136/amiajnl-2011-000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho AN, et al. Practical challenges in integrating genomic data into the electronic health record. Genet. Med. 2013;15:772&#x2013;778. doi: 10.1038/gim.2013.131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2013.131</ArticleId><ArticleId IdType="pmc">PMC4201621</ArticleId><ArticleId IdType="pubmed">24071798</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoehndorf R, Schofield PN, Gkoutos GV. The role of ontologies in biological and biomedical research: a functional perspective. Brief. Bioinform. 2015;16:1069&#x2013;1080. doi: 10.1093/bib/bbv011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbv011</ArticleId><ArticleId IdType="pmc">PMC4652617</ArticleId><ArticleId IdType="pubmed">25863278</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B, et al. The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nat. Biotechnol. 2007;25:1251&#x2013;1255. doi: 10.1038/nbt1346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt1346</ArticleId><ArticleId IdType="pmc">PMC2814061</ArticleId><ArticleId IdType="pubmed">17989687</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson R, et al. OBO Foundry in 2021: operationalizing open data principles to evaluate ontologies. Database. 2021;2021:baab069. doi: 10.1093/database/baab069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/database/baab069</ArticleId><ArticleId IdType="pmc">PMC8546234</ArticleId><ArticleId IdType="pubmed">34697637</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastarache L, et al. Improving the phenotype risk score as a scalable approach to identifying patients with Mendelian disease. J. Am. Med. Inform. Assoc. 2019;26:1437&#x2013;1447. doi: 10.1093/jamia/ocz179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocz179</ArticleId><ArticleId IdType="pmc">PMC6857501</ArticleId><ArticleId IdType="pubmed">31609419</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler S, et al. Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. Nucleic Acids Res. 2019;47:D1018&#x2013;D1027. doi: 10.1093/nar/gky1105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1105</ArticleId><ArticleId IdType="pmc">PMC6324074</ArticleId><ArticleId IdType="pubmed">30476213</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XA, et al. Semantic integration of clinical laboratory tests from electronic health records for deep phenotyping and biomarker discovery. npj Digital Med. 2019;2:1&#x2013;9. doi: 10.1038/s41746-019-0110-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-019-0110-4</ArticleId><ArticleId IdType="pmc">PMC6527418</ArticleId><ArticleId IdType="pubmed">31119199</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhombres F, Bodenreider O. Interoperability between phenotypes in research and healthcare terminologies&#x2014;investigating partial mappings between HPO and SNOMED CT. J. Biomed. Semant. 2016;7:3. doi: 10.1186/s13326-016-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13326-016-0047-3</ArticleId><ArticleId IdType="pmc">PMC4748471</ArticleId><ArticleId IdType="pubmed">26865946</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, et al. PEDSnet: a National Pediatric Learning Health System. J. Am. Med. Inform. Assoc. 2014;21:602&#x2013;606. doi: 10.1136/amiajnl-2014-002743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002743</ArticleId><ArticleId IdType="pmc">PMC4078288</ArticleId><ArticleId IdType="pubmed">24821737</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich, C. &amp; Ostropolets, A. Chapter 5 standardized vocabularies. in The Book of OHDSI (ed. Observational Health Data Sciences) Online Edition (2021).</Citation></Reference><Reference><Citation>Mungall CJ, Torniai C, Gkoutos GV, Lewis SE, Haendel MA. Uberon, an integrative multi-species anatomy ontology. Genome Biol. 2012;13:R5. doi: 10.1186/gb-2012-13-1-r5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2012-13-1-r5</ArticleId><ArticleId IdType="pmc">PMC3334586</ArticleId><ArticleId IdType="pubmed">22293552</ArticleId></ArticleIdList></Reference><Reference><Citation>Bard J, Rhee SY, Ashburner M. An ontology for cell types. Genome Biol. 2005;6:R21. doi: 10.1186/gb-2005-6-2-r21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2005-6-2-r21</ArticleId><ArticleId IdType="pmc">PMC551541</ArticleId><ArticleId IdType="pubmed">15693950</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler DL, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2008;36:D13&#x2013;D21. doi: 10.1093/nar/gkm1000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm1000</ArticleId><ArticleId IdType="pmc">PMC2238880</ArticleId><ArticleId IdType="pubmed">18045790</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastings J, et al. ChEBI in 2016: improved services and an expanding collection of metabolites. Nucleic Acids Res. 2016;44:D1214&#x2013;D1219. doi: 10.1093/nar/gkv1031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv1031</ArticleId><ArticleId IdType="pmc">PMC4702775</ArticleId><ArticleId IdType="pubmed">26467479</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, et al. VIOLIN: vaccine investigation and online information network. Nucleic Acids Res. 2008;36:D923&#x2013;D928. doi: 10.1093/nar/gkm1039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm1039</ArticleId><ArticleId IdType="pmc">PMC2238972</ArticleId><ArticleId IdType="pubmed">18025042</ArticleId></ArticleIdList></Reference><Reference><Citation>Natale DA, et al. The Protein Ontology: a structured representation of protein forms and complexes. Nucleic Acids Res. 2011;39:D539&#x2013;D545. doi: 10.1093/nar/gkq907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq907</ArticleId><ArticleId IdType="pmc">PMC3013777</ArticleId><ArticleId IdType="pubmed">20935045</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res. 2004;32:D267&#x2013;D270. doi: 10.1093/nar/gkh061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkh061</ArticleId><ArticleId IdType="pmc">PMC308795</ArticleId><ArticleId IdType="pubmed">14681409</ArticleId></ArticleIdList></Reference><Reference><Citation>McCray, A. T. Representing biomedical knowledge in the UMLS semantic network. in High Performance Medical Libraries: Advances in Information Management for the Virtual Era 45&#x2013;55 (Meckler Corporation, 1993).</Citation></Reference><Reference><Citation>Ostropolets, A., Ryan, P. B. &amp; Hripcsak, G. OHDSI network study: concept prevalence. https://forums.ohdsi.org/t/network-study-concept-prevalence/6562 (2019).</Citation></Reference><Reference><Citation>Ostropolets, A., Ryan, P. &amp; Hripcsak, G. OHDSI network study: concept prevalence. https://github.com/ohdsi-studies/ConceptPrevalence (2020).</Citation></Reference><Reference><Citation>Ostropolets, A., Ryan, P. &amp; Hripcsak, G. Concept Prevalence Study Protocol. https://github.com/ohdsi-studies/ConceptPrevalence/blob/master/extras/ConceptPrevalenceStudyProtocol_v1.0.docx (2020).</Citation></Reference><Reference><Citation>Ostropolets A, Ryan P, Hripcsak G. Phenotyping in distributed data networks: selecting the right codes for the right patients. AMIA Annu. Symp. Proc. 2022;2022:826&#x2013;835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10148372</ArticleId><ArticleId IdType="pubmed">37128407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin MC, Vreeman DJ, McDonald CJ, Huff SM. Auditing consistency and usefulness of LOINC use among three large institutions&#x2014;using version spaces for grouping LOINC codes. J. Biomed. Inform. 2012;45:658&#x2013;666. doi: 10.1016/j.jbi.2012.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2012.01.008</ArticleId><ArticleId IdType="pmc">PMC3374914</ArticleId><ArticleId IdType="pubmed">22306382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer LS, et al. Genetic diagnosis of mendelian disorders via RNA sequencing. Nat. Commun. 2017;8:15824. doi: 10.1038/ncomms15824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15824</ArticleId><ArticleId IdType="pmc">PMC5499207</ArticleId><ArticleId IdType="pubmed">28604674</ArticleId></ArticleIdList></Reference><Reference><Citation>Splinter K, et al. Effect of genetic diagnosis on patients with previously undiagnosed disease. N. Engl. J. Med. 2018;379:2131&#x2013;2139. doi: 10.1056/NEJMoa1714458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1714458</ArticleId><ArticleId IdType="pmc">PMC6481166</ArticleId><ArticleId IdType="pubmed">30304647</ArticleId></ArticleIdList></Reference><Reference><Citation>Groopman EE, et al. Diagnostic utility of exome sequencing for kidney disease. N. Engl. J. Med. 2019;380:142&#x2013;151. doi: 10.1056/NEJMoa1806891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1806891</ArticleId><ArticleId IdType="pmc">PMC6510541</ArticleId><ArticleId IdType="pubmed">30586318</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med. 2013;369:1502&#x2013;1511. doi: 10.1056/NEJMoa1306555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1306555</ArticleId><ArticleId IdType="pmc">PMC4211433</ArticleId><ArticleId IdType="pubmed">24088041</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastarache L, et al. Phenotype risk scores identify patients with unrecognized mendelian disease patterns. Science. 2018;359:1233&#x2013;1239. doi: 10.1126/science.aal4043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aal4043</ArticleId><ArticleId IdType="pmc">PMC5959723</ArticleId><ArticleId IdType="pubmed">29590070</ArticleId></ArticleIdList></Reference><Reference><Citation>Morley TJ, et al. Phenotypic signatures in clinical data enable systematic identification of patients for genetic testing. Nat. Med. 2021;27:1097&#x2013;1104. doi: 10.1038/s41591-021-01356-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01356-z</ArticleId><ArticleId IdType="pmc">PMC8981189</ArticleId><ArticleId IdType="pubmed">34083811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesan S, et al. A longitudinal footprint of genetic epilepsies using automated electronic medical record interpretation. Genet. Med. 2020;22:2060&#x2013;2070. doi: 10.1038/s41436-020-0923-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-020-0923-1</ArticleId><ArticleId IdType="pmc">PMC7708303</ArticleId><ArticleId IdType="pubmed">32773773</ArticleId></ArticleIdList></Reference><Reference><Citation>Movaghar A, et al. Artificial intelligence-assisted phenotype discovery of fragile X syndrome in a population-based sample. Genet. Med. 2021;23:1273&#x2013;1280. doi: 10.1038/s41436-021-01144-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-021-01144-7</ArticleId><ArticleId IdType="pmc">PMC8257481</ArticleId><ArticleId IdType="pubmed">33772223</ArticleId></ArticleIdList></Reference><Reference><Citation>Kafkas &#x15e;, et al. PathoPhenoDB, linking human pathogens to their phenotypes in support of infectious disease research. Sci. Data. 2019;6:79. doi: 10.1038/s41597-019-0090-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-019-0090-x</ArticleId><ArticleId IdType="pmc">PMC6546783</ArticleId><ArticleId IdType="pubmed">31160594</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson R, et al. Increasing phenotypic annotation improves the diagnostic rate of exome sequencing in a rare neuromuscular disorder. Hum. Mutat. 2019;40:1797&#x2013;1812. doi: 10.1002/humu.23792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23792</ArticleId><ArticleId IdType="pubmed">31231902</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang X, Chen W, Zeng Z, Ding K, Zhou Z. An ontology-based classification of Ebstein&#x2019;s anomaly and its implications in clinical adverse outcomes. Int. J. Cardiol. 2020;316:79&#x2013;86. doi: 10.1016/j.ijcard.2020.04.073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2020.04.073</ArticleId><ArticleId IdType="pubmed">32348812</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgren H, Mano B, Laaksonen M. Efficient curation and ontology mapping of clinical and phenotypic data. Cancer Res. 2018;78:2276&#x2013;2276. doi: 10.1158/1538-7445.AM2018-2276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1538-7445.AM2018-2276</ArticleId></ArticleIdList></Reference><Reference><Citation>Gourdine J-PF, et al. Representing glycophenotypes: semantic unification of glycobiology resources for disease discovery. Database. 2019;2019:baz114. doi: 10.1093/database/baz114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/database/baz114</ArticleId><ArticleId IdType="pmc">PMC6859258</ArticleId><ArticleId IdType="pubmed">31735951</ArticleId></ArticleIdList></Reference><Reference><Citation>Raje S, Bodenreider O. Interoperability of disease concepts in clinical and research ontologies: contrasting coverage and structure in the Disease Ontology and SNOMED CT. Stud. Health Technol. Inform. 2017;245:925&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5881393</ArticleId><ArticleId IdType="pubmed">29295235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner M, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000;25:25&#x2013;29. doi: 10.1038/75556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/75556</ArticleId><ArticleId IdType="pmc">PMC3037419</ArticleId><ArticleId IdType="pubmed">10802651</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando, H. M. et al. Challenges in defining long COVID: striking differences across literature, electronic health records, and patient-reported information. medRxiv10.1101/2021.03.20.21253896 (2021).</Citation></Reference><Reference><Citation>Reese, J. et al. Generalizable long COVID subtypes: findings from the NIH N3C and RECOVER programs. bioRxiv10.1101/2022.05.24.22275398 (2022).</Citation></Reference><Reference><Citation>Deer RR, et al. Characterizing long COVID: deep phenotype of a complex condition. EBioMedicine. 2021;74:103722. doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman, B. et al. Manifestations associated with post acute sequelae of SARS-CoV2 infection (PASC) predict diagnosis of new-onset psychiatric disease: findings from the NIH N3C and RECOVER studies. bioRxiv10.1101/2022.07.08.22277388 (2022).</Citation></Reference><Reference><Citation>Callahan, T. J., Hunter, L. E. &amp; Kahn, M. G. Leveraging a neural-symbolic representation of biomedical knowledge to improve pediatric subphenotyping. 10.5281/zenodo.5746187 (2021).</Citation></Reference><Reference><Citation>Jacobsen JOB, et al. The GA4GH Phenopacket schema defines a computable representation of clinical data. Nat. Biotechnol. 2022;40:817&#x2013;820. doi: 10.1038/s41587-022-01357-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-022-01357-4</ArticleId><ArticleId IdType="pmc">PMC9363006</ArticleId><ArticleId IdType="pubmed">35705716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilicoglu H, Shin D, Fiszman M, Rosemblat G, Rindflesch TC. SemMedDB: a PubMed-scale repository of biomedical semantic predications. Bioinformatics. 2012;28:3158&#x2013;3160. doi: 10.1093/bioinformatics/bts591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts591</ArticleId><ArticleId IdType="pmc">PMC3509487</ArticleId><ArticleId IdType="pubmed">23044550</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyt CT, et al. Unifying the identification of biomedical entities with the Bioregistry. Sci. Data. 2022;9:714. doi: 10.1038/s41597-022-01807-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-022-01807-3</ArticleId><ArticleId IdType="pmc">PMC9675740</ArticleId><ArticleId IdType="pubmed">36402838</ArticleId></ArticleIdList></Reference><Reference><Citation>Matentzoglu N, et al. A Simple Standard for Sharing Ontological Mappings (SSSOM) Database. 2022;2022:baac035. doi: 10.1093/database/baac035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/database/baac035</ArticleId><ArticleId IdType="pmc">PMC9216545</ArticleId><ArticleId IdType="pubmed">35616100</ArticleId></ArticleIdList></Reference><Reference><Citation>Matentzoglu N, et al. Ontology Development Kit: a toolkit for building, maintaining and standardizing biomedical ontologies. Database. 2022;2022:baac087. doi: 10.1093/database/baac087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/database/baac087</ArticleId><ArticleId IdType="pmc">PMC9547537</ArticleId><ArticleId IdType="pubmed">36208225</ArticleId></ArticleIdList></Reference><Reference><Citation>Amith M, He Z, Bian J, Lossio-Ventura JA, Tao C. Assessing the practice of biomedical ontology evaluation: Gaps and opportunities. J. Biomed. Inform. 2018;80:1&#x2013;13. doi: 10.1016/j.jbi.2018.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2018.02.010</ArticleId><ArticleId IdType="pmc">PMC5882531</ArticleId><ArticleId IdType="pubmed">29462669</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrande&#x10d;i&#x107;, D. Ontology evaluation. in Handbook on Ontologies (eds Staab, S. &amp; Studer, R.) 293&#x2013;313 (Springer, 2009).</Citation></Reference><Reference><Citation>G&#xf3;mez-P&#xe9;rez, A. Ontology evaluation. in Handbook on Ontologies (eds Staab, S. &amp; Studer, R.) 251&#x2013;273 (Springer, 2004).</Citation></Reference><Reference><Citation>National Library of Medicine. UMLS release file archives: 2020AA. https://www.nlm.nih.gov/research/umls/licensedcontent/umlsarchives04.html (2020).</Citation></Reference><Reference><Citation>Banda, J. M. OHDSI Ananke&#x2014;a tool for mapping between OHDSI Concept Identifiers to Unified Medical Language System (UMLS) identifiers. https://github.com/thepanacealab/OHDSIananke (2020).</Citation></Reference><Reference><Citation>Callahan, T. J. OMOP2OBO Code Normalization Dictionary. OMOP2OBO: Initial Release. https://github.com/callahantiff/OMOP2OBO/blob/master/resources/mappings/source_code_vocab_map.csv; 10.5281/zenodo.5655853 (2020).</Citation></Reference><Reference><Citation>Pedregosa F, et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 2011;12:2825&#x2013;2830.</Citation></Reference><Reference><Citation>Harris ZS. Distributional structure. Word World. 1954;10:146&#x2013;162. doi: 10.1080/00437956.1954.11659520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00437956.1954.11659520</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajaraman, A. &amp; Ullman, J. D. Data mining. in Mining of Massive Datasets 1&#x2013;17 (Cambridge University Press, 2011).</Citation></Reference><Reference><Citation>Zhan, X., Humbert-Droz, M., Mukherjee, P. &amp; Gevaert, O. Structuring clinical text with AI: old vs. new natural language processing techniques evaluated on eight common cardiovascular diseases. bioRxiv10.1101/2021.01.27.21250477 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8276012</ArticleId><ArticleId IdType="pubmed">34286303</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolyvakis P, Kalousis A, Smith B, Kiritsis D. Biomedical ontology alignment: an approach based on representation learning. J. Biomed. Semant. 2018;9:21. doi: 10.1186/s13326-018-0187-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13326-018-0187-8</ArticleId><ArticleId IdType="pmc">PMC6094585</ArticleId><ArticleId IdType="pubmed">30111369</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird, S., Klein, E. &amp; Loper, E. Natural Language Processing with Python: Analyzing Text with the Natural Language Toolkit (O&#x2019;Reilly Media, Inc., 2009).</Citation></Reference><Reference><Citation>Aaron, Z. X. et al. LOINC2HPO Annotations. Semantic integration of clinical laboratory tests from electronic health records for deep phenotyping and biomarker discovery. https://github.com/monarch-initiative/loinc2hpo/annotations.tsv (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6527418</ArticleId><ArticleId IdType="pubmed">31119199</ArticleId></ArticleIdList></Reference><Reference><Citation>Mungall CJ, et al. The Monarch Initiative: an integrative data and analytic platform connecting phenotypes to genotypes across species. Nucleic Acids Res. 2017;45:D712&#x2013;D722. doi: 10.1093/nar/gkw1128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1128</ArticleId><ArticleId IdType="pmc">PMC5210586</ArticleId><ArticleId IdType="pubmed">27899636</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan, T. J. Survey to evaluate OMOP2OBO measurement mappings. Qualtricshttps://survey.az1.qualtrics.com/jfe/form/SV_cAZvVBV7LU0YVa5?Q_CHL=qr (2018).</Citation></Reference><Reference><Citation>Miller DT, et al. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG) Genet. Med. 2021;23:1381&#x2013;1390. doi: 10.1038/s41436-021-01172-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-021-01172-3</ArticleId><ArticleId IdType="pubmed">34012068</ArticleId></ArticleIdList></Reference><Reference><Citation>The Human Phenotype Ontology. Gene to phenotype annotations. http://purl.obolibrary.org/obo/hp/hpoa/genes_to_phenotype.txt (2022).</Citation></Reference><Reference><Citation>Ramirez AH, Gebo KA, Harris PA. Progress with the All of Us Research Program: opening access for researchers. JAMA. 2021;325:2441&#x2013;2442. doi: 10.1001/jama.2021.7702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.7702</ArticleId><ArticleId IdType="pubmed">34115137</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan, T. J. et al. OMOP2OBO Condition Occurrence Mappings. 10.5281/zenodo.6949688 (2020).</Citation></Reference><Reference><Citation>Callahan, T. J. et al. OMOP2OBO Drug Exposure Ingredient Mappings. 10.5281/zenodo.6949696 (2020).</Citation></Reference><Reference><Citation>Callahan, T. J. et al. OMOP2OBO Measurement Mappings. 10.5281/zenodo.6949858 (2020).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37224727</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>238</Volume><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Computer methods and programs in biomedicine</Title><ISOAbbreviation>Comput Methods Programs Biomed</ISOAbbreviation></Journal><ArticleTitle>SEnDAE: A resource for expanding research into social and environmental determinants of health.</ArticleTitle><Pagination><StartPage>107542</StartPage><MedlinePgn>107542</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cmpb.2023.107542</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0169-2607(23)00207-9</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="OBJECTIVE">Social and Environmental Determinants of Health (SEDoH) are of increasing interest to researchers in personal and public health. Collecting SEDoH and associating them with patient medical record can be challenging, especially for environmental variables. We announce here the release of SEnDAE, the Social and Environmental Determinants Address Enhancement toolkit, and open-source resource for ingesting a range of environmental variables and measurements from a variety of sources and associated them with arbitrary addresses.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">SEnDAE includes optional components for geocoding addresses, in case an organization does not have independent capabilities in that area, and recipes for extending the OMOP CDM and the ontology of an i2b2 instance to display and compute over the SEnDAE variables within i2b2.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">On a set of 5000 synthetic addresses, SEnDAE was able to geocode 83%. SEnDAE geocodes addresses to the same Census tract as ESRI 98.1% of the time.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Development of SEnDAE is ongoing, but we hope that teams will find it useful to increase their usage of environmental variables and increase the field's general understanding of these important determinants of health.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kingsbury</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Keck School of Medicine, University of Southern California, 2250 Alcazar St CSC 212, Los Angeles CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abajian</LastName><ForeName>Hakob</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Keck School of Medicine, University of Southern California, 2250 Alcazar St CSC 212, Los Angeles CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abajian</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Keck School of Medicine, University of Southern California, 2250 Alcazar St CSC 212, Los Angeles CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angyan</LastName><ForeName>Praveen</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Keck School of Medicine, University of Southern California, 2250 Alcazar St CSC 212, Los Angeles CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espinoza</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacDonald</LastName><ForeName>Beau</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Spatial Sciences Institute, University of Southern California, Los Angeles CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meeker</LastName><ForeName>Daniella</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Population and Public Health Sciences, University of Southern California, Los Angeles CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>John P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Spatial Sciences Institute, University of Southern California, Los Angeles CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahroos</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Keck School of Medicine, University of Southern California, 2250 Alcazar St CSC 212, Los Angeles CA 90033, USA. Electronic address: Neil.Bahroos@med.usc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Comput Methods Programs Biomed</MedlineTA><NlmUniqueID>8506513</NlmUniqueID><ISSNLinking>0169-2607</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="Y">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008499" MajorTopicYN="Y">Medical Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Geocoding</Keyword><Keyword MajorTopicYN="N">Open-source toolkit</Keyword><Keyword MajorTopicYN="N">Social and environmental determinants of health (SEDoH)</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest JE is a paid consultant for AI Health. AI Health played no role in the design, execution, analysis, or write up of this work. AI Health did not play a role in the decision to publish this manuscript and had no editorial input.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>25</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>18</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37224727</ArticleId><ArticleId IdType="doi">10.1016/j.cmpb.2023.107542</ArticleId><ArticleId IdType="pii">S0169-2607(23)00207-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37267810</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8243</ISSN><JournalIssue CitedMedium="Internet"><Volume>176</Volume><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>International journal of medical informatics</Title><ISOAbbreviation>Int J Med Inform</ISOAbbreviation></Journal><ArticleTitle>Assessing the FAIRness of databases on the EHDEN portal: A case study on two Dutch ICU databases.</ArticleTitle><Pagination><StartPage>105104</StartPage><MedlinePgn>105104</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijmedinf.2023.105104</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1386-5056(23)00122-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To address the growing need for effective data reuse in health research, healthcare institutions need to make their data Findable, Accessible, Interoperable, and Reusable (FAIR). A prevailing method to model databases for interoperability is the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM), developed by the Observational Health Data Sciences and Informatics (OHDSI) initiative. A European repository for OMOP CDM-converted databases called the "European Health Data &amp; Evidence Network (EHDEN) portal" was developed, aiming to make these databases Findable and Accessible. This paper aims to assess the FAIRness of databases on the EHDEN portal.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Two researchers involved in the OMOP CDM conversion of separate Dutch Intensive Care Unit (ICU) research databases each manually assessed their own database using seventeen metrics. These were defined by the FAIRsFAIR project as a list of minimum requirements for a database to be FAIR. Each metric is given a score from zero to four based on how well the database adheres to the metric. The maximum score for each metric varies from one to four based on the importance of the metric.</AbstractText><AbstractText Label="RESULTS">Fourteen out of the seventeen metrics were unanimously rated: seven were rated the highest score, one was rated half of the highest score, and five were rated the lowest score. The remaining three metrics were assessed differently for the two use cases. The total scores achieved were 15.5 and 12 out of a maximum of 25.</AbstractText><AbstractText Label="CONCLUSION">The main omissions in supporting FAIRness were the lack of globally unique identifiers such as Uniform Resource Identifiers (URIs) in the OMOP CDM and the lack of metadata standardization and linkage in the EHDEN portal. By implementing these in future updates, the EHDEN portal can be more FAIR.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Puttmann</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, Amsterdam, the Netherlands; Amsterdam Public Health Research Institute, Digital Health &amp; Methodology, Amsterdam, the Netherlands; National Intensive Care Evaluation (NICE) Foundation, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Groot</LastName><ForeName>Rowdy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, Amsterdam, the Netherlands; Amsterdam Public Health Research Institute, Digital Health &amp; Methodology, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Keizer</LastName><ForeName>Nicolette</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cornet</LastName><ForeName>Ronald</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, Amsterdam, the Netherlands; Amsterdam Public Health Research Institute, Digital Health &amp; Methodology, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elbers</LastName><ForeName>Paul W G</ForeName><Initials>PWG</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Center for Critical Care Computation Intelligence (C4i), Amsterdam Medical Data Science (AMDS), Amsterdam Public Health (APH), Amsterdam Cardiovascular Science (ACS), Amsterdam Institute for Infection and Immunity (AII), Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dongelmans</LastName><ForeName>Dave</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Amsterdam Public Health Research Institute, Digital Health &amp; Methodology, Amsterdam, the Netherlands; Department of Critical Care, Amsterdam University Medical Center, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakhshi-Raiez</LastName><ForeName>Ferishta</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Amsterdam UMC location University of Amsterdam, Department of Medical Informatics, Amsterdam, the Netherlands; Amsterdam Public Health Research Institute, Digital Health &amp; Methodology, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Dutch ICU Data Sharing Against COVID-19 Collaborators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Int J Med Inform</MedlineTA><NlmUniqueID>9711057</NlmUniqueID><ISSNLinking>1386-5056</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005006" MajorTopicYN="Y">Ethnicity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006268" MajorTopicYN="Y">Health Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EHDEN</Keyword><Keyword MajorTopicYN="N">FAIR</Keyword><Keyword MajorTopicYN="N">FAIR assessment</Keyword><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>3</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>18</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37267810</ArticleId><ArticleId IdType="doi">10.1016/j.ijmedinf.2023.105104</ArticleId><ArticleId IdType="pii">S1386-5056(23)00122-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37305615</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2352-9148</ISSN><JournalIssue CitedMedium="Print"><Volume>39</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Informatics in medicine unlocked</Title><ISOAbbreviation>Inform Med Unlocked</ISOAbbreviation></Journal><ArticleTitle>Building the observational medical outcomes partnership's T-MSIS Analytic File common data model.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">101259</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.imu.2023.101259</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">This effort used Databricks to create an Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) for Transformed MSIS Analytic File (TAF) Medicaid records.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">Our process included data volume and content assessment of TAF, translation mapping of TAF concepts to OMOP concepts and the creation of Extract Transform and Load (ETL) code.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The final CDM contained 119,048,562 individuals and 24,806,828,121 clinical observations from 2014 through 2018.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">The transformation of TAF into OMOP can support the generation of evidence with special attention to low-income patients on public insurance. Such patients are perhaps underrepresented in academic medical center patient populations.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our effort successfully used Databricks to transform TAF records into OMOP CDM. Our CDM can be used to generate evidence for OMOP network studies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Nick</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National Library of Medicine, Lister Hill National Center for Biomedical Communications, Bethesda, MD United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z99 LM999999</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Inform Med Unlocked</MedlineTA><NlmUniqueID>101718051</NlmUniqueID><ISSNLinking>2352-9148</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Centers for Medicare and Medicaid Services</Keyword><Keyword MajorTopicYN="N">Common Data Model</Keyword><Keyword MajorTopicYN="N">Medicaid</Keyword><Keyword MajorTopicYN="N">Observational Health Data Sciences and Informatics</Keyword><Keyword MajorTopicYN="N">Observational Medical Outcomes Partnership</Keyword></KeywordList><CoiStatement>Declaration of interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Nick Williams reports financial support was provided by US Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>4</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37305615</ArticleId><ArticleId IdType="mid">NIHMS1901835</ArticleId><ArticleId IdType="pmc">PMC10249773</ArticleId><ArticleId IdType="doi">10.1016/j.imu.2023.101259</ArticleId><ArticleId IdType="pii">101259</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davidoff F, Haynes B, Sackett D, Smith R. Evidence based medicine. BMJ. 1995;310(6987):1085&#x2013;1086. doi:10.1136/bmj.310.6987.1085</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.310.6987.1085</ArticleId><ArticleId IdType="pmc">PMC2549494</ArticleId><ArticleId IdType="pubmed">7742666</ArticleId></ArticleIdList></Reference><Reference><Citation>Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: a quarter century on. The Lancet. 2017;390(10092):415&#x2013;423. doi:10.1016/S0140-6736(16)31592-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)31592-6</ArticleId><ArticleId IdType="pubmed">28215660</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Howick J, Maskrey N. Evidence based medicine: a movement in crisis? BMJ. 2014;348:g3725. doi:10.1136/bmj.g3725</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g3725</ArticleId><ArticleId IdType="pmc">PMC4056639</ArticleId><ArticleId IdType="pubmed">24927763</ArticleId></ArticleIdList></Reference><Reference><Citation>Sackett DL, Rosenberg WMC. On the need for evidence-based medicine. Journal of Public Health. 1995;17(3):330&#x2013;334. doi:10.1093/oxfordjournals.pubmed.a043127</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.pubmed.a043127</ArticleId><ArticleId IdType="pubmed">8527187</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Giovane CD, Chaimani A, Caldwell DM, Salanti G. Evaluating the Quality of Evidence from a Network Meta-Analysis. Value in Health. 2014;17(7):A324. doi:10.1016/j.jval.2014.08.572</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2014.08.572</ArticleId><ArticleId IdType="pubmed">27200533</ArticleId></ArticleIdList></Reference><Reference><Citation>Faltinsen EG, Storeb&#xf8; OJ, Jakobsen JC, Boesen K, Lange T, Gluud C. Network meta-analysis: the highest level of medical evidence? BMJ Evidence-Based Medicine. 2018;23(2):56&#x2013;59. doi:10.1136/bmjebm-2017-l10887</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjebm-2017-l10887</ArticleId><ArticleId IdType="pubmed">29595131</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Ryan PB, Duke JD, et al. Characterizing treatment pathways at scale using the OHDSI network. PNAS. 2016;113(27):7329&#x2013;7336. doi:10.1073/pnas1510502113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas1510502113</ArticleId><ArticleId IdType="pmc">PMC4941483</ArticleId><ArticleId IdType="pubmed">27274072</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Schuemie MJ, Madigan D, Ryan PB, Suchard MA. Drawing Reproducible Conclusions from Observational Clinical Data with OHDSI. Yearb Med Inform. 2021;30(1):283&#x2013;289. doi:10.1055/s-0041-1726481</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1726481</ArticleId><ArticleId IdType="pmc">PMC8416226</ArticleId><ArticleId IdType="pubmed">33882595</ArticleId></ArticleIdList></Reference><Reference><Citation>Seong Y, You SC, Ostropolets A, et al. Incorporation of Korean Electronic Data Interchange Vocabulary into Observational Medical Outcomes Partnership Vocabulary. Healthc Inform Res. 2021;27(1):29&#x2013;38. doi:10.4258/hir.2021.27.1.29</Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2021.27.1.29</ArticleId><ArticleId IdType="pmc">PMC7921574</ArticleId><ArticleId IdType="pubmed">33611874</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinecke I, Zoch M, Reich C, Sedlmayr M, Bathelt F. The Usage of OHDSI OMOP - A Scoping Review. Stud Health Technol Inform. 2021;283:95&#x2013;103. doi:10.3233/SHTI210546</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI210546</ArticleId><ArticleId IdType="pubmed">34545824</ArticleId></ArticleIdList></Reference><Reference><Citation>MacTaggart P, Foster A, Markus A. Medicaid Statistical Information System (MSIS): a data source for quality reporting for Medicaid and the Children&#x2019;s Health Insurance Program (CHIP). Perspect Health Inf Manag. 2011;8:1d.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3070233</ArticleId><ArticleId IdType="pubmed">21464861</ArticleId></ArticleIdList></Reference><Reference><Citation>Etaati L Azure Databricks. In: Etaati L, ed. Machine Learning with Microsoft Technologies: Selecting the Right Architecture and Tools for Your Project. Apress; 2019:159&#x2013;171. doi:10.1007/978-l-4842-3658-l_10</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-l-4842-3658-l_10</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaharia M Lessons from Large-Scale Software as a Service at Databricks. In: Proceedings of the ACM Symposium on Cloud Computing. SoCC &#x2018;19. Association for Computing Machinery; 2019:101. doi:10.1145/3357223.3365870</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/3357223.3365870</ArticleId></ArticleIdList></Reference><Reference><Citation>50-Facts-in-50-Days-Pt1.pdf. Accessed April 7, 2022. https://www.cms.gov/Outreach-and-Education/Look-Up-Topics/50th-Anniversary/50-Facts-in-50-Days-Pt1.pdf</Citation></Reference><Reference><Citation>Cubanski J, Neuman T, Griffin S, Damico A. Medicare Spending at the End of Life: A Snapshot of Beneficiaries Who Died in 2014 and the Cost of Their Care. Published online 2014:12.</Citation></Reference><Reference><Citation>Griffin S, Jul 14 ADP, 2016. Medicare Spending at the End of Life: A Snapshot of Beneficiaries Who Died in 2014 and the Cost of Their Care. KFF. Published
July
14, 2016. Accessed February 3, 2022. https://www.kff.org/medicare/issue-brief/medicare-spending-at-the-end-of-life/</Citation></Reference><Reference><Citation>U.S. Census Bureau QuickFacts: United States. Accessed April 7, 2022. https://www.census.gov/quickfacts/US</Citation></Reference><Reference><Citation>IIS | NDC Crosswalk tables | Code Sets | HL7 Data | Vaccines | CDC. Published
September
25, 2018. Accessed April 7, 2022. https://wcms-wp-test-br.cdc.gov/php-app-template/index.php</Citation></Reference><Reference><Citation>Simonaitis L, McDonald CJ. Using National Drug Codes and Drug Knowledge Bases to Organize Prescription Records from Multiple Sources. Am J Health Syst Pharm. 2009;66(19):1743&#x2013;1753. doi:10.2146/ajhp080221</Citation><ArticleIdList><ArticleId IdType="doi">10.2146/ajhp080221</ArticleId><ArticleId IdType="pmc">PMC2965522</ArticleId><ArticleId IdType="pubmed">19767382</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters LB, Bodenreider O. Approaches to Supporting the Analysis of Historical Medication Datasets with RxNorm. AMIA Annu Symp Proc. 2015;2015:1034&#x2013;1041.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4765580</ArticleId><ArticleId IdType="pubmed">26958241</ArticleId></ArticleIdList></Reference><Reference><Citation>Fragidis LL, Chatzoglou PD. Implementation of a nationwide electronic health record (EHR): The international experience in 13 countries. International Journal of Health Care Quality Assurance. 2018;31(2):116&#x2013;130. doi:10.1108/IJHCQA-09-2016-0136</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/IJHCQA-09-2016-0136</ArticleId><ArticleId IdType="pubmed">29504871</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunter TD, Terry NP. The Emergence of National Electronic Health Record Architectures in the United States and Australia: Models, Costs, and Questions. Journal of Medical Internet Research. 2005;7(1):e383. doi:10.2196/jmir.7.1.e3</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.7.1.e3</ArticleId><ArticleId IdType="pmc">PMC1550638</ArticleId><ArticleId IdType="pubmed">15829475</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaulieu-Jones BK, Finlayson SG, Yuan W, et al. Examining the Use of Real-World Evidence in the Regulatory Process. Clinical Pharmacology &amp; Therapeutics. 2020;107(4):843&#x2013;852. doi:10.1002/cpt.1658</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1658</ArticleId><ArticleId IdType="pmc">PMC7093234</ArticleId><ArticleId IdType="pubmed">31562770</ArticleId></ArticleIdList></Reference><Reference><Citation>Burcu M, Dreyer NA, Franklin JM, et al. Real-world evidence to support regulatory decision-making for medicines: Considerations for external control arms. Pharmacoepidemiology and Drug Safety. 2020;29(10):1228&#x2013;1235. doi:10.1002/pds.4975</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4975</ArticleId><ArticleId IdType="pmc">PMC7687199</ArticleId><ArticleId IdType="pubmed">32162381</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y, He W, Wang H, Wu M. Key considerations in the design of real-world studies. Contemporary Clinical Trials. 2020;96:106091. doi:10.1016/j.cct.2020.106091</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2020.106091</ArticleId><ArticleId IdType="pubmed">32717351</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37309694</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1598-6357</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>23</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of Korean medical science</Title><ISOAbbreviation>J Korean Med Sci</ISOAbbreviation></Journal><ArticleTitle>Real-World Treatment Intensity and Patterns in Patients With Myopic Choroidal Neovascularization: Common Data Model in Ophthalmology.</ArticleTitle><Pagination><StartPage>e174</StartPage><MedlinePgn>e174</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e174</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3346/jkms.2023.38.e174</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A paucity of data addressing real-world treatment of myopic choroidal neovascularization (mCNV) in the era of anti-vascular endothelial growth factor (VEGF) drugs led us to investigate real-world treatment intensity and treatment patterns in patients with mCNV.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a retrospective, observational study using the Observational Medical Outcomes Partnership-Common Data Model database of treatment-na&#xef;ve patients with mCNV over the 18-year study period (2003-2020). Outcomes were treatment intensity (time trends of total/average number of prescriptions, mean number of prescriptions in the first year and the second year after initiating treatment, proportion of patients with no treatment in the second year) and treatment patterns (subsequent patterns of treatment according to the initial treatment).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our final cohort included 94 patients with at-least 1-year observation period. Overall, 96.8% of patients received anti-VEGF drugs as first-line treatment, with most of injections from bevacizumab. The number of anti-VEGF injections in each calendar year showed an increasing trend over time; however, there was a drop in the mean number of injections in the second year compared to the first year from 2.09 to 0.47. About 77% of patients did not receive any treatment in their second year of treatment regardless of drugs. Most of patients (86.2%) followed non-switching monotherapy only and bevacizumab was the most popular choice either in the first-line (68.1%) or in the second-line (53.8%) of treatment. Aflibercept was increasingly used as the first-line treatment for patients with mCNV.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Anti-VEGF drugs have become the treatment of choice and second-line treatment for mCNV over the past decade. Anti-VEGF drugs are effective for the treatment of mCNV as the non-switching monotherapy is the main treatment regimen in most cases and the number of treatments decreases significantly in the second year of treatment.</AbstractText><CopyrightInformation>&#xa9; 2023 The Korean Academy of Medical Sciences.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bui</LastName><ForeName>Manh-Hung</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0002-0184-4171</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Da Yun</ForeName><Initials>DY</Initials><Identifier Source="ORCID">0000-0002-9604-8337</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sang Jun</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0003-0542-2758</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, Korea. sangjunpark@snu.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Kyu Hyung</ForeName><Initials>KH</Initials><Identifier Source="ORCID">0000-0002-5516-8121</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Seoul National University Hospital, Seoul, Korea. jiani4@snu.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HC21C0163</GrantID><Agency>Korea Health Industry Development Institute</Agency><Country>Republic of Korea</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>J Korean Med Sci</MedlineTA><NlmUniqueID>8703518</NlmUniqueID><ISSNLinking>1011-8934</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>2S9ZZM9Q9V</RegistryNumber><NameOfSubstance UI="D000068258">Bevacizumab</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009885" MajorTopicYN="Y">Ophthalmology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068258" MajorTopicYN="N">Bevacizumab</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010361" MajorTopicYN="N">Patients</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-vascular Endothelial Growth Factor Drug</Keyword><Keyword MajorTopicYN="N">Common Data Model</Keyword><Keyword MajorTopicYN="N">Myopic Choroidal Neovascularization</Keyword><Keyword MajorTopicYN="N">Treatment Intensity</Keyword><Keyword MajorTopicYN="N">Treatment Pathways</Keyword></KeywordList><CoiStatement>The authors have no potential conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>13</Day><Hour>5</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37309694</ArticleId><ArticleId IdType="pmc">PMC10261705</ArticleId><ArticleId IdType="doi">10.3346/jkms.2023.38.e174</ArticleId><ArticleId IdType="pii">38.e174</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia. Ophthalmic Physiol Opt. 2012;32(1):3&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">22150586</ArticleId></ArticleIdList></Reference><Reference><Citation>Rim TH, Kim SH, Lim KH, Choi M, Kim HY, Baek SH, et al. Refractive errors in Koreans: the Korea National Health and Nutrition Examination Survey 2008&#x2013;2012. Korean J Ophthalmol. 2016;30(3):214&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4878982</ArticleId><ArticleId IdType="pubmed">27247521</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuehn BM. Increase in myopia reported among children during COVID-19 Lockdown. JAMA. 2021;326(11):999.</Citation><ArticleIdList><ArticleId IdType="pubmed">34546294</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma M, Xiong S, Zhao S, Zheng Z, Sun T, Li C. COVID-19 home quarantine accelerated the progression of myopia in children aged 7 to 12 years in China. Invest Ophthalmol Vis Sci. 2021;62(10):37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8411864</ArticleId><ArticleId IdType="pubmed">34463719</ArticleId></ArticleIdList></Reference><Reference><Citation>Neelam K, Cheung CM, Ohno-Matsui K, Lai TY, Wong TY. Choroidal neovascularization in pathological myopia. Prog Retin Eye Res. 2012;31(5):495&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pubmed">22569156</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang M, Wong TY. Updates on Myopia: A Clinical Perspective. Singapore, Singapore: Springer Nature; 2020.</Citation></Reference><Reference><Citation>Toto L, Di Antonio L, Costantino O, Mastropasqua R. Anti-VEGF therapy in myopic CNV. Curr Drug Targets. 2021;22(9):1054&#x2013;1063.</Citation><ArticleIdList><ArticleId IdType="pubmed">33511955</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ. Etiology of choroidal neovascularization in young patients. Ophthalmology. 1996;103(8):1241&#x2013;1244.</Citation><ArticleIdList><ArticleId IdType="pubmed">8764794</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller DG, Singerman LJ. Vision loss in younger patients: a review of choroidal neovascularization. Optom Vis Sci. 2006;83(5):316&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">16699445</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart A, Ford JA, Duckworth S, Jones C, Pereira A. Anti-VEGF therapies in the treatment of choroidal neovascularisation secondary to non-age-related macular degeneration: a systematic review. BMJ Open. 2015;5(4):e007746</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4420986</ArticleId><ArticleId IdType="pubmed">25941188</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen SY. Anti-VEGF drugs as the 2009 first-line therapy for choroidal neovascularization in pathologic myopia. Retina. 2009;29(8):1062&#x2013;1066.</Citation><ArticleIdList><ArticleId IdType="pubmed">19734760</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolf S, Balciuniene VJ, Laganovska G, Menchini U, Ohno-Matsui K, Sharma T, et al. RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology. 2014;121(3):682&#x2013;92.e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">24326106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikuno Y, Ohno-Matsui K, Wong TY, Korobelnik JF, Vitti R, Li T, et al. Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study. Ophthalmology. 2015;122(6):1220&#x2013;1227.</Citation><ArticleIdList><ArticleId IdType="pubmed">25745875</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis J, Morse L, Vitale S, Parke DW, 2nd, Rich WL, Lum F, et al. Treatment patterns for myopic choroidal neovascularization in the United States: analysis of the IRIS registry. Ophthalmology. 2017;124(7):935&#x2013;943.</Citation><ArticleIdList><ArticleId IdType="pubmed">28372860</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang MC, Chen YP, Tan EC, Leteneux C, Chang E, Chu CH, et al. Epidemiology, treatment pattern and health care utilization of myopic choroidal neovascularization: a population based study. Jpn J Ophthalmol. 2017;61(2):159&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">28062929</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno-Matsui K, Suzaki M, Teshima R, Okami N. Real-world data on ranibizumab for myopic choroidal neovascularization due to pathologic myopia: results from a post-marketing surveillance in Japan. Eye (Lond) 2018;32(12):1871&#x2013;1878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6292850</ArticleId><ArticleId IdType="pubmed">30158574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wecker T, Ehlken C, B&#xfc;hler A, Lange C, Agostini H, B&#xf6;hringer D, et al. Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV. Br J Ophthalmol. 2017;101(3):353&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5339568</ArticleId><ArticleId IdType="pubmed">27215744</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu TT, Kung YH. Two-year outcome of intravitreal injections of ranibizumab for myopic choroidal neovascularization. J Ocul Pharmacol Ther. 2014;30(10):837&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pubmed">25162313</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SJ, Kwon KE, Choi NK, Park KH, Woo SJ. Prevalence and incidence of exudative age-related macular degeneration in South Korea: a nationwide population-based study. Ophthalmology. 2015;122(10):2063&#x2013;70.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">26208437</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KA, Jin HY, Kim YJ, Im YJ, Kim EY, Park TS. Treatment patterns of type 2 diabetes assessed using a common data model based on electronic health records of 2000&#x2013;2019. J Korean Med Sci. 2021;36(36):e230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8438187</ArticleId><ArticleId IdType="pubmed">34519186</ArticleId></ArticleIdList></Reference><Reference><Citation>Mun Y, You SC, Lee DY, Kim S, Chung YR, Lee K, et al. Real-world incidence of endopthalmitis after intravitreal anti-VEGF injections in Korea: findings from the Common Data Model in ophthalmology. Epidemiol Health. 2021;43:e2021097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8864106</ArticleId><ArticleId IdType="pubmed">34773936</ArticleId></ArticleIdList></Reference><Reference><Citation>Mun Y, Park C, Lee DY, Kim TM, Jin KW, Kim S, et al. Real-world treatment intensities and pathways of macular edema following retinal vein occlusion in Korea from Common Data Model in ophthalmology. Sci Rep. 2022;12(1):10162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9205933</ArticleId><ArticleId IdType="pubmed">35715561</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang DY, Kim H, Ko S, Kim H, Shinn J, Kang MG, et al. Sodium-glucose cotransporter-2 inhibitor-related diabetic ketoacidosis: accuracy verification of operational definition. J Korean Med Sci. 2022;37(7):e53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8860766</ArticleId><ArticleId IdType="pubmed">35191230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno-Matsui K, Ikuno Y, Lai TY, Gemmy Cheung CM. Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia. Prog Retin Eye Res. 2018;63:92&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">29111299</ArticleId></ArticleIdList></Reference><Reference><Citation>Tah V, Orlans HO, Hyer J, Casswell E, Din N, Sri Shanmuganathan V, et al. Anti-VEGF therapy and the retina: an update. J Ophthalmol. 2015;2015:627674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4568374</ArticleId><ArticleId IdType="pubmed">26417453</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakabayashi T, Ikuno Y, Gomi F, Hamasaki T, Tano Y. Intravitreal bevacizumab vs sub-tenon triamcinolone acetonide for choroidal neovascularization attributable to pathologic myopia. Am J Ophthalmol. 2009;148(4):591&#x2013;596.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">19589497</ArticleId></ArticleIdList></Reference><Reference><Citation>Karasu B, Celebi AR. The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization. Int Ophthalmol. 2022;42(9):2729&#x2013;2740.</Citation><ArticleIdList><ArticleId IdType="pubmed">35357641</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallone F, Giustolisi R, Franzone F, Marenco M, Plateroti R, Nebbioso M, et al. Ten-year outcomes of intravitreal bevacizumab for myopic choroidal neovascularization: analysis of prognostic factors. Pharmaceuticals (Basel) 2021;14(10):1042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8541117</ArticleId><ArticleId IdType="pubmed">34681267</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamilton RD, Clemens A, Minnella AM, Lai TY, Dai H, Sakamoto T, et al. Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study. PLoS One. 2020;15(1):e0227557.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6974143</ArticleId><ArticleId IdType="pubmed">31961888</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan NW, Ohno-Matsui K, Koh HJ, Nagai Y, Pedros M, Freitas RL, et al. Long-term outcomes of ranibizumab treatment of myopic choroidal neovascularization in East-Asian patients from the RADIANCE study. Retina. 2018;38(11):2228&#x2013;2238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6221407</ArticleId><ArticleId IdType="pubmed">28961671</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Sharma T, Li X, Song Y, Chang Q, Lin R, et al. Ranibizumab versus verteporfin photodynamic therapy in Asian patients with myopic choroidal neovascularization: BRILLIANCE, a 12-month, randomized, double-masked study. Retina. 2019;39(10):1985&#x2013;1994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6768610</ArticleId><ArticleId IdType="pubmed">30204730</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt-Erfurth U, Chong V, Loewenstein A, Larsen M, Souied E, Schlingemann R, et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA) Br J Ophthalmol. 2014;98(9):1144&#x2013;1167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4145443</ArticleId><ArticleId IdType="pubmed">25136079</ArticleId></ArticleIdList></Reference><Reference><Citation>Amoaku WM, Ghanchi F, Bailey C, Banerjee S, Banerjee S, Downey L, et al. Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group. Eye (Lond) 2020;34(Suppl 1):1&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7337227</ArticleId><ArticleId IdType="pubmed">32504038</ArticleId></ArticleIdList></Reference><Reference><Citation>Erden B, B&#xf6;l&#xfc;kba&#x15f;&#x131; S, Ba&#x15f; E, &#xc7;ak&#x131;r A. Comparison of intravitreal aflibercept and ranibizumab for treatment of myopic choroidal neovascularization: one-year results-a retrospective, comparative study. J Ophthalmol. 2019;2019:8639243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7012232</ArticleId><ArticleId IdType="pubmed">32082619</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JK, Huang TL, Chang PY, Chen YT, Chang CW, Chen FT, et al. Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization. Sci Rep. 2018;8(1):14389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6158246</ArticleId><ArticleId IdType="pubmed">30258077</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B, Wu H, Liu X, Lin H, Li J. Ranibizumab versus bevacizumab for ophthalmic diseases related to neovascularisation: a meta-analysis of randomised controlled trials. PLoS One. 2014;9(7):e101253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4077727</ArticleId><ArticleId IdType="pubmed">24983855</ArticleId></ArticleIdList></Reference><Reference><Citation>Munk MR, R&#xfc;ckert R, Zinkernagel M, Ebneter A, Wolf S. The role of anti-VEGF agents in myopic choroidal neovascularization: current standards and future outlook. Expert Opin Biol Ther. 2016;16(4):477&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pubmed">26666589</ArticleId></ArticleIdList></Reference><Reference><Citation>Amoaku WM, Chakravarthy U, Gale R, Gavin M, Ghanchi F, Gibson J, et al. Defining response to anti-VEGF therapies in neovascular AMD. Eye (Lond) 2015;29(6):721&#x2013;731.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4469673</ArticleId><ArticleId IdType="pubmed">25882328</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang HS, Kim JG, Kim JT, Joe SG. Prognostic factors of eyes with na&#xef;ve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab. Am J Ophthalmol. 2013;156(6):1201&#x2013;1210.e2.</Citation><ArticleIdList><ArticleId IdType="pubmed">24075429</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37318234</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-217X</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2022</Year><Month>Dec</Month><Day>28</Day></PubDate></JournalIssue><Title>GigaScience</Title><ISOAbbreviation>Gigascience</ISOAbbreviation></Journal><ArticleTitle>ricu: R's interface to intensive care data.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">giad041</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/gigascience/giad041</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To develop a unified framework for analyzing data from 5 large publicly available intensive care unit (ICU) datasets.</AbstractText><AbstractText Label="FINDINGS">Using 3 American (Medical Information Mart for Intensive Care III, Medical Information Mart for Intensive Care IV, electronic ICU) and 2 European (Amsterdam University Medical Center Database, High Time Resolution ICU Dataset) databases, we constructed a mapping for each database to a set of clinically relevant concepts, which are grounded in the Observational Medical Outcomes Partnership Vocabulary wherever possible. Furthermore, we performed synchronization in the units of measurement and data type representation. On top of this, we built functionality, which allows the user to download, set up, and load data from all of the 5 databases, through a unified Application Programming Interface. The resulting ricu R-package represents the computational infrastructure for handling publicly available ICU datasets, and its latest release allows the user to load 119 existing clinical concepts from the 5 data sources.</AbstractText><AbstractText Label="CONCLUSION">The ricu R-package (available on GitHub and CRAN) is the first tool that enables users to analyze publicly available ICU datasets simultaneously (datasets are available upon request from respective owners). Such an interface saves researchers time when analyzing ICU data and helps reproducibility. We hope that ricu can become a community-wide effort, so that data harmonization is not repeated by each research group separately. One current limitation is that concepts were added on a case-to-case basis, and therefore the resulting dictionary of concepts is not comprehensive. Further work is needed to make the dictionary comprehensive.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press GigaScience.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Seminar for Statistics, ETH Z&#xfc;rich, 8092 Z&#xfc;rich (R&#xe4;mistrasse 101), Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ple&#x10d;ko</LastName><ForeName>Drago</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-5433-196X</Identifier><AffiliationInfo><Affiliation>Seminar for Statistics, ETH Z&#xfc;rich, 8092 Z&#xfc;rich (R&#xe4;mistrasse 101), Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ukor</LastName><ForeName>Ida-Fong</ForeName><Initials>IF</Initials><Identifier Source="ORCID">0000-0003-2375-3657</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Monash Health, Clayton VIC 3168, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meinshausen</LastName><ForeName>Nicolai</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Seminar for Statistics, ETH Z&#xfc;rich, 8092 Z&#xfc;rich (R&#xe4;mistrasse 101), Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xfc;hlmann</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1782-6015</Identifier><AffiliationInfo><Affiliation>Seminar for Statistics, ETH Z&#xfc;rich, 8092 Z&#xfc;rich (R&#xe4;mistrasse 101), Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>ERC_</Acronym><Agency>European Research Council</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gigascience</MedlineTA><NlmUniqueID>101596872</NlmUniqueID><ISSNLinking>2047-217X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="Y">Critical Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079803" MajorTopicYN="N">Data Management</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">computational methods</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">intensive care medicine</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>9</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37318234</ArticleId><ArticleId IdType="pmc">PMC10268223</ArticleId><ArticleId IdType="doi">10.1093/gigascience/giad041</ArticleId><ArticleId IdType="pii">7198370</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Evans RS. Electronic health records: then, now, and in the future. Yearb Med Inform. 2016;25(Suppl. 1):48&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5171496</ArticleId><ArticleId IdType="pubmed">27199197</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang F, Jiang Y, Zhi Het al. . Artificial intelligence in healthcare: past, present and future. Stroke Vasc Neurol. 2017;2(4):230&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5829945</ArticleId><ArticleId IdType="pubmed">29507784</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickering BW, Gajic O, Ahmed A, et al. . Data utilization for medical decision making at the time of patient admission to ICU. Crit Care Med. 2013;41(6):1502&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">23528804</ArticleId></ArticleIdList></Reference><Reference><Citation>Desautels T, Calvert J, Hoffman Jet al. . Prediction of sepsis in the intensive care unit with minimal electronic health record data: a machine learning approach. JMIR Med Inform. 2016;4(3):e28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5065680</ArticleId><ArticleId IdType="pubmed">27694098</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemati S, Holder A, Razmi Fet al. . An interpretable machine learning model for accurate prediction of sepsis in the ICU. Crit Care Med. 2018;46(4):547&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5851825</ArticleId><ArticleId IdType="pubmed">29286945</ArticleId></ArticleIdList></Reference><Reference><Citation>Futoma J, Hariharan S, Heller K, et al. . An improved multi-output Gaussian process RNN with real-time validation for early sepsis detection. In: 2017 Machine Learning for Healthcare Conference, PMLR, 2017. (pp. 243&#x2013;254).</Citation></Reference><Reference><Citation>Kam HJ, Kim HY.. Learning representations for the early detection of sepsis with deep neural networks. Comput Biol Med. 2017;89:248&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">28843829</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleuren LM, Klausch TLT, Zwager CL, et al. . Machine learning for the prediction of sepsis: asystematic review and meta-analysis of diagnostic test accuracy. Intensive Care Med. 2020;46(3):383&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7067741</ArticleId><ArticleId IdType="pubmed">31965266</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson AE, Pollard TJ, Shen L, et al. . MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3:160035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4878278</ArticleId><ArticleId IdType="pubmed">27219127</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A, Otles E, Donnelly JPet al. . External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients. JAMA Intern Med. 2021;181(8):1065&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8218233</ArticleId><ArticleId IdType="pubmed">34152373</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CWet al. . The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang RZ, Sun CH, Schroeder PHet al. . Predictive models of sepsis in adult ICU patients. In: 2018 IEEE International Conference on Healthcare Informatics (ICHI) Institute of Electrical and Electronics Engineers. IEEE, 2018. p. 390&#x2013;1.</Citation></Reference><Reference><Citation>Johnson AEW, Aboab J, Raffa JDet al. . A comparative analysis of sepsis identification methods in an electronic database. Crit Care Med. 2018;46(4):494&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5851804</ArticleId><ArticleId IdType="pubmed">29303796</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollard TJ, Johnson AE, Raffa JDet al. . The eICU collaborative research database, a freely available multi-center database for critical care research. Sci Data. 2018;5:180178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6132188</ArticleId><ArticleId IdType="pubmed">30204154</ArticleId></ArticleIdList></Reference><Reference><Citation>
Faltys M, Zimmermann M, Lyu Xet al. . 
HiRID, a high time-resolution ICU dataset (version 1.1.1). 2021. PhysioNet. https://physionet.org/content/hirid/1.1.1/. Accessed&#xa0;25&#xa0;April&#xa0;2022.</Citation></Reference><Reference><Citation>Thoral PJ, Peppink JM, Driessen RHet al. . Sharing ICU patient data responsibly under the Society of Critical Care Medicine/European Society of Intensive Care Medicine Joint Data Science Collaboration: The Amsterdam University Medical Centers Database (AmsterdamUMCdb) example. Crit Care Med. 2021;49 (6):e563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132908</ArticleId><ArticleId IdType="pubmed">33625129</ArticleId></ArticleIdList></Reference><Reference><Citation>
Johnson A, Bulgarelli L, Pollard T, et al. . 
MIMIC-IV (Version 1.0). 2021. https://physionet.org/content/mimiciv/1.0/. Accessed&#xa0;25&#xa0;April&#xa0;2022. PhysioNet.</Citation></Reference><Reference><Citation>Adibuzzaman M, Musselman K, Johnson Aet al. . Closing the data loop: an integrated open access analysis platform for the MIMIC database. In: 2016 Computing in Cardiology Conference (CinC) Institute of Electrical and Electronics Engineers. IEEE, 2016. p. 137&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5630151</ArticleId><ArticleId IdType="pubmed">28989936</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, McDermott MB, Chauhan Get al. . MIMIC-Extract: a data extraction, preprocessing, and representation pipeline for MIMIC-III. In: Proceedings of the ACM Conference on Health, Inference, and Learning Association for Computing Machinery. IEEE, 2020. p. 222&#x2013;35.</Citation></Reference><Reference><Citation>Glicksberg BS, Oskotsky B, Giangreco Net al. . ROMOP: a light-weight R package for interfacing with OMOP-formatted electronic health record data. JAMIA Open. 2019;2(1):10&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6800657</ArticleId><ArticleId IdType="pubmed">31633087</ArticleId></ArticleIdList></Reference><Reference><Citation>Glicksberg BS, Oskotsky B, Thangaraj PM, et al. . PatientExploreR: an extensible application for dynamic visualization of patient clinical history from electronic health records in the OMOP common data model. Bioinformatics. 2019;35(21):4515&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6821222</ArticleId><ArticleId IdType="pubmed">31214700</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberger AL, Amaral LAN, Glass L, et al. . PhysioBank, PhysioToolkit and PhysioNet. Circulation. 2000;101(23): e215&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">10851218</ArticleId></ArticleIdList></Reference><Reference><Citation>
Amsterdam University Medical Center&#x2019;s Database Collaborators and the SCCM/ESICM Joint Data Science Task Force, Amsterdam University Medical Center Database . 2020. https://amsterdammedicaldatascience.nl/amsterdamumcdb/. Accessed 18 May 2023.</Citation></Reference><Reference><Citation>Sauer CM, Dam TA, Celi LAet al. . Systematic review and comparison of publicly available ICU data sets&#x2014;a decision guide for clinicians and data scientists. Crit Care Med. 2022;50(6):e581&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9150442</ArticleId><ArticleId IdType="pubmed">35234175</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas SA, Lange T, Saugel Bet al. . Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients. Intensive Care Med. 2016;42(2):202&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">26556617</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichol A, Bailey M, Egi Met al. . Dynamic lactate indices as predictors of outcome in critically ill patients. Crit Care. 2011;15(5):R242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3334793</ArticleId><ArticleId IdType="pubmed">22014216</ArticleId></ArticleIdList></Reference><Reference><Citation>Van&#xa0;Beest PA, Brander L, Jansen SPet al. . Cumulative lactate and hospital mortality in ICU patients. Ann Intensive Care. 2013;3(1):6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3599274</ArticleId><ArticleId IdType="pubmed">23446002</ArticleId></ArticleIdList></Reference><Reference><Citation>Therneau TM, Grambsch PM.. Modeling Survival Data: Extending the Cox Model. New York: Springer-Verlag, 2000. 10.1007/978-1-4757-3294-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4757-3294-8</ArticleId></ArticleIdList></Reference><Reference><Citation>
Therneau TM.
A Package for Survival Analysis in R. 2021.; https://CRAN.R-project.org/package=survival. Accessed 18 May 2023.</Citation></Reference><Reference><Citation>
Nicolas B, Drago P, Ida-Fong Uet al. . 
Supporting data for &#x201c;ricu: R&#x2019;s Interface to Intensive Care Data.&#x201d; GigaScience Database. 2023. http://dx.doi.org/10.5524/102392.</Citation><ArticleIdList><ArticleId IdType="doi">10.5524/102392</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37321588</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2713-4148</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Clinical and experimental pediatrics</Title><ISOAbbreviation>Clin Exp Pediatr</ISOAbbreviation></Journal><ArticleTitle>Association between dyslipidemia and asthma in children: a systematic review and multicenter cohort study using a common data model.</ArticleTitle><Pagination><StartPage>357</StartPage><EndPage>365</EndPage><MedlinePgn>357-365</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3345/cep.2023.00290</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The association between dyslipidemia and asthma in children remains unclear.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This study investigated the association between dyslipidemia and cholesterol levels in children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A systematic literature review was performed to identify studies investigating the association between dyslipidemia and asthma in children. The PubMed database was searched for articles published from January 2000-March 2022. Data from a cohort study using electronic health records from 5 hospitals, converted to the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM), were used to identify the association between total cholesterol (TC) levels and asthma in children. This cohort study used the Cox proportional hazards model to examine hazard ratio (HR) of asthma after propensity score matching, and included an aggregate meta-analysis of HR.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We examined 11 studies reporting an association between dyslipidemia and asthma in children. Most were cross-sectional; however, their results were inconsistent. In OMOP-CDM multicenter analysis, the high TC (&gt;170 mg/dL) group included 29,038 children, while the normal TC (&#x2264;170 mg/dL) group included 88,823 children including all hospital datasets. In a meta-analysis of this multicenter cohort, a significant association was found between high TC levels and later development of asthma in children &lt;15 years of age (pooled HR, 1.30; 95% confidence interval, 1.12-1.52).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Elevated TC levels in children may be associated with asthma.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Ji Eun</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Kandong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Hye Min</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Kandong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ju Hee</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Kandong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departments of Pediatrics, Kyung Hee University School of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baek</LastName><ForeName>Hey Sung</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Kandong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Man Yong</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Departments of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Clin Exp Pediatr</MedlineTA><NlmUniqueID>101761234</NlmUniqueID><ISSNLinking>2713-4148</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Childhood asthma</Keyword><Keyword MajorTopicYN="N">Dyslipidemia</Keyword><Keyword MajorTopicYN="N">Hypercholesterolemia</Keyword></KeywordList><CoiStatement>
<b>Conflicts of interest</b>
. No potential conflict of interest relevant to this article was reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>19</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37321588</ArticleId><ArticleId IdType="pmc">PMC10397992</ArticleId><ArticleId IdType="doi">10.3345/cep.2023.00290</ArticleId><ArticleId IdType="pii">cep.2023.00290</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kim EY. Clinical and diagnostic importance of dyslipidemia in children and adolescents during the coronavirus disease 2019 pandemic. Clin Exp Pediatr. 2022;65:129&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8898615</ArticleId><ArticleId IdType="pubmed">35038832</ArticleId></ArticleIdList></Reference><Reference><Citation>Kit BK, Kuklina E, Carroll MD, Ostchega Y, Freedman DS, Ogden CL. Prevalence of and trends in dyslipidemia and blood pressure among US children and adolescents, 1999-2012. JAMA Pediatr. 2015;169:272&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7423159</ArticleId><ArticleId IdType="pubmed">25599372</ArticleId></ArticleIdList></Reference><Reference><Citation>Rastogi D, Holguin F. Metabolic dysregulation, systemic inflammation, and pediatric obesity-related asthma. Ann Am Thorac Soc. 2017;14(Supplement_5):S363&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5711274</ArticleId><ArticleId IdType="pubmed">29161075</ArticleId></ArticleIdList></Reference><Reference><Citation>Su X, Ren Y, Li M, Zhao X, Kong L, Kang J. Association between lipid profile and the prevalence of asthma: a meta-analysis and systemic review. Curr Med Res Opin. 2018;34:423&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">28945108</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J, Huang Y. Meta-analysis of the association between asthma and serum levels of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol. Ann Allergy Asthma Immunol. 2017;118:61&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">27839668</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon D, Ahn EK, Park MY, Cho SY, Ryan P, Schuemie MJ, et al. Conversion and data quality assessment of electronic health record data at a Korean Tertiary Teaching Hospital to a Common Data Model for Distributed Network Research. Healthc Inform Res. 2016;22:54&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4756059</ArticleId><ArticleId IdType="pubmed">26893951</ArticleId></ArticleIdList></Reference><Reference><Citation>Rijnbeek PR. Converting to a common data model: what is lost in translation? : Commentary on "fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model". Drug Saf. 2014;37:893&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25187018</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim JS, Kim EY, Kim JH, Yoo JH, Yi KH, Chae HW, et al. 2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents. Clin Exp Pediatr. 2020;63:454&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7738765</ArticleId><ArticleId IdType="pubmed">33264558</ArticleId></ArticleIdList></Reference><Reference><Citation>To T, Dell S, Dick PT, Cicutto L, Harris JK, MacLusky IB, et al. Case verification of children with asthma in Ontario. Pediatr Allergy Immunol. 2006;17:69&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">16426258</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousif A, Dault R, Courteau M, Blais L, Cloutier AM, Lacasse A, et al. The validity of diagnostic algorithms to identify asthma patients in healthcare administrative databases: a systematic literature review. J Asthma. 2022;59:152&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">32990481</ArticleId></ArticleIdList></Reference><Reference><Citation>Gershon AS, Wang C, Guan J, Vasilevska-Ristovska J, Cicutto L, To T. Identifying patients with physician-diagnosed asthma in health administrative databases. Can Respir J. 2009;16:183&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2807792</ArticleId><ArticleId IdType="pubmed">20011725</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34:3661&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4626409</ArticleId><ArticleId IdType="pubmed">26238958</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu M, Wu B, Qiao R, Gu H, Din Y, Dong X. No associations between serum lipid levels or HOMA-IR and asthma in children and adolescents: a NHANES analysis. J Clin Res Pediatr Endocrinol. 2019;11:270&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6745451</ArticleId><ArticleId IdType="pubmed">30759963</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanachon PN, Jotikasthira W, Kiewngam P, Sawatchai A, Kanchongkittiphon W, Manuyakorn W. Association of dyslipidemia and respiratory resistance assessed by the forced oscillation technique in asthmatic children. Lung. 2022;200:73&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">35064334</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanachon PN, Jotikasthira W, Kiewngam P, Sawatchai A, Kanchongkittiphon W, Manuyakorn W. TG/HDL-C ratio independent of obesity associates with airflow obstruction in children with asthma. Indian J Pediatr. 2022;89:92.</Citation><ArticleIdList><ArticleId IdType="pubmed">34480717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko SH, Jeong J, Baeg MK, Han KD, Kim HS, Yoon JS, et al. Lipid profiles in adolescents with and without asthma: Korea National Health and nutrition examination survey data. Lipids Health Dis. 2018;17:158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6052620</ArticleId><ArticleId IdType="pubmed">30021597</ArticleId></ArticleIdList></Reference><Reference><Citation>Cottrell L, Neal WA, Ice C, Perez MK, Piedimonte G. Metabolic abnormalities in children with asthma. Am J Respir Crit Care Med. 2011;183:441&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3056222</ArticleId><ArticleId IdType="pubmed">20851922</ArticleId></ArticleIdList></Reference><Reference><Citation>Fessler MB, Massing MW, Spruell B, Jaramillo R, Draper DW, Madenspacher JH, et al. Novel relationship of serum cholesterol with asthma and wheeze in the United States. J Allergy Clin Immunol. 2009;124:967&#x2013;74.e1-15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3936400</ArticleId><ArticleId IdType="pubmed">19800678</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, Tung KY, Tsai CH, Su MW, Wang PC, Chen CH, et al. Lipid profiles in children with and without asthma: interaction of asthma and obesity on hyperlipidemia. Diabetes Metab Syndr. 2013;7:20&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">23517791</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiallouros PK, Savva SC, Kolokotroni O, Dima K, Zerva A, Kouis P, et al. Asthma: the role of low high-density-lipoprotein cholesterol in childhood and adolescence. Int Arch Allergy Immunol. 2014;165:91&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">25377880</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen F, Hancox RJ, Nair P, Hansen HS, Siersted HC, Nybo M. Associations between airway hyperresponsiveness, obesity and lipoproteins in a longitudinal cohort. Clin Respir J. 2013;7:268&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">22906044</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiallouros PK, Savva SC, Kolokotroni O, Behbod B, Zeniou M, Economou M, et al. Low serum high-density lipoprotein cholesterol in childhood is associated with adolescent asthma. Clin Exp Allergy. 2012;42:423&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">22356143</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokes KY, Cooper D, Tailor A, Granger DN. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radic Biol Med. 2002;33:1026&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">12374614</ArticleId></ArticleIdList></Reference><Reference><Citation>Shore SA. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol. 2008;121:1087&#x2013;93. quiz 1094-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">18405959</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson AK, Zhou X, Strandvik B, Hansson GK. Severe hypercholesterolaemia leads to strong Th2 responses to an exogenous antigen. Scand J Immunol. 2004;59:285&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">15030580</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheha DS, El-Korashi LA, AbdAllah AM, El-Begermy MM, Elmahdi AR. Dyslipidemia among allergic rhinitis patients: frequency and risk factors. World Allergy Organ J. 2021;14:100523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937983</ArticleId><ArticleId IdType="pubmed">33747342</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Shawwa B, Al-Huniti N, Titus G, Abu-Hasan M. Hypercholesterolemia is a potential risk factor for asthma. J Asthma. 2006;43:231&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">16754527</ArticleId></ArticleIdList></Reference><Reference><Citation>Pite H, Aguiar L, Morello J, Monteiro EC, Alves AC, Bourbon M, et al. Metabolic dysfunction and asthma: current perspectives. J Asthma Allergy. 2020;13:237&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7394599</ArticleId><ArticleId IdType="pubmed">32801785</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubo T, Takahashi K, Furujo M, Hyodo Y, Tsuchiya H, Hattori M, et al. Usefulness of non-fasting lipid parameters in children. J Pediatr Endocrinol Metab. 2017;30:77&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">27977407</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37328600</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1179-1942</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Drug safety</Title><ISOAbbreviation>Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance.</ArticleTitle><Pagination><StartPage>797</StartPage><EndPage>807</EndPage><MedlinePgn>797-807</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40264-023-01324-1</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Vaccine safety surveillance commonly includes a serial testing approach with a sensitive method for 'signal generation' and specific method for 'signal validation.' The extent to which serial testing in real-world studies improves or hinders overall performance in terms of sensitivity and specificity remains unknown.</AbstractText><AbstractText Label="METHODS">We assessed the overall performance of serial testing using three administrative claims and one electronic health record database. We compared type I and II errors before and after empirical calibration for historical comparator, self-controlled case series (SCCS), and the serial combination of those designs against six vaccine exposure groups with 93 negative control and 279 imputed positive control outcomes.</AbstractText><AbstractText Label="RESULTS">The historical comparator design mostly had fewer type II errors than SCCS. SCCS had fewer type I errors than the historical comparator. Before empirical calibration, the serial combination increased specificity and decreased sensitivity. Type II errors mostly exceeded 50%. After empirical calibration, type I errors returned to nominal; sensitivity was lowest when the methods were combined.</AbstractText><AbstractText Label="CONCLUSION">While serial combination produced fewer false-positive signals compared with the most specific method, it generated more false-negative signals compared with the most sensitive method. Using a historical comparator design followed by an SCCS analysis yielded decreased sensitivity in evaluating safety signals relative to a one-stage SCCS approach. While the current use of serial testing in vaccine surveillance may provide a practical paradigm for signal identification and triage, single epidemiological designs should be explored as valuable approaches to detecting signals.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arshad</LastName><ForeName>Faaizah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen R&amp;D, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bu</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minty</LastName><ForeName>Evan P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>O'Brien Institute for Public Health, Faculty of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Lana Y H</ForeName><Initials>LYH</Initials><AffiliationInfo><Affiliation>Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fortin</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen R&amp;D, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyberg</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, G&#xf6;teborg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Analytics, Janssen R&amp;D, Titusville, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics Services, New York-Presbyterian Hospital, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Sciences, Medical Informatics, Erasmus Medical Center University, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0001-9818-479X</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, University of California, Los Angeles, Los Angeles, CA, USA. msuchard@ucla.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, USA. msuchard@ucla.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA, USA. msuchard@ucla.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Informatics and Computing Infrastructure, US Department of Veterans Affairs, Salt Lake City, UT, USA. msuchard@ucla.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI153044</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drug Saf</MedlineTA><NlmUniqueID>9002928</NlmUniqueID><ISSNLinking>0114-5916</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Drug Saf. 2024 Apr;47(4):401-402. doi: 10.1007/s40264-024-01410-y</RefSource><PMID Version="1">38441751</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="Y">Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>FA and FB declare no competing interests. MAS receives grant funding from the US National Institutes of Health and the US Food and Drug Administration and contracts from the US Department of Veterans Affairs and Janssen Research and Development. PBR, SF and MJS are employees of Janssen Research and Development and shareholders in Johnson &amp; Johnson. GH receives grant funding from the US National Institutes of Health and the US Food and Drug Administration. DPA&#x2019;s research group has received grant support from Amgen, Chesi-Taylor, Novartis, and UCB Biopharma. His department has received advisory or consultancy fees from Amgen, Astellas, AstraZeneca, Johnson, and Johnson, and UCB Biopharma and fees for speaker services from Amgen and UCB Biopharma. Janssen, on behalf of IMI-funded EHDEN and EMIF consortiums, and Synapse Management Partners have supported training programmes organized by DPA's department and open for external participants organized by his department outside submitted work. FN was an employee of AstraZeneca until 2019 and owns some AstraZeneca shares. EPM, LYHL, TMA, and TDS declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>17</Day><Hour>5</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>16</Day><Hour>23</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37328600</ArticleId><ArticleId IdType="pmc">PMC10345011</ArticleId><ArticleId IdType="doi">10.1007/s40264-023-01324-1</ArticleId><ArticleId IdType="pii">10.1007/s40264-023-01324-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bloomberg [Internet]. https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/ [cited 18 Nov 2021].</Citation></Reference><Reference><Citation>WHO Coronavirus (COVID-19) dashboard [Internet]. https://covid19.who.int [cited 14 Dec 2022].</Citation></Reference><Reference><Citation>CDC. COVID Data Tracker [Internet]; 2020. https://covid.cdc.gov/covid-data-tracker/ [cited 28 July 2021].</Citation></Reference><Reference><Citation>Holder J. Tracking Coronavirus Vaccinations Around the World. The New York Times [Internet]; 2021 Jan 29. https://www.nytimes.com/interactive/2021/world/covid-vaccinations-tracker.html [cited 16 Aug 2021].</Citation></Reference><Reference><Citation>COVID-19 Vaccine Tracker [Internet]. https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html [cited 28 July 2021].</Citation></Reference><Reference><Citation>Kim HS, Lee S, Kim JH. Real-world evidence versus randomized controlled trial: clinical research based on electronic medical records. J Korean Med Sci. 2018;33(34):e213. doi: 10.3346/jkms.2018.33.e213.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2018.33.e213</ArticleId><ArticleId IdType="pmc">PMC6097073</ArticleId><ArticleId IdType="pubmed">30127705</ArticleId></ArticleIdList></Reference><Reference><Citation>[Internet]. https://cioms.ch/wp-content/uploads/2018/03/WG8-Signal-Detection.pdf [cited 1 May 2023].</Citation></Reference><Reference><Citation>Kumar A, Khan H. Signal detection and their assessment in pharmacovigilance. Open Pharm Sci J. 2015;2(1):66&#x2013;73. doi: 10.2174/1874844901502010066.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1874844901502010066</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Ryan PB, Wei Y, Friedman C. A method to combine signals from spontaneous reporting systems and observational healthcare data to detect adverse drug reactions. Drug Saf. 2015;38(10):895. doi: 10.1007/s40264-015-0314-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-015-0314-8</ArticleId><ArticleId IdType="pmc">PMC4579260</ArticleId><ArticleId IdType="pubmed">26153397</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesfin YM, Cheng A, Lawrie J, Buttery J. Use of routinely collected electronic healthcare data for postlicensure vaccine safety signal detection: a systematic review. BMJ Glob Health. 2019;4(4):e001065. doi: 10.1136/bmjgh-2018-001065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2018-001065</ArticleId><ArticleId IdType="pmc">PMC6615875</ArticleId><ArticleId IdType="pubmed">31354969</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.brookings.edu/wp-content/uploads/2012/04/Setting-Priorities_Discussion-guide_20110527.pdf [cited 1 May 2023].</Citation></Reference><Reference><Citation>Vaccine Safety Datalink (VSD) [Internet]; 2022. https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vsd/index.html [cited 1 May 2023].</Citation></Reference><Reference><Citation>[Internet]. https://www.fda.gov/media/71238/download [cited 1 May 2023].</Citation></Reference><Reference><Citation>Maxim LD, Niebo R, Utell MJ. Screening tests: a review with examples. Inhal Toxicol. 2014;26(13):811&#x2013;828. doi: 10.3109/08958378.2014.955932.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08958378.2014.955932</ArticleId><ArticleId IdType="pmc">PMC4389712</ArticleId><ArticleId IdType="pubmed">25264934</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepe MS, Thompson ML. Combining diagnostic test results to increase accuracy. Biostatistics. 2000;1(2):123&#x2013;140. doi: 10.1093/biostatistics/1.2.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/1.2.123</ArticleId><ArticleId IdType="pubmed">12933515</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson ML. Assessing the diagnostic accuracy of a sequence of tests. Biostatistics. 2003;4(3):341&#x2013;351. doi: 10.1093/biostatistics/4.3.341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/4.3.341</ArticleId><ArticleId IdType="pubmed">12925502</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Arshad F, Pratt N, Nyberg F, Alshammari TM, Hripcsak G, et al. Vaccine safety surveillance using routinely collected healthcare data-an empirical evaluation of epidemiological designs. Front Pharmacol. 2022;6(13):893484. doi: 10.3389/fphar.2022.893484.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.893484</ArticleId><ArticleId IdType="pmc">PMC9299244</ArticleId><ArticleId IdType="pubmed">35873596</ArticleId></ArticleIdList></Reference><Reference><Citation>Protocol.utf8 [Internet]. https://ohdsi-studies.github.io/Eumaeus/Protocol.html [cited 30 Sep 2021].</Citation></Reference><Reference><Citation>Li X, Lai LY, Ostropolets A, Arshad F, Tan EH, Casajust P, et al. Bias, precision and timeliness of historical (background) rate comparison methods for vaccine safety monitoring: an empirical multi-database analysis. Front Pharmacol. 2021;24(12):773875. doi: 10.3389/fphar.2021.773875.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.773875</ArticleId><ArticleId IdType="pmc">PMC8652333</ArticleId><ArticleId IdType="pubmed">34899334</ArticleId></ArticleIdList></Reference><Reference><Citation>Yih WK, Kulldorff M, Fireman BH, Shui IM, Lewis EM, Klein NP, et al. Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project. Pediatrics. 2011;127(Suppl 1):S54&#x2013;S64. doi: 10.1542/peds.2010-1722I.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2010-1722I</ArticleId><ArticleId IdType="pubmed">21502252</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker HJ, Paddy Farrington C, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method [Internet] Stat Med. 2006;25:1768&#x2013;1797. doi: 10.1002/sim.2302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.2302</ArticleId><ArticleId IdType="pubmed">16220518</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen I, Douglas I, Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs [Internet] BMJ. 2016;354:i4515. doi: 10.1136/bmj.i4515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4515</ArticleId><ArticleId IdType="pubmed">27618829</ArticleId></ArticleIdList></Reference><Reference><Citation>Weldeselassie YG, Whitaker HJ, Farrington CP. Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice. Epidemiol Infect. 2011;139(12):1805&#x2013;1817. doi: 10.1017/S0950268811001531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268811001531</ArticleId><ArticleId IdType="pubmed">21849099</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, DuMouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Stat Med. 2014;33(2):209&#x2013;218. doi: 10.1002/sim.5925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5925</ArticleId><ArticleId IdType="pmc">PMC4285234</ArticleId><ArticleId IdType="pubmed">23900808</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Empirical confidence interval calibration for population-level effect estimation studies in observational healthcare data. Proc Natl Acad Sci USA. 2018;115(11):2571&#x2013;2577. doi: 10.1073/pnas.1708282114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708282114</ArticleId><ArticleId IdType="pmc">PMC5856503</ArticleId><ArticleId IdType="pubmed">29531023</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Hripcsak G, Ryan PB, Madigan D, Suchard MA. Robust empirical calibration of p-values using observational data. Stat Med. 2016;35(22):3883&#x2013;3888. doi: 10.1002/sim.6977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.6977</ArticleId><ArticleId IdType="pmc">PMC5108459</ArticleId><ArticleId IdType="pubmed">27592566</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis JPA. Why most published research findings are false. PLoS Med. 2005;2(8):e124. doi: 10.1371/journal.pmed.0020124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0020124</ArticleId><ArticleId IdType="pmc">PMC1182327</ArticleId><ArticleId IdType="pubmed">16060722</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Ryan PB, Pratt N, Chen R, You SC, Krumholz HM, et al. Principles of large-scale evidence generation and evaluation across a network of databases (LEGEND) J Am Med Inform Assoc. 2020;27(8):1331&#x2013;1337. doi: 10.1093/jamia/ocaa103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa103</ArticleId><ArticleId IdType="pmc">PMC7481029</ArticleId><ArticleId IdType="pubmed">32909033</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson JC, Yu O, Dominguez-Islas CP, Cook AJ, Peterson D, Greene SK, et al. Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013;177(2):131&#x2013;141. doi: 10.1093/aje/kws317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kws317</ArticleId><ArticleId IdType="pubmed">23292957</ArticleId></ArticleIdList></Reference><Reference><Citation>Maro JC, Brown JS, Dal Pan GJ, Kulldorff M. Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity. Pharmacoepidemiol Drug Saf. 2014;23(8):839&#x2013;848. doi: 10.1002/pds.3618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3618</ArticleId><ArticleId IdType="pmc">PMC7181336</ArticleId><ArticleId IdType="pubmed">24700557</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbachu II, Udigwe G, Joseph I, John O, Samuel UO, Joseph U, et al. The evaluation of accuracy of serial rapid HIV test algorithm in the diagnosis of HIV antibodies among pregnant women in south east Nigeria. BMC Res Notes. 2015;12(8):557. doi: 10.1186/s13104-015-1454-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13104-015-1454-8</ArticleId><ArticleId IdType="pmc">PMC4603774</ArticleId><ArticleId IdType="pubmed">26459010</ArticleId></ArticleIdList></Reference><Reference><Citation>Koblavi-D&#xe8;me S, Maurice C, Yavo D, Sibailly TS, N&#x2019;guessan K, Kamelan-Tano Y, et al. Sensitivity and specificity of human immunodeficiency virus rapid serologic assays and testing algorithms in an antenatal clinic in Abidjan Ivory Coast. J Clin Microbiol. 2001;39(5):1808&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC88030</ArticleId><ArticleId IdType="pubmed">11325995</ArticleId></ArticleIdList></Reference><Reference><Citation>Galiwango RM, Musoke R, Lubyayi L, Ssekubugu R, Kalibbala S, Ssekweyama V, et al. Evaluation of current rapid HIV test algorithms in Rakai, Uganda. J Virol Methods. 2013;192(1&#x2013;2):25&#x2013;27. doi: 10.1016/j.jviromet.2013.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2013.04.003</ArticleId><ArticleId IdType="pmc">PMC3749432</ArticleId><ArticleId IdType="pubmed">23583487</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal HS, Solomon S, Murugavel KG, Solomon SS, Balakrishnan P. Evaluation of two indigenous rapid and two ELISA assays for the diagnosis of HIV infection India. Indian J Med Microbiol [Internet]. 2012;30(4). https://pubmed.ncbi.nlm.nih.gov/23183462/ [cited 17 Dec 2021].</Citation><ArticleIdList><ArticleId IdType="pubmed">23183462</ArticleId></ArticleIdList></Reference><Reference><Citation>Moses MW, Zwerling A, Cattamanchi A, Denkinger CM, Banaei N, Kik SV, et al. Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: a Markov model. Sci Rep. 2016;6(1):1&#x2013;8. doi: 10.1038/srep30781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep30781</ArticleId><ArticleId IdType="pmc">PMC4965809</ArticleId><ArticleId IdType="pubmed">27469388</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith DS, Catalona WJ, Herschman JD. Longitudinal screening for prostate cancer with prostate-specific antigen. JAMA. 1996;276(16):1309&#x2013;1315. doi: 10.1001/jama.1996.03540160031029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1996.03540160031029</ArticleId><ArticleId IdType="pubmed">8861989</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhelev Z, Ohtake H, Iwata M, Terasawa T, Rogers M, Peters JL, et al. Diagnostic accuracy of contemporary and high-sensitivity cardiac troponin assays used in serial testing, versus single-sample testing as a comparator, to triage patients suspected of acute non-ST-segment elevation myocardial infarction: a systematic review protocol. BMJ Open. 2019;9(3):e026012. doi: 10.1136/bmjopen-2018-026012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2018-026012</ArticleId><ArticleId IdType="pmc">PMC6475186</ArticleId><ArticleId IdType="pubmed">30928947</ArticleId></ArticleIdList></Reference><Reference><Citation>Berek JS, Bast RC., Jr Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection. Cancer. 1995;76(10):2092&#x2013;2096. doi: 10.1002/1097-0142(19951115)76:10+&lt;2092::AID-CNCR2820761331&gt;3.0.CO;2-T.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-0142(19951115)76:10+&lt;2092::AID-CNCR2820761331&gt;3.0.CO;2-T</ArticleId><ArticleId IdType="pubmed">8635006</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, Trannel A, Holley SA, Alsuhaibani MA, Abosi OJ, Jenn KE, et al. Coronavirus disease 2019 serial testing among hospitalized patients in a Midwest Tertiary Medical Center, July&#x2013;September 2020. Clin Infect Dis. 2020;73(9):e3116&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665386</ArticleId><ArticleId IdType="pubmed">33103196</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson JC, Wellman R, Yu O, Cook AJ, Maro JC, Ouellet-Hellstrom R, et al. A synthesis of current surveillance planning methods for the sequential monitoring of drug and vaccine adverse effects using electronic health care data. EGEMS (Wash DC) 2016;4(1):1219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5051582</ArticleId><ArticleId IdType="pubmed">27713904</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37350911</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2153-4063</ISSN><JournalIssue CitedMedium="Internet"><Volume>2023</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science</Title><ISOAbbreviation>AMIA Jt Summits Transl Sci Proc</ISOAbbreviation></Journal><ArticleTitle>Mild Cognitive Impairment: Data-Driven Prediction, Risk Factors, and Workup.</ArticleTitle><Pagination><StartPage>167</StartPage><EndPage>175</EndPage><MedlinePgn>167-175</MedlinePgn></Pagination><Abstract><AbstractText>Over 78 million people will suffer from dementia by 2030, emphasizing the need for early identification of patients with mild cognitive impairment (MCI) at risk, and personalized clinical evaluation steps to diagnose potentially reversible causes. Here, we leverage real-world electronic health records in the observational medical outcomes partnership (OMOP) data model to develop machine learning models to predict MCI up to a year in advance of recorded diagnosis. Our experimental results with logistic regression, random forest, and xgboost models trained and evaluated on more than 531K patient visits show random forest model can predict MCI onset with ROC-AUC of 68.2&#xb1;0.7. We identify the clinical factors mentioned in clinician notes that are most predictive of MCI. Using similar association mining techniques, we develop a data-driven list of clinical procedures commonly ordered in the workup of MCI cases, that could be used as a basis for guidelines and clinical order set templates.</AbstractText><CopyrightInformation>&#xa9;2023 AMIA - All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fouladvand</LastName><ForeName>Sajjad</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noshad</LastName><ForeName>Morteza</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>Mary Kane</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Health Policy/Center for Primary Care and Outcomes Research.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Periyakoil</LastName><ForeName>V J</ForeName><Initials>VJ</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jonathan H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Stanford Center for Biomedical Informatics Research.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hospital Medicine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Excellence Research Center; Stanford University, Stanford, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>AMIA Jt Summits Transl Sci Proc</MedlineTA><NlmUniqueID>101539486</NlmUniqueID></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>10</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37350911</ArticleId><ArticleId IdType="pmc">PMC10283085</ArticleId><ArticleId IdType="pii">2267</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gauthier S, Rosa-Neto P, Morais JA, Webster C. World Alzheimer Report 2021: Journey through the diagnosis of dementia. London: Alzheimer&#x2019;s Disease International; 2021.</Citation></Reference><Reference><Citation>Robinson L, Tang E, Taylor JP. Dementia: timely diagnosis and early intervention. BMJ [Internet] 2015 Jun 16 [cited 2022 Mar 2];350. Available from:  https://www.bmj.com/content/350/bmj.h3029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4468575</ArticleId><ArticleId IdType="pubmed">26079686</ArticleId></ArticleIdList></Reference><Reference><Citation>Fouladvand S, Mielke MM, Vassilaki M, Sauver JSt, Petersen RC, Sohn S. Deep Learning Prediction of Mild Cognitive Impairment using Electronic Health Records. Proceedings (IEEE Int Conf Bioinformatics Biomed) 2019 Nov;2019:799&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665163</ArticleId><ArticleId IdType="pubmed">33194303</ArticleId></ArticleIdList></Reference><Reference><Citation>Goudarzvand S, Sauver JSt, Mielke MM, Takahashi PY, Sohn S. Analyzing Early Signals of Older Adult Cognitive Impairment in Electronic Health Records. 2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2018:1636&#x2013;40.</Citation></Reference><Reference><Citation>Goudarzvand S, St Sauver J, Mielke MM, Takahashi PY, Lee Y, Sohn S. Early temporal characteristics of elderly patient cognitive impairment in electronic health records. BMC Med Inform Decis Mak. 2019 Aug 8;19(Suppl 4):149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6686236</ArticleId><ArticleId IdType="pubmed">31391041</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Simon G, Yu F. Advancing Alzheimer&#x2019;s research: A review of big data promises. Int J Med Inform. 2017 Oct;106:48&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5590222</ArticleId><ArticleId IdType="pubmed">28870383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohannim O, Hua X, Hibar DP, Lee S, Chou YY, Toga AW, et al. Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging. 2010 Aug;31(8):1429&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2903199</ArticleId><ArticleId IdType="pubmed">20541286</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Oishi K, He X, Qin Y, Gao F, Mori S, et al. An Efficient Approach for Differentiating Alzheimer&#x2019;s Disease from Normal Elderly Based on Multicenter MRI Using Gray-Level Invariant Features. PLOS ONE. 2014 Aug 20;9(8):e105563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4139346</ArticleId><ArticleId IdType="pubmed">25140532</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gils M, Koikkalainen J, Mattila J, Herukka S, Lotjonen J, Soininen H. Discovery and use of efficient biomarkers for objective disease state assessment in Alzheimer&#x2019;s disease. Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:2886&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21095977</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer&#x2019;s Disease Neuroimaging Initiative [Internet]  [cited 2022 Mar 3]. Available from:  http://adni.loni.usc.edu/</Citation></Reference><Reference><Citation>Lovestone S, Francis P, Kloszewska I, Mecocci P, Simmons A, Soininen H, et al. AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer&#x2019;s disease. Ann N Y Acad Sci. 2009 Oct;1180:36&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">19906259</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen PH, Lien CW, Wu WC, Lee LS, Shaw JS. Gait-Based Machine Learning for Classifying Patients with Different Types of Mild Cognitive Impairment. J Med Syst. 2020 Apr 23;44(6):107.</Citation><ArticleIdList><ArticleId IdType="pubmed">32328889</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeron MF, Landset S, Zhou X, Ding T, Khoshgoftaar TM, Zhao F, et al. Utility of MemTrax and Machine Learning Modeling in Classification of Mild Cognitive Impairment. Journal of Alzheimer&#x2019;s Disease. 2020 Jan 1;77(4):1545&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7683062</ArticleId><ArticleId IdType="pubmed">32894241</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Zhou F, Ou-Yang L, Wang T, Lei B. Graph Convolutional Network Analysis for Mild Cognitive Impairment Prediction. 2019 IEEE 16th International Symposium on Biomedical Imaging (ISBI 2019) 2019:1598&#x2013;601.</Citation></Reference><Reference><Citation>Wang L, Laurentiev J, Yang J, Lo YC, Amariglio RE, Blacker D, et al. Development and Validation of a Deep Learning Model for Earlier Detection of Cognitive Decline From Clinical Notes in Electronic Health Records. JAMA Network Open. 2021 Nov 18;4(11):e2135174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8603078</ArticleId><ArticleId IdType="pubmed">34792589</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu S, Ibrahim OA, Wang Y, Vassilaki M, Petersen RC, Mielke MM, et al. Prediction of Incident Dementia Using Patient Temporal Health Status. Stud Health Technol Inform. 2022 Jun 6;290:757&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9754075</ArticleId><ArticleId IdType="pubmed">35673119</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman WW, Bridewell W, Hanbury P, Cooper GF, Buchanan BG. A Simple Algorithm for Identifying Negated Findings and Diseases in Discharge Summaries. Journal of Biomedical Informatics. 2001 Oct 1;34(5):301&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">12123149</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman W, Dowling J, Chu D. ConText: An Algorithm for Identifying Contextual Features from Clinical Text. Biological, translational, and clinical language processing [Internet]. Prague, Czech Republic: Association for Computational Linguistics. 2007 [cited 2022 Sep 14]:81&#x2013;8. Available from:  https://aclanthology.org/W07-1011.</Citation></Reference><Reference><Citation>OMOP NOTE_NLP Table [Internet]  [cited 2022 Sep 14]. Available from:  https://www.ohdsi.org/web/wiki/doku.php?id=documentation:cdm:note_nlp.</Citation></Reference><Reference><Citation>Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: Machine Learning in Python. Journal of Machine Learning Research. 2011;12(85):2825&#x2013;30.</Citation></Reference><Reference><Citation>Breiman L. Random Forests. Machine Learning. 2001 Oct 1;45(1):5&#x2013;32.</Citation></Reference><Reference><Citation>Chen T, Guestrin C. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining [Internet] New York, NY, USA: Association for Computing Machinery; 2016 [cited 2022 Mar 3]. XGBoost: A Scalable Tree Boosting System; pp. 785&#x2013;94. (KDD &#x2019;16). Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/2939672.2939785</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, Phillips NA, B&#xe9;dirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. Journal of the American Geriatrics Society. 2005;53(4):695&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37361151</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Enabling data sharing and utilization for African population health data using OHDSI tools with an OMOP-common data model.</ArticleTitle><Pagination><StartPage>1116682</StartPage><MedlinePgn>1116682</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1116682</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2023.1116682</ELocationID><Abstract><AbstractText>The COVID-19 pandemic has spurred the use of AI and DS innovations in data collection and aggregation. Extensive data on many aspects of the COVID-19 has been collected and used to optimize public health response to the pandemic and to manage the recovery of patients in Sub-Saharan Africa. However, there is no standard mechanism for collecting, documenting and disseminating COVID-19 related data or metadata, which makes the use and reuse a challenge. INSPIRE utilizes the Observational Medical Outcomes Partnership (OMOP) as the Common Data Model (CDM) implemented in the cloud as a Platform as a Service (PaaS) for COVID-19 data. The INSPIRE PaaS for COVID-19 data leverages the cloud gateway for both individual research organizations and for data networks. Individual research institutions may choose to use the PaaS to access the FAIR data management, data analysis and data sharing capabilities which come with the OMOP CDM. Network data hubs may be interested in harmonizing data across localities using the CDM conditioned by the data ownership and data sharing agreements available under OMOP's federated model. The INSPIRE platform for evaluation of COVID-19 Harmonized data (PEACH) harmonizes data from Kenya and Malawi. Data sharing platforms must remain trusted digital spaces that protect human rights and foster citizens' participation is vital in an era where information overload from the internet exists. The channel for sharing data between localities is included in the PaaS and is based on data sharing agreements provided by the data producer. This allows the data producers to retain control over how their data are used, which can be further protected through the use of the federated CDM. Federated regional OMOP-CDM are based on the PaaS instances and analysis workbenches in INSPIRE-PEACH with harmonized analysis powered by the AI technologies in OMOP. These AI technologies can be used to discover and evaluate pathways that COVID-19 cohorts take through public health interventions and treatments. By using both the data mapping and terminology mapping, we construct ETLs that populate the data and/or metadata elements of the CDM, making the hub both a central model and a distributed model.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Kiwuwa-Muyingo, Todd, Bhattacharjee, Taylor and Greenfield.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kiwuwa-Muyingo</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>African Population and Health Research Center (APHRC), Nairobi, Kenya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>Jim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhattacharjee</LastName><ForeName>Tathagata</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Amelia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Computing and Information Technology, Malawi University of Business and Applied Sciences, Blantyre, Malawi.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenfield</LastName><ForeName>Jay</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Committee on Data of the International Science Council, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>224834_Z_21_Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079803" MajorTopicYN="N">Data Management</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">common data models</Keyword><Keyword MajorTopicYN="N">data sharing</Keyword><Keyword MajorTopicYN="N">data standards</Keyword><Keyword MajorTopicYN="N">pandemic response</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>19</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>12</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37361151</ArticleId><ArticleId IdType="pmc">PMC10287979</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2023.1116682</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>iSHARE Repository . (2022). Available online at: https://www.indepth-ishare.org/index.php/home (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Ohmann C, Moher D, Siebert M, Motschall E, Naudet F. Status, use and impact of sharing individual participant data from clinical trials: a scoping review. BMJ Open. (2021) 11:e049228. 10.1136/bmjopen-2021-049228</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-049228</ArticleId><ArticleId IdType="pmc">PMC8375721</ArticleId><ArticleId IdType="pubmed">34408052</ArticleId></ArticleIdList></Reference><Reference><Citation>Dron L, Kalatharan V, Gupta A, Haggstrom J, Zariffa N, Morris AD, et al. . Data capture and sharing in the COVID-19 pandemic: a cause for concern. Lancet Digit Health. (2022) 4:e748&#x2013;56. 10.1016/S2589-7500(22)00147-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00147-9</ArticleId><ArticleId IdType="pmc">PMC9489064</ArticleId><ArticleId IdType="pubmed">36150783</ArticleId></ArticleIdList></Reference><Reference><Citation>FOR-WEB-Data-specification-for-ALPHA-mortality-data.pdf.  (2022). Available online at: https://alpha.lshtm.ac.uk/wp-content/uploads//2022/06/FOR-WEB-Data-specification-for-ALPHA-mortality-data.pdf (accessed November 30, 2022).</Citation></Reference><Reference><Citation>FOR-WEB-Data-specification-for-ALPHA-HIV-incidence-data.pdf.  (2022). Available online at: https://alpha.lshtm.ac.uk/wp-content/uploads//2022/06/FOR-WEB-Data-specification-for-ALPHA-HIV-incidence-data.pdf (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Sankoh O, Byass P. The INDEPTH Network: filling vital gaps in global epidemiology. Int J Epidemiol. (2012) 41:579&#x2013;88. 10.1093/ije/dys081</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys081</ArticleId><ArticleId IdType="pmc">PMC3396316</ArticleId><ArticleId IdType="pubmed">22798690</ArticleId></ArticleIdList></Reference><Reference><Citation>National COVID Cohort Collaborative (N3C) | National Center for Advancing Translational Sciences.  (2022). Available online at: https://ncats.nih.gov/n3c (accessed November 30, 2022).</Citation></Reference><Reference><Citation>EHDEN Portal. ehden.eu. (2022). Available online at: https://www.ehden.eu/ehden-portal/ (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Inspire Data Network.  (2022). Available online at: https://www.inspiredata.network/ (accessed December 5, 2022).</Citation></Reference><Reference><Citation>WorldFAIR . CODATA, The Committee on Data for Science and Technology. (2022). Available online at: https://codata.org/initiatives/decadal-programme2/worldfair/ (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Chen Y, Li J, Hodson S, Dietrich M, Ferrari T, Zhang L. The Global Open Science Cloud Landscape. (2021). Available online at: https://zenodo.org/record/5575275 (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Biedermann P, Ong R, Davydov A, Orlova A, Solovyev P, Sun H, et al. . Standardizing registry data to the OMOP Common Data Model: experience from three pulmonary hypertension databases. BMC Med Res Methodol. (2021) 21:238. 10.1186/s12874-021-01434-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-021-01434-3</ArticleId><ArticleId IdType="pmc">PMC8565035</ArticleId><ArticleId IdType="pubmed">34727871</ArticleId></ArticleIdList></Reference><Reference><Citation>Belenkaya R, Gurley MJ, Golozar A, Dymshyts D, Miller RT, Williams AE, et al. . Extending the OMOP Common Data Model and Standardized Vocabularies to Support Observational Cancer Research. JCO Clin Cancer Inform. (2021) (5):12&#x2013;20. 10.1200/CCI.20.00079</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.20.00079</ArticleId><ArticleId IdType="pmc">PMC8140810</ArticleId><ArticleId IdType="pubmed">33411620</ArticleId></ArticleIdList></Reference><Reference><Citation>Technical Guidelines for Integrated Disease Surveillance Response in the African Region: Third edition . WHO | Regional Office for Africa. (2022). Available online at: https://www.afro.who.int/publications/technical-guidelines-integrated-disease-surveillance-and-response-african-region-third (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Demographic Surveillance System . In: Wikipedia. 2021 (2022). Available online at: https://en.wikipedia.org/w/index.php?title=Demographic_surveillance_system&amp;oldid=1057747767 (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Risher KA, Cori A, Reniers G, Marston M, Calvert C, Crampin A, et al. . Age patterns of HIV incidence in eastern and southern Africa: a modelling analysis of observational population-based cohort studies. Lancet HIV. (2021) 8:e429&#x2013;39. 10.1016/S2352-3018(21)00069-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3018(21)00069-2</ArticleId><ArticleId IdType="pmc">PMC8258368</ArticleId><ArticleId IdType="pubmed">34197773</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI . Geographic Information System Workgroup Update (Aug. 23 Community Call). (2022). Available online at: https://www.youtube.com/watch?v=d8jIAm9cssM (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Kiragga AN, Twinomuhwezi E, Banturaki G, Achieng M, Nampala J, Bagaya I, et al. . Outcomes of retained and disengaged pregnant women living with HIV in Uganda. PLoS ONE. (2021) 16:e0251413. 10.1371/journal.pone.0251413</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0251413</ArticleId><ArticleId IdType="pmc">PMC8139492</ArticleId><ArticleId IdType="pubmed">34019568</ArticleId></ArticleIdList></Reference><Reference><Citation>N3C Data Overview . National Center for Advancing Translational Sciences. (2020). Available online at: https://ncats.nih.gov/n3c/about/data-overview (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Hawkes S, Pantazis A, Purdie A, Gautam A, Kiwuwa-Muyingo S, Buse K, et al. . Sex-disaggregated data matters: tracking the impact of COVID-19 on the health of women and men. Econ Polit. (2022) 39:55&#x2013;73. 10.1007/s40888-021-00254-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40888-021-00254-4</ArticleId><ArticleId IdType="pmc">PMC8773398</ArticleId><ArticleId IdType="pubmed">35422585</ArticleId></ArticleIdList></Reference><Reference><Citation>Beames JR, Kikas K, O'Gradey-Lee M, Gale N, Werner-Seidler A, Boydell KM, et al. . A new normal: integrating lived experience into scientific data syntheses. Front Psychiatry. (2021) 12:763005. 10.3389/fpsyt.2021.763005</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.763005</ArticleId><ArticleId IdType="pmc">PMC8585932</ArticleId><ArticleId IdType="pubmed">34777064</ArticleId></ArticleIdList></Reference><Reference><Citation>INDEPTH Network | Better Health Information for Better Health Policy.  (2022). Available online at: http://www.indepth-network.org/ (accessed November 30, 2022).</Citation></Reference><Reference><Citation>OHDSI_Odysseus_ARACHNE_Platform.pdf.  (2022). Available online at: https://www.ohdsi.org/wp-content/uploads/2015/04/OHDSI_Odysseus_ARACHNE_Platform.pdf (accessed November 30, 2022).</Citation></Reference><Reference><Citation>EHDEN Academy.  (2022). Available online at: https://academy.ehden.eu/ (accessed November 30, 2022).</Citation></Reference><Reference><Citation>OHDSI (OMOP) Services - IQVIA.  (2022). Available online at: https://www.iqvia.com/solutions/real-world-evidence/evidence-networks/ohdsi-omop (accessed November 30, 2022).</Citation></Reference><Reference><Citation>INDEPTH Network | Better Health Information for Better Health Policy.  (2022). Available online at: http://www.indepth-network.org/ (accessed November 30, 2022).</Citation></Reference><Reference><Citation>London School of Hygiene Tropical Medicine.  (2022). ALPHA Network. ALPHA Network. (2022). Available online at: https://alpha.lshtm.ac.uk/ (accessed November 30, 2022).</Citation></Reference><Reference><Citation>World Health Organization.  (2022). Verbal autopsy standards: ascertaining and attributing causes of death tool. (2022). Available online at: https://www.who.int/standards/classifications/other-classifications/verbal-autopsy-standards-ascertaining-and-attributing-causes-of-death-tool (accessed November 30, 2022).</Citation></Reference><Reference><Citation>COVID-19 CRF - ISARIC.  (2022). Available online at: https://isaric.org/research/covid-19-clinical-research-resources/covid-19-crf/ (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Technical Guidelines for Integrated Disease Surveillance Response in the African Region: Third edition | WHO | Regional Office for Africa.  (2022). Available online at: https://www.afro.who.int/publications/technical-guidelines-integrated-disease-surveillance-and-response-african-region-third (accessed November 30, 2022).</Citation></Reference><Reference><Citation>IHCC Wellcome Trust Release COVID-19 Questionnaire &#x2013; International HundredK+ Cohorts Consortium (IHCC).  (2022). Available online at: https://ihccglobal.org/ihcc-and-wellcome-trust-release-covid-19-questionnaire/ (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Pentaho . In: Wikipedia. (2022). Available online at: https://en.wikipedia.org/w/index.php?title=Pentaho&amp;oldid=1111342926 (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Word Health Organization. Climate change and health. Climate change and health.  (2022). Available online at: https://www.who.int/news-room/fact-sheets/detail/climate-change-and-health (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Zhang H, Hu H, Diller M, Hogan WR, Prosperi M, Guo Y, et al. . Semantic standards of external exposome data. Environ Res. (2021) 197:111185. 10.1016/j.envres.2021.111185</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2021.111185</ArticleId><ArticleId IdType="pmc">PMC8597904</ArticleId><ArticleId IdType="pubmed">33901445</ArticleId></ArticleIdList></Reference><Reference><Citation>Medium.  (2022). Understanding the Analytics Maturity Model. (2022). Available online at: https://medium.com/@milind.bapuji.desai/understanding-the-analytics-maturity-model-84982836b107 (accessed September 30, 2022).</Citation></Reference><Reference><Citation>Wikipedia . Prescriptive analytics - Wikipedia. (2022). Available online at: https://en.wikipedia.org/wiki/Prescriptive_analytics (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Microsoft.  (2022). Create a sunburst chart in Office. (2022). Available online at: https://support.microsoft.com/en-us/office/create-a-sunburst-chart-in-office-4a127977-62cd-4c11-b8c7-65b84a358e0c (accessed September 30, 2022).</Citation></Reference><Reference><Citation>Create a Sunburst Chart in Office - Microsoft Support.  (2022). Available online at: https://support.microsoft.com/en-us/office/create-a-sunburst-chart-in-office-4a127977-62cd-4c11-b8c7-65b84a358e0c (accessed November 30, 2022).</Citation></Reference><Reference><Citation>HADES . Cohort Definitions in OHDSI Phenotype Library. (2022). Available online at: https://ohdsi.github.io/PhenotypeLibrary/articles/CohortDefinitionsInOhdsiPhenotypeLibrary.html (accessed November 30, 2022).</Citation></Reference><Reference><Citation>The Book of OHDSI.  (2022). Characterization. Chapter 11 Characterization | The Book of OHDSI. (2022). Available online at: https://ohdsi.github.io/TheBookOfOhdsi/Characterization.html (accessed November 30, 2022).</Citation></Reference><Reference><Citation>The Book of OHDSI . Patient-Level Prediction. Chapter 13 Patient-Level Prediction | The Book of OHDSI. (2022). Available online at: https://ohdsi.github.io/TheBookOfOhdsi/PatientLevelPrediction.html (accessed November 30, 2022).</Citation></Reference><Reference><Citation>The Book of OHDSI . Population-Level Estimation. Chapter 12 Population-Level Estimation | The Book of OHDSI. (2022). Available online at: https://ohdsi.github.io/TheBookOfOhdsi/PopulationLevelEstimation.html (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Vos Korthout - Improving the FAIR Level of OHDSI Studies Using in.pdf . (2022). Available online at: https://api.thehyve.nl/uploads/Vos-FAIR-metadata-1.pdf (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Metadata Technology . SDMX Software for Official Statistics | Metadata Technology. (2022). Available online at: https://metadatatechnology.com/fmr/fusionmetadataregistry/ (accessed November 30, 2022).</Citation></Reference><Reference><Citation>European Commission,. SDMX- Eurostat. (2022). Available online at: https://ec.europa.eu/eurostat/web/sdmx-web-services/sdmx (accessed November 30, 2022).</Citation></Reference><Reference><Citation>United Nations Statistical Division . Statistical Data Metadata Exchange (SDMX). UNSD &#x2014; Methodology. (2022). Available online at: https://unstats.un.org/unsd/methodology/sdmx/ (accessed November 30, 2022).</Citation></Reference><Reference><Citation>SDG-DSD-Guidelines.pdf.  (2022). Available online at: https://unstats.un.org/sdgs/files/SDG-DSD-Guidelines.pdf (accessed November 30, 2022).</Citation></Reference><Reference><Citation>Terry RF, Littler K, Olliaro PL. Sharing health research data &#x2013; the role of funders in improving the impact. F1000Research. (2018) 7:1641. 10.12688/f1000research.16523.2</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.16523.2</ArticleId><ArticleId IdType="pmc">PMC6317492</ArticleId><ArticleId IdType="pubmed">30647910</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. (2016) 64:333&#x2013;41. 10.1016/j.jbi.2016.10.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>CODATA . Sensitive data federation analysis model in population health. CODATA, The Committee on Data for Science and Technology. (2022). Available online at: https://codata.org/initiatives/decadal-programme2/global-open-science-cloud/case-studies/sensitive-data-in-population-health/ (accessed November 30, 2022).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37364547</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1421-9875</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>5</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Digestive diseases (Basel, Switzerland)</Title><ISOAbbreviation>Dig Dis</ISOAbbreviation></Journal><ArticleTitle>Efficacy of Co-Medications in Patients with Alcoholic Liver Disease.</ArticleTitle><Pagination><StartPage>780</StartPage><EndPage>788</EndPage><MedlinePgn>780-788</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000529914</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Alcoholic liver disease (ALD) is still increasing and leads to acute liver injury but also liver cirrhosis and subsequent complications such as liver failure or hepatocellular carcinoma (HCC). As most patients fail to achieve alcohol abstinence, it is essential to identify alternative treatment options in order to improve the outcome of ALD patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Evaluating two large cohorts of patients with ALD from the USA and Korea with a total of 12,006 patients, we investigated the effect on survival of aspirin, metformin, metoprolol, dopamine, and dobutamine drugs in patients with ALD between 2000 and 2020. Patient data were obtained through the "The Observational Health Data Sciences and Informatics consortium," an open-source, multi-stakeholder, and interdisciplinary collaborative effort.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The use of aspirin (p = 0.000, p = 0.000), metoprolol (p = 0.002, p = 0.000), and metformin (p = 0.000, p = 0.000) confers a survival benefit for both AUSOM- and NY-treated cohorts. Need of catecholamines dobutamine (p = 0.000, p = 0.000) and dopamine (p = 0.000, p = 0.000) was strongly indicative of poor survival. &#x3b2;-Blocker treatment with metoprolol (p = 0.128, p = 0.196) or carvedilol (p = 0.520, p = 0.679) was not shown to be protective in any of the female subgroups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Overall, our data fill a large gap in long-term, real-world data on patients with ALD, confirming an impact of metformin, acetylsalicylic acid, and &#x3b2;-blockers on ALD patient's survival. However, gender and ethnic background lead to diverse efficacy in those patients.</AbstractText><CopyrightInformation>&#xa9; 2023 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Itzel</LastName><ForeName>Timo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Hepatology, Division of Bioinformatics, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden-W&#xfc;rttemberg (CPDBW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roig</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Hepatology, Division of Bioinformatics, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden-W&#xfc;rttemberg (CPDBW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daza</LastName><ForeName>Jimmy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Hepatology, Division of Bioinformatics, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden-W&#xfc;rttemberg (CPDBW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jimyung</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheong</LastName><ForeName>Jae Youn</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiest</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Hepatology, Division of Bioinformatics, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden-W&#xfc;rttemberg (CPDBW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebert</LastName><ForeName>Matthias P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden-W&#xfc;rttemberg (CPDBW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teufel</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Hepatology, Division of Bioinformatics, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden-W&#xfc;rttemberg (CPDBW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Dig Dis</MedlineTA><NlmUniqueID>8701186</NlmUniqueID><ISSNLinking>0257-2753</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>GEB06NHM23</RegistryNumber><NameOfSubstance UI="D008790">Metoprolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>3S12J47372</RegistryNumber><NameOfSubstance UI="D004280">Dobutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>VTD58H1Z2X</RegistryNumber><NameOfSubstance UI="D004298">Dopamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006528" MajorTopicYN="Y">Carcinoma, Hepatocellular</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008790" MajorTopicYN="N">Metoprolol</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004280" MajorTopicYN="N">Dobutamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008113" MajorTopicYN="Y">Liver Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008108" MajorTopicYN="Y">Liver Diseases, Alcoholic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alcoholic liver disease</Keyword><Keyword MajorTopicYN="N">Cohort</Keyword><Keyword MajorTopicYN="N">Medication</Keyword><Keyword MajorTopicYN="N">Survival</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37364547</ArticleId><ArticleId IdType="doi">10.1159/000529914</ArticleId><ArticleId IdType="pii">000529914</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37366649</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>Investigation of hepatic adverse events due to quetiapine by using the common data model.</ArticleTitle><Pagination><StartPage>1341</StartPage><EndPage>1349</EndPage><MedlinePgn>1341-1349</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.5663</ELocationID><Abstract><AbstractText Label="PURPOSE">Quetiapine is a drug used to treat schizophrenia, bipolar disorder, and major depressive disorder. However, it can cause mild or severe hepatic adverse events and rarely fatal liver damage. This study was aimed at investigating hepatic toxicity caused by quetiapine use by analyzing the information captured from hospital electronic health records by using the Observational Medical Outcomes Partnership common data model (CDM).</AbstractText><AbstractText Label="METHODS">This was a retrospective observational study involving a nested case-control method. A CDM based on an electronic health record database from five hospitals between January 2009 and May 2020 was used. We analyzed the status of quetiapine use, adverse events, and hepatic impairment.</AbstractText><AbstractText Label="RESULTS">The numbers of patients with non-serious and severe hepatic adverse reactions were 2566 (5.05%) and 835 (1.64%) out of 50&#x2009;766 patients, respectively. After adjusting for covariates, the odds ratio of hepatic adverse events was 2.35 (95% CI: 2.03-2.72), and the odds ratio of severe hepatic adverse events was 1.76 (95% CI: 1.16-2.66).</AbstractText><AbstractText Label="CONCLUSION">Our findings suggest that quetiapine should be cautiously used, and hepatic function should be monitored in patients using quetiapine because it can cause mild or severe hepatic adverse events, complications, and in rare cases, fatal liver damage.</AbstractText><CopyrightInformation>&#xa9; 2023 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>SooJeong</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6550-9188</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedicine &amp; Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Se-Hyun</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-0681-764X</Identifier><AffiliationInfo><Affiliation>Division of Healthcare and Artificial Intelligence, Korea National Institute of Health, Osong Health Technology Administration Complex 202, Cheongju, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Yeon Woong</ForeName><Initials>YW</Initials><Identifier Source="ORCID">0000-0002-3072-9295</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology and Visual Science, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Young-Gyun</ForeName><Initials>YG</Initials><Identifier Source="ORCID">0000-0001-8294-1741</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Dong-Yoon</ForeName><Initials>DY</Initials><Identifier Source="ORCID">0000-0003-4283-2633</Identifier><AffiliationInfo><Affiliation>Department of Preventive Medicine, Ulsan University Hospital, Ulsan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kwangsoo</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-4586-5062</Identifier><AffiliationInfo><Affiliation>Transdisciplinary Department of Medicine &amp; Advanced Technology, Seoul National University Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Dong-Jin</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0002-4763-1219</Identifier><AffiliationInfo><Affiliation>Department of Ophthalmology, Yeouido St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>In Young</ForeName><Initials>IY</Initials><Identifier Source="ORCID">0000-0002-2860-9411</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>20003883</GrantID><Agency>Bio Industrial Strategic Technology Development Program</Agency><Country/></Grant><Grant><Agency>Ministry of Trade, Industry &amp;amp; Energy</Agency><Country/></Grant><Grant><Agency>Korea Institute of Drug Safety and Risk Management</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>2S3PL1B6UJ</RegistryNumber><NameOfSubstance UI="D000069348">Quetiapine Fumarate</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069348" MajorTopicYN="N">Quetiapine Fumarate</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014150" MajorTopicYN="Y">Antipsychotic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="Y">Depressive Disorder, Major</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="Y">Bipolar Disorder</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">hepatic adverse events</Keyword><Keyword MajorTopicYN="N">liver function</Keyword><Keyword MajorTopicYN="N">quetiapine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>13</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>9</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37366649</ArticleId><ArticleId IdType="doi">10.1002/pds.5663</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Suttajit S, Srisurapanont M, Maneeton N, Maneeton B. Quetiapine for acute bipolar depression: a systematic review and meta-analysis. Drug Des Dev Ther. 2014;8:827-838. doi:10.2147/DDDT.S63779</Citation></Reference><Reference><Citation>Garver DL. Review of quetiapine side effects. J Clin Psychiatry. 2000;61(Suppl 8):31-33; discussion 34-35.</Citation></Reference><Reference><Citation>Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry. 1997;54:549-557. doi:10.1001/archpsyc.1997.01830180067009</Citation></Reference><Reference><Citation>Emsley RA, Raniwalla J, Bailey PJ, Jones AM. A comparison of the effects of quetiapine (&#x201c;Seroquel&#x201d;) and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group. Int Clin Psychopharmacol. 2000;15:121-131. doi:10.1097/00004850-200015030-00001</Citation></Reference><Reference><Citation>Copolov DL, Link CG, Kowalcyk B. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, &#x201c;Seroquel&#x201d;) and haloperidol in schizophrenia. Psychol Med. 2000;30:95-105. doi:10.1017/s0033291799001476</Citation></Reference><Reference><Citation>Mullen J, Jibson MD, Sweitzer D. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study. Clin Ther. 2001;23:1839-1854. doi:10.1016/s0149-2918(00)89080-3</Citation></Reference><Reference><Citation>Hellewell JS, Kalali AH, Langham SJ, McKellar J, Awad AG. Patient satisfaction and acceptability of long-term treatment with quetiapine. Int J Psychiatry Clin Pract. 1999;3:105-113. doi:10.3109/13651509909024770</Citation></Reference><Reference><Citation>Nemeroff CB, Kinkead B, Goldstein J. Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing. J Clin Psychiatry. 2002;63(Suppl 13):5-11.</Citation></Reference><Reference><Citation>Glazer WM, Morgenstern H, Pultz JA, Yeung PP. Incidence of persistent tardive dyskinesia may be lower with quetiapine treatment than previously reported with typical antipsychotics in patients with psychoses. Neurology. 2000;54:A51.</Citation></Reference><Reference><Citation>Kasper S, M&#xfc;ller-Spahn F. Review of quetiapine and its clinical applications in schizophrenia. Expert Opin Pharmacother. 2000;1:783-801. doi:10.1517/14656566.1.4.783</Citation></Reference><Reference><Citation>Dev V, Raniwalla J. Quetiapine: a review of its safety in the management of schizophrenia. Drug Saf. 2000;23:295-307. doi:10.2165/00002018-200023040-00003</Citation></Reference><Reference><Citation>Li Q, Su YA, Liu Y, et al. Pharmacokinetics and tolerability of extended-release quetiapine fumarate in Han Chinese patients with schizophrenia. Clin Pharmacokinet. 2014;53:455-465. doi:10.1007/s40262-013-0127-9</Citation></Reference><Reference><Citation>Quetiapine fumarate FDA label.</Citation></Reference><Reference><Citation>Ko S, Kim H, Shinn J, Byeon SJ, Choi JH, Kim HS. Estimation of sodium-glucose cotransporter 2 inhibitor-related genital and urinary tract infections via electronic medical record-based common data model. J Clin Pharm Ther. 2021;46:975-983. doi:10.1111/jcpt.13381</Citation></Reference><Reference><Citation>Choi SA, Kim H, Kim S, et al. Analysis of antiseizure drug-related adverse reactions from the electronic health record using the common data model. Epilepsia. 2020;61:610-616. doi:10.1111/epi.16472</Citation></Reference><Reference><Citation>Seo SI, You SC, Park CH, et al. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: a 15-year hospital cohort study using a common data model. J Gastroenterol Hepatol. 2020;35:1325-1330. doi:10.1111/jgh.14983</Citation></Reference><Reference><Citation>Choi W, Yang YS, Chang DJ, et al. Association between the use of allopurinol and risk of increased thyroid-stimulating hormone level. Sci Rep. 2021;11:20305. doi:10.1038/s41598-021-98954-1</Citation></Reference><Reference><Citation>Wang L, Voss EA, Weaver J, et al. Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: an observational study of four US administrative claims databases. Pharmacoepidemiol Drug Saf. 2019;28:1620-1628. doi:10.1002/pds.4887</Citation></Reference><Reference><Citation>Vashisht R, Jung K, Schuler A, et al. Association of hemoglobin A1c levels with use of sulfonylureas, dipeptidyl peptidase 4 inhibitors, and thiazolidinediones in patients with Type 2 diabetes treated with metformin: analysis from the observational health data sciences and informatics initiative. JAMA Netw Open. 2018;1:e181755. doi:10.1001/jamanetworkopen.2018.1755</Citation></Reference><Reference><Citation>Samwald M, Xu H, Blagec K, et al. Incidence of exposure of patients in the United States to multiple drugs for which pharmacogenomic guidelines are available. PLoS One. 2016;11:e0164972. doi:10.1371/journal.pone.0164972</Citation></Reference><Reference><Citation>Fitzhenry F, Resnic FS, Robbins SL, et al. Creating a common data model for comparative effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform. 2015;6:536-547. doi:10.4338/ACI-2014-12-CR-0121</Citation></Reference><Reference><Citation>Son NY, Kim BG, Chung SY, Han SY. Korean pharmacovigilance system based on EHR-CDM. Stud Health Technol Inform. 2019;264:1592-1593.</Citation></Reference><Reference><Citation>Atasoy N, Erdogan A, Yalug I, et al. A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1255-1260. doi:10.1016/j.pnpbp.2007.05.005</Citation></Reference><Reference><Citation>El Hajj I, Sharara AI, Rockey DC. Subfulminant liver failure associated with quetiapine. Eur J Gastroenterol Hepatol. 2004;16:1415-1418. doi:10.1097/00042737-200412000-00029</Citation></Reference><Reference><Citation>Shpaner A, Li W, Ankoma-Sey V, Botero RC. Drug-induced liver injury: hepatotoxicity of quetiapine revisited. Eur J Gastroenterol Hepatol. 2008;20:1106-1109. doi:10.1097/MEG.0b013e3282f8e3a0</Citation></Reference><Reference><Citation>Naharci MI, Karadurmus N, Demir O, Bozoglu E, Ak M, Doruk H. Fatal hepatotoxicity in an elderly patient receiving low-dose quetiapine. Am J Psychiatry. 2011;168:212-213. doi:10.1176/appi.ajp.2010.10091292</Citation></Reference><Reference><Citation>Al Mutairi F, Dwivedi G, Al Ameel TA. Fulminant hepatic failure in association with quetiapine: a case report. J Med Case Reports. 2012;6:418. doi:10.1186/1752-1947-6-418</Citation></Reference><Reference><Citation>Millar J. The need for a global language - SNOMED CT introduction. Stud Health Technol Inform. 2016;225:683-685.</Citation></Reference><Reference><Citation>Forrey AW, McDonald CJ, DeMoor G, et al. Logical observation identifier names and codes (LOINC) database: a public use set of codes and names for electronic reporting of clinical laboratory test results. Clin Chem. 1996;42:81-90. doi:10.1093/clinchem/42.1.81</Citation></Reference><Reference><Citation>Bodenreider O, Cornet R, Vreeman DJ. Recent developments in clinical terminologies - SNOMED CT, LOINC, and RxNorm. Yearb Med Inform. 2018;27:129-139. doi:10.1055/s-0038-1667077</Citation></Reference><Reference><Citation>Bj&#xf6;rnsson ES. Hepatotoxicity by drugs: the most common implicated agents. Int J Mol Sci. 2016;17:224. doi:10.3390/ijms17020224</Citation></Reference><Reference><Citation>Ernster VL. Nested case-control studies. Prev Med. 1994;23:587-590. doi:10.1006/pmed.1994.1093</Citation></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383. doi:10.1016/0021-9681(87)90171-8</Citation></Reference><Reference><Citation>Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676-682. doi:10.1093/aje/kwq433</Citation></Reference><Reference><Citation>Thygesen SK, Christiansen CF, Christensen S, Lash TL, S&#xf8;rensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83. doi:10.1186/1471-2288-11-83</Citation></Reference><Reference><Citation>R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; 2021 https://www.R-project.org/</Citation></Reference><Reference><Citation>El-Saifi N, Moyle W, Jones C, Tuffaha H. Quetiapine safety in older adults: a systematic literature review. J Clin Pharm Ther. 2016;41:7-18. doi:10.1111/jcpt.12357</Citation></Reference><Reference><Citation>Pretorius RW, Gataric G, Swedlund SK, Miller JR. Reducing the risk of adverse drug events in older adults. Am Fam Physician. 2013;87(5):331-336.</Citation></Reference><Reference><Citation>http://ohdsi.github.io/CommonDataModel/cdm54.html</Citation></Reference><Reference><Citation>https://opendata.hira.or.kr/home.do#none</Citation></Reference><Reference><Citation>Matthew G, Julie D. Antipsychotic safety in liver disease: a narrative review and practical guide for the clinician. J Acad Consult Liaison Psychiatry. 2022;64:73-82. doi:10.1016/j.jaclp.2022.09.006</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37387003</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>305</Volume><PubDate><Year>2023</Year><Month>Jun</Month><Day>29</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Use of Real-World Data to Support Adverse Drug Reactions Prevention During ePrescription.</ArticleTitle><Pagination><StartPage>226</StartPage><EndPage>229</EndPage><MedlinePgn>226-229</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230469</ELocationID><Abstract><AbstractText>Adverse Drug Reactions (ADRs) are a crucial public health issue due to the significant health and monetary burden that they can impose. Real-World Data (RWD), e.g., Electronic Health Records, claims data, etc., can support the identification of potentially unknown ADRs and thus, they could provide raw data to mine ADR prevention rules. The PrescIT project aims to create a Clinical Decision Support System (CDSS) for ADR prevention during ePrescription and uses OMOP-CDM as the main data model to mine ADR prevention rules, based on the software stack provided by the OHDSI initiative. This paper presents the deployment of OMOP-CDM infrastructure using the MIMIC-III as a testbed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dimitriadis</LastName><ForeName>Vlasios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chytas</LastName><ForeName>Achilleas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grammatikopoulou</LastName><ForeName>Margarita</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikolaidis</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Ergobyte SA, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pliatsika</LastName><ForeName>Jenny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ergobyte SA, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zachariadou</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ergobyte SA, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikolopoulos</LastName><ForeName>Spiros</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natsiavas</LastName><ForeName>Pantelis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="Y">Drug-Related Side Effects and Adverse Reactions</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adverse Drug Reactions</Keyword><Keyword MajorTopicYN="N">Drug Safety</Keyword><Keyword MajorTopicYN="N">Real-World Data</Keyword><Keyword MajorTopicYN="N">ePrescription</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>4</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37387003</ArticleId><ArticleId IdType="doi">10.3233/SHTI230469</ArticleId><ArticleId IdType="pii">SHTI230469</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37387004</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>305</Volume><PubDate><Year>2023</Year><Month>Jun</Month><Day>29</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Diabetes Prevalence and Duration Data Extracted from Outpatient Records Representative for the Bulgarian Population.</ArticleTitle><Pagination><StartPage>230</StartPage><EndPage>233</EndPage><MedlinePgn>230-233</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230470</ELocationID><Abstract><AbstractText>This paper presents new data about diabetes prevalence and illness duration from a population of patients with diabetes Type 1(43,818) and Type 2 (457,247). Unlike the usual approach that employs adjusted estimates in similar prevalence reports, this study extracts data from a large number of original clinical documents such as all the outpatient records (6,887,876) issued in Bulgaria to all the 501,065 patients with diabetics during 2018 (9.77% of all the 5,128,172 patients recorded in 2018, 4.43% male and 5.35% female). Diabetes prevalence data are described in terms of distributions of Type 1 and Type 2 diabetes over age and gender. It is mapped to an Observational Medical Outcomes Partnership Common Data Model that is publicly available. The distribution of Type 2 diabetics agrees with peak values of BMI established in related research. A major novelty in this research are the data about the diabetes illness duration. It is an essential metric for evaluating the quality of processes evolving over time. Accurate estimates are obtained for the duration measured in years of Type 1 (95% CI 10.92, 11.08) and Type 2 (95% CI 7.97, 8.02) diabetics from the Bulgarian population. The patients with diabetes Type 1 have longer diabetes duration relatively to those with Type 2. It is recommended to include this metric in official diabetes prevalence reports.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krastev</LastName><ForeName>Evgeniy</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Mathematics and Informatics, Sofia University St. Kliment Ohridsky, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abanos</LastName><ForeName>Simeon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Mathematics and Informatics, Sofia University St. Kliment Ohridsky, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kovachev</LastName><ForeName>Petko</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Mathematics and Informatics, Sofia University St. Kliment Ohridsky, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tcharaktchiev</LastName><ForeName>Dimitar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Medical University, Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002031" MajorTopicYN="N" Type="Geographic">Bulgaria</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="Y">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">illness duration</Keyword><Keyword MajorTopicYN="N">outpatient record</Keyword><Keyword MajorTopicYN="N">population</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>4</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37387004</ArticleId><ArticleId IdType="doi">10.3233/SHTI230470</ArticleId><ArticleId IdType="pii">SHTI230470</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37387019</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>305</Volume><PubDate><Year>2023</Year><Month>Jun</Month><Day>29</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Harmonisation of German Health Care Data Using the OMOP Common Data Model - A Practice Report.</ArticleTitle><Pagination><StartPage>287</StartPage><EndPage>290</EndPage><MedlinePgn>287-290</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230485</ELocationID><Abstract><AbstractText>Data harmonization is an important step in large-scale data analysis and for generating evidence on real world data in healthcare. With the OMOP common data model, a relevant instrument for data harmonization is available that is being promoted by different networks and communities. At the Hannover Medical School (MHH) in Germany, an Enterprise Clinical Research Data Warehouse (ECRDW) is established and harmonization of that data source is the focus of this work. We present MHH's first implementation of the OMOP common data model on top of the ECRDW data source and demonstrate the challenges concerning the mapping of German healthcare terminologies to a standardized format.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hechtel</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Peter L. Reichertz Institute for Medical Informatics, University of Braunschweig - Institute of Technology and Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apfel-Starke</LastName><ForeName>Johanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MHH Information Technology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xf6;hler</LastName><ForeName>Sophia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>MHH Information Technology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fradziak</LastName><ForeName>Maikel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>MHH Information Technology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xf6;nfeld</LastName><ForeName>Norman</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>MHH Information Technology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinmeyer</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MHH Information Technology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oeltze-Jafra</LastName><ForeName>Steffen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Peter L. Reichertz Institute for Medical Informatics, University of Braunschweig - Institute of Technology and Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><MeshHeadingList><MeshHeading><DescriptorName UI="D000078332" MajorTopicYN="Y">Data Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073458" MajorTopicYN="Y">Data Warehousing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006268" MajorTopicYN="N">Health Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012577" MajorTopicYN="N">Schools, Medical</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data Harmonization</Keyword><Keyword MajorTopicYN="N">Data Warehousing</Keyword><Keyword MajorTopicYN="N">Secondary Data Analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>30</Day><Hour>4</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37387019</ArticleId><ArticleId IdType="doi">10.3233/SHTI230485</ArticleId><ArticleId IdType="pii">SHTI230485</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37409312</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-3287</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>JAAD international</Title><ISOAbbreviation>JAAD Int</ISOAbbreviation></Journal><ArticleTitle>Characteristics and treatment pathways in pediatric and adult hidradenitis suppurativa: An examination using real world data.</ArticleTitle><Pagination><StartPage>124</StartPage><EndPage>132</EndPage><MedlinePgn>124-132</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jdin.2023.05.011</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Hidradenitis suppurativa (HS) is a chronic, debilitating, inflammatory disease. Contemporaneous real-world data can be used to elucidate the clinical treatment of pediatric patients and how treatment strategies compare with adult hidradenitis suppurativa patients.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The objective of this study is to evaluate clinical and treatment characteristics of pediatric and adult HS patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">HS adult and pediatric patients were identified in 3 the United States administrative claims databases during the study period between 2016 to 2021. Patients were required to have 2 diagnostic codes for HS and have at least 365 days of prior observation time to the first HS diagnosis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Pediatric and adult HS treatments were similar. The proportions of subjects treated with topical and oral antibiotic or oral antibiotic alone or topical medication alone or surgery alone covered 90% of the treated pediatric subjects and 91% of treated adult subjects. The remaining proportion of subjects received other treatment combinations.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="UNASSIGNED">The databases represent subjects with commercial or government insurance coverage and thus do not necessarily represent the broader US population. The databases do not capture information about medications obtained without insurance.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Although subtle differences exist, this study confirms that topical and systemic therapeutic treatment of HS in adults and adolescents is very similar.</AbstractText><CopyrightInformation>&#xa9; 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hardin</LastName><ForeName>Jill</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makadia</LastName><ForeName>Rupa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Raritan, New Jersey.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics (OHDSI), New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Shawn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Spring House, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lara-Corrales</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>The Hospital for Sick Children, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Lucia Z</ForeName><Initials>LZ</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The University of Texas at Austin, Austin, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirby</LastName><ForeName>Joslyn S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Pennsylvania State University, Hershey, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DeKlotz</LastName><ForeName>Cynthia M C</ForeName><Initials>CMC</Initials><AffiliationInfo><Affiliation>Janssen Research and Development, Spring House, Pennsylvania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAAD Int</MedlineTA><NlmUniqueID>101774762</NlmUniqueID><ISSNLinking>2666-3287</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">hidradenitis suppurativa</Keyword><Keyword MajorTopicYN="N">medical dermatology</Keyword><Keyword MajorTopicYN="N">observational data</Keyword><Keyword MajorTopicYN="N">pediatric dermatology</Keyword><Keyword MajorTopicYN="N">pharmacoepidemiology</Keyword><Keyword MajorTopicYN="N">real-world data</Keyword></KeywordList><CoiStatement>Drs Hardin, Makadia, Black, and DeKlotz are employees of Janssen Research &amp; Development, LLC, and may own stock and/or stock options. The work on this study was part of their employment. Drs Lara-Corrales, Diaz, and Kirby report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>4</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37409312</ArticleId><ArticleId IdType="pmc">PMC10319301</ArticleId><ArticleId IdType="doi">10.1016/j.jdin.2023.05.011</ArticleId><ArticleId IdType="pii">S2666-3287(23)00084-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cosmatos I., Matcho A., Weinstein R., Montgomery M.O., Stang P. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2013;68(3):412&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">22921795</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis S.A., Lin H.C., Balkrishnan R., Feldman S.R. Hidradenitis suppurativa management in the United States: an analysis of the National Ambulatory Medical Care Survey and MarketScan Medicaid Databases. Skin Appendage Disord. 2015;1(2):65&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4857854</ArticleId><ArticleId IdType="pubmed">27172455</ArticleId></ArticleIdList></Reference><Reference><Citation>Marvel J., Vlahiotis A., Sainski-Nguyen A., Willson T., Kimball A. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data. BMJ Open. 2019;9(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6797383</ArticleId><ArticleId IdType="pubmed">31575575</ArticleId></ArticleIdList></Reference><Reference><Citation>Alikhan A., Lynch P.J., Eisen D.B. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60(4):539&#x2013;561. quiz 62-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">19293006</ArticleId></ArticleIdList></Reference><Reference><Citation>Liy-Wong C., Pope E., Lara-Corrales I. Hidradenitis suppurativa in the pediatric population. J Am Acad Dermatol. 2015;73(5 suppl 1):S36&#x2013;S41.</Citation><ArticleIdList><ArticleId IdType="pubmed">26470613</ArticleId></ArticleIdList></Reference><Reference><Citation>Liy-Wong C., Kim M., Kirkorian A.Y., et al. Hidradenitis suppurativa in the pediatric population: an international, multicenter, retrospective, cross-sectional study of 481 pediatric patients. JAMA Dermatol. 2021;157(4):385&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7905696</ArticleId><ArticleId IdType="pubmed">33625473</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiri H., Jokelainen J., Timonen M., Tasanen K., Huilaja L. Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents. J Am Acad Dermatol. 2018;79(3):514&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">29518461</ArticleId></ArticleIdList></Reference><Reference><Citation>Misitzis A., Goldust M., Jafferany M., Lotti T. Psychiatric comorbidities in patients with hidradenitis suppurativa. Dermatol Ther. 2020;33(4)</Citation><ArticleIdList><ArticleId IdType="pubmed">32385861</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel Z.S., Hoffman L.K., Buse D.C., et al. Pain, psychological comorbidities, disability, and Impaired quality of life in hidradenitis suppurativa [corrected] Curr Pain Headache Rep. 2017;21(12):49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5784845</ArticleId><ArticleId IdType="pubmed">29094219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunger R.E., Laffitte E., L&#xe4;uchli S., et al. Swiss practice recommendations for the management of hidradenitis suppurativa/acne inversa. Dermatology. 2017;233(2-3):113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">28683447</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulliver W., Zouboulis C.C., Prens E., Jemec G.B., Tzellos T. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord. 2016;17(3):343&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5156664</ArticleId><ArticleId IdType="pubmed">26831295</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimball A.B., Okun M.M., Williams D.A., et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016;375(5):422&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">27518661</ArticleId></ArticleIdList></Reference><Reference><Citation>Zouboulis C.C., Desai N., Emtestam L., et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29(4):619&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pubmed">25640693</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosales Santillan M., Morss P.C., Porter M.L., Kimball A.B. Biologic therapies for the treatment of hidradenitis suppurativa. Expert Opin Biol Ther. 2020;20(6):621&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">32077334</ArticleId></ArticleIdList></Reference><Reference><Citation>Orenstein L.A.V., Nguyen T.V., Damiani G., Sayed C., Jemec G.B.E., Hamzavi I. Medical and surgical management of hidradenitis suppurativa: a review of international treatment guidelines and implementation in general dermatology practice. Dermatology. 2020;236(5):393&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8177083</ArticleId><ArticleId IdType="pubmed">32408306</ArticleId></ArticleIdList></Reference><Reference><Citation>Flood K.S., Porter M.L., Kimball A.B. Biologic treatment for hidradenitis suppurativa. Am J Clin Dermatol. 2019;20(5):625&#x2013;638.</Citation><ArticleIdList><ArticleId IdType="pubmed">31140067</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A., Naik H.B., Alavi A., et al. Real-world findings on the characteristics and treatment exposures of patients with hidradenitis suppurativa from US claims data. Dermatol Ther (Heidelb) 2023;13(2):581&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9884733</ArticleId><ArticleId IdType="pubmed">36585607</ArticleId></ArticleIdList></Reference><Reference><Citation>Zouboulis C.C., Bechara F.G., Dickinson-Blok J.L., et al. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group. J Eur Acad Dermatol Venereol. 2019;33(1):19&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6587546</ArticleId><ArticleId IdType="pubmed">30176066</ArticleId></ArticleIdList></Reference><Reference><Citation>Alikhan A., Sayed C., Alavi A., et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part II: topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81(1):91&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9131892</ArticleId><ArticleId IdType="pubmed">30872149</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Medicare &amp; Medicaid Services  Who Enrolls in Medicaid &amp; CHIP? https://www.medicaid.gov/state-overviews/scorecard/who-enrolls-medicaid-chip/index.html</Citation></Reference><Reference><Citation>Voss E.A., Makadia R., Matcho A., Ma Q., Knoll C., Schuemie M., et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(3):553&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardin J., Murray G., Swerdel J. Phenotype algorithms to identify hidradenitis suppurativa using real-world data: development and validation study. JMIR Dermatol. 2022;5(4)</Citation></Reference><Reference><Citation>Austin P. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009;38:1228&#x2013;1234.</Citation></Reference><Reference><Citation>Prens E.P., Lugo-Somolinos A.M., Paller A.S., et al. Baseline characteristics from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa (acne inversa) in clinical practice. Am J Clin Dermatol. 2020;21(4):579&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371670</ArticleId><ArticleId IdType="pubmed">32077014</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallock K.K., Mizerak M.R., Dempsey A., Maczuga S., Kirby J.S. Differences between children and adults with hidradenitis suppurativa. JAMA Dermatol. 2021;157(9):1095&#x2013;1101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8358812</ArticleId><ArticleId IdType="pubmed">34379074</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37414703</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-7560</ISSN><JournalIssue CitedMedium="Internet"><Volume>85</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>European urology</Title><ISOAbbreviation>Eur Urol</ISOAbbreviation></Journal><ArticleTitle>Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data.</ArticleTitle><Pagination><StartPage>457</StartPage><EndPage>465</EndPage><MedlinePgn>457-465</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eururo.2023.06.012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0302-2838(23)02944-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Conservative management is an option for prostate cancer (PCa) patients either with the objective of delaying or even avoiding curative therapy, or to wait until palliative treatment is needed. PIONEER, funded by the European Commission Innovative Medicines Initiative, aims at improving PCa care across Europe through the application of big data analytics.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To describe the clinical characteristics and long-term outcomes of PCa patients on conservative management by using an international large network of real-world data.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="METHODS">From an initial cohort of &gt;100&#xa0;000&#xa0;000 adult individuals included in eight databases evaluated during a virtual study-a-thon hosted by PIONEER, we identified newly diagnosed PCa cases (n&#xa0;=&#xa0;527&#xa0;311). Among those, we selected patients who did not receive curative or palliative treatment within 6 mo from diagnosis (n&#xa0;=&#xa0;123&#xa0;146).</AbstractText><AbstractText Label="OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS" NlmCategory="METHODS">Patient and disease characteristics were reported. The number of patients who experienced the main study outcomes was quantified for each stratum and the overall cohort. Kaplan-Meier analyses were used to estimate the distribution of time to event data.</AbstractText><AbstractText Label="RESULTS AND LIMITATIONS" NlmCategory="CONCLUSIONS">The most common comorbidities were hypertension (35-73%), obesity (9.2-54%), and type 2 diabetes (11-28%). The rate of PCa-related symptomatic progression ranged between 2.6% and 6.2%. Hospitalization (12-25%) and emergency department visits (10-14%) were common events during the 1st year of follow-up. The probability of being free from both palliative and curative treatments decreased during follow-up. Limitations include a lack of information on patients and disease characteristics and on treatment intent.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results allow us to better understand the current landscape of patients with PCa managed with conservative treatment. PIONEER offers a unique opportunity to characterize the baseline features and outcomes of PCa patients managed conservatively using real-world data.</AbstractText><AbstractText Label="PATIENT SUMMARY" NlmCategory="RESULTS">Up to 25% of men with prostate cancer (PCa) managed conservatively experienced hospitalization and emergency department visits within the 1st year after diagnosis; 6% experienced PCa-related symptoms. The probability of receiving therapies for PCa decreased according to time elapsed after the diagnosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gandaglia</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: Gandaglia.giorgio@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellegrino</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Golozar</LastName><ForeName>Asieh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Odysseus Data Services, New York, NY, USA; OHDSI Center, Northeastern University, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Meulder</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Association EISBM, Vourles, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbott</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Astellas Pharma, Inc., Northbrook, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Achtman</LastName><ForeName>Ariel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Movember Foundation, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Imran Omar</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Academic Urology Unit, University of Aberdeen, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Thamir</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Riyadh Elm University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Areia</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asiimwe</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beyer</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Translational Oncology and Urology Research, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bjartell</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Translational Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campi</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cornford</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Liverpool University Hospitals, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Astellas Pharma, Inc., Northbrook, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mengchun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nanfang Hospital, Southern Medical University, Guangzhou, China; DHC Technologies, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrera</LastName><ForeName>Ronald</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>Nigel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Epidemiology, Janssen R&amp;D, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hulsen</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Philips Research, Department of Hospital Services &amp; Informatics, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinnaird</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of Alberta, Edmonton, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Lana Y H</ForeName><Initials>LYH</Initials><AffiliationInfo><Affiliation>University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maresca</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Urology, NHS Grampian, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mottet</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oja</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Computer Science, University of Tartu, Tartu, Estonia; STACC, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prinsen</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Netherlands Comprehensive Cancer Organization, Eindhoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IQVIA, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remmers</LastName><ForeName>Sebastiaan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Erasmus University Medical Centre, Cancer Institute, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roobol</LastName><ForeName>Monique J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Erasmus University Medical Centre, Cancer Institute, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakalis</LastName><ForeName>Vasileios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Urology, General Hospital of Thessaloniki Agios Pavlos, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seager</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>RWS, IQVIA, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Emma J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snijder</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Astellas Pharma, Inc., Northbrook, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinbeisser</LastName><ForeName>Carl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thurin</LastName><ForeName>Nicolas H</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>INSERM CIC-P 1401, Bordeaux PharmacoEpi, Universit&#xe9; de Bordeaux, Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hijazy</LastName><ForeName>Ayman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Association EISBM, Vourles, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Bochove</LastName><ForeName>Kees</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>The Hyve, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van den Bergh</LastName><ForeName>Roderick C N</ForeName><Initials>RCN</Initials><AffiliationInfo><Affiliation>St Antonius Hospital, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Hemelrijck</LastName><ForeName>Mieke</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Translational Oncology and Urology Research, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Willemse</LastName><ForeName>Peter-Paul</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Department of Urology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Andrew E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>The Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zounemat Kermani</LastName><ForeName>Nazanin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Computing, Data Science Institute, Imperial College London, London, England.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Evans-Axelsson</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bayer AG, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briganti</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Department of Urology and Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N'Dow</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Guidelines Office, European Association of Urology, Arnhem, The Netherlands; Academic Urology Unit, University of Aberdeen, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PIONEER Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Eur Urol</MedlineTA><NlmUniqueID>7512719</NlmUniqueID><ISSNLinking>0302-2838</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077558" MajorTopicYN="N">Big Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="Y">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Big data</Keyword><Keyword MajorTopicYN="N">Conservative management</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">PIONEER</Keyword><Keyword MajorTopicYN="N">Prostate cancer</Keyword><Keyword MajorTopicYN="N">Survival</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>16</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>7</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>6</Day><Hour>22</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37414703</ArticleId><ArticleId IdType="doi">10.1016/j.eururo.2023.06.012</ArticleId><ArticleId IdType="pii">S0302-2838(23)02944-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37418391</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>7</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Learning important common data elements from shared study data: The All of Us program analysis.</ArticleTitle><Pagination><StartPage>e0283601</StartPage><MedlinePgn>e0283601</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0283601</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0283601</ELocationID><Abstract><AbstractText>There are many initiatives attempting to harmonize data collection across human clinical studies using common data elements (CDEs). The increased use of CDEs in large prior studies can guide researchers planning new studies. For that purpose, we analyzed the All of Us (AoU) program, an ongoing US study intending to enroll one million participants and serve as a platform for numerous observational analyses. AoU adopted the OMOP Common Data Model to standardize both research (Case Report Form [CRF]) and real-world (imported from Electronic Health Records [EHRs]) data. AoU standardized specific data elements and values by including CDEs from terminologies such as LOINC and SNOMED CT. For this study, we defined all elements from established terminologies as CDEs and all custom concepts created in the Participant Provided Information (PPI) terminology as unique data elements (UDEs). We found 1 033 research elements, 4 592 element-value combinations and 932 distinct values. Most elements were UDEs (869, 84.1%), while most CDEs were from LOINC (103 elements, 10.0%) or SNOMED CT (60, 5.8%). Of the LOINC CDEs, 87 (53.1% of 164 CDEs) originated from previous data collection initiatives, such as PhenX (17 CDEs) and PROMIS (15 CDEs). On a CRF level, The Basics (12 of 21 elements, 57.1%) and Lifestyle (10 of 14, 71.4%) were the only CRFs with multiple CDEs. On a value level, 61.7% of distinct values are from an established terminology. AoU demonstrates the use of the OMOP model for integrating research and routine healthcare data (64 elements in both contexts), which allows for monitoring lifestyle and health changes outside the research setting. The increased inclusion of CDEs in large studies (like AoU) is important in facilitating the use of existing tools and improving the ease of understanding and analyzing the data collected, which is more challenging when using study specific formats.</AbstractText><CopyrightInformation>Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mayer</LastName><ForeName>Craig S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0002-2705-9550</Identifier><AffiliationInfo><Affiliation>Lister Hill National Center for Biomedical Communication, National Library of Medicine, NIH, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huser</LastName><ForeName>Vojtech</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Lister Hill National Center for Biomedical Communication, National Library of Medicine, NIH, Bethesda, Maryland, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>OT2 OD026556</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U2C OD023196</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD025315</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026551</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 OD023121</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026552</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026549</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD025337</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD025277</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026555</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026550</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026553</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD023205</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD025276</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026557</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026554</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 OD023163</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD023206</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 OD023176</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026548</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065709" MajorTopicYN="Y">Common Data Elements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075485" MajorTopicYN="Y">Population Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039061" MajorTopicYN="N">Systematized Nomenclature of Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>NO authors have competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>7</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>7</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37418391</ArticleId><ArticleId IdType="pmc">PMC10328251</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0283601</ArticleId><ArticleId IdType="pii">PONE-D-21-40725</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sheehan J, Hirschfeld S, Foster E, Ghitza U, Goetz K, Karpinski J, et al.. Improving the value of clinical research through the use of Common Data Elements. Clin Trials Lond Engl. 2016;13(6):671&#x2013;6. doi: 10.1177/1740774516653238</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1740774516653238</ArticleId><ArticleId IdType="pmc">PMC5133155</ArticleId><ArticleId IdType="pubmed">27311638</ArticleId></ArticleIdList></Reference><Reference><Citation>Huser V, Amos L. Analyzing Real-World Use of Research Common Data Elements. AMIA Annu Symp Proc AMIA Symp. 2018;2018:602&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6371255</ArticleId><ArticleId IdType="pubmed">30815101</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health (NIH) | National Institutes of Health (NIH)&#x2014;All of Us [Internet]. [cited 2021 Nov 29]. https://allofus.nih.gov/</Citation></Reference><Reference><Citation>All of Us Research Program Investigators, Denny JC, Rutter JL, Goldstein DB, Philippakis A, Smoller JW, et al.. The &#x201c;All of Us&#x201d; Research Program. N Engl J Med. 2019. 15;381(7):668&#x2013;76. doi: 10.1056/NEJMsr1809937</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr1809937</ArticleId><ArticleId IdType="pmc">PMC8291101</ArticleId><ArticleId IdType="pubmed">31412182</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner SP, Pompea ST, Williams KL, Kraemer DA, Sholle ET, Chen C, et al.. Implementation of Informatics to Support the NIH All of Us Research Program in a Healthcare Provider Organization. AMIA Jt Summits Transl Sci Proc AMIA Jt Summits Transl Sci. 2019;2019:602&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6568061</ArticleId><ArticleId IdType="pubmed">31259015</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronin RM, Jerome RN, Mapes B, Andrade R, Johnston R, Ayala J, et al.. Development of the Initial Surveys for the All of Us Research Program. Epidemiol Camb Mass. 2019. Jul;30(4):597&#x2013;608. doi: 10.1097/EDE.0000000000001028</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000001028</ArticleId><ArticleId IdType="pmc">PMC6548672</ArticleId><ArticleId IdType="pubmed">31045611</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI. OHDSI GIthub repository for OMOP Athena Vocabulary: PPI vocabulary [Internet]. GitHub. [cited 2021 Jan 13]. https://github.com/OHDSI/Vocabulary-v5.0</Citation></Reference><Reference><Citation>Mayer CS, Williams N, Huser V. Analysis of data dictionary formats of HIV clinical trials. PloS One. 2020;15(10):e0240047. doi: 10.1371/journal.pone.0240047</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240047</ArticleId><ArticleId IdType="pmc">PMC7535029</ArticleId><ArticleId IdType="pubmed">33017454</ArticleId></ArticleIdList></Reference><Reference><Citation>cmayer2. r4aou [Internet]. 2021 [cited 2021 Nov 30]. https://github.com/cmayer2/r4aou</Citation></Reference><Reference><Citation>CRI/AoU/CDE at master &#xb7; lhncbc/CRI &#xb7; GitHub [Internet]. [cited 2021 Oct 29]. https://github.com/lhncbc/CRI/tree/master/AoU/CDE</Citation></Reference><Reference><Citation>dbGaP Study [Internet]. [cited 2021 Oct 27]. https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000007.v32.p13</Citation></Reference><Reference><Citation>ATLAS: Home [Internet]. [cited 2021 Nov 5]. https://atlas-demo.ohdsi.org/#/home</Citation></Reference><Reference><Citation>OHDSI/Achilles: Automated Characterization of Health Information at Large-scale Longitudinal Evidence Systems (ACHILLES)&#x2014;descriptive statistics about a OMOP CDM database [Internet]. [cited 2021 Nov 5]. https://github.com/OHDSI/Achilles</Citation></Reference><Reference><Citation>Codesystem-data-absent-reason&#x2014;FHIR v4.0.1 [Internet]. [cited 2021 Jan 25]. http://hl7.org/fhir/codesystem-data-absent-reason.html#data-absent-reason-asked-declined</Citation></Reference><Reference><Citation>Lifestyle.pdf [Internet]. [cited 2021 Nov 8]. https://www.researchallofus.org/wp-content/themes/research-hub-wordpress-theme/media/2019/02/Lifestyle.pdf</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37442314</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>144</Volume><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Eos and OMOCL: Towards a seamless integration of openEHR records into the OMOP Common Data Model.</ArticleTitle><Pagination><StartPage>104437</StartPage><MedlinePgn>104437</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2023.104437</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(23)00158-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">The reuse of data from electronic health records (EHRs) for research purposes promises to improve the data foundation for clinical trials and may even support to enable them. Nevertheless, EHRs are characterized by both, heterogeneous structure and semantics. To standardize this data for research, the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) standard has recently seen an increase in use. However, the conversion of these EHRs into the OMOP CDM requires complex and resource intensive Extract Transform and Load (ETL) processes. This hampers the reuse of clinical data for research. To solve the issues of heterogeneity of EHRs and the lack of semantic precision on the care site, the openEHR standard has recently seen wider adoption. A standardized process to integrate openEHR records into the CDM potentially lowers the barriers of making EHRs accessible for research. Yet, a comprehensive approach about the integration of openEHR records into the OMOP CDM has not yet been made.</AbstractText><AbstractText Label="METHODS">We analyzed both standards and compared their models to identify possible mappings. Based on this, we defined the necessary processes to transform openEHR records into CDM tables. We also discuss the limitation of openEHR with its unspecific demographics model and propose two possible solutions.</AbstractText><AbstractText Label="RESULTS">We developed the OMOP Conversion Language (OMOCL) which enabled us to define a declarative openEHR archetype-to-CDM mapping language. Using OMOCL, it was possible to define a set of mappings. As a proof-of-concept, we implemented the Eos tool, which uses the OMOCL-files to successfully automatize the ETL from real-world and sample EHRs into the OMOP CDM.</AbstractText><AbstractText Label="DISCUSSION">Both Eos and OMOCL provide a way to define generic mappings for an integration of openEHR records into OMOP. Thus, it represents a significant step towards achieving interoperability between the clinical and the research data domains. However, the transformation of openEHR data into the less expressive OMOP CDM leads to a loss of semantics.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kohler</LastName><ForeName>Severin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Berlin Institute of Health at Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Digital Health Center, Kapelle-Ufer 2, 10117 Berlin, Germany. Electronic address: severin.kohler@bih-charite.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosc&#xe1;</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>VeraTech for Health, Avenida del Puerto 237 - Puerta 1, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xe4;rcher</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Health Data Science Unit, Heidelberg University Hospital and BioQuant, Im Neuenheimer Feld 267, 69120 Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haarbrandt</LastName><ForeName>Birger</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Peter L. Reichertz Institute for Medical Informatics of TU Braunschweig and Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prinz</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Leibniz Information Centre for Science and Technology, Welfengarten 1 B, 30167 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marschollek</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Peter L. Reichertz Institute for Medical Informatics of TU Braunschweig and Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eils</LastName><ForeName>Roland</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Berlin Institute of Health at Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Digital Health Center, Kapelle-Ufer 2, 10117 Berlin, Germany; Health Data Science Unit, Heidelberg University Hospital and BioQuant, Im Neuenheimer Feld 267, 69120 Heidelberg, Germany. Electronic address: roland.eils@charite.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012660" MajorTopicYN="Y">Semantics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012015" MajorTopicYN="N">Reference Standards</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EHR</Keyword><Keyword MajorTopicYN="N">ETL</Keyword><Keyword MajorTopicYN="N">OHDSI</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">OpenEHR</Keyword><Keyword MajorTopicYN="N">Secondary use</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>13</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37442314</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2023.104437</ArticleId><ArticleId IdType="pii">S1532-0464(23)00158-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37447187</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>13</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>24</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Association of Serum Vitamin D Level with Temporomandibular Disorder Incidence: A Retrospective, Multi-Center Cohort Study Using Six Hospital Databases.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2860</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu15132860</ELocationID><Abstract><AbstractText>The relationship between serum vitamin D levels and temporomandibular disorders (TMDs) remains unclear. Therefore, this study aimed to investigate the association between serum 25-hydroxyvitamin D (25[OH]D) levels and TMD incidence using large-scale health data. Clinical data from the electronic health records of six secondary or tertiary hospitals in Korea were used to evaluate the relationship between serum 25(OH)D levels and TMD incidence. The data were converted to the Observational Medical Outcomes Partnership Common Data Model. A cohort study was designed using the Cox proportional hazards model to examine the hazard ratio (HR) of TMD development after propensity score matching (PSM). An aggregate meta-analysis of the HR was subsequently performed. After 1:4 PSM, a target group with deficient 25(OH)D levels (&lt;20 ng/mL) (N = 34,560) and comparator group with non-deficient 25(OH)D levels (&#x2265;20 ng/mL) (N = 47,359) were pooled from six hospital databases. HR meta-analysis demonstrated a significant association between deficient 25(OH)D levels and TMD incidence (pooled HR: 1.50; 95% confidence interval: 1.07-2.12). In conclusion, deficient 25(OH)D levels were found to be associated with an increased TMD risk. Therefore, vitamin D deficiency is a potential risk factor for TMD development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Im</LastName><ForeName>Yeong-Gwan</ForeName><Initials>YG</Initials><Identifier Source="ORCID">0000-0003-2703-1475</Identifier><AffiliationInfo><Affiliation>Department of Oral Medicine, Dental Science Research Institute, School of Dentistry, Chonnam National University, Gwangju 61186, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Man-Yong</ForeName><Initials>MY</Initials><Identifier Source="ORCID">0000-0002-9077-5779</Identifier><AffiliationInfo><Affiliation>Departments of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13496, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baek</LastName><ForeName>Hey-Sung</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul 05355, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="Y">Vitamin D</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014808" MajorTopicYN="Y">Vitamin D Deficiency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Vitamin D</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">temporomandibular disorders</Keyword></KeywordList><CoiStatement>There are no financial or other issues that might lead to conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>1</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37447187</ArticleId><ArticleId IdType="pmc">PMC10343618</ArticleId><ArticleId IdType="doi">10.3390/nu15132860</ArticleId><ArticleId IdType="pii">nu15132860</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007;357:266&#x2013;281. doi: 10.1056/NEJMra070553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra070553</ArticleId><ArticleId IdType="pubmed">17634462</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen C.J., Adams J.S., Bikle D.D., Black D.M., Demay M.B., Manson J.E., Murad M.H., Kovacs C.S. The nonskeletal effects of vitamin D: An Endocrine Society scientific statement. Endocr. Rev. 2012;33:456&#x2013;492. doi: 10.1210/er.2012-1000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2012-1000</ArticleId><ArticleId IdType="pmc">PMC3365859</ArticleId><ArticleId IdType="pubmed">22596255</ArticleId></ArticleIdList></Reference><Reference><Citation>Pludowski P., Holick M.F., Pilz S., Wagner C.L., Hollis B.W., Grant W.B., Shoenfeld Y., Lerchbaum E., Llewellyn D.J., Kienreich K., et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun. Rev. 2013;12:976&#x2013;989. doi: 10.1016/j.autrev.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2013.02.004</ArticleId><ArticleId IdType="pubmed">23542507</ArticleId></ArticleIdList></Reference><Reference><Citation>Garland C.F., Mohr S.B., Gorham E.D., Grant W.B., Garland F.C. Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer. Am. J. Prev. Med. 2006;31:512&#x2013;514. doi: 10.1016/j.amepre.2006.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2006.08.018</ArticleId><ArticleId IdType="pubmed">17169713</ArticleId></ArticleIdList></Reference><Reference><Citation>Lips P. Vitamin D physiology. Prog. Biophys. Mol. Biol. 2006;92:4&#x2013;8. doi: 10.1016/j.pbiomolbio.2006.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2006.02.016</ArticleId><ArticleId IdType="pubmed">16563471</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen H.C., Samson M.M., Verhaar H.J. Vitamin D deficiency, muscle function, and falls in elderly people. Am. J. Clin. Nutr. 2002;75:611&#x2013;615. doi: 10.1093/ajcn/75.4.611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/75.4.611</ArticleId><ArticleId IdType="pubmed">11916748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceglia L., Harris S.S. Vitamin D and its role in skeletal muscle. Calcif. Tissue Int. 2013;92:151&#x2013;162. doi: 10.1007/s00223-012-9645-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-012-9645-y</ArticleId><ArticleId IdType="pubmed">22968766</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol. Aspects Med. 2008;29:407&#x2013;414. doi: 10.1016/j.mam.2008.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2008.07.002</ArticleId><ArticleId IdType="pubmed">18727936</ArticleId></ArticleIdList></Reference><Reference><Citation>Plotnikoff G.A., Quigley J.M. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin. Proc. 2003;78:1463&#x2013;1470. doi: 10.4065/78.12.1463.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/78.12.1463</ArticleId><ArticleId IdType="pubmed">14661675</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimalawansa S.J. Non-musculoskeletal benefits of vitamin D. J. Steroid Biochem. Mol. Biol. 2018;175:60&#x2013;81. doi: 10.1016/j.jsbmb.2016.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2016.09.016</ArticleId><ArticleId IdType="pubmed">27662817</ArticleId></ArticleIdList></Reference><Reference><Citation>De Leeuw R., Klasser G.D. Orofacial Pain: Guidelines for Assessment, Diagnosis, and Management. 5th ed. Quintessence; Hanover Park, IL, USA: 2013. Chapter 8. Diagnosis and management of TMDs.</Citation></Reference><Reference><Citation>Schiffman E., Ohrbach R., Truelove E., Look J., Anderson G., Goulet J.P., List T., Svensson P., Gonzalez Y., Lobbezoo F., et al. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: Recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Groupdagger. J. Oral Facial Pain Headache. 2014;28:6&#x2013;27. doi: 10.11607/jop.1151.</Citation><ArticleIdList><ArticleId IdType="doi">10.11607/jop.1151</ArticleId><ArticleId IdType="pmc">PMC4478082</ArticleId><ArticleId IdType="pubmed">24482784</ArticleId></ArticleIdList></Reference><Reference><Citation>Manfredini D., Guarda-Nardini L., Winocur E., Piccotti F., Ahlberg J., Lobbezoo F. Research diagnostic criteria for temporomandibular disorders: A systematic review of axis I epidemiologic findings. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2011;112:453&#x2013;462. doi: 10.1016/j.tripleo.2011.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tripleo.2011.04.021</ArticleId><ArticleId IdType="pubmed">21835653</ArticleId></ArticleIdList></Reference><Reference><Citation>Slade G.D., Fillingim R.B., Sanders A.E., Bair E., Greenspan J.D., Ohrbach R., Dubner R., Diatchenko L., Smith S.B., Knott C., et al. Summary of findings from the OPPERA prospective cohort study of incidence of first-onset temporomandibular disorder: Implications and future directions. J. Pain. 2013;14:T116&#x2013;T124. doi: 10.1016/j.jpain.2013.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2013.09.010</ArticleId><ArticleId IdType="pmc">PMC3857103</ArticleId><ArticleId IdType="pubmed">24275219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindler S., Samietz S., Houshmand M., Grabe H.J., Bernhardt O., Biffar R., Kocher T., Meyer G., Volzke H., Metelmann H.R., et al. Depressive and anxiety symptoms as risk factors for temporomandibular joint pain: A prospective cohort study in the general population. J. Pain. 2012;13:1188&#x2013;1197. doi: 10.1016/j.jpain.2012.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2012.09.004</ArticleId><ArticleId IdType="pubmed">23141187</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelotti A., Iodice G. The role of orthodontics in temporomandibular disorders. J. Oral Rehabil. 2010;37:411&#x2013;429. doi: 10.1111/j.1365-2842.2010.02087.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2842.2010.02087.x</ArticleId><ArticleId IdType="pubmed">20406353</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalladka M., Young A., Thomas D., Heir G.M., Quek S.Y.P., Khan J. The relation of temporomandibular disorders and dental occlusion: A narrative review. Quintessence Int. 2022;53:450&#x2013;459. doi: 10.3290/j.qi.b2793201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3290/j.qi.b2793201</ArticleId><ArticleId IdType="pubmed">35274511</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemati M., Tabrizi R., Rasooli F., Ghafari S. Is the Prevalence of Vitamin D deficiency in Patients with Temporomandibular Disorder Higher than Healthy Control Group? J. Maxillofac. Oral Surg. 2022;21:1205&#x2013;1208. doi: 10.1007/s12663-021-01522-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12663-021-01522-3</ArticleId><ArticleId IdType="pmc">PMC9989067</ArticleId><ArticleId IdType="pubmed">36896049</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrillo M., Migliario M., Marotta N., Fortunato F., Bindi M., Pezzotti F., Ammendolia A., Giudice A., Foglio Bonda P.L., de Sire A. Temporomandibular disorders and neck pain in primary headache patients: A retrospective machine learning study. Acta Odontol. Scand. 2023;81:151&#x2013;157. doi: 10.1080/00016357.2022.2105945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00016357.2022.2105945</ArticleId><ArticleId IdType="pubmed">35906722</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayouni I., Chebbi R., Hela Z., Dhidah M. Comorbidity between fibromyalgia and temporomandibular disorders: A systematic review. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2019;128:33&#x2013;42. doi: 10.1016/j.oooo.2019.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.oooo.2019.02.023</ArticleId><ArticleId IdType="pubmed">30981530</ArticleId></ArticleIdList></Reference><Reference><Citation>Minervini G., Mariani P., Fiorillo L., Cervino G., Cicciu M., Laino L. Prevalence of temporomandibular disorders in people with multiple sclerosis: A systematic review and meta-analysis. Cranio. 2022:1&#x2013;9. doi: 10.1080/08869634.2022.2137129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08869634.2022.2137129</ArticleId><ArticleId IdType="pubmed">36315017</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieckiewicz M., Boening K., Wiland P., Shiau Y.Y., Paradowska-Stolarz A. Reported concepts for the treatment modalities and pain management of temporomandibular disorders. J. Headache Pain. 2015;16:106. doi: 10.1186/s10194-015-0586-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-015-0586-5</ArticleId><ArticleId IdType="pmc">PMC4671990</ArticleId><ArticleId IdType="pubmed">26644030</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M., Cai J., Yu Y., Hu S., Wang Y., Wu M. Therapeutic Agents for the Treatment of Temporomandibular Joint Disorders: Progress and Perspective. Front. Pharmacol. 2020;11:596099. doi: 10.3389/fphar.2020.596099.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.596099</ArticleId><ArticleId IdType="pmc">PMC7878564</ArticleId><ArticleId IdType="pubmed">33584275</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrillo M., Lippi L., Giudice A., Calafiore D., Paolucci T., Reno F., Migliario M., Fortunato L., Invernizzi M., de Sire A. Temporomandibular Disorders and Vitamin D Deficiency: What Is the Linkage between These Conditions? A Systematic Review. J. Clin. Med. 2022;11:6231. doi: 10.3390/jcm11216231.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11216231</ArticleId><ArticleId IdType="pmc">PMC9655046</ArticleId><ArticleId IdType="pubmed">36362456</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildiz S., Tumer M.K., Yigit S., Nursal A.F., Rustemoglu A., Balel Y. Relation of vitamin D and BsmI variant with temporomandibular diseases in the Turkish population. Br. J. Oral Maxillofac. Surg. 2021;59:555&#x2013;560. doi: 10.1016/j.bjoms.2020.08.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjoms.2020.08.101</ArticleId><ArticleId IdType="pubmed">33863594</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S.W., Kang J.H. Bone mineral density, bone microstructure, and bone turnover markers in females with temporomandibular joint osteoarthritis. Clin. Oral Investig. 2021;25:6435&#x2013;6448. doi: 10.1007/s00784-021-03946-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00784-021-03946-0</ArticleId><ArticleId IdType="pubmed">33864149</ArticleId></ArticleIdList></Reference><Reference><Citation>Madani A., Shamsian S.A., Layegh P., Abrisham S.M., Ravaghi A., Tayarani Najjaran N. Are certain factors involved in calcium metabolism associated with temporomandibular disorders? Cranio. 2021;39:202&#x2013;208. doi: 10.1080/08869634.2019.1596054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08869634.2019.1596054</ArticleId><ArticleId IdType="pubmed">30931843</ArticleId></ArticleIdList></Reference><Reference><Citation>Demir C.Y., Ersoz M.E. Biochemical changes associated with temporomandibular disorders. J. Int. Med. Res. 2019;47:765&#x2013;771. doi: 10.1177/0300060518811009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060518811009</ArticleId><ArticleId IdType="pmc">PMC6381509</ArticleId><ArticleId IdType="pubmed">30465456</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz A.D., Yazicioglu D., Tuzuner Oncul A.M., Yilmaz E., Eres G. Vitamin D receptor gene polymorphisms (Apa1 and Taq1) in temporomandibular joint internal derangement/osteoarthritis in a group of Turkish patients. Mol. Biol. Rep. 2018;45:1839&#x2013;1848. doi: 10.1007/s11033-018-4330-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-018-4330-5</ArticleId><ArticleId IdType="pubmed">30155592</ArticleId></ArticleIdList></Reference><Reference><Citation>Staniszewski K., Lygre H., Berge T., Rosen A. Serum Analysis in Patients with Temporomandibular Disorders: A Controlled Cross-Sectional Study in Norway. Pain Res. Manag. 2019;2019:1360725. doi: 10.1155/2019/1360725.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/1360725</ArticleId><ArticleId IdType="pmc">PMC6800918</ArticleId><ArticleId IdType="pubmed">31687055</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., Duke J.D., Shah N.H., Reich C.G., Huser V., Schuemie M.J., Suchard M.A., Park R.W., Wong I.C., Rijnbeek P.R., et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud. Health Technol. Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzHenry F., Resnic F.S., Robbins S.L., Denton J., Nookala L., Meeker D., Ohno-Machado L., Matheny M.E. Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership. Appl. Clin. Inform. 2015;6:536&#x2013;547. doi: 10.4338/ACI-2014-12-CR-0121.</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/ACI-2014-12-CR-0121</ArticleId><ArticleId IdType="pmc">PMC4586341</ArticleId><ArticleId IdType="pubmed">26448797</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., Murad M.H., Weaver C.M., Endocrine S. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011;96:1911&#x2013;1930. doi: 10.1210/jc.2011-0385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2011-0385</ArticleId><ArticleId IdType="pubmed">21646368</ArticleId></ArticleIdList></Reference><Reference><Citation>Amrein K., Scherkl M., Hoffmann M., Neuwersch-Sommeregger S., Kostenberger M., Tmava Berisha A., Martucci G., Pilz S., Malle O. Vitamin D deficiency 2.0: An update on the current status worldwide. Eur. J. Clin. Nutr. 2020;74:1498&#x2013;1513. doi: 10.1038/s41430-020-0558-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41430-020-0558-y</ArticleId><ArticleId IdType="pmc">PMC7091696</ArticleId><ArticleId IdType="pubmed">31959942</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin P.C. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm. Stat. 2011;10:150&#x2013;161. doi: 10.1002/pst.433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pst.433</ArticleId><ArticleId IdType="pmc">PMC3120982</ArticleId><ArticleId IdType="pubmed">20925139</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen M., Luo Y., Niu Y., Chen L., Yuan X., Goltzman D., Chen N., Miao D. 1,25(OH)2D deficiency induces temporomandibular joint osteoarthritis via secretion of senescence-associated inflammatory cytokines. Bone. 2013;55:400&#x2013;409. doi: 10.1016/j.bone.2013.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2013.04.015</ArticleId><ArticleId IdType="pubmed">23624390</ArticleId></ArticleIdList></Reference><Reference><Citation>Slade G.D., Ohrbach R., Greenspan J.D., Fillingim R.B., Bair E., Sanders A.E., Dubner R., Diatchenko L., Meloto C.B., Smith S., et al. Painful Temporomandibular Disorder: Decade of Discovery from OPPERA Studies. J. Dent. Res. 2016;95:1084&#x2013;1092. doi: 10.1177/0022034516653743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0022034516653743</ArticleId><ArticleId IdType="pmc">PMC5004239</ArticleId><ArticleId IdType="pubmed">27339423</ArticleId></ArticleIdList></Reference><Reference><Citation>Melis M., Di Giosia M. The role of genetic factors in the etiology of temporomandibular disorders: A review. Cranio. 2016;34:43&#x2013;51. doi: 10.1179/2151090314Y.0000000027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/2151090314Y.0000000027</ArticleId><ArticleId IdType="pubmed">25220856</ArticleId></ArticleIdList></Reference><Reference><Citation>Uitterlinden A.G., Fang Y., Van Meurs J.B., Pols H.A., Van Leeuwen J.P. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338:143&#x2013;156. doi: 10.1016/j.gene.2004.05.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2004.05.014</ArticleId><ArticleId IdType="pubmed">15315818</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoseinkhani Z., Rastegari-Pouyani M., Tajemiri F., Yari K., Mansouri K. Association of Vitamin D Receptor Polymorphisms (FokI (Rs2228570), ApaI (Rs7975232), BsmI (Rs1544410), and TaqI (Rs731236)) with Gastric Cancer in a Kurdish Population from West of Iran. Rep. Biochem. Mol. Biol. 2021;9:435&#x2013;441. doi: 10.52547/rbmb.9.4.435.</Citation><ArticleIdList><ArticleId IdType="doi">10.52547/rbmb.9.4.435</ArticleId><ArticleId IdType="pmc">PMC8068443</ArticleId><ArticleId IdType="pubmed">33969137</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombini A., Cauci S., Lombardi G., Lanteri P., Croiset S., Brayda-Bruno M., Banfi G. Relationship between vitamin D receptor gene (VDR) polymorphisms, vitamin D status, osteoarthritis and intervertebral disc degeneration. J. Steroid Biochem. Mol. Biol. 2013;138:24&#x2013;40. doi: 10.1016/j.jsbmb.2013.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2013.03.001</ArticleId><ArticleId IdType="pubmed">23500379</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasco J.A., Henry M.J., Kotowicz M.A., Sanders K.M., Seeman E., Pasco J.R., Schneider H.G., Nicholson G.C. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: The Geelong Osteoporosis Study. J. Bone Miner. Res. 2004;19:752&#x2013;758. doi: 10.1359/jbmr.040125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/jbmr.040125</ArticleId><ArticleId IdType="pubmed">15068498</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr D.C., Zava D.T., Piper W.T., Saturn S.R., Frei B., Gombart A.F. Associations between vitamin D levels and depressive symptoms in healthy young adult women. Psychiatry Res. 2015;227:46&#x2013;51. doi: 10.1016/j.psychres.2015.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2015.02.016</ArticleId><ArticleId IdType="pmc">PMC4420707</ArticleId><ArticleId IdType="pubmed">25791903</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37449050</PMID><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-9145</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Ophthalmology science</Title><ISOAbbreviation>Ophthalmol Sci</ISOAbbreviation></Journal><ArticleTitle>Concept Coverage Analysis of Ophthalmic Infections and Trauma among the Standardized Medical Terminologies SNOMED-CT, ICD-10-CM, and ICD-11.</ArticleTitle><Pagination><StartPage>100337</StartPage><MedlinePgn>100337</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100337</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xops.2023.100337</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Widespread electronic health record adoption has generated a large volume of data and emphasized the need for standardized terminology to describe clinical concepts. Here, we undertook a systematic concept coverage analysis to determine the representation of clinical concepts in ophthalmic infection and ophthalmic trauma among standardized medical terminologies, including the Systematized Nomenclature of Medicine Clinical Terms (SNOMED-CT), the International Classification of Diseases (ICD) version 10 with clinical modifications (ICD-10-CM), and ICD version 11 (ICD-11).</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">Extraction of concepts related to ophthalmic infection and ophthalmic trauma and structured search in terminology browsers.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="UNASSIGNED">The American Academy of Ophthalmology Basic and Clinical Science Course (BCSC), SNOMED-CT, and ICD-10-CM terminologies from the Observational Health Data Sciences and Informatics Athena browser, and the ICD-11 terminology browser.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Concepts pertaining to ophthalmic infection and ophthalmic trauma were extracted from the 2022 BCSC free text and index terms. We searched terminology browsers to identify corresponding codes and classified the extent of semantic alignment as <i>equal</i>, <i>wide</i>, <i>narrow</i>, or <i>unmatched</i> in each terminology. The overlap of equal concepts in each terminology was represented in a Venn diagram.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="UNASSIGNED">Proportions of clinical concepts with corresponding codes at various levels of semantic alignment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 443 concepts were identified: 304 concepts related to ophthalmic infection and 139 concepts related to ophthalmic trauma. The SNOMED-CT had the highest proportion of equal coverage, with 82.0% (249 of 304) among concepts related to ophthalmic infection and 82.0% (115 of 139) among concepts related to ophthalmic trauma. Across all concepts, 28% (124 of 443) were classified as equal in ICD-10-CM and 52.8% (234 of 443) were classified as equal in ICD-11.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The SNOMED-CT had significantly better semantic alignment than ICD-10-CM and ICD-11 for ophthalmic infections and ophthalmic trauma. This demonstrates opportunity for continuing advancement of representation of ophthalmic concepts in standardized medical terminologies.</AbstractText><CopyrightInformation>&#xa9; 2023 by the American Academy of Ophthalmology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tavakoli</LastName><ForeName>Kiana</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalaw</LastName><ForeName>Fritz Gerald P</ForeName><Initials>FGP</Initials><AffiliationInfo><Affiliation>Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhanvadia</LastName><ForeName>Sonali</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hogarth</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baxter</LastName><ForeName>Sally L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Division of Ophthalmology Informatics and Data Science, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Biomedical Informatics, Department of Medicine, University of California San Diego, La Jolla, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ophthalmol Sci</MedlineTA><NlmUniqueID>9918230896206676</NlmUniqueID><ISSNLinking>2666-9145</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data standards</Keyword><Keyword MajorTopicYN="N">Electronic health records</Keyword><Keyword MajorTopicYN="N">ICD</Keyword><Keyword MajorTopicYN="N">Ophthalmology</Keyword><Keyword MajorTopicYN="N">SNOMED</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>14</Day><Hour>3</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37449050</ArticleId><ArticleId IdType="pmc">PMC10336190</ArticleId><ArticleId IdType="doi">10.1016/j.xops.2023.100337</ArticleId><ArticleId IdType="pii">S2666-9145(23)00069-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Travers D.A., Haas S.W. Unified medical language system coverage of emergency-medicine chief complaints. Acad Emerg Med. 2006;13:1319&#x2013;1323.</Citation><ArticleIdList><ArticleId IdType="pubmed">17079790</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., Albers D.J. Next-generation phenotyping of electronic health records. J&#xa0;Am Med Inform Assoc. 2013;20:117&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555337</ArticleId><ArticleId IdType="pubmed">22955496</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak J., Bailey K.R., Beebe C.E., et al. Normalization and standardization of electronic health records for high-throughput phenotyping: the SHARPn consortium. J&#xa0;Am Med Inform Assoc. 2013;20:e341&#x2013;e348.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3861933</ArticleId><ArticleId IdType="pubmed">24190931</ArticleId></ArticleIdList></Reference><Reference><Citation>Klann J.G., Phillips L.C., Turchin A., et al. A&#xa0;numerical similarity approach for using retired current procedural terminology (CPT) codes for electronic phenotyping in the scalable collaborative infrastructure for a learning health system (SCILHS) BMC Med Inform Decis Mak. 2015;15:104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4676189</ArticleId><ArticleId IdType="pubmed">26655696</ArticleId></ArticleIdList></Reference><Reference><Citation>Amith M., He Z., Bian J., et al. Assessing the practice of biomedical ontology evaluation: gaps and opportunities. J&#xa0;Biomed Inform. 2018;80:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5882531</ArticleId><ArticleId IdType="pubmed">29462669</ArticleId></ArticleIdList></Reference><Reference><Citation>Chute C.G. Clinical classification and terminology: some history and current observations. J&#xa0;Am Med Inform Assoc. 2000;7:298&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC61433</ArticleId><ArticleId IdType="pubmed">10833167</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez D., Otegi A., Soroa A., Agirre E. Improving search over electronic health records using UMLS-based query expansion through random walks. J&#xa0;Biomed Inform. 2014;51:100&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">24768598</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X.D., Li M.M. A&#xa0;novel nomogram to predict mortality in patients with stroke: a survival analysis based on the MIMIC-III clinical database. BMC Med Inform Decis Mak. 2022;22:92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8988376</ArticleId><ArticleId IdType="pubmed">35387672</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter S.L., Lee A.Y. Gaps in standards for integrating artificial intelligence technologies into ophthalmic practice. Curr Opin Ophthalmol. 2021;32:431&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8373825</ArticleId><ArticleId IdType="pubmed">34231531</ArticleId></ArticleIdList></Reference><Reference><Citation>Halfpenny W., Baxter S.L. Towards effective data sharing in ophthalmology: data standardization and data privacy. Curr Opin Ophthalmol. 2022;33:418&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9357189</ArticleId><ArticleId IdType="pubmed">35819893</ArticleId></ArticleIdList></Reference><Reference><Citation>Basic, Clinical Science Course . Ebook. American Academy of Ophthalmology; 2022.</Citation></Reference><Reference><Citation>de Keizer N.F., Abu-Hanna A. Understanding terminological systems. II: experience with conceptual and formal representation of structure. Methods Inf Med. 2000;39:22&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">10786066</ArticleId></ArticleIdList></Reference><Reference><Citation>de Keizer N.F., Abu-Hanna A., Zwetsloot-Schonk J.H. Understanding terminological systems. I: terminology and typology. Methods Inf Med. 2000;39:16&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10786065</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakhshi-Raiez F., Cornet R., de Keizer N.F. Development and application of a framework for maintenance of medical terminological systems. J&#xa0;Am Med Inform Assoc. 2008;15:687&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2528044</ArticleId><ArticleId IdType="pubmed">18579838</ArticleId></ArticleIdList></Reference><Reference><Citation>Vikstr&#xf6;m A., Nystr&#xf6;m M., Ahlfeldt H., et al. Views of diagnosis distribution in primary care in 2.5 million encounters in Stockholm: a comparison between ICD-10 and SNOMED CT. Inform Prim Care. 2010;18:17&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">20429975</ArticleId></ArticleIdList></Reference><Reference><Citation>Khorrami F., Ahmadi M., Sheikhtaheri A. Evaluation of SNOMED CT content coverage: a systematic literature review. Stud Health Technol Inform. 2018;248:212&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">29726439</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L., Zhu W., Tao S., et al. Mining non-lattice subgraphs for detecting missing hierarchical relations and concepts in SNOMED CT. J&#xa0;Am Med Inform Assoc. 2017;24:788&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6080685</ArticleId><ArticleId IdType="pubmed">28339775</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang M.F., Casper D.S., Cimino J.J., Starren J. Representation of ophthalmology concepts by electronic systems: adequacy of controlled medical terminologies. Ophthalmology. 2005;112:175&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">15691548</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoskins H.D., Hildebrand P.L., Lum F. The American academy of ophthalmology adopts SNOMED CT as its official clinical terminology. Ophthalmology. 2008;115:225&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">18243903</ArticleId></ArticleIdList></Reference><Reference><Citation>Allones J.L., Martinez D., Taboada M. Automated mapping of clinical terms into SNOMED-CT. An application to codify procedures in pathology. J&#xa0;Med Syst. 2014;38:134.</Citation><ArticleIdList><ArticleId IdType="pubmed">25178272</ArticleId></ArticleIdList></Reference><Reference><Citation>Thun S., Dewenter H. [ICD-11, ICHI and SNOMED CT-what do the standards mean for eHealth applications?] Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61:812&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pubmed">29846742</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung K.W., Xu J., Rosenbloom S.T., Campbell J.R. Using SNOMED CT-encoded problems to improve ICD-10-CM coding-a randomized controlled experiment. Int J Med Inform. 2019;126:19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487871</ArticleId><ArticleId IdType="pubmed">31029260</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison J.E., Weber S., Jakob R., Chute C.G. ICD-11: an international classification of diseases for the twenty-first century. BMC Med Inform Decis Mak. 2021;21:206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8577172</ArticleId><ArticleId IdType="pubmed">34753471</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung K.W., Xu J., Bodenreider O. The new International classification of diseases 11th edition: a comparative analysis with ICD-10 and ICD-10-CM. J&#xa0;Am Med Inform Assoc. 2020;2:738&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7309235</ArticleId><ArticleId IdType="pubmed">32364236</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanno L.K., Calderon M.A., Papadopoulos N.G., et al. Revisiting desensitization and allergen immunotherapy concepts for the international classification of diseases (ICD)-11. J&#xa0;Allergy Clin Immunol Pract. 2016;4:643&#x2013;649.</Citation><ArticleIdList><ArticleId IdType="pubmed">26969269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kort&#xfc;m K., Hirnei&#xdf; C., M&#xfc;ller M., et al. The influence of a specific ophthalmological electronic health record on ICD-10 coding. BMC Med Inform Decis Mak. 2016;16:100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4962360</ArticleId><ArticleId IdType="pubmed">27460682</ArticleId></ArticleIdList></Reference><Reference><Citation>Unified medical language system (UMLS) 2022. https://www.nlm.nih.gov/research/umls/index.html</Citation></Reference><Reference><Citation>ICD-11 for mortality and morbidity statistics. 2022. https://icd.who.int/browse11/l-m/en</Citation></Reference><Reference><Citation>Athena &#x2013; OHDSI vocabularies repository. 2022. https://athena.ohdsi.org/</Citation></Reference><Reference><Citation>Oniki T.A., Coyle J.F., Parker C.G., Huff S.M. Lessons learned in detailed clinical modeling at Intermountain Healthcare. J&#xa0;Am Med Inform Assoc. 2014;21:1076&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4215059</ArticleId><ArticleId IdType="pubmed">24993546</ArticleId></ArticleIdList></Reference><Reference><Citation>Sclafani A.P., Sclafani M.S., Long S., et al. Injury patterns in pediatric facial fractures unique to an urban environment. Facial Plast Surg. 2021;37:564&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">33621987</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorman A., O'Hagan S., Gole G. Epidemiology of severe ocular trauma following the implementation of alcohol restrictions in far North Queensland. Clin Exp Ophthalmol. 2020;48:879&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pubmed">32548929</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino S.M., Parke D.W., Lum F. Return to the operating room after vitrectomy for vitreous opacities: intelligent research in sight registry analysis. Ophthalmol Retina. 2021;5:4&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32688085</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacy M., Kung T.P.H., Owen J.P., et al. Endophthalmitis rate in immediately sequential versus delayed sequential bilateral cataract surgery within the intelligent research in Sight (IRIS&#xae;) registry data. Ophthalmology. 2022;129:129&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755857</ArticleId><ArticleId IdType="pubmed">34265315</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter S.L., Klie A.R., Radha Saseendrakumar B., et al. Text processing for detection of fungal ocular involvement in critical care patients: cross-sectional study. J&#xa0;Med Internet Res. 2020;22</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455861</ArticleId><ArticleId IdType="pubmed">32795984</ArticleId></ArticleIdList></Reference><Reference><Citation>Matney S.A., Warren J.J., Evans J.L., et al. Development of the nursing problem list subset of SNOMED CT&#xae;. J&#xa0;Biomed Inform. 2012;45:683&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pubmed">22202620</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37459703</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8243</ISSN><JournalIssue CitedMedium="Internet"><Volume>177</Volume><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>International journal of medical informatics</Title><ISOAbbreviation>Int J Med Inform</ISOAbbreviation></Journal><ArticleTitle>ReDWINE: A clinical datamart with text analytical capabilities to facilitate rehabilitation research.</ArticleTitle><Pagination><StartPage>105144</StartPage><MedlinePgn>105144</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijmedinf.2023.105144</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1386-5056(23)00162-4</ELocationID><Abstract><AbstractText>Rehabilitation research focuses on determining the components of a treatment intervention, the mechanism of how these components lead to recovery and rehabilitation, and ultimately the optimal intervention strategies to maximize patients' physical, psychologic, and social functioning. Traditional randomized clinical trials that study and establish new interventions face challenges, such as high cost and time commitment. Observational studies that use existing clinical data to observe the effect of an intervention have shown several advantages over RCTs. Electronic Health Records (EHRs) have become an increasingly important resource for conducting observational studies. To support these studies, we developed a clinical research datamart, called ReDWINE (Rehabilitation Datamart With Informatics iNfrastructure for rEsearch), that transforms the rehabilitation-related EHR data collected from the UPMC health care system to the Observational Health Data Sciences and Informatics (OHDSI) Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) to facilitate rehabilitation research. The standardized EHR data stored in ReDWINE will further reduce the time and effort required by investigators to pool, harmonize, clean, and analyze data from multiple sources, leading to more robust and comprehensive research findings. ReDWINE also includes deployment of data visualization and data analytics tools to facilitate cohort definition and clinical data analysis. These include among others the Open Health Natural Language Processing (OHNLP) toolkit, a high-throughput NLP pipeline, to provide text analytical capabilities at scale in ReDWINE. Using this comprehensive representation of patient data in ReDWINE for rehabilitation research will facilitate real-world evidence for health interventions and outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oniani</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Health Information Management, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parmanto</LastName><ForeName>Bambang</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Health Information Management, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saptono</LastName><ForeName>Andi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Health Information Management, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Allyn</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freburger</LastName><ForeName>Janet</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Visweswaran</LastName><ForeName>Shyam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Intelligent Systems Program, University of Pittsburgh, Pittsburgh, PA, USA; Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappella</LastName><ForeName>Nickie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLay</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silverstein</LastName><ForeName>Jonathan C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becich</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delitto</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skidmore</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Occupational Therapy, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanshan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Information Management, University of Pittsburgh, Pittsburgh, PA, USA; Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Intelligent Systems Program, University of Pittsburgh, Pittsburgh, PA, USA; Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: yanshan.wang@pitt.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR001857</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24OH009077</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 OH009077</GrantID><Acronym>OH</Acronym><Agency>NIOSH CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U24 TR004111</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>OT2 OD026554</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Int J Med Inform</MedlineTA><NlmUniqueID>9711057</NlmUniqueID><ISSNLinking>1386-5056</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066768" MajorTopicYN="Y">Rehabilitation Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008490" MajorTopicYN="Y">Medical Informatics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="N">Natural Language Processing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical research informatics</Keyword><Keyword MajorTopicYN="N">Common data model</Keyword><Keyword MajorTopicYN="N">Electronic health records</Keyword><Keyword MajorTopicYN="N">Informatics infrastructure</Keyword><Keyword MajorTopicYN="N">Natural language processing</Keyword><Keyword MajorTopicYN="N">Rehabilitation</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>19</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>17</Day><Hour>18</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37459703</ArticleId><ArticleId IdType="mid">NIHMS1918582</ArticleId><ArticleId IdType="pmc">PMC10528160</ArticleId><ArticleId IdType="doi">10.1016/j.ijmedinf.2023.105144</ArticleId><ArticleId IdType="pii">S1386-5056(23)00162-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>[https://www.who.int/news-room/fact-sheets/detail/rehabilitation]</Citation></Reference><Reference><Citation>Kroll T, Moms J: Challenges and opportunities in using mixed method designs in rehabilitation research. Archives of Physical Medicine and Rehabilitation 2009, 90:S11&#x2013;S16.</Citation><ArticleIdList><ArticleId IdType="pubmed">19892069</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan A, Shah NH, Chen JH: Research and reporting considerations for observational studies using electronic health record data. Annals of internal medicine 2020, 172:S79&#x2013;S84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7413106</ArticleId><ArticleId IdType="pubmed">32479175</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI: The Book of OHDSI: Observational Health Data Sciences and Informatics. OHDSI; 2019.</Citation></Reference><Reference><Citation>Murphy SN, Visweswaran S, Becich MJ, Campion TR, Knosp BM, Melton-Meaux GB, Lenert LA: Research data warehouse best practices: catalyzing national data sharing through informatics innovation, vol. 29. pp. 581&#x2013;584: Oxford University Press; 2022:581-584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8922176</ArticleId><ArticleId IdType="pubmed">35289371</ArticleId></ArticleIdList></Reference><Reference><Citation>Becich M: Information management: moving from test results to clinical information. Clinical leadership &amp; management review: the journal of CLAM 2000, 14:296&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">11210218</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen A, Fu S, Moon S, El Wazir M, Rosenbaum A, Kaggal VC, Liu S, Solm S, Liu H, Fan J: Desiderata for delivering NLP to accelerate healthcare AI advancement and a Mayo Clinic NLP-as-a-service implementation. NPJ digital medicine 2019, 2:130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6917754</ArticleId><ArticleId IdType="pubmed">31872069</ArticleId></ArticleIdList></Reference><Reference><Citation>Visweswaran S, McLay B, Cappella N, Morris M, Milnes JT, Reis SE, Silverstein JC, Becich MJ: An atomic approach to the design and implementation of a research data warehouse. Journal of the American Medical Informatics Association 2022, 29:601&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8922189</ArticleId><ArticleId IdType="pubmed">34613409</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffran SW, Gao F, Denny PE, Aldhahwani BM, Bove A, Visweswaran S, Wang Y: Extracting Physical Rehabilitation Exercise Information from Clinical Notes: a Comparison of Rule-Based and Machine Learning Natural Language Processing Techniques. arXivpreprint arXiv:230313466 2023.</Citation></Reference><Reference><Citation>Cotton RJ, Segal RL, Seamon BA, Sahu A, McLeod MM, Davis RD, Ramey SL, French MA, Roemmich RT, Daley K: Precision Rehabilitation: Optimizing Function, Adding Value to Health Care. Archives of physical medicine and rehabilitation 2022, 103:1883&#x2013;1884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9979846</ArticleId><ArticleId IdType="pubmed">35690092</ArticleId></ArticleIdList></Reference><Reference><Citation>French MA, Roemmich RT, Daley K, Beier M, Penttinen S, Raghavan P, Searson P, Wegener S, Celnik P: Precision rehabilitation: optimizing function, adding value to health care. Archives of physical medicine and rehabilitation 2022, 103:1233&#x2013;1239.</Citation><ArticleIdList><ArticleId IdType="pubmed">35181267</ArticleId></ArticleIdList></Reference><Reference><Citation>Alunadi N, Peng Y, Wolfien M, Zoch M, Sedlmayr M: OMOP CDM Can Facilitate Data-Driven Studies for Cancer Prediction: A Systematic Review. International Journal of Molecular Sciences 2022, 23:11834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9569469</ArticleId><ArticleId IdType="pubmed">36233137</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Wen A, Wang L, He H, Fu S, Miller R, Williams A, Harris D, Kavuluru R, Liu M: An open natural language processing development framework for EHR-based clinical research: a case demonstration using the national COVID cohort collaborative (N3C). arXiv preprint arXiv:211010780 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10654844</ArticleId><ArticleId IdType="pubmed">37555837</ArticleId></ArticleIdList></Reference><Reference><Citation>He X, Zhao K, Chu X: AutoML: A survey of the state-of-the-art. Knowledge-Based Systems 2021, 212:106622.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37507616</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1179-6901</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Drugs in R&amp;D</Title><ISOAbbreviation>Drugs R D</ISOAbbreviation></Journal><ArticleTitle>Risk of Hyponatremia after Tramadol/Acetaminophen Single-Pill Combination Therapy: A Real-World Study Based on the OMOP-CDM Database.</ArticleTitle><Pagination><StartPage>289</StartPage><EndPage>296</EndPage><MedlinePgn>289-296</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s40268-023-00436-4</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVE" NlmCategory="OBJECTIVE">Tramadol has been reported to cause hyponatremia but the evidence is conflicting. The risk of hyponatremia resulting from combination oral tramadol/acetaminophen (TA) therapy is thus unknown. This study examined whether, compared with acetaminophen (AA), TA use is associated with an increased risk of hyponatremia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Hospital data compatible with the Observational Medical Outcomes Partnership-Common Data Model (OMOP-CDM; version 5.3) for 30,999 patients taking TA or AA from 2011 through 2020 were analyzed. New-onset hyponatremia was defined as a serum sodium level &lt;&#xa0;135&#xa0;mEq/L within 10&#xa0;days after drug initiation. The incidence rate ratio was calculated based on crude and 1:1 propensity-score-matched models. Subgroup analyses compared patients taking TA extended-release (TA-ER) and TA immediate-release (TA-IR) formulations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 30,999 patients, 12,122 (39.1%) were aged &gt;&#xa0;65&#xa0;years and 16,654 (53.7%) were male. Hyponatremia within 10&#xa0;days developed in 1613 (8.4%) of the 19,149 patients in the TA group; the incidence rate was higher than in the AA group (4.2%; 493 out of 11,850 cases). In the propensity-score-matched model, the incidence rate of hyponatremia in the TA group was 6.8 per 1000 person-days (PD), which was 1.57-fold (1.31, 1.89) higher than that in the AA group (4.3 per 1000 PD). In both the crude and propensity-score-matched models, the incidence rate of hyponatremia was significantly higher in the TA-ER than TA-IR subgroup.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this real-world study, hyponatremia was more frequently observed in the TA than AA group, and in the TA-ER than TA-IR subgroup. Therefore, it is imperative to prescribe tramadol cautiously and closely monitor electrolyte levels.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yu Jeong</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Pusan National University Hospital, Pusan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jinmi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Clinical Trial Center, Biomedical Research Institute, Pusan National University Hospital, Pusan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Youngmi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>R&amp;D Team, Visual Terminology Co., Pusan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Kyuhyun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Convergence Medical Institute of Technology, Pusan National University Hospital, Pusan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Byungkwan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Pusan National University Hospital, Pusan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Tae Ryom</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Il Young</ForeName><Initials>IY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Pusan National University School of Medicine, Pusan, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rhee</LastName><ForeName>Harin</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-6257-8551</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Pusan National University School of Medicine, Pusan, South Korea. rheeharin@pusan.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Biomedical Research Institute, Pusan National University Hospital, 305 Gudeok-ro, Seo-gu, Busan, 602-739, South Korea. rheeharin@pusan.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CMIT PRP 2022-04</GrantID><Agency>Pusan National University Hospital</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Drugs R D</MedlineTA><NlmUniqueID>100883647</NlmUniqueID><ISSNLinking>1174-5886</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>362O9ITL9D</RegistryNumber><NameOfSubstance UI="D000082">Acetaminophen</NameOfSubstance></Chemical><Chemical><RegistryNumber>39J1LGJ30J</RegistryNumber><NameOfSubstance UI="D014147">Tramadol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000082" MajorTopicYN="N">Acetaminophen</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007010" MajorTopicYN="Y">Hyponatremia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014147" MajorTopicYN="Y">Tramadol</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>23</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37507616</ArticleId><ArticleId IdType="pmc">PMC10439094</ArticleId><ArticleId IdType="doi">10.1007/s40268-023-00436-4</ArticleId><ArticleId IdType="pii">10.1007/s40268-023-00436-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schnitzer T. The new analgesic combination tramadol/acetaminophen. Eur J Anaesthesiol Suppl. 2003;28:13&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">12785457</ArticleId></ArticleIdList></Reference><Reference><Citation>Beakley BD, Kaye AM, Kaye AD. Tramadol, pharmacology, side effects, and serotonin syndrome: a review. Pain Physician. 2015;18(4):395&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">26218943</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson BJ. Paracetamol (acetaminophen): mechanisms of action. Paediatr Anaesth. 2008;18(10):915&#x2013;921. doi: 10.1111/j.1460-9592.2008.02764.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9592.2008.02764.x</ArticleId><ArticleId IdType="pubmed">18811827</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K, Lee H, Shin JY. Explosive increase in tramadol use in Korea 2003&#x2013;2013: analysis of patient trends based on the Korea National Health Insurance Database. J Psychoactive Drugs. 2020;52(2):153&#x2013;161. doi: 10.1080/02791072.2019.1612125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02791072.2019.1612125</ArticleId><ArticleId IdType="pubmed">31079571</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright EA, Katz JN, Abrams S, Solomon DH, Losina E. Trends in prescription of opioids from 2003&#x2013;2009 in persons with knee osteoarthritis. Arthritis Care Res (Hoboken). 2014;66(10):1489&#x2013;1495. doi: 10.1002/acr.22360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22360</ArticleId><ArticleId IdType="pmc">PMC4177407</ArticleId><ArticleId IdType="pubmed">24782079</ArticleId></ArticleIdList></Reference><Reference><Citation>Buffington MA, Abreo K. Hyponatremia: a review. J Intensive Care Med. 2016;31(4):223&#x2013;236. doi: 10.1177/0885066614566794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066614566794</ArticleId><ArticleId IdType="pubmed">25592330</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyer S, Gayot C, Bimou C, Mergans T, Kajeu P, Castelli M, et al. Prevalence of mild hyponatremia and its association with falls in older adults admitted to an emergency geriatric medicine unit (the MUPA unit) BMC Geriatr. 2019;19(1):265. doi: 10.1186/s12877-019-1282-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-019-1282-0</ArticleId><ArticleId IdType="pmc">PMC6792197</ArticleId><ArticleId IdType="pubmed">31615437</ArticleId></ArticleIdList></Reference><Reference><Citation>Dokmak A, Madias NE. Hyponatremia and in-hospital falls and fractures in older adults. J Am Geriatr Soc. 2019;67(8):1752&#x2013;1753. doi: 10.1111/jgs.15946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.15946</ArticleId><ArticleId IdType="pubmed">31012949</ArticleId></ArticleIdList></Reference><Reference><Citation>Upala S, Sanguankeo A. Association between hyponatremia, osteoporosis, and fracture: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2016;101(4):1880&#x2013;1886. doi: 10.1210/jc.2015-4228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2015-4228</ArticleId><ArticleId IdType="pubmed">26913635</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo CB, Gan MY, Tay RYK, Loh WJ, Loh NW. Association of preoperative hyponatremia with surgical outcomes: a systematic review and meta-analysis of 32 observational studies. J Clin Endocrinol Metab. 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10099166</ArticleId><ArticleId IdType="pubmed">36472931</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk GC, Lindner G, Druml W, Metnitz B, Schwarz C, Bauer P, et al. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med. 2010;36(2):304&#x2013;311. doi: 10.1007/s00134-009-1692-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1692-0</ArticleId><ArticleId IdType="pubmed">19847398</ArticleId></ArticleIdList></Reference><Reference><Citation>Garakani A. Hyponatremia associated with tramadol in a patient with alcohol use disorder and anxiety taking desvenlafaxine. Prim Care Companion CNS Disord. 2018;20(6):27341. doi: 10.4088/PCC.18l02316.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/PCC.18l02316</ArticleId><ArticleId IdType="pubmed">30550646</ArticleId></ArticleIdList></Reference><Reference><Citation>Udy A, Deacy N, Barnes D, Sigston P. Tramadol-induced hyponatraemia following unicompartmental knee replacement surgery. Anaesthesia. 2005;60(8):814&#x2013;816. doi: 10.1111/j.1365-2044.2005.04260.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2005.04260.x</ArticleId><ArticleId IdType="pubmed">16029233</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong TY, Khow KSF. Hyponatraemia associated with tramadol use: a case report. Curr Drug Saf. 2018;13(3):217&#x2013;220. doi: 10.2174/1574886313666180508123232.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1574886313666180508123232</ArticleId><ArticleId IdType="pubmed">29745338</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Berre JP, Desrame J, Lecoules S, Coutant G, Bechade D, Algayres JP. Hyponatremia due to tramadol. Rev Med Interne. 2007;28(12):888&#x2013;889.</Citation><ArticleIdList><ArticleId IdType="pubmed">17624638</ArticleId></ArticleIdList></Reference><Reference><Citation>Falhammar H, Calissendorff J, Skov J, Nathanson D, Lindh JD, Mannheimer B. Tramadol- and codeine-induced severe hyponatremia: a Swedish population-based case-control study. Eur J Intern Med. 2019;69:20&#x2013;24. doi: 10.1016/j.ejim.2019.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2019.08.006</ArticleId><ArticleId IdType="pubmed">31416660</ArticleId></ArticleIdList></Reference><Reference><Citation>de Canecaude C, Rousseau V, Chebane L, Lafaurie M, Durrieu G, Montastruc JL. Can tramadol really induce hyponatraemia? A pharmacovigilance study. Br J Clin Pharmacol. 2021;87(2):683&#x2013;686. doi: 10.1111/bcp.14401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.14401</ArticleId><ArticleId IdType="pubmed">32470196</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YB, Ha CW, Cho SD, Lee MC, Lee JH, Seo SS, et al. A randomized study to compare the efficacy and safety of extended-release and immediate-release tramadol HCl/acetaminophen in patients with acute pain following total knee replacement. Curr Med Res Opin. 2015;31(1):75&#x2013;84. doi: 10.1185/03007995.2014.975338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/03007995.2014.975338</ArticleId><ArticleId IdType="pubmed">25299350</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi S, Chung YJ, Kim TE, Shin HS, Yoon SH, Cho JY, et al. Pharmacokinetics of extended-release versus conventional tramadol/acetaminophen fixed-dose combination tablets: an open-label, 2-treatment, multiple-dose, randomized-sequence crossover study in healthy Korean male volunteers. Clin Ther. 2011;33(6):728&#x2013;737. doi: 10.1016/j.clinthera.2011.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2011.04.023</ArticleId><ArticleId IdType="pubmed">21704237</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigal LM, Bibeau K, Dunbar S. Tramadol prescription over a 4-year period in the USA. Curr Pain Headache Rep. 2019;23(10):76. doi: 10.1007/s11916-019-0777-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-019-0777-x</ArticleId><ArticleId IdType="pubmed">31388761</ArticleId></ArticleIdList></Reference><Reference><Citation>Zin CS, Nazar NI, Rahman NS, Alias NE, Ahmad WR, Rani NS, et al. Trends and patterns of analgesic prescribing in Malaysian public hospitals from 2010 to 2016: tramadol predominately used. J Pain Res. 2018;11:1959&#x2013;1966. doi: 10.2147/JPR.S164774.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S164774</ArticleId><ArticleId IdType="pmc">PMC6160284</ArticleId><ArticleId IdType="pubmed">30288090</ArticleId></ArticleIdList></Reference><Reference><Citation>Buon M, Gaillard C, Martin J, Fedrizzi S, Mosquet B, Coquerel A, et al. Risk of proton pump inhibitor-induced mild hyponatremia in older adults. J Am Geriatr Soc. 2013;61(11):2052&#x2013;2054. doi: 10.1111/jgs.12534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.12534</ArticleId><ArticleId IdType="pubmed">24219214</ArticleId></ArticleIdList></Reference><Reference><Citation>Fournier JP, Yin H, Nessim SJ, Montastruc JL, Azoulay L. Tramadol for noncancer pain and the risk of hyponatremia. Am J Med. 2015;128(4):418&#x2013;25 e5. doi: 10.1016/j.amjmed.2014.10.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2014.10.046</ArticleId><ArticleId IdType="pubmed">25460534</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarret D, Le Berre JP, Zemraoui N. Tramadol-induced hyponatremia. Am J Kidney Dis. 2008;52(5):1026. doi: 10.1053/j.ajkd.2008.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2008.08.007</ArticleId><ArticleId IdType="pubmed">18971023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lota AS, Dubrey SW, Wills P. Profound hyponatraemia following a tramadol overdose. QJM. 2012;105(4):397&#x2013;398. doi: 10.1093/qjmed/hcs027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcs027</ArticleId><ArticleId IdType="pubmed">22328544</ArticleId></ArticleIdList></Reference><Reference><Citation>Frieden TR, Houry D. Reducing the risks of relief&#x2014;the CDC opioid-prescribing guideline. N Engl J Med. 2016;374(16):1501&#x2013;1504. doi: 10.1056/NEJMp1515917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1515917</ArticleId><ArticleId IdType="pmc">PMC4852278</ArticleId><ArticleId IdType="pubmed">26977701</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain&#x2014;United States, 2022. MMWR Recomm Rep. 2022;71(3):1&#x2013;95. doi: 10.15585/mmwr.rr7103a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.rr7103a1</ArticleId><ArticleId IdType="pmc">PMC9639433</ArticleId><ArticleId IdType="pubmed">36327391</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentrasti G, Scortichini L, Torniai M, Giampieri R, Morgese F, Rinaldi S, et al. Syndrome of inappropriate antidiuretic hormone secretion (SIADH): optimal management. Ther Clin Risk Manag. 2020;16:663&#x2013;672. doi: 10.2147/TCRM.S206066.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TCRM.S206066</ArticleId><ArticleId IdType="pmc">PMC7386802</ArticleId><ArticleId IdType="pubmed">32801723</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37535410</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2023</Year><Month>Aug</Month><Day>03</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>Methods Used in the Development of Common Data Models for Health Data: Scoping Review.</ArticleTitle><Pagination><StartPage>e45116</StartPage><MedlinePgn>e45116</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e45116</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/45116</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Common data models (CDMs) are essential tools for data harmonization, which can lead to significant improvements in the health domain. CDMs unite data from disparate sources and ease collaborations across institutions, resulting in the generation of large standardized data repositories across different entities. An overview of existing CDMs and methods used to develop these data sets may assist in the development process of future models for the health domain, such as for decision support systems.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This scoping review investigates methods used in the development of CDMs for health data. We aim to provide a broad overview of approaches and guidelines that are used in the development of CDMs (ie, common data elements or common data sets) for different health domains on an international level.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This scoping review followed the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) checklist. We conducted the literature search in prominent databases, namely, PubMed, Web of Science, Science Direct, and Scopus, starting from January 2000 until March 2022. We identified and screened 1309 articles. The included articles were evaluated based on the type of adopted method, which was used in the conception, users' needs collection, implementation, and evaluation phases of CDMs, and whether stakeholders (such as medical experts, patients' representatives, and IT staff) were involved during the process. Moreover, the models were grouped into iterative or linear types based on the imperativeness of the stages during development.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We finally identified 59 articles that fit our eligibility criteria. Of these articles, 45 specifically focused on common medical conditions, 10 focused on rare medical conditions, and the remaining 4 focused on both conditions. The development process usually involved stakeholders but in different ways (eg, working group meetings, Delphi approaches, interviews, and questionnaires). Twenty-two models followed an iterative process.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The included articles showed the diversity of methods used to develop a CDM in different domains of health. We highlight the need for more specialized CDM development methods in the health domain and propose a suggestive development process that might ease the development of CDMs in the health domain in the future.</AbstractText><CopyrightInformation>&#xa9;Najia Ahmadi, Michele Zoch, Patricia Kelbert, Richard Noll, Jannik Schaaf, Markus Wolfien, Martin Sedlmayr. Originally published in JMIR Medical Informatics (https://medinform.jmir.org), 03.08.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmadi</LastName><ForeName>Najia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-9769-5109</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoch</LastName><ForeName>Michele</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5577-7760</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelbert</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-3698-4748</Identifier><AffiliationInfo><Affiliation>Fraunhofer Institute for Experimental Software Engineering IESE, Kaiserslautern, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noll</LastName><ForeName>Richard</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-5240-8484</Identifier><AffiliationInfo><Affiliation>Institute of Medical Informatics, Goethe University Frankfurt, University Hospital, Frankfurt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaaf</LastName><ForeName>Jannik</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0058-155X</Identifier><AffiliationInfo><Affiliation>Institute of Medical Informatics, Goethe University Frankfurt, University Hospital, Frankfurt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolfien</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1887-4772</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Scalable Data Analytics and Artificial Intelligence, Dresden/Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9888-8460</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data harmonisation</Keyword><Keyword MajorTopicYN="N">Healthcare</Keyword><Keyword MajorTopicYN="N">Interoperability</Keyword><Keyword MajorTopicYN="N">Medical Informatics</Keyword><Keyword MajorTopicYN="N">Observational Medical Outcomes Partnership</Keyword><Keyword MajorTopicYN="N">Standardized Data Repositories</Keyword><Keyword MajorTopicYN="N">Suggestive Development Process</Keyword><Keyword MajorTopicYN="N">common data elements</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">electronic health record</Keyword><Keyword MajorTopicYN="N">health data</Keyword><Keyword MajorTopicYN="N">stakeholder involvement</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>13</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>13</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>3</Day><Hour>11</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37535410</ArticleId><ArticleId IdType="pmc">PMC10436118</ArticleId><ArticleId IdType="doi">10.2196/45116</ArticleId><ArticleId IdType="pii">v11i1e45116</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dash S, Shakyawar SK, Sharma M, Kaushik S. Big data in healthcare: management, analysis and future prospects. J Big Data. 2019 Jun 19;6(1):54. doi: 10.1186/s40537-019-0217-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40537-019-0217-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Razzak MI, Imran M, Xu G. Big data analytics for preventive medicine. Neural Comput Appl. 2020 Mar 16;32(9):4417&#x2013;4451. doi: 10.1007/s00521-019-04095-y. 
 
4095</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00521-019-04095-y</ArticleId><ArticleId IdType="pmc">PMC7088441</ArticleId><ArticleId IdType="pubmed">32205918</ArticleId></ArticleIdList></Reference><Reference><Citation>Asche CV, Seal B, Kahler KH, Oehrlein EM, Baumgartner MG. Evaluation of healthcare interventions and big data: review of associated data issues. Pharmacoeconomics. 2017 Aug;35(8):759&#x2013;765. doi: 10.1007/s40273-017-0513-5.10.1007/s40273-017-0513-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-017-0513-5</ArticleId><ArticleId IdType="pubmed">28474299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent S, Burn E, Dawoud D, Jonsson P, &#xd8;stby Jens Torup, Hughes N, Rijnbeek P, Bouvy JC. Common problems, common data model solutions: evidence generation for health technology assessment. Pharmacoeconomics. 2021 Mar;39(3):275&#x2013;285. doi: 10.1007/s40273-020-00981-9. 
 
10.1007/s40273-020-00981-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40273-020-00981-9</ArticleId><ArticleId IdType="pmc">PMC7746423</ArticleId><ArticleId IdType="pubmed">33336320</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier C, Lang L, Storf H, Vormstein P, Bieber R, Bernarding J, Herrmann T, Haverkamp C, Horki P, Laufer J, Berger F, H&#xf6;ning G, Fritsch H, Sch&#xfc;ttler J, Ganslandt T, Prokosch H, Sedlmayr M. Towards implementation of OMOP in a German university hospital consortium. Appl Clin Inform. 2018 Jan;9(1):54&#x2013;61. doi: 10.1055/s-0037-1617452. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1617452</ArticleId><ArticleId IdType="pmc">PMC5801887</ArticleId><ArticleId IdType="pubmed">29365340</ArticleId></ArticleIdList></Reference><Reference><Citation>Simko LC, Chen L, Amtmann D, Gibran N, Herndon D, Kowalske K, Miller AC, Bulger E, Friedman R, Wolfe A, Chung KK, Mosier M, Jeng J, Giacino J, Zafonte R, Kazis LE, Schneider JC, Ryan CM. Challenges to the standardization of trauma data collection in burn, traumatic brain injury, spinal cord injury, and other trauma populations: a call for common data elements for acute and longitudinal trauma databases. Arch Phys Med Rehabil. 2019 May;100(5):891&#x2013;898. doi: 10.1016/j.apmr.2018.10.004. 
 
S0003-9993(18)31400-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2018.10.004</ArticleId><ArticleId IdType="pmc">PMC9140315</ArticleId><ArticleId IdType="pubmed">31030731</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke J, Shah N, Reich C, Huser V, Schuemie M, Suchard M, Park R, Wong I, Rijnbeek P, van der Lei J, Pratt N, Nor&#xe9;n G Niklas, Li Y, Stang P, Madigan D, Ryan P. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;8. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M, Del Fiol G, Tenenbaum J, Walden A, Zozus MN. Evaluating common data models for use with a longitudinal community registry. J Biomed Inform. 2016 Dec;64:333&#x2013;341. doi: 10.1016/j.jbi.2016.10.016. 
 
S1532-0464(16)30153-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy SN, Weber G, Mendis M, Gainer V, Chueh HC, Churchill S, Kohane I. Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2) J Am Med Inform Assoc. 2010 Feb 26;17(2):124&#x2013;30. doi: 10.1136/jamia.2009.000893. 
 
17/2/124</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.000893</ArticleId><ArticleId IdType="pmc">PMC3000779</ArticleId><ArticleId IdType="pubmed">20190053</ArticleId></ArticleIdList></Reference><Reference><Citation>Taruscio D, Mollo E, Gainotti S, Posada de la Paz M, Bianchi F, Vittozzi L. The EPIRARE proposal of a set of indicators and common data elements for the European platform for rare disease registration. Arch Public Health. 2014 Oct 13;72(1):35. doi: 10.1186/2049-3258-72-35. 
 
5051</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2049-3258-72-35</ArticleId><ArticleId IdType="doi">10.1186/2049-3258-72-35</ArticleId><ArticleId IdType="pmc">PMC4210567</ArticleId><ArticleId IdType="pubmed">25352985</ArticleId></ArticleIdList></Reference><Reference><Citation>Choquet R, Maaroufi M, de Carrara A, Messiaen C, Luigi E, Landais P. A methodology for a minimum data set for rare diseases to support national centers of excellence for healthcare and research. J Am Med Inform Assoc. 2015 Jan;22(1):76&#x2013;85. doi: 10.1136/amiajnl-2014-002794. 
 
amiajnl-2014-002794</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2014-002794</ArticleId><ArticleId IdType="pmc">PMC4433369</ArticleId><ArticleId IdType="pubmed">25038198</ArticleId></ArticleIdList></Reference><Reference><Citation>Park C, You SC, Jeon H, Jeong CW, Choi JW, Park RW. Development and Validation of the Radiology Common Data Model (R-CDM) for the International Standardization of Medical Imaging Data. Yonsei Med J. 2022;63(Suppl):S74. doi: 10.3349/ymj.2022.63.s74.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2022.63.s74</ArticleId><ArticleId IdType="pmc">PMC8790584</ArticleId><ArticleId IdType="pubmed">35040608</ArticleId></ArticleIdList></Reference><Reference><Citation>Melles M, Albayrak A, Goossens R. Innovating health care: key characteristics of human-centered design. Int J Qual Health Care. 2021 Jan 12;33(Supplement_1):37&#x2013;44. doi: 10.1093/intqhc/mzaa127. 
 
5928348</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intqhc/mzaa127</ArticleId><ArticleId IdType="pmc">PMC7802070</ArticleId><ArticleId IdType="pubmed">33068104</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacristan JA, Aguaron A, Avenda&#xf1;o C, Garrido P, Carrion J, Gutierrez A, Kroes R, Flores A. Patient involvement in clinical research: why, when, and how. Patient Preference and Adherence. 2016 Apr;:631&#x2013;640. doi: 10.2147/ppa.s104259.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ppa.s104259</ArticleId><ArticleId IdType="pmc">PMC4854260</ArticleId><ArticleId IdType="pubmed">27175063</ArticleId></ArticleIdList></Reference><Reference><Citation>Gericke K, Blessing L. An analysis of design process models across disciplines. DS 70: Proceedings of DESIGN 2012, the 12th International Design Conference; 12th International Design Conference; May 21-24, 2012; Dubrovnik, Croatia. 2012.</Citation></Reference><Reference><Citation>Bobbe T, Krzywinski J, Woelfel C. A comparison of design process models from academic theory and professional practice. DS 84: Proceedings of the DESIGN 2016 14th International Design Conference; 14th International Design Conference; May 16-19, 2016; Dubrovnik, Croatia. 2016.</Citation></Reference><Reference><Citation>SATURN Projekt.  [2023-07-06].  
 https://www.saturn-projekt.de/
</Citation></Reference><Reference><Citation>Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MD, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tun&#xe7;alp &#xd6;, Straus SE. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018 Oct 02;169(7):467&#x2013;473. doi: 10.7326/M18-0850. 
 
2700389</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-0850?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.7326/M18-0850</ArticleId><ArticleId IdType="pubmed">30178033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi N, Zoch M, Kelbert P, Noll R, Schaaf J, Wolfien M, Sedlmayr M. Methods used in the development of Common Data Models for health data &#x2013; A Scoping Review Protocol. OSF.  [2023-07-06].  
 https://osf.io/rza84/
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10436118</ArticleId><ArticleId IdType="pubmed">37535410</ArticleId></ArticleIdList></Reference><Reference><Citation>Meystre SM, Lee S, Jung CY, Chevrier RD. Common data model for natural language processing based on two existing standard information models: CDA+GrAF. J Biomed Inform. 2012 Aug;45(4):703&#x2013;10. doi: 10.1016/j.jbi.2011.11.018. 
 
S1532-0464(11)00208-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2011.11.018</ArticleId><ArticleId IdType="pubmed">22197801</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin S, You S, Roh J, Park Y, Park R. Genomic Common Data Model for Biomedical Data in Clinical Practice. Stud Health Technol Inform. 2019 Aug 21;264:1843&#x2013;1844. doi: 10.3233/SHTI190676.SHTI190676</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI190676</ArticleId><ArticleId IdType="pubmed">31438371</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones D, Shao J, Wallis H, Johansen C, Hart K, Pasquali M, Gouripeddi R, Rohrwasser A. Towards a newborn screening common data model: the Utah Newborn Screening Data Model. Int J Neonatal Screen. 2021 Oct 27;7(4):70. doi: 10.3390/ijns7040070. 
 
ijns7040070</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijns7040070</ArticleId><ArticleId IdType="pmc">PMC8628929</ArticleId><ArticleId IdType="pubmed">34842615</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman D. Advanced search features of PubMed. J Can Acad Child Adolesc Psychiatry. 2009 Feb;18(1):58&#x2013;9. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2651214</ArticleId><ArticleId IdType="pubmed">19270851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016 Dec 05;5(1):210. doi: 10.1186/s13643-016-0384-4. 
 
10.1186/s13643-016-0384-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType="doi">10.1186/s13643-016-0384-4</ArticleId><ArticleId IdType="pmc">PMC5139140</ArticleId><ArticleId IdType="pubmed">27919275</ArticleId></ArticleIdList></Reference><Reference><Citation>Niederberger M, Spranger J. Delphi technique in health sciences: a map. Front Public Health. 2020;8:457. doi: 10.3389/fpubh.2020.00457. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00457</ArticleId><ArticleId IdType="pmc">PMC7536299</ArticleId><ArticleId IdType="pubmed">33072683</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi N. VisualisationWithPython. GitHub.  [2023-07-06].  
 https://github.com/NajiaAhmadi/VisualisationWithPython
.</Citation></Reference><Reference><Citation>Meeuws S, Yue JK, Huijben JA, Nair N, Lingsma HF, Bell MJ, Manley GT, Maas AIR. Common Data Elements: Critical Assessment of Harmonization between Current Multi-Center Traumatic Brain Injury Studies. J Neurotrauma. 2020 Jun 01;37(11):1283&#x2013;1290. doi: 10.1089/neu.2019.6867. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2019.6867</ArticleId><ArticleId IdType="pmc">PMC7249452</ArticleId><ArticleId IdType="pubmed">32000562</ArticleId></ArticleIdList></Reference><Reference><Citation>Vande Vyvere T, De La Rosa E, Wilms G, Nieboer D, Steyerberg E, Maas A, Verheyden J, van den Hauwe L, Parizel P, CENTER-TBI ParticipantsInvestigators  Prognostic validation of the NINDS common data elements for the radiologic reporting of acute traumatic brain injuries: A CENTER-TBI Study. J Neurotrauma. 2020 Jun 01;37(11):1269&#x2013;1282. doi: 10.1089/neu.2019.6710. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2019.6710</ArticleId><ArticleId IdType="pubmed">31813313</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiariti V, Fowler E, Brandenburg JE, Levey E, Mcintyre S, Sukal-Moulton T, Ramey SL, Rose J, Sienko S, Stashinko E, Vogtle L, Feldman RS, Koenig JI. A common data language for clinical research studies: the National Institute of Neurological Disorders and Stroke and American Academy for Cerebral Palsy and Developmental Medicine Cerebral Palsy Common Data Elements Version 1.0 recommendations. Dev Med Child Neurol. 2018 Oct 15;60(10):976&#x2013;986. doi: 10.1111/dmcn.13723. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dmcn.13723</ArticleId><ArticleId IdType="doi">10.1111/dmcn.13723</ArticleId><ArticleId IdType="pubmed">29542813</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt C, Michalak A, Ouchterlony D, Marshall S, Masanic C, Vaidyanath C, Bhalerao S, Cusimano MD, Quon D, Fischer LK, Baker A. Common Data Elements for Concussion in Tertiary Care: Phase One in Ontario. Can J Neurol Sci. 2017 Nov 30;44(6):676&#x2013;683. doi: 10.1017/cjn.2017.222.S0317167117002220</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2017.222</ArticleId><ArticleId IdType="pubmed">29391082</ArticleId></ArticleIdList></Reference><Reference><Citation>Mawji A, Li E, Chandna A, Kortz T, Akech S, Wiens MO, Kissoon N, Ansermino M. Common data elements for predictors of pediatric sepsis: a framework to standardize data collection. PLoS One. 2021;16(6):e0253051. doi: 10.1371/journal.pone.0253051. 
 
PONE-D-20-35664</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0253051</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0253051</ArticleId><ArticleId IdType="pmc">PMC8192005</ArticleId><ArticleId IdType="pubmed">34111209</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira Manoel AL, van der Jagt M, Amin-Hanjani S, Bambakidis NC, Brophy GM, Bulsara K, Claassen J, Connolly ES, Hoffer SA, Hoh BL, Holloway RG, Kelly AG, Mayer SA, Nakaji P, Rabinstein AA, Vajkoczy P, Vergouwen MDI, Woo H, Zipfel GJ, Suarez JI, Unruptured AneurysmsSAH &#x2212; CDE Project Investigators Common data elements for unruptured intracranial aneurysms and aneurysmal subarachnoid hemorrhage: recommendations from the Working Group on Hospital Course and Acute Therapies-Proposal of a Multidisciplinary Research Group. Neurocrit Care. 2019 Jun;30(Suppl 1):36&#x2013;45. doi: 10.1007/s12028-019-00726-3.10.1007/s12028-019-00726-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-019-00726-3</ArticleId><ArticleId IdType="pubmed">31119687</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gal G, Carrier M, Castellucci LA, Cuker A, Hansen J, Klok FA, Langlois NJ, Levy JH, Middeldorp S, Righini M, Walters S, ISTH CDE Task Force  Development and implementation of common data elements for venous thromboembolism research: on behalf of SSC Subcommittee on official Communication from the SSC of the ISTH. J Thromb Haemost. 2021 Jan;19(1):297&#x2013;303. doi: 10.1111/jth.15138. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15138</ArticleId><ArticleId IdType="doi">10.1111/jth.15138</ArticleId><ArticleId IdType="pubmed">33405381</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagnon I, Friedman D, Beauchamp MH, Christie B, DeMatteo C, Macartney G, McFadyen BJ, Sirois K, Taneja C, Zabjek K, Zemek R, Mrazik M. The Canadian Pediatric Mild Traumatic Brain Injury Common Data Elements Project: Harmonizing Outcomes to Increase Understanding of Pediatric Concussion. J Neurotrauma. 2018 Aug 15;35(16):1849&#x2013;1857. doi: 10.1089/neu.2018.5887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2018.5887</ArticleId><ArticleId IdType="pubmed">30074870</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey KA, Magee LA, Dale S, Claydon J, Morris TJ, von Dadelszen P, Liston RM, Ansermino JM. A current landscape of provincial perinatal data collection in canada. J Obstet and Gynaecol Canada. 2009 Mar;31(3):236&#x2013;246. doi: 10.1016/s1701-2163(16)34122-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1701-2163(16)34122-6</ArticleId><ArticleId IdType="pubmed">19416570</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau F, Downing M, Tayler C, Fassbender K, Lesperance M, Barnett J. Toward a population-based approach to end-of-life care surveillance in Canada: initial efforts and lessons. J Palliat Care. 2018 Dec 19;29(1):13&#x2013;21. doi: 10.1177/082585971302900103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/082585971302900103</ArticleId><ArticleId IdType="pubmed">23614166</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Xu H, Qi B, Niu X, Li M, Zhao D. Stroke screening data modeling based on openEHR and NINDS Stroke CDE. 2020 IEEE International Conference on Bioinformatics and Biomedicine (BIBM); December 16-19, 2020; Seoul, Korea. 2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/BIBM49941.2020.9313127</ArticleId></ArticleIdList></Reference><Reference><Citation>Biering-S&#xf8;rensen F, Alai S, Anderson K, Charlifue S, Chen Y, DeVivo M, Flanders AE, Jones L, Kleitman N, Lans A, Noonan VK, Odenkirchen J, Steeves J, Tansey K, Widerstr&#xf6;m-Noga E, Jakeman LB. Common data elements for spinal cord injury clinical research: a National Institute for Neurological Disorders and Stroke project. Spinal Cord. 2015 Apr 10;53(4):265&#x2013;77. doi: 10.1038/sc.2014.246. 
 
sc2014246</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sc.2014.246</ArticleId><ArticleId IdType="pmc">PMC4393777</ArticleId><ArticleId IdType="pubmed">25665542</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein K. Reporting of drug allergies for use in a national decision support system. Stud Health Technol Inform. 2014;205:68&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">25160147</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurin NH, Pajouheshnia R, Roberto G, Dodd C, Hyeraci G, Bartolini C, Paoletti O, Nordeng H, Wallach-Kildemoes H, Ehrenstein V, Dudukina E, MacDonald T, De Paoli G, Loane M, Damase-Michel C, Beau A, Droz-Perroteau C, Lassalle R, Bergman J, Swart K, Schink T, Cavero-Carbonell C, Barrachina-Bonet L, Gomez-Lumbreras A, Giner-Soriano M, Arag&#xf3;n M, Neville AJ, Puccini A, Pierini A, Ientile V, Trifir&#xf2; G, Rissmann A, Leinonen MK, Martikainen V, Jordan S, Thayer D, Scanlon I, Georgiou ME, Cunnington M, Swertz M, Sturkenboom M, Gini R. From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding. Clin Pharmacol Ther. 2022 Jan 26;111(1):321&#x2013;331. doi: 10.1002/cpt.2476. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.2476</ArticleId><ArticleId IdType="pmc">PMC9299060</ArticleId><ArticleId IdType="pubmed">34826340</ArticleId></ArticleIdList></Reference><Reference><Citation>Holz C, Kessler T, Dugas M, Varghese J. Core Data Elements in Acute Myeloid Leukemia: A Unified Medical Language System-Based Semantic Analysis and Experts' Review. JMIR Med Inform. 2019 Aug 12;7(3):e13554. doi: 10.2196/13554. 
 
v7i3e13554</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/13554</ArticleId><ArticleId IdType="pmc">PMC6709897</ArticleId><ArticleId IdType="pubmed">31407666</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackenberg KAM, Algra A, Al-Shahi Salman R, Fr&#xf6;sen Juhana, Hasan D, Juvela S, Langer D, Meyers P, Morita A, Rinkel G, Etminan N, Unruptured AneurysmsSAH CDE Project Investigators Definition and prioritization of data elements for cohort studies and clinical trials on patients with unruptured intracranial aneurysms: proposal of a multidisciplinary research group. Neurocrit Care. 2019 Jun;30(Suppl 1):87&#x2013;101. doi: 10.1007/s12028-019-00729-0.10.1007/s12028-019-00729-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-019-00729-0</ArticleId><ArticleId IdType="pubmed">31102238</ArticleId></ArticleIdList></Reference><Reference><Citation>von Martial S, Brix TJ, Klotz L, Neuhaus P, Berger K, Warnke C, Meuth SG, Wiendl H, Dugas M. EMR-integrated minimal core dataset for routine health care and multiple research settings: a case study for neuroinflammatory demyelinating diseases. PLoS One. 2019;14(10):e0223886. doi: 10.1371/journal.pone.0223886. 
 
PONE-D-19-01741</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0223886</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0223886</ArticleId><ArticleId IdType="pmc">PMC6793844</ArticleId><ArticleId IdType="pubmed">31613917</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger A, Rustemeier A, G&#xf6;bel J, Kadioglu D, Britz V, Schubert K, Mohnike K, Storf H, Wagner T. How to design a registry for undiagnosed patients in the framework of rare disease diagnosis: suggestions on software, data set and coding system. Orphanet J Rare Dis. 2021 May 01;16(1):198. doi: 10.1186/s13023-021-01831-3. 
 
10.1186/s13023-021-01831-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-021-01831-3</ArticleId><ArticleId IdType="doi">10.1186/s13023-021-01831-3</ArticleId><ArticleId IdType="pmc">PMC8088651</ArticleId><ArticleId IdType="pubmed">33933089</ArticleId></ArticleIdList></Reference><Reference><Citation>Varghese J, Holz C, Neuhaus P, Bernardi M, Boehm A, Ganser A, Gore S, Heaney M, Hochhaus A, Hofmann W, Krug U, M&#xfc;ller-Tidow C, Smith A, Weltermann A, de Witte T, Hehlmann R, Dugas M. Key Data Elements in Myeloid Leukemia. Stud Health Technol Inform. 2016;228:282&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27577388</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaaf J, Chalmers J, Omran H, Pennekamp P, Sitbon O, Wagner T, Reis A, Kadioglu D, Storf H. The Registry Data Warehouse in the European Reference Network for Rare Respiratory Diseases - background, conception and implementation. Stud Health Technol Inform. 2021 May 24;278:41&#x2013;48. doi: 10.3233/SHTI210049.SHTI210049</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI210049</ArticleId><ArticleId IdType="pubmed">34042874</ArticleId></ArticleIdList></Reference><Reference><Citation>Moratilla JM, Alonso-Calvo R, Molina-Vaquero G, Paraiso-Medina S, Perez-Rey D, Maojo V. A data model based on semantically enhanced HL7 RIM for sharing patient data of breast cancer clinical trials. Stud Health Technol Inform. 2013;192:971.</Citation><ArticleIdList><ArticleId IdType="pubmed">23920745</ArticleId></ArticleIdList></Reference><Reference><Citation>Rho MJ, Kim SR, Park SH, Jang KS, Park BJ, Hong JY, Choi IY. Common data model for decision support system of adverse drug reaction to extract knowledge from multi-center database. Inf Technol Manag. 2015 Jul 3;17(1):57&#x2013;66. doi: 10.1007/s10799-015-0240-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10799-015-0240-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen JM, Cesta CE, Kjerpeseth L, Leinonen MK, H&#xe1;lfd&#xe1;narson &#xd3;, Karlstad &#xd8;, Karlsson P, Andersen M, Furu K, Hjellvik V. A common data model for harmonization in the Nordic Pregnancy Drug Safety Studies (NorPreSS) Nor J Epidemiol. 2021 Aug 16;29(1-2):117&#x2013;123. doi: 10.5324/nje.v29i1-2.4053.</Citation><ArticleIdList><ArticleId IdType="doi">10.5324/nje.v29i1-2.4053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xfc;ger A, Lockey D, Kurola J, Di Bartolomeo S, Castr&#xe9;n M, Mikkelsen S, Lossius H. A consensus-based template for documenting and reporting in physician-staffed pre-hospital services. Scand J Trauma Resusc Emerg Med. 2011 Nov 23;19(1):71. doi: 10.1186/1757-7241-19-71. 
 
1757-7241-19-71</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1757-7241-19-71</ArticleId><ArticleId IdType="doi">10.1186/1757-7241-19-71</ArticleId><ArticleId IdType="pmc">PMC3282653</ArticleId><ArticleId IdType="pubmed">22107787</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringdal KG, Lossius HM, SCANTEM ad hoc group on Scandinavian MTOSTrauma Registry Feasibility of comparing core data from existing trauma registries in scandinavia. Reaching for a Scandinavian major trauma outcome study (MTOS) Scand J Surg. 2007 Jun 24;96(4):325&#x2013;31. doi: 10.1177/145749690709600412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/145749690709600412</ArticleId><ArticleId IdType="pubmed">18265862</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaboyedoff M, Rakic M, Bachmann S, Berger C, Diezi M, Fuchs O, Frey U, Gervaix A, Gl&#xfc;cksberg Amalia Stefani, Grotzer M, Heininger U, Kahlert CR, Kaiser D, Kopp M, Lauener R, Neuhaus TJ, Paioni P, Posfay-Barbe K, Ramelli GP, Simeoni U, Simonetti G, Sokollik C, Spycher BD, Kuehni CE. SwissPedData: standardising hospital records for the benefit of paediatric research. Swiss Med Wkly. 2021 Dec 20;151:w30069. doi: 10.4414/smw.2021.w30069. 
 
Swiss Med Wkly. 2021;151:w30069</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2021.w30069</ArticleId><ArticleId IdType="pubmed">34964587</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Hsu C, Huang C. Annotating Taiwan Cancer Registry to caDSR for International Interoperability. In: Zhang Y, editor. Future Communication, Computing, Control and Management. Lecture Notes in Electrical Engineering, vol 141. Berlin, Heidelberg: Springer; 2012. pp. 257&#x2013;263.</Citation></Reference><Reference><Citation>Spronk P, Begum H, Vishwanath S, Crosbie A, Earnest A, Elder E, Lumenta D, Marinac-Dabic D, Moore C, Mureau M, Perks G, Pusic A, Stark B, von Fritschen U, Klein H, Cooter R, Rakhorst H, Hopper I. Toward International Harmonization of Breast Implant Registries: International Collaboration of Breast Registry Activities Global Common Data Set. Plast Reconstr Surg. 2020 Aug;146(2):255&#x2013;267. doi: 10.1097/PRS.0000000000006969.00006534-202008000-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PRS.0000000000006969</ArticleId><ArticleId IdType="pubmed">32740572</ArticleId></ArticleIdList></Reference><Reference><Citation>Mowforth O, Khan D, Wong M, Pickering G, Dean L, Magee J, Mullarkey L, Hirayama Y, Rihova M, Butler M, Stewart M, Goulson B, Ahmed S, Fricke K, Popa-Nimigean V, Millar Z, Venkatesh A, Willison A, Senthil K, Hazenbiller O, Sarewitz E, Sadler I, Gronlund T, Tetreault L, Harrop J, Aarabi B, Rahimi-Movaghar V, Kurpad S, Guest J, Wilson J, Kwon B, Fehlings M, McNair A, Davies B, Kotter M, AO Spine RECODE-DCM Steering CommitteeAO Spine RECODE-DCM Consortium  Gathering Global Perspectives to Establish the Research Priorities and Minimum Data Sets for Degenerative Cervical Myelopathy: Sampling Strategy of the First Round Consensus Surveys of AO Spine RECODE-DCM. Global Spine J. 2022 Feb;12(1_suppl):8S&#x2013;18S. doi: 10.1177/21925682211047546. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21925682211047546?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1177/21925682211047546</ArticleId><ArticleId IdType="pmc">PMC8859701</ArticleId><ArticleId IdType="pubmed">34879754</ArticleId></ArticleIdList></Reference><Reference><Citation>Currie AC, Cahill R, Delaney CP, Faiz OD, Kennedy RH. International expert consensus on endpoints for full-thickness laparoendoscopic colonic excision. Surg Endosc. 2016 Apr 27;30(4):1497&#x2013;502. doi: 10.1007/s00464-015-4362-z.10.1007/s00464-015-4362-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00464-015-4362-z</ArticleId><ArticleId IdType="pubmed">26123345</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies BM, Khan DZ, Mowforth OD, McNair AGK, Gronlund T, Kolias AG, Tetreault L, Starkey ML, Sadler I, Sarewitz E, Houlton D, Carter J, Kalsi-Ryan S, Aarabi B, Kwon BK, Kurpad SN, Harrop J, Wilson JR, Grossman R, Curt A, Fehlings MG, Kotter MRN. RE-CODE DCM (REsearch Objectives and Common Data Elements for Degenerative Cervical Myelopathy): A Consensus Process to Improve Research Efficiency in DCM, Through Establishment of a Standardized Dataset for Clinical Research and the Definition of the Research Priorities. Global Spine J. 2019 May 08;9(1 Suppl):65S&#x2013;76S. doi: 10.1177/2192568219832855. 
 
10.1177_2192568219832855</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2192568219832855?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1177/2192568219832855</ArticleId><ArticleId IdType="pmc">PMC6512197</ArticleId><ArticleId IdType="pubmed">31157148</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen D, Sullivan K, McNeil R, Gulf War Illness Common Data Elements Working Group: Symptoms Assessment Working Group: McNeil R, Ashford W, Bested A, Bunker J, Cheema A, Cohen D, Cook D, Cournoyer J, Craddock T, Golier J, Hardie A, Helmer D, Lindheimer J, Lloyd P, Kerr K, Krengel M, Nadkarni S, Nugent S, Paris B, Reinhard M, Rumm P, Schneiderman A, Sims K, Steele L, Turner M, Systems Assessment Working Group: Sullivan K, Abdullah L, Abreu M, Abu-Donia M, Aenlle K, Arocho J, Balbin E, Baraniuk J, Block K, Block M, DeBeer B, Engdahl B, Filipov N, Fletcher M, Kalasinsky V, Kokkotou E, Lidie K, Little D, Loging W, Morris M, Nathanson L, Nichols M, Pasinetti G, Shungu D, Waziry P, VanLeeuwen J, Younger J. A common language for Gulf War Illness (GWI) research studies: GWI common data elements. Life Sci. 2022 Feb 01;290:119818. doi: 10.1016/j.lfs.2021.119818. 
 
S0024-3205(21)00805-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119818</ArticleId><ArticleId IdType="pmc">PMC9267452</ArticleId><ArticleId IdType="pubmed">34352259</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaa A, Rahman S, Lomb&#xe8;s A, Yu-Wai-Man P, Sheikh MK, Alai-Hansen S, Cohen BH, Dimmock D, Emrick L, Falk MJ, McCormack S, Mirsky D, Moore T, Parikh S, Shoffner J, Taivassalo T, Tarnopolsky M, Tein I, Odenkirchen JC, Goldstein A, Mito Working Group Member Participants:  Common data elements for clinical research in mitochondrial disease: a National Institute for Neurological Disorders and Stroke project. J Inherit Metab Dis. 2017 May 16;40(3):403&#x2013;414. doi: 10.1007/s10545-017-0035-5. 
 
10.1007/s10545-017-0035-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10545-017-0035-5</ArticleId><ArticleId IdType="pmc">PMC7783474</ArticleId><ArticleId IdType="pubmed">28303425</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez JI, Sheikh MK, Macdonald RL, Amin-Hanjani S, Brown RD, de Oliveira Manoel AL, Derdeyn CP, Etminan N, Keller E, Leroux PD, Mayer SA, Morita A, Rinkel G, Rufennacht D, Stienen MN, Torner J, Vergouwen MDI, Wong GKC, Unruptured Intracranial AneurysmsSAH CDE Project Investigators Common Data Elements for Unruptured Intracranial Aneurysms and Subarachnoid Hemorrhage Clinical Research: A National Institute for Neurological Disorders and Stroke and National Library of Medicine Project. Neurocrit Care. 2019 Jun 13;30(Suppl 1):4&#x2013;19. doi: 10.1007/s12028-019-00723-6.10.1007/s12028-019-00723-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-019-00723-6</ArticleId><ArticleId IdType="pubmed">31087257</ArticleId></ArticleIdList></Reference><Reference><Citation>Grinspan ZM, Patel AD, Shellhaas RA, Berg AT, Axeen ET, Bolton J, Clarke DF, Coryell J, Gaillard WD, Goodkin HP, Koh S, Kukla A, Mbwana JS, Morgan LA, Singhal NS, Storey MM, Yozawitz EG, Abend NS, Fitzgerald MP, Fridinger SE, Helbig I, Massey SL, Prelack MS, Buchhalter J, Pediatric Epilepsy Learning Healthcare System  Design and implementation of electronic health record common data elements for pediatric epilepsy: Foundations for a learning health care system. Epilepsia. 2021 Jan 24;62(1):198&#x2013;216. doi: 10.1111/epi.16733. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/epi.16733</ArticleId><ArticleId IdType="pubmed">33368200</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward S, Flori H, Bennett T, Sapru A, Mourani P, Thomas N, Khemani R. Design and Rationale for Common Data Elements for Clinical Research in Pediatric Critical Care Medicine. Pediatr Crit Care Med. 2020 Nov;21(11):e1038&#x2013;e1041. doi: 10.1097/PCC.0000000000002455. 
 
00130478-202011000-00046</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000002455</ArticleId><ArticleId IdType="pmc">PMC7609513</ArticleId><ArticleId IdType="pubmed">32639472</ArticleId></ArticleIdList></Reference><Reference><Citation>Luciano MG, Batzdorf U, Kula RW, Rocque BG, Maher CO, Heiss J, Martin BA, Bolognese PA, Ashley-Koch A, Limbrick D, Poppe DJ, Esposito KM, Odenkirchen J, Esterlitz JR, Ala'i S, Joseph K, Feldman RS, Riddle R, Chiari I Malformation Common Data Element Working Group  Development of common data elements for use in chiari malformation type I clinical research: an NIH/NINDS project. Neurosurgery. 2019 Dec 01;85(6):854&#x2013;860. doi: 10.1093/neuros/nyy475. 
 
5299237</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuros/nyy475</ArticleId><ArticleId IdType="pmc">PMC7054710</ArticleId><ArticleId IdType="pubmed">30690581</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer CS, Williams N, Huser V. Identification of common data elements from pivotal FDA trials. AMIA Annu Symp Proc. 2020;2020:813&#x2013;822. 
 
116_3416812</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075437</ArticleId><ArticleId IdType="pubmed">33936456</ArticleId></ArticleIdList></Reference><Reference><Citation>Broglio SP, Kontos AP, Levin H, Schneider K, Wilde EA, Cantu RC, Feddermann-Demont N, Fuller GW, Gagnon I, Gioia GA, Giza C, Griesbach GS, Leddy JJ, Lipton ML, Mayer AR, McAllister TW, McCrea M, McKenzie LB, Putukian M, Signoretti S, Suskauer SJ, Tamburro R, Turner M, Yeates KO, Zemek R, Ala'i S, Esterlitz J, Gay K, Bellgowan PS, Joseph K. National Institute of Neurological Disorders and Stroke and Department of Defense Sport-Related Concussion Common Data Elements Version 1.0 recommendations. J Neurotrauma. 2018 Dec 01;35(23):2776&#x2013;2783. doi: 10.1089/neu.2018.5643. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2018.5643</ArticleId><ArticleId IdType="pmc">PMC6247979</ArticleId><ArticleId IdType="pubmed">29717643</ArticleId></ArticleIdList></Reference><Reference><Citation>Wandner L, Domenichiello A, Beierlein J, Pogorzala L, Aquino G, Siddons A, Porter L, Atkinson J, NIH Pain Consortium Institute and Center Representatives  NIH's Helping to End Addiction Long-term Initiative (NIH HEAL Initiative) clinical pain management common data element program. J Pain. 2022 Mar;23(3):370&#x2013;378. doi: 10.1016/j.jpain.2021.08.005. 
 
S1526-5900(21)00321-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2021.08.005</ArticleId><ArticleId IdType="pubmed">34508905</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll A, Vogel LC, Zebracki K, Noonan VK, Biering-S&#xf8;rensen F, Mulcahey MJ. Relevance of the international spinal cord injury basic data sets to youth: an Inter-Professional review with recommendations. Spinal Cord. 2017 Sep 28;55(9):875&#x2013;881. doi: 10.1038/sc.2017.14.sc201714</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sc.2017.14</ArticleId><ArticleId IdType="pubmed">28244501</ArticleId></ArticleIdList></Reference><Reference><Citation>Albino J, Tiwari T, Gansky S, Henshaw M, Barker J, Brega A, Gregorich S, Heaton B, Batliner T, Borrelli B, Geltman P, Kressin N, Weintraub J, Finlayson T, Garcia R, Early Childhood Caries Collaborating Centers  The basic research factors questionnaire for studying early childhood caries. BMC Oral Health. 2017 May 19;17(1):83. doi: 10.1186/s12903-017-0374-5. 
 
10.1186/s12903-017-0374-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12903-017-0374-5</ArticleId><ArticleId IdType="doi">10.1186/s12903-017-0374-5</ArticleId><ArticleId IdType="pmc">PMC5437655</ArticleId><ArticleId IdType="pubmed">28526003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher J, Krisa L, Middleton D, Leiby B, Harrop J, Shah L, Schwartz E, Doshi A, Faro S, Mohamed F, Flanders A. Validation of the National Institute of Neurological Disorders and Stroke Spinal Cord Injury MRI Common Data Elements Instrument. AJNR Am J Neuroradiol. 2021 Feb 11;42(4):787&#x2013;793. doi: 10.3174/ajnr.a7000.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.a7000</ArticleId><ArticleId IdType="pmc">PMC8040979</ArticleId><ArticleId IdType="pubmed">33574102</ArticleId></ArticleIdList></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012 Jan 01;19(1):54&#x2013;60. doi: 10.1136/amiajnl-2011-000376. 
 
amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner D, Knuth KH, Abato M, Erde SM, White T, DeBellis R, Gardner EP. Common data model for neuroscience data and data model exchange. J Am Med Inform Assoc. 2001 Jan 01;8(1):17&#x2013;33. doi: 10.1136/jamia.2001.0080017. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2001.0080017</ArticleId><ArticleId IdType="pmc">PMC134589</ArticleId><ArticleId IdType="pubmed">11141510</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel AA, Kajdacsy-Balla A, Berman JJ, Bosland M, Datta MW, Dhir R, Gilbertson J, Melamed J, Orenstein J, Tai K, Becich MJ. The development of common data elements for a multi-institute prostate cancer tissue bank: the Cooperative Prostate Cancer Tissue Resource (CPCTR) experience. BMC Cancer. 2005 Aug 21;5(1):108. doi: 10.1186/1471-2407-5-108. 
 
1471-2407-5-108</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2407-5-108</ArticleId><ArticleId IdType="doi">10.1186/1471-2407-5-108</ArticleId><ArticleId IdType="pmc">PMC1236914</ArticleId><ArticleId IdType="pubmed">16111498</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisinger SJ, Ryan PB, O'Hara DJ, Powell GE, Painter JL, Pattishall EN, Morris JA. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J Am Med Inform Assoc. 2010 Nov 01;17(6):652&#x2013;62. doi: 10.1136/jamia.2009.002477. 
 
17/6/652</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jamia.2009.002477</ArticleId><ArticleId IdType="pmc">PMC3000752</ArticleId><ArticleId IdType="pubmed">20962127</ArticleId></ArticleIdList></Reference><Reference><Citation>Loring D, Lowenstein D, Barbaro N, Fureman B, Odenkirchen J, Jacobs M, Austin J, Dlugos D, French J, Gaillard W, Hermann B, Hesdorffer D, Roper S, Van Cott A, Grinnon S, Stout A. Common data elements in epilepsy research: development and implementation of the NINDS epilepsy CDE project. Epilepsia. 2011 Jun;52(6):1186&#x2013;91. doi: 10.1111/j.1528-1167.2011.03018.x. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1528-1167.2011.03018.x</ArticleId><ArticleId IdType="pmc">PMC3535455</ArticleId><ArticleId IdType="pubmed">21426327</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley SR, Wilde EA, Anderson VA, Bedell G, Beers SR, Campbell TF, Chapman SB, Ewing-Cobbs L, Gerring JP, Gioia GA, Levin HS, Michaud LJ, Prasad MR, Swaine BR, Turkstra LS, Wade SL, Yeates KO, Pediatric TBI Outcomes Workgroup  Recommendations for the use of common outcome measures in pediatric traumatic brain injury research. J Neurotrauma. 2012 Mar 01;29(4):678&#x2013;705. doi: 10.1089/neu.2011.1838. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2011.1838</ArticleId><ArticleId IdType="pmc">PMC3289848</ArticleId><ArticleId IdType="pubmed">21644810</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerring JP, Wade S. The essential role of psychosocial risk and protective factors in pediatric traumatic brain injury research. J Neurotrauma. 2012 Mar 01;29(4):621&#x2013;8. doi: 10.1089/neu.2011.2234. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2011.2234</ArticleId><ArticleId IdType="pmc">PMC3289845</ArticleId><ArticleId IdType="pubmed">22091875</ArticleId></ArticleIdList></Reference><Reference><Citation>Saver JL, Warach S, Janis S, Odenkirchen J, Becker K, Benavente O, Broderick J, Dromerick AW, Duncan P, Elkind MS, Johnston K, Kidwell CS, Meschia JF, Schwamm L. Standardizing the Structure of Stroke Clinical and Epidemiologic Research Data. Stroke. 2012 Apr;43(4):967&#x2013;973. doi: 10.1161/strokeaha.111.634352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/strokeaha.111.634352</ArticleId><ArticleId IdType="pmc">PMC3493110</ArticleId><ArticleId IdType="pubmed">22308239</ArticleId></ArticleIdList></Reference><Reference><Citation>Dastgir J, Rutkowski A, Alvarez R, Cossette S, Yan K, Hoffmann R, Sewry C, Hayashi Y, Goebel H, Bonnemann C, Lawlor M. Common Data Elements for Muscle Biopsy Reporting. Arch Pathol Lab Med. 2016 Jan;140(1):51&#x2013;65. doi: 10.5858/arpa.2014-0453-OA. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2014-0453-OA</ArticleId><ArticleId IdType="pmc">PMC4975562</ArticleId><ArticleId IdType="pubmed">26132600</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone RD, Neville J, Chapman AB, Gitomer BY, Miskulin DC, Torres VE, Czerwiec FS, Dennis E, Kisler B, Kopko S, Krasa HB, LeRoy E, Castedo J, Schrier RW, Broadbent S. Therapeutic area data standards for autosomal dominant polycystic kidney disease: a report from the Polycystic Kidney Disease Outcomes Consortium (PKDOC) Am J Kidney Dis. 2015 Oct;66(4):583&#x2013;90. doi: 10.1053/j.ajkd.2015.04.044.S0272-6386(15)00758-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2015.04.044</ArticleId><ArticleId IdType="pubmed">26088508</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue JK, Vassar MJ, Lingsma HF, Cooper SR, Okonkwo DO, Valadka AB, Gordon WA, Maas AIR, Mukherjee P, Yuh EL, Puccio AM, Schnyer DM, Manley G, TRACK-TBI Investigators  Transforming research and clinical knowledge in traumatic brain injury pilot: multicenter implementation of the common data elements for traumatic brain injury. J Neurotrauma. 2013 Nov 15;30(22):1831&#x2013;44. doi: 10.1089/neu.2013.2970. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2013.2970</ArticleId><ArticleId IdType="pmc">PMC3814815</ArticleId><ArticleId IdType="pubmed">23815563</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks K, Tcheng J, Bozkurt B, Chaitman B, Cutlip D, Farb A, Fonarow G, Jacobs J, Jaff M, Lichtman J, Limacher M, Mahaffey K, Mehran R, Nissen S, Smith E, Targum S, American College of Cardiology. American Heart Association  2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards) Circulation. 2015 Jul 28;132(4):302&#x2013;61. doi: 10.1161/CIR.0000000000000156. 
 
CIR.0000000000000156</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000156</ArticleId><ArticleId IdType="pubmed">25547519</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore SM, Schiffman R, Waldrop-Valverde D, Redeker NS, McCloskey DJ, Kim MT, Heitkemper MM, Guthrie BJ, Dorsey SG, Docherty SL, Barton D, Bailey DE, Austin JK, Grady P. Recommendations of common data elements to advance the science of self-management of chronic conditions. J Nurs Scholarsh. 2016 Sep;48(5):437&#x2013;47. doi: 10.1111/jnu.12233. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnu.12233</ArticleId><ArticleId IdType="pmc">PMC5490657</ArticleId><ArticleId IdType="pubmed">27486851</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinstein YR, McInnes P. NIH/NCATS/GRDR&#xae; Common Data Elements: a leading force for standardized data collection. Contemp Clin Trials. 2015 May;42:78&#x2013;80. doi: 10.1016/j.cct.2015.03.003. 
 
S1551-7144(15)00047-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2015.03.003</ArticleId><ArticleId IdType="pmc">PMC4450118</ArticleId><ArticleId IdType="pubmed">25797358</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vito Dabbs A, Myers B, Mc Curry K, Dunbar-Jacob J, Hawkins R, Begey A, Dew M. User-centered design and interactive health technologies for patients. Comput Inform Nurs. 2009;27(3):175&#x2013;83. doi: 10.1097/NCN.0b013e31819f7c7c. 
 
00024665-200905000-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NCN.0b013e31819f7c7c</ArticleId><ArticleId IdType="pmc">PMC2818536</ArticleId><ArticleId IdType="pubmed">19411947</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37596918</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-2995</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Transfusion</Title><ISOAbbreviation>Transfusion</ISOAbbreviation></Journal><ArticleTitle>How do we build a comprehensive Vein-to-Vein (V2V) database for conduct of observational studies in transfusion medicine? Demonstrated with the Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric V2V database protocol.</ArticleTitle><Pagination><StartPage>1623</StartPage><EndPage>1632</EndPage><MedlinePgn>1623-1632</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/trf.17507</ELocationID><Abstract><AbstractText Label="BACKGROUND">The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P) is the fourth iteration of the National Heart, Lung, and Blood Institute's REDS program and includes a focus on pediatric populations. The REDS-IV-P Vein-to-Vein (V2V) database encompasses linked information from blood donors, blood components, and patients to facilitate studies in transfusion medicine.</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS">The V2V database is an Observational Medical Outcomes Partnership Common Data Model database. The study period is April 1, 2019 through December 31, 2023. Data from all donors and donations at participating blood centers, all blood components derived from the donations, and all inpatient visits and selected outpatient visits at participating hospitals are included. The database captures all information within patient data domains not restricting data to a preselected subset of medical records.</AbstractText><AbstractText Label="RESULTS">The V2V database contains data from 7 blood centers and 22 hospitals. We project the database will have over 2 billion pieces of information from 1.3 million patients with 20.6 million healthcare encounters. The database will include data on approximately 1 million transfused units and 2.3 million donors with approximately 6.8 million donation visits.</AbstractText><AbstractText Label="CONCLUSION">The REDS-IV-P V2V database is a comprehensive database with data from millions of blood donors, blood components, and patients. A diverse set of data from the encounters are included in the database such that emerging questions can likely be addressed. The Observational Medical Outcomes Partnership Common Data Model is an efficient, flexible, and increasingly used common data model. The final de-identified database will be publicly available.</AbstractText><CopyrightInformation>&#xa9; 2023 AABB.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Birch</LastName><ForeName>Rebecca Jeffries</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-2871-2750</Identifier><AffiliationInfo><Affiliation>Westat, Rockville, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umbel</LastName><ForeName>Keith</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Westat, Rockville, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karafin</LastName><ForeName>Matthew S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goel</LastName><ForeName>Ruchika</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9653-9905</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathew</LastName><ForeName>Sunitha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Westat, Rockville, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pace</LastName><ForeName>Wilson</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>DARTNet Institute, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>NHLBI Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P)</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HHSN 75N92019D00032</GrantID><Agency>National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country/></Grant><Grant><GrantID>HHSN 75N92019D00033</GrantID><Agency>National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country/></Grant><Grant><GrantID>HHSN 75N92019D00034</GrantID><Agency>National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country/></Grant><Grant><GrantID>HHSN 75N92019D00035</GrantID><Agency>National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country/></Grant><Grant><GrantID>HHSN 75N92019D00036</GrantID><Agency>National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country/></Grant><Grant><GrantID>HHSN 75N92019D00037</GrantID><Agency>National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transfusion</MedlineTA><NlmUniqueID>0417360</NlmUniqueID><ISSNLinking>0041-1132</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064826" MajorTopicYN="Y">Transfusion Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001782" MajorTopicYN="N">Blood Donors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008499" MajorTopicYN="N">Medical Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">database</Keyword><Keyword MajorTopicYN="N">health research methodology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>19</Day><Hour>20</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>19</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37596918</ArticleId><ArticleId IdType="doi">10.1111/trf.17507</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Josephson CD, Glynn S, Mathew S, Birch R, Bakkour S, Baumann Kreuziger L, et al. The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P): a research program striving to improve blood donor safety and optimize transfusion outcomes across the lifespan. Transfusion. 2022;62:982-999.</Citation></Reference><Reference><Citation>Spitalnik SL, Triulzi D, Devine DV, Dzik WH, Eder AF, Gernsheimer T, et al. 2015 Proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium. Transfusion. 2015;55(9):2282-2290.</Citation></Reference><Reference><Citation>Kleinman S, Glynn SA. Database research in transfusion medicine: the power of large numbers. Transfusion. 2015;55(7):1591-1595.</Citation></Reference><Reference><Citation>Karafin MS, Bruhn R, Westlake M, Sullivan MT, Bialkowski W, Edgren G, et al. Demographic and epidemiologic characterization of transfusion recipients from four US regions: evidence from the REDS-III recipient database. Transfusion. 2017;57(12):2903-2913.</Citation></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, Ma Q, Knoll C, Schuemie M, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22(3):553-564.</Citation></Reference><Reference><Citation>Klann JG, Joss MAH, Embree K, Murphy SN. Data model harmonization for the All Of Us Research Program: transforming i2b2 data into the OMOP common data model. PloS One. 2019;14(2):e0212463.</Citation></Reference><Reference><Citation>Sun Y, Butler A, Stewart LA, Liu H, Yuan C, Southard CT, et al. Building an OMOP common data model-compliant annotated corpus for COVID-19 clinical trials. Biomed Inform. 2021;118:103790.</Citation></Reference><Reference><Citation>Kahn MG, Callahan TJ, Barnard J, Bauck AE, Brown J, Davidson BN, et al. A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. Egems. 2016;4(1):1244.</Citation></Reference><Reference><Citation>Reinecke I, Zoch M, Reich C, Sedlmayr M, Bathelt F. The usage of OHDSI OMOP-a scoping review. Stud Health Technol Inform. 2021;283:95-103.</Citation></Reference><Reference><Citation>Rosenbloom ST, Carroll RJ, Warner JL, Matheny ME, Denny JC. Representing knowledge consistently across health systems. Yearb Med Inform. 2017 Aug;26(1):139-147.</Citation></Reference><Reference><Citation>You SC, Lee S, Choi B, Park RW. Establishment of an international evidence sharing network through common data model for cardiovascular research. Korean Circ J. 2022;52(12):853-864.</Citation></Reference><Reference><Citation>Goel R, Zhu X, Patel EU, Crowe EP, Ness PM, Katz LM, et al. Blood transfusion trends in the United States: national inpatient sample, 2015 to 2018. Blood Adv. 2021;5(20):4179-4184.</Citation></Reference><Reference><Citation>Goel R, Josephson CD, Patel EU, Petersen MR, Packman Z, Gehrie E, et al. Individual- and hospital-level correlates of red blood cell, platelet, and plasma transfusions among hospitalized children and neonates: a nationally representative study in the United States. Transfusion. 2020;60(8):1700-1712.</Citation></Reference><Reference><Citation>Goel R, Chappidi MR, Patel EU, Ness PM, Cushing MM, Frank SM, et al. Trends in red blood cell, plasma, and platelet transfusions in the United States, 1993-2014. JAMA. 2018;319(8):825-827.</Citation></Reference><Reference><Citation>Goel R, Zhu X, Makhani S, Petersen MR, Josephson CD, Katz LM, et al. Blood transfusions in gunshot-wound-related emergency department visits and hospitalizations in the United States. Transfusion. 2021;61(8):2277-2289.</Citation></Reference><Reference><Citation>Goel R, Josephson CD, Patel EU, Petersen MR, Makhani S, Frank SM, et al. Perioperative transfusions and venous thromboembolism. Pediatrics. 2020;145(4):e20192351.</Citation></Reference><Reference><Citation>Goel R, Patel EU, Cushing MM, Frank SM, Ness PM, Takemoto CM, et al. Association of perioperative red blood cell transfusions with venous thromboembolism in a North American Registry. JAMA Surg. 2018;153(9):826-833.</Citation></Reference><Reference><Citation>Zhao J, Rostgaard K, Hjalgrim H, Edgren G. The Swedish Scandinavian donations and transfusions database (SCANDAT3-S)-50&#x2009;years of donor and recipient follow-up. Transfusion. 2020;60(12):3019-3027.</Citation></Reference><Reference><Citation>Fishbein HA, Birch RJ, Mathew SM, Sawyer HL, Pulver G, Poling J, et al. The longitudinal epidemiologic assessment of diabetes risk (LEADR): unique 1.4 M patient electronic health record cohort. Healthcare. 2020;8(4):100458.</Citation></Reference><Reference><Citation>Lamer A, Osama A-A, Bourgeois A, et al. Transforming anesthesia data into the observational medical outcomes partnership common data model: development and usability study. J Med Internet Res. 2021;23(10):e29259.</Citation></Reference><Reference><Citation>USFDA. Utilization of blood components within the BEST Initiative EHR network, 2012-2018. 2020. Available from: https://bestinitiative.org/wp-content/uploads/2020/08/Blood_Component_Exposure_Report_2020.pdf</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37598737</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>145</Volume><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Pad&#xe9; approximant meets federated learning: A nearly lossless, one-shot algorithm for evidence synthesis in distributed research networks with rare outcomes.</ArticleTitle><Pagination><StartPage>104476</StartPage><MedlinePgn>104476</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2023.104476</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(23)00197-1</ELocationID><Abstract><AbstractText Label="OBJECTIVE">We developed and evaluated a novel one-shot distributed algorithm for evidence synthesis in distributed research networks with rare outcomes.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Fed-Pad&#xe9;, motivated by a classic mathematical tool, Pad&#xe9; approximants, reconstructs the multi-site data likelihood via Pad&#xe9; approximant whose key parameters can be computed distributively. Thanks to the simplicity of [2,2] Pad&#xe9; approximant, Fed-Pad&#xe9; requests an extremely simple task and low communication cost for data partners. Specifically, each data partner only needs to compute and share the log-likelihood and its first 4 gradients evaluated at an initial estimator. We evaluated the performance of our algorithm with extensive simulation studies and four observational healthcare databases.</AbstractText><AbstractText Label="RESULTS">Our simulation studies revealed that a [2,2]-Pad&#xe9; approximant can well reconstruct the multi-site likelihood so that Fed-Pad&#xe9; produces nearly identical estimates to the pooled analysis. Across all simulation scenarios considered, the median of relative bias and rate of instability of our Fed-Pad&#xe9; are both &lt;0.1%, whereas meta-analysis estimates have bias up to 50% and instability up to 75%. Furthermore, the confidence intervals derived from the Fed-Pad&#xe9; algorithm showed better coverage of the truth than confidence intervals based on the meta-analysis. In real data analysis, the Fed-Pad&#xe9; has a relative bias of &lt;1% for all three comparisons for risks of acute liver injury and decreased libido, whereas the meta-analysis estimates have a substantially higher bias (around 10%).</AbstractText><AbstractText Label="CONCLUSION">The Fed-Pad&#xe9; algorithm is nearly lossless, stable, communication-efficient, and easy to implement for models with rare outcomes. It provides an extremely suitable and convenient approach for synthesizing evidence in distributed research networks with rare outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qiong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuemie</LastName><ForeName>Martijn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, United States of America; Janssen Research &amp; Development, Titusville, NJ, United States of America; Department of Biostatistics, University of California, Los Angeles, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suchard</LastName><ForeName>Marc A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, United States of America; Department of Biostatistics, University of California, Los Angeles, CA, United States of America; Department of Human Genetics, University of California, Los Angeles, CA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, United States of America; Janssen Research &amp; Development, Titusville, NJ, United States of America; Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, United States of America; Medical Informatics Services, New York-Presbyterian Hospital, New York, NY, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rohde</LastName><ForeName>Charles A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Johns Hopkins University, Baltimore, MD, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America; Observational Health Data Sciences and Informatics, New York, NY, United States of America. Electronic address: ychen123@pennmedicine.upenn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R56 AG069880</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 TR003709</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM013519</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM012607</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI130460</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AG074604</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG073435</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003198" MajorTopicYN="N">Computer Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Distributed algorithm</Keyword><Keyword MajorTopicYN="N">Distributed research networks</Keyword><Keyword MajorTopicYN="N">Evidence synthesis</Keyword><Keyword MajorTopicYN="N">Pad&#xe9; approximants</Keyword><Keyword MajorTopicYN="N">Rare outcomes</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>20</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37598737</ArticleId><ArticleId IdType="mid">NIHMS1929844</ArticleId><ArticleId IdType="pmc">PMC11056245</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2023.104476</ArticleId><ArticleId IdType="pii">S1532-0464(23)00197-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Friedman CP, Wong AK, Blumenthal D, Achieving a nationwide learning health system, Science translational medicine 2 (57) (2010) 57cm29&#x2013;57cm29.</Citation><ArticleIdList><ArticleId IdType="pubmed">21068440</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR, et al., Observational health data sciences and informatics (ohdsi): opportunities for observational researchers, Studies in health technology and informatics 216 (2015) 574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrest CB, Margolis PA, Bailey LC, Marsolo K, Del Beccaro MA, Finkelstein JA, Milov DE, Vieland VJ, Wolf BA, Yu FB, et al., Pedsnet: a national pediatric learning health system, Journal of the American Medical Informatics Association 21 (4) (2014) 602&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078288</ArticleId><ArticleId IdType="pubmed">24821737</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS, Launching pcornet, a national patient-centered clinical research network, Journal of the American Medical Informatics Association 21 (4) (2014) 578&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078292</ArticleId><ArticleId IdType="pubmed">24821743</ArticleId></ArticleIdList></Reference><Reference><Citation>Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, Suchard MA, DuMouchel W, Berlin JA, Evaluating the impact of database heterogeneity on observational study results, American journal of epidemiology 178 (4) (2013) 645&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3736754</ArticleId><ArticleId IdType="pubmed">23648805</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu D, Yoshida K, Fireman BH, Toh S, Inverse probability weighted cox model in multi-site studies without sharing individual-level data, Statistical methods in medical research 29 (6) (2020) 1668&#x2013;1681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042068</ArticleId><ArticleId IdType="pubmed">31448681</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan R, Luo C, Schuemie MJ, Tong J, Liang CJ, Chang HH, Boland MR, Bian J, Xu H, Holmes JH, et al., Learning from local to global: An efficient distributed algorithm for modeling time-to-event data, Journal of the American Medical Informatics Association 27 (7) (2020) 1028&#x2013;1036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7647322</ArticleId><ArticleId IdType="pubmed">32626900</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C, Duan R, Chen Y, Odach: A one-shot distributed algorithm for cox model with heterogeneous multi-center data, medRxiv (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9033863</ArticleId><ArticleId IdType="pubmed">35459767</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuemie MJ, Chen Y, Madigan D, Suchard MA, Combining cox regressions across a heterogeneous distributed research network facing small and zero counts, arXiv preprint arXiv:2101.01551 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34841975</ArticleId></ArticleIdList></Reference><Reference><Citation>Duke JD, Ryan PB, Suchard MA, Hripcsak G, Jin P, Reich C, Schwalm M-S, Khoma Y, Wu Y, Xu H, et al., Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network, Epilepsia 58 (8) (2017) e101&#x2013;e106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6632067</ArticleId><ArticleId IdType="pubmed">28681416</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker GA, Baker GA Jr, Graves-Morris P, Baker G, Baker SS, Pade Approximants: Encyclopedia of Mathematics and It&#x2019;s Applications, Cambridge University Press, 1996.</Citation></Reference><Reference><Citation>Hauck WW Jr, Donner A, Wald&#x2019;s test as applied to hypotheses in logit analysis, Journal of the american statistical association 72 (360a) (1977) 851&#x2013;853.</Citation></Reference><Reference><Citation>Tian Y, Schuemie MJ, Suchard MA, Evaluating large-scale propensity score performance through real-world and synthetic data experiments, International journal of epidemiology 47 (6) (2018) 2005&#x2013;2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Wang Y, Schuemie MJ, Blei DM, Hripcsak G, Adjusting for indirectly measured confounding using large-scale propensity score, Journal of biomedical informatics 134 (2022) 104204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9692203</ArticleId><ArticleId IdType="pubmed">36108816</ArticleId></ArticleIdList></Reference><Reference><Citation>Siannis F, Barrett J, Farewell V, Tierney J, One-stage parametric meta-analysis of time-to-event outcomes, Statistics in Medicine 29 (29) (2010) 3030&#x2013;3045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3020327</ArticleId><ArticleId IdType="pubmed">20963770</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Lemey P, Baele G, Ayres DL, Drummond AJ, Rambaut A, Bayesian phylogenetic and phylodynamic data integration using beast 1.10, Virus evolution 4 (1) (2018) vey016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6007674</ArticleId><ArticleId IdType="pubmed">29942656</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Schuemie MJ, Krumholz HM, You SC, Chen R, Pratt N, Reich CG, Duke J, Madigan D, Hripcsak G, et al., Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis, The Lancet 394 (10211) (2019) 1816&#x2013;1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Liang K-Y, On the asymptotic behaviour of the pseudolikelihood ratio test statistic with boundary problems, Biometrika 97 (3) (2010) 603&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372243</ArticleId><ArticleId IdType="pubmed">22822249</ArticleId></ArticleIdList></Reference><Reference><Citation>Stijnen T, Hamza TH, Ozdemir P, Random effects meta-analysis of event outcom&#xeb; in the framework of the generalized linear mixed model with applications in sparse data, Statistics in medicine 29 (29) (2010) 3046&#x2013;3067.</Citation><ArticleIdList><ArticleId IdType="pubmed">20827667</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann HP, Goodman SN, Bayesian communication: a clinically significant paradigm for electronic publication, Journal of the American Medical Informatics Association 7 (3) (2000) 254&#x2013;266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC61428</ArticleId><ArticleId IdType="pubmed">10833162</ArticleId></ArticleIdList></Reference><Reference><Citation>McCaw ZR, Yin G, Wei L-J, Using the restricted mean survival time difference as an alternative to the hazard ratio for analyzing clinical cardiovascular studies, Circulation 140 (17) (2019) 1366&#x2013;1368.</Citation><ArticleIdList><ArticleId IdType="pubmed">31634007</ArticleId></ArticleIdList></Reference><Reference><Citation>Perego C, Sbolli M, Specchia C, Fiuzat M, McCaw ZR, Metra M, Oriecuia C, Peveri G, Wei L-J, O&#x2019;Connor CM, et al., Utility of restricted mean survival time analysis for heart failure clinical trial evaluation and interpretation, Heart Failure 8 (12) (2020) 973&#x2013;983.</Citation><ArticleIdList><ArticleId IdType="pubmed">33039446</ArticleId></ArticleIdList></Reference><Reference><Citation>Geladi P, Kowalski BR, Partial least-squares regression: a tutorial, Analytica chimica acta 185 (1986) 1&#x2013;17.</Citation></Reference><Reference><Citation>Lu C-L, Wang S, Ji Z, Wu Y, Xiong L, Jiang X, Ohno-Machado L, Webdisco: a web service for distributed cox model learning without patient-level data sharing, Journal of the American Medical Informatics Association 22 (6) (2015) 1212&#x2013;1219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5009917</ArticleId><ArticleId IdType="pubmed">26159465</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37603402</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2562-0959</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2023</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>JMIR dermatology</Title><ISOAbbreviation>JMIR Dermatol</ISOAbbreviation></Journal><ArticleTitle>Prescribing Patterns of Oral Antibiotics and Isotretinoin for Acne in a Colorado Hospital System: Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>e42883</StartPage><MedlinePgn>e42883</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e42883</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/42883</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Guidelines established by the American Academy of Dermatology recommend oral antibiotics as first-line therapy for mild, moderate, and severe acne. However, it is recommended to minimize the duration of oral antibiotic use, and there is increasing support for other systemic agents for acne.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We sought to characterize the use of oral antibiotics and isotretinoin for the treatment of acne in the pediatric and young adult population aged 10 through 20 years and the adult population aged 21 to 45 years from 2011 to 2019.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective, observational cohort study using electronic data from the enterprise data warehouse of the University of Colorado Anschutz Medical Campus and its affiliates, with data in the format of the Observational Health Data Sciences and Informatics (OHDSI) Observational Medical Outcomes Partnership (OMOP) common data model. Categorical values (sex, race, and ethnicity) were compared using chi-square tests, and continuous variables (age) were compared using 2-tailed t tests.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our cohort of 15,704 patients was composed of mostly White (12,776/15,704, 81.4%), non-Hispanic or Latino (13,307/15,704, 84.7%), and female (11,093/15,704, 70.6%) patients. Among the 4605 male patients in the eligible cohort, 1810 (39%) received an oral antibiotic treatment, in comparison to 3109 (28%) of the 11,093 eligible women (P&lt;.001). Among the 4605 men who were eligible for treatment with isotretinoin in this population, 988 (21.5%) received a course of isotretinoin, compared to only 10.4% (1159/11,093) eligible women (P&lt;.001). Male patients were 1.67 times more likely to have received an antibiotic prescription&#xa0;(odds ratio [OR] 1.67, 95% CI 1.55-1.79) and over twice as likely to have received an isotretinoin prescription (OR 2.34, 95% CI 2.13-2.57) than female patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Minocycline was the most frequently prescribed antibiotic for the treatment of acne in this study cohort. From 2015 to 2019, there was no significant change in the number of antibiotic prescriptions over time. Men were significantly more likely to receive both oral antibiotics and isotretinoin than female patients. Multiple factors could be contributing to this discrepancy, including the burden of iPLEDGE, additional systemic treatment options for female patients, and the difference in acne severity across sexes. We could not determine the difference in severity of acne between male and female patients in our cohort, and further research is needed to ascertain the variation across sexes.</AbstractText><CopyrightInformation>&#xa9;Madeline J Adelman, Torunn E Sivesind, Isaac Weber, Grace Bosma, Camille Hochheimer, Chante Karimkhani, Lisa M Schilling, John S Barbieri, Robert P Dellavalle. Originally published in JMIR Dermatology (http://derma.jmir.org), 21.08.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Adelman</LastName><ForeName>Madeline J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-7816-8220</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sivesind</LastName><ForeName>Torunn E</ForeName><Initials>TE</Initials><Identifier Source="ORCID">0000-0003-4805-0632</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Weber</LastName><ForeName>Isaac</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-4274-4708</Identifier><AffiliationInfo><Affiliation>School of Medicine, University of Missouri, Columbia, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosma</LastName><ForeName>Grace</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-2397-2772</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics and Informatics, University of Colorado School of Public Health, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hochheimer</LastName><ForeName>Camille</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0984-0909</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics and Informatics, University of Colorado School of Public Health, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karimkhani</LastName><ForeName>Chante</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2347-7576</Identifier><AffiliationInfo><Affiliation>Flatirons Dermatology, Broomfield, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0002-6878-189X</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Division of General Internal Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbieri</LastName><ForeName>John S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-5467-4102</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, Brigham and Women's Hospital, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellavalle</LastName><ForeName>Robert P</ForeName><Initials>RP</Initials><Identifier Source="ORCID">0000-0001-8132-088X</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, MI, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Dermatology, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Colorado School of Public Health, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Dermatol</MedlineTA><NlmUniqueID>101770607</NlmUniqueID><ISSNLinking>2562-0959</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acne</Keyword><Keyword MajorTopicYN="N">antibiotics</Keyword><Keyword MajorTopicYN="N">databases</Keyword><Keyword MajorTopicYN="N">guidelines</Keyword><Keyword MajorTopicYN="N">isotretinoin</Keyword><Keyword MajorTopicYN="N">prescribing</Keyword><Keyword MajorTopicYN="N">retinoids</Keyword></KeywordList><CoiStatement>Conflicts of Interest: RPD is deputy chair of the American Academy of Dermatology DataDerm Data Governance Committee and a Cochrane Council Co-Chair. RPD is also Editor-in-Chief of <i>JMIR Dermatology</i> at the time of this publication. TES received salary from Pfizer (grant 25B1519; principal investigator Stanca Birlea) and the National Institutes of Health (grant 2T32AR00741136A1; principal investigator Dennis Roop). TES served as an editorial board member-at-large for <i>JMIR Dermatology</i>. MJA received a fellowship salary from Pfizer (independent grants 65894351 and 58858477; principal investigator RPD). JSB has received consulting fees from Dexcel Pharma.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>11</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37603402</ArticleId><ArticleId IdType="pmc">PMC10477922</ArticleId><ArticleId IdType="doi">10.2196/42883</ArticleId><ArticleId IdType="pii">v6i1e42883</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, Bowe WP, Graber EM, Harper JC, Kang S, Keri JE, Leyden JJ, Reynolds RV, Silverberg NB, Gold LFS, Tollefson MM, Weiss JS, Dolan NC, Sagan AA, Stern M, Boyer KM, Bhushan R. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945&#x2013;73.e33. doi: 10.1016/j.jaad.2015.12.037. 
 
S0190-9622(15)02614-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2015.12.037</ArticleId><ArticleId IdType="pubmed">26897386</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD compare. IHME Viz Hub.  [2023-05-20].  
 https://vizhub.healthdata.org/gbd-compare/
</Citation></Reference><Reference><Citation>Sulzberger MB, Zaidens SH. Psychogenic factors in dermatologic disorders. Med Clin North Am. 1948;32(3):669&#x2013;685. doi: 10.1016/s0025-7125(16)35686-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0025-7125(16)35686-3</ArticleId><ArticleId IdType="pubmed">18857202</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbieri JS, Hoffstad O, Margolis DJ. Duration of oral tetracycline-class antibiotic therapy and use of topical retinoids for the treatment of acne among General Practitioners (GP): a retrospective cohort study. J Am Acad Dermatol. 2016;75(6):1142&#x2013;1150.e1. doi: 10.1016/j.jaad.2016.06.057.S0190-9622(16)30472-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2016.06.057</ArticleId><ArticleId IdType="pubmed">27502311</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhusayen RO, Juurlink DN, Mamdani MM, Morrow RL, Shear NH, Dormuth CR, Canadian Drug Safety Effectiveness Research Network  Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study. J Invest Dermatol. 2013;133(4):907&#x2013;912. doi: 10.1038/jid.2012.387. 
 
S0022-202X(15)36172-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2012.387</ArticleId><ArticleId IdType="pmc">PMC3728031</ArticleId><ArticleId IdType="pubmed">23096714</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbieri JS, Shin DB, Wang S, Margolis DJ, Takeshita J. Association of race/ethnicity and sex with differences in health care use and treatment for acne. JAMA Dermatol. 2020;156(3):312&#x2013;319. doi: 10.1001/jamadermatol.2019.4818. 
 
2759773</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamadermatol.2019.4818</ArticleId><ArticleId IdType="pmc">PMC7042795</ArticleId><ArticleId IdType="pubmed">32022834</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbieri JS, James WD, Margolis DJ. Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: a retrospective analysis, 2004-2013. J Am Acad Dermatol. 2017;77(3):456&#x2013;463.e4. doi: 10.1016/j.jaad.2017.04.016.S0190-9622(17)30503-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2017.04.016</ArticleId><ArticleId IdType="pubmed">28676330</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbieri JS, Bhate K, Hartnett KP, Fleming-Dutra KE, Margolis DJ. Trends in oral antibiotic prescription in dermatology, 2008 to 2016. JAMA Dermatol. 2019;155(3):290&#x2013;297. doi: 10.1001/jamadermatol.2018.4944. 
 
2720317</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamadermatol.2018.4944</ArticleId><ArticleId IdType="pmc">PMC6439939</ArticleId><ArticleId IdType="pubmed">30649187</ArticleId></ArticleIdList></Reference><Reference><Citation>Ejaz A, Malaiyandi V, Kim WB, Rogalska T, Alhusayen R. Validating the diagnostic code for acne in a tertiary care dermatology centre. Eur J Dermatol. 2015;25(5):469&#x2013;471. doi: 10.1684/ejd.2015.2606.ejd.2015.2606</Citation><ArticleIdList><ArticleId IdType="doi">10.1684/ejd.2015.2606</ArticleId><ArticleId IdType="pubmed">26518997</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Data Compass.  [2023-05-20].  
 https://www.healthdatacompass.org/
</Citation></Reference><Reference><Citation>CUDermEpiLabGroup/AcneAbxIsotretinoinJMIRDerm_HealthDataCompass. GitHub.  [2023-05-20].  
 https://github.com/CUDermEpiLabGroup/AcneAbxIsotretinoinJMIRDerm_HealthDataCompass
.</Citation></Reference><Reference><Citation>Colorado Multiple Institutional Review Board (COMIRB) guidance and policies. University of Colorado.  [2023-08-03].  
 https://research.cuanschutz.edu/comirb/home/guidance-and-policies
.</Citation></Reference><Reference><Citation>Hassan J, Grogan S, Clark-Carter D, Richards H, Yates VM. The individual health burden of acne: appearance-related distress in male and female adolescents and adults with back, chest and facial acne. J Health Psychol. 2009;14(8):1105&#x2013;1118. doi: 10.1177/1359105309342470.14/8/1105</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1359105309342470</ArticleId><ArticleId IdType="pubmed">19858331</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J, Farquhar C, Lee O, Toomath R, Jepson RG. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev. 2009;(2):CD000194. doi: 10.1002/14651858.CD000194.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD000194.pub2</ArticleId><ArticleId IdType="pubmed">14583916</ArticleId></ArticleIdList></Reference><Reference><Citation>Layton AM, Eady EA, Whitehouse H, Del Rosso JQ, Fedorowicz Z, van Zuuren EJ. Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review. Am J Clin Dermatol. 2017;18(2):169&#x2013;191. doi: 10.1007/s40257-016-0245-x. 
 
10.1007/s40257-016-0245-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40257-016-0245-x</ArticleId><ArticleId IdType="pmc">PMC5360829</ArticleId><ArticleId IdType="pubmed">28155090</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbieri JS, Choi JK, Mitra N, Margolis DJ. Frequency of treatment switching for spironolactone compared to oral tetracycline-class antibiotics for women with acne: a retrospective cohort study 2010-2016. J Drugs Dermatol. 2018;17(6):632&#x2013;638.S1545961618P0632X</Citation><ArticleIdList><ArticleId IdType="pubmed">29879250</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaminsky A, Florez-White M, Bagatin E, Arias MI, Iberian Latin American Acne Studies Group (GILEA&#x2014;Grupo Ibero-Latinoamericano de Estudio del Acne) Large prospective study on adult acne in Latin America and the Iberian Peninsula: risk factors, demographics, and clinical characteristics. Int J Dermatol. 2019;58(11):1277&#x2013;1282. doi: 10.1111/ijd.14441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijd.14441</ArticleId><ArticleId IdType="pubmed">30883707</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbieri JS, Frieden IJ, Nagler AR. Isotretinoin, patient safety, and patient-centered care-time to reform iPLEDGE. JAMA Dermatol. 2020;156(1):21&#x2013;22. doi: 10.1001/jamadermatol.2019.3270.2753270</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamadermatol.2019.3270</ArticleId><ArticleId IdType="pubmed">31664426</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro SP, Kang EM, Kim CY, Governale LA, Zhou EH, Hammad TA. Concomitant use of isotretinoin and contraceptives before and after iPledge in the United States. Pharmacoepidemiol Drug Saf. 2013;22(12):1251&#x2013;1257. doi: 10.1002/pds.3481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.3481</ArticleId><ArticleId IdType="pubmed">23913625</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbieri JS, Roe AH, Mostaghimi A. Simplifying contraception requirements for iPLEDGE: a decision analysis. J Am Acad Dermatol. 2020;83(1):104&#x2013;108. doi: 10.1016/j.jaad.2020.02.022. 
 
S0190-9622(20)30230-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2020.02.022</ArticleId><ArticleId IdType="pmc">PMC7302965</ArticleId><ArticleId IdType="pubmed">32068040</ArticleId></ArticleIdList></Reference><Reference><Citation>Straight CE, Lee YH, Liu G, Kirby JS. Duration of oral antibiotic therapy for the treatment of adult acne: a retrospective analysis investigating adherence to guideline recommendations and opportunities for cost-savings. J Am Acad Dermatol. 2015;72(5):822&#x2013;827. doi: 10.1016/j.jaad.2015.01.048.S0190-9622(15)00115-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2015.01.048</ArticleId><ArticleId IdType="pubmed">25752715</ArticleId></ArticleIdList></Reference><Reference><Citation>Garner SE, Eady A, Bennett C, Newton JN, Thomas K, Popescu CM. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev. 2012;2012(8):CD002086. doi: 10.1002/14651858.CD002086.pub2. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD002086.pub2</ArticleId><ArticleId IdType="pmc">PMC7017847</ArticleId><ArticleId IdType="pubmed">22895927</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldwin H. Oral antibiotic treatment options for acne vulgaris. J Clin Aesthet Dermatol. 2020;13(9):26&#x2013;32. 
 
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577330</ArticleId><ArticleId IdType="pubmed">33133338</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparing doxycycline vs minocycline. Drugs.com.  [2023-05-20].  
 https://www.drugs.com/compare/doxycycline-vs-minocycline
.</Citation></Reference><Reference><Citation>Carris NW, Pardo J, Montero J, Shaeer KM. Minocycline as a substitute for doxycycline in targeted scenarios: a systematic review. Open Forum Infect Dis. 2015;2(4):ofv178. doi: 10.1093/ofid/ofv178. 
 
ofv178</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofv178</ArticleId><ArticleId IdType="pmc">PMC4690502</ArticleId><ArticleId IdType="pubmed">26719847</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Collaborative Network  . Institute for Health Metrics and Evaluation (IHME) Seattle, United States of America:  [2023-07-25]. Global Burden of Disease study 2015 (GBD 2015) causes of death and nonfatal causes mapped to ICD codes. 
 https://ghdx.healthdata.org/record/ihme-data/gbd-2015-cause-icd-code-mappings
.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37608699</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1502-7708</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Season>Jul-Dec</Season></PubDate></JournalIssue><Title>Scandinavian journal of gastroenterology</Title><ISOAbbreviation>Scand J Gastroenterol</ISOAbbreviation></Journal><ArticleTitle>Impact of concomitant cardiovascular medications on overall survival in patients with liver cirrhosis.</ArticleTitle><Pagination><StartPage>1505</StartPage><EndPage>1513</EndPage><MedlinePgn>1505-1513</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/00365521.2023.2239974</ELocationID><Abstract><AbstractText Label="OBJECTIVES OF THE ARTICLE" NlmCategory="UNASSIGNED">Liver cirrhosis is the end-stage liver disease associated with poor prognosis and cardiovascular comorbidity could significantly impact mortality of cirrhotic patients. We conducted a large, retrospective study to investigate the survival impact of cardiovascular co-medications in patients with liver cirrhosis.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">A study-specific R package was processed on the local databases of partner institutions within the Observational Health Data Sciences and Informatics consortium, namely Columbia University, New York City (NYC), USA and Ajou University School of Medicine (AUSOM), South Korea. Patients with cirrhosis diagnosed between 2000 and 2020 were included. Final analysis of the anonymous survival data was performed at Medical Faculty Mannheim, Heidelberg University.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">We investigated a total of 32,366 patients with liver cirrhosis. Our data showed that administration of antiarrhythmics amiodarone or digoxin presented as a negative prognostic indicator (<i>p</i>&#x2009;=&#x2009;0.000 in both cohorts). Improved survival was associated with angiotensin-converting enzyme inhibitor ramipril (<i>p</i>&#x2009;=&#x2009;0.005 in NYC cohort, <i>p</i>&#x2009;=&#x2009;0.075 in AUSOM cohort) and angiotensin II receptor blocker losartan (<i>p</i>&#x2009;=&#x2009;0.000 in NYC cohort, <i>p</i>&#x2009;=&#x2009;0.005 in AUSOM cohort). Non-selective beta blocker carvedilol was associated with a survival advantage in the NYC (<i>p</i>&#x2009;=&#x2009;0.000) cohort but not in the AUSOM cohort (<i>p</i>&#x2009;=&#x2009;0.142). Patients who took platelet inhibitor clopidogrel had a prolonged overall survival compared to those without (<i>p</i>&#x2009;=&#x2009;0.000 in NYC cohort, <i>p</i>&#x2009;=&#x2009;0.003 in AUSOM cohort).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Concomitant cardiovascular medications are associated with distinct survival difference in cirrhotic patients. Multidisciplinary management is needed for a judicious choice of proper cardiovascular co-medications in cirrhotic patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Moying</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Itzel</LastName><ForeName>Timo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine II, Division of Hepatology, Division of Bioinformatics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden-W&#xfc;rttemberg (CPDBW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montagut</LastName><ForeName>Nathally Espinosa</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>School of Medicine, Universidad de los Andes, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falconer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daza</LastName><ForeName>Jimmy</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9902-5440</Identifier><AffiliationInfo><Affiliation>Department of Medicine II, Division of Hepatology, Division of Bioinformatics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden-W&#xfc;rttemberg (CPDBW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jimyung</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheong</LastName><ForeName>Jae Youn</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiest</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine II, Division of Hepatology, Division of Bioinformatics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden-W&#xfc;rttemberg (CPDBW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebert</LastName><ForeName>Matthias Philip</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden-W&#xfc;rttemberg (CPDBW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hripcsak</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teufel</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7953-8927</Identifier><AffiliationInfo><Affiliation>Department of Medicine II, Division of Hepatology, Division of Bioinformatics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden-W&#xfc;rttemberg (CPDBW), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Scand J Gastroenterol</MedlineTA><NlmUniqueID>0060105</NlmUniqueID><ISSNLinking>0036-5521</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>JMS50MPO89</RegistryNumber><NameOfSubstance UI="D019808">Losartan</NameOfSubstance></Chemical><Chemical><RegistryNumber>0K47UL67F2</RegistryNumber><NameOfSubstance UI="D000077261">Carvedilol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008103" MajorTopicYN="Y">Liver Cirrhosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019808" MajorTopicYN="Y">Losartan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077261" MajorTopicYN="N">Carvedilol</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Liver cirrhosis</Keyword><Keyword MajorTopicYN="N">cardiovascular co-medication</Keyword><Keyword MajorTopicYN="N">comorbidities</Keyword><Keyword MajorTopicYN="N">multidisciplinary management</Keyword><Keyword MajorTopicYN="N">overall survival</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>27</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>2</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37608699</ArticleId><ArticleId IdType="doi">10.1080/00365521.2023.2239974</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37621207</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2291-9694</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2023</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>JMIR medical informatics</Title><ISOAbbreviation>JMIR Med Inform</ISOAbbreviation></Journal><ArticleTitle>An Extract-Transform-Load Process Design for the Incremental Loading of German Real-World Data Based on FHIR and OMOP CDM: Algorithm Development and Validation.</ArticleTitle><Pagination><StartPage>e47310</StartPage><MedlinePgn>e47310</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e47310</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/47310</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">In the Medical Informatics in Research and Care in University Medicine (MIRACUM) consortium, an IT-based clinical trial recruitment support system was developed based on the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). Currently, OMOP CDM is populated with German Fast Healthcare Interoperability Resources (FHIR) using an Extract-Transform-Load (ETL) process, which was designed as a bulk load. However, the computational effort that comes with an everyday full load is not efficient for daily recruitment.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The aim of this study is to extend our existing ETL process with the option of incremental loading to efficiently support daily updated data.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Based on our existing bulk ETL process, we performed an analysis to determine the requirements of incremental loading. Furthermore, a literature review was conducted to identify adaptable approaches. Based on this, we implemented three methods to integrate incremental loading into our ETL process. Lastly, a test suite was defined to evaluate the incremental loading for data correctness and performance compared to bulk loading.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The resulting ETL process supports bulk and incremental loading. Performance tests show that the incremental load took 87.5% less execution time than the bulk load (2.12 min compared to 17.07 min) related to changes of 1 day, while no data differences occurred in OMOP CDM.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Since incremental loading is more efficient than a daily bulk load and both loading options result in the same amount of data, we recommend using bulk load for an initial load and switching to incremental load for daily updates. The resulting incremental ETL logic can be applied internationally since it is not restricted to German FHIR profiles.</AbstractText><CopyrightInformation>&#xa9; Elisa Henke, Yuan Peng, Ines Reinecke, Mich&#xe9;le Zoch, Martin Sedlmayr, Franziska Bathelt. Originally published in JMIR Medical Informatics (https://medinform.jmir.org).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Henke</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-5002-2676</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Saxony, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-6163-9532</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Saxony, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinecke</LastName><ForeName>Ines</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-0154-2867</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Saxony, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoch</LastName><ForeName>Mich&#xe9;le</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5577-7760</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Saxony, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sedlmayr</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9888-8460</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Saxony, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bathelt</LastName><ForeName>Franziska</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-4139-5489</Identifier><AffiliationInfo><Affiliation>Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universit&#xe4;t Dresden, Dresden, Saxony, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Med Inform</MedlineTA><NlmUniqueID>101645109</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ETL</Keyword><Keyword MajorTopicYN="N">Extract-Transform-Load</Keyword><Keyword MajorTopicYN="N">FHIR</Keyword><Keyword MajorTopicYN="N">Fast Healthcare Interoperability Resources</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">Observational Medical Outcomes Partnership Common Data Model</Keyword><Keyword MajorTopicYN="N">incremental loading</Keyword><Keyword MajorTopicYN="N">interoperability</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>3</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37621207</ArticleId><ArticleId IdType="pmc">PMC10466444</ArticleId><ArticleId IdType="doi">10.2196/47310</ArticleId><ArticleId IdType="pii">v11i1e47310</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hariton E, Locascio JJ. Randomised controlled trials&#x2014;the gold standard for effectiveness research. BJOG: Int J Obstet Gy. 2018 Dec;125(13):1716&#x2013;1716. doi: 10.1111/1471-0528.15199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.15199</ArticleId><ArticleId IdType="pmc">PMC6235704</ArticleId><ArticleId IdType="pubmed">29916205</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y, Henke E, Reinecke I, Zoch M, Sedlmayr M, Bathelt F. An ETL-process design for data harmonization to participate in international research with German real-world data based on FHIR and OMOP CDM. Int J Med Inform. 2023 Jan;169:104925. doi: 10.1016/j.ijmedinf.2022.104925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2022.104925</ArticleId><ArticleId IdType="pubmed">36395615</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics  Standardized data: the OMOP common data model.  [2022-11-7].  
 www.ohdsi.org/data-standardization/
</Citation></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler SC, Wissing F, Heyder R. German Medical Informatics Initiative. Methods Inf Med. 2018 Jul;57(S 01):e50&#x2013;e56. doi: 10.3414/ME18-03-0003.</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME18-03-0003</ArticleId><ArticleId IdType="pmc">PMC6178199</ArticleId><ArticleId IdType="pubmed">30016818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabachinski J. What is Health Level 7? Biomed Instrum Technol. 2006 Sep-Oct;40(5):375&#x2013;379. doi: 10.2345/i0899-8205-40-5-375.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.2345/i0899-8205-40-5-375.1</ArticleId><ArticleId IdType="pubmed">17078369</ArticleId></ArticleIdList></Reference><Reference><Citation>Medical Informatics Initiative  The Medical Informatics Initiative&#x2019;s core data set.  [2022-11-7].  
 www.medizininformatik-initiative.de/en/medical-informatics-initiatives-core-data-set
.</Citation></Reference><Reference><Citation>GitHub  FHIR gateway. 2023.  [2023-03-15].  
 github.com/miracum/fhir-gateway
.</Citation></Reference><Reference><Citation>GitHub  HAPI FHIR. 2023.  [2023-03-15].  
 github.com/hapifhir/hapi-fhir
.</Citation></Reference><Reference><Citation>GitHub  Blaze. 2023.  [2023-03-15].  
 github.com/samply/blaze
.</Citation></Reference><Reference><Citation>OMOP Common Data Model  OMOP CDM V5.3.1.  [2022-11-7].  
 ohdsi.github.io/CommonDataModel/cdm531.html
.</Citation></Reference><Reference><Citation>Spring  Spring Batch - reference documentation.  [2022-11-7].  
 docs.spring.io/spring-batch/docs/current/reference/html/index.html
.</Citation></Reference><Reference><Citation>Observational Health Data Sciences and Informatics  The Book of OHDSI. 2021.  [2022-04-19].  
 ohdsi.github.io/TheBookOfOhdsi/
</Citation></Reference><Reference><Citation>Prokosch H-U, Acker T, Bernarding J, Binder H, Boeker M, Boerries M, et al. MIRACUM: Medical Informatics in Research and Care in University Medicine. Methods Inf Med. 2018 Jul;57(S 01):e82&#x2013;e91. doi: 10.3414/ME17-02-0025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3414/ME17-02-0025</ArticleId><ArticleId IdType="pmc">PMC6178200</ArticleId><ArticleId IdType="pubmed">30016814</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinecke I, Gulden C, K&#xfc;mmel M, Nassirian A, Blasini R, Sedlmayr M. Design for a modular clinical trial recruitment support system based on FHIR and OMOP. Stud Health Technol Inform. 2020 Jun 16;270:158&#x2013;162. doi: 10.3233/SHTI200142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/SHTI200142</ArticleId><ArticleId IdType="pubmed">32570366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch KE, Deppen SA, DuVall SL, Viernes B, Cao A, Park D, et al. Incrementally transforming electronic medical records into the observational medical outcomes partnership common data model: a multidimensional quality assurance approach. Appl Clin Inform. 2019 Oct;10(5):794&#x2013;803. doi: 10.1055/s-0039-1697598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1697598</ArticleId><ArticleId IdType="pmc">PMC6811349</ArticleId><ArticleId IdType="pubmed">31645076</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahn MG, Callahan TJ, Barnard J, Bauck AE, Brown J, Davidson BN, et al. A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data. EGEMS (Wash DC) 2016 Sep 11;4(1):1244. doi: 10.13063/2327-9214.1244.</Citation><ArticleIdList><ArticleId IdType="doi">10.13063/2327-9214.1244</ArticleId><ArticleId IdType="pmc">PMC5051581</ArticleId><ArticleId IdType="pubmed">27713905</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenert LA, Ilatovskiy AV, Agnew J, Rudisill P, Jacobs J, Weatherston D, et al. Automated production of research data marts from a canonical Fast Healthcare Interoperability Resource data repository: applications to COVID-19 research. J Am Med Inform Assoc. 2021 Jul 30;28(8):1605&#x2013;1611. doi: 10.1093/jamia/ocab108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab108</ArticleId><ArticleId IdType="pmc">PMC8243354</ArticleId><ArticleId IdType="pubmed">33993254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kathiravelu P, Sharma A, Galhardas H, Roy P, Veiga L. On-demand big data integration: a hybrid ETL approach for reproducible scientific research. Distributed Parallel Databases. 2018 Apr 24;(37):273&#x2013;295. doi: 10.1007/s10619-018-7248-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10619-018-7248-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen WJ. Research on the incremental updating mechanism of marine environmental data warehouse. Appl Mechanics Materials. 2014 Oct;668-669:1378&#x2013;1381. doi: 10.4028/www.scientific.net/AMM.668-669.1378.</Citation><ArticleIdList><ArticleId IdType="doi">10.4028/www.scientific.net/AMM.668-669.1378</ArticleId></ArticleIdList></Reference><Reference><Citation>Thulasiram S, Ramaiah N. Real time data warehouse updates through extraction-transformation-loading process using change data capture method. Second International Conference on Computer Networks and Communication Technologies; May 23-24; Coimbatore, India. 2019. pp. 552&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-37051-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y-Y. Research and implementation of an efficient incremental synchronization method based on Timestamp. 3rd International Conference on Computing, Networks and Internet of Things; May 20-22; Qingdao, China. 2022. pp. 158&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/CNIOT55862.2022.00035</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Dessloch S. Extracting deltas from column oriented NoSQL databases for different incremental applications and diverse data targets. Data Knowledge Eng. 2014 Sep;93:42&#x2013;59. doi: 10.1016/j.datak.2014.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.datak.2014.07.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Du D, Zou X. Differential snapshot algorithms based on hadoop mapreduce. 12th International Conference on Fuzzy Systems and Knowledge Discovery; August 15-17; Zhangjiajie, China. 2015. pp. 1203&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/FSKD.2015.7382113</ArticleId></ArticleIdList></Reference><Reference><Citation>GitHub  FHIR-to-OMOP. 2023.  [2023-03-15].  
 github.com/OHDSI/ETL-German-FHIR-Core
.</Citation></Reference><Reference><Citation>Health Level Seven International  US Core Implementation Guide.  [2023-03-15].  
 www.hl7.org/fhir/us/core/
</Citation></Reference><Reference><Citation>Apache Kafka   [2023-03-15].  
 kafka.apache.org/
</Citation></Reference><Reference><Citation>GitHub  ATLAS. 2023.  [2023-03-15].  
 github.com/OHDSI/Atlas
.</Citation></Reference><Reference><Citation>GitHub  Achilles. 2023.  [2023-03-15].  
 github.com/OHDSI/Achilles
.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37627087</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2072-6694</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>16</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>11</Day></PubDate></JournalIssue><Title>Cancers</Title><ISOAbbreviation>Cancers (Basel)</ISOAbbreviation></Journal><ArticleTitle>Mapping the Oncological Basis Dataset to the Standardized Vocabularies of a Common Data Model: A Feasibility Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4059</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cancers15164059</ELocationID><Abstract><AbstractText>In their joint effort against cancer, all involved parties within the German healthcare system are obligated to report diagnostics, treatments, progression, and follow-up information for tumor patients to the respective cancer registries. Given the federal structure of Germany, the oncological basis dataset (oBDS) operates as the legally required national standard for oncological reporting. Unfortunately, the usage of various documentation software solutions leads to semantic and technical heterogeneity of the data, complicating the establishment of research networks and collective data analysis. Within this feasibility study, we evaluated the transferability of all oBDS characteristics to the standardized vocabularies, a metadata repository of the observational medical outcomes partnership (OMOP) common data model (CDM). A total of 17,844 oBDS expressions were mapped automatically or manually to standardized concepts of the OMOP CDM. In a second step, we converted real patient data retrieved from the Hamburg Cancer Registry to the new terminologies. Given our pipeline, we transformed 1773.373 cancer-related data elements to the OMOP CDM. The mapping of the oBDS to the standardized vocabularies of the OMOP CDM promotes the semantic interoperability of oncological data in Germany. Moreover, it allows the participation in network studies of the observational health data sciences and informatics under the usage of federated analysis beyond the level of individual countries.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carus</LastName><ForeName>Jasmin</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0002-0572-721X</Identifier><AffiliationInfo><Affiliation>Institute for Applied Medical Informatics, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamburg Cancer Registry, Authority for Science, Research, Equality, and Districts, 20097 Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tr&#xfc;be</LastName><ForeName>Leona</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute for Applied Medical Informatics, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szczepanski</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hamburg Cancer Registry, Authority for Science, Research, Equality, and Districts, 20097 Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N&#xfc;rnberg</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Applied Medical Informatics, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hees</LastName><ForeName>Hanna</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute for Applied Medical Informatics, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartels</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nennecke</LastName><ForeName>Alice</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7115-5160</Identifier><AffiliationInfo><Affiliation>Hamburg Cancer Registry, Authority for Science, Research, Equality, and Districts, 20097 Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xdc;ckert</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Applied Medical Informatics, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gundler</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Applied Medical Informatics, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cancers (Basel)</MedlineTA><NlmUniqueID>101526829</NlmUniqueID><ISSNLinking>2072-6694</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">cancer registry</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">semantic interoperability</Keyword><Keyword MajorTopicYN="N">standardized vocabulary</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37627087</ArticleId><ArticleId IdType="pmc">PMC10452256</ArticleId><ArticleId IdType="doi">10.3390/cancers15164059</ArticleId><ArticleId IdType="pii">cancers15164059</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>European Cancer Mortality Predictions for the Year 2023 with Focus on Lung Cancer&#x2014;Annals of Oncology.  [(accessed on 24 May 2023)].  Available online:  https://www.annalsofoncology.org/article/S0923-7534(23)00048-0/fulltext.</Citation><ArticleIdList><ArticleId IdType="pubmed">36882139</ArticleId></ArticleIdList></Reference><Reference><Citation>ADT/GEKID Basisdatensatz [Engl. Basis Dataset]  [(accessed on 5 June 2023)].  Available online:  https://www.gekid.de/adt-gekid-basisdatensatz.</Citation></Reference><Reference><Citation>Stegmaier C., Hentschel S., Hofst&#xe4;dter F., Katalinic A., Tillack A., Klinkhammer-Schalke M. Das Manual der Krebsregistrierung. [Engl. The Cancer Registration Manual]  [(accessed on 14 November 2022)].  Available online:  https://www.gekid.de/manual-der-krebsregistrierung.</Citation></Reference><Reference><Citation>H&#xf6;lzel D., Schubert-Fritschle G., Schmidt M., Eckel R., Engel J. Klinisch-epidemiologische Krebsregistrierung in Deutschland. Pathologe. 2016;37:371&#x2013;387. doi: 10.1007/s00292-016-0188-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00292-016-0188-2</ArticleId><ArticleId IdType="pubmed">27384334</ArticleId></ArticleIdList></Reference><Reference><Citation>Pigeot I., Kraywinkel K. Epidemiologische Krebsregistrierung in Deutschland: Eine beeindruckende Forschungsressource. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz. 2014;57:5&#x2013;6. doi: 10.1007/s00103-013-1885-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00103-013-1885-0</ArticleId><ArticleId IdType="pubmed">24357165</ArticleId></ArticleIdList></Reference><Reference><Citation>Gennari P., Gerken M., M&#xe9;sz&#xe1;ros J., Klinkhammer-Schalke M., Ortmann O., Eggemann H., Ignatov A. Minimal-Invasive or Open Approach for Surgery of Early Cervical Cancer: The Treatment Center Matters. Arch. Gynecol. Obstet. 2021;304:503&#x2013;510. doi: 10.1007/s00404-020-05947-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-020-05947-y</ArticleId><ArticleId IdType="pubmed">33483846</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C.-Y., Datzmann T., Hernandez D., Schmitt J., Schlander M. Do Certified Cancer Centers Provide More Cost-Effective Care? A Health Economic Analysis of Colon Cancer Care in Germany Using Administrative Data. Int. J. Cancer. 2021;149:1744&#x2013;1754. doi: 10.1002/ijc.33728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.33728</ArticleId><ArticleId IdType="pubmed">34213799</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler M., Schmitt J., Bobeth C., Gerken M., Kleihues-van Tol K., Reissfelder C., Rau B.M., Distler M., Piso P., G&#xfc;nster C., et al. Is Treatment in Certified Cancer Centers Related to Better Survival in Patients with Pancreatic Cancer? Evidence from a Large German Cohort Study. BMC Cancer. 2022;22:621. doi: 10.1186/s12885-022-09731-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-022-09731-w</ArticleId><ArticleId IdType="pmc">PMC9172168</ArticleId><ArticleId IdType="pubmed">35672675</ArticleId></ArticleIdList></Reference><Reference><Citation>Malone E.R., Oliva M., Sabatini P.J.B., Stockley T.L., Siu L.L. Molecular Profiling for Precision Cancer Therapies. Genome Med. 2020;12:8. doi: 10.1186/s13073-019-0703-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-019-0703-1</ArticleId><ArticleId IdType="pmc">PMC6961404</ArticleId><ArticleId IdType="pubmed">31937368</ArticleId></ArticleIdList></Reference><Reference><Citation>Federal Ministry of Health  Cancer Registry Data Merge Act. 11 August 2021.  [(accessed on 6 March 2022)].  Available online:  https://www.bundesgesundheitsministerium.de/fileadmin/Dateien/3_Downloads/Gesetze_und_Verordnungen/GuV/K/Krebsregisterdaten-GE_Kabinett.pdf.</Citation></Reference><Reference><Citation>Altmann U., Katz F.R., Tafazzoli A.G., Haeberlin V., Dudeck J. Proceedings: A Conference of the American Medical Informatics Association. AMIA Fall Symposium. Hanley and Belfus Inc.; Philadelphia, PA, USA: 1996. GTDS&#x2014;A Tool for Tumor Registries to Support Shared Patient Care; pp. 512&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2232993</ArticleId><ArticleId IdType="pubmed">8947719</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks J., Pardee R. Learning to Share Health Care Data: A Brief Timeline of Influential Common Data Models and Distributed Health Data Networks in U.S. Health Care Research. eGEMs. 2019;7:4. doi: 10.5334/egems.279.</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/egems.279</ArticleId><ArticleId IdType="pmc">PMC6437693</ArticleId><ArticleId IdType="pubmed">30937326</ArticleId></ArticleIdList></Reference><Reference><Citation>Garza M., Del Fiol G., Tenenbaum J., Walden A., Zozus M.N. Evaluating Common Data Models for Use with a Longitudinal Community Registry. J. Biomed. Inform. 2016;64:333&#x2013;341. doi: 10.1016/j.jbi.2016.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2016.10.016</ArticleId><ArticleId IdType="pmc">PMC6810649</ArticleId><ArticleId IdType="pubmed">27989817</ArticleId></ArticleIdList></Reference><Reference><Citation>Googletrans: Free Google Translate API for Python. Translates Totally Free of Charge.  [(accessed on 24 May 2023)].  Available online:  https://github.com/ssut/py-googletrans.</Citation></Reference><Reference><Citation>DeepL Translate&#x2014;Der Pr&#xe4;ziseste &#xdc;bersetzer der Welt.  [(accessed on 31 May 2023)].  Available online:  https://www.DeepL.com/translator.</Citation></Reference><Reference><Citation>Athena.  [(accessed on 13 February 2023)].  Available online:  https://athena.ohdsi.org/vocabulary/list.</Citation></Reference><Reference><Citation>Davis J.C., Moyer D., Kazerouni A.M., Lee D. Testing Regex Generalizability and Its Implications: A Large-Scale Many-Language Measurement Study; Proceedings of the 2019 34th IEEE/ACM International Conference on Automated Software Engineering (ASE); San Diego, CA, USA. 11&#x2013;15 November 2019; pp. 427&#x2013;439.</Citation></Reference><Reference><Citation>Oncology Working Group OncoRegimenFinder.  [(accessed on 13 February 2023)].  Available online:  https://github.com/OHDSI/OncologyWG/tree/master/OncoRegimenFinder.</Citation></Reference><Reference><Citation>Havrlant L., Kreinovich V. A Simple Probabilistic Explanation of Term Frequency-Inverse Document Frequency (Tf-Idf) Heuristic (and Variations Motivated by This Explanation) Int. J. Gen. Syst. 2017;46:27&#x2013;36. doi: 10.1080/03081079.2017.1291635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03081079.2017.1291635</ArticleId></ArticleIdList></Reference><Reference><Citation>Usagi.  [(accessed on 17 February 2023)].  Available online:  https://github.com/OHDSI/Usagi.</Citation></Reference><Reference><Citation>OHDSI . The Book of OHDSI: Observational Health Data Sciences and Informatics. OHDSI; North Bethesda, MD, USA: 2019.</Citation></Reference><Reference><Citation>Kimball R., Caserta J. The Data Warehouse ETL Toolkit: Practical Techniques for Extracting, Cleaning, Conforming, and Delivering Data. Wiley; Indianapolis, IN, USA: 2004.</Citation></Reference><Reference><Citation>OHDSI  Automated Characterization of Health Information at Large-Scale Longitudinal Evidence Systems (ACHILLES)  [(accessed on 17 February 2023)].  Available online:  https://github.com/OHDSI/Achilles.</Citation></Reference><Reference><Citation>Carus J., N&#xfc;rnberg S., &#xdc;ckert F., Schl&#xfc;ter C., Bartels S. Mapping Cancer Registry Data to the Episode Domain of the Observational Medical Outcomes Partnership Model (OMOP) Appl. Sci. 2022;12:4010. doi: 10.3390/app12084010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app12084010</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E., You S.C., Sena A.G., Kostka K., Abedtash H., Abrah&#xe3;o M.T.F., Alberga A., Alghoul H., Alser O., Alshammari T.M., et al. Deep Phenotyping of 34,128 Adult Patients Hospitalised with COVID-19 in an International Network Study. Nat. Commun. 2020;11:5009. doi: 10.1038/s41467-020-18849-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Recalde M., Roel E., Pistillo A., Sena A.G., Prats-Uribe A., Ahmed W.-U.-R., Alghoul H., Alshammari T.M., Alser O., Areia C., et al. Characteristics and Outcomes of 627 044 COVID-19 Patients Living with and without Obesity in the United States, Spain, and the United Kingdom. Int. J. Obes. 2021;45:2347&#x2013;2357. doi: 10.1038/s41366-021-00893-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-021-00893-4</ArticleId><ArticleId IdType="pmc">PMC8281807</ArticleId><ArticleId IdType="pubmed">34267326</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps J.M., Williams R.D., You S.C., Falconer T., Minty E., Callahan A., Ryan P.B., Park R.W., Lim H.-S., Rijnbeek P. Feasibility and Evaluation of a Large-Scale External Validation Approach for Patient-Level Prediction in an International Data Network: Validation of Models Predicting Stroke in Female Patients Newly Diagnosed with Atrial Fibrillation. BMC Med. Res. Methodol. 2020;20:102. doi: 10.1186/s12874-020-00991-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-020-00991-3</ArticleId><ArticleId IdType="pmc">PMC7201646</ArticleId><ArticleId IdType="pubmed">32375693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempf E., Vaterkowski M., Leprovost D., Griffon N., Ouagne D., Breant S., Serre P., Mouchet A., Rance B., Chatellier G., et al. How to Improve Cancer Patients ENrollment in Clinical Trials from REal-Life Databases Using the Observational Medical Outcomes Partnership Oncology Extension: Results of the PENELOPE Initiative in Urologic Cancers. JCO Clin. Cancer Inform. 2023;7:e2200179. doi: 10.1200/CCI.22.00179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/CCI.22.00179</ArticleId><ArticleId IdType="pubmed">37167578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Bang J.-I., Boo D., Kim B., Choi I.Y., Ko S., Yoo I.R., Kim K., Kim J., Joo Y., et al. Second Primary Malignancy Risk in Thyroid Cancer and Matched Patients with and without Radioiodine Therapy Analysis from the Observational Health Data Sciences and Informatics. Eur. J. Nucl. Med. Mol. Imaging. 2022;49:3547&#x2013;3556. doi: 10.1007/s00259-022-05779-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-022-05779-9</ArticleId><ArticleId IdType="pubmed">35362796</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin V., Tsouchnika A., Allakhverdiiev E., Rosen A.W., G&#xf6;genur M., Clausen J.S.R., Br&#xe4;uner K.B., Walbech J.S., Rijnbeek P., Drakos I., et al. Training Prediction Models for Individual Risk Assessment of Postoperative Complications after Surgery for Colorectal Cancer. Tech. Coloproctol. 2022;26:665&#x2013;675. doi: 10.1007/s10151-022-02624-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10151-022-02624-x</ArticleId><ArticleId IdType="pubmed">35593971</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37632892</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2562-0959</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>30</Day></PubDate></JournalIssue><Title>JMIR dermatology</Title><ISOAbbreviation>JMIR Dermatol</ISOAbbreviation></Journal><ArticleTitle>Phenotype Algorithms to Identify Hidradenitis Suppurativa Using Real-World Data: Development and Validation Study.</ArticleTitle><Pagination><StartPage>e38783</StartPage><MedlinePgn>e38783</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e38783</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/38783</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hidradenitis suppurativa (HS) is a potentially debilitating, chronic, recurring inflammatory disease. Observational databases provide opportunities to study the epidemiology of HS.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study's objective was to develop phenotype algorithms for HS suitable for epidemiological studies based on a network of observational databases.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A data-driven approach was used to develop 4 HS algorithms. A literature search identified prior HS algorithms. Standardized databases from the Observational Medical Outcomes Partnership (n=9) were used to develop 2 incident and 2 prevalent HS phenotype algorithms. Two open-source diagnostic tools, CohortDiagnostics and PheValuator, were used to evaluate and generate phenotype performance metric estimates, including sensitivity, specificity, positive predictive value (PPV), and negative predictive value.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We developed 2 prevalent and 2 incident HS algorithms. Validation showed that PPV estimates were highest (mean 86%) for the prevalent HS algorithm requiring at least two HS diagnosis codes. Sensitivity estimates were highest (mean 58%) for the prevalent HS algorithm requiring at least one HS code.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study illustrates the evaluation process and provides performance metrics for 2 incident and 2 prevalent HS algorithms across 9 observational databases. The use of a rigorous data-driven approach applied to a large number of databases provides confidence that the HS algorithms can correctly identify HS subjects.</AbstractText><CopyrightInformation>&#xa9;Jill Hardin, Gayle Murray, Joel Swerdel. Originally published in JMIR Dermatology (http://derma.jmir.org), 30.11.2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Hardin</LastName><ForeName>Jill</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2682-2187</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Murray</LastName><ForeName>Gayle</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-3685-269X</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Swerdel</LastName><ForeName>Joel</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9491-2737</Identifier><AffiliationInfo><Affiliation>Janssen Research and Development, Titusville, NJ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Observational Health Data Sciences and Informatics, New York, NY, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Dermatol</MedlineTA><NlmUniqueID>101770607</NlmUniqueID><ISSNLinking>2562-0959</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">algorithm</Keyword><Keyword MajorTopicYN="N">dermatology</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">hidradenitis suppurativa</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">medical dermatology</Keyword><Keyword MajorTopicYN="N">observational data</Keyword><Keyword MajorTopicYN="N">phenotype</Keyword><Keyword MajorTopicYN="N">skin disease</Keyword></KeywordList><CoiStatement>Conflicts of Interest: All authors are employees of Janssen Research and Development, LLC, and may own stock or stock options. The work performed for this study was part of their employment.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>27</Day><Hour>5</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>27</Day><Hour>5</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>16</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37632892</ArticleId><ArticleId IdType="pmc">PMC10334943</ArticleId><ArticleId IdType="doi">10.2196/38783</ArticleId><ArticleId IdType="pii">v5i4e38783</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009 Apr;60(4):539&#x2013;61; quiz 562. doi: 10.1016/j.jaad.2008.11.911.S0190-9622(09)00036-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2008.11.911</ArticleId><ArticleId IdType="pubmed">19293006</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiri H, Jokelainen J, Timonen M, Tasanen K, Huilaja L. Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents. J Am Acad Dermatol. 2018 Sep;79(3):514&#x2013;519. doi: 10.1016/j.jaad.2018.02.067.S0190-9622(18)30353-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2018.02.067</ArticleId><ArticleId IdType="pubmed">29518461</ArticleId></ArticleIdList></Reference><Reference><Citation>Overby CL, Pathak J, Gottesman O, Haerian K, Perotte A, Murphy S, Bruce K, Johnson S, Talwalkar J, Shen Y, Ellis S, Kullo I, Chute C, Friedman C, Bottinger E, Hripcsak G, Weng C. A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J Am Med Inform Assoc. 2013 Dec 01;20(e2):e243&#x2013;52. doi: 10.1136/amiajnl-2013-001930. 
 
amiajnl-2013-001930</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2013-001930</ArticleId><ArticleId IdType="pmc">PMC3861914</ArticleId><ArticleId IdType="pubmed">23837993</ArticleId></ArticleIdList></Reference><Reference><Citation>Aletaha D, Epstein AJ, Skup M, Zueger P, Garg V, Panaccione R. Risk of Developing Additional Immune-Mediated Manifestations: A Retrospective Matched Cohort Study. Adv Ther. 2019 Jul 17;36(7):1672&#x2013;1683. doi: 10.1007/s12325-019-00964-z. 
 
10.1007/s12325-019-00964-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-019-00964-z</ArticleId><ArticleId IdType="pmc">PMC6824390</ArticleId><ArticleId IdType="pubmed">31102202</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosmatos I, Matcho A, Weinstein R, Montgomery MO, Stang P. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2013 Mar;68(3):412&#x2013;9. doi: 10.1016/j.jaad.2012.07.027.S0190-9622(12)00812-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2012.07.027</ArticleId><ArticleId IdType="pubmed">22921795</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai N, Shah P. High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics. Br J Dermatol. 2017 Apr 21;176(4):1048&#x2013;1055. doi: 10.1111/bjd.14976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.14976</ArticleId><ArticleId IdType="pubmed">27534703</ArticleId></ArticleIdList></Reference><Reference><Citation>Egeberg A, Gislason GH, Hansen PR. Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hidradenitis Suppurativa. JAMA Dermatol. 2016 Apr;152(4):429&#x2013;34. doi: 10.1001/jamadermatol.2015.6264.2491691</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamadermatol.2015.6264</ArticleId><ArticleId IdType="pubmed">26885728</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A, Birabaharan M, Strunk A. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States. J Am Acad Dermatol. 2018 Jul;79(1):71&#x2013;76. doi: 10.1016/j.jaad.2018.01.014.S0190-9622(18)30098-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2018.01.014</ArticleId><ArticleId IdType="pubmed">29339240</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 2017 Aug 01;153(8):760&#x2013;764. doi: 10.1001/jamadermatol.2017.0201. 
 
2626146</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamadermatol.2017.0201</ArticleId><ArticleId IdType="pmc">PMC5710402</ArticleId><ArticleId IdType="pubmed">28492923</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A, Lavian J, Lin G, Strunk A, Alloo A. Incidence of hidradenitis suppurativa in the United States: A sex- and age-adjusted population analysis. J Am Acad Dermatol. 2017 Jul;77(1):118&#x2013;122. doi: 10.1016/j.jaad.2017.02.005.S0190-9622(17)30163-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2017.02.005</ArticleId><ArticleId IdType="pubmed">28285782</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung C, Chiang C, Chung C, Tsao C, Chien W, Wang W. Increased risk of cardiovascular comorbidities in hidradenitis suppurativa: A nationwide, population-based, cohort study in Taiwan. J Dermatol. 2019 Oct;46(10):867&#x2013;873. doi: 10.1111/1346-8138.15038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1346-8138.15038</ArticleId><ArticleId IdType="pubmed">31389066</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingram J, Jenkins-Jones S, Knipe D, Morgan C, Cannings-John R, Piguet V. Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa. Br J Dermatol. 2018 Apr;178(4):917&#x2013;924. doi: 10.1111/bjd.16101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.16101</ArticleId><ArticleId IdType="pubmed">29094346</ArticleId></ArticleIdList></Reference><Reference><Citation>Jemec GBE, Gu&#xe9;rin Annie, Kaminsky M, Okun M, Sundaram M. What happens after a single surgical intervention for hidradenitis suppurativa? A retrospective claims-based analysis. J Med Econ. 2016 Jul 14;19(7):710&#x2013;7. doi: 10.3111/13696998.2016.1161636. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3111/13696998.2016.1161636</ArticleId><ArticleId IdType="doi">10.3111/13696998.2016.1161636</ArticleId><ArticleId IdType="pubmed">26938967</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung JM, Lee KH, Kim Y, Chang SE, Lee MW, Choi JH, Won CH, Lee WJ. Assessment of overall and specific cancer risks in patients with hidradenitis suppurativa. JAMA Dermatol. 2020 Aug 01;156(8):844&#x2013;853. doi: 10.1001/jamadermatol.2020.1422. 
 
2766018</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamadermatol.2020.1422</ArticleId><ArticleId IdType="pmc">PMC7254443</ArticleId><ArticleId IdType="pubmed">32459291</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalsa A, Liu G, Kirby JS. Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa. J Am Acad Dermatol. 2015 Oct;73(4):609&#x2013;14. doi: 10.1016/j.jaad.2015.06.053.S0190-9622(15)01859-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2015.06.053</ArticleId><ArticleId IdType="pubmed">26190241</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G, Shlyankevich J, Kimball A. The validity of the diagnostic code for hidradenitis suppurativa in an electronic database. Br J Dermatol. 2014 Aug;171(2):338&#x2013;42. doi: 10.1111/bjd.13041. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.13041</ArticleId><ArticleId IdType="pmc">PMC4219870</ArticleId><ArticleId IdType="pubmed">24712395</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimball AB, Sundaram M, Gauthier G, Gu&#xe9;rin Annie, Pivneva I, Singh R, Ganguli A. The comorbidity burden of hidradenitis suppurativa in the United States: a claims data analysis. Dermatol Ther (Heidelb) 2018 Dec;8(4):557&#x2013;569. doi: 10.1007/s13555-018-0264-z. 
 
10.1007/s13555-018-0264-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13555-018-0264-z</ArticleId><ArticleId IdType="pmc">PMC6261111</ArticleId><ArticleId IdType="pubmed">30306395</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby JS, Miller JJ, Adams DR, Leslie D. Health care utilization patterns and costs for patients with hidradenitis suppurativa. JAMA Dermatol. 2014 Sep;150(9):937&#x2013;44. doi: 10.1001/jamadermatol.2014.691.1878305</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamadermatol.2014.691</ArticleId><ArticleId IdType="pubmed">24908260</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirsten N, Petersen J, Hagenstr&#xf6;m K, Augustin M. Epidemiology of hidradenitis suppurativa in Germany - an observational cohort study based on a multisource approach. J Eur Acad Dermatol Venereol. 2020 Jan;34(1):174&#x2013;179. doi: 10.1111/jdv.15940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.15940</ArticleId><ArticleId IdType="pubmed">31494987</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Kwon H, Jung H, Kim G, Bae J. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study. J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1784&#x2013;1790. doi: 10.1111/jdv.15071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.15071</ArticleId><ArticleId IdType="pubmed">29761904</ArticleId></ArticleIdList></Reference><Reference><Citation>Marvel J, Vlahiotis A, Sainski-Nguyen A, Willson T, Kimball A. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data. BMJ Open. 2019 Sep 30;9(9):e030579. doi: 10.1136/bmjopen-2019-030579. 
 
bmjopen-2019-030579</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-030579</ArticleId><ArticleId IdType="pmc">PMC6797383</ArticleId><ArticleId IdType="pubmed">31575575</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan Kathleen. Hidradenitis suppurativa: number of diagnosed patients, demographic characteristics, and treatment patterns in the United States. Am J Epidemiol. 2014 Jun 15;179(12):1477&#x2013;83. doi: 10.1093/aje/kwu078.kwu078</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwu078</ArticleId><ArticleId IdType="pubmed">24812161</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehdizadeh A, Rosella L, Alavi A, Sibbald G, Farzanfar D, Hazrati A, Vernich L, Laporte A, Hu H, Bashash M. A Canadian population-based cohort to the study cost and burden of surgically resected hidradenitis suppurativa. J Cutan Med Surg. 2018;22(3):312&#x2013;317. doi: 10.1177/1203475418763536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1203475418763536</ArticleId><ArticleId IdType="pubmed">29528753</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel K, Rastogi S, Singam V, Lee H, Amin A, Silverberg J. Association between hidradenitis suppurativa and hospitalization for psychiatric disorders: a cross-sectional analysis of the National Inpatient Sample. Br J Dermatol. 2019 Aug;181(2):275&#x2013;281. doi: 10.1111/bjd.17416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.17416</ArticleId><ArticleId IdType="pubmed">30422314</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinter A, Kokolakis G, Rech J, Biermann MHC, H&#xe4;berle Benjamin M, Multmeier J, Reinhardt M. Hidradenitis suppurativa and concurrent psoriasis: comparison of epidemiology, comorbidity profiles, and risk factors. Dermatol Ther (Heidelb) 2020 Aug;10(4):721&#x2013;734. doi: 10.1007/s13555-020-00401-y. 
 
10.1007/s13555-020-00401-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13555-020-00401-y</ArticleId><ArticleId IdType="pmc">PMC7367943</ArticleId><ArticleId IdType="pubmed">32500484</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Rodriguez AJ, Timerman D, Khan A, Bonomo L, Hunjan MK, Lemor A. The in-hospital burden of hidradenitis suppurativa in patients with inflammatory bowel disease: a decade nationwide analysis from 2004 to 2014. Int J Dermatol. 2018 May;57(5):547&#x2013;552. doi: 10.1111/ijd.13932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijd.13932</ArticleId><ArticleId IdType="pubmed">29431201</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan QZ, Chen AD, Singhal D, Lee BT, Fukudome EY. Surgical management of hidradenitis suppurativa: procedural trends and risk factors. J Surg Res. 2018 Sep;229:200&#x2013;207. doi: 10.1016/j.jss.2018.04.007.S0022-4804(18)30246-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2018.04.007</ArticleId><ArticleId IdType="pubmed">29936991</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeweiss M, Merola J, Schneeweiss S, Wyss R, Rosmarin D. Risk of connective tissue disease, morphoea and systemic vasculitis in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):195&#x2013;202. doi: 10.1111/jdv.16728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.16728</ArticleId><ArticleId IdType="pubmed">32531094</ArticleId></ArticleIdList></Reference><Reference><Citation>Shlyankevich J, Chen AJ, Kim GE, Kimball AB. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol. 2014 Dec;71(6):1144&#x2013;50. doi: 10.1016/j.jaad.2014.09.012.S0190-9622(14)01912-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2014.09.012</ArticleId><ArticleId IdType="pubmed">25440440</ArticleId></ArticleIdList></Reference><Reference><Citation>Strunk A, Midura M, Papagermanos V, Alloo A, Garg A. Validation of a case-finding algorithm for hidradenitis suppurativa using administrative coding from a clinical database. Dermatology. 2017;233(1):53&#x2013;57. doi: 10.1159/000468148.000468148</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000468148</ArticleId><ArticleId IdType="pubmed">28448975</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzellos T, Yang H, Mu F, Calimlim B, Signorovitch J. Impact of hidradenitis suppurativa on work loss, indirect costs and income. Br J Dermatol. 2019 Jul;181(1):147&#x2013;154. doi: 10.1111/bjd.17101. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.17101</ArticleId><ArticleId IdType="pmc">PMC7379487</ArticleId><ArticleId IdType="pubmed">30120887</ArticleId></ArticleIdList></Reference><Reference><Citation>Wertenteil S, Strunk A, Garg A. Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa. J Am Acad Dermatol. 2019 May;80(5):1308&#x2013;1313. doi: 10.1016/j.jaad.2018.09.040.S0190-9622(18)32651-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2018.09.040</ArticleId><ArticleId IdType="pubmed">30287328</ArticleId></ArticleIdList></Reference><Reference><Citation>Atlas. GitHub.  [2022-11-16].  
 https://github.com/OHDSI/Atlas
.</Citation></Reference><Reference><Citation>Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Validation of a common data model for active safety surveillance research. J Am Med Inform Assoc. 2012;19(1):54&#x2013;60. doi: 10.1136/amiajnl-2011-000376. 
 
amiajnl-2011-000376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000376</ArticleId><ArticleId IdType="pmc">PMC3240764</ArticleId><ArticleId IdType="pubmed">22037893</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI/PhenotypeEvaluations/tree/main/HS/inst/cohorts. GitHub.  [2022-11-16].  
 https://github.com/OHDSI/PhenotypeEvaluations/tree/main/HS/inst/cohorts
.</Citation></Reference><Reference><Citation>CohortDiagnostics | Introduction. GitHub.  [2022-11-16].  
 https://github.com/OHDSI/CohortDiagnostics
.</Citation></Reference><Reference><Citation>Swerdel JN, Hripcsak G, Ryan PB. PheValuator: Development and evaluation of a phenotype algorithm evaluator. J Biomed Inform. 2019 Sep;97:103258. doi: 10.1016/j.jbi.2019.103258. 
 
S1532-0464(19)30177-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103258</ArticleId><ArticleId IdType="pmc">PMC7736922</ArticleId><ArticleId IdType="pubmed">31369862</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdel JN, Schuemie M, Murray G, Ryan PB. PheValuator 2.0: Methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation. J Biomed Inform. 2022 Nov;135:104177. doi: 10.1016/j.jbi.2022.104177. 
 
S1532-0464(22)00188-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2022.104177</ArticleId><ArticleId IdType="pubmed">35995107</ArticleId></ArticleIdList></Reference><Reference><Citation>OHDSI/PhenotypeEvaluations/tree/main/HS. GitHub.  [2022-11-16].  
 https://github.com/OHDSI/PhenotypeEvaluations/tree/main/HS
.</Citation></Reference><Reference><Citation>Cohort Definition. OHDSI Cohort Diagnostics.  [2022-11-16].  
 https://data.ohdsi.org/HSCohortDiagnostics
.</Citation></Reference><Reference><Citation>Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat Simul Comput. 2009 Apr 09;38(6):1228&#x2013;1234. doi: 10.1080/03610910902859574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03610910902859574</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin B, Chen G, Graham M, Quan H. Coding of obesity in administrative hospital discharge abstract data: accuracy and impact for future research studies. BMC Health Serv Res. 2014 Feb 13;14:70. doi: 10.1186/1472-6963-14-70. 
 
1472-6963-14-70</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-14-70</ArticleId><ArticleId IdType="doi">10.1186/1472-6963-14-70</ArticleId><ArticleId IdType="pmc">PMC3996078</ArticleId><ArticleId IdType="pubmed">24524687</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyree PT, Lind BK, Lafferty WE. Challenges of using medical insurance claims data for utilization analysis. Am J Med Qual. 2006;21(4):269&#x2013;75. doi: 10.1177/1062860606288774. 
 
21/4/269</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1062860606288774</ArticleId><ArticleId IdType="pmc">PMC1533763</ArticleId><ArticleId IdType="pubmed">16849784</ArticleId></ArticleIdList></Reference><Reference><Citation>Humira (adalimumab) | A Biologic Treatment Option. AbbVie Inc.  [2022-11-16].  
 https://www.humira.com/
</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37647114</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2562-0959</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2023</Year><Month>Aug</Month><Day>30</Day></PubDate></JournalIssue><Title>JMIR dermatology</Title><ISOAbbreviation>JMIR Dermatol</ISOAbbreviation></Journal><ArticleTitle>Prescribing Patterns of Dupilumab for Atopic Dermatitis in Adults: Retrospective, Observational Cohort Study.</ArticleTitle><Pagination><StartPage>e41194</StartPage><MedlinePgn>e41194</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e41194</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/41194</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Atopic dermatitis (AD) is a common inflammatory disease caused by a type 2 T helper cell-mediated immune response to environmental antigens. Approximately 1 in 5 patients with AD presents with moderate to severe disease, and treatments approved by the Food and Drug Administration include emollients, topical glucocorticoids, and calcineurin inhibitors. Dupilumab, a fully human monoclonal antibody, improves AD via inhibition of interleukin-4 and interleukin-13.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Our aim was to characterize the prescribing patterns of dupilumab for AD in adults at a large university-affiliated health system.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective, observational cohort study was conducted using electronic data from the Observational Health Data Sciences and Informatics database, assessing data from the University of Colorado Medical Campus and its affiliates. The outcome measured was the prevalence of dupilumab prescribed for adults with AD (n=6421), between March 28, 2013, and March 28, 2021. We assessed whether the characteristics of patients who received dupilumab were different from those who did not. Each patient characteristic was assessed using a univariate logistic regression with the binary outcome of receiving or not receiving dupilumab.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found a population prevalence of 5.6% (6421/114,476) for AD. In our cohort, Black patients with AD were more than twice as likely to have received dupilumab compared to White patients (odds ratio 2.352, 95% CI 1.58-3.39). Patients with a diagnosis of atopic neurodermatitis were approximately twice as likely to have received dupilumab compared to those with other diagnostic variants of AD (odds ratio 1.87, 95% CI 1.01-3.22).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results demonstrate that both patient racial characteristics and specific AD diagnoses were associated with variations in dupilumab prescription patterns.</AbstractText><CopyrightInformation>&#xa9;Torunn E Sivesind, Ani Oganesyan, Grace Bosma, Camille Hochheimer, Lisa M Schilling, Robert Dellavalle. Originally published in JMIR Dermatology (http://derma.jmir.org), 30.08.2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sivesind</LastName><ForeName>Torunn E</ForeName><Initials>TE</Initials><Identifier Source="ORCID">0000-0003-4805-0632</Identifier><AffiliationInfo><Affiliation>Department of Dermatology, University of Colorado School of Medicine, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oganesyan</LastName><ForeName>Ani</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2305-6029</Identifier><AffiliationInfo><Affiliation>University of Colorado School of Medicine, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosma</LastName><ForeName>Grace</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-2397-2772</Identifier><AffiliationInfo><Affiliation>Center for Innovative Design and Analysis, The Colorado School of Public Health, University of Colorado School of Medicine, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hochheimer</LastName><ForeName>Camille</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0984-0909</Identifier><AffiliationInfo><Affiliation>Center for Innovative Design and Analysis, The Colorado School of Public Health, University of Colorado School of Medicine, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0002-6878-189X</Identifier><AffiliationInfo><Affiliation>Department of Medicine, University of Colorado School of Medicine, Aurora, CO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of General Internal Medicine, University of Colorado School of Medicine, Aurora, CO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellavalle</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8132-088X</Identifier><AffiliationInfo><Affiliation>The Colorado School of Public Health, University of Colorado School of Medicine, Aurora, CO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dermatology Service, Eastern Colorado Health Care System, US Department of Veterans Affairs, Denver, CO, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Dermatol</MedlineTA><NlmUniqueID>101770607</NlmUniqueID><ISSNLinking>2562-0959</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dupixent</Keyword><Keyword MajorTopicYN="N">adults</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">atopic dermatitis</Keyword><Keyword MajorTopicYN="N">biologics</Keyword><Keyword MajorTopicYN="N">chronic sinusitis</Keyword><Keyword MajorTopicYN="N">data</Keyword><Keyword MajorTopicYN="N">dermatitis</Keyword><Keyword MajorTopicYN="N">dermatologist</Keyword><Keyword MajorTopicYN="N">dermatology</Keyword><Keyword MajorTopicYN="N">disease</Keyword><Keyword MajorTopicYN="N">dupilumab</Keyword><Keyword MajorTopicYN="N">eczema</Keyword><Keyword MajorTopicYN="N">eosinophilic</Keyword><Keyword MajorTopicYN="N">immune</Keyword><Keyword MajorTopicYN="N">immune response</Keyword><Keyword MajorTopicYN="N">inflammatory</Keyword><Keyword MajorTopicYN="N">monoclonal antibody</Keyword><Keyword MajorTopicYN="N">nasal polyp</Keyword><Keyword MajorTopicYN="N">neurodermatitis</Keyword><Keyword MajorTopicYN="N">prescribing patterns</Keyword><Keyword MajorTopicYN="N">systemic treatment</Keyword></KeywordList><CoiStatement>Conflicts of Interest: RD is editor in chief of the <i>JMIR Dermatology</i>, an editor for <i>Cochrane Skin</i>, a dermatology section editor for UpToDate, a social media editor for the <i>Journal of the American Academy of Dermatology (JAAD)</i>, and a Cochrane council cochair. TES is an editorial board member at large for <i>JMIR Dermatology</i>. RD receives editorial stipends (<i>JMIR Dermatology</i>), royalties (UpToDate), and expense reimbursement from Cochrane. TES receives fellowship funding from Pfizer, Inc. All other authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>30</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37647114</ArticleId><ArticleId IdType="pmc">PMC10500357</ArticleId><ArticleId IdType="doi">10.2196/41194</ArticleId><ArticleId IdType="pii">v6i1e41194</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chiesa Fuxench ZC, Block J, Boguniewicz M, Boyle J, Fonacier L, Gelfand J, Grayson M, Margolis D, Mitchell L, Silverberg J, Schwartz L, Simpson E, Ong P. Atopic dermatitis in America study: a&#xa0;cross-sectional study examining the prevalence&#xa0;and disease burden of atopic dermatitis in the US adult population. J Invest Dermatol. 2019 Mar;139(3):583&#x2013;590. doi: 10.1016/j.jid.2018.08.028. 
 
S0022-202X(18)32678-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2018.08.028</ArticleId><ArticleId IdType="pubmed">30389491</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw T, Currie G, Koudelka C, Simpson E. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol. 2011 Jan;131(1):67&#x2013;73. doi: 10.1038/jid.2010.251. 
 
S0022-202X(15)35013-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2010.251</ArticleId><ArticleId IdType="pmc">PMC3130508</ArticleId><ArticleId IdType="pubmed">20739951</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverberg J, Hanifin J. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol. 2013 Nov;132(5):1132&#x2013;8. doi: 10.1016/j.jaci.2013.08.031.S0091-6749(13)01366-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2013.08.031</ArticleId><ArticleId IdType="pubmed">24094544</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverberg J, Simpson E. Associations of childhood eczema severity: a US population-based study. Dermatitis. 2014;25(3):107&#x2013;14. doi: 10.1097/DER.0000000000000034. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DER.0000000000000034</ArticleId><ArticleId IdType="pmc">PMC4118692</ArticleId><ArticleId IdType="pubmed">24819283</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, Simpson EL, Ong PY, Chiesa Fuxench ZC. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018 Sep;121(3):340&#x2013;347. doi: 10.1016/j.anai.2018.07.006. 
 
S1081-1206(18)30567-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2018.07.006</ArticleId><ArticleId IdType="pubmed">30025911</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwa L, Silverberg JI. Financial burden of emergency department visits for atopic dermatitis in the United States. J Am Acad Dermatol. 2018 Sep;79(3):443&#x2013;447. doi: 10.1016/j.jaad.2018.05.025.S0190-9622(18)30821-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2018.05.025</ArticleId><ArticleId IdType="pubmed">29800581</ArticleId></ArticleIdList></Reference><Reference><Citation>Narla S, Hsu DY, Thyssen JP, Silverberg JI. Inpatient financial burden of atopic dermatitis in the United States. J Invest Dermatol. 2017 Jul;137(7):1461&#x2013;1467. doi: 10.1016/j.jid.2017.02.975. 
 
S0022-202X(17)31160-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2017.02.975</ArticleId><ArticleId IdType="pubmed">28259687</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha S, Miao R, Wang L, Chao J, Yuce H, Wei W. Burden of atopic dermatitis in the United States: analysis of healthcare claims data in the commercial, medicare, and Medi-Cal databases. Adv Ther. 2017 Aug;34(8):1989&#x2013;2006. doi: 10.1007/s12325-017-0582-z. 
 
10.1007/s12325-017-0582-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12325-017-0582-z</ArticleId><ArticleId IdType="pmc">PMC5565673</ArticleId><ArticleId IdType="pubmed">28707285</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanifin JM, Baghoomian W, Grinich E, Leshem YA, Jacobson M, Simpson EL. The eczema area and severity index&#x2014;a practical guide. Dermatitis. 2022;33(3):187&#x2013;192. doi: 10.1097/DER.0000000000000895. 
 
01206501-202205000-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DER.0000000000000895</ArticleId><ArticleId IdType="pmc">PMC9154300</ArticleId><ArticleId IdType="pubmed">35594457</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidbury R, Davis D, Cohen D, Cordoro K, Berger T, Bergman J, Chamlin S, Cooper K, Feldman S, Hanifin J, Krol A, Margolis D, Paller A, Schwarzenberger K, Silverman R, Simpson E, Tom W, Williams H, Elmets C, Block J, Harrod C, Begolka W, Eichenfield L, American Academy of Dermatology  Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014 Aug;71(2):327&#x2013;49. doi: 10.1016/j.jaad.2014.03.030. 
 
S0190-9622(14)01264-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2014.03.030</ArticleId><ArticleId IdType="pmc">PMC4410179</ArticleId><ArticleId IdType="pubmed">24813298</ArticleId></ArticleIdList></Reference><Reference><Citation>Seger EW, Wechter T, Strowd L, Feldman SR. Relative efficacy of systemic treatments for atopic dermatitis. J Am Acad Dermatol. 2019 Feb;80(2):411&#x2013;416.e4. doi: 10.1016/j.jaad.2018.09.053.S0190-9622(18)32669-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2018.09.053</ArticleId><ArticleId IdType="pubmed">30296535</ArticleId></ArticleIdList></Reference><Reference><Citation>Guttman-Yassky E, Bissonnette R, Ungar B, Su&#xe1;rez-Fari&#xf1;as M, Ardeleanu M, Esaki H, Suprun M, Estrada Y, Xu H, Peng X, Silverberg JI, Menter A, Krueger JG, Zhang R, Chaudhry U, Swanson B, Graham NM, Pirozzi G, Yancopoulos GD, D Hamilton JD. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis. J Allergy Clin Immunol. 2019 Jan;143(1):155&#x2013;172. doi: 10.1016/j.jaci.2018.08.022. 
 
S0091-6749(18)31266-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.08.022</ArticleId><ArticleId IdType="pubmed">30194992</ArticleId></ArticleIdList></Reference><Reference><Citation>Team S. How much is Dupixent without insurance? 2022.  [2023-08-11].  
 https://www.singlecare.com/blog/dupixent-without-insurance/
</Citation></Reference><Reference><Citation>Croce EA, Levy ML, Adamson AS, Matsui EC. Reframing racial and ethnic disparities in atopic dermatitis in Black and Latinx populations. J Allergy Clin Immunol. 2021 Nov;148(5):1104&#x2013;1111. doi: 10.1016/j.jaci.2021.09.015. 
 
S0091-6749(21)01417-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2021.09.015</ArticleId><ArticleId IdType="pmc">PMC8578465</ArticleId><ArticleId IdType="pubmed">34600773</ArticleId></ArticleIdList></Reference><Reference><Citation>Tackett KJ, Jenkins F, Morrell DS, McShane DB, Burkhart CN. Structural racism and its influence on the severity of atopic dermatitis in African American children. Pediatr Dermatol. 2020 Jan 18;37(1):142&#x2013;146. doi: 10.1111/pde.14058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pde.14058</ArticleId><ArticleId IdType="pubmed">31854003</ArticleId></ArticleIdList></Reference><Reference><Citation>Polcari I, Becker L, Stein S, Smith M, Paller A. Filaggrin gene mutations in African Americans with both ichthyosis vulgaris and atopic dermatitis. Pediatr Dermatol. 2014;31(4):489&#x2013;92. doi: 10.1111/pde.12355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pde.12355</ArticleId><ArticleId IdType="pubmed">24920311</ArticleId></ArticleIdList></Reference><Reference><Citation>Margolis DJ, Mitra N, Wubbenhorst B, D'Andrea Kurt, Kraya AA, Hoffstad O, Shah S, Nathanson KL. Association of filaggrin loss-of-function variants with race in children with aAtopic dermatitis. JAMA Dermatol. 2019 Nov 01;155(11):1269&#x2013;1276. doi: 10.1001/jamadermatol.2019.1946. 
 
2739071</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamadermatol.2019.1946</ArticleId><ArticleId IdType="pmc">PMC6669787</ArticleId><ArticleId IdType="pubmed">31365035</ArticleId></ArticleIdList></Reference><Reference><Citation>Jungersted J, H&#xf8;gh J K, Hellgren L, Jemec G, Agner T. Ethnicity and stratum corneum ceramides. Br J Dermatol. 2010 Dec;163(6):1169&#x2013;73. doi: 10.1111/j.1365-2133.2010.10080.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2133.2010.10080.x</ArticleId><ArticleId IdType="pubmed">21039401</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyal RD, Pavel AB, Glickman J, Chan TC, Zheng X, Zhang N, Cueto I, Peng X, Estrada Y, Fuentes-Duculan J, Alexis AF, Krueger JG, Guttman-Yassky E. Atopic dermatitis in African American patients is T2/T22-skewed with T1/T17 attenuation. Ann Allergy Asthma Immunol. 2019 Jan;122(1):99&#x2013;110.e6. doi: 10.1016/j.anai.2018.08.024.S1081-1206(18)30746-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2018.08.024</ArticleId><ArticleId IdType="pubmed">30223113</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A, Shin D, Margolis D, Takeshita J. Racial and ethnic differences in health care utilization for childhood eczema: an analysis of the 2001-2013 Medical Expenditure Panel Surveys. J Am Acad Dermatol. 2017 Dec;77(6):1060&#x2013;1067. doi: 10.1016/j.jaad.2017.08.035. 
 
S0190-9622(17)32268-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2017.08.035</ArticleId><ArticleId IdType="pmc">PMC5916760</ArticleId><ArticleId IdType="pubmed">28964540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan J, Oganisian A, Spieker AJ, Hoffstad OJ, Mitra N, Margolis DJ, Takeshita J. Racial/ethnic variation in use of ambulatory and emergency care for atopic dermatitis among US children. JID. 2019 Sep;139(9):1906&#x2013;1913.e1. doi: 10.1016/j.jid.2019.02.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2019.02.024</ArticleId><ArticleId IdType="pmc">PMC8320361</ArticleId><ArticleId IdType="pubmed">30878673</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie C, Silverberg JI. The prevalence and persistence of atopic dermatitis in urban United States children. Ann Allergy Asthma Immunol. 2019 Aug;123(2):173&#x2013;178.e1. doi: 10.1016/j.anai.2019.05.014.S1081-1206(19)30371-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anai.2019.05.014</ArticleId><ArticleId IdType="pubmed">31128232</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell MA, Whang KA, Thomas J, Aguh C, Kwatra SG. Racial and ethnic disparities in access to emerging and frontline therapies in common dermatological conditions: a cross-sectional study. J Natl Med Assoc. 2020 Dec;112(6):650&#x2013;653. doi: 10.1016/j.jnma.2020.06.009.S0027-9684(20)30133-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnma.2020.06.009</ArticleId><ArticleId IdType="pubmed">32641259</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeshita J, Eriksen W, Raziano V, Bocage C, Hur L, Shah RV, Gelfand Joel M, Barg Frances K. Racial differences in perceptions of psoriasis therapies: implications for racial disparities in psoriasis treatment. J Invest Dermatol. 2019 Aug;139(8):1672&#x2013;1679.e1. doi: 10.1016/j.jid.2018.12.032. 
 
S0022-202X(19)30099-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2018.12.032</ArticleId><ArticleId IdType="pmc">PMC6650313</ArticleId><ArticleId IdType="pubmed">30738054</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeshita J, Gelfand J, Li P, Pinto L, Yu X, Rao P, Viswanathan H, Doshi J. Psoriasis in the US Medicare population: prevalence, treatment, and factors associated with biologic use. J Invest Dermatol. 2015 Dec;135(12):2955&#x2013;2963. doi: 10.1038/jid.2015.296. 
 
S0022-202X(15)60159-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2015.296</ArticleId><ArticleId IdType="pmc">PMC4549797</ArticleId><ArticleId IdType="pubmed">26214380</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Data Compass.  [2023-08-11].  
 https://www.healthdatacompass.org/
</Citation></Reference><Reference><Citation>Tripathi R, Knusel KD, Ezaldein HH, Scott JF, Bordeaux JS. Association of demographic and socioeconomic characteristics with differences in use of outpatient dermatology services in the United States. JAMA Dermatol. 2018 Nov 01;154(11):1286&#x2013;1291. doi: 10.1001/jamadermatol.2018.3114. 
 
2702471</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamadermatol.2018.3114</ArticleId><ArticleId IdType="pmc">PMC6248122</ArticleId><ArticleId IdType="pubmed">30267073</ArticleId></ArticleIdList></Reference><Reference><Citation>Flasar MH, Johnson T, Roghmann M, Cross RK. Disparities in the use of immunomodulators and biologics for the treatment of inflammatory bowel disease: a retrospective cohort study. Inflamm Bowel Dis. 2008 Jan;14(1):13&#x2013;9. doi: 10.1002/ibd.20298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ibd.20298</ArticleId><ArticleId IdType="pubmed">17973305</ArticleId></ArticleIdList></Reference><Reference><Citation>An J, Liu Y, Xiao S, Wang J, Geng S, Dong Y. Quality of life of patients with neurodermatitis. Int J Med Sci. 2013;10(5):593&#x2013;8. doi: 10.7150/ijms.5624. 
 
ijmsv10p0593</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijms.5624</ArticleId><ArticleId IdType="pmc">PMC3607245</ArticleId><ArticleId IdType="pubmed">23533146</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavecchio S, Angileri L, Pozzo Giuffrida F, Germiniasi F, Marzano A, Ferrucci S. Efficacy of dupilumab on different phenotypes of atopic dermatitis: one-year experience of 221 patients. J Clin Med. 2020 Aug 19;9(9):2684. doi: 10.3390/jcm9092684. 
 
jcm9092684</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092684</ArticleId><ArticleId IdType="pmc">PMC7564127</ArticleId><ArticleId IdType="pubmed">32824992</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37674813</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2813-0626</ISSN><JournalIssue CitedMedium="Internet"><Volume>1</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in nephrology</Title><ISOAbbreviation>Front Nephrol</ISOAbbreviation></Journal><ArticleTitle>The Effect of Statins on Mortality of Patients With Chronic Kidney Disease Based on Data of the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM) and Korea National Health Insurance Claims Database.</ArticleTitle><Pagination><StartPage>821585</StartPage><MedlinePgn>821585</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">821585</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneph.2021.821585</ELocationID><Abstract><AbstractText>The role of statins in chronic kidney disease (CKD) has been extensively evaluated, but it remains controversial in specific population such as dialysis-dependent CKD. This study examined the effect of statins on mortality in CKD patients using two large databases. In data from the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM) from two hospitals, CKD was defined as an estimated glomerular filtration rate &lt; 60 mL/min/m<sup>2</sup>; we compared survival between patients with or without statin treatment. As a sensitivity analysis, the results were validated with the Korea National Health Insurance (KNHI) claims database. In the analysis of CDM datasets, statin users showed significantly lower risks of all-cause and cardiovascular mortality in both hospitals, compared to non-users. Similar results were observed in CKD patients from the KNHI claims database. Lower mortality in the statin group was consistently evident in all subgroup analyses, including patients on dialysis and low-risk young patients. In conclusion, we found that statins were associated with lower mortality in CKD patients, regardless of dialysis status or other risk factors.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Kim, Choi, Oh, Kim, Jo, Cho, Ahn, Kwon and Ko.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ji Eun</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University Guro Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Yun Jin</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Biomedical Research Institute, Korea University Guro Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Se Won</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University Anam Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Myung Gyu</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University Anam Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>Sang Kyung</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University Anam Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Won Yong</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University Anam Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Shin Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University Guro Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Young Joo</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University Guro Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Gang-Jee</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University Guro Hospital, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Nephrol</MedlineTA><NlmUniqueID>9918469487906676</NlmUniqueID><ISSNLinking>2813-0626</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">all-cause mortality</Keyword><Keyword MajorTopicYN="N">cardiovascular mortality</Keyword><Keyword MajorTopicYN="N">chronic kidney disease</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">population-based study</Keyword><Keyword MajorTopicYN="N">statins</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>2</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>2</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>4</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37674813</ArticleId><ArticleId IdType="pmc">PMC10479676</ArticleId><ArticleId IdType="doi">10.3389/fneph.2021.821585</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Collaboration GBDCKD . Global, Regional, and National Burden of Chronic Kidney Disease, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet (2020) 395(10225):709&#x2013;33. doi:&#xa0;10.1016/S0140-6736(20)30045-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30045-3</ArticleId><ArticleId IdType="pmc">PMC7049905</ArticleId><ArticleId IdType="pubmed">32061315</ArticleId></ArticleIdList></Reference><Reference><Citation>Carracedo J, Alique M, Vida C, Bodega G, Ceprian N, Morales E, et al. . Mechanisms of Cardiovascular Disorders in Patients With Chronic Kidney Disease: A Process Related to Accelerated Senescence. Front Cell Dev Biol (2020) 8:185. doi:&#xa0;10.3389/fcell.2020.00185</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00185</ArticleId><ArticleId IdType="pmc">PMC7099607</ArticleId><ArticleId IdType="pubmed">32266265</ArticleId></ArticleIdList></Reference><Reference><Citation>Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. N Engl J Med (2004) 351(13):1296&#x2013;305. doi:&#xa0;10.1056/NEJMoa041031</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa041031</ArticleId><ArticleId IdType="pubmed">15385656</ArticleId></ArticleIdList></Reference><Reference><Citation>Drueke TB, Massy ZA. Atherosclerosis in CKD: Differences From the General Population. Nat Rev Nephrol (2010) 6(12):723&#x2013;35. doi:&#xa0;10.1038/nrneph.2010.143</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2010.143</ArticleId><ArticleId IdType="pubmed">20978469</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanner C, Tonelli M. Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group M. KDIGO Clinical Practice Guideline for Lipid Management in CKD: Summary of Recommendation Statements and Clinical Approach to the Patient. Kidney Int (2014) 85(6):1303&#x2013;9. doi:&#xa0;10.1038/ki.2014.31</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2014.31</ArticleId><ArticleId IdType="pubmed">24552851</ArticleId></ArticleIdList></Reference><Reference><Citation>Stancu C, Sima A. Statins: Mechanism of Action and Effects. J Cell Mol Med (2001) 5(4):378&#x2013;87. doi:&#xa0;10.1111/j.1582-4934.2001.tb00172.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1582-4934.2001.tb00172.x</ArticleId><ArticleId IdType="pmc">PMC6740083</ArticleId><ArticleId IdType="pubmed">12067471</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain MK, Ridker PM. Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms. Nat. Rev. Drug Discov (2005) 4(12):977&#x2013;87. doi:&#xa0;10.1038/nrd1901</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd1901</ArticleId><ArticleId IdType="pubmed">16341063</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonopoulos AS, Margaritis M, Lee R, Channon K, Antoniades C. Statins as Anti-Inflammatory Agents in Atherogenesis: Molecular Mechanisms and Lessons From the Recent Clinical Trials. Curr Pharm Des (2012) 18(11):1519&#x2013;30. doi:&#xa0;10.2174/138161212799504803</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161212799504803</ArticleId><ArticleId IdType="pmc">PMC3394171</ArticleId><ArticleId IdType="pubmed">22364136</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, et al. . Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud Health Technol Inform (2015) 216:574&#x2013;8. doi: 10.3233/978-1-61499-564-7-574</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/978-1-61499-564-7-574</ArticleId><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong M, Gardner HL, Dieterle N, Rentko V. Optimization of Electronic Medical Records for Data Mining Using a Common Data Model. Top Companion Anim Med (2019) 37:100364. doi:&#xa0;10.1016/j.tcam.2019.100364</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcam.2019.100364</ArticleId><ArticleId IdType="pmc">PMC7874511</ArticleId><ArticleId IdType="pubmed">31837755</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. . A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med (2009) 150(9):604&#x2013;12. doi:&#xa0;10.7326/0003-4819-150-9-200905050-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-150-9-200905050-00006</ArticleId><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S, et al. . Cause of Death in Patients With Reduced Kidney Function. J Am Soc Nephrol (2015) 26(10):2504&#x2013;11. doi:&#xa0;10.1681/ASN.2014070714</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2014070714</ArticleId><ArticleId IdType="pmc">PMC4587695</ArticleId><ArticleId IdType="pubmed">25733525</ArticleId></ArticleIdList></Reference><Reference><Citation>Speer T, Ridker PM, von Eckardstein A, Schunk SJ, Fliser D. Lipoproteins in Chronic Kidney Disease: From Bench to Bedside. Eur Heart J (2021) 42(22):2170&#x2013;85. doi:&#xa0;10.1093/eurheartj/ehaa1050</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa1050</ArticleId><ArticleId IdType="pubmed">33393990</ArticleId></ArticleIdList></Reference><Reference><Citation>Speer T, Owala FO, Holy EW, Zewinger S, Frenzel FL, Stahli BE, et al. . Carbamylated Low-Density Lipoprotein Induces Endothelial Dysfunction. Eur Heart J (2014) 35(43):3021&#x2013;32. doi:&#xa0;10.1093/eurheartj/ehu111</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu111</ArticleId><ArticleId IdType="pubmed">24658767</ArticleId></ArticleIdList></Reference><Reference><Citation>Noels H, Lehrke M, Vanholder R, Jankowski J. Lipoproteins and Fatty Acids in Chronic Kidney Disease: Molecular and Metabolic Alterations. Nat Rev Nephrol (2021) 17(8):528&#x2013;42. doi:&#xa0;10.1038/s41581-021-00423-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00423-5</ArticleId><ArticleId IdType="pubmed">33972752</ArticleId></ArticleIdList></Reference><Reference><Citation>Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. . Relation Between Renal Dysfunction and Cardiovascular Outcomes After Myocardial Infarction. N Engl J Med (2004) 351(13):1285&#x2013;95. doi:&#xa0;10.1056/NEJMoa041365</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa041365</ArticleId><ArticleId IdType="pubmed">15385655</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M, et al. . Proteinuria, Impaired Kidney Function, and Adverse Outcomes in People With Coronary Disease: Analysis of a Previously Conducted Randomised Trial. BMJ (2006) 332(7555):1426. doi:&#xa0;10.1136/bmj.38814.566019.2F</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38814.566019.2F</ArticleId><ArticleId IdType="pmc">PMC1479622</ArticleId><ArticleId IdType="pubmed">16714328</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, et al. . Effect of Pravastatin on Cardiovascular Events in People With Chronic Kidney Disease. Circulation (2004) 110(12):1557&#x2013;63. doi:&#xa0;10.1161/01.CIR.0000143892.84582.60</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000143892.84582.60</ArticleId><ArticleId IdType="pubmed">15364796</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, et al. . Intensive Lipid Lowering With Atorvastatin in Patients With Coronary Heart Disease and Chronic Kidney Disease: The TNT (Treating to New Targets) Study. J Am Coll Cardiol (2008) 51(15):1448&#x2013;54. doi:&#xa0;10.1016/j.jacc.2007.11.072</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2007.11.072</ArticleId><ArticleId IdType="pubmed">18402899</ArticleId></ArticleIdList></Reference><Reference><Citation>Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al. . The Effects of Lowering LDL Cholesterol With Simvastatin Plus Ezetimibe in Patients With Chronic Kidney Disease (Study of Heart and Renal Protection): A Randomised Placebo-Controlled Trial. Lancet (2011) 377(9784):2181&#x2013;92. doi:&#xa0;10.1016/S0140-6736(11)60739-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60739-3</ArticleId><ArticleId IdType="pmc">PMC3145073</ArticleId><ArticleId IdType="pubmed">21663949</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, et al. . Atorvastatin in Patients With Type 2 Diabetes Mellitus Undergoing Hemodialysis. N Engl J Med (2005) 353(3):238&#x2013;48. doi:&#xa0;10.1056/NEJMoa043545</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa043545</ArticleId><ArticleId IdType="pubmed">16034009</ArticleId></ArticleIdList></Reference><Reference><Citation>Fellstrom BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, et al. . Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis. N Engl J Med (2009) 360(14):1395&#x2013;407. doi:&#xa0;10.1056/NEJMoa0810177</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0810177</ArticleId><ArticleId IdType="pubmed">19332456</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason NA, Bailie GR, Satayathum S, Bragg-Gresham JL, Akiba T, Akizawa T, et al. . HMG-Coenzyme a Reductase Inhibitor Use is Associated With Mortality Reduction in Hemodialysis Patients. Am J Kidney Dis (2005) 45(1):119&#x2013;26. doi:&#xa0;10.1053/j.ajkd.2004.09.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2004.09.025</ArticleId><ArticleId IdType="pubmed">15696451</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, Park S, Kim MS, Kang SJ, Lee JW, Kim KS, et al. . Statin Initiation and All-Cause Mortality in Incident Statin-Naive Dialysis Patients. Atherosclerosis (2021) 337:59&#x2013;65. doi:&#xa0;10.1016/j.atherosclerosis.2021.08.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2021.08.026</ArticleId><ArticleId IdType="pubmed">34429195</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung J, Bae GH, Kang M, Kim SW, Lee DH. Statins and All-Cause Mortality in Patients Undergoing Hemodialysis. J Am Heart Assoc (2020) 9(5):e014840. doi:&#xa0;10.1161/JAHA.119.014840</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.014840</ArticleId><ArticleId IdType="pmc">PMC7335561</ArticleId><ArticleId IdType="pubmed">32089045</ArticleId></ArticleIdList></Reference><Reference><Citation>Shurraw S, Tonelli M. AURORA: Is There a Role for Statin Therapy in Dialysis Patients? Am J Kidney Dis (2010) 55(2):237&#x2013;40. doi:&#xa0;10.1053/j.ajkd.2009.09.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2009.09.018</ArticleId><ArticleId IdType="pubmed">19926372</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee EJ, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, et al. . Guidelines for the Management of Dyslipidemia. Korean J Intern Med (2019) 34(4):723&#x2013;71. doi:&#xa0;10.3904/kjim.2019.188</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjim.2019.188</ArticleId><ArticleId IdType="pmc">PMC6610190</ArticleId><ArticleId IdType="pubmed">31272142</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, et al. . Comparison of the Efficacy and Tolerability of Pitavastatin and Atorvastatin: An 8-Week, Multicenter, Randomized, Open-Label, Dose-Titration Study in Korean Patients With Hypercholesterolemia. Clin Ther (2007) 29(11):2365&#x2013;73. doi:&#xa0;10.1016/j.clinthera.2007.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2007.11.002</ArticleId><ArticleId IdType="pubmed">18158077</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong YJ, Jeong MH, Hachinohe D, Ahmed K, Choi YH, Cho SH, et al. . Comparison of Effects of Rosuvastatin and Atorvastatin on Plaque Regression in Korean Patients With Untreated Intermediate Coronary Stenosis. Circ J (2011) 75(2):398&#x2013;406. doi:&#xa0;10.1253/circj.cj-10-0658</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.cj-10-0658</ArticleId><ArticleId IdType="pubmed">21157106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Kang HJ, Kim HS, Sohn DW, Oh BH, Park YB. Effects of Ezetimibe/Simvastatin 10/20 Mg vs. Atorvastatin 20 Mg on Apolipoprotein B/apolipoprotein A1 in Korean Patients With Type 2 Diabetes Mellitus: Results of a Randomized Controlled Trial. Am J Cardiovasc Drugs (2013) 13(5):343&#x2013;51. doi:&#xa0;10.1007/s40256-013-0031-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40256-013-0031-6</ArticleId><ArticleId IdType="pubmed">23728830</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CW, Kang SJ, Ahn JM, Song HG, Lee JY, Kim WJ, et al. . Comparison of Effects of Atorvastatin (20 Mg) Versus Rosuvastatin (10 Mg) Therapy on Mild Coronary Atherosclerotic Plaques (From the ARTMAP Trial). Am J Cardiol (2012) 109(12):1700&#x2013;4. doi:&#xa0;10.1016/j.amjcard.2012.01.399</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2012.01.399</ArticleId><ArticleId IdType="pubmed">22440123</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Seo MK, Yoon MH, Choi DH, Hong TJ, Kim HS. Assessment of the Efficacy and Tolerability of 2 Formulations of Atorvastatin in Korean Adults With Hypercholesterolemia: A Multicenter, Prospective, Open-Label, Randomized Trial. Clin Ther (2013) 35(1):77&#x2013;86. doi:&#xa0;10.1016/j.clinthera.2012.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2012.11.009</ArticleId><ArticleId IdType="pubmed">23274145</ArticleId></ArticleIdList></Reference><Reference><Citation>Her AY, Kim JY, Kang SM, Choi D, Jang Y, Chung N, et al. . Effects of Atorvastatin 20 Mg, Rosuvastatin 10 Mg, and Atorvastatin/Ezetimibe 5 Mg/5 Mg on Lipoproteins and Glucose Metabolism. J Cardiovasc Pharmacol Ther (2010) 15(2):167&#x2013;74. doi:&#xa0;10.1177/1074248409357922</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074248409357922</ArticleId><ArticleId IdType="pubmed">20147603</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Park K, Hong SJ, Cho YS, Sung JD, Moon GW, et al. . Efficacy and Tolerability of a Generic and a Branded Formulation of Atorvastatin 20 Mg/D in Hypercholesterolemic Korean Adults at High Risk for Cardiovascular Disease: A Multicenter, Prospective, Randomized, Double-Blind, Double-Dummy Clinical Trial. Clin Ther (2010) 32(11):1896&#x2013;905. doi:&#xa0;10.1016/j.clinthera.2010.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2010.10.004</ArticleId><ArticleId IdType="pubmed">21095484</ArticleId></ArticleIdList></Reference><Reference><Citation>Modi ZJ, Lu Y, Ji N, Kapke A, Selewski DT, Dietrich X, et al. . Risk of Cardiovascular Disease and Mortality in Young Adults With End-Stage Renal Disease: An Analysis of the US Renal Data System. JAMA Cardiol (2019) 4(4):353&#x2013;62. doi:&#xa0;10.1001/jamacardio.2019.0375</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2019.0375</ArticleId><ArticleId IdType="pmc">PMC6484951</ArticleId><ArticleId IdType="pubmed">30892557</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37697861</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1879-8365</ISSN><JournalIssue CitedMedium="Internet"><Volume>307</Volume><PubDate><Year>2023</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>Studies in health technology and informatics</Title><ISOAbbreviation>Stud Health Technol Inform</ISOAbbreviation></Journal><ArticleTitle>Design and Implementation of an ETL-Process to Transfer Wound-Related Data into a Standardized Common Data Model.</ArticleTitle><Pagination><StartPage>258</StartPage><EndPage>266</EndPage><MedlinePgn>258-266</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3233/SHTI230723</ELocationID><Abstract><AbstractText>For observational studies, which are relevant especially for chronic conditions like chronic wounds, the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) offers a standardized database schema. In this study an ETL process for the transition of wound related data was developed. After understanding the data in general and mapping the relevant codes to concepts available in OMOP, the ETL process was implemented. In a first step, a generic algorithm to convert data to a csv format was implemented in Java. The resulting csv file was then processed within KNIME to be loaded into an OMOP CDM conformant database. During the whole ETL process, HL7 FHIR CodeSystem and ConceptMap resources were used for coding and mapping. First clinical test cases to retrieve data were successfully processed as an example to demonstrate the feasibility and usefulness. They concerned wound size at the first visit and the main issues of patients in the wound quality of life questionnaire (n = 24). In general, the ETL process worked well, yet some challenges arose, like post coordinated SNOMED codes or conditions, which might occur more than once.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Przysucha</LastName><ForeName>Mareike</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Health Informatics Research Group, Osnabr&#xfc;ck University of AS, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xfc;sers</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Informatics Research Group, Osnabr&#xfc;ck University of AS, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liberman</LastName><ForeName>Daniil</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>apenio GmbH &amp; Co. KG, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kersten</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>apenio GmbH &amp; Co. KG, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schl&#xfc;ter</LastName><ForeName>Aphrodite</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>apenio GmbH &amp; Co. KG, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraas</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>apenio GmbH &amp; Co. KG, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busch</LastName><ForeName>Dorothee</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moelleken</LastName><ForeName>Maurice</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Venerology and Allergology, University Hospital of Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erfurt-Berge</LastName><ForeName>Cornelia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander University Erlangen-N&#xfc;rnberg (FAU), Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dissemond</LastName><ForeName>Joachim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Dermatology, Venerology and Allergology, University Hospital of Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xfc;bner</LastName><ForeName>Ursula</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Health Informatics Research Group, Osnabr&#xfc;ck University of AS, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Stud Health Technol Inform</MedlineTA><NlmUniqueID>9214582</NlmUniqueID><ISSNLinking>0926-9630</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016568">Drugs, Generic</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016568" MajorTopicYN="N">Drugs, Generic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011996" MajorTopicYN="N">Records</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ETL Process</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">Wound Care</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>3</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37697861</ArticleId><ArticleId IdType="doi">10.3233/SHTI230723</ArticleId><ArticleId IdType="pii">SHTI230723</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37703800</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-8243</ISSN><JournalIssue CitedMedium="Internet"><Volume>178</Volume><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>International journal of medical informatics</Title><ISOAbbreviation>Int J Med Inform</ISOAbbreviation></Journal><ArticleTitle>Determining and assessing characteristics of data element names impacting the performance of annotation using Usagi.</ArticleTitle><Pagination><StartPage>105200</StartPage><MedlinePgn>105200</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijmedinf.2023.105200</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1386-5056(23)00218-6</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Hospitals generate large amounts of data and this data is generally modeled and labeled in a proprietary way, hampering its exchange and integration. Manually annotating data element names to internationally standardized data element identifiers is a time-consuming effort. Tools can support performing this task automatically. This study aimed to determine what factors influence the quality of automatic annotations.</AbstractText><AbstractText Label="METHODS">Data element names were used from the Dutch COVID-19 ICU Data Warehouse containing data on intensive care patients with COVID-19 from 25 hospitals in the Netherlands. In this data warehouse, the data had been merged using a proprietary terminology system while also storing the original hospital labels (synonymous names). Usagi, an OHDSI annotation tool, was used to perform the annotation for the data. A gold standard was used to determine if Usagi made correct annotations. Logistic regression was used to determine if the number of characters, number of words, match score (Usagi's certainty) and hospital label origin influenced Usagi's performance to annotate correctly.</AbstractText><AbstractText Label="RESULTS">Usagi automatically annotated 30.5% of the data element names correctly and 5.5% of the synonymous names. The match score is the best predictor for Usagi finding the correct annotation. It was determined that the AUC of data element names was 0.651 and 0.752 for the synonymous names respectively. The AUC for the individual hospital label origins varied between 0.460 to 0.905.</AbstractText><AbstractText Label="DISCUSSION">The results show that Usagi performed better to annotate the data element names than the synonymous names. The hospital origin in the synonymous names dataset was associated with the amount of correctly annotated concepts. Hospitals that performed better had shorter synonymous names and fewer words. Using shorter data element names or synonymous names should be considered to optimize the automatic annotating process. Overall, the performance of Usagi is too poor to completely rely on for automatic annotation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Groot</LastName><ForeName>Rowdy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Amsterdam UMC Location University of Amsterdam, Department of Medical Informatics, Amsterdam, the Netherlands. Electronic address: rowdy.degroot@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xfc;ttmann</LastName><ForeName>Daniel P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Amsterdam UMC Location University of Amsterdam, Department of Medical Informatics, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleuren</LastName><ForeName>Lucas M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Center for Critical Care Computation Intelligence (C4i), Amsterdam Medical Data Science (AMDS), Amsterdam Public Health (APH), Amsterdam Cardiovascular Science (ACS), Amsterdam Institute for Infection and Immunity (AII), Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thoral</LastName><ForeName>Patrick J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Center for Critical Care Computation Intelligence (C4i), Amsterdam Medical Data Science (AMDS), Amsterdam Public Health (APH), Amsterdam Cardiovascular Science (ACS), Amsterdam Institute for Infection and Immunity (AII), Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elbers</LastName><ForeName>Paul W G</ForeName><Initials>PWG</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Center for Critical Care Computation Intelligence (C4i), Amsterdam Medical Data Science (AMDS), Amsterdam Public Health (APH), Amsterdam Cardiovascular Science (ACS), Amsterdam Institute for Infection and Immunity (AII), Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Keizer</LastName><ForeName>Nicolette F</ForeName><Initials>NF</Initials><AffiliationInfo><Affiliation>Amsterdam UMC Location University of Amsterdam, Department of Medical Informatics, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cornet</LastName><ForeName>Ronald</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Amsterdam UMC Location University of Amsterdam, Department of Medical Informatics, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Dutch ICU Data Sharing Against COVID-19 Collaborators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Int J Med Inform</MedlineTA><NlmUniqueID>9711057</NlmUniqueID><ISSNLinking>1386-5056</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data annotation</Keyword><Keyword MajorTopicYN="N">Data interoperability</Keyword><Keyword MajorTopicYN="N">Data quality</Keyword><Keyword MajorTopicYN="N">Data standardization</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">Usagi</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>14</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>18</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37703800</ArticleId><ArticleId IdType="doi">10.1016/j.ijmedinf.2023.105200</ArticleId><ArticleId IdType="pii">S1386-5056(23)00218-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37710363</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1557</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Pharmacoepidemiology and drug safety</Title><ISOAbbreviation>Pharmacoepidemiol Drug Saf</ISOAbbreviation></Journal><ArticleTitle>MetaLAB-HOI: Template standardization of health outcomes enable massive and accurate detection of adverse drug reactions from electronic health records.</ArticleTitle><Pagination><StartPage>e5694</StartPage><MedlinePgn>e5694</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/pds.5694</ELocationID><Abstract><AbstractText Label="PURPOSE">This study aimed to advance the MetaLAB algorithm and verify its performance with multicenter data to effectively detect major adverse drug reactions (ADRs), including drug-induced liver injury.</AbstractText><AbstractText Label="METHODS">Based on MetaLAB, we created an optimal scenario for detecting ADRs by considering demographic and clinical records. MetaLAB-HOI was developed to identify ADR signals using common model-based multicenter electronic health record (EHR) data from the clinical health outcomes of interest (HOI) template and design for drug-exposed and nonexposed groups. In this study, we calculated the odds ratio of 101 drugs for HOI in Konyang University Hospital, Seoul National University Hospital, Chungbuk National University Hospital, and Seoul National University Bundang Hospital.</AbstractText><AbstractText Label="RESULTS">The overlapping drugs in four medical centers are amlodipine, aspirin, bisoprolol, carvedilol, clopidogrel, clozapine, digoxin, diltiazem, methotrexate, and rosuvastatin. We developed MetaLAB-HOI, an algorithm that can detect ADRs more efficiently using EHR. We compared the detection results of four medical centers, with drug-induced liver injuries as representative ADRs.</AbstractText><AbstractText Label="CONCLUSIONS">MetaLAB-HOI's strength lies in fully utilizing the patient's clinical information, such as prescription, procedure, and laboratory results, to detect ADR signals. Considering changes in the patient's condition over time, we created an algorithm based on a scenario that accounted for each drug exposure and onset period supervised by specialists for HOI. We determined that when a template capable of detecting ADR based on clinical evidence is developed and manualized, it can be applied in medical centers for new drugs with insufficient data.</AbstractText><CopyrightInformation>&#xa9; 2023 John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Suehyun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0651-6481</Identifier><AffiliationInfo><Affiliation>Department of Computer Engineering, Gachon University, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Hyunah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Healthcare Data Science Center, Konyang University Hospital, Daejeon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choe</LastName><ForeName>Seon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Seoul National University Biomedical Informatics (SNUBI), Division of Biomedical Informatics, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Min-Gyu</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Subdivision of Allergy, Chungbuk National University Hospital and Chungbuk National College of Medicine, Cheongju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sae-Hoon</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Dong Yoon</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Ulsan University Hospital, Ulsan, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ju Han</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Seoul National University Biomedical Informatics (SNUBI), Division of Biomedical Informatics, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HI18C2386</GrantID><Agency>Ministry of Health and Welfare in the Republic of Korea</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pharmacoepidemiol Drug Saf</MedlineTA><NlmUniqueID>9208369</NlmUniqueID><ISSNLinking>1053-8569</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016907" MajorTopicYN="N">Adverse Drug Reaction Reporting Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056486" MajorTopicYN="Y">Chemical and Drug Induced Liver Injury</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064420" MajorTopicYN="Y">Drug-Related Side Effects and Adverse Reactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MetaLAB</Keyword><Keyword MajorTopicYN="N">OMOP-CDM</Keyword><Keyword MajorTopicYN="N">adverse drug reaction</Keyword><Keyword MajorTopicYN="N">drug-induced liver injury</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37710363</ArticleId><ArticleId IdType="doi">10.1002/pds.5694</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Alexander J et al. World Health Organization-technical report series: introduction. World Health Organization-Technical Report Series. 2010;959:1-105.</Citation></Reference><Reference><Citation>Juntti-Patinen L, Neuvonen P. Drug-related deaths in a university central hospital. Eur J Clin Pharmacol. 2002;58(7):479-482.</Citation></Reference><Reference><Citation>Bouvy JC, De Bruin ML, Koopmanschap MA. Epidemiology of adverse drug reactions in Europe: a review of recent observational studies. Drug Saf. 2015;38(5):437-453.</Citation></Reference><Reference><Citation>Lazorou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA. 1998;279(15):1200-1205.</Citation></Reference><Reference><Citation>Alsaleh FM, Alzaid SW, Abahussain EA, Bayoud T, Lemay J. Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait. Saudi Pharm J. 2017;25(6):830-837.</Citation></Reference><Reference><Citation>Lee S, Choi J, Kim H-S, et al. Standard-based comprehensive detection of adverse drug reaction signals from nursing statements and laboratory results in electronic health records. J Am Med Inform Assoc. 2017;24(4):697-708.</Citation></Reference><Reference><Citation>Park MY, Yoon D, Lee KY, et al. A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database. Pharmacoepidemiol Drug Saf. 2011;20(6):598-607.</Citation></Reference><Reference><Citation>Yoon D, Park MY, Choi NK, Park BJ, Kim JH, Park RW. Detection of adverse drug reaction signals using an electronic health records database: comparison of the laboratory extreme abnormality ratio (CLEAR) algorithm. Clin Pharmacol Ther. 2012;91(3):467-474.</Citation></Reference><Reference><Citation>Ennis RH, Norris SP. Critical thinking assessment: status, issues, needs. Cognitive Assessment of Language and Math Outcomes. 1990;36:1.</Citation></Reference><Reference><Citation>Harpaz R, DuMochel W, Shah NH. Big data and adverse drug reaction detection. Clin Pharmacol Ther. 2016;99(3):268-270.</Citation></Reference><Reference><Citation>Stang PE, Ryan PB, Dusetzina SB, et al. Health outcomes of interest in observational data: issues in identifying definitions in the literature. Health Outcomes Research in Medicine. 2012;3(1):e37-e44.</Citation></Reference><Reference><Citation>Haerian K, Salmasian H, Friedman C. Methods for identifying suicide or suicidal ideation in EHRs. AMIA Annu Symp Proc. 2012;2012:1244-1253.</Citation></Reference><Reference><Citation>Fox BI, Hollingsworth JC, Gray MD, Hollingsworth ML, Gao J, Hansen RA. Developing an expert panel process to refine health outcome definitions in observational data. J Biomed Inform. 2013;46(5):795-804.</Citation></Reference><Reference><Citation>Devarbhavi H. An update on drug-induced liver injury. J Clin Exp Hepatol. 2012;2(3):247-259.</Citation></Reference><Reference><Citation>Sandhu N, Navarro V. Drug-induced liver injury in GI practice. Hepatol Commun. 2020;4(5):631-645.</Citation></Reference><Reference><Citation>Suk KT, Baik SK, Yoon JH, et al. Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol. 2012;18(1):1-21.</Citation></Reference><Reference><Citation>Brinker AD, Lyndly J, Tonning J, et al. Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA adverse event reporting system (FAERS) database. Drug Saf. 2013;36(12):1169-1178.</Citation></Reference><Reference><Citation>Billioti de Gage S, Collin C, Le-Tri T, et al. Antidepressants and hepatotoxicity: a cohort study among 5 million individuals registered in the French National Health Insurance Database. CNS Drugs. 2018;32(7):673-684.</Citation></Reference><Reference><Citation>Lin ND, Norman H, Regev A, et al. Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database. BMC Gastroenterol. 2015;15(1):1-13.</Citation></Reference><Reference><Citation>Overby CL, Pathak J, Gottesman O, et al. A collaborative approach to developing an electronic health record phenotyping algorithm for drug-induced liver injury. J Am Med Inform Assoc. 2013;20(e2):e243-e252.</Citation></Reference><Reference><Citation>Kang Y, Kim S-H, Park S-Y, et al. Evaluation of drug-induced liver injury developed during hospitalization using electronic health record (EHR)-based algorithm. Allergy, Asthma Immunol Res. 2020;12(3):430-442.</Citation></Reference><Reference><Citation>Yeboah-Korang A, Louissaint J, Tsung I, Prabhu S, Fontana RJ. Utility of a computerized ICD-10 algorithm to identify idiosyncratic drug-induced liver injury cases in the electronic medical record. Drug Saf. 2020;43(4):371-377.</Citation></Reference><Reference><Citation>Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, Withdrawn, Severely Restricted or Not Approved by Governments. United Nations Publication; 2009.</Citation></Reference><Reference><Citation>Ninan, B, Wertheimer AI. Withdrawing Drugs in the US Versus Other Countries. University of Minnesota, College of Pharmacy; 2012.</Citation></Reference><Reference><Citation>Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716-2724.</Citation></Reference><Reference><Citation>Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 medical expenditure panel survey. JAMA. 2001;286(22):2823-2829.</Citation></Reference><Reference><Citation>ICH E1. Clinical investigation of medicinal products in the paediatric population. Note for guidance on clinicalinvestigation of medicinal products in the paediatric population (CPMP/ICH/2711/99). London. 2000.</Citation></Reference><Reference><Citation>Taketomo CK, Hurlburt Hodding J, Kraus DM. Pediatric and Neonatal Dosage Handbook. Lexi Comp; 2010.</Citation></Reference><Reference><Citation>Kliegman RM et al. Nelson Textbook of Pediatrics e-Book. Elsevier Health Sciences; 2007.</Citation></Reference><Reference><Citation>Shin H, Lee S. An OMOP-CDM based pharmacovigilance data-processing pipeline (PDP) providing active surveillance for ADR signal detection from real-world data sources. BMC Med Inform Decis Mak. 2021;21(1):1-11.</Citation></Reference><Reference><Citation>Xu Y, Zhou X, Suehs BT, et al. A comparative assessment of observational medical outcomes partnership and mini-sentinel common data models and analytics: implications for active drug safety surveillance. Drug Saf. 2015;38(8):749-765.</Citation></Reference><Reference><Citation>Alessandrino F, Qin L, Cruz G, et al. 5-fluorouracil induced liver toxicity in patients with colorectal cancer: role of computed tomography texture analysis as a potential biomarker. Abdom Radiol. 2019;44(9):3099-3106.</Citation></Reference><Reference><Citation>Rho MJ et al. Development common data model for adverse drug signal detection based on multi-center emr systems. 2013 International Conference on Information Science and Applications (ICISA). IEEE; 2013.</Citation></Reference><Reference><Citation>Zhou X, Murugesan S, Bhullar H, et al. An evaluation of the THIN database in the OMOP common data model for active drug safety surveillance. Drug Saf. 2013;36(2):119-134.</Citation></Reference><Reference><Citation>Rho MJ, Kim SR, Park SH, et al. Common data model for decision support system of adverse drug reaction to extract knowledge from multi-center database. Inf Technol Manag. 2016;17(1):57-66.</Citation></Reference><Reference><Citation>Rathi C, Pipaliya N, Patel R, Ingle M, Phadke A, Sawant P. Drug induced liver injury at a tertiary hospital in India: etiology, clinical features and predictors of mortality. Ann Hepatol. 2017;16(3):442-450.</Citation></Reference><Reference><Citation>David S, Hamilton JP. Drug-induced liver injury. US Gastroenterol Hepatol Rev. 2010;6:73.</Citation></Reference><Reference><Citation>Verma S, Kaplowitz N. Diagnosis, management and prevention of drug-induced liver injury. Gut. 2009;58(11):1555-1564.</Citation></Reference><Reference><Citation>Kuhn M, Letunic I, Jensen LJ, Bork P. The SIDER database of drugs and side effects. Nucleic Acids Res. 2016;44(D1):D1075-D1079.</Citation></Reference><Reference><Citation>Laster J, Satoskar R. Aspirin-induced acute liver injury. ACG Case Rep J. 2014;2(1):48-49.</Citation></Reference><Reference><Citation>Rua J, Prata AR, Marques R, et al. Carvedilol-induced liver injury, a rare cause of mixed hepatitis: a clinical case. GE-Port J Gastroenterol. 2019;26(3):196-201.</Citation></Reference><Reference><Citation>Valentino MA, Danaf JADA, Frisch D. Digoxin toxicity caused by an interaction with the novel hepatitis C medication ledipasvir/sofosbuvir. J Innov Card Rhythm Manag. 2016;7(4):2343-2347.</Citation></Reference><Reference><Citation>Cano A, Cifuentes L, Amariles P. Toxicidad hep&#xe1;tica causada por medicamentos: revisi&#xf3;n estructurada. Revista Colombiana de Gastroenterolog&#xed;a. 2017;32(4):337-348.</Citation></Reference><Reference><Citation>Cure E, Kirbas A, Tumkaya L, et al. Protective effect of infliximab on methotrexate-induced liver injury in rats: unexpected drug interaction. J Cancer Res Ther. 2015;11(1):164-169.</Citation></Reference><Reference><Citation>Langman G, Hall PDLM, Todd G. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury. J Gastroenterol Hepatol. 2001;16(12):1395-1401.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37724311</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1179-1349</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Clinical epidemiology</Title><ISOAbbreviation>Clin Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research.</ArticleTitle><Pagination><StartPage>969</StartPage><EndPage>986</EndPage><MedlinePgn>969-986</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2147/CLEP.S419481</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">The primary aim of this work was to convert the Information System for Research in Primary Care (SIDIAP) from Catalonia, Spain, to the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). Our second aim was to provide a descriptive analysis of COVID-19-related outcomes among the general population.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">We mapped patient-level data from SIDIAP to the OMOP CDM and we performed more than 3,400 data quality checks to assess its readiness for research. We established a general population cohort as of the 1st March 2020 and identified outpatient COVID-19 diagnoses or tested positive for, hospitalised with, admitted to intensive care units (ICU) with, died with, or vaccinated against COVID-19 up to 30th June 2022.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">After verifying the high quality of the transformed dataset, we included 5,870,274 individuals in the general population cohort. Of those, 604,472 had either an outpatient COVID-19 diagnosis or positive test result, 58,991 had a hospitalisation, 5,642 had an ICU admission, and 11,233 died with COVID-19. A total of 4,584,515 received a COVID-19 vaccine. People who were hospitalised or died were more commonly older, male, and with more comorbidities. Those admitted to ICU with COVID-19 were generally younger and more often male than those hospitalised and those who died.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">We successfully transformed SIDIAP to the OMOP CDM. From this dataset, a general population cohort of 5.9 million individuals was identified and their COVID-19-related outcomes over time were described. The transformed SIDIAP database is a valuable resource that can enable distributed network research in COVID-19 and beyond.</AbstractText><CopyrightInformation>&#xa9; 2023 Ravent&#xf3;s et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ravent&#xf3;s</LastName><ForeName>Berta</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-4668-2970</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Bellaterra (Cerdanyola del Vall&#xe8;s), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fern&#xe1;ndez-Bertol&#xed;n</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arag&#xf3;n</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5990-6953</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voss</LastName><ForeName>Erica A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0002-0651-0613</Identifier><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blacketer</LastName><ForeName>Clair</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Janssen Pharmaceutical Research and Development, Titusville, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe9;ndez-Boo</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-9215-4378</Identifier><AffiliationInfo><Affiliation>Sistemes d'Informaci&#xf3; dels Serveis d'Atenci&#xf3; Prim&#xe0;ria (SISAP), Institut Catal&#xe0; de la Salut, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Recalde</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roel</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Aut&#xf2;noma de Barcelona, Bellaterra (Cerdanyola del Vall&#xe8;s), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pistillo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4467-0220</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universitat Pompeu Fabra, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes</LastName><ForeName>Carlen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Sandijk</LastName><ForeName>Sebastiaan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Odysseus Data Services s.r.o., Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halvorsen</LastName><ForeName>Lars</ForeName><Initials>L</Initials><Identifier Source="ORCID">0009-0006-6779-1136</Identifier><AffiliationInfo><Affiliation>edenceHealth NV, Kontich, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rijnbeek</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>OHDSI Collaborators, Observational Health Data Sciences and Informatics (OHDSI), New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burn</LastName><ForeName>Edward</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9286-1128</Identifier><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Statistics in Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duarte-Salles</LastName><ForeName>Talita</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; Institut Universitari per a la recerca a l'Atenci&#xf3; Prim&#xe0;ria de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>New Zealand</Country><MedlineTA>Clin Epidemiol</MedlineTA><NlmUniqueID>101531700</NlmUniqueID><ISSNLinking>1179-1349</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">common data model</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">medical ontologies</Keyword><Keyword MajorTopicYN="N">secondary data use</Keyword></KeywordList><CoiStatement>EAV and CB are employees of Janssen Research and Development LLC and shareholders of Johnson &amp; Johnson (J&amp;J) stock. LH reports edenceHealth, as a certified EHDEN SME, received payment for certifying the earlier OMOP CDM transformation work done by SIDIAP in their function as an EHDEN Data Partner, during the conduct of the study. TD-S reports grants from Innovative Medicines Initiative 2, during the conduct of the study. The authors report no other conflicts of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>19</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>19</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>19</Day><Hour>3</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37724311</ArticleId><ArticleId IdType="pmc">PMC10505380</ArticleId><ArticleId IdType="doi">10.2147/CLEP.S419481</ArticleId><ArticleId IdType="pii">419481</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roser M, Ortiz-Ospina E. Spain: what is the daily number of confirmed deaths?
Available from: OurWorldInData.org; Accessed January
23, 2023.</Citation></Reference><Reference><Citation>G&#xe9;rvas J, P&#xe9;rez Fern&#xe1;ndez M, Starfield BH. Primary care, financing and gatekeeping in Western Europe. Fam Pract. 1994;11(3):307&#x2013;317. doi:10.1093/fampra/11.3.307</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/11.3.307</ArticleId><ArticleId IdType="pubmed">7843523</ArticleId></ArticleIdList></Reference><Reference><Citation>Borras-Bermejo B, Mart&#xed;nez-G&#xf3;mez X, Gutierrez-San Miguel M, et al. Asymptomatic SARS-CoV-2 infection in nursing homes, Barcelona, Spain, April 2020. Emerg Infect Dis. 2020;26(9):2281&#x2013;2283. doi:10.3201/eid2609.202603</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2609.202603</ArticleId><ArticleId IdType="pmc">PMC7454057</ArticleId><ArticleId IdType="pubmed">32574139</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu E, Ritchie H, Ortiz-Ospina E, et al. What share of the population has received at least one dose of vaccine?. Available from: OurWorldInData.org; Accessed January
23, 2020.</Citation></Reference><Reference><Citation>Recalde M, Rodr&#xed;guez C, Burn E, et al. Data resource profile: the information system for research in primary care (SIDIAP). Int J Epidemiol. 2022;51(6):e324&#x2013;e336. doi:10.1093/ije/dyac068</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyac068</ArticleId><ArticleId IdType="pmc">PMC9749711</ArticleId><ArticleId IdType="pubmed">35415748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos R, Comas-Cuf&#xed; M, Mart&#xed;-Lluch R, et al. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study. BMJ. 2018;362:k3359. doi:10.1136/bmj.k3359</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k3359</ArticleId><ArticleId IdType="pmc">PMC6123838</ArticleId><ArticleId IdType="pubmed">30185425</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander M, Loomis AK, van der Lei J, et al. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults. BMJ. 2019;367. doi:10.1136/bmj.l5367</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l5367</ArticleId><ArticleId IdType="pmc">PMC6780322</ArticleId><ArticleId IdType="pubmed">31594780</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, Murray DW, Hawker GA, Pinedo-Villanueva R, Prieto-Alhambra D. Lifetime risk of knee and Hip replacement following a GP diagnosis of osteoarthritis: a real-world cohort study. Osteoarthritis and Cartilage. 2019;27:1627&#x2013;1635. doi:10.1016/j.joca.2019.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2019.06.004</ArticleId><ArticleId IdType="pubmed">31220608</ArticleId></ArticleIdList></Reference><Reference><Citation>Prieto-Alhambra D, Ball&#xf3; E, Coma E, et al. Filling the gaps in the characterization of the clinical management of COVID-19: 30-day hospital admission and fatality rates in a cohort of 118&#x2009;150 cases diagnosed in outpatient settings in Spain. Int J Epidemiol. 2021;49(6):1930&#x2013;1939. doi:10.1093/ije/dyaa190</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyaa190</ArticleId><ArticleId IdType="pmc">PMC7665572</ArticleId><ArticleId IdType="pubmed">33118037</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G, Duke JD, Shah NH, et al. Observational health data sciences and informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss EA, Makadia R, Matcho A, et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases. J Am Med Inform Assoc. 2015;22:553&#x2013;564. doi:10.1093/jamia/ocu023</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocu023</ArticleId><ArticleId IdType="pmc">PMC4457111</ArticleId><ArticleId IdType="pubmed">25670757</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S, Posada J, Olson G, et al. A new paradigm for accelerating clinical data science at Stanford medicine. arXiv. 2020. doi:10.48550/arXiv.2003.10534</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2003.10534</ArticleId></ArticleIdList></Reference><Reference><Citation>Junior EPP, Normando P, Flores-Ortiz R, et al. Integrating real-world data from Brazil and Pakistan into the OMOP common data model and standardized health analytics framework to characterize COVID-19 in the Global South. J Am Med Inform Assoc. 2022:ocac180. doi:10.1093/jamia/ocac180</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocac180</ArticleId><ArticleId IdType="pmc">PMC9619798</ArticleId><ArticleId IdType="pubmed">36264262</ArticleId></ArticleIdList></Reference><Reference><Citation>Papez V, Moinat M, Voss EA, et al. Transforming and evaluating the UK Biobank to the OMOP common data model for COVID-19 research and beyond. J Am Med Inform Assoc. 2022;30(1):103&#x2013;111. doi:10.1093/jamia/ocac203</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocac203</ArticleId><ArticleId IdType="pmc">PMC9619789</ArticleId><ArticleId IdType="pubmed">36227072</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics. The Book of OHDSI. Independently published; 2019.</Citation></Reference><Reference><Citation>Blacketer C, Defalco FJ, Ryan PB, Rijnbeek PR. Increasing trust in real-world evidence through evaluation of observational data quality. J Am Med Inform Assoc. 2021;28(10):2251&#x2013;2257. doi:10.1093/jamia/ocab132</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab132</ArticleId><ArticleId IdType="pmc">PMC8449628</ArticleId><ArticleId IdType="pubmed">34313749</ArticleId></ArticleIdList></Reference><Reference><Citation>Golozar A, Lai LY, Sena AG, et al. Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including &gt;3.32 million people tested with real-time PCR and &gt;219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States. medRxiv. 2020;2020:1.</Citation></Reference><Reference><Citation>Burn E, You SC, Sena AG, et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun. 2020;11(1):5009. doi:10.1038/s41467-020-18849-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte-Salles T, Vizcaya D, Pistillo A, et al. Thirty-day outcomes of children and adolescents with COVID-19: an international experience. Pediatrics. 2021;148(3):e2020042929. doi:10.1542/peds.2020-042929</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2020-042929</ArticleId><ArticleId IdType="pubmed">34049958</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EH, Sena AG, Prats-Uribe A, et al. COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology. 2021;60(SI):SI37&#x2013;SI50. doi:10.1093/rheumatology/keab250</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab250</ArticleId><ArticleId IdType="pmc">PMC7989171</ArticleId><ArticleId IdType="pubmed">33725121</ArticleId></ArticleIdList></Reference><Reference><Citation>Recalde M, Roel E, Pistillo A, et al. Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom. Int J Obes. 2021;45(11):2347&#x2013;2357. doi:10.1038/s41366-021-00893-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-021-00893-4</ArticleId><ArticleId IdType="pmc">PMC8281807</ArticleId><ArticleId IdType="pubmed">34267326</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes C, Pistillo A, Fern&#xe1;ndez-Bertol&#xed;n S, et al. Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study. BMJ Open. 2021;11(12):e057632. doi:10.1136/bmjopen-2021-057632</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-057632</ArticleId><ArticleId IdType="pmc">PMC8704062</ArticleId><ArticleId IdType="pubmed">34937726</ArticleId></ArticleIdList></Reference><Reference><Citation>Roel E, Pistillo A, Recalde M, et al. Characteristics and outcomes of over 300,000 patients with COVID-19 and history of cancer in the United States and Spain. Cancer Epidemiol Biomarkers Prev. 2021;30(10):1884&#x2013;1894. doi:10.1158/1055-9965.EPI-21-0266</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-21-0266</ArticleId><ArticleId IdType="pmc">PMC8974356</ArticleId><ArticleId IdType="pubmed">34272262</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A, Xie J, Kostka K, et al. International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients. Front Pharmacol. 2022;13:945592. doi:10.3389/fphar.2022.945592</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.945592</ArticleId><ArticleId IdType="pmc">PMC9518954</ArticleId><ArticleId IdType="pubmed">36188566</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales DR, Conover MM, You SC, et al. Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Lancet Digit Health. 2021;3(2):e98&#x2013;e114. doi:10.1016/S2589-7500(20)30289-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(20)30289-2</ArticleId><ArticleId IdType="pmc">PMC7834915</ArticleId><ArticleId IdType="pubmed">33342753</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams RD, Markus AF, Yang C, et al. Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network. BMC Med Res Methodol. 2022;22(1):35. doi:10.1186/s12874-022-01505-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-022-01505-z</ArticleId><ArticleId IdType="pmc">PMC8801189</ArticleId><ArticleId IdType="pubmed">35094685</ArticleId></ArticleIdList></Reference><Reference><Citation>Reps JM, Kim C, Williams RD, et al. Implementation of the COVID-19 vulnerability index across an international network of health care data sets: collaborative external validation study. JMIR Med Inform. 2021;9(4):e21547. doi:10.2196/21547</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/21547</ArticleId><ArticleId IdType="pmc">PMC8023380</ArticleId><ArticleId IdType="pubmed">33661754</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Ostropolets A, Makadia R, et al. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ. 2021;373:1435. doi:10.1136/bmj.n1435</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1435</ArticleId><ArticleId IdType="pmc">PMC8193077</ArticleId><ArticleId IdType="pubmed">35727911</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, Li X, Kostka K, et al. Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf. 2022;31(5):495&#x2013;510. doi:10.1002/pds.5419</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.5419</ArticleId><ArticleId IdType="pmc">PMC9088543</ArticleId><ArticleId IdType="pubmed">35191114</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Burn E, Duarte-Salles T, et al. Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US. BMJ. 2022;379:e071594. doi:10.1136/bmj-2022-071594</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-071594</ArticleId><ArticleId IdType="pmc">PMC9597610</ArticleId><ArticleId IdType="pubmed">36288813</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, Duarte-Salles T, Fernandez-Bertolin S, et al. Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study. Lancet Infect Dis. 2022;22(8):1142&#x2013;1152. doi:10.1016/S1473-3099(22)00223-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00223-7</ArticleId><ArticleId IdType="pmc">PMC9106320</ArticleId><ArticleId IdType="pubmed">35576963</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, Roel E, Pistillo A, et al. Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain. Nat Commun. 2022;13(1):7169. doi:10.1038/s41467-022-34669-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34669-9</ArticleId><ArticleId IdType="pmc">PMC9684434</ArticleId><ArticleId IdType="pubmed">36418321</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Ravent&#xf3;s B, Roel E, et al. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ. 2022;376:e068373. doi:10.1136/bmj-2021-068373</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068373</ArticleId><ArticleId IdType="pmc">PMC8924704</ArticleId><ArticleId IdType="pubmed">35296468</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, Teb&#xe9; C, Fernandez-Bertolin S, et al. The natural history of symptomatic COVID-19 during the first wave in Catalonia. Nat Commun. 2021;12(1):777. doi:10.1038/s41467-021-21100-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21100-y</ArticleId><ArticleId IdType="pmc">PMC7858639</ArticleId><ArticleId IdType="pubmed">33536436</ArticleId></ArticleIdList></Reference><Reference><Citation>Roel E, Pistillo A, Recalde M, et al. Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: a population-based multistate cohort study including 4&#x2009;618&#x2009;377 adults in Catalonia, Spain. Int J Cancer. 2022;150(5):782&#x2013;794. doi:10.1002/ijc.33846</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.33846</ArticleId><ArticleId IdType="pmc">PMC8652827</ArticleId><ArticleId IdType="pubmed">34655476</ArticleId></ArticleIdList></Reference><Reference><Citation>Recalde M, Pistillo A, Fernandez-Bertolin S, et al. Body mass index and risk of COVID-19 diagnosis, hospitalization, and death: a cohort study of 2 524 926 catalans. J Clin Endocrinol Metab. 2021;106(12):e5030&#x2013;e5042. doi:10.1210/clinem/dgab546</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab546</ArticleId><ArticleId IdType="pmc">PMC8344917</ArticleId><ArticleId IdType="pubmed">34297116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravent&#xf3;s B, Abellan A, Pistillo A, Reyes C, Burn E, Duarte-Salles T. Impact of the COVID-19 pandemic on eating disorders diagnoses among adolescents and young adults in Catalonia: a population-based cohort study. Int J Eat Disord. 2023;56(1):225&#x2013;234. doi:10.1002/eat.23848</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eat.23848</ArticleId><ArticleId IdType="pmc">PMC9878228</ArticleId><ArticleId IdType="pubmed">36352763</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravent&#xf3;s B, Pistillo A, Reyes C, et al. Impact of the COVID-19 pandemic on diagnoses of common mental health disorders in adults in Catalonia, Spain: a population-based cohort study. BMJ Open. 2022;12(4):e057866. doi:10.1136/bmjopen-2021-057866</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-057866</ArticleId><ArticleId IdType="pmc">PMC8995576</ArticleId><ArticleId IdType="pubmed">35396302</ArticleId></ArticleIdList></Reference><Reference><Citation>Roel E, Ravent&#xf3;s B, Burn E, Pistillo A, Prieto-Alhambra D, Duarte-Salles T. Socioeconomic Inequalities in COVID-19 Vaccination and Infection in Adults, Catalonia, Spain. Emerg Infect Dis. 2022;28(11):2243&#x2013;2252. doi:10.3201/eid2811.220614</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2811.220614</ArticleId><ArticleId IdType="pmc">PMC9622244</ArticleId><ArticleId IdType="pubmed">36220130</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054&#x2013;1062. doi:10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369. doi:10.1136/bmj.m1985</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Hayek SS, Wang W, et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180(11):1436&#x2013;1447. doi:10.1001/jamainternmed.2020.3596</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.3596</ArticleId><ArticleId IdType="pmc">PMC7364338</ArticleId><ArticleId IdType="pubmed">32667668</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430&#x2013;436. doi:10.1038/s41586-020-2521-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lusignan S, Dorward J, Correa A, et al. Risk factors for SARS-CoV-2 among patients in the oxford royal college of general practitioners research and surveillance centre primary care network: a cross-sectional study. Lancet Infect Dis. 2020;20(9):1034&#x2013;1042. doi:10.1016/S1473-3099(20)30371-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30371-6</ArticleId><ArticleId IdType="pmc">PMC7228715</ArticleId><ArticleId IdType="pubmed">32422204</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho FK, Celis-Morales CA, Gray SR, et al. Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study. BMJ Open. 2020;10(11):e040402. doi:10.1136/bmjopen-2020-040402</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-040402</ArticleId><ArticleId IdType="pmc">PMC7678347</ArticleId><ArticleId IdType="pubmed">33444201</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian J, Zhao L, Ye R-Z, Li X-J, Liu Y-L. Age-dependent gender differences of COVID-19 in mainland China: comparative study. Clin Infect Dis. 2020;71(9):2488&#x2013;2494. doi:10.1093/cid/ciaa683</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa683</ArticleId><ArticleId IdType="pmc">PMC7314154</ArticleId><ArticleId IdType="pubmed">32473009</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369. doi:10.1136/bmj.m1966</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1966</ArticleId><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Generalitat de Catalunya. Salut/Dades COVID. Available from: dadescovid.cat. Accessed January
23, 2023.</Citation></Reference><Reference><Citation>Griffith GJ, Morris TT, Tudball MJ, et al. Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. 2020;11(1):5749. doi:10.1038/s41467-020-19478-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19478-2</ArticleId><ArticleId IdType="pmc">PMC7665028</ArticleId><ArticleId IdType="pubmed">33184277</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham A, Cummings M, Lindeman C, Drummond N, Williamson T. Recognizing misclassification bias in research and medical practice. Fam Pract. 2019;36(6):804&#x2013;807. doi:10.1093/fampra/cmy130</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmy130</ArticleId><ArticleId IdType="pubmed">31738429</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant MC, Geoghegan L, Arbyn M, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15(6):e0234765. doi:10.1371/journal.pone.0234765</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0234765</ArticleId><ArticleId IdType="pmc">PMC7310678</ArticleId><ArticleId IdType="pubmed">32574165</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Valdes AM, Freidin MB, et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020;26(7):1037&#x2013;1040. doi:10.1038/s41591-020-0916-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0916-2</ArticleId><ArticleId IdType="pmc">PMC7751267</ArticleId><ArticleId IdType="pubmed">32393804</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostka K, Duarte-Salles T, Prats-Uribe A, et al. Unraveling COVID-19: a large-scale characterization of 4.5 Million COVID-19 cases using CHARYBDIS. Clin Epidemiol. 2022;14:369&#x2013;384. doi:10.2147/CLEP.S323292</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S323292</ArticleId><ArticleId IdType="pmc">PMC8957305</ArticleId><ArticleId IdType="pubmed">35345821</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37726928</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2055-5822</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>ESC heart failure</Title><ISOAbbreviation>ESC Heart Fail</ISOAbbreviation></Journal><ArticleTitle>Detection of transthyretin amyloid cardiomyopathy by automated data extraction from electronic health records.</ArticleTitle><Pagination><StartPage>3483</StartPage><EndPage>3492</EndPage><MedlinePgn>3483-3492</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ehf2.14517</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Transthyretin amyloid cardiomyopathy (ATTR-CM), a progressive and fatal cardiomyopathy, is frequently misdiagnosed or entails diagnostic delays, hindering patients from timely treatment. This study aimed to generate a systematic framework based on data from electronic health records (EHRs) to assess patients with ATTR-CM in a real-world population of heart failure (HF) patients. Predictive factors or combinations of predictive factors related to ATTR-CM in a European population were also assessed.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">Retrospective unstructured and semi-structured data from EHRs of patients from OLV Hospital Aalst, Belgium (2012-20), were processed using natural language processing (NLP) to generate an Observational Medical Outcomes Partnership Common Data Model database. NLP model performance was assessed on a random subset of EHRs by comparing algorithm outputs to a physician-generated standard (using precision, recall, and their harmonic mean, or F1-score). Of the 3127 HF patients, 103 potentially had ATTR-CM (age 78&#xa0;&#xb1;&#xa0;9&#xa0;years; male 55%; ejection fraction of 48%&#xa0;&#xb1;&#xa0;16). The mean diagnostic delay between HF and ATTR-CM diagnosis was 1.8&#xa0;years. Besides HF and cardiomyopathy-related phenotypes, the strongest cardiac predictor was atrial fibrillation (AF; 72% in ATTR-CM vs. 60% in non-ATTR-CM, P&#xa0;=&#xa0;0.02), whereas the strongest non-cardiac predictor was carpal tunnel syndrome (21% in ATTR-CM vs. 3% in non-ATTR-CM, P&#xa0;&lt;&#xa0;0.001). The strongest combination predictor was AF, joint disorders, and HF with preserved ejection fraction (29% in ATTR-CM vs. 18% in non-ATTR-CM: odds ratio&#xa0;=&#xa0;2.03, 95% confidence interval&#xa0;=&#xa0;1.28-3.22).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Not only well-known variables associated with ATTR-CM but also unique combinations of cardiac and non-cardiac phenotypes are able to predict ATTR-CM in a real-world HF population, aiding in early identification of ATTR-CM patients.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. ESC Heart Failure published by John Wiley &amp; Sons Ltd on behalf of European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moya</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, OLV Hospital Aalst, Moorselbaan n. 164, Aalst, 9300, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CardioPath PhD Program, Department of Advanced Biomedical Sciences, Cardiovascular Pathophysiology and Therapeutics, University of Naples Federico II, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oeste</LastName><ForeName>Clara L</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0002-7035-132X</Identifier><AffiliationInfo><Affiliation>LynxCare Inc., Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beles</LastName><ForeName>Monika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, OLV Hospital Aalst, Moorselbaan n. 164, Aalst, 9300, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verstreken</LastName><ForeName>Sofie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, OLV Hospital Aalst, Moorselbaan n. 164, Aalst, 9300, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dierckx</LastName><ForeName>Riet</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, OLV Hospital Aalst, Moorselbaan n. 164, Aalst, 9300, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heggermont</LastName><ForeName>Ward</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, OLV Hospital Aalst, Moorselbaan n. 164, Aalst, 9300, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartunek</LastName><ForeName>Jozef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, OLV Hospital Aalst, Moorselbaan n. 164, Aalst, 9300, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogaerts</LastName><ForeName>Eline</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, OLV Hospital Aalst, Moorselbaan n. 164, Aalst, 9300, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masuy</LastName><ForeName>Imke</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>LynxCare Inc., Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hens</LastName><ForeName>Dries</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>LynxCare Inc., Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertolone</LastName><ForeName>Dario</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, OLV Hospital Aalst, Moorselbaan n. 164, Aalst, 9300, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CardioPath PhD Program, Department of Advanced Biomedical Sciences, Cardiovascular Pathophysiology and Therapeutics, University of Naples Federico II, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanderheyden</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, OLV Hospital Aalst, Moorselbaan n. 164, Aalst, 9300, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>LynxCare Clinical Informatics</Agency><Country/></Grant><Grant><Agency>Cardiovascular Center, OLV Hospital Aalst</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ESC Heart Fail</MedlineTA><NlmUniqueID>101669191</NlmUniqueID><ISSNLinking>2055-5822</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011228">Prealbumin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D028227" MajorTopicYN="Y">Amyloid Neuropathies, Familial</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057210" MajorTopicYN="N">Delayed Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011228" MajorTopicYN="N">Prealbumin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">Phenotype</Keyword><Keyword MajorTopicYN="N">Transthyretin amyloid cardiomyopathy</Keyword></KeywordList><CoiStatement>W.H. received support from AstraZeneca for congress attendance and participation to data safety monitoring/advisory board, outside of the submitted work. M.V. received support from Pfizer and Boehringer Ingelheim for participation to advisory boards, outside of the submitted work. A.M., C.L.O., M.B., S.V., R.D., J.B., E.B., D.B., I.M., and D.H. have nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>0</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37726928</ArticleId><ArticleId IdType="pmc">PMC10682883</ArticleId><ArticleId IdType="doi">10.1002/ehf2.14517</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state&#x2010;of&#x2010;the&#x2010;art review. J Am Coll Cardiol 2019;73:2872&#x2010;2891. doi:10.1016/j.jacc.2019.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.04.003</ArticleId><ArticleId IdType="pmc">PMC6724183</ArticleId><ArticleId IdType="pubmed">31171094</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation 2012;126:1286&#x2010;1300. doi:10.1161/CIRCULATIONAHA.111.078915</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.078915</ArticleId><ArticleId IdType="pmc">PMC3501197</ArticleId><ArticleId IdType="pubmed">22949539</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams D, Gonzalez&#x2010;Duarte A, O'Riordan WD, Yang C&#x2010;C, Ueda M, Kristen AV, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 2018;379:11&#x2010;21. doi:10.1056/NEJMoa1716153</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1716153</ArticleId><ArticleId IdType="pubmed">29972753</ArticleId></ArticleIdList></Reference><Reference><Citation>Benson MD, Waddington&#x2010;Cruz M, Berk JL, Polydefkis M, Dyck PJ, Wang AK, et al. Inotersen treatment for patients with hereditary transthyretin amyloidosis. N Engl J Med 2018;379:22&#x2010;31. doi:10.1056/NEJMoa1716793</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1716793</ArticleId><ArticleId IdType="pubmed">29972757</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington&#x2010;Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 2018;379:1007&#x2010;1016. doi:10.1056/NEJMoa1805689</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1805689</ArticleId><ArticleId IdType="pubmed">30145929</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Egolum U, Parker S, Andrews E, Ombengi D, Ling H. Tafamidis: A first&#x2010;in&#x2010;class transthyretin stabilizer for transthyretin amyloid cardiomyopathy. Ann Pharmacother 2020;54:470&#x2010;477. doi:10.1177/1060028019888489</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1060028019888489</ArticleId><ArticleId IdType="pubmed">31735059</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozenbaum MH, Large S, Bhambri R, Stewart M, Whelan J, van Doornewaard A, et al. Impact of delayed diagnosis and misdiagnosis for patients with transthyretin amyloid cardiomyopathy (ATTR&#x2010;CM): A targeted literature review. Cardiol Ther 2021;10:141&#x2010;159. doi:10.1007/s40119-021-00219-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40119-021-00219-5</ArticleId><ArticleId IdType="pmc">PMC8126532</ArticleId><ArticleId IdType="pubmed">33877591</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 2016;133:2404&#x2010;2412. doi:10.1161/CIRCULATIONAHA.116.021612</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.021612</ArticleId><ArticleId IdType="pubmed">27143678</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelan D, Collier P, Thavendiranathan P, Popovi&#x107; ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two&#x2010;dimensional speckle&#x2010;tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 2012;98:1442&#x2010;1448. doi:10.1136/heartjnl-2012-302353</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2012-302353</ArticleId><ArticleId IdType="pubmed">22865865</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez&#x2010;Naharro A, Treibel TA, Abdel&#x2010;Gadir A, Bulluck H, Zumbo G, Knight DS, et al. Magnetic resonance in transthyretin cardiac amyloidosis. J Am Coll Cardiol 2017;70:466&#x2010;477. doi:10.1016/j.jacc.2017.05.053</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.05.053</ArticleId><ArticleId IdType="pubmed">28728692</ArticleId></ArticleIdList></Reference><Reference><Citation>Damy T, Bourel G, Slama M, Algalarrondo V, Lairez O, Pelcot F, et al. PCV67 epidemiology of transthyretin amyloid cardiomyopathy (ATTR&#x2010;CM) in France: EPACT, a study based on the French Nationwide Claims Database Snds. Value Health 2020;23:S498&#x2010;S499. doi:10.1016/j.jval.2020.08.558</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2020.08.558</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott P, Drachman BM, Gottlieb SS, Hoffman JE, Hummel SL, Lenihan DJ, et al. Long&#x2010;term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy. Circ Heart Fail 2022;15:e008193. doi:10.1161/CIRCHEARTFAILURE.120.008193</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.120.008193</ArticleId><ArticleId IdType="pmc">PMC8763250</ArticleId><ArticleId IdType="pubmed">34923848</ArticleId></ArticleIdList></Reference><Reference><Citation>Aus dem Siepen F, Hein S, Prestel S, Baumgartner C, Schonland S, Hegenbart U, et al. Carpal tunnel syndrome and spinal canal stenosis: Harbingers of transthyretin amyloid cardiomyopathy? Clin Res Cardiol 2019;108:1324&#x2010;1330. doi:10.1007/s00392-019-01467-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-019-01467-1</ArticleId><ArticleId IdType="pubmed">30953182</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperry BW, Reyes BA, Ikram A, Donnelly JP, Phelan D, Jaber WA, et al. Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release. J Am Coll Cardiol 2018;72:2040&#x2010;2050. doi:10.1016/j.jacc.2018.07.092</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.07.092</ArticleId><ArticleId IdType="pubmed">30336828</ArticleId></ArticleIdList></Reference><Reference><Citation>Geller HI, Singh A, Alexander KM, Mirto TM, Falk RH. Association between ruptured distal biceps tendon and wild&#x2010;type transthyretin cardiac amyloidosis. JAMA 2017;318:962&#x2010;963. doi:10.1001/jama.2017.9236</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.9236</ArticleId><ArticleId IdType="pmc">PMC5818850</ArticleId><ArticleId IdType="pubmed">28898370</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr AS, Shah S, Choi D, Blake J, Phadke R, Gilbertson J, et al. Spinal stenosis in familial transthyretin amyloidosis. J Neuromuscul Dis 2019;6:267&#x2010;270. doi:10.3233/JND-180348</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-180348</ArticleId><ArticleId IdType="pubmed">30856118</ArticleId></ArticleIdList></Reference><Reference><Citation>Westermark P, Westermark GT, Suhr OB, Berg S. Transthyretin&#x2010;derived amyloidosis: Probably a common cause of lumbar spinal stenosis. Ups J Med Sci 2014;119:223&#x2010;228. doi:10.3109/03009734.2014.895786</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03009734.2014.895786</ArticleId><ArticleId IdType="pmc">PMC4116761</ArticleId><ArticleId IdType="pubmed">24620715</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanagisawa A, Ueda M, Sueyoshi T, Okada T, Fujimoto T, Ogi Y, et al. Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis. Mod Pathol 2015;28:201&#x2010;207. doi:10.1038/modpathol.2014.102</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/modpathol.2014.102</ArticleId><ArticleId IdType="pubmed">25189643</ArticleId></ArticleIdList></Reference><Reference><Citation>Huda A, Casta&#xf1;o A, Niyogi A, Schumacher J, Stewart M, Bruno M, et al. A machine learning model for identifying patients at risk for wild&#x2010;type transthyretin amyloid cardiomyopathy. Nat Commun 2021;12:2725. doi:10.1038/s41467-021-22876-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22876-9</ArticleId><ArticleId IdType="pmc">PMC8113237</ArticleId><ArticleId IdType="pubmed">33976166</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez&#x2010;Boussard T, Monda KL, Crespo BC, Riskin D. Real world evidence in cardiovascular medicine: Ensuring data validity in electronic health record&#x2010;based studies. J Am Med Inform Assoc 2019;26:1189&#x2010;1194. doi:10.1093/jamia/ocz119</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocz119</ArticleId><ArticleId IdType="pmc">PMC6798570</ArticleId><ArticleId IdType="pubmed">31414700</ArticleId></ArticleIdList></Reference><Reference><Citation>Reading Turchioe M, Volodarskiy A, Pathak J, Wright DN, Tcheng JE, Slotwiner D. Systematic review of current natural language processing methods and applications in cardiology. Heart 2022;108:909&#x2010;916. doi:10.1136/heartjnl-2021-319769</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2021-319769</ArticleId><ArticleId IdType="pmc">PMC9046466</ArticleId><ArticleId IdType="pubmed">34711662</ArticleId></ArticleIdList></Reference><Reference><Citation>Hens D, Wyers L, Claeys KG. Validation of an artificial intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: Hereditary transthyretin amyloidosis polyneuropathy as a key example. J Peripher Nerv Syst 2022;28:79&#x2010;85. doi:10.1111/jns.12523</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jns.12523</ArticleId><ArticleId IdType="pubmed">36468607</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Meulebroucke C, Beckers J, Corten K. What can we expect following anterior total hip arthroplasty on a regular operating table? A validation study of an artificial intelligence algorithm to monitor adverse events in a high&#x2010;volume, nonacademic setting. J Arthroplasty 2019;34:2260&#x2010;2266. doi:10.1016/j.arth.2019.07.039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2019.07.039</ArticleId><ArticleId IdType="pubmed">31445868</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 2007;370:1453&#x2010;1457. doi:10.1016/S0140-6736(07)61602-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61602-X</ArticleId><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Dispenzieri A, Coelho T, Concei&#xe7;&#xe3;o I, Waddington&#x2010;Cruz M, Wixner J, Kristen AV, et al.; THAOS investigators . Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14&#x2010;year update. Orphanet J Rare Dis 2022;17:236. doi:10.1186/s13023-022-02359-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-022-02359-w</ArticleId><ArticleId IdType="pmc">PMC9206752</ArticleId><ArticleId IdType="pubmed">35717381</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JD, Lenihan DJ, Reed C, Huda A, Nolen K, Bruno M, et al. Implementing a machine&#x2010;learning&#x2010;adapted algorithm to identify possible transthyretin amyloid cardiomyopathy at an academic medical center. Clin Med Insights: Cardiol 2022;16:11795468221133608. doi:10.1177/11795468221133608</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/11795468221133608</ArticleId><ArticleId IdType="pmc">PMC9663613</ArticleId><ArticleId IdType="pubmed">36386406</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroi F, Fischer N, Gezin A, Hashim M, Rozenbaum MH. Estimating the gender distribution of patients with wild&#x2010;type transthyretin amyloid cardiomyopathy: A systematic review and meta&#x2010;analysis. Cardiol Ther 2021;10:41&#x2010;55. doi:10.1007/s40119-020-00205-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40119-020-00205-3</ArticleId><ArticleId IdType="pmc">PMC8126539</ArticleId><ArticleId IdType="pubmed">33315233</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez&#x2010;L&#xf3;pez E, Gagliardi C, Dominguez F, Quarta CC, de Haro&#x2010;del Moral FJ, Milandri A, et al. Clinical characteristics of wild&#x2010;type transthyretin cardiac amyloidosis: Disproving myths. Eur Heart J 2017;38:1895&#x2010;1904. doi:10.1093/eurheartj/ehx043</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx043</ArticleId><ArticleId IdType="pubmed">28329248</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia&#x2010;Pavia P, Grogan M, Dispenzieri A, Mundayat R, Amass L, Rapezzi C. P336A descriptive analysis of patients with wild&#x2010;type ATTR cardiomyopathy from the Transthyretin Amyloidosis Outcomes Survey. Eur Heart J 2019;40: doi:10.1093/eurheartj/ehz747.0170</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz747.0170</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa M, Sekijima Y, Yazaki M, Tojo K, Yoshinaga T, Doden T, et al. Carpal tunnel syndrome: A common initial symptom of systemic wild&#x2010;type ATTR (ATTRwt) amyloidosis. Amyloid 2016;23:58&#x2010;63. doi:10.3109/13506129.2015.1135792</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13506129.2015.1135792</ArticleId><ArticleId IdType="pubmed">26852880</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladefoged B, Dybro A, Povlsen JA, Vase H, Clemmensen TS, Poulsen SH. Diagnostic delay in wild type transthyretin cardiac amyloidosis&#x2014;A clinical challenge. Int J Cardiol 2020;304:138&#x2010;143. doi:10.1016/j.ijcard.2019.12.063</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2019.12.063</ArticleId><ArticleId IdType="pubmed">32033783</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37743838</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-8978</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>13</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Psychological medicine</Title><ISOAbbreviation>Psychol Med</ISOAbbreviation></Journal><ArticleTitle>The association between persistent cognitive difficulties and depression and functional outcomes in people with major depressive disorder.</ArticleTitle><Pagination><StartPage>6334</StartPage><EndPage>6344</EndPage><MedlinePgn>6334-6344</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0033291722003671</ELocationID><Abstract><AbstractText Label="BACKGROUND">Cognitive symptoms are common during and following episodes of depression. Little is known about the persistence of self-reported and performance-based cognition with depression and functional outcomes.</AbstractText><AbstractText Label="METHODS">This is a secondary analysis of a prospective naturalistic observational clinical cohort study of individuals with recurrent major depressive disorder (MDD; <i>N</i> = 623). Participants completed app-based self-reported and performance-based cognitive function assessments alongside validated measures of depression, functional disability, and self-esteem every 3 months. Participants were followed-up for a maximum of 2-years. Multilevel hierarchically nested modelling was employed to explore between- and within-participant variation over time to identify whether persistent cognitive difficulties are related to levels of depression and functional impairment during follow-up.</AbstractText><AbstractText Label="RESULTS">508 individuals (81.5%) provided data (mean age: 46.6, s.d.: 15.6; 76.2% female). Increasing persistence of self-reported cognitive difficulty was associated with higher levels of depression and functional impairment throughout the follow-up. In comparison to low persistence of objective cognitive difficulty (&lt;25% of timepoints), those with high persistence (&gt;75% of timepoints) reported significantly higher levels of depression (<i>B</i> = 5.17, s.e. = 2.21, <i>p</i> = 0.019) and functional impairment (<i>B</i> = 4.82, s.e. = 1.79, <i>p</i> = 0.002) over time. Examination of the individual cognitive modules shows that persistently impaired executive function is associated with worse functioning, and poor processing speed is particularly important for worsened depressive symptoms.</AbstractText><AbstractText Label="CONCLUSIONS">We replicated previous findings of greater persistence of cognitive difficulty with increasing severity of depression and further demonstrate that these cognitive difficulties are associated with pervasive functional disability. Difficulties with cognition may be an indicator and target for further treatment input.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matcham</LastName><ForeName>F</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-4055-904X</Identifier><AffiliationInfo><Affiliation>The Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Psychology, University of Sussex, Falmer, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simblett</LastName><ForeName>S K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>The Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leightley</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalby</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Muna Therapeutics, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siddi</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Parc Sanitari Sant Joan de D&#xe9;u, Fundaci&#xf3; San Joan de D&#xe9;u, Universitat de Barcelona, CIBERSAM, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haro</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Parc Sanitari Sant Joan de D&#xe9;u, Fundaci&#xf3; San Joan de D&#xe9;u, Universitat de Barcelona, CIBERSAM, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamers</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Amsterdam UMC location Vrije Universiteit Amsterdam, Boelelaan 1117, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, Mental Health Program, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penninx</LastName><ForeName>B W H J</ForeName><Initials>BWHJ</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Amsterdam UMC location Vrije Universiteit Amsterdam, Boelelaan 1117, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, Mental Health Program, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruce</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nica</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Romanian League for Mental Health, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zormpas</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>EPIONI Greek Carers Network, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilpin</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>The Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>K M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>The Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oetzmann</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Annas</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>H. Lundbeck A/S, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brasen</LastName><ForeName>J C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>H. Lundbeck A/S, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narayan</LastName><ForeName>V A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Janssen Pharmaceutica NV, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hotopf</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>South London and Maudsley NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wykes</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>South London and Maudsley NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>RADAR-CNS consortium</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychol Med</MedlineTA><NlmUniqueID>1254142</NlmUniqueID><ISSNLinking>0033-2917</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003865" MajorTopicYN="Y">Depressive Disorder, Major</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cognitive function</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">longitudinal</Keyword><Keyword MajorTopicYN="N">major depressive disorder</Keyword><Keyword MajorTopicYN="N">predictive</Keyword><Keyword MajorTopicYN="N">remote measurement</Keyword></KeywordList><CoiStatement>JCB and PA are full-time employees of H. Lundbeck A/S. VN is an employee of Janssen Research and Development, LLC and holds company stocks/stock options. JMH has received economic compensation for participating in advisory boards or giving educational lectures from Eli Lilly &amp; Co, Sanofi, Lundbeck, and Otsuka. CO is supported by the UK Medical Research Council (MR/N013700/1) and King&#x2019;s College London member of the MRC Doctoral Training Partnership in Biomedical Sciences. No other authors have competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>26</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37743838</ArticleId><ArticleId IdType="pmc">PMC10520589</ArticleId><ArticleId IdType="doi">10.1017/S0033291722003671</ArticleId><ArticleId IdType="pii">S0033291722003671</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abramovitch, A., Short, T., &amp; Schweiger, A. (2021). The C factor: Cognitive dysfunction as a transdiagnostic dimension in psychopathology. Clinical Psychology Review, 86, 102007.</Citation><ArticleIdList><ArticleId IdType="pubmed">33864968</ArticleId></ArticleIdList></Reference><Reference><Citation>Atique-Ur-Rehman, H., &amp; Neill, J. C. (2019). Cognitive dysfunction in major depression: From assessment to novel therapies. Pharmacology &amp; Therapeutics, 202, 53&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">31173838</ArticleId></ArticleIdList></Reference><Reference><Citation>Baune, B. T., Malhi, G. S., Morris, G., Outhred, T., Hamilton, A., Das, P., &#x2026; Lyndon, B. (2018). Cognition in depression: Can we THINC-it better. Journal of Affective Disorders, 225, 559&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pubmed">28869910</ArticleId></ArticleIdList></Reference><Reference><Citation>Baune, B. T., &amp; Renger, L. (2014). Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression &#x2013; A systematic review. Psychiatry Research, 219(1), 25&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">24863864</ArticleId></ArticleIdList></Reference><Reference><Citation>Belgaied, W., Samp, J., Vimont, A., R&#xe9;muzat, C., Aball&#xe9;a, S., El Hammi, E., &#x2026; Akhras, K. (2014). Routine clinical assessment of cognitive functioning in schizophrenia, major depressive disorder, and bipolar disorder. European Neuropsychopharmacology, 24(1), 133&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">24314852</ArticleId></ArticleIdList></Reference><Reference><Citation>Bora, E., Harrison, B. J., Y&#xfc;cel, M., &amp; Pantelis, C. (2013). Cognitive impairment in euthymic major depressive disorder: A meta-analysis. Psychological Medicine, 43(10), 2017&#x2013;2026.</Citation><ArticleIdList><ArticleId IdType="pubmed">23098294</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha, D. S., Carmona, N. E., Subramaniapillai, M., Mansur, R. B., Lee, Y., Lee, J. H., &#x2026; Park, C. (2017). Cognitive impairment as measured by the THINC-integrated tool (THINC-it&#xae;): Association with psychosocial function in major depressive disorder. Journal of Affective Disorders, 222, 14&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">28667888</ArticleId></ArticleIdList></Reference><Reference><Citation>Conradi, H., Ormel, J., &amp; De Jonge, P. (2011). Presence of individual (residual) symptoms during depressive episodes and periods of remission: A 3-year prospective study. Psychological Medicine, 41(6), 1165&#x2013;1174.</Citation><ArticleIdList><ArticleId IdType="pubmed">20932356</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalby, M., Annas, P., 23andMe Research Team., &amp; Harrison, J. (2022). Further validation of the THINC-it tool and extension of the normative data set in a study of n = 10.019 typical controls. International Journal of Methods in Psychiatric Research, e1922. doi: 10.1002/mpr.1922</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mpr.1922</ArticleId><ArticleId IdType="pmc">PMC9720188</ArticleId><ArticleId IdType="pubmed">35748111</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho Filho, M. K., &amp; Yuzawa, M. (2010). The effects of social cues on confidence judgements mediated by knowledge and regulation of cognition. The Journal of Experimental Education, 69(4), 325&#x2013;343.</Citation></Reference><Reference><Citation>Ebert, B., Miskowiak, K., Kloster, M., Johansen, J., Eckholm, C., W&#xe6;rner, T., &#x2026; Bruun, L. M. (2017). An ethnographic study of the effects of cognitive symptoms in patients with major depressive disorder: The IMPACT study. BMC Psychiatry, 17(1), 370. 10.1186/s12888-017-1523-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-017-1523-8</ArticleId><ArticleId IdType="pmc">PMC5697414</ArticleId><ArticleId IdType="pubmed">29157207</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazeli, M., Ehteshamzadeh, P., &amp; Hashemi, S. E. (2015). The effectiveness of cognitive behavior therapy on cognitive flexibility of depressed people. Thoughts and Behavior in Clinical Psychology, 9(34), 27&#x2013;36.</Citation></Reference><Reference><Citation>Fried, E. I., &amp; Nesse, R. M. (2014). The impact of individual depressive symptoms on impairment of psychosocial functioning. PloS One, 9(2), e90311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3938686</ArticleId><ArticleId IdType="pubmed">24587318</ArticleId></ArticleIdList></Reference><Reference><Citation>Gili, M., Luciano, J. V., Bauz&#xe1;, N., Aguado, J., Serrano, M. J., Armengol, S., &amp; Roca, M. (2011). Psychometric properties of the IDS-SR30 for the assessment of depressive symptoms in spanish population. Medical Research Methodology, 11, 131. 10.1186/1471-2288-11-131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-11-131</ArticleId><ArticleId IdType="pmc">PMC3188477</ArticleId><ArticleId IdType="pubmed">21936925</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonda, X., Pompili, M., Serafini, G., Carvalho, A. F., Rihmer, Z., &amp; Dome, P. (2015). The role of cognitive dysfunction in the symptoms and remission from depression. Annals of General Psychiatry, 14(1), 1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4578787</ArticleId><ArticleId IdType="pubmed">26396586</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberger, E., Chen, C., Dmitrieva, J., &amp; Farruggia, S. P. (2003). Item-wording and the dimensionality of the Rosenberg self-esteem scale: Do they matter? Personality and Individual Differences, 35(6), 1241&#x2013;1254.</Citation></Reference><Reference><Citation>Harrison, J. E., Barry, H., Baune, B. T., Best, M. W., Bowie, C. R., Cha, D. S., &#x2026; Harmer, C. (2018). Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers. International Journal of Methods in Psychiatric Research, 27(3), e1736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6174931</ArticleId><ArticleId IdType="pubmed">30088298</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight, B. G., Rastegar, S., &amp; Kim, S. (2016). Age differences in the connection of mood and cognition: Evidence from studies of mood congruent effects. In Schaie K. W., &amp; Willis S. L. (Eds.), Handbook of the psychology of aging (pp. 279&#x2013;302). Washington, USA: Elsevier.</Citation></Reference><Reference><Citation>Martinez-Aran, A., Scott, J., Colom, F., Torrent, C., Tabares-Seisdedos, R., Daban, C., &#x2026; Gonzalez-Pinto, A. (2009). Treatment nonadherence and neurocognitive impairment in bipolar disorder. The Journal of Clinical Ppsychiatry, 70(7), 21530.</Citation><ArticleIdList><ArticleId IdType="pubmed">19497247</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcham, F., Barattieri di San Pietro, C., Bulgari, V., De Girolamo, G., Dobson, R., Eriksson, H., &#x2026; Hotopf, M. (2019). Remote assessment of disease and relapse in major depressive disorder (RADAR-MDD): A multi-centre prospective cohort study protocol. BMC Psychiatry, 19(1), 1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6379954</ArticleId><ArticleId IdType="pubmed">30777041</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcham, F., Carr, E., White, K. M., Leightley, D., Lamers, F., Siddi, S., &#x2026; Hotopf, M. (2022a). Predictors of engagement with remote sensing technologies for symptom measurement in major depressive disorder. Journal of Affective Disorders, 310, 106&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">35525507</ArticleId></ArticleIdList></Reference><Reference><Citation>Matcham, F., Leightley, D., Siddi, S., Lamers, F., White, K. M., Annas, P., &#x2026; Hotopf, M. (2022b). Remote Assessment of Disease and Relapse in Major Depressive Disorder (RADAR-MDD): Recruitment, retention, and data availability in a longitudinal remote measurement study. BMC Psychiatry, 22(1), 1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8860359</ArticleId><ArticleId IdType="pubmed">35189842</ArticleId></ArticleIdList></Reference><Reference><Citation>McCelland, G. H., Lynch, Jr. J. G., Irwin, J. R., Spiller, S. A., &amp; Fitzsimons, G. J. (2015). Median splots, type II errors, and a false-positive consumer psychology: Don't fight the power. Journa of Consumer Psychology, 25(4), 679&#x2013;689.</Citation></Reference><Reference><Citation>McIntyre, R. S., Best, M. W., Bowie, C. R., Carmona, N. E., Cha, D. S., Lee, Y., &#x2026; Baune, B. T. (2017). The THINC-integrated tool (THINC-it&#xae;) screening assessment for cognitive dysfunction: Validation in patients with major depressive disorder. The Journal of Clinical Psychiatry, 78(7), 20938.</Citation><ArticleIdList><ArticleId IdType="pubmed">28858441</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre, R. S., Subramaniapillai, M., Park, C., Zuckerman, H., Cao, B., Lee, Y., &#x2026; Bowie, C. R. (2020). The THINC-it&#xae; tool for cognitive assessment and measurement in major depressive disorder: Sensitivity to change. Frontiers in Psychiatry, 11, 546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7327547</ArticleId><ArticleId IdType="pubmed">32670103</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskowiak, W. K., &amp; Carvalho, F. A. (2014). &#x2018;Hot&#x2019; cognition in major depressive disorder: A systematic review. CNS &amp; Neurological Disorders &#x2013; Drug Targets, 13(10), 1787&#x2013;1803. 10.2174/1871527313666141130205713.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527313666141130205713</ArticleId><ArticleId IdType="pubmed">25470389</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundt, J. C., Marks, I. M., Shear, M. K., &amp; Greist, J. M. (2002). The work and social adjustment scale: A simple measure of impairment in functioning. The British Journal of Psychiatry, 180(5), 461&#x2013;464.</Citation><ArticleIdList><ArticleId IdType="pubmed">11983645</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieto, I., Robles, E., &amp; Vazquez, C. (2020). Self-reported cognitive biases in depression: A meta-analysis. Clinical Psychology Review, 82, 101934.</Citation><ArticleIdList><ArticleId IdType="pubmed">33137610</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan, Z., Park, C., Brietzke, E., Zuckerman, H., Rong, C., Mansur, R. B., &#x2026; McIntyre, R. S. (2019). Cognitive impairment in major depressive disorder. CNS Spectrums, 24(1), 22&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">30468135</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen, J. Z., Porter, R. J., &amp; Miskowiak, K. W. (2019). Clinical characteristics associated with the discrepancy between subjective and objective cognitive impairment in depression. Journal of Affective Disorders, 246, 763&#x2013;774.</Citation><ArticleIdList><ArticleId IdType="pubmed">30623822</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu, S., Yamada, T., Yokoyama, K., Matsumura, H., Mitani, H., Adachi, A., &#x2026; Nakagome, K. (2012). Reduced prefrontal cortex activation during the working memory task associated with poor social functioning in late-onset depression: Multi-channel near-infrared spectroscopy study. Psychiatry Research: Neuroimaging, 203(2-3), 222&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">22964135</ArticleId></ArticleIdList></Reference><Reference><Citation>Rock, P. L., Roiser, J., Riedel, W. J., &amp; Blackwell, A. (2014). Cognitive impairment in depression: A systematic review and meta-analysis. Psychological Medicine, 44(10), 2029&#x2013;2040.</Citation><ArticleIdList><ArticleId IdType="pubmed">24168753</ArticleId></ArticleIdList></Reference><Reference><Citation>Rush, A. J., Carmody, T., &amp; Reimitz, P. E. (2000). The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. International Journal of Methods in Psychiatric Research, 9(2), 45&#x2013;59.</Citation></Reference><Reference><Citation>Santos, N. C., Costa, P. S., Cunha, P., Portugal-Nunes, C., Amorim, L., Cotter, J., &#x2026; Sousa, N. (2014). Clinical, physical and lifestyle variables and relationship with cognition and mood in aging: A cross-sectional analysis of distinct educational groups. Frontiers in Aging Neuroscience, 6, 21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3932406</ArticleId><ArticleId IdType="pubmed">24605100</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson, J., Hillman, R., Crawford, T., &amp; Overton, P. (2010). Self-esteem and self-disgust both mediate the relationship between dysfunctional cognitions and depressive symptoms. Motivation and Emotion, 34(4), 399&#x2013;406.</Citation></Reference><Reference><Citation>Slagboom, T. N. A., Deijen, J. B., Van Bunderen, C. C., Knoop, H. A., &amp; Drent, M. L. (2021). Psychological well-being and illness perceptions in patients with hypopituitarism. Pituitary, 24, 542&#x2013;554. 10.1007/s11102-021-01131-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11102-021-01131-w</ArticleId><ArticleId IdType="pmc">PMC8270855</ArticleId><ArticleId IdType="pubmed">33606176</ArticleId></ArticleIdList></Reference><Reference><Citation>Srisurapanont, M., Suttajit, S., Eurviriyanukul, K., &amp; Varnado, P. (2017). Discrepancy between objective and subjective cognition in adults with major depressive disorder. Scientific Reports, 7(1), 1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5478612</ArticleId><ArticleId IdType="pubmed">28634383</ArticleId></ArticleIdList></Reference><Reference><Citation>Twisk, J., de Boer, M., de Vente, W., &amp; Heymans, M. (2013). Multiple imputation of missing values was not necessary before performing a longitudinal mixed-model analysis. Journal of Clinical Epidemiology, 66(9), 1022&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pubmed">23790725</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe1;zquez Morej&#xf3;n, A., V&#xe1;zquez-Morej&#xf3;n, R., Conde &#xc1;lvarez, P. (2021). Work and Social Adjustment Scale (WSAS): Psychometric characteristics of a Spanish adaptation in a clinical population. Behavioural and Cognitive Psychotherapy, 49(6), 764&#x2013;768. doi: 10.1017/S1352465821000308</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1352465821000308</ArticleId><ArticleId IdType="pubmed">34384507</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardenaar, K. J., van Veen, T., Giltay, E. J., de Beurs, E., Penninx, B. W. J. H., &amp; Zitman, F. G. (2010). Development and validation of a 30-item short adaptation of the Mood and Anxiety Symptoms Questionnaire (MASQ). Psychiatry Research, 179(1), 101&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">20472297</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesnes, K., &amp; Pincock, C. (2002). Practice effects on cognitive tasks: A major problem? The Lancet Neruology, 1(8), 473.</Citation><ArticleIdList><ArticleId IdType="pubmed">12849328</ArticleId></ArticleIdList></Reference><Reference><Citation>Wykes, T., &amp; Reeder, C. (2006). Cognitive remediation therapy for schizophrenia: Theory and practice. Oxfordshire, UK: Routledge.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37765021</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1424-8247</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>28</Day></PubDate></JournalIssue><Title>Pharmaceuticals (Basel, Switzerland)</Title><ISOAbbreviation>Pharmaceuticals (Basel)</ISOAbbreviation></Journal><ArticleTitle>Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1213</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ph16091213</ELocationID><Abstract><AbstractText Label="BACKGROUND/AIMS" NlmCategory="OBJECTIVE">Conflicting results have been reported regarding the interaction between proton pump inhibitors (PPIs) and clopidogrel. We investigated whether concomitant PPI use influenced the risk of recurrence in patients with stroke and myocardial infarction (MI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study used two databases for two different designs, the Korean National Health Insurance Service (NHIS) database for a self-controlled case series design, and the national sample cohort of the NHIS data base converted to the Observational Medical Outcomes Partnership-Common Data Model version for a cohort study based on large-scale propensity score matching.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the PPI co-prescription group, recurrent hospitalization with stroke occurred in 17.6% of the 8201 patients with history of stroke, and recurrent MI occurred in 17.1% of the 1216 patients with history of MI within1 year. According to the self-controlled case series, the overall relative risk (RR) of recurrent stroke was 2.09 (95% confidence interval (CI); 1.83-2.38); the RR showed an increasing trend parallel to the time from the beginning of PPI co-prescription. In the cohort study, there was a higher incidence of recurrent stroke in the PPI co-prescription group (Hazard ratio (HR): 1.34, 95% CI: 1.01-1.76, <i>p</i> = 0.04). The overall RR of recurrent MI was 1.47 (95% CI; 1.02-2.11) in the self-controlled case series; however, there was no statistically significant difference in recurrent MI in the cohort study (HR:1.42, 95% CI:0.79-2.49, <i>p</i> = 0.23). The impact of individual PPIs on stroke and MI showed different patterns.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A PPI co-prescription &gt;4 weeks with clopidogrel was associated with hospitalization of recurrent stroke within 1 year of initial diagnosis; however, its association with recurrent MI remains inconclusive. The influence of individual PPIs should be clarified in the future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yong Kang</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang 10444, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Hyun Sun</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Department of Research and Analysis, National Health Insurance Service Ilsan Hospital, Goyang 10444, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Youn I</ForeName><Initials>YI</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang 10444, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choe</LastName><ForeName>Eun Ju</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0002-0012-472X</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang 10444, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Seonji</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4993-7537</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Innovation in Digital Healthcare, Yonsei University, Seoul 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Innovation in Digital Healthcare, Yonsei University, Seoul 03722, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Kyung Joo</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Medical Informatics &amp; Statistics, Kangdong Sacred Heart Hospital, Seoul 05355, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yerim</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul 24252, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Da Hee</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Institute for Liver and Digestive Diseases, Hallym University, Chuncheon 24252, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul 05355, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Woon Geon</ForeName><Initials>WG</Initials><Identifier Source="ORCID">0000-0002-9851-5576</Identifier><AffiliationInfo><Affiliation>Institute for Liver and Digestive Diseases, Hallym University, Chuncheon 24252, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul 05355, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Seung In</ForeName><Initials>SI</Initials><Identifier Source="ORCID">0000-0003-4417-0135</Identifier><AffiliationInfo><Affiliation>Institute for Liver and Digestive Diseases, Hallym University, Chuncheon 24252, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul 05355, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NHIMC 2020-20-020</GrantID><Agency>National Health Insurance Service Ilsan Hospital Grant</Agency><Country/></Grant><Grant><GrantID>KCHUGR 202102003</GrantID><Agency>Korean College of Helicobacter and Upper Gastrointestinal Research Foundation Grant</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pharmaceuticals (Basel)</MedlineTA><NlmUniqueID>101238453</NlmUniqueID><ISSNLinking>1424-8247</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">clopidogrel</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">proton pump inhibitors</Keyword><Keyword MajorTopicYN="N">stroke</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37765021</ArticleId><ArticleId IdType="pmc">PMC10535402</ArticleId><ArticleId IdType="doi">10.3390/ph16091213</ArticleId><ArticleId IdType="pii">ph16091213</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Scally B., Emberson J.R., Spata E., Reith C., Davies K., Halls H., Holland L., Wilson K., Bhala N., Hawkey C., et al. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: A meta-analysis of randomised trials. Lancet Gastroenterol. Hepatol. 2018;3:231&#x2013;241. doi: 10.1016/S2468-1253(18)30037-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(18)30037-2</ArticleId><ArticleId IdType="pmc">PMC5842491</ArticleId><ArticleId IdType="pubmed">29475806</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz P.O., Dunbar K.B., Schnoll-Sussman F.H., Greer K.B., Yadlapati R., Spechler S.J. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am. J. Gastroenterol. 2022;117:27&#x2013;56. doi: 10.14309/ajg.0000000000001538.</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/ajg.0000000000001538</ArticleId><ArticleId IdType="pmc">PMC8754510</ArticleId><ArticleId IdType="pubmed">34807007</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwakiri K., Fujiwara Y., Manabe N., Ihara E., Kuribayashi S., Akiyama J., Kondo T., Yamashita H., Ishimura N., Kitasako Y., et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021. J. Gastroenterol. 2022;57:267&#x2013;285. doi: 10.1007/s00535-022-01861-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-022-01861-z</ArticleId><ArticleId IdType="pmc">PMC8938399</ArticleId><ArticleId IdType="pubmed">35226174</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung H.K., Tae C.H., Song K.H., Kang S.J., Park J.K., Gong E.J., Shin J.E., Lim H.C., Lee S.K., Jung D.H., et al. 2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease. J. Neurogastroenterol. Motil. 2021;27:453&#x2013;481. doi: 10.5056/jnm21077.</Citation><ArticleIdList><ArticleId IdType="doi">10.5056/jnm21077</ArticleId><ArticleId IdType="pmc">PMC8521465</ArticleId><ArticleId IdType="pubmed">34642267</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham N.S., Hlatky M.A., Antman E.M., Bhatt D.L., Bjorkman D.J., Clark C.B., Furberg C.D., Johnson D.A., Kahi C.J., Laine L., et al. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: A focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J. Am. Coll. Cardiol. 2010;56:2051&#x2013;2066. doi: 10.1016/j.jacc.2010.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.09.010</ArticleId><ArticleId IdType="pubmed">21126648</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfertheiner P., Kandulski A., Venerito M. Proton-pump inhibitors: Understanding the complications and risks. Nat. Rev. Gastroenterol. Hepatol. 2017;14:697&#x2013;710. doi: 10.1038/nrgastro.2017.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2017.117</ArticleId><ArticleId IdType="pubmed">28930292</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaezi M.F., Yang Y.X., Howden C.W. Complications of Proton Pump Inhibitor Therapy. Gastroenterology. 2017;153:35&#x2013;48. doi: 10.1053/j.gastro.2017.04.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2017.04.047</ArticleId><ArticleId IdType="pubmed">28528705</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarino V., Marabotto E., Zentilin P., Furnari M., Bodini G., De Maria C., Pellegatta G., Coppo C., Savarino E. Proton pump inhibitors: Use and misuse in the clinical setting. Expert Rev. Clin. Pharmacol. 2018;11:1123&#x2013;1134. doi: 10.1080/17512433.2018.1531703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17512433.2018.1531703</ArticleId><ArticleId IdType="pubmed">30295105</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthiah M.D., Zheng H.L., Chew N.W.S., Xiao J.L., Lim L.G., Tan H.C., Lee C.H., Low A.F., Foo L.L., Richards A.M., et al. Outcomes of a multi-ethnic Asian population on combined treatment with clopidogrel and omeprazole in 12,440 patients. J. Thromb. Thrombolysis. 2021;52:925&#x2013;933. doi: 10.1007/s11239-021-02472-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-021-02472-w</ArticleId><ArticleId IdType="pubmed">33959860</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt D.L., Cryer B.L., Contant C.F., Cohen M., Lanas A., Schnitzer T.J., Shook T.L., Lapuerta P., Goldsmith M.A., Laine L., et al. Clopidogrel with or without omeprazole in coronary artery disease. N. Engl. J. Med. 2010;363:1909&#x2013;1917. doi: 10.1056/NEJMoa1007964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1007964</ArticleId><ArticleId IdType="pubmed">20925534</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaduganathan M., Cannon C.P., Cryer B.L., Liu Y., Hsieh W.H., Doros G., Cohen M., Lanas A., Schnitzer T.J., Shook T.L., et al. Efficacy and Safety of Proton-Pump Inhibitors in High-Risk Cardiovascular Subsets of the COGENT Trial. Am. J. Med. 2016;129:1002&#x2013;1005. doi: 10.1016/j.amjmed.2016.03.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2016.03.042</ArticleId><ArticleId IdType="pubmed">27143321</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou D., Goh K.L. East Asian perspective on the interaction between proton pump inhibitors and clopidogrel. J. Gastroenterol. Hepatol. 2017;32:1152&#x2013;1159. doi: 10.1111/jgh.13712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.13712</ArticleId><ArticleId IdType="pubmed">28024166</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman S.G., Clare R., Pieper K.S., Nicolau J.C., Storey R.F., Cantor W.J., Mahaffey K.W., Angiolillo D.J., Husted S., Cannon C.P., et al. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: Insights from the platelet inhibition and patient outcomes trial. Circulation. 2012;125:978&#x2013;986. doi: 10.1161/CIRCULATIONAHA.111.032912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.032912</ArticleId><ArticleId IdType="pubmed">22261200</ArticleId></ArticleIdList></Reference><Reference><Citation>Malhotra K., Katsanos A.H., Bilal M., Ishfaq M.F., Goyal N., Tsivgoulis G. Cerebrovascular Outcomes With Proton Pump Inhibitors and Thienopyridines: A Systematic Review and Meta-Analysis. Stroke. 2018;49:312&#x2013;318. doi: 10.1161/STROKEAHA.117.019166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.019166</ArticleId><ArticleId IdType="pubmed">29339434</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho P.M., Maddox T.M., Wang L., Fihn S.D., Jesse R.L., Peterson E.D., Rumsfeld J.S. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA. 2009;301:937&#x2013;944. doi: 10.1001/jama.2009.261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.261</ArticleId><ArticleId IdType="pubmed">19258584</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassen J.A., Choudhry N.K., Avorn J., Schneeweiss S. Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation. 2009;120:2322&#x2013;2329. doi: 10.1161/CIRCULATIONAHA.109.873497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.873497</ArticleId><ArticleId IdType="pmc">PMC2818789</ArticleId><ArticleId IdType="pubmed">19933932</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas I.J., Evans S.J., Hingorani A.D., Grosso A.M., Timmis A., Hemingway H., Smeeth L. Clopidogrel and interaction with proton pump inhibitors: Comparison between cohort and within person study designs. BMJ. 2012;345:e4388. doi: 10.1136/bmj.e4388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.e4388</ArticleId><ArticleId IdType="pmc">PMC3392956</ArticleId><ArticleId IdType="pubmed">22782731</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang J., Wu Q., Zhang Z., Zheng T.Z., Xiang Q., Zhang P., Liu X., Zhang C., Tan H., Huang J., et al. Efficacy and safety of clopidogrel only vs. clopidogrel added proton pump inhibitors in the treatment of patients with coronary heart disease after percutaneous coronary intervention: A systematic review and meta-analysis. Int. J. Cardiol. Heart Vasc. 2019;23:100317. doi: 10.1016/j.ijcha.2018.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2018.12.016</ArticleId><ArticleId IdType="pmc">PMC6612751</ArticleId><ArticleId IdType="pubmed">31321282</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu W., Luo Y., Yang X. Inappropriate Use of Proton Pump Inhibitors Increases Cardiovascular Events in Patients with Coronary Heart Disease. Int. J. Gen. Med. 2022;15:8685&#x2013;8691. doi: 10.2147/IJGM.S392767.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S392767</ArticleId><ArticleId IdType="pmc">PMC9792105</ArticleId><ArticleId IdType="pubmed">36578351</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi W., Ni L., Yang J., Fan X., Yu M., Yang H., Yu M., Yang Y., China Acute Myocardial Infarction Registry study g. The Clinical Impact of Proton Pump Inhibitors When Co-Administered With Dual Antiplatelet Therapy in Patients Having Acute Myocardial Infarction With Low Risk of Gastrointestinal Bleeding: Insights From the China Acute Myocardial Infarction Registry. Front. Cardiovasc. Med. 2021;8:685072. doi: 10.3389/fcvm.2021.685072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.685072</ArticleId><ArticleId IdType="pmc">PMC8492977</ArticleId><ArticleId IdType="pubmed">34631809</ArticleId></ArticleIdList></Reference><Reference><Citation>Saven H., Zhong L., McFarlane I.M. Co-prescription of Dual-Antiplatelet Therapy and Proton Pump Inhibitors: Current Guidelines. Cureus. 2022;14:e21885. doi: 10.7759/cureus.21885.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.21885</ArticleId><ArticleId IdType="pmc">PMC8901154</ArticleId><ArticleId IdType="pubmed">35273851</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima J.J., Thomas C.D., Barbarino J., Desta Z., Van Driest S.L., El Rouby N., Johnson J.A., Cavallari L.H., Shakhnovich V., Thacker D.L., et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing. Clin. Pharmacol. Ther. 2021;109:1417&#x2013;1423. doi: 10.1002/cpt.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.2015</ArticleId><ArticleId IdType="pmc">PMC7868475</ArticleId><ArticleId IdType="pubmed">32770672</ArticleId></ArticleIdList></Reference><Reference><Citation>Sibbing D., Morath T., Stegherr J., Braun S., Vogt W., Hadamitzky M., Sch&#xf6;mig A., Kastrati A., von Beckerath N. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thromb. Haemost. 2009;101:714&#x2013;719.</Citation><ArticleIdList><ArticleId IdType="pubmed">19350116</ArticleId></ArticleIdList></Reference><Reference><Citation>Siller-Matula J.M., Spiel A.O., Lang I.M., Kreiner G., Christ G., Jilma B. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am. Heart J. 2009;157:148.e1&#x2013;148.e5. doi: 10.1016/j.ahj.2008.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2008.09.017</ArticleId><ArticleId IdType="pubmed">19081411</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA  Early Communication about an Ongoing Safety Review of Clopidogrel Bisulfate (Marketed as Plavix)  [(accessed on 19 September 2021)];2009  Available online:  https://www.ktgh.com.tw/Public/Medicament_News/2009131945327055.pdf.</Citation></Reference><Reference><Citation>Bundhun P.K., Teeluck A.R., Bhurtu A., Huang W.Q. Is the concomitant use of clopidogrel and Proton Pump Inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty?: A systematic review and meta-analysis of recently published studies (2012&#x2013;2016) BMC Cardiovasc. Disord. 2017;17:3. doi: 10.1186/s12872-016-0453-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-016-0453-6</ArticleId><ArticleId IdType="pmc">PMC5221663</ArticleId><ArticleId IdType="pubmed">28056809</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi W.C., Yan L., Yang J.G., Yu M.Y. Ethnic variance on long term clinical outcomes of concomitant use of proton pump inhibitors and clopidogrel in patients with stent implantation A PRISMA-complaint systematic review with meta-analysis. Medicine. 2021;100:e24366. doi: 10.1097/MD.0000000000024366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000024366</ArticleId><ArticleId IdType="pmc">PMC7886473</ArticleId><ArticleId IdType="pubmed">33578533</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhat N., Haddad N., Crispo J., Birkett N., McNair D., Momoli F., Wen S.W., Mattison D.R., Krewski D. Trends in concomitant clopidogrel and proton pump inhibitor treatment among ACS inpatients, 2000-2016. Eur. J. Clin. Pharmacol. 2019;75:227&#x2013;235. doi: 10.1007/s00228-018-2564-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00228-018-2564-8</ArticleId><ArticleId IdType="pubmed">30324301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D., Kim J.S., Kim B.J., Shin S.Y., Kim D.B., Ahn H.S. Influence of individual proton pump inhibitors on clinical outcomes in patients receiving clopidogrel following percutaneous coronary intervention. Medicine. 2021;100:e27411. doi: 10.1097/MD.0000000000027411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000027411</ArticleId><ArticleId IdType="pmc">PMC8718184</ArticleId><ArticleId IdType="pubmed">34967346</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y.J., Kim N., Jang I.J., Cho J.Y., Nam R.H., Park J.H., Jo H.J., Yoon H., Shin C.M., Park Y.S., et al. Pantoprazole Does Not Reduce the Antiplatelet Effect of Clopidogrel: A Randomized Controlled Trial in Korea. Gut Liver. 2017;11:504&#x2013;511. doi: 10.5009/gnl16352.</Citation><ArticleIdList><ArticleId IdType="doi">10.5009/gnl16352</ArticleId><ArticleId IdType="pmc">PMC5491085</ArticleId><ArticleId IdType="pubmed">28395507</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker H.J., Hocine M.N., Farrington C.P. The methodology of self-controlled case series studies. Stat. Methods Med. Res. 2009;18:7&#x2013;26. doi: 10.1177/0962280208092342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280208092342</ArticleId><ArticleId IdType="pubmed">18562396</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Wang Y., Schuemie M.J., Blei D.M., Hripcsak G. Adjusting for indirectly measured confounding using large-scale propensity score. J. Biomed. Inform. 2022;134:104204. doi: 10.1016/j.jbi.2022.104204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2022.104204</ArticleId><ArticleId IdType="pmc">PMC9692203</ArticleId><ArticleId IdType="pubmed">36108816</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y., Schuemie M.J., Suchard M.A. Evaluating large-scale propensity score performance through real-world and synthetic data experiments. Int. J. Epidemiol. 2018;47:2005&#x2013;2014. doi: 10.1093/ije/dyy120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyy120</ArticleId><ArticleId IdType="pmc">PMC6280944</ArticleId><ArticleId IdType="pubmed">29939268</ArticleId></ArticleIdList></Reference><Reference><Citation>You S.C., Rho Y., Bikdeli B., Kim J., Siapos A., Weaver J., Londhe A., Cho J., Park J., Schuemie M., et al. Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. JAMA. 2020;324:1640&#x2013;1650. doi: 10.1001/jama.2020.16167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.16167</ArticleId><ArticleId IdType="pmc">PMC7592033</ArticleId><ArticleId IdType="pubmed">33107944</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard M.A., Schuemie M.J., Krumholz H.M., You S.C., Chen R., Pratt N., Reich C.G., Duke J., Madigan D., Hripcsak G., et al. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: A systematic, multinational, large-scale analysis. Lancet. 2019;394:1816&#x2013;1826. doi: 10.1016/S0140-6736(19)32317-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32317-7</ArticleId><ArticleId IdType="pmc">PMC6924620</ArticleId><ArticleId IdType="pubmed">31668726</ArticleId></ArticleIdList></Reference><Reference><Citation>Requena G., Douglas I.J., Huerta C., de Abajo F. Impact of pre-exposure time bias in self-controlled case series when the event conditions the exposure: Hip/femur fracture and use of benzodiazepines as a case study. Pharmacoepidemiol. Drug Saf. 2020;29:388&#x2013;395. doi: 10.1002/pds.4959.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pds.4959</ArticleId><ArticleId IdType="pubmed">31923351</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S.O., Jung C.H., Song Y.D., Park C.Y., Kwon H.S., Cha B.S., Park J.Y., Lee K.U., Ko K.S., Lee B.W. Background and data configuration process of a nationwide population-based study using the korean national health insurance system. Diabetes Metab. J. 2014;38:395&#x2013;403. doi: 10.4093/dmj.2014.38.5.395.</Citation><ArticleIdList><ArticleId IdType="doi">10.4093/dmj.2014.38.5.395</ArticleId><ArticleId IdType="pmc">PMC4209354</ArticleId><ArticleId IdType="pubmed">25349827</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.H., Han K., Ko S.H., Ko K.S., Lee K.U. Data Analytic Process of a Nationwide Population-Based Study Using National Health Information Database Established by National Health Insurance Service. Diabetes Metab. J. 2016;40:79&#x2013;82. doi: 10.4093/dmj.2016.40.1.79.</Citation><ArticleIdList><ArticleId IdType="doi">10.4093/dmj.2016.40.1.79</ArticleId><ArticleId IdType="pmc">PMC4768054</ArticleId><ArticleId IdType="pubmed">26912157</ArticleId></ArticleIdList></Reference><Reference><Citation>You S.C., Lee S., Cho S.Y., Park H., Jung S., Cho J., Yoon D., Park R.W. Conversion of National Health Insurance Service-National Sample Cohort (NHIS-NSC) Database into Observational Medical Outcomes Partnership-Common Data Model (OMOP-CDM) Stud. Health Technol. Inform. 2017;245:467&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">29295138</ArticleId></ArticleIdList></Reference><Reference><Citation>Hripcsak G., Duke J.D., Shah N.H., Reich C.G., Huser V., Schuemie M.J., Suchard M.A., Park R.W., Wong I.C., Rijnbeek P.R., et al. Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. Stud. Health Technol. Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo S.I., Park C.H., You S.C., Kim J.Y., Lee K.J., Kim J., Kim Y., Yoo J.J., Seo W.W., Lee H.S., et al. Association between proton pump inhibitor use and gastric cancer: A population-based cohort study using two different types of nationwide databases in Korea. Gut. 2021;70:2066&#x2013;2075. doi: 10.1136/gutjnl-2020-323845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323845</ArticleId><ArticleId IdType="pubmed">33975868</ArticleId></ArticleIdList></Reference><Reference><Citation>Park D.H., Seo S.I., Lee K.J., Kim J., Kim Y., Seo W.W., Lee H.S., Shin W.G., Yoo J.J. Long-term proton pump inhibitor use and risk of osteoporosis and hip fractures: A nationwide population-based and multicenter cohort study using a common data model. J. Gastroenterol. Hepatol. 2022;37:1534&#x2013;1543. doi: 10.1111/jgh.15879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15879</ArticleId><ArticleId IdType="pubmed">35501296</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo S.I., Park C.H., Kim T.J., Bang C.S., Kim J.Y., Lee K.J., Kim J., Kim H.H., You S.C., Shin W.G. Aspirin, metformin, and statin use on the risk of gastric cancer: A nationwide population-based cohort study in Korea with systematic review and meta-analysis. Cancer Med. 2022;11:1217&#x2013;1231. doi: 10.1002/cam4.4514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cam4.4514</ArticleId><ArticleId IdType="pmc">PMC8855895</ArticleId><ArticleId IdType="pubmed">34970858</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37769828</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>146</Volume><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Introducing the BlendedICU dataset, the first harmonized, international intensive care dataset.</ArticleTitle><Pagination><StartPage>104502</StartPage><MedlinePgn>104502</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2023.104502</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(23)00223-X</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study introduces the BlendedICU dataset, a massive dataset of international intensive care data. This dataset aims to facilitate generalizability studies of machine learning models, as well as statistical studies of clinical practices in the intensive care units.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Four publicly available and patient-level intensive care databases were used as source databases. A unique and customizable preprocessing pipeline extracted clinically relevant patient-related variables from each source database. The variables were then harmonized and standardized to the Observational Medical Outcomes Partnership (OMOP) Common Data Format. Finally, a brief comparison was carried out to explore differences in the source databases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The BlendedICU dataset features 41 timeseries variables as well as the exposure times to 113 active ingredients extracted from the AmsterdamUMCdb, eICU, HiRID, and MIMIC-IV databases. This resulted in a database of more than 309000 intensive care admissions, spanning over 13 years and three countries. We found that data collection, drug exposure, and patient outcomes varied strongly between source databases.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The variability in data collection, drug exposure, and patient outcomes between the source databases indicated some dissimilarity in patient phenotypes and clinical practices between different intensive care units. This demonstrated the need for generalizability studies of machine learning models. This study provides the clinical data research community with essential data to build efficient and generalizable machine learning models, as well as to explore clinical practices in intensive care units around the world.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oliver</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Methodological Support Unit, Reunion University Hospital, La R&#xe9;union, France; Clinical Informatics Department, Reunion University Hospital, La R&#xe9;union, France. Electronic address: matthieu.oliver@chu-reunion.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allyn</LastName><ForeName>J&#xe9;r&#xf4;me</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Methodological Support Unit, Reunion University Hospital, La R&#xe9;union, France; Intensive Care Unit, Reunion University Hospital, La R&#xe9;union, France; Clinical Informatics Department, Reunion University Hospital, La R&#xe9;union, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carencotte</LastName><ForeName>R&#xe9;mi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Methodological Support Unit, Reunion University Hospital, La R&#xe9;union, France; Clinical Informatics Department, Reunion University Hospital, La R&#xe9;union, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allou</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Methodological Support Unit, Reunion University Hospital, La R&#xe9;union, France; Intensive Care Unit, Reunion University Hospital, La R&#xe9;union, France; Clinical Informatics Department, Reunion University Hospital, La R&#xe9;union, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferdynus</LastName><ForeName>Cyril</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Methodological Support Unit, Reunion University Hospital, La R&#xe9;union, France; Clinical Informatics Department, Reunion University Hospital, La R&#xe9;union, France; Clinical Research Department, INSERM CIC1410, F-97410, La R&#xe9;union, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Data integration</Keyword><Keyword MajorTopicYN="N">Intensive care unit database</Keyword><Keyword MajorTopicYN="N">OMOP common data format</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>19</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37769828</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2023.104502</ArticleId><ArticleId IdType="pii">S1532-0464(23)00223-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37774908</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0480</ISSN><JournalIssue CitedMedium="Internet"><Volume>147</Volume><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of biomedical informatics</Title><ISOAbbreviation>J Biomed Inform</ISOAbbreviation></Journal><ArticleTitle>Evaluation of OMOP CDM, i2b2 and ICGC ARGO for supporting data harmonization in a breast cancer use case of a multicentric European AI project.</ArticleTitle><Pagination><StartPage>104505</StartPage><MedlinePgn>104505</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbi.2023.104505</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1532-0464(23)00226-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Observational research in cancer poses great challenges regarding adequate data sharing and consolidation based on a homogeneous data semantic base. Common Data Models (CDMs) can help consolidate health data repositories from different institutions minimizing loss of meaning by organizing data into a standard structure. This study aims to evaluate the performance of the Observational Medical Outcomes Partnership (OMOP) CDM, Informatics for Integrating Biology &amp; the Bedside (i2b2) and International Cancer Genome Consortium, Accelerating Research in Genomic Oncology (ICGC ARGO) for representing non-imaging data in a breast cancer use case of EuCanImage.</AbstractText><AbstractText Label="METHODS">We used ontologies to represent metamodels of OMOP, i2b2, and ICGC ARGO and variables used in a cancer use case of a European AI project. We selected four evaluation criteria for the CDMs adapted from previous research: content coverage, simplicity, integration, implementability.</AbstractText><AbstractText Label="RESULTS">i2b2 and OMOP exhibited higher element completeness (100% each) than ICGC ARGO (58.1%), while the three achieved 100% domain completeness. ICGC ARGO normalizes only one of our variables with a standard terminology, while i2b2 and OMOP use standardized vocabularies for all of them. In terms of simplicity, ICGC ARGO and i2b2 proved to be simpler both in terms of ontological model (276 and 175 elements, respectively) and in the queries (7 and 20 lines of code, respectively), while OMOP required a much more complex ontological model (615 elements) and queries similar to those of i2b2 (20 lines). Regarding implementability, OMOP had the highest number of mentions in articles in PubMed (130) and Google Scholar (1,810), ICGC ARGO had the highest number of updates to the CDM since 2020 (4), and i2b2 is the model with more tools specifically developed for the CDM (26).</AbstractText><AbstractText Label="CONCLUSION">ICGC ARGO proved to be rigid and very limited in the representation of oncologic concepts, while i2b2 and OMOP showed a very good performance. i2b2's lack of a common dictionary hinders its scalability, requiring sites that will share data to explicitly define a conceptual framework, and suggesting that OMOP and its Oncology extension could be the more suitable choice. Future research employing these CDMs with actual datasets is needed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Frid</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Informatics Service, Hospital Cl&#xed;nic de Barcelona, Villarroel 170, 08036 Barcelona, Spain. Electronic address: https://twitter.com/santifrik.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bracons Cuc&#xf3;</LastName><ForeName>Guillem</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3; de Recerca Cl&#xed;nic Barcelona - Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer, Rossell&#xf3; 149-153, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil Rojas</LastName><ForeName>Jessyca</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinical Informatics Service, Hospital Cl&#xed;nic de Barcelona, Villarroel 170, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Rueda</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Informatics Service, Hospital Cl&#xed;nic de Barcelona, Villarroel 170, 08036 Barcelona, Spain; Radiology Service, Hospital Cl&#xed;nic de Barcelona, Villarroel 170, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastor Duran</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Clinical Informatics Service, Hospital Cl&#xed;nic de Barcelona, Villarroel 170, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-S&#xe1;ez</LastName><ForeName>Olga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Oncology Service, Hospital Cl&#xed;nic de Barcelona, Villarroel 170, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lozano-Rub&#xed;</LastName><ForeName>Raimundo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Oncology Service, Hospital Cl&#xed;nic de Barcelona, Villarroel 170, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biomed Inform</MedlineTA><NlmUniqueID>100970413</NlmUniqueID><ISSNLinking>1532-0464</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="N">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="N">Genomics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Health information interoperability</Keyword><Keyword MajorTopicYN="N">Health research</Keyword><Keyword MajorTopicYN="N">I2b2</Keyword><Keyword MajorTopicYN="N">ICGC ARGO</Keyword><Keyword MajorTopicYN="N">OMOP CDM</Keyword><Keyword MajorTopicYN="N">Secondary use of health data</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37774908</ArticleId><ArticleId IdType="doi">10.1016/j.jbi.2023.104505</ArticleId><ArticleId IdType="pii">S1532-0464(23)00226-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37794003</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>06</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2052-4463</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>04</Day></PubDate></JournalIssue><Title>Scientific data</Title><ISOAbbreviation>Sci Data</ISOAbbreviation></Journal><ArticleTitle>Scalable Infrastructure Supporting Reproducible Nationwide Healthcare Data Analysis toward FAIR Stewardship.</ArticleTitle><Pagination><StartPage>674</StartPage><MedlinePgn>674</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">674</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41597-023-02580-7</ELocationID><Abstract><AbstractText>Transparent and FAIR disclosure of meta-information about healthcare data and infrastructure is essential but has not been well publicized. In this paper, we provide a transparent disclosure of the process of standardizing a common data model and developing a national data infrastructure using national claims data. We established an Observational Medical Outcome Partnership (OMOP) common data model database for national claims data of the Health Insurance Review and Assessment Service of South Korea. To introduce a data openness policy, we built a distributed data analysis environment and released metadata based on the FAIR principle. A total of 10,098,730,241 claims and 56,579,726 patients' data were converted as OMOP common data model. We also built an analytics environment for distributed research and made the metadata publicly available. Disclosure of this infrastructure to researchers will help to eliminate information inequality and contribute to the generation of high-quality medical evidence.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Kim</LastName><ForeName>Ji-Woo</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Big Data Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kim</LastName><ForeName>Chungsoo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1802-1777</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Kyoung-Hoon</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Review and Assessment Research Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yujin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Review and Assessment Research Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Dong Han</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Big Data Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yun</LastName><ForeName>Jeongwon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Big Data Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baek</LastName><ForeName>Hyeran</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Big Data Department, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Rae Woong</ForeName><Initials>RW</Initials><Identifier Source="ORCID">0000-0003-4989-3287</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, Ajou University Graduate School of Medicine, Suwon, Republic of Korea. veritas@ajou.ac.kr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, Republic of Korea. veritas@ajou.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>You</LastName><ForeName>Seng Chan</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-5052-6399</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea. chandryou@yuhs.ac.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institution for Innovation in Digital Healthcare, Yonsei University, Seoul, Republic of Korea. chandryou@yuhs.ac.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Data</MedlineTA><NlmUniqueID>101640192</NlmUniqueID><ISSNLinking>2052-4463</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>RWP reports grants from the Ministry of Trade, Industry &amp; Energy (MOTIE, Korea) and the Ministry of Health &amp; Welfare (Korea). SCY reports being CTO of PHI Digital Healthcare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>1</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37794003</ArticleId><ArticleId IdType="pmc">PMC10550904</ArticleId><ArticleId IdType="doi">10.1038/s41597-023-02580-7</ArticleId><ArticleId IdType="pii">10.1038/s41597-023-02580-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schneeweiss S. Learning from Big Health Care Data. New England Journal of Medicine. 2014;370:2161&#x2013;2163. doi: 10.1056/NEJMp1401111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1401111</ArticleId><ArticleId IdType="pubmed">24897079</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, Krumholz HM. The Evolution of Evidence-Based Medicine: When the Magic of the Randomized Clinical Trial Meets Real-World Data. Circulation. 2022;145:107&#x2013;109. doi: 10.1161/CIRCULATIONAHA.121.057931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.057931</ArticleId><ArticleId IdType="pubmed">35007161</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo-Ciganic W-H, et al. Developing and validating a machine-learning algorithm to predict opioid overdose in Medicaid beneficiaries in two US states: a prognostic modelling study. The Lancet Digital Health. 2022;4:e455&#x2013;e465. doi: 10.1016/S2589-7500(22)00062-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00062-0</ArticleId><ArticleId IdType="pmc">PMC9236281</ArticleId><ArticleId IdType="pubmed">35623798</ArticleId></ArticleIdList></Reference><Reference><Citation>Nosrati E. Harnessing administrative data to study health inequality. The Lancet Public Health. 2022;7:e726&#x2013;e727. doi: 10.1016/S2468-2667(22)00172-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(22)00172-4</ArticleId><ArticleId IdType="pubmed">35907411</ArticleId></ArticleIdList></Reference><Reference><Citation>Portuondo JI, Harris AHS, Massarweh NN. Using Administrative Codes to Measure Health Care Quality. JAMA. 2022;328:825&#x2013;826. doi: 10.1001/jama.2022.12823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.12823</ArticleId><ArticleId IdType="pubmed">35904795</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarrazin MSV, Rosenthal GE. Finding Pure and Simple Truths With Administrative Data. JAMA. 2012;307:1433&#x2013;1435. doi: 10.1001/jama.2012.404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.404</ArticleId><ArticleId IdType="pubmed">22474208</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J-A, Yoon S, Kim L-Y, Kim D-S. Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data. J Korean Med Sci. 2017;32:718&#x2013;728. doi: 10.3346/jkms.2017.32.5.718.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2017.32.5.718</ArticleId><ArticleId IdType="pmc">PMC5383602</ArticleId><ArticleId IdType="pubmed">28378543</ArticleId></ArticleIdList></Reference><Reference><Citation>Suissa S, Garbe E. Primer: administrative health databases in observational studies of drug effects&#x2014;advantages and disadvantages. Nature Clinical Practice Rheumatology. 2007;3:725&#x2013;732. doi: 10.1038/ncprheum0652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncprheum0652</ArticleId><ArticleId IdType="pubmed">18037932</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbusch PJM, Oostenbrink JB, Zuurbier JJ, Schaepkens FJM. The risk of upcoding in casemix systems: A comparative study. Health Policy. 2007;81:289&#x2013;299. doi: 10.1016/j.healthpol.2006.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healthpol.2006.06.002</ArticleId><ArticleId IdType="pubmed">16908086</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, Lee S, Choi B, Park RW. Establishment of an International Evidence Sharing Network Through Common Data Model for Cardiovascular Research. Korean Circ J. 2022;52:853&#x2013;864. doi: 10.4070/kcj.2022.0294.</Citation><ArticleIdList><ArticleId IdType="doi">10.4070/kcj.2022.0294</ArticleId><ArticleId IdType="pmc">PMC9742390</ArticleId><ArticleId IdType="pubmed">36478647</ArticleId></ArticleIdList></Reference><Reference><Citation>Rho Y, et al. COVID-19 International Collaborative Research by the Health Insurance Review and Assessment Service Using Its Nationwide Real-world Data: Database, Outcomes, and Implications. J Prev Med Public Health. 2021;54:8&#x2013;16. doi: 10.3961/jpmph.20.616.</Citation><ArticleIdList><ArticleId IdType="doi">10.3961/jpmph.20.616</ArticleId><ArticleId IdType="pmc">PMC7939755</ArticleId><ArticleId IdType="pubmed">33618494</ArticleId></ArticleIdList></Reference><Reference><Citation>Burn E, et al. Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nature Communications. 2020;11:5009. doi: 10.1038/s41467-020-18849-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18849-z</ArticleId><ArticleId IdType="pmc">PMC7538555</ArticleId><ArticleId IdType="pubmed">33024121</ArticleId></ArticleIdList></Reference><Reference><Citation>You SC, et al. Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. JAMA. 2020;324:1640&#x2013;1650. doi: 10.1001/jama.2020.16167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.16167</ArticleId><ArticleId IdType="pmc">PMC7592033</ArticleId><ArticleId IdType="pubmed">33107944</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson MD, et al. The FAIR Guiding Principles for scientific data management and stewardship. Scientific Data. 2016;3:160018. doi: 10.1038/sdata.2016.18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sdata.2016.18</ArticleId><ArticleId IdType="pmc">PMC4792175</ArticleId><ArticleId IdType="pubmed">26978244</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams RD, et al. Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network. BMC Medical Research Methodology. 2022;22:35. doi: 10.1186/s12874-022-01505-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-022-01505-z</ArticleId><ArticleId IdType="pmc">PMC8801189</ArticleId><ArticleId IdType="pubmed">35094685</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkel D. Docker: lightweight Linux containers for consistent development and deployment. Linux J. 2014;2014:Article 2. doi: 10.5555/2600239.2600241.</Citation><ArticleIdList><ArticleId IdType="doi">10.5555/2600239.2600241</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacketer C, Defalco FJ, Ryan PB, Rijnbeek PR. Increasing trust in real-world evidence through evaluation of observational data quality. Journal of the American Medical Informatics Association. 2021;28:2251&#x2013;2257. doi: 10.1093/jamia/ocab132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocab132</ArticleId><ArticleId IdType="pmc">PMC8449628</ArticleId><ArticleId IdType="pubmed">34313749</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford, H. &amp; Noorden, R. V. in Nature (Nature, 2020).</Citation></Reference><Reference><Citation>Ioannidis JPA. Why Most Published Research Findings Are False. PLOS Medicine. 2005;2:e124. doi: 10.1371/journal.pmed.0020124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0020124</ArticleId><ArticleId IdType="pmc">PMC1182327</ArticleId><ArticleId IdType="pubmed">16060722</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanelli D. How Many Scientists Fabricate and Falsify Research? A Systematic Review and Meta-Analysis of Survey Data. PLOS ONE. 2009;4:e5738. doi: 10.1371/journal.pone.0005738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005738</ArticleId><ArticleId IdType="pmc">PMC2685008</ArticleId><ArticleId IdType="pubmed">19478950</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyakawa T. No raw data, no science: another possible source of the reproducibility crisis. Molecular Brain. 2020;13:24. doi: 10.1186/s13041-020-0552-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-020-0552-2</ArticleId><ArticleId IdType="pmc">PMC7033918</ArticleId><ArticleId IdType="pubmed">32079532</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendel MA, et al. The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment. Journal of the American Medical Informatics Association. 2021;28:427&#x2013;443. doi: 10.1093/jamia/ocaa196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa196</ArticleId><ArticleId IdType="pmc">PMC7454687</ArticleId><ArticleId IdType="pubmed">32805036</ArticleId></ArticleIdList></Reference><Reference><Citation>Puttmann D, et al. Assessing the FAIRness of databases on the EHDEN portal: A case study on two Dutch ICU databases. International Journal of Medical Informatics. 2023;176:105104. doi: 10.1016/j.ijmedinf.2023.105104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2023.105104</ArticleId><ArticleId IdType="pubmed">37267810</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlett P, Kjaer J, Broich K, Cooke E. Real-World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value. Clinical pharmacology and therapeutics. 2022;111:21&#x2013;23. doi: 10.1002/cpt.2479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.2479</ArticleId><ArticleId IdType="pmc">PMC9299492</ArticleId><ArticleId IdType="pubmed">34797920</ArticleId></ArticleIdList></Reference><Reference><Citation>Seong Y, et al. Incorporation of Korean Electronic Data Interchange Vocabulary into Observational Medical Outcomes Partnership Vocabulary. Healthc Inform Res. 2021;27:29&#x2013;38. doi: 10.4258/hir.2021.27.1.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.4258/hir.2021.27.1.29</ArticleId><ArticleId IdType="pmc">PMC7921574</ArticleId><ArticleId IdType="pubmed">33611874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko SH, et al. Past and Current Status of Adult Type 2 Diabetes Mellitus Management in Korea: A National Health Insurance Service Database Analysis. Diabetes Metab J. 2018;42:93&#x2013;100. doi: 10.4093/dmj.2018.42.2.93.</Citation><ArticleIdList><ArticleId IdType="doi">10.4093/dmj.2018.42.2.93</ArticleId><ArticleId IdType="pmc">PMC5911525</ArticleId><ArticleId IdType="pubmed">29676539</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37811595</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-828X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Personalized medicine</Title><ISOAbbreviation>Per Med</ISOAbbreviation></Journal><ArticleTitle>Cloud-based digital healthcare development for precision medical hospital information system.</ArticleTitle><Pagination><StartPage>435</StartPage><EndPage>444</EndPage><MedlinePgn>435-444</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2217/pme-2023-0074</ELocationID><Abstract><AbstractText><b>Aim:</b> This study aims to develop a cloud-based digital healthcare system for precision medical hospital information systems (P-HIS). <b>Methods:</b> In 2020, international standardization of P-HIS clinical terms and codes was performed. In 2021, South Korea's first tertiary hospital cloud was established and implemented successfully. <b>Results:</b> P-HIS was applied at Korea's first tertiary general hospital. Common data model-compatible precision medicine/medical service solutions were developed for medical support. Ultrahigh-quality medical data for precision medicine were acquired and built using big data. Joint global commercialization and dissemination/spreading were achieved using the P-HIS consortium and global common data model-based observational medical outcome partnership network. <b>Conclusion:</b> To provide personalized precision medical services in the future, establishing and using big medical data is essential.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>SeJun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6332-107X</Identifier><AffiliationInfo><Affiliation>Human Behavior &amp; Genetic Institute, Associate Research Center, Korea University, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Hyung Joon</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0000-0003-1846-8464</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Korea University of College of Medicine, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sohn</LastName><ForeName>Jang Wook</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0003-4792-0456</Identifier><AffiliationInfo><Affiliation>Division of Infectious Disease, Department of Internal Medicine, Korea University College of Medicine, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sangsoo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Global Sport Studies, Korea University Sejong Campus, Sejong, 30019, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Jin Su</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-8263-0852</Identifier><AffiliationInfo><Affiliation>Human Behavior &amp; Genetic Institute, Associate Research Center, Korea University, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seong</LastName><ForeName>Jiwon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Korea University Medicine Center, Seoul, Biomedical Research Institute, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Huniverse, Seoul, 02566, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Kwang Jin</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Huniverse, Seoul, 02566, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sang Heon</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0003-0701-0028</Identifier><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Korea University Medical Center, Seoul, 02841, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>IITP-2023-2020-0-01819</GrantID><Agency>Ministry of Science and ICT, South Korea</Agency><Country/></Grant><Grant><GrantID>HR22C1302</GrantID><Agency>The Korea Health Industry Development Institute</Agency><Country/></Grant><Grant><GrantID>S1906-21-1001</GrantID><Agency>The Ministry of Science and ICT and the Ministry of Health and Welfare</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Per Med</MedlineTA><NlmUniqueID>101238549</NlmUniqueID><ISSNLinking>1741-0541</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067917" MajorTopicYN="Y">Cloud Computing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006751" MajorTopicYN="Y">Hospital Information Systems</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CDM</Keyword><Keyword MajorTopicYN="N">OMOP</Keyword><Keyword MajorTopicYN="N">P-HIS</Keyword><Keyword MajorTopicYN="N">digital health care</Keyword><Keyword MajorTopicYN="N">precision medical</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>9</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37811595</ArticleId><ArticleId IdType="doi">10.2217/pme-2023-0074</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>